PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Scarpa, A; Chang, DK; Nones, K; Corbo, V; Patch, AM; Bailey, P; Lawlor, RT; Johns, AL; Miller, DK; Mafficini, A; Rusev, B; Scardoni, M; Antonello, D; Barbi, S; Sikora, KO; Cingarlini, S; Vicentini, C; McKay, S; Quinn, MCJ; Bruxner, TJC; Christ, AN; Harliwong, I; Idrisoglu, S; McLean, S; Nourse, C; Nourbakhsh, E; Wilson, PJ; Anderson, MJ; Fink, JL; Newell, F; Waddell, N; Holmes, O; Kazakoff, SH; Leonard, C; Wood, S; Xu, QY; Nagaraj, SH; Amato, E; Dalai, I; Bersanif, S; Cataldo, I; Tos, APD; Capelli, P; Davi, MV; Landoni, L; Malpaga, A; Miotto, M; Whitehall, VLJ; Leggett, BA; Harris, JL; Harris, J; Jones, MD; Humphris, J; Chantrill, LA; Chin, V; Nagrial, AM; Pajic, M; Scarlett, CJ; Pinho, A; Rooman, I; Toon, C; Wu, JM; Pinese, M; Cowley, M; Barbour, A; Mawson, A; Humphrey, ES; Colvin, EK; Chou, A; Lovell, JA; Jamieson, NB; Duthie, F; Gingras, MC; Fisher, WE; Dagg, RA; Lau, LMS; Lee, M; Pickett, HA; Reddel, RR; Samra, JS; Kench, JG; Merrett, ND; Epari, K; Nguyen, NQ; Zeps, N; Falconi, M; Simbolo, M; Butturini, G; Van Buren, G; Partelli, S; Fassan, M; Khanna, KK; Gill, AJ; Wheeler, DA; Gibbs, RA; Musgrove, EA; Bassi, C; Tortora, G; Pederzoli, P; Pearson, JV; Waddell, N; Biankin, AV; Grimmond, SM				Scarpa, Aldo; Chang, David K.; Nones, Katia; Corbo, Vincenzo; Patch, Ann-Marie; Bailey, Peter; Lawlor, Rita T.; Johns, Amber L.; Miller, David K.; Mafficini, Andrea; Rusev, Borislav; Scardoni, Maria; Antonello, Davide; Barbi, Stefano; Sikora, Katarzyna O.; Cingarlini, Sara; Vicentini, Caterina; McKay, Skye; Quinn, Michael C. J.; Bruxner, Timothy J. C.; Christ, Angelika N.; Harliwong, Ivon; Idrisoglu, Senel; McLean, Suzanne; Nourse, Craig; Nourbakhsh, Ehsan; Wilson, Peter J.; Anderson, Matthew J.; Fink, J. Lynn; Newell, Felicity; Waddell, Nick; Holmes, Oliver; Kazakoff, Stephen H.; Leonard, Conrad; Wood, Scott; Xu, Qinying; Nagaraj, Shivashankar Hiriyur; Amato, Eliana; Dalai, Irene; Bersanif, Samantha; Cataldo, Ivana; Tos, Angelo P. Dei; Capelli, Paola; Davi, Maria Vittoria; Landoni, Luca; Malpaga, Anna; Miotto, Marco; Whitehall, Vicki L. J.; Leggett, Barbara A.; Harris, Janelle L.; Harris, Jonathan; Jones, Marc D.; Humphris, Jeremy; Chantrill, Lorraine A.; Chin, Venessa; Nagrial, Adnan M.; Pajic, Marina; Scarlett, Christopher J.; Pinho, Andreia; Rooman, Ilse; Toon, Christopher; Wu, Jianmin; Pinese, Mark; Cowley, Mark; Barbour, Andrew; Mawson, Amanda; Humphrey, Emily S.; Colvin, Emily K.; Chou, Angela; Lovell, Jessica A.; Jamieson, Nigel B.; Duthie, Fraser; Gingras, Marie-Claude; Fisher, William E.; Dagg, Rebecca A.; Lau, Loretta M. S.; Lee, Michael; Pickett, Hilda A.; Reddel, Roger R.; Samra, Jaswinder S.; Kench, James G.; Merrett, Neil D.; Epari, Krishna; Nguyen, Nam Q.; Zeps, Nikolajs; Falconi, Massimo; Simbolo, Michele; Butturini, Giovanni; Van Buren, George; Partelli, Stefano; Fassan, Matteo; Khanna, Kum Kum; Gill, Anthony J.; Wheeler, David A.; Gibbs, Richard A.; Musgrove, Elizabeth A.; Bassi, Claudio; Tortora, Giampaolo; Pederzoli, Paolo; Pearson, John V.; Waddell, Nicola; Biankin, Andrew V.; Grimmond, Sean M.		Australian Pancreatic Canc Genome	Whole-genome landscape of pancreatic neuroendocrine tumours	NATURE			English	Article							EWING SARCOMA; MUTATIONAL PROCESSES; MOLECULAR SUBTYPES; TP53 MUTATIONS; PATHWAY GENES; MTOR PATHWAY; CANCER; PROTEIN; TRANSLOCATION; SUPPRESSOR	The diagnosis of pancreatic neuroendocrine tumours (PanNETs) is increasing owing to more sensitive detection methods, and this increase is creating challenges for clinical management. We performed whole-genome sequencing of 102 primary PanNETs and defined the genomic events that characterize their pathogenesis. Here we describe the mutational signatures they harbour, including a deficiency in G: C > T: A base excision repair due to inactivation of MUTYH, which encodes a DNA glycosylase. Clinically sporadic PanNETs contain a larger-than-expected proportion of germline mutations, including previously unreported mutations in the DNA repair genes MUTYH, CHEK2 and BRCA2. Together with mutations in MEN1 and VHL, these mutations occur in 17% of patients. Somatic mutations, including point mutations and gene fusions, were commonly found in genes involved in four main pathways: chromatin remodelling, DNA damage repair, activation of mTOR signalling (including previously undescribed EWSR1 gene fusions), and telomere maintenance. In addition, our gene expression analyses identified a subgroup of tumours associated with hypoxia and HIF signalling.	[Scarpa, Aldo; Corbo, Vincenzo; Lawlor, Rita T.; Mafficini, Andrea; Rusev, Borislav; Sikora, Katarzyna O.; Vicentini, Caterina; Amato, Eliana; Dalai, Irene; Cataldo, Ivana; Simbolo, Michele; Fassan, Matteo] Univ & Hosp Trust Verona, IARC Net Ctr Appl Res Canc, I-37134 Verona, Italy; [Scarpa, Aldo; Corbo, Vincenzo; Lawlor, Rita T.; Scardoni, Maria; Barbi, Stefano; Amato, Eliana; Dalai, Irene; Bersanif, Samantha; Cataldo, Ivana; Capelli, Paola] Univ & Hosp Trust Verona, Dept Pathol & Diagnost, I-37134 Verona, Italy; [Chang, David K.; Bailey, Peter; Nourse, Craig; Jones, Marc D.; Jamieson, Nigel B.; Duthie, Fraser; Musgrove, Elizabeth A.; Biankin, Andrew V.] Univ Glasgow, Inst Canc Sci, Wolfson Wohl Canc Res Ctr, Garscube Estate,Switchback Rd, Glasgow G61 1QH, Lanark, Scotland; [Chang, David K.; Jamieson, Nigel B.; Biankin, Andrew V.] West Scotland Pancreat Unit, Glasgow Royal Infirm, Glasgow G31 2ER, Lanark, Scotland; [Chang, David K.; Johns, Amber L.; McKay, Skye; Humphris, Jeremy; Chantrill, Lorraine A.; Chin, Venessa; Nagrial, Adnan M.; Pajic, Marina; Scarlett, Christopher J.; Pinho, Andreia; Rooman, Ilse; Toon, Christopher; Wu, Jianmin; Pinese, Mark; Cowley, Mark; Mawson, Amanda; Humphrey, Emily S.; Colvin, Emily K.; Chou, Angela; Lovell, Jessica A.; Kench, James G.; Gill, Anthony J.; Biankin, Andrew V.] Univ New South Wales, Garvan Inst Med Res, Canc Div, Kinghorn Canc Ctr, 384 Victoria St,Sydney, Darlinghurst, NSW, Australia; [Chang, David K.; Merrett, Neil D.; Biankin, Andrew V.] Bankstown Hosp, Dept Surg, Eldridge Rd, Sydney, NSW, Australia; [Chang, David K.; Biankin, Andrew V.] Univ New South Wales, South Western Sydney Clin Sch, Fac Med, Liverpool, NSW 2170, Australia; [Nones, Katia; Patch, Ann-Marie; Quinn, Michael C. J.; Newell, Felicity; Holmes, Oliver; Kazakoff, Stephen H.; Leonard, Conrad; Wood, Scott; Xu, Qinying; Whitehall, Vicki L. J.; Leggett, Barbara A.; Harris, Janelle L.; Khanna, Kum Kum; Pearson, John V.; Waddell, Nicola] QIMR Berghofer Med Res Inst, Herston, Qld, Australia; [Nones, Katia; Patch, Ann-Marie; Bailey, Peter; Miller, David K.; Quinn, Michael C. J.; Bruxner, Timothy J. C.; Christ, Angelika N.; Harliwong, Ivon; Idrisoglu, Senel; McLean, Suzanne; Nourse, Craig; Nourbakhsh, Ehsan; Wilson, Peter J.; Anderson, Matthew J.; Fink, J. Lynn; Newell, Felicity; Waddell, Nick; Holmes, Oliver; Kazakoff, Stephen H.; Leonard, Conrad; Wood, Scott; Xu, Qinying; Nagaraj, Shivashankar Hiriyur; Pearson, John V.; Waddell, Nicola] Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, St Lucia, Qld, Australia; [Antonello, Davide; Landoni, Luca; Malpaga, Anna; Miotto, Marco; Falconi, Massimo; Butturini, Giovanni; Partelli, Stefano; Bassi, Claudio; Pederzoli, Paolo] Univ & Hosp Trust Verona, Pancreas Inst, Dept Surg, I-37134 Verona, Italy; [Cingarlini, Sara; Tortora, Giampaolo] Univ & Hosp Trust Verona, Med Oncol, Verona, Italy; [Tos, Angelo P. Dei] Univ Padua, Gen Hosp Treviso, Dept Med, Padua, Italy; Univ Padua, Dept Med, Padua, Italy; [Davi, Maria Vittoria] Univ & Hosp Trust Verona, Endocrinol Sect, Dept Med, Verona, Italy; [Whitehall, Vicki L. J.; Leggett, Barbara A.] Univ Queensland, Sch Med, Brisbane, Qld 4006, Australia; [Whitehall, Vicki L. J.] Pathol Queensland, Brisbane, Qld 4006, Australia; [Leggett, Barbara A.] Royal Brisbane & Womens Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld 4006, Australia; [Harris, Jonathan] Queensland Univ Technol, Inst Hlth Biomed Innovat, Brisbane, Qld, Australia; [Scarlett, Christopher J.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW 2258, Australia; [Wu, Jianmin] Key Lab Carcinogenesis & Translat Res Minist Educ, Peking Univ Canc Hosp Inst, Ctr Canc Bioinformat, Beijing 100142, Peoples R China; [Barbour, Andrew] Princess Alexandra Hosp, Dept Surg, Ipswich Rd, Brisbane, Qld 4102, Australia; [Chou, Angela] Dept Anat Pathol St Vincents Hosp, Sydney, NSW 2010, Australia; [Jamieson, Nigel B.] Univ Glasgow, Sch Med, Coll Med, Acad Surg Unit, Glasgow G4 OSF, Lanark, Scotland; [Duthie, Fraser] Queen Elizabeth Univ Hosp, Greater Glasgow Clyde NHS, Dept Pathol, Glasgow G51 4TF, Lanark, Scotland; [Gingras, Marie-Claude; Wheeler, David A.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Dept Mol & Human Genet, 1 Baylor Plaza, MS226, Houston, TX 77030 USA; [Gingras, Marie-Claude; Fisher, William E.; Van Buren, George] Michael DeBakey Dept Surg & Elkins Pancreas Ctr, Baylor Coll Med, 1 Baylor Plaza, Houston, TX 77030 USA; [Dagg, Rebecca A.; Lau, Loretta M. S.] Childrens Hosp, Westmead, NSW 2145, Australia; [Lee, Michael; Pickett, Hilda A.; Reddel, Roger R.] Univ Sydney, Med Res Inst, Westmead, NSW, Australia; [Samra, Jaswinder S.] Royal N Shore Hosp, Dept Surg, St Leonards, NSW, Australia; [Samra, Jaswinder S.; Kench, James G.; Gill, Anthony J.] Univ Sydney, New South Wales 2006, Sydney, NSW 2006, Australia; [Kench, James G.] Royal Prince Alfred Hosp, Tissue Pathol & Diagnost Oncol, Camperdown, NSW 2050, Australia; [Merrett, Neil D.] Univ Western Sydney, Sch Med, Penrith, NSW 2175, Australia; [Epari, Krishna] Fremantle Hosp, Dept Surg, Alma St, Fremantle, WA 6160, Australia; [Nguyen, Nam Q.] Royal Adelaide Hosp, Dept Gastroenterol, N Terrace, Adelaide, SA 5000, Australia; [Zeps, Nikolajs] Univ Western Australia, Sch Surg, M507, 35 Stirling Highway, Nedlands, WA 6009, Australia; [Zeps, Nikolajs] St John God Pathol, 12 Salvado Rd, Subiaco, WA 6008, Australia; [Zeps, Nikolajs] St John God Subiaco Hosp, Bendat Family Comprehens Canc Ctr, Subiaco, WA 6008, Australia; [Grimmond, Sean M.] Univ Melbourne, Univ Melbourne Ctr Canc Res, Victoria, Melbourne 3010, Australia; [Rooman, Ilse] Vrije Univ Brussel, Oncol Res Ctr, Brussels, Belgium; Pancreat Canc Translat Res Grp, Adult Canc Program, Lowy Canc Res Ctr, Prince Wales Clin Sch, Sydney, NSW, Australia	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Glasgow; University of Glasgow; Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney; QIMR Berghofer Medical Research Institute; University of Queensland; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Padua; University of Padua; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Queensland; Royal Brisbane & Women's Hospital; Queensland University of Technology (QUT); University of Newcastle; Peking University; University of Glasgow; Queen Elizabeth University Hospital (QEUH); Baylor College of Medicine; Baylor College of Medicine; University of Sydney; University of Sydney; Royal North Shore Hospital; University of Sydney; University of Sydney; Western Sydney University; Royal Adelaide Hospital; University of Western Australia; St John of God Health Care; St John of God Health Care; University of Melbourne; Vrije Universiteit Brussel	Scarpa, A (corresponding author), Univ & Hosp Trust Verona, IARC Net Ctr Appl Res Canc, I-37134 Verona, Italy.; Scarpa, A (corresponding author), Univ & Hosp Trust Verona, Dept Pathol & Diagnost, I-37134 Verona, Italy.; Biankin, AV (corresponding author), Univ Glasgow, Inst Canc Sci, Wolfson Wohl Canc Res Ctr, Garscube Estate,Switchback Rd, Glasgow G61 1QH, Lanark, Scotland.; Biankin, AV (corresponding author), West Scotland Pancreat Unit, Glasgow Royal Infirm, Glasgow G31 2ER, Lanark, Scotland.; Biankin, AV (corresponding author), Univ New South Wales, Garvan Inst Med Res, Canc Div, Kinghorn Canc Ctr, 384 Victoria St,Sydney, Darlinghurst, NSW, Australia.; Biankin, AV (corresponding author), Bankstown Hosp, Dept Surg, Eldridge Rd, Sydney, NSW, Australia.; Biankin, AV (corresponding author), Univ New South Wales, South Western Sydney Clin Sch, Fac Med, Liverpool, NSW 2170, Australia.; Biankin, AV (corresponding author), QIMR Berghofer Med Res Inst, Herston, Qld, Australia.; Grimmond, SM (corresponding author), Univ Melbourne, Univ Melbourne Ctr Canc Res, Victoria, Melbourne 3010, Australia.	aldo.scarpa@univr.it; andrew.biankin@glasgow.ac.uk; sean.grimmond@unimelb.edu.au	Merrett, Neil/ABB-4342-2021; Reddel, Roger R/A-6635-2014; Leonard, Conrad/AAD-2587-2020; Wheeler, David A/M-9740-2018; Tortora, Giampaolo/AAA-1252-2019; Gill, Anthony/D-4215-2015; Chantrill, Lorraine/GXF-5117-2022; Pearson, John/AAT-4211-2020; cingarlini, sara/ABB-5280-2020; Waddell, Nicola/H-4929-2015; Butturini, Giovanni/B-5567-2017; Merrett, Neil/H-8033-2019; Newell, Felicity/AAN-1253-2020; Fink, Lynn/C-2031-2008; Partelli, Stefano/K-3787-2018; scarpa, aldo/K-6832-2016; Patch, Ann-Marie/C-4201-2018; Jamieson, Nigel/X-1071-2019; Grimmond, Sean/K-3246-2019; Lau, Loretta MS/B-1565-2008; Nones, Katia/AAX-6453-2021; Mafficini, Andrea/AAK-8158-2020; Cingarlini, Sara/AAJ-5263-2021; Zeps, Nikolajs/AAF-3186-2021; Gill, Anthony J./M-5015-2019; Falconi, Massimo/K-2194-2016; Simbolo, Michele/AAB-1851-2019; Whitehall, Vicki/E-5414-2019; Cowley, Mark/K-8731-2019; Dei Tos, Angelo/AAN-3244-2020; Whitehall, Vicki/B-6262-2013; Corbo, Vincenzo/J-7754-2016; Fassan, Matteo/F-5152-2012; Wu, Jianmin/G-3629-2010	Merrett, Neil/0000-0002-8370-0293; Reddel, Roger R/0000-0002-6302-6107; Leonard, Conrad/0000-0002-4131-2065; Wheeler, David A/0000-0002-9056-6299; Gill, Anthony/0000-0002-9447-1967; Waddell, Nicola/0000-0002-3950-2476; Butturini, Giovanni/0000-0002-9172-4885; Merrett, Neil/0000-0002-8370-0293; Fink, Lynn/0000-0003-2912-6048; Partelli, Stefano/0000-0001-8938-6170; scarpa, aldo/0000-0003-1678-739X; Patch, Ann-Marie/0000-0001-6121-4019; Jamieson, Nigel/0000-0002-9552-4725; Grimmond, Sean/0000-0002-8102-7998; Lau, Loretta MS/0000-0002-3172-0970; Nones, Katia/0000-0003-1925-5196; Mafficini, Andrea/0000-0002-7471-3121; Cingarlini, Sara/0000-0003-4786-4781; Zeps, Nikolajs/0000-0002-6404-6839; Falconi, Massimo/0000-0001-9654-7243; Simbolo, Michele/0000-0002-0866-4499; Cowley, Mark/0000-0002-9519-5714; Dei Tos, Angelo/0000-0002-1228-8940; Pajic, Marina/0000-0002-3871-3829; Scarlett, Christopher/0000-0002-4140-7785; Bailey, Peter/0000-0002-0857-2041; SALVIA, Roberto/0000-0002-3514-8473; Landoni, Luca/0000-0002-2474-3496; Harris, Jonathan/0000-0003-4209-2380; Chantrill, Lorraine/0000-0002-5790-0208; Whitehall, Vicki/0000-0002-8285-2391; Colvin, Emily/0000-0002-5435-5902; Rooman, Ilse/0000-0001-7264-2246; Corbo, Vincenzo/0000-0002-6340-8009; Pearson, John/0000-0003-0904-4598; Pinho, Andreia V./0000-0003-0647-4015; Chang, David/0000-0002-4821-3078; Fassan, Matteo/0000-0001-6515-5482; Barbour, Andrew/0000-0002-0991-7662; Pinese, Mark/0000-0001-5078-6687; Chou, Angela/0000-0001-9212-6927; Lee, Michael/0000-0002-0186-4439; Biankin, Andrew/0000-0002-0362-5597; Kench, James Geoffrey/0000-0001-8687-4988; Jones, Marc/0000-0002-3078-8359; Khanna, Kum Kum/0000-0001-8650-5381; CATALDO, Ivana/0000-0003-2032-2085; Wu, Jianmin/0000-0002-8876-128X; Leggett, Barbara/0000-0003-2062-7380; Chin, Venessa/0000-0002-4630-4451; Bruxner, Timothy/0000-0002-8088-316X; Dagg, Rebecca/0000-0002-3023-9616; lawlor, Rita/0000-0003-3160-0634; Hancock, Janelle/0000-0001-6703-7228	Italian Ministry of Research [FIRB RBAP10AHJB]; Associazione Italiana Ricerca Cancro (AIRC) [12182]; Fondazione Italiana Malattie Pancreas - Ministero Salute [CUP_J33G13000210001]; National Health and Medical Research Council of Australia (NHMRC) [631701, 535903, CDF 1112113, PRF 1025427, SRF 455857]; Queensland State Government Smart State National and International Research Alliances Program (NIRAP); Institute for Molecular Bioscience/University of Queensland; Royal Australasian College of Physicians; Sidney Catalyst; NHMRC; Pancare Australia; Australian Government: Department of Innovation, Industry, Science and Research (DIISR); Australian Cancer Research Foundation (ACRF); Cancer Council NSW [SRP06-01, SRP11-01.ICGC]; Cancer Institute NSW [10/ECF/2-26, 06/ECF/1-24, 09/CDF/2-40, 07/CDF/1-03, 10/CRF/1-01, 08/RSA/1-15, 07/CDF/1-28, 10/CDF/2-26, 10/FRL/2-03, 06/RSA/1-05, 09/RIG/1-02, 10/TPG/1-04, 11/REG/1-10, 11/CDF/3-26]; Garvan Institute of Medical Research; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Petre Foundation; Philip Hemstritch Foundation; Gastroenterological Society of Australia (GESA Senior Research Fellowship); Royal Australasian College of Surgeons (RACS); Royal Australasian College of Physicians (RACP); Royal College of Pathologists of Australasia (RCPA); QIMR Berghofer Medical Research; Keith Boden Fellowship; NHGRI [U54 HG003273]; CPRIT grant [RP101353-P7]; Wellcome Trust [103721/Z/14/Z]; CRUK Programme [C29717/A17263, C29717/A18484]; CRUK Glasgow Centre [C596/A18076]; CRUK Clinical Training Award [C596/A20921]; Pancreatic Cancer UK Future Research Leaders Fund; Howat Foundation; University of Glasgow; Academy of Medical Sciences (AMS) [AMS-SGCL9-Jamieson] Funding Source: researchfish; Cancer Research UK [22533, 23526, 17263] Funding Source: researchfish; Medical Research Council [MR/N005813/1] Funding Source: researchfish; Pancreatic Cancer UK [RIF2015_A06_Jamieson, FLF2015_04_Glasgow] Funding Source: researchfish; MRC [MR/N005813/1] Funding Source: UKRI	Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Italiana Malattie Pancreas - Ministero Salute; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Queensland State Government Smart State National and International Research Alliances Program (NIRAP); Institute for Molecular Bioscience/University of Queensland; Royal Australasian College of Physicians(General Electric); Sidney Catalyst; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Pancare Australia; Australian Government: Department of Innovation, Industry, Science and Research (DIISR)(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Cancer Research Foundation (ACRF); Cancer Council NSW(Cancer Council New South Wales); Cancer Institute NSW; Garvan Institute of Medical Research; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Petre Foundation; Philip Hemstritch Foundation; Gastroenterological Society of Australia (GESA Senior Research Fellowship); Royal Australasian College of Surgeons (RACS); Royal Australasian College of Physicians (RACP); Royal College of Pathologists of Australasia (RCPA); QIMR Berghofer Medical Research; Keith Boden Fellowship; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); CPRIT grant; Wellcome Trust(Wellcome TrustEuropean Commission); CRUK Programme; CRUK Glasgow Centre; CRUK Clinical Training Award; Pancreatic Cancer UK Future Research Leaders Fund; Howat Foundation; University of Glasgow; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Pancreatic Cancer UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank E. Missiaglia, S. Beghelli, N. Sperandio, G. Bonizzato, S. Grimaldi, F. Pisani, C. Cantu, G. Zamboni and P. Merlini for assistance at the ARC-Net Research Centre and Verona University; C. Axford, M.-A. Brancato, S. Rowe, M. Thomas, S. Simpson and G. Hammond for central coordination of the Australian Pancreatic Cancer Genome Initiative, data management and quality control; M. Martyn-Smith, L. Braatvedt, H. Tang, V. Papangelis and M. Beilin for biospecimen acquisition; D. Gwynne and D. Stetner for support at the Queensland Centre for Medical Genomics; and The Kinghorn Centre for Clinical Genomics for genome sequencing of validation samples. Funding support was from: Italian Ministry of Research (Cancer Genome Project FIRB RBAP10AHJB); Associazione Italiana Ricerca Cancro (AIRC n. 12182); Fondazione Italiana Malattie Pancreas - Ministero Salute (CUP_J33G13000210001); National Health and Medical Research Council of Australia (NHMRC; 631701, 535903, CDF 1112113, PRF 1025427, SRF 455857, 535903); The Queensland State Government Smart State National and International Research Alliances Program (NIRAP); Institute for Molecular Bioscience/University of Queensland; The Royal Australasian College of Physicians, Sidney Catalyst, NHMRC, Pancare Australia; Australian Government: Department of Innovation, Industry, Science and Research (DIISR); Australian Cancer Research Foundation (ACRF); Cancer Council NSW (SRP06-01, SRP11-01.ICGC); Cancer Institute NSW (10/ECF/2-26; 06/ECF/1-24; 09/CDF/2-40; 07/CDF/1-03; 10/CRF/1-01, 08/RSA/1-15, 07/CDF/1-28, 10/CDF/2-26,10/FRL/2-03, 06/RSA/1-05, 09/RIG/1-02, 10/TPG/1-04, 11/REG/1-10, 11/CDF/3-26); Garvan Institute of Medical Research; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Petre Foundation; Philip Hemstritch Foundation; Gastroenterological Society of Australia (GESA Senior Research Fellowship); Royal Australasian College of Surgeons (RACS); Royal Australasian College of Physicians (RACP); Royal College of Pathologists of Australasia (RCPA); QIMR Berghofer Medical Research; The Keith Boden Fellowship (K.N.); NHGRI U54 HG003273; CPRIT grant RP101353-P7; Wellcome Trust Senior Investigator Award (103721/Z/14/Z); CRUK Programme (C29717/A17263 and C29717/A18484); CRUK Glasgow Centre (C596/A18076); CRUK Clinical Training Award (C596/A20921); Pancreatic Cancer UK Future Research Leaders Fund; The Howat Foundation; and the University of Glasgow.	Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Aretz S, 2014, EUR J HUM GENET, V22, P923, DOI 10.1038/ejhg.2012.309; Asai A, 2015, GENE, V558, P220, DOI 10.1016/j.gene.2014.12.064; Baba T, 2015, MOL CARCINOGEN, V54, P608, DOI 10.1002/mc.22127; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bell DW, 2007, INT J CANCER, V121, P2661, DOI 10.1002/ijc.23026; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Brohl AS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004475; Cai Z, 2009, MOL CELL, V35, P818, DOI 10.1016/j.molcel.2009.09.007; Corbo V, 2010, ENDOCR-RELAT CANCER, V17, P771, DOI 10.1677/ERC-10-0028; Crompton BD, 2014, CANCER DISCOV, V4, P1326, DOI 10.1158/2159-8290.CD-13-1037; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Dong XY, 2003, AM J HUM GENET, V72, P270, DOI 10.1086/346094; Elsasser SJ, 2011, SCIENCE, V331, P1145, DOI 10.1126/science.1203280; Fang H, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0064-8; Fang MG, 2013, MOL CELL BIOL, V33, P2635, DOI 10.1128/MCB.00167-13; Francis JM, 2013, NAT GENET, V45, P1483, DOI 10.1038/ng.2821; Georgitsi M, 2007, J CLIN ENDOCR METAB, V92, P3321, DOI 10.1210/jc.2006-2843; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kambara T, 2004, GENE CHROMOSOME CANC, V40, P1, DOI 10.1002/gcc.20011; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lewis TB, 2007, MODERN PATHOL, V20, P397, DOI 10.1038/modpathol.3800755; Li BE, 2013, BLOOD, V122, P2039, DOI 10.1182/blood-2013-03-486647; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Lindahl M, 2001, J BIOL CHEM, V276, P9344, DOI 10.1074/jbc.M008279200; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Lubensky IA, 1998, AM J PATHOL, V153, P223, DOI 10.1016/S0002-9440(10)65563-0; Marinoni I, 2014, GASTROENTEROLOGY, V146, P453, DOI 10.1053/j.gastro.2013.10.020; Matkar S, 2013, TRENDS BIOCHEM SCI, V38, P394, DOI [10.1016/j.tibs.2013.0S.005, 10.1016/j.tibs.2013.05.005]; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Missiaglia E, 2010, J CLIN ONCOL, V28, P245, DOI 10.1200/JCO.2008.21.5988; Neychev V, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008248; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nones K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6224; O'Callaghan NJ, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-3; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Popova T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r128; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Rossi S, 2007, CLIN CANCER RES, V13, P7322, DOI 10.1158/1078-0432.CCR-07-1744; Sadanandam A, 2015, CANCER DISCOV, V5, P1296, DOI 10.1158/2159-8290.CD-15-0068; Sankar S, 2011, CANCER GENET-NY, V204, P351, DOI 10.1016/j.cancergen.2011.07.008; Song S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045835; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stockman DL, 2012, AM J SURG PATHOL, V36, P857, DOI 10.1097/PAS.0b013e31824644ac; Sturm D, 2016, CELL, V164, P1060, DOI 10.1016/j.cell.2016.01.015; Tang M, 2013, J BIOL CHEM, V288, P27680, DOI 10.1074/jbc.M113.482349; Tirode F, 2014, CANCER DISCOV, V4, P1342, DOI 10.1158/2159-8290.CD-14-0622; Vogt S, 2009, GASTROENTEROLOGY, V137, P1976, DOI 10.1053/j.gastro.2009.08.052; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wang Y, 2011, CANCER RES, V71, P371, DOI 10.1158/0008-5472.CAN-10-3221; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170	63	491	508	3	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					65	+		10.1038/nature21063	http://dx.doi.org/10.1038/nature21063			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0AA	28199314	Green Accepted			2022-12-28	WOS:000395671500033
J	Cohen, J				Cohen, Jon			CRISPR patent ruling leaves license holders scrambling	SCIENCE			English	News Item																			0	3	4	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					786	786		10.1126/science.355.6327.786	http://dx.doi.org/10.1126/science.355.6327.786			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28232532				2022-12-28	WOS:000395127600014
J	Leuenberger, P; Ganscha, S; Kahraman, A; Cappelletti, V; Boersema, PJ; von Mering, C; Claassen, M; Picotti, P				Leuenberger, Pascal; Ganscha, Stefan; Kahraman, Abdullah; Cappelletti, Valentina; Boersema, Paul J.; von Mering, Christian; Claassen, Manfred; Picotti, Paola			Cell-wide analysis of protein thermal unfolding reveals determinants of thermostability	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; EXPRESSION LEVELS; STABILITY; AGGREGATION; PREDICTION; BINDING; TEMPERATURE; ANNOTATION; SOLUBILITY; MECHANISMS	Temperature-induced cell death is thought to be due to protein denaturation, but the determinants of thermal sensitivity of proteomes remain largely uncharacterized. We developed a structural proteomic strategy to measure protein thermostability on a proteome-wide scale and with domain-level resolution. We applied it to Escherichia coli, Saccharomyces cerevisiae, Thermus thermophilus, and human cells, yielding thermostability data for more than 8000 proteins. Our results (i) indicate that temperature-induced cellular collapse is due to the loss of a subset of proteins with key functions, (ii) shed light on the evolutionary conservation of protein and domain stability, and (iii) suggest that natively disordered proteins in a cell are less prevalent than predicted and (iv) that highly expressed proteins are stable because they are designed to tolerate translational errors that would lead to the accumulation of toxic misfolded species.	[Leuenberger, Pascal; Cappelletti, Valentina; Boersema, Paul J.; Picotti, Paola] ETHZ, Dept Biol, Inst Biochem, CH-8093 Zurich, Switzerland; [Leuenberger, Pascal; Ganscha, Stefan] ETHZ, Syst Biol Grad Sch PhD Program, CH-8093 Zurich, Switzerland; [Leuenberger, Pascal; Ganscha, Stefan] Univ Zurich, CH-8093 Zurich, Switzerland; [Ganscha, Stefan; Claassen, Manfred] ETHZ, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Kahraman, Abdullah; von Mering, Christian] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Kahraman, Abdullah; von Mering, Christian] Univ Zurich, Swiss Inst Bioinformat, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Institute of Bioinformatics; University of Zurich	Picotti, P (corresponding author), ETHZ, Dept Biol, Inst Biochem, CH-8093 Zurich, Switzerland.	paola.picotti@bc.biol.ethz.ch	von Mering, Christian/B-3300-2008	von Mering, Christian/0000-0001-7734-9102; Claassen, Manfred/0000-0002-4583-9083; Kahraman, Abdullah/0000-0003-3523-4467	European Union Seventh Framework Program (FP7)-European Research Council (ERC) Starting Grant [FP7-ERC-StG-337965]; "Foerderungsprofessur" grant from the Swiss National Science Foundation [PP00P3_133670]; Promedica Stiftung [2-70669-11]; short-term European Molecular Biology Organization fellowship; SystemX.ch	European Union Seventh Framework Program (FP7)-European Research Council (ERC) Starting Grant; "Foerderungsprofessur" grant from the Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); Promedica Stiftung; short-term European Molecular Biology Organization fellowship; SystemX.ch	P.P. is supported by a European Union Seventh Framework Program (FP7)-European Research Council (ERC) Starting Grant (FP7-ERC-StG-337965), by a "Foerderungsprofessur" grant from the Swiss National Science Foundation (grant PP00P3_133670), and by a Promedica Stiftung (grant 2-70669-11). V.C. is supported by a short-term European Molecular Biology Organization fellowship. C.v.M. and A.K. acknowledge SystemX.ch for funding. We are grateful to R. Glockshuber, R. Riek, J. Greenwald (ETHZ), J. Gsponer (University of British Columbia), and C. Vogel (New York University) for insightful discussions. We thank H.M. Fischer (ETHZ) for the T. thermophilus strain used in the study. P.L. and P.P. designed the experiments. P.L. performed mass spectrometry data analysis. P.J.B. contributed to mass spectrometry measurements. S.G. and M.C. designed and implemented the analysis of peptide denaturation profiles resulting from MS measurements. P.L., A.K., and V.C. analyzed melting curve data. P.L., A.K., C.v.M., and P.P. wrote the manuscript. P.P. conceived and supervised the project. P.P. is a scientific advisor for the company Biognosys AG (Zurich, Switzerland). P.P. is an inventor on a patent licensed by Biognosys AG that covers the LiP method used in this manuscript as a general tool to study protein structural changes. Thermal unfolding curves and fitting parameters have been deposited at Harvard Dataverse, doi:10.7910/DVN/Q4SQZL and doi:10.7910/DVN/ZT1EZG.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Ariesandi W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053487; Baets J, 2015, BRAIN, V138, P845, DOI 10.1093/brain/awv010; Bava KA, 2004, NUCLEIC ACIDS RES, V32, pD120, DOI 10.1093/nar/gkh082; Berovic M, 2005, BIOTECHNOL ANN REV, V11, P257, DOI 10.1016/S1387-2656(05)11008-4; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Carcamo-Noriega EN, 2016, PEERJ, V4, DOI 10.7717/peerj.1676; Chang RL, 2013, SCIENCE, V340, P1220, DOI 10.1126/science.1234012; Christiano R, 2014, CELL REP, V9, P1959, DOI 10.1016/j.celrep.2014.10.065; Coffey DS, 2006, JAMA-J AM MED ASSOC, V296, P445, DOI 10.1001/jama.296.4.445; Das Rajdeep, 2000, Functional and Integrative Genomics, V1, P76, DOI 10.1007/s101420050009; Dill KA, 2011, P NATL ACAD SCI USA, V108, P17876, DOI 10.1073/pnas.1114477108; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Durairajanayagam D, 2015, REPROD BIOMED ONLINE, V30, P14, DOI 10.1016/j.rbmo.2014.09.018; Evans SS, 2015, NAT REV IMMUNOL, V15, P335, DOI 10.1038/nri3843; Feng YH, 2014, NAT BIOTECHNOL, V32, P1036, DOI 10.1038/nbt.2999; FERGUSON MWJ, 1982, NATURE, V296, P850, DOI 10.1038/296850a0; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Fontana A, 1997, FOLD DES, V2, pR17, DOI 10.1016/S1359-0278(97)00010-2; Gawron D, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156662; Gershenson A, 2011, CURR OPIN STRUC BIOL, V21, P32, DOI 10.1016/j.sbi.2010.11.001; Ghosh K, 2010, BIOPHYS J, V99, P3996, DOI 10.1016/j.bpj.2010.10.036; Ghosh K, 2009, P NATL ACAD SCI USA, V106, P10649, DOI 10.1073/pnas.0903995106; Greaves RB, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-18; Gsponer J, 2012, CELL REP, V2, P1425, DOI 10.1016/j.celrep.2012.09.036; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Guo MH, 2012, P NATL ACAD SCI USA, V109, P17863, DOI 10.1073/pnas.1201797109; Hegyi H, 2001, GENOME RES, V11, P1632, DOI 10.1101/gr. 183801; HENNRICH N, 1973, H-S Z PHYSIOL CHEM, V354, P1339, DOI 10.1515/bchm2.1973.354.2.1339; Hong JA, 2010, J AM CHEM SOC, V132, P10445, DOI 10.1021/ja103166y; Ignatova Z, 2004, P NATL ACAD SCI USA, V101, P523, DOI 10.1073/pnas.0304533101; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Li Z, 2004, CURR PROTOC IMMUNOL, V1, DOI [10.1002/0471142735.ima01ts58, DOI 10.1002/0471142735.IMA01TS58]; Lilie H, 1998, CURR OPIN BIOTECH, V9, P497, DOI 10.1016/S0958-1669(98)80035-9; Luke KA, 2007, FEBS J, V274, P4023, DOI 10.1111/j.1742-4658.2007.05955.x; Makhatadze GI, 1998, PROTEIN SCI, V7, P689, DOI 10.1002/pro.5560070318; Martin-Perez M, 2015, ANAL CHEM, V87, P4008, DOI 10.1021/acs.analchem.5b00264; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Minde DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046147; MOORE MN, 1976, CELL TISSUE RES, V175, P279; Nasir A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003452; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Polizzi KM, 2007, CURR OPIN CHEM BIOL, V11, P220, DOI 10.1016/j.cbpa.2007.01.685; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Rudner DZ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000307; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Tartaglia GG, 2007, TRENDS BIOCHEM SCI, V32, P204, DOI 10.1016/j.tibs.2007.03.005; Tartaglia GG, 2009, J MOL BIOL, V388, P381, DOI 10.1016/j.jmb.2009.03.002; Tsao D, 2010, PHYS CHEM CHEM PHYS, V12, P3491, DOI 10.1039/b924236h; Uversky VN, 2008, CURR PROTEIN PEPT SC, V9, P507, DOI 10.2174/138920308785915218; Uversky VN, 2015, FEBS J, V282, P1182, DOI 10.1111/febs.13202; Vogel C, 2004, J MOL BIOL, V336, P809, DOI 10.1016/j.jmb.2003.12.026; Yang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008378; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zhou HX, 2013, FEBS LETT, V587, P1053, DOI 10.1016/j.febslet.2013.01.064	63	208	212	12	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327							eaai7825	10.1126/science.aai7825	http://dx.doi.org/10.1126/science.aai7825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28232526				2022-12-28	WOS:000395127600033
J	Karras, GI; Yi, S; Sahni, N; Fischer, M; Xie, J; Vidal, M; D'Andrea, AD; Whitesell, L; Lindquist, S				Karras, Georgios I.; Yi, Song; Sahni, Nidhi; Fischer, Mate; Xie, Jenny; Vidal, Marc; D'Andrea, Alan D.; Whitesell, Luke; Lindquist, Susan			HSP90 Shapes the Consequences of Human Genetic Variation	CELL			English	Article							FANCONI-ANEMIA PATHWAY; MORPHOLOGICAL EVOLUTION; PROTEIN HOMEOSTASIS; CHAPERONES; CAPACITOR; THERAPY; CANCER; MECHANISMS; PRINCIPLES; RESISTANCE	HSP90 acts as a protein-folding buffer that shapes the manifestations of genetic variation in model organisms. Whether HSP90 influences the consequences of mutations in humans, potentially modifying the clinical course of genetic diseases, remains unknown. By mining data for >1,500 disease-causing mutants, we found a strong correlation between reduced phenotypic severity and a dominant (HSP90 R HSP70) increase in mutant engagement by HSP90. Examining the cancer predisposition syndrome Fanconi anemia in depth revealed that mutant FANCA proteins engaged predominantly by HSP70 had severely compromised function. In contrast, the function of less severe mutants was preserved by a dominant increase in HSP90 binding. Reducing HSP90' s buffering capacity with inhibitors or febrile temperatures destabilized HSP90-buffered mutants, exacerbating FA-related chemosensitivities. Strikingly, a compensatory FANCA somatic mutation from an "experiment of nature'' in monozygotic twins both prevented anemia and reduced HSP90 binding. These findings provide one plausible mechanism for the variable expressivity and environmental sensitivity of genetic diseases.	[Karras, Georgios I.; Fischer, Mate; Whitesell, Luke; Lindquist, Susan] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Yi, Song; Sahni, Nidhi; Vidal, Marc] Dana Farber Canc Inst, CCSB, Boston, MA 02215 USA; [Yi, Song; Sahni, Nidhi; Vidal, Marc] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Xie, Jenny; D'Andrea, Alan D.] Harvard Med Sch, Dana Farber Canc Inst, Ctr DNA Damage & Repair, Boston, MA 02215 USA; [Xie, Jenny; D'Andrea, Alan D.] Harvard Med Sch, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA; [Lindquist, Susan] MIT, Dept Biol, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Yi, Song; Sahni, Nidhi] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Sahni, Nidhi] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Karras, GI; Whitesell, L (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	gkarras@wi.mit.edu; whitesell@wi.mit.edu	Vidal, Marc/Y-2466-2019; Yi, Song/ABG-6526-2020	Vidal, Marc/0000-0003-3391-5410; Yi, Song/0000-0003-0047-8103; Sahni, Nidhi/0000-0002-9155-5882; Fischer, Mate/0000-0002-6970-5039; Karras, Georgios/0000-0003-2933-1535	Fanconi Anemia Research Fund; Department of Defense (CDMRP BCRP) [W81XWH-14-1-0157]; Harold and Leila Y. Mathers Foundation; NIH [R37HL052725, RO1DK43889, PO1HL048546, P50HG004233, R01HG001715, RC4HG006066]; Cancer Prevention and Research Institute of Texas (CPRIT) [RR160021]; EMBO; HFSP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052725, R37HL052725, P01HL048546] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004233, R01HG001715, RC4HG006066, U41HG001715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK043889, R01DK043889] Funding Source: NIH RePORTER	Fanconi Anemia Research Fund; Department of Defense (CDMRP BCRP); Harold and Leila Y. Mathers Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); EMBO(European Molecular Biology Organization (EMBO)); HFSP(Human Frontier Science Program); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank L. Clayton for reviewing and editing the manuscript. We are grateful to D. Hill for providing the human ORFeome and for constructive feedback. We thank J. Peng, G.L. Moldovan, members of the DFCI Department of Radiation Oncology, and J. Cheah and C. Soule at The David H. Koch Institute's High Throughput Screening Facility for providing expertise and reagents. We also thank M. Taipale, D. Pincus, S. Lourido, M. Mendillo, C.A. McLellan and C. Kayatekin for constructive comments on the manuscript. This work was supported by the Fanconi Anemia Research Fund (to S.L.), the Department of Defense (CDMRP BCRP W81XWH-14-1-0157 to S.L.), the Harold and Leila Y. Mathers Foundation, and the NIH (R37HL052725, RO1DK43889, and PO1HL048546 to A.D.D.; P50HG004233 and R01HG001715 to M.V.; and RC4HG006066 to M.V., L.W. and S.L.). N.S. is supported by Cancer Prevention and Research Institute of Texas (CPRIT) New Investigator Award RR160021. S.L. was an investigator of the Howard Hughes Medical Institute. G.I.K. was supported by EMBO and HFSP Long-Term Fellowships.	Adachi D, 2002, HUM MOL GENET, V11, P3125, DOI 10.1093/hmg/11.25.3125; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Burga A, 2011, NATURE, V480, P250, DOI 10.1038/nature10665; Castella M, 2011, BLOOD, V117, P3759, DOI 10.1182/blood-2010-08-299917; Ceccaldi R, 2016, NAT REV MOL CELL BIO, V17, P337, DOI 10.1038/nrm.2016.48; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Gross M, 2002, CYTOGENET GENOME RES, V98, P126, DOI 10.1159/000069805; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Jarosz DF, 2010, ANNU REV GENET, V44, P189, DOI 10.1146/annurev.genet.40.110405.090412; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Lindquist S, 2009, COLD SH Q B, V74, P103, DOI 10.1101/sqb.2009.74.043; Mankad A, 2006, BLOOD, V107, P3084, DOI 10.1182/blood-2005-07-2638; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Oda T, 2007, BLOOD, V109, P5016, DOI 10.1182/blood-2006-08-038638; POOLE SR, 1992, AM J MED GENET, V42, P780, DOI 10.1002/ajmg.1320420606; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rohner N, 2013, SCIENCE, V342, P1372, DOI 10.1126/science.1240276; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013; Taipale M, 2014, CELL, V158, P434, DOI 10.1016/j.cell.2014.05.039; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Vincent BM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001692; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Whitesell L, 2014, P NATL ACAD SCI USA, V111, P18297, DOI 10.1073/pnas.1421323111; Xie J, 2015, J CLIN INVEST, V125, P1523, DOI 10.1172/JCI79325; Yagasaki H, 2004, HUM MUTAT, V24, P481, DOI 10.1002/humu.20099; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yeyati PL, 2007, PLOS GENET, V3, P431, DOI 10.1371/journal.pgen.0030043	34	68	70	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					856	+		10.1016/j.cell.2017.01.023	http://dx.doi.org/10.1016/j.cell.2017.01.023			23	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28215707	Green Accepted, Bronze			2022-12-28	WOS:000396284800014
J	Liu, PF; Yuan, B; Carvalho, CMB; Wuster, A; Walter, K; Zhang, L; Gambin, T; Chong, ZC; Campbell, IM; Akdemir, ZC; Gelowani, V; Writzl, K; Bacino, CA; Lindsay, SJ; Withers, M; Gonzaga-Jauregui, C; Wiszniewska, J; Scull, J; Stankiewicz, P; Jhangiani, SN; Muzny, DM; Zhang, F; Chen, K; Gibbs, RA; Rautenstrauss, B; Cheung, SW; Smith, J; Breman, A; Shaw, CA; Patel, A; Hurles, ME; Lupski, JR				Liu, Pengfei; Yuan, Bo; Carvalho, Claudia M. B.; Wuster, Arthur; Walter, Klaudia; Zhang, Ling; Gambin, Tomasz; Chong, Zechen; Campbell, Ian M.; Akdemir, Zeynep Coban; Gelowani, Violet; Writzl, Karin; Bacino, Carlos A.; Lindsay, Sarah J.; Withers, Marjorie; Gonzaga-Jauregui, Claudia; Wiszniewska, Joanna; Scull, Jennifer; Stankiewicz, Pawe; Jhangiani, Shalini N.; Muzny, Donna M.; Zhang, Feng; Chen, Ken; Gibbs, Richard A.; Rautenstrauss, Bernd; Cheung, Sau Wai; Smith, Janice; Breman, Amy; Shaw, Chad A.; Patel, Ankita; Hurles, Matthew E.; Lupski, James R.			An Organismal CNV Mutator Phenotype Restricted to Early Human Development	CELL			English	Article							TANDEM DUPLICATOR PHENOTYPE; REPLICATIVE MECHANISMS; GENOMIC ARCHITECTURE; REARRANGEMENTS; MUTATIONS; INSTABILITY; RATES; DELETIONS; HALLMARK; DIVERSE	De novo copy number variants (dnCNVs) arising at multiple loci in a personal genome have usually been considered to reflect cancer somatic genomic instabilities. We describe a multiple dnCNV (MdnCNV) phenomenon in which individuals with genomic disorders carry five to ten constitutional dnCNVs. These CNVs originate from independent formation incidences, are predominantly tandem duplications or complex gains, exhibit breakpoint junction features reminiscent of replicative repair, and show increased de novo point mutations flanking the rearrangement junctions. The active CNV mutation shower appears to be restricted to a transient perizygotic period. We propose that a defect in the CNV formation process is responsible for the "CNV-mutator state,'' and this state is dampened after early embryogenesis. The constitutional MdnCNV phenomenon resembles chromosomal instability in various cancers. Investigations of this phenomenon may provide unique access to understanding genomic disorders, structural variant mutagenesis, human evolution, and cancer biology.	[Liu, Pengfei; Yuan, Bo; Carvalho, Claudia M. B.; Gambin, Tomasz; Campbell, Ian M.; Akdemir, Zeynep Coban; Gelowani, Violet; Bacino, Carlos A.; Withers, Marjorie; Gonzaga-Jauregui, Claudia; Wiszniewska, Joanna; Scull, Jennifer; Stankiewicz, Pawe; Jhangiani, Shalini N.; Muzny, Donna M.; Gibbs, Richard A.; Cheung, Sau Wai; Smith, Janice; Breman, Amy; Shaw, Chad A.; Patel, Ankita; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Jhangiani, Shalini N.; Muzny, Donna M.; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Liu, Pengfei; Bacino, Carlos A.; Scull, Jennifer; Stankiewicz, Pawe; Cheung, Sau Wai; Smith, Janice; Breman, Amy; Shaw, Chad A.; Patel, Ankita] Baylor Genet, Houston, TX 77021 USA; [Wuster, Arthur; Walter, Klaudia; Lindsay, Sarah J.; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Zhang, Ling; Zhang, Feng] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Inst Reprod & Dev, Obstet & Gynecol Hosp, Shanghai 200011, Peoples R China; [Chong, Zechen; Chen, Ken] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Writzl, Karin] Univ Med Ctr Ljubljana, Clin Inst Med Genet, Ljubljana 1000, Slovenia; [Bacino, Carlos A.; Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Rautenstrauss, Bernd] Med Genet Ctr, Bayerstr 3-5, D-80335 Munich, Germany	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Wellcome Trust Sanger Institute; Fudan University; University of Texas System; UTMD Anderson Cancer Center; University Medical Centre Ljubljana; Baylor College of Medicine	Liu, PF; Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Lupski, JR (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.; Lupski, JR (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.; Liu, PF (corresponding author), Baylor Genet, Houston, TX 77021 USA.; Lupski, JR (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.	pengfei.liu@bcm.edu; jlupski@bcm.edu	Stankiewicz, Paweł/AAP-7906-2021; Lindsay, Sarah/CAF-4613-2022; Zhang, Feng/C-7735-2009; Liu, Pengfei/U-9743-2019; Gambin, Tomasz/HDN-5840-2022; Gonzaga-Jauregui, Claudia/H-4752-2019; Chen, Ken/AAU-1432-2021	Stankiewicz, Paweł/0000-0002-6456-7490; Zhang, Feng/0000-0003-4556-8276; Liu, Pengfei/0000-0002-4177-709X; Gambin, Tomasz/0000-0002-0941-4571; Gonzaga-Jauregui, Claudia/0000-0002-4667-3679; Chen, Ken/0000-0003-4013-5279; Cheung, Sau W/0000-0002-3813-5256; Wuster, Arthur/0000-0003-4162-5931; Campbell, Ian/0000-0002-3749-2884; Lindsay, Sarah/0000-0002-0965-3070; Breman, Amy/0000-0003-0299-0100	US National Institute of Neurological Disorders and Stroke [R01NS058529]; National Human Genome Research Institute (NHGRI) [U54HG003273]; NHGRI [U54HG006542]; BCM Intellectual and Developmental Disabilities Research Center, IDDRC grant [5P30HD024064-23]; Eunice Kennedy Shriver National Institute of Child Health & Human Development; Wellcome Trust [WT098051]; Regeneron Pharmaceuticals; GE-Clarient; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA172652] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); BCM Intellectual and Developmental Disabilities Research Center, IDDRC grant; Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission); Regeneron Pharmaceuticals(Regeneron); GE-Clarient; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all the family members and collaborators who participated in this study. This work was supported in part by grants from the US National Institute of Neurological Disorders and Stroke (https://www.ninds.nih.gov/, R01NS058529), the National Human Genome Research Institute (NHGRI https://www.genome.gov/, U54HG003273), a joint NHGRI (https://www.genome.gov/)/National Heart Blood and Lung Institute (https://www.nhlbi.nih.gov/) grant (U54HG006542) to the Baylor Hopkins Center for Mendelian Genomics, and the BCM Intellectual and Developmental Disabilities Research Center, IDDRC grant number 5P30HD024064-23, from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The work was also partially supported by the Wellcome Trust (WT098051). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development, the Wellcome Trust, or the National Institutes of Health. Baylor College of Medicine (BCM) and Miraca Holdings have formed a joint venture with shared ownership and governance of the Baylor Genetics (BG), which performs clinical microarray analysis and clinical exome sequencing. P.L., C.A.B., J. Scull, P.S., S.W.C., J. Smith, A.B., C.S., A.P., and J.R.L. are employees of BCM and derive support through a professional services agreement with the BG. J.R.L. serves on the Scientific Advisory Board of the BG. J.R.L. has stock ownership in 23andMe, is a paid consultant for Regeneron Pharmaceuticals, has stock options in Lasergen, and is a co-inventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. R.A.G. reports consulting fees from GE-Clarient. A.W. is an employee of Genentech.	Acuna-Hidalgo R, 2015, AM J HUM GENET, V97, P67, DOI 10.1016/j.ajhg.2015.05.008; Anand RP, 2014, GENE DEV, V28, P2394, DOI 10.1101/gad.250258.114; Arlt MF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002981; Arlt MF, 2009, AM J HUM GENET, V84, P339, DOI 10.1016/j.ajhg.2009.01.024; Boone PM, 2014, AM J HUM GENET, V95, P143, DOI 10.1016/j.ajhg.2014.06.014; Boone PM, 2011, GENET MED, V13, P582, DOI 10.1097/GIM.0b013e3182106775; Carvalho CMB, 2016, NAT REV GENET, V17, P224, DOI 10.1038/nrg.2015.25; Carvalho CMB, 2015, AM J HUM GENET, V96, P555, DOI 10.1016/j.ajhg.2015.01.021; Carvalho CMB, 2013, NAT GENET, V45, P1319, DOI 10.1038/ng.2768; Carvalho CMB, 2011, NAT GENET, V43, P1074, DOI 10.1038/ng.944; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chen L, 2015, HUM MOL GENET, V24, P1574, DOI 10.1093/hmg/ddu572; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; Chong ZC, 2017, NAT METHODS, V14, P65, DOI [10.1038/NMETH.4084, 10.1038/nmeth.4084]; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Deem A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000594; Girirajan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002334; Goldmann JM, 2016, NAT GENET, V48, P935, DOI 10.1038/ng.3597; Gu S, 2015, HUM MOL GENET, V24, P4061, DOI 10.1093/hmg/ddv146; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kloosterman WP, 2012, CELL REP, V1, P648, DOI 10.1016/j.celrep.2012.05.009; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Liu PF, 2012, CURR OPIN GENET DEV, V22, P211, DOI 10.1016/j.gde.2012.02.012; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Loeb LA, 2001, CANCER RES, V61, P3230; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lupski JR, 2015, ENVIRON MOL MUTAGEN, V56, P419, DOI 10.1002/em.21943; Macheret M, 2015, ANNU REV PATHOL-MECH, V10, P425, DOI 10.1146/annurev-pathol-012414-040424; Mayle R, 2015, SCIENCE, V349, P742, DOI 10.1126/science.aaa8391; McRae AF, 2015, TWIN RES HUM GENET, V18, P13, DOI 10.1017/thg.2014.85; Menghi F, 2016, P NATL ACAD SCI USA, V113, pE2373, DOI 10.1073/pnas.1520010113; MEZARD C, 1992, CELL, V70, P659, DOI 10.1016/0092-8674(92)90434-E; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; MIYAKE T, 1960, GENETICS, V45, P11; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Newman S, 2015, AM J HUM GENET, V96, P208, DOI 10.1016/j.ajhg.2014.12.017; Ng CKY, 2012, J PATHOL, V226, P703, DOI 10.1002/path.3980; Nicolaides NC, 1998, MOL CELL BIOL, V18, P1635, DOI 10.1128/MCB.18.3.1635; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Plough H. H., 1941, Cold Spring Harbor Symposia on Quantitative Biology, V9, P127; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; Ramu A, 2013, NAT METHODS, V10, P985, DOI 10.1038/nmeth.2611; Robberecht C, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-19; Sakofsky CJ, 2015, MOL CELL, V60, P860, DOI 10.1016/j.molcel.2015.10.041; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; TREFFERS HP, 1954, P NATL ACAD SCI USA, V40, P1064, DOI 10.1073/pnas.40.11.1064; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Weckselblatt B, 2015, TRENDS GENET, V31, P587, DOI 10.1016/j.tig.2015.05.010; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Xiao JQ, 2014, MOL GENET GENOMICS, V289, P755, DOI 10.1007/s00438-014-0850-4; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	62	51	51	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					830	+		10.1016/j.cell.2017.01.037	http://dx.doi.org/10.1016/j.cell.2017.01.037			20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28235197	Bronze, Green Accepted			2022-12-28	WOS:000396284800012
J	Rimmer, A				Rimmer, Abi			Foundation programme will have unfilled places this year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Moberly T., 2017, BMJ CAREERS; Rimmer A., 2017, BMJ CAREERS	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2017	356								j903	10.1136/bmj.j903	http://dx.doi.org/10.1136/bmj.j903			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KV	28228383				2022-12-28	WOS:000395631300004
J	Wong, J; Motulsky, A; Abrahamowicz, M; Eguale, T; Buckeridge, DL; Tamblyn, R				Wong, Jenna; Motulsky, Aude; Abrahamowicz, Michal; Eguale, Tewodros; Buckeridge, David L.; Tamblyn, Robyn			Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEROTONIN REUPTAKE INHIBITORS; BRITISH ASSOCIATION; DRUG-USE; GUIDELINES; APPROVAL; PATIENT; QUEBEC; CANADA; SAFETY; RISK	OBJECTIVE To examine off-label indications for antidepressants in primary care and determine the level of scientific support for off-label prescribing. DESIGN Descriptive study of antidepressant prescriptions written by primary care physicians using an indication based electronic prescribing system. SETTING Primary care practices in and around two major urban centres in Quebec, Canada. PARTICIPANTS Patients aged 18 years or older who visited a study physician between 1 January 2003 and 30 September 2015 and were prescribed an antidepressant through the electronic prescribing system. MAIN OUTCOME MEASURES Prevalence of off-label indications for antidepressant prescriptions by class and by individual drug. Among off-label antidepressant prescriptions, the proportion of prescriptions in each of the following categories was measured: strong evidence supporting use of the prescribed drug for the respective indication; no strong evidence for the prescribed drug but strong evidence supporting use of another drug in the same class for the indication; or no strong evidence supporting use of the prescribed drug and all other drugs in the same class for the indication. RESULTS 106 850 antidepressant prescriptions were written by 174 physicians for 20 920 adults. By class, tricyclic antidepressants had the highest prevalence of off-label indications (81.4%, 95% confidence interval, 77.3% to 85.5%), largely due to a high off-label prescribing rate for amitriptyline (93%, 89.6% to 95.7%). Trazodone use for insomnia was the most common off-label use for antidepressants, accounting for 26.2% (21.9% to 30.4%) of all off-label prescriptions. For only 15.9% (13.0% to 19.3%) of all off-label prescriptions, the prescribed drug had strong scientific evidence for the respective indication. For 39.6% (35.7% to 43.2%) of off-label prescriptions, the prescribed drug did not have strong evidence but another antidepressant in the same class had strong evidence for the respective indication. For the remaining 44.6% (40.2% to 49.0%) of off-label prescriptions, neither the prescribed drug nor any other drugs in the class had strong evidence for the indication. CONCLUSIONS When primary care physicians prescribed antidepressants for off-label indications, these indications were usually not supported by strong scientific evidence, yet often another antidepressant in the same class existed that had strong evidence for the respective indication. There is an important need to generate and provide physicians with evidence on off-label antidepressant use to optimise prescribing decisions.	[Wong, Jenna; Motulsky, Aude; Abrahamowicz, Michal; Buckeridge, David L.; Tamblyn, Robyn] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Motulsky, Aude] Univ Montreal, Sch Publ Hlth, Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada; [Eguale, Tewodros] Massachusetts Coll Pharm & Hlth Sci Univ, Boston, MA USA	McGill University; Universite de Montreal	Wong, J (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	jenna.wong@mail.mcgill.ca		Abrahamowicz, Michal/0000-0002-3172-3952	Canadian Institutes of Health Research (CIHR) [IOP-112675]; Vanier Canada Graduate Scholarship (CIHR); Max E Binz Fellowship (Faculty of Medicine, McGill University)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Vanier Canada Graduate Scholarship (CIHR)(Canadian Institutes of Health Research (CIHR)); Max E Binz Fellowship (Faculty of Medicine, McGill University)(Eli Lilly)	This study was funded by the Canadian Institutes of Health Research (CIHR; grant IOP-112675). JW is supported by the Vanier Canada Graduate Scholarship (CIHR) and the Max E Binz Fellowship (Faculty of Medicine, McGill University). MA is a James McGill professor of biostatistics at McGill University. The funders had no role in the study design; collection, analysis, interpretation of the data; writing of the manuscript; or in the decision to submit the manuscript for publication.	Anglin R, 2014, AM J GASTROENTEROL, V109, P810, DOI 10.1038/ajg.2014.82; Baldwin DS, 2014, J PSYCHOPHARMACOL, V28, P403, DOI 10.1177/0269881114525674; Bartlett Gillian, 2005, Acta bioeth., V11, P145, DOI 10.4067/S1726-569X2005000200005; Carvalho AF, 2016, PSYCHOTHER PSYCHOSOM, V85, P270, DOI 10.1159/000447034; Cascade Elisa, 2009, Psychiatry (Edgmont), V6, P16; Center for Medicare Advocacy, 2010, CMA REP MED COV OFF; Chen DT, 2009, PHARMACOEPIDEM DR S, V18, P1094, DOI 10.1002/pds.1825; Chen H, 2006, J CLIN PSYCHIAT, V67, P972, DOI 10.4088/JCP.v67n0615; Dall M, 2009, CLIN GASTROENTEROL H, V7, P1314, DOI 10.1016/j.cgh.2009.08.019; Dieleman JP, 2005, CURR MED RES OPIN, V21, P1461, DOI 10.1185/030079905X61866; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; Dresser R, 2009, J LAW MED ETHICS, V37, P476, DOI 10.1111/j.1748-720X.2009.00408.x; Eguale T, 2016, JAMA INTERN MED, V176, P55, DOI 10.1001/jamainternmed.2015.6058; Eguale T, 2012, ARCH INTERN MED, V172, P781, DOI 10.1001/archinternmed.2012.340; Eguale T, 2010, DRUG SAFETY, V33, P559, DOI 10.2165/11534580-000000000-00000; Eom CS, 2012, J BONE MINER RES, V27, P1186, DOI 10.1002/jbmr.1554; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Furberg CD, 2001, CURR CONTR TRIALS C, V2, P205, DOI 10.1186/CVM-2-5-205; Ghinea N, 2015, THER INNOV REGUL SCI, V49, P359, DOI 10.1177/2168479015570337; Godwin Marshall, 2003, BMC Med Educ, V3, P10, DOI 10.1186/1472-6920-3-10; Hemels MEH, 2002, ANN PHARMACOTHER, V36, P1375, DOI 10.1345/aph.1A331; Hu XH, 2004, J CLIN PSYCHIAT, V65, P959; Johnston A, 2010, BRIT J CLIN PHARMACO, V70, P320, DOI 10.1111/j.1365-2125.2010.03681.x; Katzman MA, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-S1-S1; Largent EA, 2009, ARCH INTERN MED, V169, P1745, DOI 10.1001/archinternmed.2009.314; Li Ying, 2011, AMIA Annu Symp Proc, V2011, P768; McAlister FA, 1999, JAMA-J AM MED ASSOC, V282, P1371, DOI 10.1001/jama.282.14.1371; Moore M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3999; National Center forHealth Statistics, 2011, HLTH US 2010 SPEC FE; O'Malley PG, 2012, ARCH INTERN MED, V172, P759, DOI 10.1001/archinternmed.2012.789; Pomey MP, 2007, MILBANK Q, V85, P469, DOI 10.1111/j.1468-0009.2007.00496.x; Prescribing and Medicines Team, 2016, PRESCR DISP COMM ENG; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Rost K, 1994, Arch Fam Med, V3, P333, DOI 10.1001/archfami.3.4.333; Sbarbaro JA, 2001, CLIN INFECT DIS, V33, pS240, DOI 10.1086/321856; Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107; Stone KJ, 2003, AM FAM PHYSICIAN, V68, P498; Tamblyn R, 2006, J AM MED INFORM ASSN, V13, P148, DOI 10.1197/jamia.M1887; Thomson Micromedex, DRUGD SYST INT DAT; Walton SN, 2008, PHARMACOTHERAPY, V28, P1443, DOI 10.1592/phco.28.12.1443; Wang B, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4679; Wilson SJ, 2010, J PSYCHOPHARMACOL, V24, P1577, DOI 10.1177/0269881110379307; Wittich CM, 2012, MAYO CLIN PROC, V87, P982, DOI 10.1016/j.mayocp.2012.04.017; Wong J, 2016, JAMA-J AM MED ASSOC, V315, P2230, DOI 10.1001/jama.2016.3445; Xiao YL, 2010, STAT MED, V29, P915, DOI 10.1002/sim.3807	45	105	110	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2017	356								j603	10.1136/bmj.j603	http://dx.doi.org/10.1136/bmj.j603			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9KS	28228380	Green Published, hybrid			2022-12-28	WOS:000395631000003
J	Riley, D				Riley, Donna			Dream Big Engineering Our World	SCIENCE			English	Book Review									[Riley, Donna] Virginia Polytech Inst & State Univ, Dept Engn Educ, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Riley, D (corresponding author), Virginia Polytech Inst & State Univ, Dept Engn Educ, Blacksburg, VA 24061 USA.	dmriley@vt.edu						*MACGL FREEM FIL, DREAM BIG ENGINEERIN; National Academy of Engineering [NAE], 2008, CHANG CONV MESS IMPR, DOI [10.17226/12187, DOI 10.17226/12187]; Petroski H., 2006, ASEE PRISM, V16, P2; Ruelas R., 2014, ARIZONA REPUBLIC	4	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					702	702		10.1126/science.aam5826	http://dx.doi.org/10.1126/science.aam5826			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2AC	28209865				2022-12-28	WOS:000395117700028
J	Tacconelli, E; Autenrieth, IB; Peschel, A				Tacconelli, Evelina; Autenrieth, Ingo B.; Peschel, Andreas			Fighting the enemy within	SCIENCE			English	Editorial Material							ENTEROBACTERIACEAE; COLONIZATION; RISK; RESISTANCE; INFECTION; ESBL		[Tacconelli, Evelina] Univ Tubingen, Dept Internal Med 1, Div Infect Dis, D-72076 Tubingen, Germany; [Tacconelli, Evelina; Autenrieth, Ingo B.; Peschel, Andreas] German Ctr Infect Res DZIF, Partner Site, D-72076 Tubingen, Germany; [Autenrieth, Ingo B.] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Med Microbiol, D-72076 Tubingen, Germany; [Peschel, Andreas] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Infect Biol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; German Center for Infection Research; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Peschel, A (corresponding author), German Ctr Infect Res DZIF, Partner Site, D-72076 Tubingen, Germany.; Peschel, A (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med, Infect Biol, D-72076 Tubingen, Germany.	andreas.peschel@uni-tuebingen.de	Tacconelli, Evelina/AAC-8200-2019	Peschel, Andreas/0000-0002-3209-8626	German Center for Infection Research; German Research Council [SFB766, GRK1708, SFB685, TRR34, TRR156]; European Union	German Center for Infection Research; German Research Council(German Research Foundation (DFG)); European Union(European Commission)	Our research is funded by grants from the German Center for Infection Research to E.T., I.B.A., and A.P.; the German Research Council to I.B.A. (SFB766 and GRK1708) and A.P. (SFB685, TRR34, SFB766, GRK1708, and TRR156); and the European Union to E.T. (IMI-COMBACTE-MAGNET and DRIVE-AB) and A.P. (IMI-COMBACTE).	Antonoy NK, 2015, ANTIMICROB AGENTS CH, V59, P3350, DOI 10.1128/AAC.00079-15; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Caballero S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005132; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Donskey CJ, 2015, INFECT DIS CLIN N AM, V29, P13, DOI 10.1016/j.idc.2014.11.001; Evaluate Ltd, 2016, BACTR WORLDW OV; Hauser AR, 2016, CLIN INFECT DIS, V63, P89, DOI 10.1093/cid/ciw200; Karanika S, 2016, CLIN INFECT DIS, V63, P310, DOI 10.1093/cid/ciw283; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Rieg S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1225-0; Stecher B, 2012, P NATL ACAD SCI USA, V109, P1269, DOI 10.1073/pnas.1113246109; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Vehreschild MJGT, 2014, J ANTIMICROB CHEMOTH, V69, P3387, DOI 10.1093/jac/dku305; World Health Organization, 2016, ANTIMICROBIAL RESIST; Zipperer A, 2016, NATURE, V535, P511, DOI 10.1038/nature18634	15	8	8	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					689	690		10.1126/science.aam6372	http://dx.doi.org/10.1126/science.aam6372			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2AC	28209857				2022-12-28	WOS:000395117700019
J	Tilley, J				Tilley, John			Robert P C MacDonald OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2017	356								j806	10.1136/bmj.j806	http://dx.doi.org/10.1136/bmj.j806			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GP	28213562				2022-12-28	WOS:000394580000004
J	[Anonymous]				[Anonymous]			TRANSPORTATION Superconductors drive trains	NATURE			English	Editorial Material																			0	0	0	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					275	275		10.1038/542275b	http://dx.doi.org/10.1038/542275b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7YF	28202968	Bronze			2022-12-28	WOS:000454457400006
J	Mayor, S				Mayor, Susan			More than nine in 10 who take antibiotics abroad return with resistant bacteria	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Kantele A, 2017, TRAVEL MED INFECT DI, DOI [10.1016/j.timaid.2017.01.003, DOI 10.1016/J.TIMAID.2017.01.003]	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2017	356								j754	10.1136/bmj.j754	http://dx.doi.org/10.1136/bmj.j754			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GI	28193675				2022-12-28	WOS:000394579300007
J	Shennan, AH; Green, M; Chappell, LC				Shennan, Andrew H.; Green, Marcus; Chappell, Lucy C.			Maternal deaths in the UK: pre-eclampsia deaths are avoidable	LANCET			English	Editorial Material									[Shennan, Andrew H.; Chappell, Lucy C.] Kings Coll London, Womens Hlth Acad Ctr, London SE1 7EH, England; [Green, Marcus] Act Preeclampsia, Evesham, England	University of London; King's College London	Shennan, AH (corresponding author), Kings Coll London, Womens Hlth Acad Ctr, London SE1 7EH, England.	andrew.shennan@kcl.ac.uk		Shennan, Andrew/0000-0001-5273-3132	National Institute for Health Research [12/25/03, RP-2014-05-019, 15/59/06] Funding Source: researchfish; Department of Health [RP-2014-05-019, HTA/15/59/06, 12/25/03] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Confidential Enquiry into Maternal and Child Health, 2004, WHY MOTH DIE 2000 20; Cottrell EC, 2015, INT J MOL SCI, V16, P12907, DOI 10.3390/ijms160612907; Division of Reproductive Health National Center for Chronic Disease Prevention and Health Promotion, 2016, PREGN MORT SURV SYST; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Knight M, BEHALF MBRRACE UK SA; Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; National Institute for Health and Care Excellence, 2010, HYPERTENSION PREGNAN; Office for National Statistics, 2014, DEATH REG SUMM TABL; Shennan AH, 2012, LANCET, V379, P1686, DOI 10.1016/S0140-6736(11)60785-X; World Health Organization, WORLD HLTH STAT 2015	12	24	32	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2017	389	10069					582	584		10.1016/S0140-6736(17)30184-8	http://dx.doi.org/10.1016/S0140-6736(17)30184-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9AF	28195043				2022-12-28	WOS:000394910800008
J	Cornwall, W				Cornwall, Warren			RULES OF EVIDENCE	SCIENCE			English	Editorial Material																			0	1	1	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					564	567		10.1126/science.355.6325.564	http://dx.doi.org/10.1126/science.355.6325.564			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK0SF	28183924				2022-12-28	WOS:000393636700015
J	Clark, TD				Clark, Timothy D.			Science, lies and video-taped experiments	NATURE			English	Editorial Material									[Clark, Timothy D.] Univ Tasmania, Hobart, Tas 7001, Australia; [Clark, Timothy D.] CSIRO, Hobart, Tas, Australia	University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Clark, TD (corresponding author), Univ Tasmania, Hobart, Tas 7001, Australia.; Clark, TD (corresponding author), CSIRO, Hobart, Tas, Australia.	timothy.clark.mail@gmail.com	Clark, Timothy Darren/K-7129-2012	Clark, Timothy Darren/0000-0001-8738-3347					0	10	10	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					139	139		10.1038/542139a	http://dx.doi.org/10.1038/542139a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK2DJ	28179685	Green Submitted, Bronze			2022-12-28	WOS:000393737500004
J	Hyman, DM; Taylor, BS; Baselga, J				Hyman, David M.; Taylor, Barry S.; Baselga, Jose			Implementing Genome-Driven Oncology	CELL			English	Review							CELL LUNG-CANCER; CHRONIC MYELOID-LEUKEMIA; METASTATIC BREAST-CANCER; TARGETED THERAPY; PROSTATE-CANCER; OPEN-LABEL; ACQUIRED-RESISTANCE; PRECISION MEDICINE; COLORECTAL-CANCER; PD-1 BLOCKADE	Early successes in identifying and targeting individual oncogenic drivers, together with the increasing feasibility of sequencing tumor genomes, have brought forth the promise of genomedriven oncology care. As we expand the breadth and depth of genomic analyses, the biological and clinical complexity of its implementation will be unparalleled. Challenges include target credentialing and validation, implementing drug combinations, clinical trial designs, targeting tumor heterogeneity, and deploying technologies beyond DNA sequencing, among others. We review how contemporary approaches are tackling these challenges and will ultimately serve as an engine for biological discovery and increase our insight into cancer and its treatment.	[Hyman, David M.; Baselga, Jose] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10065 USA; [Taylor, Barry S.; Baselga, Jose] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10065 USA; [Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 1275 York Ave, New York, NY 10065 USA; [Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10065 USA; [Hyman, David M.; Baselga, Jose] Weill Cornell Med Coll, 1300 York Ave, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Baselga, J (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10065 USA.; Baselga, J (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10065 USA.; Baselga, J (corresponding author), Weill Cornell Med Coll, 1300 York Ave, New York, NY 10065 USA.	baselgaj@mskcc.org			Prostate Cancer Foundation; Sontag Foundation; Josie Robertson Foundation; Breast Cancer Research Foundation; Geoffrey Beene Cancer Research Center; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; Cycle for Survival; National Institutes of Health [R01 CA190642-01A1, P50 CA092629, R01 CA207244, U54 OD202355, P30 CA008748]; NATIONAL CANCER INSTITUTE [R01CA204749, R01CA190642, P50CA092629, P30CA008748, R01CA207244] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U54OD020355] Funding Source: NIH RePORTER	Prostate Cancer Foundation; Sontag Foundation; Josie Robertson Foundation; Breast Cancer Research Foundation; Geoffrey Beene Cancer Research Center; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; Cycle for Survival; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Alison M. Schram and Maurizio Scaltriti for their critical reading of this manuscript, Jianjiong Gao and Nikolaus Schultz for clinical annotation of sequenced specimens, and Scott Johnson for assistance with medical graphics. The authors acknowledge support from the Prostate Cancer Foundation, the Sontag Foundation, the Josie Robertson Foundation, the Breast Cancer Research Foundation, the Geoffrey Beene Cancer Research Center, the Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Cycle for Survival, and National Institutes of Health awards R01 CA190642-01A1 (J.B.), P50 CA092629 (B.S.T.), R01 CA207244 (D.M.H. and B.S.T.), U54 OD202355 (B.S.T.), and P30 CA008748. J.B. is a member of the scientific advisory board of GRAIL.	Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Beltran H, 2015, JAMA ONCOL, V1, P466, DOI 10.1001/jamaoncol.2015.1313; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; Bleeker FE, 2008, ONCOGENE, V27, P5648, DOI 10.1038/onc.2008.170; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Bower H, 2016, J CLIN ONCOL, V34, P2851, DOI 10.1200/JCO.2015.66.2866; Brenan L, 2016, CELL REP, V17, P1171, DOI 10.1016/j.celrep.2016.09.061; Brose MS, 2016, LANCET ONCOL, V17, P1272, DOI 10.1016/S1470-2045(16)30166-8; Cardoso F, 2016, NEW ENGL J MED, V375, P717, DOI 10.1056/NEJMoa1602253; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Cunanan KM, 2017, J CLIN ONCOL, V35, P271, DOI 10.1200/JCO.2016.69.9751; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Drilon A, 2016, LANCET ONCOL, V17, P1653, DOI 10.1016/S1470-2045(16)30562-9; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Eubank MH, 2016, J AM MED INFORM ASSN, V23, P777, DOI 10.1093/jamia/ocw020; Frampton GM, 2015, CANCER DISCOV, V5, P850, DOI 10.1158/2159-8290.CD-15-0285; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; HALEVY O, 1990, SCIENCE, V250, P113, DOI 10.1126/science.2218501; Hata AN, 2016, NAT MED, V22, P262, DOI 10.1038/nm.4040; He J, 2016, BLOOD, V127, P3004, DOI 10.1182/blood-2015-08-664649; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hyman DM, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.SABCS15-PD5-05; Hyman D. M., 2015, AM ASS CANC RES S2, V14, pB109, DOI DOI 10.1158/1535-7163.TARG-15-B109; Hyman DM, 2015, DRUG DISCOV TODAY, V20, P1422, DOI 10.1016/j.drudis.2015.08.005; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Juric D, 2015, NATURE, V518, P240, DOI 10.1038/nature13948; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kaufman B, 2015, J CLIN ONCOL, V33, P244, DOI 10.1200/JCO.2014.56.2728; Kim E, 2016, CANCER DISCOV, V6, P714, DOI 10.1158/2159-8290.CD-16-0160; Kitzman JO, 2015, NAT METHODS, V12, P203, DOI [10.1038/NMETH.3223, 10.1038/nmeth.3223]; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; LaFave LM, 2015, NAT MED, V21, P1344, DOI 10.1038/nm.3947; Lai A, 2015, J MED CHEM, V58, P4888, DOI 10.1021/acs.jmedchem.5b00054; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lanman RB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140712; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Melnikov A, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku511; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Meric-Bernstam F, 2015, J CLIN ONCOL, V33, P2753, DOI 10.1200/JCO.2014.60.4165; Milojkovic D, 2009, CLIN CANCER RES, V15, P7519, DOI 10.1158/1078-0432.CCR-09-1068; Mirza MR, 2016, NEW ENGL J MED, V375, P2154, DOI 10.1056/NEJMoa1611310; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Pearson A, 2016, CANCER DISCOV, V6, P838, DOI 10.1158/2159-8290.CD-15-1246; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Planchard D, 2016, LANCET ONCOL, V17, P642, DOI 10.1016/S1470-2045(16)00077-2; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Pritchard CC, 2016, NEW ENGL J MED, V375, P443, DOI 10.1056/NEJMoa1603144; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Russo M, 2016, CANCER DISCOV, V6, P147, DOI 10.1158/2159-8290.CD-15-1283; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Schrader KA, 2016, JAMA ONCOL, V2, P104, DOI 10.1001/jamaoncol.2015.5208; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Shen RL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw520; Siu LL, 2016, NAT MED, V22, P464, DOI 10.1038/nm.4089; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stransky N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5846; Swain SM, 2015, NEW ENGL J MED, V372, P724, DOI 10.1056/NEJMoa1413513; Tabernero J, 2015, J CLIN ONCOL, V33, P3401, DOI 10.1200/JCO.2014.60.7341; Telli ML, 2016, CLIN CANCER RES, V22, P3764, DOI 10.1158/1078-0432.CCR-15-2477; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Tiacci E, 2015, NEW ENGL J MED, V373, P1733, DOI 10.1056/NEJMoa1506583; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Turner NC, 2015, NEW ENGL J MED, V373, P209, DOI 10.1056/NEJMoa1505270; Vaishnavi A, 2015, CANCER DISCOV, V5, P25, DOI 10.1158/2159-8290.CD-14-0765; Voest EE, 2016, CANCER DISCOV, V6, P130, DOI 10.1158/2159-8290.CD-15-1321; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Yang JCH, 2015, LANCET ONCOL, V16, P830, DOI 10.1016/S1470-2045(15)00026-1; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhang JH, 2015, NEW ENGL J MED, V373, P2336, DOI 10.1056/NEJMoa1508054	87	281	286	6	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2017	168	4					584	599		10.1016/j.cell.2016.12.015	http://dx.doi.org/10.1016/j.cell.2016.12.015			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8VJ	28187282	Green Accepted, Bronze			2022-12-28	WOS:000396277600011
J	Kucherlapati, R				Kucherlapati, Raju			Oliver Smithies (1925-2017) OBITUARY	NATURE			English	Biographical-Item									[Kucherlapati, Raju] Harvard Med Sch, Genet & Med, Boston, MA 02215 USA; [Kucherlapati, Raju] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Kucherlapati, R (corresponding author), Harvard Med Sch, Genet & Med, Boston, MA 02215 USA.; Kucherlapati, R (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	rkucherlapati@partners.org	Kucherlapati, Raju/ABC-8807-2021					SMITHIES O, PUBLICATION LIST	1	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					166	166		10.1038/542166a	http://dx.doi.org/10.1038/542166a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK2DJ	28179651	Bronze			2022-12-28	WOS:000393737500022
J	Sharma, P; Hu-Lieskovan, S; Wargo, JA; Ribas, A				Sharma, Padmanee; Hu-Lieskovan, Siwen; Wargo, Jennifer A.; Ribas, Antoni			Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy	CELL			English	Review							REGULATORY T-CELLS; TUMOR-ASSOCIATED MACROPHAGES; ANTITUMOR IMMUNE-RESPONSES; PD-1 BLOCKADE; CHECKPOINT BLOCKADE; TGF-BETA; ADVANCED MELANOMA; BRAF INHIBITION; CTLA-4 BLOCKADE; INDOLEAMINE 2,3-DIOXYGENASE	Cancer immunotherapy can induce long lasting responses in patients with metastatic cancers of a wide range of histologies. Broadening the clinical applicability of these treatments requires an improved understanding of the mechanisms limiting cancer immunotherapy. The interactions between the immune system and cancer cells are continuous, dynamic, and evolving from the initial establishment of a cancer cell to the development of metastatic disease, which is dependent on immune evasion. As the molecular mechanisms of resistance to immunotherapy are elucidated, actionable strategies to prevent or treat them may be derived to improve clinical outcomes for patients.	[Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol & Immunol, Houston, TX 77030 USA; [Hu-Lieskovan, Siwen; Ribas, Antoni] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Hu-Lieskovan, Siwen; Ribas, Antoni] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Wargo, Jennifer A.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Sharma, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol & Immunol, Houston, TX 77030 USA.; Ribas, A (corresponding author), Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA.; Ribas, A (corresponding author), Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.	padsharma@mdanderson.org; aribas@mednet.ucla.edu			Parker Institute for Cancer Immunotherapy; NIH/NCI [R01 CA1633793, R35 CA197633, P01 CA168585]; Cancer Prevention Research in Texas (CPRIT) [RP120108]; Ressler Family Fund; Garcia-Corsini Family Fund; Samuels Family Fund; Grimaldi Family Fund; Stand Up To Cancer-Cancer Research Institute Cancer Immunology Dream Team Translational Research Grant [SU2C-AACR-DT1012]; American Society of Clinical Oncology (ASCO); Tower Cancer Research Foundation Grant; Hope Foundation; UCLA KL2 Award; NATIONAL CANCER INSTITUTE [K08CA160692, P30CA016672, R01CA163793] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001881, UL1TR000124] Funding Source: NIH RePORTER	Parker Institute for Cancer Immunotherapy; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention Research in Texas (CPRIT); Ressler Family Fund; Garcia-Corsini Family Fund; Samuels Family Fund; Grimaldi Family Fund; Stand Up To Cancer-Cancer Research Institute Cancer Immunology Dream Team Translational Research Grant; American Society of Clinical Oncology (ASCO); Tower Cancer Research Foundation Grant; Hope Foundation; UCLA KL2 Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by the Parker Institute for Cancer Immunotherapy, NIH/NCI grants R01 CA1633793 (P.S.), R35 CA197633, and P01 CA168585 (A.R.), Cancer Prevention Research in Texas (CPRIT) grant RP120108 (P.S.), the Ressler Family Fund, the Garcia-Corsini Family Fund, the Samuels Family Fund, and the Grimaldi Family Fund (A.R.), and a Stand Up To Cancer-Cancer Research Institute Cancer Immunology Dream Team Translational Research Grant (SU2C-AACR-DT1012; P.S. and A.R.). S.H.-L. was supported by a Career Development Award from the American Society of Clinical Oncology (ASCO), a Tower Cancer Research Foundation Grant, a Dr. Charles Coltman Fellowship Award from the Hope Foundation, and a UCLA KL2 Award.	Akbay EA, 2013, CANCER DISCOV, V3, P1355, DOI 10.1158/2159-8290.CD-13-0310; Allard B, 2014, INT J CANCER, V134, P1466, DOI 10.1002/ijc.28456; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Beatty GL, 2014, CANCER IMMUNOL RES, V2, P112, DOI 10.1158/2326-6066.CIR-13-0170; Beavis PA, 2015, ONCOIMMUNOLOGY, V4; Benci JL, 2016, CELL, V167, P1540, DOI 10.1016/j.cell.2016.11.022; Berrien-Elliott MM, 2013, CANCER RES, V73, P605, DOI 10.1158/0008-5472.CAN-12-2179; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Boni A, 2010, CANCER RES, V70, P5213, DOI 10.1158/0008-5472.CAN-10-0118; Bradley SD, 2015, CANCER IMMUNOL RES, V3, P602, DOI 10.1158/2326-6066.CIR-15-0030; Bronte V, 1998, J IMMUNOL, V161, P5313; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Burnet F M, 1971, Transplant Rev, V7, P3; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Chang CH, 2016, NAT IMMUNOL, V17, P364, DOI 10.1038/ni.3415; Chang DK, 2012, MOL CANCER THER, V11, P2451, DOI 10.1158/1535-7163.MCT-12-0278; Chanmee T, 2014, CANCERS, V6, P1670, DOI 10.3390/cancers6031670; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chaudhary B, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4030028; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chen PL, 2016, CANCER DISCOV, V6, P827, DOI 10.1158/2159-8290.CD-15-1545; Chodon T, 2014, CLIN CANCER RES, V20, P2457, DOI 10.1158/1078-0432.CCR-13-3017; Coley W. B., 1910, P ROY SOC MED, V3, P1, DOI DOI 10.1177/003591571000301601; Comin-Anduix B, 2010, CLIN CANCER RES, V16, P6040, DOI 10.1158/1078-0432.CCR-10-1911; Cooper ZA, 2014, CANCER IMMUNOL RES, V2, P643, DOI 10.1158/2326-6066.CIR-13-0215; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Das R, 2015, J IMMUNOL, V194, P950, DOI 10.4049/jimmunol.1401686; De Henau O, 2016, NATURE, V539, P443, DOI 10.1038/nature20554; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Dorand RD, 2016, SCIENCE, V353, P399, DOI 10.1126/science.aae0477; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; DURSO CM, 1991, J CLIN INVEST, V87, P284, DOI 10.1172/JCI114984; Ehrlich P., 1956, COLLECTED PAPERS 4 V; ESHHAR Z, 1993, P NATL ACAD SCI USA, V90, P720, DOI 10.1073/pnas.90.2.720; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fritz JM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00587; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; GERSHON RK, 1970, IMMUNOLOGY, V18, P723; Gil M, 2014, J IMMUNOL, V193, P5327, DOI 10.4049/jimmunol.1400201; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hamid O, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-204; Hanks B.A., 2014, ASCO ANN M P; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Heninger E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00029; Hicklin DJ, 1998, J CLIN INVEST, V101, P2720, DOI 10.1172/JCI498; Highfill SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007974; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Holmgaard RB, 2013, J EXP MED, V210, P1389, DOI 10.1084/jem.20130066; Hu W, 2016, CLIN TRANSL ONCOL, V18, P251, DOI 10.1007/s12094-015-1373-0; Hu-Lieskovan S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4691; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Kaplan MH, 1998, J EXP MED, V188, P1191, DOI 10.1084/jem.188.6.1191; Karpf AR, 2002, ONCOGENE, V21, P5496, DOI 10.1038/sj.onc.1205602; Kataoka K, 2016, NATURE, V534, P402, DOI 10.1038/nature18294; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Kodumudi KN, 2012, J IMMUNOL, V189, P5147, DOI 10.4049/jimmunol.1200274; Koya RC, 2012, CANCER RES, V72, P3928, DOI 10.1158/0008-5472.CAN-11-2837; Koyama S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10501; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Laborde RR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00147; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Larkin J, 2015, JAMA ONCOL, V1, P433, DOI 10.1001/jamaoncol.2015.1184; Lastwika KJ, 2016, CANCER RES, V76, P227, DOI 10.1158/0008-5472.CAN-14-3362; Le DT, 2013, J IMMUNOTHER, V36, P382, DOI 10.1097/CJI.0b013e31829fb7a2; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lebrun Jean-Jacques, 2012, ISRN Mol Biol, V2012, P381428, DOI 10.5402/2012/381428; Leclerc BG, 2016, CLIN CANCER RES, V22, P158, DOI 10.1158/1078-0432.CCR-15-1181; Lin RL, 2015, CANCER BIOL MED, V12, P385, DOI 10.7497/j.issn.2095-3941.2015.0015; Liu CW, 2013, CLIN CANCER RES, V19, P393, DOI 10.1158/1078-0432.CCR-12-1626; Loi S, 2013, P NATL ACAD SCI USA, V110, P11091, DOI 10.1073/pnas.1222251110; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Ma C, 2013, CANCER DISCOV, V3, P418, DOI 10.1158/2159-8290.CD-12-0383; Ma C, 2011, NAT MED, V17, P738, DOI 10.1038/nm.2375; Madore J, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12340; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Meyer C, 2014, CANCER IMMUNOL IMMUN, V63, P247, DOI 10.1007/s00262-013-1508-5; Miller JFAP, 2015, CANCER CELL, V27, P439, DOI 10.1016/j.ccell.2015.03.007; Miller RE, 2002, J IMMUNOL, V169, P1792, DOI 10.4049/jimmunol.169.4.1792; Mittal D., 2016, CANC RES, V76; Mok S, 2014, CANCER RES, V74, P153, DOI 10.1158/0008-5472.CAN-13-1816; Moon EK, 2014, CLIN CANCER RES, V20, P4262, DOI 10.1158/1078-0432.CCR-13-2627; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Ninomiya S, 2015, BLOOD, V125, P3905, DOI 10.1182/blood-2015-01-621474; Oida T, 2003, J IMMUNOL, V170, P2516, DOI 10.4049/jimmunol.170.5.2516; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Ormandy LA, 2005, CANCER RES, V65, P2457, DOI 10.1158/0008-5472.CAN-04-3232; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Peng WY, 2016, CANCER DISCOV, V6, P202, DOI 10.1158/2159-8290.CD-15-0283; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Puzanov I, 2016, J CLIN ONCOL, V34, P2619, DOI 10.1200/JCO.2016.67.1529; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Redmond WL, 2007, J IMMUNOL, V179, P7244, DOI 10.4049/jimmunol.179.11.7244; Redmond WL, 2014, CANCER IMMUNOL RES, V2, P142, DOI 10.1158/2326-6066.CIR-13-0031-T; Restifo NP, 1996, J NATL CANCER I, V88, P100, DOI 10.1093/jnci/88.2.100; Ribas A, 2015, CANCER DISCOV, V5, P915, DOI 10.1158/2159-8290.CD-15-0563; Ribas A, 2015, LANCET ONCOL, V16, P908, DOI 10.1016/S1470-2045(15)00083-2; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Roszik J, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0705-4; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Ruella M, 2016, J CLIN INVEST, V126, P3814, DOI 10.1172/JCI87366; Ruffell B, 2015, CANCER CELL, V27, P462, DOI 10.1016/j.ccell.2015.02.015; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Sadelain M, 2016, CURR OPIN IMMUNOL, V41, P68, DOI 10.1016/j.coi.2016.06.004; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Schachter J, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_supll.9504; Schadendorf D., 2015, J CLIN ONCOL, V33; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Shin DS, 2015, CURR OPIN IMMUNOL, V33, P23, DOI 10.1016/j.coi.2015.01.006; Shin DS, 2016, CANC DISCOV; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Solito S, 2011, BLOOD, V118, P2254, DOI 10.1182/blood-2010-12-325753; Sotillo E, 2015, CANCER DISCOV, V5, P1282, DOI 10.1158/2159-8290.CD-15-1020; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Spranger S, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-3; Stagg J, 2010, P NATL ACAD SCI USA, V107, P1547, DOI 10.1073/pnas.0908801107; Sucker A, 2014, CLIN CANCER RES, V20, P6593, DOI 10.1158/1078-0432.CCR-14-0567; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Sundstedt A, 2003, J IMMUNOL, V170, P1240, DOI 10.4049/jimmunol.170.3.1240; TAKAHASHI H, 1993, CANCER RES, V53, P1612; Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581; Tang DYL, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00236; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Tham M, 2015, ONCOTARGET, V6, P22857, DOI 10.18632/oncotarget.3127; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Turcotte M, 2015, CANCER RES, V75, P4494, DOI 10.1158/0008-5472.CAN-14-3569; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Vanpouille-Box C, 2015, CANCER RES, V75, P2232, DOI 10.1158/0008-5472.CAN-14-3511; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Viehl CT, 2006, ANN SURG ONCOL, V13, P1252, DOI 10.1245/s10434-006-9015-y; Vo DD, 2009, CANCER RES, V69, P8693, DOI 10.1158/0008-5472.CAN-09-1456; Wang LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062924; Wargo JA, 2016, CURR OPIN IMMUNOL, V41, P23, DOI 10.1016/j.coi.2016.05.006; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8; Wesolowski R, 2013, J IMMUNOTHER CANCER, V1, DOI 10.1186/2051-1426-1-10; Wilmott JS, 2012, CLIN CANCER RES, V18, P1386, DOI 10.1158/1078-0432.CCR-11-2479; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wu XS, 2014, J INVEST DERMATOL, V134, P2814, DOI 10.1038/jid.2014.206; Yang J.C., 2016, ADV IMMUNOL, P279; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yee C, 2015, CANCER J, V21, P492, DOI 10.1097/PPO.0000000000000158; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhang H, 2004, J IMMUNOL, V173, P932, DOI 10.4049/jimmunol.173.2.932; Zhu Y, 2014, CANCER RES, V74, P5057, DOI 10.1158/0008-5472.CAN-13-3723; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	178	2321	2425	53	737	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2017	168	4					707	723		10.1016/j.cell.2017.01.017	http://dx.doi.org/10.1016/j.cell.2017.01.017			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8VJ	28187290	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000396277600019
J	Thwaites, GE; Day, NPJ				Thwaites, Guy E.; Day, Nicholas P. J.			Approach to Fever in the Returning Traveler	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							COMPUTER-PROGRAM GIDEON; INTERNATIONAL TRAVELERS; INFECTIOUS-DISEASES; SIERRA-LEONE; EBOLA-VIRUS; SURVEILLANCE; DIAGNOSIS; ILLNESS; HEALTH; GUIDELINES		[Thwaites, Guy E.; Day, Nicholas P. J.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England; [Thwaites, Guy E.] Univ Oxford, Clin Res Unit, 764 Vo Van Kiet,Quan 5, Ho Chi Minh City, Vietnam; [Day, Nicholas P. J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Bangkok, Thailand	University of Oxford; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University	Thwaites, GE (corresponding author), Univ Oxford, Clin Res Unit, 764 Vo Van Kiet,Quan 5, Ho Chi Minh City, Vietnam.	gthwaites@oucru.org	Keske, Siran/Q-1451-2019; Keske, Şiran/U-7339-2019; Thwaites, Guy E/R-4993-2019	Thwaites, Guy E/0000-0002-2858-2087				Ambresin AE, 2007, COMPUT METH PROG BIO, V85, P19, DOI 10.1016/j.cmpb.2006.09.004; [Anonymous], 2015, EB EB VIR DIS EP RIS; Boggild AK, 2015, ANN INTERN MED, V162, P757, DOI 10.7326/M15-0074; Boggild AK, 2010, VACCINE, V28, P7389, DOI 10.1016/j.vaccine.2010.09.009; Bottieau E, 2008, MED DECIS MAKING, V28, P435, DOI 10.1177/0272989X07312715; Bottieau E, 2006, ARCH INTERN MED, V166, P1642, DOI 10.1001/archinte.166.15.1642; Brownstein JS, 2010, NEW ENGL J MED, V362, P1731, DOI 10.1056/NEJMsr1002707; Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151; Demeester RP, 2011, J TRAVEL MED, V18, P386, DOI 10.1111/j.1708-8305.2011.00566.x; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Edberg SC, 2005, CLIN INFECT DIS, V40, P123, DOI 10.1086/426549; Faiz MA, 2005, LANCET, V366, P717; Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331; Ftika L, 2013, J HOSP INFECT, V83, P185, DOI 10.1016/j.jhin.2012.10.013; Gautret P, 2012, J TRAVEL MED, V19, P169, DOI 10.1111/j.1708-8305.2012.00613.x; Gherardin A, 2012, AUST PRESCR, V35, P10, DOI 10.18773/austprescr.2012.010; Hagmann S, 2010, PEDIATRICS, V125, pE1072, DOI 10.1542/peds.2009-1951; Hill DR, 2000, J TRAVEL MED, V7, P259, DOI 10.2310/7060.2000.00075; Hui DS, 2015, CURR OPIN PULM MED, V21, P284, DOI 10.1097/MCP.0000000000000153; Jensenius M, 2013, AM J TROP MED HYG, V88, P397, DOI 10.4269/ajtmh.12-0551; Johnston V, 2009, J INFECTION, V59, P1, DOI 10.1016/j.jinf.2009.05.005; Kantele A, 2015, CLIN INFECT DIS, V60, P837, DOI 10.1093/cid/ciu957; Kimura Mikio, 2005, Travel Med Infect Dis, V3, P157, DOI 10.1016/j.tmaid.2004.08.003; Kundavaram AP, 2013, J POSTGRAD MED, V59, P177, DOI 10.4103/0022-3859.118033; Leder Karin, 2009, Curr Infect Dis Rep, V11, P51, DOI 10.1007/s11908-009-0008-4; Leder K, 2006, CLIN INFECT DIS, V43, P1185, DOI 10.1086/507893; Lim PL, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-386; Luo RF, 2006, CLIN INFECT DIS, V42, P157, DOI 10.1086/498752; Marano C, 2009, CURR OPIN INFECT DIS, V22, P423, DOI 10.1097/QCO.0b013e32832ee896; Matteelli A, 2013, LANCET INFECT DIS, V13, P205, DOI 10.1016/S1473-3099(12)70291-8; Molton JS, 2013, CLIN INFECT DIS, V56, P1310, DOI 10.1093/cid/cit020; Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003; Mueller Y, 2014, J TRAVEL MED, V21, P169, DOI 10.1111/jtm.12099; Nielsen CF, 2015, MMWR-MORBID MORTAL W, V64, P20; Nusch-Inderbinen M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0948-2; O'Brien DP, 2006, J TRAVEL MED, V13, P145, DOI 10.1111/j.1708-8305.2006.00033.x; Pitman MC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003586; Public Health England, 2015, RISK ASS EB VIR DIS; Public Health England, 2015, VIR HAEM FEV ACDP AL; Rahi M, 2015, INDIAN J MED RES, V141, P417, DOI 10.4103/0971-5916.159279; Rogstad KE, 2015, CURR OPIN INFECT DIS, V28, P83, DOI 10.1097/QCO.0000000000000135; Ross JJ, 1998, CLIN INFECT DIS, V26, P766, DOI 10.1086/517123; Ruppe E, 2015, CLIN INFECT DIS, V61, P593, DOI 10.1093/cid/civ333; Ryan ET, 2002, NEW ENGL J MED, V347, P505, DOI 10.1056/NEJMra020118; Schlagenhauf P, 2015, LANCET INFECT DIS, V15, P55, DOI 10.1016/S1473-3099(14)71000-X; Schlagenhauf P, 2010, CLIN INFECT DIS, V50, P826, DOI 10.1086/650575; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Taylor AJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003971; Torresi J, 2009, NAT REV MICROBIOL, V7, P895, DOI 10.1038/nrmicro2238; van der Bij AK, 2012, J ANTIMICROB CHEMOTH, V67, P2090, DOI 10.1093/jac/dks214; Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X; Wilson ME, 2007, CURR OPIN INFECT DIS, V20, P449; Wilson ME, 2007, CLIN INFECT DIS, V44, P1560, DOI 10.1086/518173	53	43	46	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2017	376	6					548	560		10.1056/NEJMra1508435	http://dx.doi.org/10.1056/NEJMra1508435			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8XL	28177860	Green Published			2022-12-28	WOS:000393510500009
J	Kintisch, E				Kintisch, Eli			MELTDOWN As algae, detritus, and meltwater darken Greenland's ice, it is shrinking ever faster	SCIENCE			English	Editorial Material																			0	8	8	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					788	791		10.1126/science.355.6327.788	http://dx.doi.org/10.1126/science.355.6327.788			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28232534				2022-12-28	WOS:000395127600016
J	Rosen, J				Rosen, Julia			California rains put spotlight on atmospheric rivers	SCIENCE			English	News Item																			0	6	6	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					787	787		10.1126/science.355.6327.787	http://dx.doi.org/10.1126/science.355.6327.787			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28232533				2022-12-28	WOS:000395127600015
J	Simkin, DJ; Greene, JA; Jung, JLN; Sacks, BC; Fessler, HE				Simkin, Daren J.; Greene, Jeremy A.; Jung, Julianna; Sacks, Bethany C.; Fessler, Henry E.			The Death of Animals in Medical School	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Simkin, Daren J.; Greene, Jeremy A.; Jung, Julianna; Sacks, Bethany C.; Fessler, Henry E.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University	Simkin, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.							Association of American Medical Colleges, 2008, AAMC POL US AN MED R; Council on Scientific Affairs American Medical Association, 1991, JAMA-J AM MED ASSOC, V266, P836; Gawande A., 2002, NEW YORKER, V77, P52; Hansen LA, 2002, ACAD MED, V77, P1147, DOI 10.1097/00001888-200211000-00018; LEDERER SE, 1992, ISIS, V83, P61, DOI 10.1086/356025	5	8	9	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2017	376	8					713	715		10.1056/NEJMp1612992	http://dx.doi.org/10.1056/NEJMp1612992			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JO	28225675				2022-12-28	WOS:000395627900004
J	Hanson, M; Mullins, E; Modi, N				Hanson, Mark; Mullins, Edward; Modi, Neena			Time for the UK to commit to tackling child obesity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hanson, Mark] Univ Southampton, Inst Dev Sci, Tremona Rd, Southampton SO16 6YD, Hants, England; [Mullins, Edward] Imperial Coll Healthcare NHS Trust, Queen Charlottes & Chelsea Hosp, Du Cane Rd, London W12 0HS, England; [Modi, Neena] Imperial Coll London, Dept Med, Chelsea & Westminster Campus,369 Fulham Rd, London SW10, England	University of Southampton; Imperial College London; Imperial College London	Hanson, M (corresponding author), Univ Southampton, Inst Dev Sci, Tremona Rd, Southampton SO16 6YD, Hants, England.	m.hanson@soton.ac.uk	Hanson, Mark/AAE-8236-2019	Hanson, Mark/0000-0002-6907-613X; Mullins, Edward/0000-0003-1886-6358	British Heart Foundation [PG/14/33/30827] Funding Source: researchfish	British Heart Foundation(British Heart Foundation)		[Anonymous], 2016, LANCET, V388, P841, DOI 10.1016/S0140-6736(16)31476-3; Boseley S, 2016, GUARDIAN; Britto PR, 2017, LANCET, V389, P91, DOI 10.1016/S0140-6736(16)31390-3; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; Department of Health, 2014, CHIEF MED OFF ANN RE; Gillman MW, 2013, NEW ENGL J MED, V369, P2173, DOI 10.1056/NEJMp1310577; Hanson MA, 2015, INT J GYNECOL OBSTET, V131, pS213, DOI 10.1016/S0020-7292(15)30034-5; Hanson MA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1025; HM Government, 2016, CHILDH OB PLAN ACT; Knai C, 2016, BMJ-BRIT MED J, V356, pi4613; Lobstein T, 2016, LANCET, V388, P853, DOI 10.1016/S0140-6736(16)31471-4; Ma RCW, 2013, CLIN OBSTET GYNECOL, V56, P633, DOI 10.1097/GRF.0b013e31829e5bb0; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Pelone F, 2012, OBES REV, V13, P431, DOI 10.1111/j.1467-789X.2011.00968.x; Poston L, 2012, MATERNAL OBESITY, P100; Redsell SA, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-54; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Robinson SM, 2015, AM J CLIN NUTR, V101, P368, DOI [10.3945/ajcn.114.094268, 10.3945/ajcn.1]; Royal College of Paediatrics and Child Health, RCPCH RESP WEAK CHIL; Story MT, 2002, PEDIATRICS, V110, P210; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; United Nations, SUST DEV GOALS; World Health Organization, 2016, REP COMM END CHILDH; World Health Organization, 2016, UNH FOOD DRINK MARK; World Health Organization (WHO), REP COMM END CHILDH	25	4	4	2	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2017	356								j762	10.1136/bmj.j762	http://dx.doi.org/10.1136/bmj.j762			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KS	28228379	Green Submitted			2022-12-28	WOS:000395631000005
J	Lenzer, J				Lenzer, Jeanne			Is the United States Preventive Services Task Force still a voice of caution?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jlenzer@bmj.com						Agency for Healthcare Research and Quality, METHODOLOGY; Agency for Healthcare Research and Quality, 2015, EV BAS PRACT CTR PRO; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Bergus GR, 2005, J RURAL HEALTH, V21, P303, DOI 10.1111/j.1748-0361.2005.tb00099.x; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P1997, DOI 10.1001/jama.2016.15450; Bishop TF, 2016, HEALTH AFFAIR, V35, P1271, DOI 10.1377/hlthaff.2015.1643; Bishop TF, 2014, JAMA PSYCHIAT, V71, P176, DOI 10.1001/jamapsychiatry.2013.2862; Borgmeyer C, 2014, EVIDENCE LACKING SUP; Brownlee S, 2009, PAINKILLER TRIAL RAI; Deyo RA, 1997, NEW ENGL J MED, V336, P1176, DOI 10.1056/NEJM199704173361611; Dowrick C, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7140; Duke Clinical Research Institute, 2015, ANN REP ANSW TOD QUE; Effective Healthcare, AHRQ EV BAS PRACT CT; Fedorkow D, 2011, ANN INTERN MED, V155, DOI 10.7326/0003-4819-155-6-201109200-02008; Frances A., 2016, SCREEN EVERYONE DEPR; Frieden J, 2015, HOUSE COMMITTEE VOTE; Health Resources and Services Administration, WHAT AR FED QUAL HLT; Jarjoura D, 2004, J GEN INTERN MED, V19, P78, DOI 10.1111/j.1525-1497.2004.21249.x; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; Joffres M, 2013, CAN MED ASSOC J, V185, P775, DOI 10.1503/cmaj.130403; Le Noury J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4320; Lenzer J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1332; Leventhal R, 2015, AHRQ SEES BUDGET CUT; McDonagh M, 2014, ANTIDEPRESSANT TREAT; Mojtabai R, 2013, PSYCHOTHER PSYCHOSOM, V82, P161, DOI 10.1159/000345968; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Moyer VA, 2012, ANN INTERN MED, V157, P900, DOI 10.7326/0003-4819-157-11-201212040-00539; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; O'Connor E, EVIDENCE SYNTHESES; Prasad V, 2016, BMJ-BRIT MED J, V352, ph6080, DOI DOI 10.1136/BMJ.H6080; Redberg RF, 2016, JAMA-J AM MED ASSOC, V316, P1979, DOI 10.1001/jama.2016.15085; Ridker PM, 2010, CIRC-CARDIOVASC QUAL, V3, P447, DOI 10.1161/CIRCOUTCOMES.110.938118; Rost K, 2001, J GEN INTERN MED, V16, P143, DOI 10.1111/j.1525-1497.2001.00537.x; Schroll JB, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2231; Siu AL, 2016, ANN INTERN MED, V164, P360, DOI 10.7326/M15-2957; Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P380, DOI 10.1001/jama.2015.18392; Thombs BD, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-13; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; UK National Screening Committee, 2015, SCREEN DEPR; US Preventive Services Task Force, CONFL INT DISCL; Vaccarino V, 2009, CIRC-CARDIOVASC QUAL, V2, P286, DOI 10.1161/CIRCOUTCOMES.109.850404; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Williams JW, 1999, AM J MED, V106, P36, DOI 10.1016/S0002-9343(98)00371-4	44	6	6	2	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2017	356								j743	10.1136/bmj.j743	http://dx.doi.org/10.1136/bmj.j743			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KS	28223421	Green Published			2022-12-28	WOS:000395631000004
J	Sahnan, K; Adegbola, SO; Tozer, PJ; Watfah, J; Phillips, RKS				Sahnan, Kapil; Adegbola, Samuel O.; Tozer, Phillip J.; Watfah, Josef; Phillips, Robin K. S.			CLINICAL UPDATES Perianal abscess	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sahnan, Kapil; Adegbola, Samuel O.; Tozer, Phillip J.; Phillips, Robin K. S.] Imperial Coll, Fac Med, St Marks Hosp, London SW7 2AZ, England; [Watfah, Josef] Northwick Pk Hosp & Clin Res Ctr, London, England	Imperial College London; Imperial College London	Sahnan, K (corresponding author), Imperial Coll, Fac Med, St Marks Hosp, London SW7 2AZ, England.	ks303@doctors.org.uk	Sahnan, Kapil/W-6310-2019; Adegbola, Samuel O./M-7620-2019	Sahnan, Kapil/0000-0003-3885-5752; Adegbola, Samuel O./0000-0003-2522-3895				Abcarian Herand, 2011, Clin Colon Rectal Surg, V24, P14, DOI 10.1055/s-0031-1272819; Adamo K, 2016, INT J COLORECTAL DIS, V31, P669, DOI 10.1007/s00384-015-2500-7; [Anonymous], EM SURG STAND UNSCH; Causey MW, 2013, GASTROENTEROL REP, V1, P58, DOI 10.1093/gastro/got001; Cohen JS, 1996, DIS COLON RECTUM, V39, P981, DOI 10.1007/BF02054685; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; EISENHAMMER S, 1956, SURG GYNECOL OBSTET, V103, P501; FRY GA, 1965, MAYO CLIN PROC, V40, P296; GRACE RH, 1982, BRIT J SURG, V69, P401, DOI 10.1002/bjs.1800690715; Gupta P J, 2005, Afr Health Sci, V5, P345; HENRICHSEN S, 1986, BRIT J SURG, V73, P371, DOI 10.1002/bjs.1800730515; Hyder SA, 2006, DIS COLON RECTUM, V49, P1837, DOI 10.1007/s10350-006-0656-5; LLERA JL, 1985, ANN EMERG MED, V14, P15, DOI 10.1016/S0196-0644(85)80727-7; MACFIE J, 1977, BRIT J SURG, V64, P264, DOI 10.1002/bjs.1800640410; Malik AI, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006827.pub2; Marzo M, 2015, WORLD J GASTROENTERO, V21, P1394, DOI 10.3748/wjg.v21.i5.1394; Nelson R, 2002, SURG CLIN N AM, V82, P1139, DOI 10.1016/S0039-6109(02)00063-4; NHS Digital, HOSP EP STAT ADM PAT; Onaca N, 2001, DIS COLON RECTUM, V44, P1469, DOI 10.1007/BF02234599; PARKS AG, 1976, BRIT J SURG, V63, P1, DOI 10.1002/bjs.1800630102; Pearce L, 2016, BRIT J SURG, V103, P1063, DOI 10.1002/bjs.10154; Perera AP, 2015, LANGENBECK ARCH SURG, V400, P267, DOI 10.1007/s00423-014-1231-5; RAMANUJAM PS, 1984, DIS COLON RECTUM, V27, P593, DOI 10.1007/BF02553848; READ DR, 1979, DIS COLON RECTUM, V22, P566, DOI 10.1007/BF02587008; SAINIO P, 1984, ANN CHIR GYNAECOL FE, V73, P219; Smith SR, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011193.pub2; Sozener U, 2011, DIS COLON RECTUM, V54, P923, DOI 10.1097/DCR.0b013e31821cc1f9; Thia KT, 2009, INFLAMM BOWEL DIS, V15, P17, DOI 10.1002/ibd.20608; Tonkin DM, 2004, DIS COLON RECTUM, V47, P1510, DOI 10.1007/s10350-004-0620-1; VASILEVSKY CA, 1984, DIS COLON RECTUM, V27, P126, DOI 10.1007/BF02553995; Wei PL, 2013, INT J COLORECTAL DIS, V28, P235, DOI 10.1007/s00384-012-1519-2; West RL, 2004, ALIMENT PHARM THERAP, V20, P1329, DOI 10.1111/j.1365-2036.2004.02247.x; Whiteford Mark H, 2007, Clin Colon Rectal Surg, V20, P102, DOI 10.1055/s-2007-977488; Xu RW, 2016, ANZ J SURG, V86, P782, DOI 10.1111/ans.13630	34	28	34	5	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2017	356								j475	10.1136/bmj.j475	http://dx.doi.org/10.1136/bmj.j475			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KS	28223268	Green Published			2022-12-28	WOS:000395631000001
J	Contreras, JL; Sherkow, JS				Contreras, Jorge L.; Sherkow, Jacob S.			CRISPR, surrogate licensing, and scientific discovery	SCIENCE			English	Editorial Material									[Contreras, Jorge L.] Univ Utah, SJ Quinney Coll Law, Salt Lake City, UT 84112 USA; [Contreras, Jorge L.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Sherkow, Jacob S.] New York Law Sch, Innovat Ctr Law & Technol, New York, NY 10013 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Contreras, JL (corresponding author), Univ Utah, SJ Quinney Coll Law, Salt Lake City, UT 84112 USA.; Contreras, JL (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	jorge.contreras@law.utah.edu; jacob.sherkow@nyls.edu		Contreras, Jorge/0000-0002-7899-3060; Sherkow, Jacob/0000-0002-9724-9261				Goldman G., 2015, PROGR PROBLEMS GOVT; GRIFO F, 2008, FEDERAL SCI PUBLIC G; Halpern M, 2015, SCIENCE, V348, P479, DOI 10.1126/science.aac4245; Mooney Chris, 2005, REPUBLICAN WAR SCI; Negar Azimi, 2016, NEW YORKER; Office of Inspector General Department of the Interior, 2006, INV REP ALL JUL MACD; Otto SL, 2016, WAR SCI WHOS WAGING; REVKIN AC, 2004, NY TIMES        1019, pF1; Rosenberg AA, 2015, SCIENCE, V348, P964, DOI 10.1126/science.aab2939; Ryan P., 2016, A BETTER WAY; U. S. Environmental Protection Agency, 2015, FY 2015 ALL; UCS, 2007, VIOC FED SCI; UCS, 2017, PRES SCI INT FED POL; Wagner W., 2012, BENDING SCI SPECIAL; Williamson E., 2007, WASHINGTON POST	15	31	33	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					698	700		10.1126/science.aal4222	http://dx.doi.org/10.1126/science.aal4222			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2AC	28209863	Green Published			2022-12-28	WOS:000395117700025
J	Lamb, JB; van de Water, JAJM; Bourne, DG; Altier, C; Hein, MY; Fiorenza, EA; Abu, N; Jompa, J; Harvell, CD				Lamb, Joleah B.; van de Water, Jeroen A. J. M.; Bourne, David G.; Altier, Craig; Hein, Margaux Y.; Fiorenza, Evan A.; Abu, Nur; Jompa, Jamaluddin; Harvell, C. Drew			Seagrass ecosystems reduce exposure to bacterial pathogens of humans, fishes, and invertebrates	SCIENCE			English	Article							CONSTRUCTED WETLANDS; WASTE-WATER; DISEASE	Plants are important in urban environments for removing pathogens and improving water quality. Seagrass meadows are the most widespread coastal ecosystem on the planet. Although these plants are known to be associated with natural biocide production, they have not been evaluated for their ability to remove microbiological contamination. Using amplicon sequencing of the 16S ribosomal RNA gene, we found that when seagrass meadows are present, there was a 50% reduction in the relative abundance of potential bacterial pathogens capable of causing disease in humans and marine organisms. Moreover, field surveys of more than 8000 reef-building corals located adjacent to seagrass meadows showed twofold reductions in disease levels compared to corals at paired sites without adjacent seagrass meadows. These results highlight the importance of seagrass ecosystems to the health of humans and other organisms.	[Lamb, Joleah B.; Fiorenza, Evan A.; Harvell, C. Drew] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [van de Water, Jeroen A. J. M.; Bourne, David G.] Australian Inst Marine Sci, Townsville, Qld, Australia; [van de Water, Jeroen A. J. M.] Ctr Sci Monaco, Dept Marine Biol, Monaco, Monaco; [Bourne, David G.; Hein, Margaux Y.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Altier, Craig] Cornell Univ, Dept Populat Med & Diagnost Sci, Coll Vet Med, Ithaca, NY USA; [Abu, Nur; Jompa, Jamaluddin] Hasanuddin Univ, Fac Marine Sci & Fisheries, Makassar, Sulawesi, Indonesia	Cornell University; Australian Institute of Marine Science; James Cook University; Cornell University; Universitas Hasanuddin	Lamb, JB (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA.	joleah.lamb@cornell.edu	Lamb, Joleah/D-1994-2018; Fiorenza, Evan/AAN-1069-2020; van de Water, Jeroen A.J.M./F-1302-2011; Bourne, David G/B-5073-2008; Jompa, Jamaluddin/AAD-9280-2021	Lamb, Joleah/0000-0002-7005-9994; van de Water, Jeroen A.J.M./0000-0001-6974-2270; Bourne, David G/0000-0002-1492-8710; Jompa, Jamaluddin/0000-0001-9740-333X; Altier, Craig/0000-0002-3740-9163; Fiorenza, Evan/0000-0002-5421-0148; Hein, Margaux/0000-0001-6951-4075	Nature Conservancy NatureNet Fellowship Atkinson Center for a Sustainable Future at Cornell University; Capturing Coral Reef and Ecosystern Related Services (CORES) Project - Global Environment Facility; World Bank [P123933]	Nature Conservancy NatureNet Fellowship Atkinson Center for a Sustainable Future at Cornell University; Capturing Coral Reef and Ecosystern Related Services (CORES) Project - Global Environment Facility; World Bank(The World Bank India)	This research was supported by The Nature Conservancy NatureNet Fellowship Atkinson Center for a Sustainable Future at Cornell University, and the Capturing Coral Reef and Ecosystern Related Services (CORES) Project funded by the Global Environment Facility and the World Bank (Project ID P123933). We thank R. Yoshioka and A. Tracy, A. Massinai, P Ambo-Rappe A Ahmad, S. Beveridge, and S. Steven for statistical, laboratory and field assistance. Vector illustrations are credited to T. Saxby of the Integration and Application Network at the University of Maryland Center for Environmental Science and Shutterstock contributors R. A. Hillman (image ID 25377103) and K. Ka (image ID 250306321). We acknowledge village community members for their permission to conduct this study through Hasanuddin University. Sequence data. are archived at the National Center for Biotechnology Information (accession no. SRP095480). Data and code are available at the Dryad Digital Repository (doi:10.5061/dryad.51275).	Al-Moghrabi SM, 2001, CORAL REEFS, V19, P330, DOI 10.1007/s003380000127; Burke L., 2011, REEFS RISK REVISITED; Byappanahalli MN, 2012, MICROBIOL MOL BIOL R, V76, P685, DOI 10.1128/MMBR.00023-12; Graczyk TK, 2006, APPL ENVIRON MICROB, V72, P3390, DOI 10.1128/AEM.72.5.3390-3395.2006; Grant SB, 2012, SCIENCE, V337, P681, DOI 10.1126/science.1216852; Hart DE, 2007, CORAL REEFS, V26, P53, DOI 10.1007/s00338-006-0168-8; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; HODGSON G, 1990, MAR BIOL, V104, P493, DOI 10.1007/BF01314355; Kannan RRR, 2010, ASIAN PAC J TROP MED, V3, P890, DOI 10.1016/S1995-7645(10)60214-3; Lamb JB, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0210; Manez KS, 2012, ENVIRON SCI POLICY, V23, P74, DOI 10.1016/j.envsci.2012.07.004; Nagelkerken I, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P1; Olsen JL, 2016, NATURE, V530, P331, DOI 10.1038/nature16548; Pollock FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102498; Stottmeister U, 2003, BIOTECHNOL ADV, V22, P93, DOI 10.1016/j.biotechadv.2003.08.010; Sutherland KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023468; U. S. Environmental Protection Agency, 2012, USITC PUBL; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; White I, 2010, HYDROGEOL J, V18, P227, DOI 10.1007/s10040-009-0525-0; Wu SB, 2016, SCI TOTAL ENVIRON, V541, P8, DOI 10.1016/j.scitotenv.2015.09.047; Yang Q, 2008, MAR POLLUT BULL, V57, P735, DOI 10.1016/j.marpolbul.2008.01.037	21	228	246	16	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					731	+		10.1126/science.aal1956	http://dx.doi.org/10.1126/science.aal1956			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2AC	28209895				2022-12-28	WOS:000395117700038
J	Opstelten, W; Klaasen, R				Opstelten, Wim; Klaasen, Ruth			CASE REVIEW A swollen red finger	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK		[Opstelten, Wim] Dutch Coll Gen Practitioners, Utrecht, Netherlands; [Klaasen, Ruth] Meander Med Ctr, Amersfoort, Netherlands	Meander Medisch Centrum	Opstelten, W (corresponding author), Dutch Coll Gen Practitioners, Utrecht, Netherlands.	w.opstelten@nhg.org						Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Chen SY, 2001, METABOLISM, V50, P1203, DOI 10.1053/meta.2001.26705; De Souza AWS, 2005, J RHEUMATOL, V32, P2186; Dong Z, 2015, INT J RHEUM DIS, V18, P382, DOI 10.1111/1756-185X.12519; Hueskes BAA, 2012, SEMIN ARTHRITIS RHEU, V41, P879, DOI 10.1016/j.semarthrit.2011.11.008; Janssens HJEM, 2009, HUISARTS WET, V356, P439; Kuo CF, 2015, NAT REV RHEUMATOL, V11, P649, DOI 10.1038/nrrheum.2015.91; Richette P, 2017, ANN RHEUM DIS, V76, P29, DOI [10.1136/annrheumdis-2016-209707, 10.1136/annrheumdis-2016-210356]; Rosenthal AK, 2016, NEW ENGL J MED, V374, P2575, DOI 10.1056/NEJMra1511117; Zhu YY, 2012, AM J MED, V125, P679, DOI 10.1016/j.amjmed.2011.09.033	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2017	356								j734	10.1136/bmj.j734	http://dx.doi.org/10.1136/bmj.j734			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GN	28209574				2022-12-28	WOS:000394579800003
J	[Anonymous]				[Anonymous]			MICROBIOLOGY Gut bacteria boost bee immunity	NATURE			English	Editorial Material																			0	0	0	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					274	274		10.1038/542274a	http://dx.doi.org/10.1038/542274a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7YF	28202955	Bronze			2022-12-28	WOS:000454457400003
J	Gulland, A				Gulland, Anne			Sixty seconds on ... swine flu vaccine	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cohen D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2912; DYER C, 2013, BMJ-BRIT MED J, V347, P46270, DOI DOI 10.1136/BMJ.F5645; Miller E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f794; O'Dowd A, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3033	4	0	0	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	2017	356								j749	10.1136/bmj.j749	http://dx.doi.org/10.1136/bmj.j749			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GM	28202448				2022-12-28	WOS:000394579700006
J	Berger, RE; Pai, M; Rajasekhar, A				Berger, Rebecca E.; Pai, Menaka; Rajasekhar, Anita			Thromboprophylaxis after Knee Arthroscopy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VENOUS THROMBOEMBOLISM; THROMBOSIS; SURGERY; RISK		[Pai, Menaka] McMaster Univ, Div Hematol & Thromboembol, Hamilton, ON 32611, Canada; [Rajasekhar, Anita] Univ Florida, Div Hematol & Oncol, Gainesville, FL USA	McMaster University; State University System of Florida; University of Florida				Pai, Menaka/0000-0002-6053-689X				Camporese G, 2008, ANN INTERN MED, V149, P73, DOI 10.7326/0003-4819-149-2-200807150-00003; Camporese G, 2016, THROMB HAEMOSTASIS, V116, P349, DOI 10.1160/TH16-02-0118; Couturaud F, 2014, BLOOD, V124, P2124, DOI 10.1182/blood-2014-03-559757; Cushman M, 2007, SEMIN HEMATOL, V44, P62, DOI 10.1053/j.seminhematol.2007.02.004; Falck-Ytter Y, 2012, CHEST, V141, pE278S, DOI 10.1378/chest.11-2404; Krych AJ, 2015, ARTHROSCOPY, V31, P2112, DOI 10.1016/j.arthro.2015.04.091; Mauck KF, 2013, J THROMB HAEMOST, V11, P1279, DOI 10.1111/jth.12283; Pannucci CJ, 2012, ANN SURG, V255, P1093, DOI 10.1097/SLA.0b013e3182519ccf; Ramos J, 2008, COCHRANE DB SYST REV, V4; Van Adrichem RA, 2015, J THROMB HAEMOST, V13, P1441, DOI 10.1111/jth.12996; van Adrichem RA, 2017, NEW ENGL J MED, V376, P515, DOI 10.1056/NEJMoa1613303	11	6	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2017	376	6					580	583		10.1056/NEJMclde1615661	http://dx.doi.org/10.1056/NEJMclde1615661			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ8XL	28177874				2022-12-28	WOS:000393510500017
J	Liu, XS; Mardis, ER				Liu, X. Shirley; Mardis, Elaine R.			Applications of Immunogenomics to Cancer	CELL			English	Article							T-CELL REPERTOIRE; IDENTIFYING FUSION TRANSCRIPTS; B-CELLS; PD-1 BLOCKADE; TUMOR PURITY; CHIMERIC RECEPTORS; HYBRID SELECTION; IMMUNE-RESPONSES; CTLA-4 BLOCKADE; SEQUENCING DATA	Cancer immunogenomics originally was framed by research supporting the hypothesis that cancer mutations generated novel peptides seen as "non-self'' by the immune system. The search for these "neoantigens'' has been facilitated by the combination of new sequencing technologies, specialized computational analyses, and HLA binding predictions that evaluate somatic alterations in a cancer genome and interpret their ability to produce an immune-stimulatory peptide. The resulting information can characterize a tumor's neoantigen load, its cadre of infiltrating immune cell types, the T or B cell receptor repertoire, and direct the design of a personalized therapeutic.	[Liu, X. Shirley] Harvard TH Chan Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, 450 Brookline Ave, Boston, MA 02215 USA; [Mardis, Elaine R.] Nationwide Childrens Hosp, Inst Genom Med, 575 Childrens Crossrd, Columbus, OH 43205 USA; [Mardis, Elaine R.] Ohio State Univ, Coll Med, 575 Childrens Crossrd, Columbus, OH 43205 USA	Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University	Liu, XS (corresponding author), Harvard TH Chan Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, 450 Brookline Ave, Boston, MA 02215 USA.; Mardis, ER (corresponding author), Nationwide Childrens Hosp, Inst Genom Med, 575 Childrens Crossrd, Columbus, OH 43205 USA.; Mardis, ER (corresponding author), Ohio State Univ, Coll Med, 575 Childrens Crossrd, Columbus, OH 43205 USA.	xsliu@jimmy.harvard.edu; elaine.mardis@nationwidechildrens.org	Mardis, Elaine/W-2202-2019		National Institutes of Health [1U01 CA180980]; NATIONAL CANCER INSTITUTE [U01CA180980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by the National Institutes of Health (1U01 CA180980 to X.S.L.).	Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Angelova M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0620-6; Aouinti S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142353; BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; Bagaev DV, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2799-7; Bainbridge MN, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r62; Bassani-Sternberg M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13404; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Calis JJA, 2014, TRENDS IMMUNOL, V35, P581, DOI 10.1016/j.it.2014.09.004; Carreno BM, 2015, SCIENCE, V348, P803, DOI 10.1126/science.aaa3828; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; CEROTTINI JC, 1974, J EXP MED, V140, P703, DOI 10.1084/jem.140.3.703; Cole C, 2016, J IMMUNOL, V196, P2902, DOI 10.4049/jimmunol.1502563; Cole G.A., 2005, HDB OF ELISPOT, P191; Cornish A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/456479; DEPLAEN E, 1988, P NATL ACAD SCI USA, V85, P2274; DiLillo DJ, 2010, J IMMUNOL, V184, P4006, DOI 10.4049/jimmunol.0903009; Duan F, 2014, J EXP MED, V211, P2231, DOI 10.1084/jem.20141308; Dubey P, 1997, J EXP MED, V185, P695, DOI 10.1084/jem.185.4.695; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Emerson RO, 2013, J PATHOL, V231, P433, DOI 10.1002/path.4260; FOLEY EJ, 1953, CANCER RES, V13, P835; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; Galluzzi L, 2014, ONCOTARGET, V5, P12472, DOI 10.18632/oncotarget.2998; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Ghoneim Dalia H, 2014, BMC Res Notes, V7, P864, DOI 10.1186/1756-0500-7-864; GILLIS S, 1977, NATURE, V268, P154, DOI 10.1038/268154a0; Giudicelli V, 1997, NUCLEIC ACIDS RES, V25, P206, DOI 10.1093/nar/25.1.206; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Greiff V, 2015, TRENDS IMMUNOL, V36, P738, DOI 10.1016/j.it.2015.09.006; Greiff V, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0169-8; Gubin MM, 2015, J CLIN INVEST, V125, P3413, DOI 10.1172/JCI80008; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hirayama M, 2016, INT IMMUNOL, V28, P319, DOI 10.1093/intimm/dxw027; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; Hou XL, 2016, GENES IMMUN, V17, P153, DOI 10.1038/gene.2016.9; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Imai C, 2004, LEUKEMIA, V18, P676, DOI 10.1038/sj.leu.2403302; Jiang Y, 2015, NUCLEIC ACIDS RES, V43, P7217, DOI 10.1093/nar/gkv677; Jiang Y, 2012, BIOINFORMATICS, V28, P2576, DOI 10.1093/bioinformatics/bts484; Johnson PLF, 2014, IMMUNOLOGY, V142, P167, DOI 10.1111/imm.12244; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kloss CC, 2013, NAT BIOTECHNOL, V31, P71, DOI 10.1038/nbt.2459; KNUTH A, 1984, P NATL ACAD SCI-BIOL, V81, P3511, DOI 10.1073/pnas.81.11.3511; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Kroeger DR, 2016, CLIN CANCER RES, V22, P3005, DOI 10.1158/1078-0432.CCR-15-2762; Kroigard AB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151664; Kumar S, 2016, WIRES RNA, V7, P811, DOI 10.1002/wrna.1382; Lao XM, 2016, ONCOL LETT, V11, P2027, DOI 10.3892/ol.2016.4184; Li B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1028-7; Li B, 2016, NAT GENET, V48, P725, DOI 10.1038/ng.3581; Li B, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0473-4; Li Y, 2011, BIOINFORMATICS, V27, P1708, DOI 10.1093/bioinformatics/btr265; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mardis ER, 2017, NAT PROTOC, V12, P213, DOI 10.1038/nprot.2016.182; McKinney DM, 2013, IMMUNOGENETICS, V65, P357, DOI 10.1007/s00251-013-0684-y; McNeel DG, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0175-4; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; MONACH PA, 1995, IMMUNITY, V2, P45, DOI 10.1016/1074-7613(95)90078-0; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Mose LE, 2016, BIOINFORMATICS, V32, P3729, DOI 10.1093/bioinformatics/btw526; Mose LE, 2014, BIOINFORMATICS, V30, P2813, DOI 10.1093/bioinformatics/btu376; Muraro PA, 2014, J CLIN INVEST, V124, P1168, DOI 10.1172/JCI71691; Narzisi G, 2014, NAT METHODS, V11, P1033, DOI [10.1038/NMETH.3069, 10.1038/nmeth.3069]; Nelson BH, 2010, J IMMUNOL, V185, P4977, DOI 10.4049/jimmunol.1001323; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; OLD LJ, 1964, ANNU REV MED, V15, P167, DOI 10.1146/annurev.me.15.020164.001123; Overwijk WW, 2013, J IMMUNOTHER CANCER, V1, DOI 10.1186/2051-1426-1-11; Pasternack M.S., 1994, CLIN INFECT DIS, V19, P996; Perricone MA, 2004, J IMMUNOTHER, V27, P273, DOI 10.1097/00002371-200407000-00003; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Postow MA, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0070-4; PREHN RT, 1957, J NATL CANCER I, V18, P769; Qin ZH, 1998, NAT MED, V4, P627, DOI 10.1038/nm0598-627; Rasmussen M, 2016, J IMMUNOL, V197, P1517, DOI 10.4049/jimmunol.1600582; Ratan A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0483-6; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Robbins PF, 1996, J EXP MED, V183, P1185, DOI 10.1084/jem.183.3.1185; Robert L, 2014, CLIN CANCER RES, V20, P2424, DOI 10.1158/1078-0432.CCR-13-2648; Robins H, 2013, CURR OPIN IMMUNOL, V25, P646, DOI 10.1016/j.coi.2013.09.017; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI [10.1093/nar/gkg070, 10.1093/nar/GKG070]; Robinson J, 2001, NUCLEIC ACIDS RES, V29, P210, DOI 10.1093/nar/29.1.210; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Saethang T, 2013, J IMMUNOL METHODS, V387, P293, DOI 10.1016/j.jim.2012.09.016; SAHIN U, 1995, P NATL ACAD SCI USA, V92, P11810, DOI 10.1073/pnas.92.25.11810; Saul L, 2016, SCI REP-UK, V6, DOI 10.1038/srep29736; SCHULTZ KR, 1990, SCIENCE, V249, P921, DOI 10.1126/science.2118273; Schumacher T, 2014, NATURE, V512, P324, DOI 10.1038/nature13387; Scolnick JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128916; Senbabaoglu Y, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1092-z; Shi JY, 2013, CLIN CANCER RES, V19, P5994, DOI 10.1158/1078-0432.CCR-12-3497; Shugay M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004503; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/NMETH.2960, 10.1038/nmeth.2960]; Shukla SA, 2015, NAT BIOTECHNOL, V33, P1152, DOI 10.1038/nbt.3344; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Srivastava A, 2013, J IMMUNOL METHODS, V387, P284, DOI 10.1016/j.jim.2012.09.013; Szolek A, 2014, BIOINFORMATICS, V30, P3310, DOI 10.1093/bioinformatics/btu548; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; VANDENEYNDE B, 1989, INT J CANCER, V44, P634; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vormehr M, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/595363; Warren RL, 2012, GENOME MED, V4, DOI 10.1186/gm396; Yaari G, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0243-2; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhang H, 2009, BIOINFORMATICS, V25, P1293, DOI 10.1093/bioinformatics/btp137; Zhang J, 2016, GENOME RES, V26, P108, DOI 10.1101/gr.186114.114; Zhang NQ, 2015, BIOINFORMATICS, V31, P3401, DOI 10.1093/bioinformatics/btv370; Zhang X., 2016, VACCINE; Zheng XQ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0419-x	127	132	138	3	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2017	168	4					600	612		10.1016/j.cell.2017.01.014	http://dx.doi.org/10.1016/j.cell.2017.01.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8VJ	28187283	Green Accepted, Bronze			2022-12-28	WOS:000396277600012
J	Bayliss, LE; Culliford, D; Monk, AP; Glyn-Jones, S; Prieto-Alhambra, D; Judge, A; Cooper, C; Carr, AJ; Arden, NK; Beard, DJ; Price, AJ				Bayliss, Lee E.; Culliford, David; Monk, A. Paul; Glyn-Jones, Sion; Prieto-Alhambra, Daniel; Judge, Andrew; Cooper, Cyrus; Carr, Andrew J.; Arden, Nigel K.; Beard, David J.; Price, Andrew J.			The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study	LANCET			English	Article							PRACTICE RESEARCH DATALINK; NATIONAL JOINT REGISTRY; LIFETIME RISK; OSTEOARTHRITIS; ARTHROPLASTY; MORTALITY; SURGERY; OUTCOMES; ENGLAND; WALES	Background Total joint replacements for end-stage osteoarthritis of the hip and knee are cost-effective and demonstrate significant clinical improvement. However, robust population based lifetime-risk data for implant revision are not available to aid patient decision making, which is a particular problem in young patient groups deciding on best-timing for surgery. Methods We did implant survival analysis on all patients within the Clinical Practice Research Datalink who had undergone total hip replacement or total knee replacement. These data were adjusted for all-cause mortality with data from the Office for National Statistics and used to generate lifetime risks of revision surgery based on increasing age at the time of primary surgery. Findings We identified 63 158 patients who had undergone total hip replacement and 54 276 who had total knee replacement between Jan 1, 1991, and Aug 10, 2011, and followed up these patients to a maximum of 20 years. For total hip replacement, 10-year implant survival rate was 95.6% (95% CI 95.3-95.9) and 20-year rate was 85.0% (83.2-86.6). For total knee replacement, 10-year implant survival rate was 96.1% (95.8-96.4), and 20-year implant survival rate was 89.7% (87.5-91.5). The lifetime risk of requiring revision surgery in patients who had total hip replacement or total knee replacement over the age of 70 years was about 5% with no difference between sexes. For those who had surgery younger than 70 years, however, the lifetime risk of revision increased for younger patients, up to 35% (95% CI 30.9-39.1) for men in their early 50s, with large differences seen between male and female patients (15% lower for women in same age group). The median time to revision for patients who had surgery younger than age 60 was 4.4 years. Interpretation Our study used novel methodology to investigate and offer new insight into the importance of young age and risk of revision after total hip or knee replacement. Our evidence challenges the increasing trend for more total hip replacements and total knee replacements to be done in the younger patient group, and these data should be offered to patients as part of the shared decision making process.	[Bayliss, Lee E.; Monk, A. Paul; Glyn-Jones, Sion; Prieto-Alhambra, Daniel; Judge, Andrew; Cooper, Cyrus; Carr, Andrew J.; Beard, David J.; Price, Andrew J.] Univ Oxford, NIHR Biomed Res Unit, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Arden, Nigel K.] Univ Oxford, Arthrit Res UK Ctr Sport Exercise & Osteoarthrit, Oxford, England; [Prieto-Alhambra, Daniel] Univ Autonoma Barcelona, GREMPAL Res Grp Idiap Jordi Gol & CIBERFes, Barcelona, Spain; [Prieto-Alhambra, Daniel] Inst Salud Carlos III, Barcelona, Spain; [Prieto-Alhambra, Daniel; Judge, Andrew; Cooper, Cyrus; Arden, Nigel K.] Univ Southampton, Lifecourse Epidemiol Unit, MRC, Southampton, Hants, England; [Culliford, David] Univ Southampton, NIHR CLAHRC Wessex Methodol Hub, Southampton, Hants, England	University of Oxford; University of Oxford; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERFES; Instituto de Salud Carlos III; University of Southampton; University of Southampton	Price, AJ (corresponding author), Univ Oxford, NIHR Biomed Res Unit, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England.	andrew.price@ndorms.ox.ac.uk		Beard, David/0000-0001-7884-6389; monk, Andrew/0000-0002-1673-2148; Judge, Andrew/0000-0003-3015-0432; Prieto-Alhambra, Daniel/0000-0002-3950-6346; Cooper, Cyrus/0000-0003-3510-0709	Oxford Musculoskeletal Biomedical Research Unit, National Institute for Health Research; MRC [MC_U147585819, G0400491, MC_PC_12020, MC_PC_14103, MC_U147585827] Funding Source: UKRI; Medical Research Council [MC_UU_12011/1, MC_PC_14103, MC_U147585827, MC_U147585819, MC_U147585824, G0400491, MC_UP_A620_1014, MC_PC_12020, U1475000001] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10085, NF-SI-0611-10216, RP-PG-0407-10064, NF-SI-0508-10082] Funding Source: researchfish; Orthopaedic Research UK [501] Funding Source: researchfish	Oxford Musculoskeletal Biomedical Research Unit, National Institute for Health Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Orthopaedic Research UK	Oxford Musculoskeletal Biomedical Research Unit, National Institute for Health Research.	Carr AJ, 2012, LANCET, V379, P1331, DOI 10.1016/S0140-6736(11)60752-6; Culliford D, 2015, OSTEOARTHR CARTILAGE, V23, P594, DOI 10.1016/j.joca.2014.12.022; Culliford DJ, 2012, OSTEOARTHR CARTILAGE, V20, P519, DOI 10.1016/j.joca.2012.02.636; Dakin H, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000332; Dieppe P, 2011, INT J RHEUM DIS, V14, P175, DOI 10.1111/j.1756-185X.2011.01611.x; Fortin J M, 2001, BMC Med Inform Decis Mak, V1, P2, DOI 10.1186/1472-6947-1-2; Garellick G, 2014, SWEDISH HIP ARTHROPL, P1; Havelin L, 2016, NORWEGIAN NATL ADVIS; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Hinde A., 1998, DEMOGRAPHIC METHODS; Hook S, 2006, J BONE JOINT SURG BR, V88B, P1584, DOI 10.1302/0301-620X.88B12.18345; Hunt LP, 2014, LANCET, V384, P1429, DOI 10.1016/S0140-6736(14)60540-7; Hunt LP, 2013, LANCET, V382, P1097, DOI 10.1016/S0140-6736(13)61749-3; Judge A, 2012, J BONE JOINT SURG BR, V94B, P412, DOI 10.1302/0301-620X.94B3.27425; Kandala NB, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h756; Kurtz SM, 2009, CLIN ORTHOP RELAT R, V467, P2606, DOI 10.1007/s11999-009-0834-6; Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7; Losina E, 2013, ARTHRIT CARE RES, V65, P703, DOI 10.1002/acr.21898; Lubbeke A, 2007, J RHEUMATOL, V34, P394; Martin CT, 2016, CLIN ORTHOP RELAT R, V474, P402, DOI 10.1007/s11999-015-4260-7; Miric A, 2015, J ARTHROPLASTY, V30, P1324, DOI 10.1016/j.arth.2015.03.008; Murphy L, 2008, ARTHRIT RHEUM-ARTHR, V59, P1207, DOI 10.1002/art.24021; NJR. National Joint Registry for England Wales and Northern Ireland, 2015, 12 ANN REP, V2015, P41; Nuesch E, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1165; Price AJ, 2010, KNEE, V17, P196, DOI 10.1016/j.knee.2009.09.003; Rasanen P, 2007, ACTA ORTHOP, V78, P108, DOI 10.1080/17453670610013501; Riddle DL, 2014, ARTHRITIS RHEUMATOL, V66, P2134, DOI 10.1002/art.38685; Wainwright C, 2011, J BONE JOINT SURG BR, V93B, P1411, DOI 10.1302/0301-620X.93B10.27100	28	345	357	4	33	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2017	389	10077					1424	1430		10.1016/S0140-6736(17)30059-4	http://dx.doi.org/10.1016/S0140-6736(17)30059-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ8OJ	28209371	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000398345100034
J	Hegade, VS; Kendrick, SFW; Dobbins, RL; Miller, SR; Thompson, D; Richards, D; Storey, J; Dukes, GE; Corrigan, M; Elferink, RPJO; Beuers, U; Hirschfield, GM; Jones, DE				Hegade, Vinod S.; Kendrick, Stuart F. W.; Dobbins, Robert L.; Miller, Sam R.; Thompson, Douglas; Richards, Duncan; Storey, James; Dukes, George E.; Corrigan, Margaret; Elferink, Ronald P. J. Oude; Beuers, Ulrich; Hirschfield, Gideon M.; Jones, David E.			Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study	LANCET			English	Article							CHOLESTATIC PRURITUS; OBETICHOLIC ACID; CIRRHOSIS; LIVER; EFFICACY; ITCH; ABSORPTION; RIFAMPIN; SAFETY; POTENT	Background Up to 70% of patients with primary biliary cholangitis develop pruritus (itch) during the course of their disease. Treatment of pruritus in primary biliary cholangitis is challenging and novel therapies are needed. Ursodeoxycholic acid, the standard first-line treatment for primary biliary cholangitis, is largely ineffective for pruritus. We investigated the efficacy and safety of GSK2330672, a selective inhibitor of human ileal bile acid transporter (IBAT), in patients with primary biliary cholangitis with pruritus. Methods We conducted this phase 2a, double-blind, randomised, placebo-controlled, crossover trial in two UK medical centres. Following 2 weeks of open placebo run-in, patients were randomly assigned in a 1: 1 ratio with a block size of 4 to receive GSK2330672 or placebo twice daily during two consecutive 14-day treatment periods in a crossover sequence. The treatment periods were followed by a 14-day single-blinded placebo follow-up period. The primary endpoints were safety of GSK2330672, assessed using clinical and laboratory parameters, and tolerability as rated by the Gastrointestinal Symptom Rating Scale. The secondary endpoints were changes in pruritus scores measured using the 0 to 10 numerical rating scale (NRS), primary biliary cholangitis-40 (PBC-40) itch domain score and 5-D itch scale, changes in serum total bile acids and 7 alpha hydroxy-4-cholesten-3-one (C4), and changes in the pharmacokinetic parameters of ursodeoxycholic acid and its conjugates. The trial was registered with ClinicalTrials. gov, number NCT01899703. Findings Between March 10, 2014, and Oct 7, 2015, we enrolled 22 patients. 11 patients were assigned to receive intervention followed by placebo (sequence 1), and 11 patients were assigned to receive placebo followed by intervention (sequence 2). One patient assigned to sequence 2 withdrew consent prior to receiving randomised therapy. One patient did not attend the placebo follow-up period, but was included in the final analysis. GSK2330672 treatment for 14 days was safe with no serious adverse events reported. Diarrhoea was the most frequent adverse event during treatment with GSK2330672 (seven with GSK2330672 vs one with placebo) and headache was the most frequent adverse event during treatment with placebo (seven with placebo vs six with GSK2330672). After GSK2330672 treatment, the percentage changes from baseline itch scores were-57% (95% CI-73 to-42, p< 0.0001) in the NRS,-31% (-42 to-20, p< 0.0001) in the PBC-40 itch domain and-35% (-45 to-25, p< 0.0001) in the 5-D itch scale. GSK2330672 produced significantly greater reduction from baseline than the double-blind placebo in the NRS (-23%, 95% CI-45 to-1; p= 0.037), PBC-40 itch domain, (-14%,-26 to-1; p= 0.034), and 5-D itch scale (-20%,-34 to-7; p= 0.0045). After GSK2330672 treatment, serum total bile acid concentrations declined by 50% (95% CI-37 to-61, p< 0.0001) from 30 to 15 mu M, with a significant 3.1-times increase (95% CI 2.4 to 4.0, p< 0.0001) in serum C4 concentrations from 7.9 to 24.7ng/ mL. Interpretation In patients with primary biliary cholangitis with pruritus, 14 days of ileal bile acid transporter inhibition by GSK2330672 was generally well tolerated without serious adverse events, and demonstrated efficacy in reducing pruritus severity. GSK2330672 has the potential to be a significant and novel advance for the treatment of pruritus in primary biliary cholangitis. Diarrhoea, the most common adverse event associated with GSK2330672 treatment, might limit the long-term use of this drug. Funding GlaxoSmithKline and National Institute for Health Research.	[Hegade, Vinod S.; Jones, David E.] Newcastle Univ, NIHR Newcastle Biomed Res Ctr, Framlington Pl, Newcastle Upon Tyne, Tyne & Wear, England; [Hegade, Vinod S.; Jones, David E.] Newcastle Univ, Inst Cellular Med, Framlington Pl, Newcastle Upon Tyne, Tyne & Wear, England; [Kendrick, Stuart F. W.; Miller, Sam R.; Thompson, Douglas; Richards, Duncan; Storey, James] GlaxoSmithKline, Stevenage, Herts, England; [Dobbins, Robert L.; Dukes, George E.] GlaxoSmithKline, Res Triangle Pk, NC USA; [Corrigan, Margaret; Hirschfield, Gideon M.] Univ Birmingham, Birmingham, W Midlands, England; [Corrigan, Margaret; Hirschfield, Gideon M.] NIHR Birmingham Liver Biomed Res Unit, Birmingham, W Midlands, England; [Elferink, Ronald P. J. Oude; Beuers, Ulrich] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands	Newcastle University - UK; Newcastle University - UK; GlaxoSmithKline; GlaxoSmithKline; University of Birmingham; University of Amsterdam; Academic Medical Center Amsterdam	Hegade, VS (corresponding author), Newcastle Univ, NIHR Newcastle Biomed Res Ctr, Inst Cellular Med, Fac Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	Vinod.hegade@ncl.ac.uk	; Hirschfield, Gideon/M-2143-2015	Kendrick, Stuart/0000-0002-0804-5743; Hirschfield, Gideon/0000-0002-6736-2255; Richards, Duncan/0000-0002-8093-7084	GlaxoSmithKline; National Institute for Health Research; Medical Research Council [MR/L001489/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10091] Funding Source: researchfish; MRC [MR/L001489/1] Funding Source: UKRI	GlaxoSmithKline(GlaxoSmithKline); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	GlaxoSmithKline and National Institute for Health Research.	Alemi F, 2013, J CLIN INVEST, V123, P1513, DOI 10.1172/JCI64551; Alrefai WA, 2007, DIGEST DIS SCI, V52, P1270, DOI 10.1007/s10620-006-9090-8; Baghdasaryan A, 2016, J HEPATOL, V64, P674, DOI 10.1016/j.jhep.2015.10.024; Beuers U, 2015, HEPATOLOGY, V62, P1620, DOI 10.1002/hep.28140; Beuers U, 2014, HEPATOLOGY, V60, P399, DOI 10.1002/hep.26909; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Dawson PA, 2003, J BIOL CHEM, V278, P33920, DOI 10.1074/jbc.M306370200; Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200; Dyson JK, 2015, J HEPATOL, V62, P208, DOI 10.1016/j.jhep.2014.09.010; Graffner H, 2016, ALIMENT PHARM THER, V43, P303, DOI 10.1111/apt.13457; Hegade VS, 2016, ALIMENT PHARM THER, V43, P294, DOI 10.1111/apt.13449; Hegade VS, 2015, J HEPATOL, V62, pS785, DOI 10.1016/S0168-8278(15)31349-0; Hegade VS, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0481-9; Hegade VS, 2016, THER ADV GASTROENTER, V9, P376, DOI 10.1177/1756283X16630712; Hegade VS, 2014, HEPATOLOGY, V60, p362A; Hirschfield GM, 2015, GASTROENTEROLOGY, V148, P751, DOI 10.1053/j.gastro.2014.12.005; Hofmann AF, 2003, GUT, V52, P1239, DOI 10.1136/gut.52.9.1239; Hofmann AF, 2009, HEPATOLOGY, V49, P1403, DOI 10.1002/hep.22789; International Conference on Harmonisation (ICH), 1996, HARM TRIP GUID GUID; Jones DEJ, 2012, HEPATOLOGY, V56, P1194, DOI 10.1002/hep.25847; Khurana S, 2006, LIVER INT, V26, P943, DOI 10.1111/j.1478-3231.2006.01326.x; Kremer AE, 2014, BBA-MOL BASIS DIS, V1842, P869, DOI 10.1016/j.bbadis.2014.02.007; Kremer AE, 2012, HEPATOLOGY, V56, P1391, DOI 10.1002/hep.25748; Kremer AE, 2010, GASTROENTEROLOGY, V139, P1008, DOI 10.1053/j.gastro.2010.05.009; Kuiper EMM, 2010, HEPATOLOGY, V52, P1334, DOI 10.1002/hep.23821; Lanzini A, 2003, GUT, V52, P1371, DOI 10.1136/gut.52.9.1371; Levy Cynthia, 2011, Gastroenterol Hepatol (N Y), V7, P615; Lieu T, 2014, GASTROENTEROLOGY, V147, P1417, DOI 10.1053/j.gastro.2014.08.042; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Mayo MJ, 2016, J HEPATOL, V64, pS197, DOI 10.1016/S0168-8278(16)00146-X; Miethke AG, 2016, HEPATOLOGY, V63, P512, DOI 10.1002/hep.27973; Nevens F, 2016, NEW ENGL J MED, V375, P631, DOI 10.1056/NEJMoa1509840; Nunez DJ, 2016, DIABETES OBES METAB, V18, P654, DOI 10.1111/dom.12656; Prince MI, 2002, GUT, V50, P436, DOI 10.1136/gut.50.3.436; Raimondi F, 2008, AM J PHYSIOL-GASTR L, V294, pG906, DOI 10.1152/ajpgi.00043.2007; Rao AS, 2010, GASTROENTEROLOGY, V139, P1549, DOI 10.1053/j.gastro.2010.07.052; Rudic JS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000551.pub3; Sauter G, 1996, HEPATOLOGY, V24, P123, DOI 10.1053/jhep.1996.v24.pm0008707250; Talwalkar JA, 2003, CLIN GASTROENTEROL H, V1, P297, DOI 10.1016/S1542-3565(03)00134-4; Tandon P, 2007, AM J GASTROENTEROL, V102, P1528, DOI 10.1111/j.1572-0241.2007.01200.x; Wu YL, 2013, J MED CHEM, V56, P5094, DOI 10.1021/jm400459m	41	113	117	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2017	389	10074					1114	1123		10.1016/S0140-6736(17)30319-7	http://dx.doi.org/10.1016/S0140-6736(17)30319-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO0SR	28187915	Green Published			2022-12-28	WOS:000396408700027
J	Pandey, MK; Burrow, TA; Rani, R; Martin, LJ; Witte, D; Setchell, KD; Mckay, MA; Magnusen, AF; Zhang, WJ; Liou, B; Kohl, J; Grabowski, GA				Pandey, Manoj K.; Burrow, Thomas A.; Rani, Reena; Martin, Lisa J.; Witte, David; Setchell, Kenneth D.; Mckay, Mary A.; Magnusen, Albert F.; Zhang, Wujuan; Liou, Benjamin; Koehl, Joerg; Grabowski, Gregory A.			Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease	NATURE			English	Article							DENDRITIC CELLS; MOUSE MODEL; C5A; RECEPTORS; DEFICIENCY; RESPONSES	Gaucher disease is caused by mutations in GBA1, which encodes the lysosomal enzyme glucocerebrosidase (GCase). GBA1 mutations drive extensive accumulation of glucosylceramide (GC) in multiple innate and adaptive immune cells in the spleen, liver, lung and bone marrow, often leading to chronic inflammation(1). The mechanisms that connect excess GC to tissue inflammation remain unknown. Here we show that activation of complement C5a and C5a receptor 1 (C5aR1) controls GC accumulation and the inflammatory response in experimental and clinical Gaucher disease. Marked local and systemic complement activation occurred in GCase-deficient mice or after pharmacological inhibition of GCase and was associated with GC storage, tissue inflammation and proinflammatory cytokine production. Whereas all GCase-inhibited mice died within 4-5 weeks, mice deficient in both GCase and C5aR1, and wild-type mice in which GCase and C5aR were pharmacologically inhibited, were protected from these adverse effects and consequently survived. In mice and humans, GCase deficiency was associated with strong formation of complement-activating GC-specific IgG autoantibodies, leading to complement activation and C5a generation. Subsequent C5aR1 activation controlled UDP-glucose ceramide glucosyltransferase production, thereby tipping the balance between GC formation and degradation. Thus, extensive GC storage induces complement-activating IgG autoantibodies that drive a pathway of C5a generation and C5aR1 activation that fuels a cycle of cellular GC accumulation, innate and adaptive immune cell recruitment and activation in Gaucher disease. As enzyme replacement and substrate reduction therapies are expensive(2) and still associated with inflammation(3,4), increased risk of cancer(5) and Parkinson disease(6), targeting C5aR1 may serve as a treatment option for patients with Gaucher disease and, possibly, other lysosomal storage diseases.	[Pandey, Manoj K.; Burrow, Thomas A.; Martin, Lisa J.; Mckay, Mary A.; Liou, Benjamin; Grabowski, Gregory A.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Rani, Reena; Magnusen, Albert F.; Koehl, Joerg] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Rani, Reena; Magnusen, Albert F.; Koehl, Joerg] Cincinnati Childrens Hosp Med Ctr, Ctr Syst Immunol, Cincinnati, OH 45229 USA; [Witte, David] Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH 45229 USA; [Setchell, Kenneth D.; Zhang, Wujuan; Koehl, Joerg] Cincinnati Childrens Hosp Med Ctr, Lab Mass Spect, Cincinnati, OH 45229 USA; [Koehl, Joerg] Univ Lubeck, Inst System Inflammat Res, D-23562 Lubeck, Germany	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Lubeck	Pandey, MK (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA.; Kohl, J (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA.; Kohl, J (corresponding author), Cincinnati Childrens Hosp Med Ctr, Ctr Syst Immunol, Cincinnati, OH 45229 USA.; Kohl, J (corresponding author), Univ Lubeck, Inst System Inflammat Res, D-23562 Lubeck, Germany.	manoj.pandey@cchmc.org; joerg.koehl@uksh.de	Martin, Lisa/E-2425-2016; Pandey, Manoj Kumar/V-4557-2019; Koehl, Joerg/C-8531-2011	Martin, Lisa/0000-0001-8702-9946; Pandey, Manoj Kumar/0000-0002-0495-830X; McKay, Mary/0000-0002-5412-0986; Koehl, Joerg/0000-0003-1121-3178	Alexion Rare Disease Innovation [31-91010-584000-137015]; Division of Human Genetics funds; German Research Foundation [EXC 306/2, IRTG 1911]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	Alexion Rare Disease Innovation; Division of Human Genetics funds; German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. L. Tinch, V. Inskeep, B. Quinn and D. N. Magnusen for technical assistance. We thank L. Bailey for help with submission of the IRB protocol to use healthy human control and Gaucher disease patients' sera and C. Loftice for office and laboratory support. We also thank Cincinnati Children's Hospital Medical Center FACS, pathology and animal cores for their efforts and C. M. Karsten for his help with the model detailing the role of C5a in Gaucher disease. This study was supported by the Alexion Rare Disease Innovation (31-91010-584000-137015) and Division of Human Genetics funds to M.K.P. as well as the German Research Foundation (EXC 306/2, CL XII; and IRTG 1911) to J.K.	Aflaki E, 2016, AGING CELL, V15, P77, DOI 10.1111/acel.12409; Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; Boot RG, 2004, BLOOD, V103, P33, DOI 10.1182/blood-2003-05-1612; Bultron G, 2010, J INHERIT METAB DIS, V33, P167, DOI 10.1007/s10545-010-9055-0; Cluzeau CVM, 2012, HUM MOL GENET, V21, P3632, DOI 10.1093/hmg/dds193; Gervas-Arruga J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126153; KANFER JN, 1975, BIOCHEM BIOPH RES CO, V67, P85, DOI 10.1016/0006-291X(75)90286-7; Klos A, 2013, PHARMACOL REV, V65, P500, DOI 10.1124/pr.111.005223; Kolev M, 2014, NAT REV IMMUNOL, V14, P811, DOI 10.1038/nri3761; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mistry Pramod K., 2013, Critical Reviews in Oncogenesis, V18, P235; Nair S, 2016, NEW ENGL J MED, V374, P555, DOI 10.1056/NEJMoa1508808; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Otto M, 2004, J BIOL CHEM, V279, P142, DOI 10.1074/jbc.M310078200; Pandey MK, 2014, MOL GENET METAB, V111, P163, DOI 10.1016/j.ymgme.2013.09.002; Pandey Manoj Kumar, 2013, Critical Reviews in Oncogenesis, V18, P197; Pandey MK, 2012, MOL GENET METAB, V106, P310, DOI 10.1016/j.ymgme.2012.04.020; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Sun Y, 2010, HUM MOL GENET, V19, P1088, DOI 10.1093/hmg/ddp580; Syed SN, 2009, EUR J IMMUNOL, V39, P3343, DOI 10.1002/eji.200939884; van Dussen L, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-51; Weaver DJ, 2010, EUR J IMMUNOL, V40, P710, DOI 10.1002/eji.200939333; Xu YH, 2003, AM J PATHOL, V163, P2093, DOI 10.1016/S0002-9440(10)63566-3; Xu YH, 2008, MOL GENET METAB, V94, P190, DOI 10.1016/j.ymgme.2008.01.013	25	105	107	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					108	+		10.1038/nature21368	http://dx.doi.org/10.1038/nature21368			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0AA	28225753				2022-12-28	WOS:000395671500042
J	Turner, KM; Deshpande, V; Beyter, D; Koga, T; Rusert, J; Lee, C; Li, B; Arden, K; Ren, B; Nathanson, DA; Kornblum, HI; Taylor, MD; Kaushal, S; Cavenee, WK; Wechsler-Reya, R; Furnari, FB; Vandenberg, SR; Rao, PN; Wahl, GM; Bafna, V; Mischel, PS				Turner, Kristen M.; Deshpande, Viraj; Beyter, Doruk; Koga, Tomoyuki; Rusert, Jessica; Lee, Catherine; Li, Bin; Arden, Karen; Ren, Bing; Nathanson, David A.; Kornblum, Harley I.; Taylor, Michael D.; Kaushal, Sharmeela; Cavenee, Webster K.; Wechsler-Reya, Robert; Furnari, Frank B.; Vandenberg, Scott R.; Rao, P. Nagesh; Wahl, Geoffrey M.; Bafna, Vineet; Mischel, Paul S.			Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity	NATURE			English	Article							TARGETED THERAPY; CLONAL EVOLUTION; CANCER; RESISTANCE; MUTATIONS	Human cells have twenty-three pairs of chromosomes. In cancer, however, genes can be amplified in chromosomes or in circular extrachromosomal DNA (ecDNA), although the frequency and functional importance of ecDNA are not understood(1-4). We performed whole-genome sequencing, structural modelling and cytogenetic analyses of 17 different cancer types, including analysis of the structure and function of chromosomes during metaphase of 2,572 dividing cells, and developed a software package called ECdetect to conduct unbiased, integrated ecDNA detection and analysis. Here we show that ecDNA was found in nearly half of human cancers; its frequency varied by tumour type, but it was almost never found in normal cells. Driver oncogenes were amplified most commonly in ecDNA, thereby increasing transcript level. Mathematical modelling predicted that ecDNA amplification would increase oncogene copy number and intratumoural heterogeneity more effectively than chromosomal amplification. We validated these predictions by quantitative analyses of cancer samples. The results presented here suggest that ecDNA contributes to accelerated evolution in cancer.	[Turner, Kristen M.; Koga, Tomoyuki; Li, Bin; Arden, Karen; Ren, Bing; Cavenee, Webster K.; Furnari, Frank B.; Mischel, Paul S.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Deshpande, Viraj; Bafna, Vineet] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; [Rusert, Jessica; Wechsler-Reya, Robert] Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, Tumor Initiat & Maintenance Program, La Jolla, CA 92037 USA; [Nathanson, David A.; Kornblum, Harley I.] David Geffen UCLA Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Kornblum, Harley I.] David Geffen UCLA Sch Med, Neuropsychiat Inst, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Kornblum, Harley I.] David Geffen UCLA Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Taylor, Michael D.; Mischel, Paul S.] Hosp Sick Children, Arthur & Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [Kaushal, Sharmeela] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Vandenberg, Scott R.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Rao, P. Nagesh] David Geffen UCLA Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Wahl, Geoffrey M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Mischel, Paul S.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Salk Institute; University of California System; University of California San Diego	Bafna, V (corresponding author), Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA.	vbafna@cs.ucsd.edu	Bafna, Vineet/AAY-8111-2020	Bafna, Vineet/0000-0002-5810-6241; Koga, Tomoyuki/0000-0002-8330-117X; Mischel, Paul/0000-0002-4560-2211; Furnari, Frank/0000-0003-1909-4361; Beyter, Doruk/0000-0002-3644-5760; Lee, Catherine/0000-0002-3105-3557; Taylor, Michael/0000-0001-7009-3466	Ludwig Institute for Cancer Research; Defeat GBM Program of the National Brain Tumor Society; Ben and Catherine Ivy Foundation; Susan G. Komen Foundation [SAC110036]; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; Breast Cancer Research Foundation (BCRF); CureSearch for Children's Cancer; California Institute for Regenerative Medicine; NIH [NS73831, GM114362, NS80939, CA014195, CA159859, CA151819, T32CA121938]; NSF [NSF-IIS-1318386, NSF-DBI-1458557]; NATIONAL CANCER INSTITUTE [R01CA159859, P30CA014195, T32CA121938, U54CA151819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073831, R01NS080939] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; Defeat GBM Program of the National Brain Tumor Society; Ben and Catherine Ivy Foundation; Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Leona M. and Harry B. Helmsley Charitable Trust; Breast Cancer Research Foundation (BCRF); CureSearch for Children's Cancer; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Kolodner, W. Mischel, D. Geschwind, members of the Mischel laboratory, A. Akbari, A. Iranmehr and A. Patel for helpful comments. This work was supported by the Ludwig Institute for Cancer Research (P.S.M., B.R., K.A., W.K.C., F.B.F.), Defeat GBM Program of the National Brain Tumor Society (P.S.M., F.B.F.), The Ben and Catherine Ivy Foundation (P.S.M.), generous donations from the Ziering Family Foundation in memory of Sigi Ziering (P.S.M.); The Susan G. Komen Foundation (SAC110036), The Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002) and The Breast Cancer Research Foundation (BCRF) to G.M.W.; CureSearch for Children's Cancer and a Leadership Award from the California Institute for Regenerative Medicine to R. W. R. This work was also supported by the following NIH grants: NS73831 (P.S.M.), GM114362 (V.B., V.D., D.B.), NS80939 (F.B.F.), CA014195 and CA159859 (G.M.W.) and CA151819 (D.A.N.) and T32CA121938 (K.M.T.) and NSF grants: NSF-IIS-1318386 and NSF-DBI-1458557 (V.B., V.D., D.B.).	Almendro V, 2014, CELL REP, V6, P514, DOI 10.1016/j.celrep.2013.12.041; Andor N, 2016, NAT MED, V22, P105, DOI 10.1038/nm.3984; [Anonymous], 2012, BAYESIAN STAT INTRO; BIEDLER JL, 1963, J NATL CANCER I, V31, P575; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Bradley Derek, 2007, Journal of Graphics Tools, V12, P13; CARROLL SM, 1988, MOL CELL BIOL, V8, P1525, DOI 10.1128/MCB.8.4.1525; Fan YH, 2011, J APPL GENET, V52, P53, DOI 10.1007/s13353-010-0007-z; Garsed DW, 2014, CANCER CELL, V26, P653, DOI 10.1016/j.ccell.2014.09.010; Gillies RJ, 2012, NAT REV CANCER, V12, P487, DOI 10.1038/nrc3298; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Kanda T, 2001, J CELL SCI, V114, P49; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XH, 2014, CANCER PREV RES, V7, P114, DOI 10.1158/1940-6207.CAPR-13-0289; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Miller CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016327; Mishra S, 2016, MOL CELL BIOL, V36, P1050, DOI 10.1128/MCB.00652-15; Mitelman F., 2016, MITELMAN DATABASE CH; Motl J, 2015, BRADLEY LOCAL IMAGE; Nathanson DA, 2014, SCIENCE, V343, P72, DOI 10.1126/science.1241328; Nikolaev S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6690; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Sanborn JZ, 2013, CANCER RES, V73, P6036, DOI 10.1158/0008-5472.CAN-13-0186; SCHIMKE RT, 1978, SCIENCE, V202, P1051, DOI 10.1126/science.715457; SCHIMKE RT, 1984, CELL, V37, P705, DOI 10.1016/0092-8674(84)90406-9; STARK GR, 1989, CELL, V57, P901, DOI 10.1016/0092-8674(89)90328-0; Storlazzi CT, 2010, GENOME RES, V20, P1198, DOI 10.1101/gr.106252.110; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; VONHOFF DD, 1988, P NATL ACAD SCI USA, V85, P4804; WINDLE B, 1991, GENE DEV, V5, P160, DOI 10.1101/gad.5.2.160; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	36	283	294	14	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					122	+		10.1038/nature21356	http://dx.doi.org/10.1038/nature21356			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0AA	28178237	Green Accepted, Green Submitted			2022-12-28	WOS:000395671500045
J	Tovey, CA				Tovey, Craig A.			The Usefulness of Useless Knowledge With a companion essay by Robbert Dijkgraaf	SCIENCE			English	Book Review									[Tovey, Craig A.] Georgia Inst Technol, H Milton Stewart Sch Ind & Syst Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Tovey, CA (corresponding author), Georgia Inst Technol, H Milton Stewart Sch Ind & Syst Engn, Atlanta, GA 30332 USA.	craig.tovey@isye.gatech.edu						Flexner Abraham, 2017, USEFULNESS USELESS K	1	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					804	804		10.1126/science.aam8870	http://dx.doi.org/10.1126/science.aam8870			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2DW	28232543				2022-12-28	WOS:000395127600025
J	Tothova, Z; Ebert, BL				Tothova, Zuzana; Ebert, Benjamin L.			Doubling Down on Mutant RAS Can MEK or Break Leukemia	CELL			English	Editorial Material							GENE		[Tothova, Zuzana; Ebert, Benjamin L.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Tothova, Zuzana; Ebert, Benjamin L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Tothova, Zuzana; Ebert, Benjamin L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Ebert, BL (corresponding author), Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA.; Ebert, BL (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Ebert, BL (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	bebert@partners.org						Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BREMNER R, 1990, CELL, V61, P407, DOI 10.1016/0092-8674(90)90523-H; Burgess MR, 2017, CELL, V168, P817, DOI 10.1016/j.cell.2017.01.020; Grabocka E, 2014, CANCER CELL, V25, P243, DOI 10.1016/j.ccr.2014.01.005; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Wang L, 2014, LEUKEMIA, V28, P938, DOI 10.1038/leu.2014.20	10	2	2	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					749	750		10.1016/j.cell.2017.02.013	http://dx.doi.org/10.1016/j.cell.2017.02.013			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28235190	Bronze			2022-12-28	WOS:000396284800003
J	Voet, T; Vermeesch, JR				Voet, Thierry; Vermeesch, Joris R.			Mutational Processes Shaping the Genome in Early Human Embryos	CELL			English	Editorial Material							COPY NUMBER VARIATION		[Voet, Thierry; Vermeesch, Joris R.] Katholieke Univ Leuven, Univ Leuven, Dept Human Genet, Herestr 49, B-3000 Leuven, Belgium; [Voet, Thierry] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	KU Leuven; Wellcome Trust Sanger Institute	Voet, T; Vermeesch, JR (corresponding author), Katholieke Univ Leuven, Univ Leuven, Dept Human Genet, Herestr 49, B-3000 Leuven, Belgium.; Voet, T (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England.	thierry.voet@kuleuven.be; joris.vermeesch@kuleuven.be	Voet, Thierry/E-8877-2017	Voet, Thierry/0000-0003-1204-9963; Vermeesch, Joris/0000-0002-3071-1191	KU Leuven (SymBioSys) [PFV/10/016]; FWO [G.0924.15]; EU [692065]; Wellcome Trust; MRC	KU Leuven (SymBioSys); FWO(FWO); EU(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	T.V. and J.R.V. are supported by KU Leuven (SymBioSys, PFV/10/016), FWO (G.0924.15) and EU (Horizon 2020 WIDENLIFE: 692065). T.V. is also supported by the Wellcome Trust and MRC. T.V. and J.R.V. are co-inventors on patent applications PCT/EP2011/060211-WO/2011/157846, "Methods for haplotyping single cells;'' PCT/EP2013/070858WO/2014/053664, "High-throughput genotyping by sequencing low amounts of genetic material;'' and PCT/EP2014/068315-WO/2015/028576, "Haplotyping and copy number typing using polymorphic variant allelic frequencies.''	Carvalho CMB, 2016, NAT REV GENET, V17, P224, DOI 10.1038/nrg.2015.25; Gawad C, 2016, NAT REV GENET, V17, P175, DOI 10.1038/nrg.2015.16; Greco E, 2015, NEW ENGL J MED, V373, P2089, DOI 10.1056/NEJMc1500421; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Liu PF, 2017, CELL, V168, P830, DOI 10.1016/j.cell.2017.01.037; Macaulay IC, 2017, TRENDS GENET, V33, P155, DOI 10.1016/j.tig.2016.12.003; Robberecht C, 2013, GENOME RES, V23, P411, DOI 10.1101/gr.145631.112; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Vermeesch JR, 2016, NAT REV GENET, V17, P643, DOI 10.1038/nrg.2016.97; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871	10	7	7	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					751	+		10.1016/j.cell.2017.02.008	http://dx.doi.org/10.1016/j.cell.2017.02.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28235191	Bronze			2022-12-28	WOS:000396284800006
J	Williamson, L; Saponaro, M; Boeing, S; East, P; Mitter, R; Kantidakis, T; Kelly, GP; Lobley, A; Walker, J; Spencer-Dene, B; Howell, M; Stewart, A; Svejstrup, JQ				Williamson, Laura; Saponaro, Marco; Boeing, Stefan; East, Philip; Mitter, Richard; Kantidakis, Theodoros; Kelly, Gavin P.; Lobley, Anna; Walker, Jane; Spencer-Dene, Bradley; Howell, Michael; Stewart, Aengus; Svejstrup, Jesper Q.			UV Irradiation Induces a Non-coding RNA that Functionally Opposes the Protein Encoded by the Same Gene	CELL			English	Article							INDUCED DNA-DAMAGE; POLYMERASE-II ELONGATION; ULTRAVIOLET-LIGHT; COCKAYNE-SYNDROME; TRANSCRIPTION; CHROMATIN; REPAIR; EXPRESSION; REPRESSION; INHIBITION	The transcription-related DNA damage response was analyzed on a genome-wide scale with great spatial and temporal resolution. Upon UV irradiation, a slow-down of transcript elongation and restriction of gene activity to the promoter-proximal similar to 25 kb is observed. This is associated with a shift from expression of long mRNAs to shorter isoforms, incorporating alternative last exons (ALEs) that are more proximal to the transcription start site. Notably, this includes a shift from a protein-coding ASCC3 mRNA to a shorter ALE isoform of which the RNA, rather than an encoded protein, is critical for the eventual recovery of transcription. The non-coding ASCC3 isoform counteracts the function of the protein-coding isoform, indicating crosstalk between them. Thus, the ASCC3 gene expresses both coding and non-coding transcript isoforms with opposite effects on transcription recovery after UV-induced DNA damage.	[Williamson, Laura; Saponaro, Marco; Boeing, Stefan; Kantidakis, Theodoros; Walker, Jane; Svejstrup, Jesper Q.] Francis Crick Inst, Clare Hall Labs, Mech Transcript Lab, S Mimms EN6 3LD, Herts, England; [Saponaro, Marco] Univ Birmingham, Inst Canc & Genom Sci, Vincent Dr, Birmingham B15 2TT, W Midlands, England; [Boeing, Stefan; East, Philip; Mitter, Richard; Kelly, Gavin P.; Lobley, Anna; Stewart, Aengus] Francis Crick Inst, Bioinformat & Biostat, 1 Midland Rd, London NW1 1AT, England; [Spencer-Dene, Bradley] Francis Crick Inst, Expt Histopathol, 1 Midland Rd, London NW1 1AT, England; [Howell, Michael] Francis Crick Inst, High Throughput Screening Lab, 1 Midland Rd, London NW1 1AT, England	University of Birmingham; Francis Crick Institute; Francis Crick Institute; Francis Crick Institute	Svejstrup, JQ (corresponding author), Francis Crick Inst, Clare Hall Labs, Mech Transcript Lab, S Mimms EN6 3LD, Herts, England.	jesper.svejstrup@crick.ac.uk	Saponaro, Marco/M-1854-2015; Kelly, Gavin/ABG-2715-2021; Kantidakis, Theo/Q-8031-2016	Saponaro, Marco/0000-0002-9302-2553; Kelly, Gavin/0000-0001-7219-560X; Kantidakis, Theo/0000-0002-3515-5235; Mitter, Richard/0000-0002-1279-3760; Svejstrup, Jesper/0000-0003-4964-6147; East, Philip/0000-0001-5801-5713; Howell, Michael/0000-0003-0912-0079; Stewart, Aengus/0000-0001-5182-653X	Francis Crick Institute; Cancer Research UK [FC001166]; UK Medical Research Council [FC001166]; Wellcome Trust [FC001166, 090532/Z/09/Z]; European Research Council [693327, 268797]; Cancer Research UK [11567] Funding Source: researchfish; The Francis Crick Institute [10490, 10168, 10166, 10009, 10008, 10002] Funding Source: researchfish	Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK); The Francis Crick Institute	This work was supported by the Francis Crick Institute (that receives its core funding from Cancer Research UK [FC001166], the UK Medical Research Council [FC001166], and the Wellcome Trust [FC001166]) and by grants from the European Research Council, Agreements 693327 (TRANSDAM) and 268797 (TRANSINTEG). We thank The Francis Crick Advanced Sequencing Facility, the Cell Services Facility, the High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics (funded by Wellcome Trust grant 090532/Z/09/Z) for expression array analysis, and Yang Shi for the kind gift of ASCC3 antibody. Peter Verrijzer and members of the Svejstrup laboratory are thanked for comments on the manuscript.	Abdelmohsen K, 2013, AGING CELL, V12, P890, DOI 10.1111/acel.12115; Adam S, 2013, CELL, V155, P94, DOI 10.1016/j.cell.2013.08.029; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Andrade-Lima LC, 2015, NUCLEIC ACIDS RES, V43, P2744, DOI 10.1093/nar/gkv148; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Boeing S, 2016, CELL REP, V15, P1597, DOI 10.1016/j.celrep.2016.04.047; Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dinant C, 2013, MOL CELL, V51, P469, DOI 10.1016/j.molcel.2013.08.007; Ehrensberger AH, 2013, CELL, V154, P713, DOI 10.1016/j.cell.2013.07.032; Fong N, 2014, GENE DEV, V28, P2663, DOI 10.1101/gad.252106.114; Gaillard H, 2013, BBA-GENE REGUL MECH, V1829, P141, DOI 10.1016/j.bbagrm.2012.09.008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Ip JY, 2011, GENOME RES, V21, P390, DOI 10.1101/gr.111070.110; Jung DJ, 2002, MOL CELL BIOL, V22, P5203, DOI 10.1128/MCB.22.14.5203-5211.2002; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Leygue, 2007, NUCL RECEPT SIGNAL, V5, DOI [DOI 10.1621/NRS.05006, 10.1621/nrs.05006]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JQ, 2013, MBIO, V4, DOI 10.1128/mBio.00385-13; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mayer A, 2015, CELL, V161, P541, DOI 10.1016/j.cell.2015.03.010; MAYNE LV, 1982, CANCER RES, V42, P1473; McKay BC, 2004, P NATL ACAD SCI USA, V101, P6582, DOI 10.1073/pnas.0308181101; Munoz MJ, 2009, CELL, V137, P708, DOI 10.1016/j.cell.2009.03.010; Nojima T, 2015, CELL, V161, P526, DOI 10.1016/j.cell.2015.03.027; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pinto PAB, 2011, EMBO J, V30, P2431, DOI 10.1038/emboj.2011.156; Proietti-De-Santis L, 2006, EMBO J, V25, P1915, DOI 10.1038/sj.emboj.7601071; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rockx DAP, 2000, P NATL ACAD SCI USA, V97, P10503, DOI 10.1073/pnas.180169797; Rutenberg-Schoenberg M, 2016, ANNU REV GENOM HUM G, V17, P69, DOI 10.1146/annurev-genom-090314-024939; Sampath K, 2016, DEVELOPMENT, V143, P1234, DOI 10.1242/dev.133298; Sanchez A, 2016, P NATL ACAD SCI USA, V113, P11243, DOI 10.1073/pnas.1610735113; Saponaro M, 2014, CELL, V157, P1037, DOI 10.1016/j.cell.2014.03.048; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; Vichi P, 1997, EMBO J, V16, P7444, DOI 10.1093/emboj/16.24.7444; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wilson MD, 2013, BBA-GENE REGUL MECH, V1829, P151, DOI 10.1016/j.bbagrm.2012.08.002; Zhang F, 2013, J CELL SCI, V126, P4850, DOI 10.1242/jcs.132514	47	109	114	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					843	+		10.1016/j.cell.2017.01.019	http://dx.doi.org/10.1016/j.cell.2017.01.019			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28215706	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000396284800013
J	Buchanan, TL; Hull, KL				Buchanan, Travis L.; Hull, Kami L.			Illuminating amination	SCIENCE			English	Editorial Material							ANTI-MARKOVNIKOV HYDROAMINATION; AMINES		[Buchanan, Travis L.; Hull, Kami L.] Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Hull, KL (corresponding author), Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA.	kamihull@illinois.edu	Hull, Kami/N-2437-2015	Hull, Kami/0000-0003-3102-2686				Beller M, 1999, CHEM-EUR J, V5, P1306, DOI 10.1002/(SICI)1521-3765(19990401)5:4<1306::AID-CHEM1306>3.0.CO;2-4; Ensign SC, 2015, J AM CHEM SOC, V137, P13748, DOI 10.1021/jacs.5b08500; Kemper J, 2005, ANGEW CHEM INT EDIT, V44, P4914, DOI 10.1002/anie.200463032; Muller TE, 2008, CHEM REV, V108, P3795, DOI 10.1021/cr0306788; Musacchio AJ, 2017, SCIENCE, V355, P727, DOI 10.1126/science.aal3010; Pirnot MT, 2016, ANGEW CHEM INT EDIT, V55, P48, DOI 10.1002/anie.201507594; Roughley SD, 2011, J MED CHEM, V54, P3451, DOI 10.1021/jm200187y; Vitaku E, 2014, J MED CHEM, V57, P10257, DOI 10.1021/jm501100b	8	1	1	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					690	691		10.1126/science.aam6382	http://dx.doi.org/10.1126/science.aam6382			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2AC	28209858				2022-12-28	WOS:000395117700020
J	Clery, D				Clery, Daniel			ASTROPHYSICS European gravitational wave detector falters	SCIENCE			English	News Item														Clery, Daniel/0000-0002-8742-3596					0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					673	674		10.1126/science.355.6326.673	http://dx.doi.org/10.1126/science.355.6326.673			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2AC	28209846				2022-12-28	WOS:000395117700009
J	Musacchio, AJ; Lainhart, BC; Zhang, X; Naguib, SG; Sherwood, TC; Knowles, RR				Musacchio, Andrew J.; Lainhart, Brendan C.; Zhang, Xin; Naguib, Saeed G.; Sherwood, Trevor C.; Knowles, Robert R.			Catalytic intermolecular hydroaminations of unactivated olefins with secondary alkyl amines	SCIENCE			English	Article							ANTI-MARKOVNIKOV HYDROAMINATION; INTRAMOLECULAR HYDROAMINATION; PHOTOREDOX CATALYSIS; RADICAL REACTIONS; ALKENES; COMPLEXES; HYDROAMIDATION; CYCLIZATIONS; KINETICS	The intermolecular hydroamination of unactivated alkenes with simple dialkyl amines remains an unsolved problem in organic synthesis. We report a catalytic protocol for efficient additions of cyclic and acyclic secondary alkyl amines to a wide range of alkyl olefins with complete anti-Markovnikov regioselectivity. In this process, carbon-nitrogen bond formation proceeds through a key aminium radical cation intermediate that is generated via electron transfer between an excited-state iridium photocatalyst and an amine substrate. These reactions are redox-neutral and completely atom-economical, exhibit broad functional group tolerance, and occur readily at room temperature under visible light irradiation. Certain tertiary amine products generated through this method are formally endergonic relative to their constituent olefin and amine starting materials and thus are not accessible via direct coupling with conventional ground-state catalysts.	[Musacchio, Andrew J.; Lainhart, Brendan C.; Zhang, Xin; Naguib, Saeed G.; Knowles, Robert R.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Sherwood, Trevor C.] Bristol Myers Squibb Co, Discovery Chem, Princeton, NJ 08543 USA	Princeton University; Bristol-Myers Squibb	Knowles, RR (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	rknowles@princeton.edu		Zhang, Xin/0000-0001-5019-5545; Musacchio, Andrew/0000-0002-8110-3540; Knowles, Robert/0000-0003-1044-4900	Sloan Foundation research fellowship; Amgen Young Investigator award; Eli Lilly grantee award; NIH [R01 GM120530]; Bristol-Myers Squibb; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120530] Funding Source: NIH RePORTER	Sloan Foundation research fellowship(Alfred P. Sloan Foundation); Amgen Young Investigator award(Amgen); Eli Lilly grantee award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by a Sloan Foundation research fellowship, an Amgen Young Investigator award, and an Eli Lilly grantee award (R.R.K.) and by NIH grant R01 GM120530 and Bristol-Myers Squibb. We thank D. C. Miller for calculations, and W. (R.) Ewing, L. Lombardo, M. Eastgate, and R. Borzilleri for helpful discussions.	Bender CF, 2005, J AM CHEM SOC, V127, P1070, DOI 10.1021/ja043278q; COULSON DR, 1971, TETRAHEDRON LETT, P429; Crimmin MR, 2009, J AM CHEM SOC, V131, P9670, DOI 10.1021/ja9003377; Goldsmith JI, 2005, J AM CHEM SOC, V127, P7502, DOI 10.1021/ja0427101; Gui JH, 2015, SCIENCE, V348, P886, DOI 10.1126/science.aab0245; Guin J, 2007, J AM CHEM SOC, V129, P4498, DOI 10.1021/ja0692581; Hong S, 2004, ACCOUNTS CHEM RES, V37, P673, DOI 10.1021/ar040051r; HORNER JH, 1995, J AM CHEM SOC, V117, P11124, DOI 10.1021/ja00150a012; Huang LB, 2015, CHEM REV, V115, P2596, DOI 10.1021/cr300389u; Ickes AR, 2014, J AM CHEM SOC, V136, P11256, DOI 10.1021/ja505794u; Johns AM, 2006, J AM CHEM SOC, V128, P9306, DOI 10.1021/ja062773e; Ladouceur S, 2011, INORG CHEM, V50, P11514, DOI 10.1021/ic2014013; LaLonde RL, 2007, J AM CHEM SOC, V129, P2452, DOI 10.1021/ja068819l; Maity S, 2012, ANGEW CHEM INT EDIT, V51, P9562, DOI 10.1002/anie.201205137; Margrey KA, 2016, ACCOUNTS CHEM RES, V49, P1997, DOI 10.1021/acs.accounts.6b00304; Miki Y, 2013, ANGEW CHEM INT EDIT, V52, P10830, DOI 10.1002/anie.201304365; Miller DC, 2015, J AM CHEM SOC, V137, P13492, DOI 10.1021/jacs.5b09671; Muller TE, 1998, CHEM REV, V98, P675, DOI 10.1021/cr960433d; Musacchio AJ, 2014, J AM CHEM SOC, V136, P12217, DOI 10.1021/ja5056774; NEWCOMB M, 1990, TETRAHEDRON, V46, P2317, DOI 10.1016/S0040-4020(01)82012-3; Nguyen TM, 2013, J AM CHEM SOC, V135, P9588, DOI 10.1021/ja4031616; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Reznichenko AL, 2010, ANGEW CHEM INT EDIT, V49, P8984, DOI 10.1002/anie.201004570; ROBERTS BP, 1994, J CHEM SOC PERK T 2, P2155, DOI 10.1039/p29940002155; Roth HG, 2016, SYNLETT, V27, P714, DOI 10.1055/s-0035-1561297; Sevov CS, 2014, J AM CHEM SOC, V136, P3200, DOI 10.1021/ja412116d; Singh K, 2014, J AM CHEM SOC, V136, P5275, DOI 10.1021/ja5019749; STELLA L, 1983, ANGEW CHEM INT EDIT, V22, P337, DOI 10.1002/anie.198303373; Utsunomiya M, 2003, J AM CHEM SOC, V125, P5608, DOI 10.1021/ja0293608; Wagner BD, 1996, J AM CHEM SOC, V118, P13, DOI 10.1021/ja950133y; Waser J, 2006, J AM CHEM SOC, V128, P11693, DOI 10.1021/ja062355+; Yayla HG, 2016, J AM CHEM SOC, V138, P10794, DOI 10.1021/jacs.6b06517; Zhu SL, 2013, J AM CHEM SOC, V135, P15746, DOI 10.1021/ja4092819	33	210	208	10	293	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					727	730		10.1126/science.aal3010	http://dx.doi.org/10.1126/science.aal3010			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2AC	28209894	Green Accepted			2022-12-28	WOS:000395117700037
J	Vogel, G				Vogel, Gretchen			NEGLECTED DISEASES Parasitic worm may trigger mystery nodding syndrome	SCIENCE			English	News Item																			0	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					678	678		10.1126/science.355.6326.678	http://dx.doi.org/10.1126/science.355.6326.678			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2AC	28209852				2022-12-28	WOS:000395117700014
J	Williams, PA; Harder, JM; Foxworth, NE; Cochran, KE; Philip, VM; Porciatti, V; Smithies, O; John, SWM				Williams, Pete A.; Harder, Jeffrey M.; Foxworth, Nicole E.; Cochran, Kelly E.; Philip, Vivek M.; Porciatti, Vittorio; Smithies, Oliver; John, Simon W. M.			Vitamin B-3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice	SCIENCE			English	Article							NECROSIS-FACTOR-ALPHA; MOUSE MODEL; CELL FUNCTION; NEURODEGENERATION; COMMUNICATION; DEGENERATION; DYSFUNCTION; COMPLEMENT; RESPONSES; PATHWAY	Glaucomas are neurodegenerative diseases that cause vision loss, especially in the elderly. The mechanisms initiating glaucoma and driving neuronal vulnerability during normal aging are unknown. Studying glaucoma-prone mice, we show that mitochondrial abnormalities are an early driver of neuronal dysfunction, occurring before detectable degeneration. Retinal levels of nicotinamide adenine dinucleotide (NAD(+), a key molecule in energy and redox metabolism) decrease with age and render aging neurons vulnerable to disease-related insults. Oral administration of the NAD(+) precursor nicotinamide (vitamin B-3), and/or gene therapy (driving expression of Nmnat1, a key NAD(+)-producing enzyme), was protective both prophylactically and as an intervention. At the highest dose tested, 93% of eyes did not develop glaucoma. This supports therapeutic use of vitamin B-3 in glaucoma and potentially other age-related neurodegenerations.	[Williams, Pete A.; Harder, Jeffrey M.; Foxworth, Nicole E.; Cochran, Kelly E.; Philip, Vivek M.; John, Simon W. M.] Jackson Lab, Bar Harbor, ME 04609 USA; [Porciatti, Vittorio] Univ Miami, Bascom Palmer Eye Inst, Miller Sch Med, Miami, FL 33136 USA; [Smithies, Oliver] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [John, Simon W. M.] Tufts Univ Med, Dept Ophthalmol, Boston, MA 02111 USA; [John, Simon W. M.] Howard Hughes Med Inst, Bar Harbor, ME 04609 USA	Jackson Laboratory; Bascom Palmer Eye Institute; University of Miami; University of North Carolina; University of North Carolina Chapel Hill; Tufts University; Howard Hughes Medical Institute	John, SWM (corresponding author), Jackson Lab, Bar Harbor, ME 04609 USA.; John, SWM (corresponding author), Tufts Univ Med, Dept Ophthalmol, Boston, MA 02111 USA.; John, SWM (corresponding author), Howard Hughes Med Inst, Bar Harbor, ME 04609 USA.	simon.john@jax.org		Williams, Pete/0000-0001-6194-8397; Philip, Vivek/0000-0001-5126-707X; Harder, Jeffrey/0000-0003-3832-3553; Porciatti, Vittorio/0000-0002-1592-3532	Jackson Laboratory Fellowships; Barbara and Joseph Cohen Foundation; Lano Family Foundation;  [EY11721];  [HL49277]; NATIONAL EYE INSTITUTE [R01EY011721, R01EY019077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049277] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1262049] Funding Source: National Science Foundation	Jackson Laboratory Fellowships; Barbara and Joseph Cohen Foundation; Lano Family Foundation; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The data reported in this paper are available in the supplementary materials. RNA-seq data are available through the Gene Expression Omnibus (accession number GSE90654). The authors would like to thank the staff of the flow cytometry, histology, gene expression services, and computational sciences at the Jackson Laboratory; G. Howell and R. Libby for discussion and experiment design; K. Kizhatil for reading the manuscript; M. de Vries for assistance with diet and organizing; B. Cardozo for colony maintenance and drug changes; and A. Bell for intraocular pressure measurements. The authors would also like to thank their sources of funding: the Jackson Laboratory Fellowships (P.A.W. and J.M.H.), partial support from EY11721 (S.W.M.J.), the Barbara and Joseph Cohen Foundation (S.W.M.J.), and HL49277 (O.S.). S.W.M.J. is an Investigator of The Howard Hughes Medical Institute. S.W.M.J. and P.A.W. are inventors on a provisional patent application (no current patent number) submitted by the Jackson Laboratory that covers NAD-related therapies in glaucoma. S.W.M.J. holds additional philanthropic funding from the Lano Family Foundation.	Ali YO, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002472; Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; Baker BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002760; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chrysostomou V, 2013, CURR OPIN PHARMACOL, V13, P12, DOI 10.1016/j.coph.2012.09.008; Di Stefano M, 2015, CELL DEATH DIFFER, V22, P731, DOI 10.1038/cdd.2014.164; Gandin V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11127; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Kotiadis VN, 2014, BBA-GEN SUBJECTS, V1840, P1254, DOI 10.1016/j.bbagen.2013.10.041; Krizaj D, 2014, CURR EYE RES, V39, P105, DOI 10.3109/02713683.2013.836541; Lee S, 2011, EXP EYE RES, V93, P204, DOI 10.1016/j.exer.2010.07.015; Li F, 2016, P NATL ACAD SCI USA, V113, P13450, DOI 10.1073/pnas.1614947113; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Nickells RW, 2012, ANNU REV NEUROSCI, V35, P153, DOI 10.1146/annurev.neuro.051508.135728; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quiros PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23; Saleh M, 2007, INVEST OPHTH VIS SCI, V48, P4564, DOI 10.1167/iovs.07-0483; Schonfeld P, 2013, J CEREBR BLOOD F MET, V33, P1493, DOI 10.1038/jcbfm.2013.128; Soto I, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a017269; Stein LR, 2014, EMBO J, V33, P1321, DOI 10.1002/embj.201386917; Williams PA, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0091-6; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.3.CO;2-V; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693	28	263	269	7	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					756	760		10.1126/science.aal0092	http://dx.doi.org/10.1126/science.aal0092			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2AC	28209901	Green Accepted			2022-12-28	WOS:000395117700045
J	Bassis, JN; Petersen, SV; Mac Cathles, L				Bassis, Jeremy N.; Petersen, Sierra V.; Mac Cathles, L.			Heinrich events triggered by ocean forcing and modulated by isostatic adjustment	NATURE			English	Article							NORTH-ATLANTIC; ICE-SHEET; ICEBERG DISCHARGES; GREENLAND ICE; SEA-LEVEL; GLACIERS; RETREAT; RECORDS; CLIMATE	During the last glacial period, the Laurentide Ice Sheet sporadically discharged huge numbers of icebergs through the Hudson Strait into the North Atlantic Ocean, leaving behind distinct layers of ice-rafted debris in the ocean sediments(1-3). Perplexingly, these massive discharge events-Heinrich events-occurred during the cold portion of millennial-scale climate oscillations called Dansgaard-Oeschger cycles(2,4). This is in contrast to the expectation that ice sheets expand in colder climates and shrink in warmer climates. Here we use an ice sheet model to show that the magnitude and timing of Heinrich events can be explained by the same processes that drive the retreat of modern marine-terminating glaciers. In our model, subsurface ocean warming associated with variations in the overturning circulation increases underwater melt along the calving face, triggering rapid margin retreat and increased iceberg discharge. On millennial timescales, isostatic adjustment causes the bed to uplift, isolating the terminus from subsurface warming and allowing the ice sheet to advance again until, at its most advanced position, it is poised for another Heinrich event. This mechanism not only explains the timing and magnitude of observed Heinrich events, but also suggests that ice sheets in contact with warming oceans may be vulnerable to catastrophic collapse even with little atmospheric warming.	[Bassis, Jeremy N.; Mac Cathles, L.] Univ Michigan, Dept Climate & Space Sci & Engn, Ann Arbor, MI 48109 USA; [Petersen, Sierra V.; Mac Cathles, L.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Bassis, JN (corresponding author), Univ Michigan, Dept Climate & Space Sci & Engn, Ann Arbor, MI 48109 USA.	jbassis@umich.edu	Bassis, Jeremy N/J-1706-2012; Bassis, Jeremy/ABB-8628-2021	Bassis, Jeremy N/0000-0003-2946-7176; Bassis, Jeremy/0000-0003-2946-7176	NSF-ANT [114085]; Polar Programs [PLR-1341568]; NOAH [NA13OAR4310096]; NSF-OCE-PRF [1420902]; Michigan Society of Fellows; Directorate For Geosciences [1341568] Funding Source: National Science Foundation	NSF-ANT(National Science Foundation (NSF)); Polar Programs; NOAH; NSF-OCE-PRF; Michigan Society of Fellows; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We were supported by grant NSF-ANT 114085, Polar Programs grant PLR-1341568, NOAH Award NA13OAR4310096, grant NSF-OCE-PRF 1420902 and the Michigan Society of Fellows.	Alvarez-Solas J, 2013, P NATL ACAD SCI USA, V110, P16350, DOI 10.1073/pnas.1306622110; Alvarez-Solas J, 2011, P NATL ACAD SCI USA, V108, pE1359, DOI 10.1073/pnas.1116575108; Andrews JT, 2002, QUATERNARY SCI REV, V21, P443, DOI 10.1016/S0277-3791(01)00073-7; Bassis JN, 2013, NAT GEOSCI, V6, P833, DOI [10.1038/ngeo1887, 10.1038/NGEO1887]; Bassis JN, 2012, P ROY SOC A-MATH PHY, V468, P913, DOI 10.1098/rspa.2011.0422; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; BOND GC, 1995, SCIENCE, V267, P1005, DOI 10.1126/science.267.5200.1005; Bueler E, 2007, ANN GLACIOL-SER, V46, P97, DOI 10.3189/172756407782871567; Clarke G., 1999, MECH GLOBAL CLIMATE, V394; de Vernal A, 2000, CAN J EARTH SCI, V37, P725, DOI [10.1139/e99-091, 10.1139/cjes-37-5-725]; DeConto RM, 2016, NATURE, V531, P591, DOI 10.1038/nature17145; Gomez N, 2010, NAT GEOSCI, V3, P850, DOI 10.1038/NGEO1012; HEINRICH H, 1988, QUATERNARY RES, V29, P142, DOI 10.1016/0033-5894(88)90057-9; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Hesse R, 1999, MAR GEOL, V155, P249, DOI 10.1016/S0025-3227(98)00054-1; Holland DM, 2008, NAT GEOSCI, V1, P659, DOI 10.1038/ngeo316; Hulbe CL, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000890; Konrad H, 2015, EARTH PLANET SC LETT, V432, P254, DOI 10.1016/j.epsl.2015.10.008; MACAYEAL DR, 1993, PALEOCEANOGRAPHY, V8, P775, DOI 10.1029/93PA02200; Marcott SA, 2011, P NATL ACAD SCI USA, V108, P13415, DOI 10.1073/pnas.1104772108; Mitrovica JX, 2004, EARTH PLANET SC LETT, V225, P177, DOI 10.1016/j.epsl.2004.06.005; Murray T, 2015, ARCT ANTARCT ALP RES, V47, P427, DOI 10.1657/AAAR0014-049; Nick FM, 2009, NAT GEOSCI, V2, P110, DOI 10.1038/NGEO394; Rasmussen SO, 2014, QUATERNARY SCI REV, V106, P14, DOI 10.1016/j.quascirev.2014.09.007; Rignot E, 2010, NAT GEOSCI, V3, P187, DOI 10.1038/NGEO765; Roberts WHG, 2014, EARTH PLANET SC LETT, V386, P1, DOI 10.1016/j.epsl.2013.10.020; Seierstad IK, 2014, QUATERNARY SCI REV, V106, P29, DOI 10.1016/j.quascirev.2014.10.032; Shaffer G, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020968; Stoner JS, 2000, EARTH PLANET SC LETT, V183, P161, DOI 10.1016/S0012-821X(00)00272-7; Straneo F, 2013, NATURE, V504, P36, DOI 10.1038/nature12854	30	71	72	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					332	334		10.1038/nature21069	http://dx.doi.org/10.1038/nature21069			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2LQ	28202970				2022-12-28	WOS:000394451600033
J	John, PA; Caplan, AL; Dal-Re, R				John, P. A.; Caplan, Arthur L.; Dal-Re, Rafael			Outcome reporting bias in clinical trials: why monitoring matters	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[John, P. A.] Stanford Univ, Dept Med, Palo Alto, CA 94305 USA; [John, P. A.] Stanford Univ, Dept Hlth Res & Policy, Palo Alto, CA 94305 USA; [John, P. A.] Stanford Univ, Dept Stat, Palo Alto, CA 94305 USA; [John, P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Palo Alto, CA 94305 USA; [Caplan, Arthur L.] NYU, Sch Med, Langone Med Ctr, Div Med Eth, New York, NY 10016 USA; [Dal-Re, Rafael] Univ Autonoma Madrid, Clin Res, BUC Biosci UAM CSIC Program, Int Campus Excellence,Ciudad Univ Cantoblanco, E-28049 Madrid, Spain	Stanford University; Stanford University; Stanford University; Stanford University; New York University; NYU Langone Medical Center; Autonomous University of Madrid	John, PA (corresponding author), Stanford Univ, Dept Med, Palo Alto, CA 94305 USA.; John, PA (corresponding author), Stanford Univ, Dept Hlth Res & Policy, Palo Alto, CA 94305 USA.; John, PA (corresponding author), Stanford Univ, Dept Stat, Palo Alto, CA 94305 USA.; John, PA (corresponding author), Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Palo Alto, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011; Harding, Richard/G-9729-2012	Ioannidis, John P./0000-0003-3118-6859				[Anonymous], 2016, BMJ-BRIT MED J, V356, pi195; Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Chauvin A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0395-3; Dal-Re R, 2016, J CLIN EPIDEMIOL, V75, P100, DOI 10.1016/j.jclinepi.2016.01.017; Dal-Re R, 2015, EUR J CLIN INVEST, V45, P895, DOI 10.1111/eci.12484; Dal-Re R, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1323; Dal-Re R, 2014, EUR J CLIN PHARMACOL, V70, P491, DOI 10.1007/s00228-013-1635-0; De Oliveira GS, 2015, ANESTH ANALG, V121, P1030, DOI 10.1213/ANE.0000000000000824; Ebrahim S, 2016, J CLIN EPIDEMIOL, V79, P130, DOI 10.1016/j.jclinepi.2016.05.016; Gargon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099111; Gilbody S, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5627; Goldacre B, THE COMPARE PROJECT; Hoffmann T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3223; Hooft L, 2014, NETH J MED, V72, P349; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h72; Jones CW, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0520-3; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Mathieu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059910; Saquib N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4313; Schmucker C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114023; Stegert M, 2016, J CLIN EPIDEMIOL, V69, P152, DOI 10.1016/j.jclinepi.2015.05.023; Taichman DB, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i255; van Lent M, 2015, J CLIN EPIDEMIOL, V68, P1059, DOI 10.1016/j.jclinepi.2014.11.019; Viergever RF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084727; Weston J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010075; Williams RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127242	27	41	41	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2017	356								j408	10.1136/bmj.j408	http://dx.doi.org/10.1136/bmj.j408			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GL	28196819				2022-12-28	WOS:000394579600002
J	Sederer, LI				Sederer, Lloyd I.			The One With Friends A TV Show Within a Play	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sederer, Lloyd I.] Columbia Mailman Sch Publ Hlth, New York, NY 10032 USA		Sederer, LI (corresponding author), Columbia Mailman Sch Publ Hlth, New York, NY 10032 USA.	askdrlloyd@gmail.com							0	0	0	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2017	317	6					568	569		10.1001/jama.2016.20747	http://dx.doi.org/10.1001/jama.2016.20747			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8LI	28196231				2022-12-28	WOS:000394870900001
J	Hawkes, N				Hawkes, Nigel			An endorsement of PCSK9 inhibitors funded by ... their manufacturers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Garde D., 2016, STAT NEWS       1028; Kazi DS, 2016, JAMA-J AM MED ASSOC, V316, P743, DOI 10.1001/jama.2016.11004; Mancini GBJ, 2016, CAN J CARDIOL, V32, pS35, DOI 10.1016/j.cjca.2016.01.003; McGettigan P, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j188; Stroes ES, 2015, EUR HEART J, V36, P1012, DOI 10.1093/eurheartj/ehv043	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2017	356								j712	10.1136/bmj.j712	http://dx.doi.org/10.1136/bmj.j712			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GI	28193639				2022-12-28	WOS:000394579300003
J	Xiao, J; Ha, T				Xiao, Jie; Ha, Taekjip			Flipping nanoscopy on its head	SCIENCE			English	Editorial Material							FLUORESCENCE MICROSCOPY; STIMULATED-EMISSION; RESOLUTION LIMIT		[Xiao, Jie; Ha, Taekjip] Johns Hopkins Univ, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Ha, Taekjip] Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21205 USA; [Ha, Taekjip] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; [Ha, Taekjip] Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute	Xiao, J (corresponding author), Johns Hopkins Univ, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	xiao@jhmi.edu; tjha@jhu.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Xiao, Jie/0000-0003-1433-5437	NIGMS NIH HHS [R01 GM086447] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balzarotti F, 2017, SCIENCE, V355, P606, DOI 10.1126/science.aak9913; BETZIG E, 1995, OPT LETT, V20, P237, DOI 10.1364/OL.20.000237; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Dai MJ, 2016, NAT NANOTECHNOL, V11, P798, DOI [10.1038/NNANO.2016.95, 10.1038/nnano.2016.95]; Eggeling C, 2015, Q REV BIOPHYS, V48, P178, DOI [10.1017/S0033583515000219, 10.1017/S0033583514000146]; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	12	0	0	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					582	584		10.1126/science.aam5409	http://dx.doi.org/10.1126/science.aam5409			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK0SF	28183938	Green Accepted			2022-12-28	WOS:000393636700029
J	Cescon, D; Siu, LL				Cescon, Dave; Siu, Lillian L.			Cancer Clinical Trials: The Rear-View Mirror and the Crystal Ball	CELL			English	Editorial Material							CELL LUNG-CANCER; APPROVAL; IDENTIFICATION; PEMBROLIZUMAB; MELANOMA	Clinical trials are key to translating scientific advances into progress in cancer research and care. Confronted by developments in basic science, the landscape of clinical cancer research is rapidly evolving. Here, we review recent changes in clinical trials' design and conduct, and we forecast future directions toward personalized and global impact.	[Cescon, Dave; Siu, Lillian L.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 1Z5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Siu, LL (corresponding author), Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 1Z5, Canada.	lillian.siu@uhn.ca						Ellis LM, 2014, J CLIN ONCOL, V32, P1277, DOI 10.1200/JCO.2013.53.8009; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Johnson JR, 2003, CLIN CANCER RES, V9, P1972; Kazandjian D, 2014, ONCOLOGIST, V19, pE5, DOI 10.1634/theoncologist.2014-0241; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Poole RM, 2014, DRUGS, V74, P1973, DOI 10.1007/s40265-014-0314-5; Siu LL, 2016, NAT MED, V22, P464, DOI 10.1038/nm.4089; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Viergever RF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008932; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	13	9	9	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2017	168	4					575	578		10.1016/j.cell.2017.01.027	http://dx.doi.org/10.1016/j.cell.2017.01.027			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8VJ	28187280	Bronze			2022-12-28	WOS:000396277600009
J	Tubbs, A; Nussenzweig, A				Tubbs, Anthony; Nussenzweig, Andre			Endogenous DNA Damage as a Source of Genomic Instability in Cancer	CELL			English	Review							DOUBLE-STRAND BREAKS; REGIONAL MUTATION-RATES; SOMATIC MUTATIONS; SEQUENCING REVEALS; SUPER-ENHANCERS; TOPOISOMERASE 1; TRANSCRIPTION; REPAIR; REPLICATION; EVOLUTION	Genome instability, defined as higher than normal rates of mutation, is a double-edged sword. As a source of genetic diversity and natural selection, mutations are beneficial for evolution. On the other hand, genomic instability can have catastrophic consequences for age-related diseases such as cancer. Mutations arise either from inactivation of DNA repair pathways or in a repair-competent background due to genotoxic stress from celluar processes such as transcription and replication that overwhelm high-fidelity DNA repair. Here, we review recent studies that shed light on endogenous sources of mutation and epigenomic features that promote genomic instability during cancer evolution.	[Tubbs, Anthony; Nussenzweig, Andre] NIH, Lab Genome Integr, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Nussenzweig, A (corresponding author), NIH, Lab Genome Integr, Bldg 10, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov			NIH; National Cancer Institute; Center for Cancer Research; US Department of Defense [BC133858, BC151331]; Ellison Foundation; Alex's Lemonade Stand Foundation; American Cancer Society [PF-16-037-01-DMC]; NATIONAL CANCER INSTITUTE [ZIABC010283, ZIABC010959] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Defense(United States Department of Defense); Ellison Foundation(Lawrence Ellison Foundation); Alex's Lemonade Stand Foundation; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are especially grateful to Joshua Waterfall, Ferenc Livak, Avinash Bhandoola, and Sam John for comments on the manuscript and to Jiri Lukas, Keith Caldecott, and Yossi Shiloh for discussions. This work was supported by the Intramural Research Program of the NIH, the National Cancer Institute, and the Center for Cancer Research. A.N. was also supported by the US Department of Defense (BCRP DOD Idea Expansion Award BC133858 and BCRP Breakthrough Award BC151331), the Ellison Foundation Award for Aging Research, and Alex's Lemonade Stand Foundation Reach Award. A.T. has been supported by a fellowship from the American Cancer Society (PF-16-037-01-DMC).	Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Alexandrov LB, 2014, CURR OPIN GENET DEV, V24, P52, DOI 10.1016/j.gde.2013.11.014; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768; Bunch H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10191; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Calderwood SK, 2016, TRANSCR-AUSTIN, V7, P75, DOI 10.1080/21541264.2016.1181142; Canela A, 2016, MOL CELL, V63, P898, DOI 10.1016/j.molcel.2016.06.034; Chaudhuri AR, 2016, NATURE, V535, P382, DOI 10.1038/nature18325; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; CRICK F, 1974, NATURE, V248, P766, DOI 10.1038/248766a0; DATTA A, 1995, SCIENCE, V268, P1616, DOI 10.1126/science.7777859; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Friedberg EC, 2008, CELL RES, V18, P3, DOI 10.1038/cr.2007.113; Gao RL, 2016, NAT GENET, V48, P1119, DOI 10.1038/ng.3641; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363; Haber JE, 2015, CELL, V162, P1183, DOI 10.1016/j.cell.2015.08.034; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Haradhvala NJ, 2016, CELL, V164, P538, DOI 10.1016/j.cell.2015.12.050; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kantidakis T, 2016, GENE DEV, V30, P408, DOI 10.1101/gad.275453.115; Kanu N, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1042-9; Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kunkel TA, 2015, CELL, V163, P1301, DOI 10.1016/j.cell.2015.11.028; Law EK, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601737; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Lensing SV, 2016, NAT METHODS, V13, P855, DOI 10.1038/nmeth.3960; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Lippert MJ, 2011, P NATL ACAD SCI USA, V108, P698, DOI 10.1073/pnas.1012363108; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Lodato MA, 2015, SCIENCE, V350, P94, DOI 10.1126/science.aab1785; LOEB LA, 1974, CANCER RES, V34, P2311; Lord CJ, 2015, ANNU REV MED, V66, P455, DOI 10.1146/annurev-med-050913-022545; Madabhushi R, 2015, CELL, V161, P1592, DOI 10.1016/j.cell.2015.05.032; McKinnon PJ, 2013, NAT NEUROSCI, V16, P1523, DOI 10.1038/nn.3537; Meng FL, 2014, CELL, V159, P1538, DOI 10.1016/j.cell.2014.11.014; Morganella S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11383; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Notta F, 2016, NATURE, V538, P378, DOI 10.1038/nature19823; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Perera D, 2016, NATURE, V532, P259, DOI 10.1038/nature17437; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Periyasamy M, 2015, CELL REP, V13, P108, DOI 10.1016/j.celrep.2015.08.066; Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111; Pritchard CC, 2016, NEW ENGL J MED, V375, P443, DOI 10.1056/NEJMoa1603144; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Rialdi A, 2016, SCIENCE, V352, DOI 10.1126/science.aad7993; Sabarinathan R, 2016, NATURE, V532, P264, DOI 10.1038/nature17661; Sankar TS, 2016, NATURE, V535, P178, DOI 10.1038/nature18316; Saponaro M, 2014, CELL, V157, P1037, DOI 10.1016/j.cell.2014.03.048; Sarni D, 2016, CURR OPIN CELL BIOL, V40, P131, DOI 10.1016/j.ceb.2016.03.017; SCARANO E, 1967, P NATL ACAD SCI USA, V57, P1394, DOI 10.1073/pnas.57.5.1394; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Shlien A, 2015, NAT GENET, V47, P257, DOI 10.1038/ng.3202; Sima J, 2014, CURR OPIN GENET DEV, V25, P93, DOI 10.1016/j.gde.2013.11.022; Stork CT, 2016, ELIFE, V5, DOI 10.7554/eLife.17548; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173; Supek F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004585; Swanton C, 2015, CANCER DISCOV, V5, P704, DOI 10.1158/2159-8290.CD-15-0344; Takahashi T, 2011, P NATL ACAD SCI USA, V108, P692, DOI 10.1073/pnas.1012582108; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Tsouroula K, 2016, MOL CELL, V63, P293, DOI 10.1016/j.molcel.2016.06.002; Waters LS, 2006, P NATL ACAD SCI USA, V103, P8971, DOI 10.1073/pnas.0510167103; Wei PC, 2016, CELL, V164, P644, DOI 10.1016/j.cell.2015.12.039; Williamson LM, 2011, CARCINOGENESIS, V32, P279, DOI 10.1093/carcin/bgq255; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Wu S, 2016, NATURE, V529, P43, DOI 10.1038/nature16166; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493; Zhang CZ, 2013, GENE DEV, V27, P2513, DOI 10.1101/gad.229559.113; Zheng CL, 2014, CELL REP, V9, P1228, DOI 10.1016/j.celrep.2014.10.031	92	654	659	11	165	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2017	168	4								10.1016/j.cell.2017.01.002	http://dx.doi.org/10.1016/j.cell.2017.01.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8VJ	28187286	Green Accepted, Bronze			2022-12-28	WOS:000396277600015
J	Yang, XX; Lyu, ZX; Miguel, A; McQuillen, R; Huang, KC; Xiao, J				Yang, Xinxing; Lyu, Zhixin; Miguel, Amanda; McQuillen, Ryan; Huang, Kerwyn Casey; Xiao, Jie			GTPase activity-coupled treadmilling of the bacterial tubulin FtsZ organizes septal cell wall synthesis	SCIENCE			English	Article							DIVISION PROTEIN FTSZ; Z-RING STRUCTURE; SUPERRESOLUTION; PEPTIDOGLYCAN; MUTATIONS; DYNAMICS; MUTANTS; BINDING	The bacterial tubulin FtsZ is the central component of the cell division machinery, coordinating an ensemble of proteins involved in septal cell wall synthesis to ensure successful constriction. How cells achieve this coordination is unknown. We found that in Escherichia coli cells, FtsZ exhibits dynamic treadmilling predominantly determined by its guanosine triphosphatase activity. The treadmilling dynamics direct the processive movement of the septal cell wall synthesis machinery but do not limit the rate of septal synthesis. In FtsZ mutants with severely reduced treadmilling, the spatial distribution of septal synthesis and the molecular composition and ultrastructure of the septal cell wall were substantially altered. Thus, FtsZ treadmilling provides a mechanism for achieving uniform septal cell wall synthesis to enable correct polar morphology.	[Yang, Xinxing; Lyu, Zhixin; McQuillen, Ryan; Xiao, Jie] Johns Hopkins Univ, Dept Biophys & Biophys Chem, Sch Med, Baltimore, MD 21205 USA; [Miguel, Amanda; Huang, Kerwyn Casey] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Huang, Kerwyn Casey] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Johns Hopkins University; Stanford University; Stanford University	Xiao, J (corresponding author), Johns Hopkins Univ, Dept Biophys & Biophys Chem, Sch Med, Baltimore, MD 21205 USA.; Huang, KC (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Huang, KC (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	kchuang@stanford.edu; xiao@jhmi.edu		Xiao, Jie/0000-0003-1433-5437; McQuillen, Ryan/0000-0002-0399-5248	NIH [DP2OD006466, R01 GM086447]; NSF [MCB-1149328, PHYS-1066293]; ARCS; NSF EAGER award [MCB-1019000]; Hamilton Smith Innovative Research award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008403, R01GM086447, P50GM107615] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006466] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); ARCS; NSF EAGER award(National Science Foundation (NSF)); Hamilton Smith Innovative Research award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Xiao and Huang labs for helpful discussions and technical assistance; E. Goley, P. Levin, C. Coltharp, J. Buss, G. Lan, J. Lutkenhaus, E. Garner, and G. Squyres for critical discussions; E. Kuru, Y. Brun, and M. VanNieuwenhze for the HADA dye and assistance in its use; J. Lutkenhaus for the MC123 strain; H. Erickson for the FtsZ antibody and internal FtsZ-FP fusion; P. de Boer for the TB43 strain; E. Goley, P. Levin, and their lab members for helpful advice on protein purification and GTPase assay; R. Tsien for the TagRFP-t construct; M. Delannoy for assistance with SEM; K. Esther, D. Jesse, and Nikon for assistance with N-SIM imaging; and J. Franklin for assistance with whole-genome sequencing. Supported by NIH New Innovator award DP2OD006466 and NSF career award MCB-1149328 (K.C.H.); an NSF graduate research fellowship and an ARCS Scholar Awards fellowship (A.M.); NIH grant R01 GM086447, NSF EAGER award MCB-1019000, and a Hamilton Smith Innovative Research award (J.X.); and NSF grant PHYS-1066293. We are grateful for the hospitality of the Aspen Center for Physics. HADAs were received under a material transfer agreement from M. VanNieuwenhze at Indiana University.	Addinall SG, 1996, MOL MICROBIOL, V22, P231, DOI 10.1046/j.1365-2958.1996.00100.x; Arjes HA, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0544-z; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BI E, 1990, J BACTERIOL, V172, P5602, DOI 10.1128/jb.172.10.5602-5609.1990; BI E, 1992, J BACTERIOL, V174, P5414, DOI 10.1128/JB.174.16.5414-5423.1992; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Bisson AW, 2017, SCIENCE, V355, P739, DOI 10.1126/science.aak9973; Buss J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005128; Buss J, 2013, MOL MICROBIOL, V89, P1099, DOI 10.1111/mmi.12331; Chen YD, 2005, BIOPHYS J, V88, P505, DOI 10.1529/biophysj.104.044149; Coltharp C, 2016, P NATL ACAD SCI USA, V113, pE1044, DOI 10.1073/pnas.1514296113; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Erickson HP, 2009, P NATL ACAD SCI USA, V106, P9238, DOI 10.1073/pnas.0902258106; FU G, 2010, PLOS ONE, V0005; Holden SJ, 2014, P NATL ACAD SCI USA, V111, P4566, DOI 10.1073/pnas.1313368111; Jacq M, 2015, MBIO, V6, DOI 10.1128/mBio.01108-15; Kuru E, 2012, ANGEW CHEM INT EDIT, V51, P12519, DOI 10.1002/anie.201206749; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Loose M, 2014, NAT CELL BIOL, V16, P38, DOI 10.1038/ncb2885; Lu C, 2001, BMC Microbiol, V1, P7, DOI 10.1186/1471-2180-1-7; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; Lyu ZX, 2016, BIOPOLYMERS, V105, P725, DOI 10.1002/bip.22895; Moore DA, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00553-16; Niu LL, 2008, BIOPHYS J, V95, P2009, DOI 10.1529/biophysj.108.128751; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; Rowlett VW, 2014, BIOPHYS J, V107, pL17, DOI 10.1016/j.bpj.2014.08.024; Strauss MP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001389; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Stricker J, 2003, J BACTERIOL, V185, P4796, DOI 10.1128/JB.185.16.4796-4805.2003; Sundararajan K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8281; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048; Vaughan S, 2004, J MOL EVOL, V58, P19, DOI 10.1007/s00239-003-2523-5	35	256	257	5	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					744	+		10.1126/science.aak9995	http://dx.doi.org/10.1126/science.aak9995			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2AC	28209899	Green Accepted, Green Submitted			2022-12-28	WOS:000395117700042
J	Adinolfi, V; Sargent, EH				Adinolfi, Valerio; Sargent, Edward H.			Photovoltage field-effect transistors	NATURE			English	Article							QUANTUM-DOT PHOTODETECTORS; SOLAR-CELLS; SILICON; OPTOELECTRONICS; RECOMBINATION	The detection of infrared radiation enables night vision, health monitoring, optical communications and three-dimensional object recognition. Silicon is widely used in modern electronics, but its electronic bandgap prevents the detection of light at wavelengths longer than about 1,100 nanometres. It is therefore of interest to extend the performance of silicon photodetectors into the infrared spectrum, beyond the bandgap of silicon(1,2). Here we demonstrate a photovoltage field-effect transistor that uses silicon for charge transport, but is also sensitive to infrared light owing to the use of a quantum dot light absorber. The photovoltage generated at the interface between the silicon and the quantum dot, combined with the high transconductance provided by the silicon device, leads to high gain (more than 10(4) electrons per photon at 1,500 nanometres), fast time response (less than 10 microseconds) and a widely tunable spectral response. Our photovoltage field-effect transistor has a responsivity that is five orders of magnitude higher at a wavelength of 1,500 nanometres than that of previous infrared-sensitized silicon detectors(3). The sensitization is achieved using a room-temperature solution process and does not rely on traditional high-temperature epitaxial growth of semiconductors (such as is used for germanium and III-V semiconductors)(4,5). Our results show that colloidal quantum dots can be used as an efficient platform for silicon-based infrared detection, competitive with state-of-the-art epitaxial semiconductors.	[Adinolfi, Valerio; Sargent, Edward H.] Univ Toronto, Dept Elect & Comp Engn, 10 Kings Coll Rd, Toronto, ON M5S 3G4, Canada	University of Toronto	Sargent, EH (corresponding author), Univ Toronto, Dept Elect & Comp Engn, 10 Kings Coll Rd, Toronto, ON M5S 3G4, Canada.	ted.sargent@utoronto.com	Sargent, Edward H./O-9520-2014	Sargent, Edward H./0000-0003-0396-6495	Natural Sciences and Engineering Research Council (NSERC) of Canada	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	We acknowledge L. Lavina, E. Palmiano, R. Wolowiec and D. Kopilovic for technical assistance and guidance, and S. Masala, S. Hoogland, F. P Garcia de Arguer, O. Ouellette, M. Liu, X. Gong, G. Conte, C. Maragliano and A de lacovo for discussions. We are grateful to S. Boccia, J. Tam and the OCCAM group at the University of Toronto for assistance with SEM and TEM measurements. This work benefited from support from CMC Canada Microsystems. We thank for their assistance A. Fung, F. Aziz and the 3IT institute at the University of Sherbrooke. This publication is based on work supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada.	Adinolfi V, 2015, ACS NANO, V9, P356, DOI 10.1021/nn5053537; Baskoutas S, 2006, J APPL PHYS, V99, DOI 10.1063/1.2158502; Branz HM, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3152244; Carey JE, 2005, OPT LETT, V30, P1773, DOI 10.1364/OL.30.001773; Kamat PV, 2008, J PHYS CHEM C, V112, P18737, DOI 10.1021/jp806791s; Konstantatos G, 2006, NATURE, V442, P180, DOI 10.1038/nature04855; Konstantatos G, 2012, NAT NANOTECHNOL, V7, P363, DOI [10.1038/NNANO.2012.60, 10.1038/nnano.2012.60]; Konstantatos G, 2011, INFRARED PHYS TECHN, V54, P278, DOI 10.1016/j.infrared.2010.12.029; Kufer D, 2015, ADV MATER, V27, P176, DOI 10.1002/adma.201402471; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Ma LL, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2199593; Masala S, 2015, ADV MATER, V27, P7445, DOI 10.1002/adma.201503212; Masini G, 2003, APPL PHYS LETT, V82, P2524, DOI 10.1063/1.1567046; Masini G, 2002, MAT SCI ENG B-SOLID, V89, P2, DOI 10.1016/S0921-5107(01)00781-4; Oh J, 2012, NAT NANOTECHNOL, V7, P743, DOI [10.1038/NNANO.2012.166, 10.1038/nnano.2012.166]; Pavesi L., 2004, SILICON PHOTONICS, P239; SOREF RA, 1993, P IEEE, V81, P1687, DOI 10.1109/5.248958; Soref R, 2008, IEICE T ELECTRON, VE91C, P129, DOI 10.1093/ietele/e91-c.2.129; Sze S. M., 2007, PHYS SEMICONDUCTOR D; Tanabe K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00349; Tang J, 2012, NANO LETT, V12, P4889, DOI 10.1021/nl302436r; Wang JA, 2011, SENSORS-BASEL, V11, P696, DOI 10.3390/s110100696; YABLONOVITCH E, 1986, PHYS REV LETT, V57, P249, DOI 10.1103/PhysRevLett.57.249	23	162	163	26	480	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					324	+		10.1038/nature21050	http://dx.doi.org/10.1038/nature21050			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2LQ	28178236				2022-12-28	WOS:000394451600031
J	Moberly, T				Moberly, Tom			THE BIG PICTURE Keep the door open for child refugees	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	2017	356								j796	10.1136/bmj.j796	http://dx.doi.org/10.1136/bmj.j796			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GM	28202433				2022-12-28	WOS:000394579700011
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Is the ward round dead?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Maguire D, 2016, HOSP ACTIVITY FUNDIN; National Audit Office, 2016, HC18 SESS 2016 17; Oates T, 2016, TWITTER          DEC; Royal College of Physicians, 2016, BEING JUN DOCT	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2017	356								j635	10.1136/bmj.j635	http://dx.doi.org/10.1136/bmj.j635			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GC	28188136	Bronze			2022-12-28	WOS:000394578700002
J	Wessel, L				Wessel, Lindzi			From a tweet, a March for Science is born	SCIENCE			English	News Item																			0	4	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					556	557		10.1126/science.355.6325.556	http://dx.doi.org/10.1126/science.355.6325.556			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK0SF	28183917				2022-12-28	WOS:000393636700008
J	Kinane, TB; Lin, AE; Lahoud-Rahme, M; Westra, SJ; Mark, EJ				Kinane, T. Bernard; Lin, Angela E.; Lahoud-Rahme, Manuella; Westra, Sjirk J.; Mark, Eugene J.			Case 4-2017: A 2-Month-Old Girl with Growth Retardation and Respiratory Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PULMONARY CAPILLARY HEMANGIOMATOSIS; EHLERS-DANLOS-SYNDROME; NEUROENDOCRINE CELL HYPERPLASIA; INTERSTITIAL LUNG-DISEASE; SYNDROME TYPE-IV; MARFAN-SYNDROME; PERIVENTRICULAR HETEROTOPIAS; PERSISTENT TACHYPNEA; FILAMIN-A; INFANCY		[Kinane, T. Bernard; Lin, Angela E.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Lahoud-Rahme, Manuella] Massachusetts Gen Hosp, Dept Cardiol, Boston, MA 02114 USA; [Westra, Sjirk J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Mark, Eugene J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kinane, T. Bernard; Lin, Angela E.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Lahoud-Rahme, Manuella] Harvard Med Sch, Dept Cardiol, Boston, MA USA; [Westra, Sjirk J.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Mark, Eugene J.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kinane, TB (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.; Kinane, TB (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.			Westra, Sjirk/0000-0002-9952-6891				Attias D, 2009, CIRCULATION, V120, P2541, DOI 10.1161/CIRCULATIONAHA.109.887042; Best DH, 2014, CHEST, V145, P231, DOI 10.1378/chest.13-2366; Brody AS, 2006, PEDIATR RADIOL, V36, P1328, DOI 10.1007/s00247-006-0302-3; Canakis AM, 2002, AM J RESP CRIT CARE, V165, P1557, DOI 10.1164/rccm.2105139; Chen M. H., 2002, GENEREVIEWS; CUPO LN, 1981, AM J MED, V71, P1051, DOI 10.1016/0002-9343(81)90341-7; de Wit MCY, 2011, CLIN RES CARDIOL, V100, P45, DOI 10.1007/s00392-010-0206-y; Deterding RR, 2005, PEDIATR PULM, V40, P157, DOI 10.1002/ppul.20243; Deterding RR, 2001, PEDIATR PULM, P72; Dowton SB, 1996, CLIN GENET, V50, P510; DWYER EM, 1965, ANN INTERN MED, V62, P1285, DOI 10.7326/0003-4819-62-6-1285; Erbersdobler A, 2002, HISTOPATHOLOGY, V40, P88, DOI 10.1046/j.1365-2559.2002.01322.x; Eyries M, 2014, NAT GENET, V46, P65, DOI 10.1038/ng.2844; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Gerard-Blanluet M, 2006, AM J MED GENET A, V140A, P1041, DOI 10.1002/ajmg.a.31197; Ginns LC, 2003, CHEST, V124, P2017, DOI 10.1378/chest.124.5.2017; Gower WA, 2011, PAEDIATR RESPIR REV, V12, P223, DOI 10.1016/j.prrv.2011.01.005; HALL JR, 1984, ANN THORAC SURG, V37, P500, DOI 10.1016/S0003-4975(10)61142-3; Hatake K, 2013, LEGAL MED-TOKYO, V15, P23, DOI 10.1016/j.legalmed.2012.07.005; Havlik DM, 2000, AM J CLIN PATHOL, V113, P655, DOI 10.1309/9R7N-19BP-P5QJ-U8E7; Hislop AA, 2002, J ANAT, V201, P325, DOI 10.1046/j.1469-7580.2002.00097.x; Hoepker A, 2008, PEDIATR PULM, V43, P1004, DOI 10.1002/ppul.20900; Kurland G, 2013, AM J RESP CRIT CARE, V188, P376, DOI 10.1164/rccm.201305-0923ST; Langenstroer M, 2013, AJP REP, V3, P9, DOI 10.1055/s-0032-1329126; LANGLEBEN D, 1988, ANN INTERN MED, V109, P106, DOI 10.7326/0003-4819-109-2-106; Lantuejoul S, 2006, AM J SURG PATHOL, V30, P850, DOI 10.1097/01.pas.0000209834.69972.e5; Lin AE, 2011, AM J MED GENET A, V155A, P486, DOI 10.1002/ajmg.a.33857; Lindsay ME, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015909; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Loeys BL, 1993, GENEREVIEWS; Lord A, 2014, RESP CARE, V59, pE171, DOI 10.4187/respcare.02847; Ma LJ, 2015, APPL CLIN GENET, V8, P181, DOI 10.2147/TACG.S68635; Masurel-Paulet A, 2011, EUR J MED GENET, V54, P25, DOI 10.1016/j.ejmg.2010.09.010; RahiBuisson N, 2013, HDB CLIN NEUROL, V111, P653; Reinstein E, 2013, EUR J HUM GENET, V21, P494, DOI 10.1038/ejhg.2012.209; Sen P, 2004, J PEDIATR-US, V145, P646, DOI 10.1016/j.jpeds.2004.06.081; Sheen VL, 2005, CLIN MED RES, V3, P229, DOI 10.3121/cmr.3.4.229; Sullivan A, 2005, CHEST, V128, p576S, DOI 10.1378/chest.128.6_suppl.576S; Thomas P, 1996, NEUROLOGY, V46, P1165, DOI 10.1212/WNL.46.4.1165; VEVAINA JR, 1988, CHEST, V93, P657, DOI 10.1378/chest.93.3.657; Walsh CA, 2010, NEURON, V68, P245, DOI 10.1016/j.neuron.2010.09.042; WOOD JR, 1984, THORAX, V39, P780, DOI 10.1136/thx.39.10.780; Young LR, 2011, CHEST, V139, P1060, DOI 10.1378/chest.10-1304	44	9	9	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2017	376	6					562	574		10.1056/NEJMcpc1613465	http://dx.doi.org/10.1056/NEJMcpc1613465			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8XL	28177866				2022-12-28	WOS:000393510500012
J	[Anonymous]				[Anonymous]			Seven days in medicine: 1-7 February 2017	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2017	356								j668	10.1136/bmj.j668	http://dx.doi.org/10.1136/bmj.j668			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GB	28183706				2022-12-28	WOS:000394578600004
J	Brown, S				Brown, Sue			What if the NHS moved most care out of hospital?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Brown, Sue] Sense, Publ Policy, London, England		Brown, S (corresponding author), Sense, Publ Policy, London, England.	suecbrown@madasafish.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2017	356								j602	10.1136/bmj.j602	http://dx.doi.org/10.1136/bmj.j602			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4FX	28179218				2022-12-28	WOS:000394578200009
J	Chou, R; Deyo, R; Friedly, J; Skelly, A; Weimer, M; Fu, R; Dana, T; Kraegel, P; Griffin, J; Grusing, S				Chou, Roger; Deyo, Richard; Friedly, Janna; Skelly, Andrea; Weimer, Melissa; Fu, Rochelle; Dana, Tracy; Kraegel, Paul; Griffin, Jessica; Grusing, Sara			Systemic Pharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; BUPRENORPHINE TRANSDERMAL SYSTEM; OXYMORPHONE EXTENDED-RELEASE; OPIOID-NAIVE PATIENTS; SKELETAL-MUSCLE RELAXANT; DOUBLE-BLIND EVALUATION; LUMBAR SPINAL STENOSIS; CHRONIC NONCANCER PAIN; ACUTE SCIATICA	Background: A 2007 American College of Physicians guideline addressed pharmacologic options for low back pain. New evidence and medications have now become available. Purpose: To review the current evidence on systemic pharmacologic therapies for acute or chronic nonradicular or radicular low back pain. Data Sources: Ovid MEDLINE (January 2008 through November 2016), Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and reference lists. Study Selection: Randomized trials that reported pain, function, or harms of systemic medications versus placebo or another intervention. Data Extraction: One investigator abstracted data, and a second verified accuracy; 2 investigators independently assessed study quality. Data Synthesis: The number of trials ranged from 9 (benzodiazepines) to 70 (nonsteroidal anti-inflammatory drugs). New evidence found that acetaminophen was ineffective for acute low back pain, nonsteroidal anti-inflammatory drugs had smaller benefits for chronic low back pain than previously observed, duloxetine was effective for chronic low back pain, and benzodiazepines were ineffective for radiculopathy. For opioids, evidence remains limited to short-term trials showing modest effects for chronic low back pain; trials were not designed to assess serious harms. Skeletal muscle relaxants are effective for short-term pain relief in acute low back pain but caused sedation. Systemic corticosteroids do not seem to be effective. For effective interventions, pain relief was small to moderate and generally short-term; improvements in function were generally smaller. Evidence is insufficient to determine the effects of antiseizure medications. Limitations: Qualitatively synthesized new trials with prior metaanalyses. Only English-language studies were included, many of which had methodological shortcomings. Medications injected for local effects were not addressed. Conclusion: Several systemic medications for low back pain are associated with small to moderate, primarily short-term effects on pain. New evidence suggests that acetaminophen is ineffective for acute low back pain, and duloxetine is associated with modest effects for chronic low back pain.	[Chou, Roger; Fu, Rochelle; Dana, Tracy; Griffin, Jessica; Grusing, Sara] Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA; [Friedly, Janna] Univ Washington, Dept Rehabil Med, 325 Ninth Ave,Box 359612, Seattle, WA 98104 USA; [Skelly, Andrea] Spectrum Res, Atrium Court, 705 South 9th St,Suite 203, Tacoma, WA 98405 USA; [Deyo, Richard] Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code FM, Portland, OR 97239 USA; [Weimer, Melissa] Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code L-475, Portland, OR 97239 USA; [Kraegel, Paul] Univ Washington, Dept Pharm, Box 357630,H375 Hlth Sci Bldg, Seattle, WA 98195 USA	Oregon Health & Science University; University of Washington; University of Washington Seattle; Oregon Health & Science University; Oregon Health & Science University; University of Washington; University of Washington Seattle	Chou, R (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA.	chour@ohsu.edu	Weimer, Melissa/M-5599-2019	Weimer, Melissa/0000-0002-5624-2434; Chou, Roger/0000-0001-9889-8610	Agency for Healthcare Research and Quality [PROSPERO: CRD42014014735]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality. (PROSPERO: CRD42014014735)	Agency for Healthcare Research and Quality, 2015, INT BOD EV EX SYST R; Allan L, 2005, SPINE, V30, P2484, DOI 10.1097/01.brs.0000186860.23078.a8; AMLIE E, 1987, SPINE, V12, P473, DOI 10.1097/00007632-198706000-00010; [Anonymous], 2014, AHRQ PUBLICATION; ARBUS L, 1990, CLIN TRIALS J, V27, P258; BABEJDOLLE R, 1994, INT J CLIN PHARM TH, V32, P204; Baron R, 2015, PAIN PRACT, V15, P455, DOI 10.1111/papr.12200; Baron R, 2010, PAIN, V150, P420, DOI 10.1016/j.pain.2010.04.013; BASMAJIAN JV, 1978, ARCH PHYS MED REHAB, V59, P58; BASMAJIAN JV, 1989, SPINE, V14, P438, DOI 10.1097/00007632-198904000-00019; Beaulieu AD, 2007, CLIN THER, V29, P49, DOI 10.1016/j.clinthera.2007.01.001; Birbara CA, 2003, J PAIN, V4, P307, DOI 10.1016/S1526-5900(03)00633-3; BOYLES WF, 1983, TODAYS THERAPEUTIC T, V1, P1; BRAGSTAD A, 1979, CURR THER RES CLIN E, V26, P39; Brodt E, AHRQ PUBLICATION; Brotz D, 2010, PAIN, V149, P470, DOI 10.1016/j.pain.2010.02.015; Carey TS, 2009, SPINE, V34, P718, DOI 10.1097/BRS.0b013e31819792b0; Carson S, 2011, DRUG CLASS REV LONG; Casale R, 1988, CLIN J PAIN, V4, P81, DOI [10.1097/00002508- 198806000-00004, DOI 10.1097/00002508-198806000-00004]; Chou R, 2016, 16EHC004EF AG HEALTH; Chou R, 2009, GUIDELINE USE CHRONI; Chou R, 2007, GUIDELINE EVALUATION; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008; Chou R, 2017, ANN INTERN MED, V166, P493, DOI 10.7326/M16-2459; Chou R, 2015, ANN INTERN MED, V163, P373, DOI 10.7326/M15-0934; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Chrubasik S, 2003, RHEUMATOLOGY, V42, P141, DOI 10.1093/rheumatology/keg053; Cloutier C, 2013, PAIN RES MANAG, V18, P75, DOI 10.1155/2013/164609; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Dickens C, 2000, PSYCHOSOMATICS, V41, P490, DOI 10.1176/appi.psy.41.6.490; DORAN DML, 1975, BRIT MED J, V2, P161, DOI 10.1136/bmj.2.5964.161; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Dreiser RL, 2003, INT J CLIN PHARM TH, V41, P375; Dreiser RL, 2001, INFLAMM RES, V50, pS17; Chaparro LE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004959.pub4; Enthoven WT, 2016, COCHRANE DB SYST REV, V2; Eskin B, 2014, J EMERG MED, V47, P65, DOI 10.1016/j.jemermed.2014.02.010; Farajirad S, 2013, NEUROSURG QUART, V23, P227, DOI 10.1097/WNQ.0b013e3182817d55; Finckh A, 2006, SPINE, V31, P377, DOI 10.1097/01.brs.0000199917.04145.80; Friedman BW, 2008, SPINE, V33, pE624, DOI 10.1097/BRS.0b013e3181822711; Friedman BW, 2006, J EMERG MED, V31, P365, DOI 10.1016/j.jemermed.2005.09.023; Friedman BW, 2015, JAMA-J AM MED ASSOC, V314, P1572, DOI 10.1001/jama.2015.13043; Fritz JM, 2013, ARCH PHYS MED REHAB, V94, P808, DOI 10.1016/j.apmr.2013.01.008; Furlan AD, 2011, PAIN RES MANAG, V16, P337, DOI 10.1155/2011/465281; Goldberg H, 2015, JAMA-J AM MED ASSOC, V313, P1915, DOI 10.1001/jama.2015.4468; GOLDIE I, 1968, ACTA ORTHOP SCAND, V39, P117, DOI 10.3109/17453676808989446; Gordon A, 2010, CLIN THER, V32, P844, DOI 10.1016/j.clinthera.2010.04.018; Gostick N, 1989, P ED S PAIN CONTR ME, P137; HACKETT GI, 1988, PRACTITIONER, V232, P163; HAIMOVIC IC, 1986, NEUROLOGY, V36, P1593, DOI 10.1212/WNL.36.12.1593; Hale M, 2010, CURR MED RES OPIN, V26, P1505, DOI 10.1185/03007995.2010.484723; HALE M, 1997, PAIN RES MANAG, V2, P33; Hale ME, 2007, J PAIN, V8, P175, DOI 10.1016/j.jpain.2006.09.011; Hale ME, 2005, J PAIN, V6, P21, DOI 10.1016/j.jpain.2004.09.005; Hale ME, 1999, CLIN J PAIN, V15, P179, DOI 10.1097/00002508-199909000-00004; HEDEBOE J, 1982, ACTA NEUROL SCAND, V65, P6, DOI 10.1111/j.1600-0404.1982.tb03055.x; HENNIES OL, 1981, J INT MED RES, V9, P62, DOI 10.1177/030006058100900111; Herrmann WA, 2009, INT J CLIN PRACT, V63, P1613, DOI 10.1111/j.1742-1241.2009.02187.x; HICKEY RFJ, 1982, NEW ZEAL MED J, V95, P312; HINGORANI K, 1966, Annals of Physical Medicine, V8, P303; Holve RL, 2008, J AM BOARD FAM MED, V21, P469, DOI 10.3122/jabfm.2008.05.070220; Ivanova JI, 2011, SPINE J, V11, P622, DOI 10.1016/j.spinee.2011.03.017; Jamison RN, 1998, SPINE, V23, P2591, DOI 10.1097/00007632-199812010-00014; Kalita J, 2014, J NEUROL SCI, V342, P127, DOI 10.1016/j.jns.2014.05.002; Karjalainen KA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002269.pub2; Katz N, 2003, SPINE, V28, P851, DOI 10.1097/00007632-200305010-00002; Katz N, 2007, CURR MED RES OPIN, V23, P117, DOI 10.1185/030079906X162692; Katz N, 2011, PAIN, V152, P2248, DOI 10.1016/j.pain.2011.05.003; Khoromi S, 2005, J PAIN, V6, P829, DOI 10.1016/j.jpain.2005.08.002; Kivitz AJ, 2013, PAIN, V154, P1009, DOI 10.1016/j.pain.2013.03.006; Lee JH, 2013, CLIN THER, V35, P1830, DOI 10.1016/j.clinthera.2013.09.017; Licciardone JC, 2013, MANUAL THER, V18, P533, DOI 10.1016/j.math.2013.05.006; Majchrzycki M, 2014, THESCIENTIFICWORLDJO, V2014, DOI [DOI 10.1155/2014/287597, 10.1155/2014/287597]; Markman JD, 2015, SPINE, V40, P684, DOI 10.1097/BRS.0000000000000837; Markman JD, 2015, NEUROLOGY, V84, P265, DOI 10.1212/WNL.0000000000001168; Mazza M, 2010, EXPERT OPIN PHARMACO, V11, P1049, DOI 10.1517/14656561003730413; McCleane GJ, 2001, PAIN CLINIC, V13, P103, DOI 10.1163/156856901753420945; MILGROM C, 1993, J SPINAL DISORD, V6, P187, DOI 10.1097/00002517-199306030-00001; Miller K, 2014, CLIN J PAIN, V30, P1015, DOI 10.1097/AJP.0000000000000068; Moll W, 1973, Med Welt, V24, P1747; Moore RA, 2013, BRIT J ANAESTH, V111, P38, DOI 10.1093/bja/aet126; Muehlbacher M, 2006, CLIN J PAIN, V22, P526, DOI 10.1097/.ajp.0000192516.58578.a4; Nadler SF, 2002, SPINE, V27, P1012, DOI 10.1097/00007632-200205150-00003; National Institute for Health and Care Excellence, 2009, LOW BACK PAIN AD; Nicholson B, 2006, CURR MED RES OPIN, V22, P1503, DOI 10.1185/030079906X115603; O'Donnell JB, 2009, J INT MED RES, V37, P1789, DOI 10.1177/147323000903700615; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Owens D, 2011, METHODS GUIDE EFFECT; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Pareek A, 2009, EUR SPINE J, V18, P1836, DOI 10.1007/s00586-009-1019-4; PHEASANT H, 1983, SPINE, V8, P552, DOI 10.1097/00007632-198307000-00012; Pipino F., 1991, EUR J CLIN RES, V1, P55; PORSMAN O, 1979, SCAND J RHEUMATOL, V8, P142, DOI 10.3109/03009747909114446; Pota V, 2012, PAIN MANAG, V2, P23, DOI [10.2217/PMT.11.71, 10.2217/pmt.11.71]; Pratzel HG, 1996, PAIN, V67, P417, DOI 10.1016/0304-3959(96)03187-9; Preuper HRS, 2014, EUR SPINE J, V23, P800, DOI 10.1007/s00586-014-3229-7; Ralph L, 2008, CURR MED RES OPIN, V24, P551, DOI 10.1185/030079908X261014 ; Rauck Richard L, 2006, J Opioid Manag, V2, P155; Rauck RL, 2016, POSTGRAD MED, V128, P1, DOI 10.1080/00325481.2016.1128307; Rauck RL, 2014, PAIN MED, V15, P975, DOI 10.1111/pme.12377; Rodrigues LCL, 2014, J NEGAT RESULTS BIOM, V13, DOI 10.1186/1477-5751-13-13; Roelofs PD, 2008, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000396.PUB3; Roelofs PDDM, 2008, SPINE, V33, P1766, DOI 10.1097/BRS.0b013e31817e69d3; ROLLINGS HE, 1983, CURR THER RES CLIN E, V34, P917; Romano CL, 2009, J ORTHOP TRAUMATOL, V10, P185, DOI 10.1007/s10195-009-0077-z; Sakai Y, 2015, EUR SPINE J, V24, P1309, DOI 10.1007/s00586-015-3812-6; Salzman RT, 1999, J PAIN SYMPTOM MANAG, V18, P271, DOI 10.1016/S0885-3924(99)00079-2; Salzmann E., 1992, Journal of Drug Development, V4, P219; Saragiotto BT, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012230; Schnitzer TJ, 2000, J RHEUMATOL, V27, P772; Schukro RP, 2016, ANESTHESIOLOGY, V124, P150, DOI 10.1097/ALN.0000000000000902; Shaheed CA, 2016, JAMA INTERN MED, V176, P958, DOI 10.1001/jamainternmed.2016.1251; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Shirado O, 2010, SPINE, V35, pE811, DOI 10.1097/BRS.0b013e3181d7a4d2; Skljarevski V, 2009, EUR J NEUROL, V16, P1041, DOI 10.1111/j.1468-1331.2009.02648.x; Skljarevski V, 2010, J PAIN, V11, P1282, DOI 10.1016/j.jpain.2010.03.002; Skljarevski V, 2010, SPINE, V35, pE578, DOI 10.1097/BRS.0b013e3181d3cef6; Stein D, 1996, PSYCHOSOMATICS, V37, P63, DOI 10.1016/S0033-3182(96)71600-6; Steiner DJ, 2011, J PAIN SYMPTOM MANAG, V42, P903, DOI 10.1016/j.jpainsymman.2011.04.006; SZPALSKI M, 1994, BRIT J RHEUMATOL, V33, P74; U.S. Preventive Services Task Force. U.S. Preventive Services Task Force Procedure Manual, 2015, AHRQ PUBLICATION; Ueberall MA, 2015, CURR MED RES OPIN, V31, P1413, DOI 10.1185/03007995.2015.1047747; Urquhart DM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001703.pub3; Vorsanger Gary J, 2008, J Opioid Manag, V4, P87; Walker BF, 2000, J SPINAL DISORD, V13, P205, DOI 10.1097/00002517-200006000-00003; WEBER H, 1993, SPINE, V18, P1433, DOI 10.1097/00007632-199309010-00006; Weber H, 1980, J Oslo City Hosp, V30, P69; Wen W, 2015, EXPERT OPIN PHARMACO, V16, P1593, DOI 10.1517/14656566.2015.1060221; Whitlock EP, 2008, ANN INTERN MED, V148, P776, DOI 10.7326/0003-4819-148-10-200805200-00010; WIESEL SW, 1980, SPINE, V5, P324, DOI 10.1097/00007632-198007000-00006; Williams CM, 2014, LANCET, V384, P1586, DOI 10.1016/S0140-6736(14)60805-9; Yaksi A, 2007, SPINE, V32, P939, DOI 10.1097/01.brs.0000261029.29170.e6; Yarlas A, 2015, POSTGRAD MED, V127, P38, DOI 10.1080/00325481.2014.992715; Yildirim K, 2003, PAIN CLINIC, V15, P213, DOI 10.1163/156856903767650718	135	207	217	4	59	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2017	166	7					480	+		10.7326/M16-2458	http://dx.doi.org/10.7326/M16-2458			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ4PT	28192790				2022-12-28	WOS:000398061100010
J	Folco, HD; Chalamcharla, VR; Sugiyama, T; Thillainadesan, G; Zofall, M; Balachandran, V; Dhakshnamoorthy, J; Mizuguchi, T; Grewal, SIS				Folco, H. Diego; Chalamcharla, Venkata R.; Sugiyama, Tomoyasu; Thillainadesan, Gobi; Zofall, Martin; Balachandran, Vanivilasini; Dhakshnamoorthy, Jothy; Mizuguchi, Takeshi; Grewal, Shiv I. S.			Untimely expression of gametogenic genes in vegetative cells causes uniparental disomy	NATURE			English	Article							FACULTATIVE HETEROCHROMATIN FORMATION; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; CHROMOSOME SEGREGATION; RAPID METHOD; MEIOSIS-I; COHESION; CENTROMERES; ELIMINATION; ATTACHMENT	Uniparental disomy (UPD), in which an individual contains a pair of homologous chromosomes originating from only one parent, is a frequent phenomenon that is linked to congenital disorders and various cancers(1,2). UPD is thought to result mostly from pre- or post-zygotic chromosome missegregation(2). However, the factors that drive UPD remain unknown. Here we use the fission yeast Schizosaccharomyces pombe as a model to investigate UPD, and show that defects in the RNA interference (RNAi) machinery or in the YTH domain-containing RNA elimination factor Mmi1 cause high levels of UPD in vegetative diploid cells. This phenomenon is not due to defects in heterochromatin assembly at centromeres. Notably, in cells lacking RNAi components or Mmi1, UPD is associated with the untimely expression of gametogenic genes. Deletion of the upregulated gene encoding the meiotic cohesin Rec8 or the cyclin Crs1 suppresses UPD in both RNAi and mmi1 mutants. Moreover, overexpression of Rec8 is sufficient to trigger UPD in wild-type cells. Rec8 expressed in vegetative cells localizes to chromosomal arms and to the centromere core, where it is required for localization of the cohesin subunit Psc3. The centromeric localization of Rec8 and Psc3 promotes UPD by uniquely affecting chromosome segregation, causing a reductional segregation of one homologue. Together, these findings establish the untimely vegetative expression of gametogenic genes as a causative factor of UPD, and provide a solid foundation for understanding this phenomenon, which is linked to diverse human diseases.	[Folco, H. Diego; Chalamcharla, Venkata R.; Sugiyama, Tomoyasu; Thillainadesan, Gobi; Zofall, Martin; Balachandran, Vanivilasini; Dhakshnamoorthy, Jothy; Mizuguchi, Takeshi; Grewal, Shiv I. S.] NCI, Lab Biochem & Mol Biol, NIH, Bethesda, MD 20892 USA; [Mizuguchi, Takeshi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Fukuura 3-9, Yokohama, Kanagawa 2360004, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yokohama City University	Grewal, SIS (corresponding author), NCI, Lab Biochem & Mol Biol, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov		Grewal, Shiv/0000-0002-4552-9261; Sugiyama, Tomoyasu/0000-0001-5704-6606	National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011208] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Y. Watanabe, M. Yamamoto, Y. Hiraoka, F. Ishikawa, G. Smith and the National BioResource Project (NBRP) Japan for reagents, J. Barrowman for editing the manuscript, N. Taneja and A. Fernandez-Alvarez for technical assistance and members of the Laboratory of Biochemistry and Molecular Biology, in particular the Grewal laboratory, for discussions. This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute.	Andersen SL, 2012, P NATL ACAD SCI USA, V109, P9947, DOI 10.1073/pnas.1207736109; Averbeck N, 2005, MOL CELL, V18, P491, DOI 10.1016/j.molcel.2005.04.007; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Bershteyn M, 2014, NATURE, V507, P99, DOI 10.1038/nature12923; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chalamcharla VR, 2015, P NATL ACAD SCI USA, V112, P15548, DOI 10.1073/pnas.1522127112; Chen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020238; Ding DQ, 2006, J CELL BIOL, V174, P499, DOI 10.1083/jcb.200605074; Flor-Parra I, 2014, YEAST, V31, P61, DOI 10.1002/yea.2994; Folco HD, 2015, CURR BIOL, V25, P348, DOI 10.1016/j.cub.2014.11.060; Gao J, 2014, CURR GENET, V60, P109, DOI 10.1007/s00294-013-0406-x; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hiriart E, 2012, EMBO J, V31, P2296, DOI 10.1038/emboj.2012.105; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Kitajima TS, 2003, SCIENCE, V300, P1152, DOI 10.1126/science.1083634; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Lee NN, 2013, CELL, V155, P1061, DOI 10.1016/j.cell.2013.10.027; LIN YK, 1994, GENETICS, V136, P769; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Matsuo Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1992, DOI 10.1271/bbb.60087; Mizuguchi T, 2014, NATURE, V516, P432, DOI 10.1038/nature13833; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; NIWA O, 1986, MOL GEN GENET, V203, P397, DOI 10.1007/BF00422063; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Sakuno T, 2009, NATURE, V458, P852, DOI 10.1038/nature07876; Schmidt CK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r52; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; STEINER NC, 1994, CELL, V79, P865, DOI 10.1016/0092-8674(94)90075-2; Sugiyama T, 2016, MOL CELL, V61, P747, DOI 10.1016/j.molcel.2016.01.029; Tashiro S, 2013, GENES CELLS, V18, P327, DOI 10.1111/gtc.12038; Tuna M, 2009, TRENDS MOL MED, V15, P120, DOI 10.1016/j.molmed.2009.01.005; Vanoosthuyse V, 2007, MOL BIOL CELL, V18, P1657, DOI 10.1091/mbc.E06-10-0890; Verdaasdonk JS, 2011, NAT REV MOL CELL BIO, V12, P320, DOI 10.1038/nrm3107; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Whitehurst AW, 2014, ANNU REV PHARMACOL, V54, P251, DOI 10.1146/annurev-pharmtox-011112-140326; Yamanaka S, 2013, NATURE, V493, P557, DOI 10.1038/nature11716; Yokobayashi S, 2003, MOL CELL BIOL, V23, P3965, DOI 10.1128/MCB.23.11.3965-3973.2003; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651	43	24	24	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					126	+		10.1038/nature21372	http://dx.doi.org/10.1038/nature21372			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0AA	28199302	Green Accepted			2022-12-28	WOS:000395671500046
J	Creton, C				Creton, Costantino			POLYMERS Molecular stitches for enhanced recycling of packaging An additive creates tough blends from waste polyethylene and polypropylene	SCIENCE			English	Editorial Material							INTERFACES; POLYMERIZATION; COPOLYMERS; ADHESION		[Creton, Costantino] Univ Rech Paris Sci & Lettres, Ecole Super Phys & Chim Ind Ville Paris, Lab Sci & Ingn Matiere Molle, CNRS, 10 Rue Vauquelin, F-75005 Paris, France; [Creton, Costantino] Sorbonne Univ, Univ Pierre & Marie Curie, Lab Sci & Ingn Matiere Molle, 10 Rue Vauquelin, Paris, France; [Creton, Costantino] Hokkaido Univ, Global Inst Collaborat Res & Educ, Global Stn Soft Matter, Sapporo, Hokkaido, Japan	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); UDICE-French Research Universities; Sorbonne Universite; Hokkaido University	Creton, C (corresponding author), Univ Rech Paris Sci & Lettres, Ecole Super Phys & Chim Ind Ville Paris, Lab Sci & Ingn Matiere Molle, CNRS, 10 Rue Vauquelin, F-75005 Paris, France.; Creton, C (corresponding author), Sorbonne Univ, Univ Pierre & Marie Curie, Lab Sci & Ingn Matiere Molle, 10 Rue Vauquelin, Paris, France.; Creton, C (corresponding author), Hokkaido Univ, Global Inst Collaborat Res & Educ, Global Stn Soft Matter, Sapporo, Hokkaido, Japan.	costantino.creton@espci.fr	CRETON, COSTANTINO/B-4077-2008	CRETON, COSTANTINO/0000-0002-0177-9680				Benkoski JJ, 2003, MACROMOLECULES, V36, P3289, DOI 10.1021/ma034013j; Braunecker WA, 2007, PROG POLYM SCI, V32, P93, DOI 10.1016/j.progpolymsci.2006.11.002; CRETON C, 1991, MACROMOLECULES, V24, P1846, DOI 10.1021/ma00008a023; Creton C, 2002, ADV POLYM SCI, V156, P53; Eagan JM, 2017, SCIENCE, V355, P814, DOI 10.1126/science.aah5744; Laurens C, 2004, MACROMOLECULES, V37, P6814, DOI 10.1021/ma0400259; Lin YJ, 2009, J APPL POLYM SCI, V113, P1945, DOI 10.1002/app.30190; REMPP P, 1988, ADV POLYM SCI, V86, P145; Ruzette AV, 2005, NAT MATER, V4, P19, DOI 10.1038/nmat1295; Sturzel M, 2016, CHEM REV, V116, P1398, DOI 10.1021/acs.chemrev.5b00310	10	17	18	1	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					797	798		10.1126/science.aam5803	http://dx.doi.org/10.1126/science.aam5803			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28232538				2022-12-28	WOS:000395127600020
J	Levin-Reisman, I; Ronin, I; Gefen, O; Braniss, I; Shoresh, N; Balaban, NQ				Levin-Reisman, Irit; Ronin, Irine; Gefen, Orit; Braniss, Ilan; Shoresh, Noam; Balaban, Nathalie Q.			Antibiotic tolerance facilitates the evolution of resistance	SCIENCE			English	Article							ESCHERICHIA-COLI; PERSISTER CELLS; BETA-LACTAMASE; MUTATIONS; EMERGENCE; INSERTION; PROMOTER	Controlled experimental evolution during antibiotic treatment can help to explain the processes leading to antibiotic resistance in bacteria. Recently, intermittent antibiotic exposures have been shown to lead rapidly to the evolution of tolerance-that is, the ability to survive under treatment without developing resistance. However, whether tolerance delays or promotes the eventual emergence of resistance is unclear. Here we used in vitro evolution experiments to explore this question. We found that in all cases, tolerance preceded resistance. A mathematical population-genetics model showed how tolerance boosts the chances for resistance mutations to spread in the population. Thus, tolerance mutations pave the way for the rapid subsequent evolution of resistance. Preventing the evolution of tolerance may offer a new strategy for delaying the emergence of resistance.	[Levin-Reisman, Irit; Ronin, Irine; Gefen, Orit; Braniss, Ilan; Balaban, Nathalie Q.] Hebrew Univ Jerusalem, Racah Inst Phys, Edmond J Safra Campus, IL-91904 Jerusalem, Israel; [Levin-Reisman, Irit; Ronin, Irine; Gefen, Orit; Braniss, Ilan; Balaban, Nathalie Q.] Hebrew Univ Jerusalem, Harvey M Kruger Family Ctr Nanosci & Nanotechnol, Edmond J Safra Campus, IL-91904 Jerusalem, Israel; [Shoresh, Noam] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Balaban, NQ (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, Edmond J Safra Campus, IL-91904 Jerusalem, Israel.; Balaban, NQ (corresponding author), Hebrew Univ Jerusalem, Harvey M Kruger Family Ctr Nanosci & Nanotechnol, Edmond J Safra Campus, IL-91904 Jerusalem, Israel.	nathalie.balaban@mail.huji.ac.il	Balaban, Nathalie/AGI-1487-2022; Balaban, Nathalie/AAH-1004-2019	Balaban, Nathalie/0000-0001-8018-0766; Balaban, Nathalie/0000-0001-8018-0766; gefen, orit/0000-0001-7638-4731	European Research Council (Consolidator grant) [681819]; Israel Science Foundation [492/15]; Dalia and Dan Maydan Fellowship; BioProject [PRJNA361209]	European Research Council (Consolidator grant)(European Research Council (ERC)); Israel Science Foundation(Israel Science Foundation); Dalia and Dan Maydan Fellowship; BioProject	We thank O. Fridman for discussion and technical help with Galaxy, A. Brauner for discussion, N. Dick for the work on ScanLag UI, and E. Winter for the BreSeq analysis. We thank N. Barkai for comments on the manuscript. The work was supported by the European Research Council (Consolidator grant no. 681819) and the Israel Science Foundation (grant no. 492/15). I.L.-R. acknowledges support from the Dalia and Dan Maydan Fellowship. The accession number for the sequencing data is BioProject PRJNA361209. Additional files are available at http://bio-site.phys.huji.ac.il/Materials.	Amini S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002298; Andersson DI, 2014, NAT REV MICROBIOL, V12, P465, DOI 10.1038/nrmicro3270; Ankomah P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003300; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Baym M, 2016, SCIENCE, V353, P1147, DOI 10.1126/science.aag0822; Bigger JW, 1944, LANCET, V2, P497; Blondeau J M, 2004, J Chemother, V16 Suppl 3, P1; Brauner A, 2016, NAT REV MICROBIOL, V14, P320, DOI 10.1038/nrmicro.2016.34; Cohen NR, 2013, CELL HOST MICROBE, V13, P632, DOI 10.1016/j.chom.2013.05.009; Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Fridman O, 2014, NATURE, V513, P418, DOI 10.1038/nature13469; Girgis HS, 2012, P NATL ACAD SCI USA, V109, P12740, DOI 10.1073/pnas.1205124109; HANDWERGER S, 1985, REV INFECT DIS, V7, P368; Haraga Isao, 2002, International Journal of Infectious Diseases, V6, P302, DOI 10.1016/S1201-9712(02)90165-7; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; JAURIN B, 1983, CELL, V32, P809, DOI 10.1016/0092-8674(83)90067-3; JAURIN B, 1981, NATURE, V290, P221, DOI 10.1038/290221a0; Kim JS, 2016, ANTIMICROB AGENTS CH, V60, P2232, DOI 10.1128/AAC.01794-15; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Levin-Reisman I, 2010, NAT METHODS, V7, P737, DOI 10.1038/nmeth.1485; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lipsitch M, 2001, TRENDS MICROBIOL, V9, P438, DOI 10.1016/S0966-842X(01)02130-8; Mechler L, 2015, ANTIMICROB AGENTS CH, V59, P5366, DOI 10.1128/AAC.00643-15; Muller B, 2013, TRENDS GENET, V29, P160, DOI 10.1016/j.tig.2012.11.005; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Orman MA, 2016, FREE RADICAL BIO MED, V93, P145, DOI 10.1016/j.freeradbiomed.2016.02.003; Siu LK, 2003, ANTIMICROB AGENTS CH, V47, P2138, DOI 10.1128/AAC.47.7.2138-2144.2003; Sorg RA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9773; SZYBALSKI W, 1952, J BACTERIOL, V64, P489, DOI 10.1128/JB.64.4.489-499.1952; Toprak E, 2012, NAT GENET, V44, P101, DOI 10.1038/ng.1034; Van den Bergh B, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.20, 10.1038/nmicrobiol.2016.20]; Wahl LM, 2001, EVOLUTION, V55, P2606; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219	36	553	575	33	557	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					826	830		10.1126/science.aaj2191	http://dx.doi.org/10.1126/science.aaj2191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28183996				2022-12-28	WOS:000395127600038
J	Vogel, C				Vogel, Christine			PROTEOME Quantifying protein (dis)order A study of bacteria, yeast, and mammalian cells maps the melting behavior of cellular proteins	SCIENCE			English	Editorial Material							FAMILIES; DISEASE		[Vogel, Christine] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA	New York University	Vogel, C (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	cvogel@nyu.edu			NIH [R01 GM113237]; Zegar Family Foundation Fund for Genomics Research at New York University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113237] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zegar Family Foundation Fund for Genomics Research at New York University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I acknowledge funding by the NIH (R01 GM113237) and the Zegar Family Foundation Fund for Genomics Research at New York University.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Feng YH, 2014, NAT BIOTECHNOL, V32, P1036, DOI 10.1038/nbt.2999; KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0; Leuenberger P, 2017, SCIENCE, V355, DOI 10.1126/science.aai7825; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Tartaglia GG, 2007, TRENDS BIOCHEM SCI, V32, P204, DOI 10.1016/j.tibs.2007.03.005; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282	10	1	1	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					794	795		10.1126/science.aam8036	http://dx.doi.org/10.1126/science.aam8036			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28232536				2022-12-28	WOS:000395127600018
J	Malem, A				Malem, Andrew			CASE REVIEW Unequal pupils and ptosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Malem, Andrew] Queen Alexandra Hosp, Eye Dept, Southwick Hill Rd, Portsmouth, Hants, England	Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital	Malem, A (corresponding author), Queen Alexandra Hosp, Eye Dept, Southwick Hill Rd, Portsmouth, Hants, England.	andrew.malem@cantab.net						Brown SM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1201, DOI 10.1001/archopht.121.8.1201; Davagnanam I, 2013, EYE, V27, P291, DOI 10.1038/eye.2012.281; Freedman KA, 2005, J NEURO-OPHTHALMOL, V25, P83, DOI 10.1097/01.WNO.0000165108.31731.36; KARDON RH, 1990, ARCH OPHTHALMOL-CHIC, V108, P384, DOI 10.1001/archopht.1990.01070050082036; Koc F, 2005, BRIT J OPHTHALMOL, V89, P1442, DOI 10.1136/bjo.2005.074492; Mahoney NR, 2006, AM J OPHTHALMOL, V142, P651, DOI 10.1016/j.ajo.2006.05.047; MORRIS JGL, 1984, BRAIN, V107, P751, DOI 10.1093/brain/107.3.751; Moster ML, 2003, J NEURO-OPHTHALMOL, V23, P22, DOI 10.1097/00041327-200303000-00005; Smith SJ, 2010, ARCH OPHTHALMOL-CHIC, V128, P324, DOI 10.1001/archophthalmol.2010.6; Walton Kelly A, 2003, Curr Opin Ophthalmol, V14, P357, DOI 10.1097/00055735-200312000-00007; Wilhelm H, 1992, Ger J Ophthalmol, V1, P96	11	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2017	356								j643	10.1136/bmj.j643	http://dx.doi.org/10.1136/bmj.j643			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KY	28232306				2022-12-28	WOS:000395631700001
J	Monach, PA; Stone, JH; Sharma, A; Nazarian, RM				Monach, Paul A.; Stone, John H.; Sharma, Amita; Nazarian, Rosalynn M.			Case 6-2017: A 57-Year-Old Woman with Fatigue, Sweats, Weight Loss, Headache, and Skin Lesions	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IGG4-RELATED DISEASE; CASTLEMAN DISEASE; VASCULITIS; RITUXIMAB; BIOPSY		[Monach, Paul A.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Monach, Paul A.] Vet Affairs Boston Healthcare Syst, Med Serv, Boston, MA 02130 USA; [Stone, John H.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Sharma, Amita] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Nazarian, Rosalynn M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Stone, John H.] Harvard Med Sch, Dept Med, Boston, MA USA; [Sharma, Amita] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Nazarian, Rosalynn M.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Monach, PA (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.; Monach, PA (corresponding author), Vet Affairs Boston Healthcare Syst, Med Serv, Boston, MA 02130 USA.		Nazarian, Rosalynn/AFL-3176-2022	Nazarian, Rosalynn/0000-0003-4003-7193				Alamino RP, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0348-9; Carruthers MN, 2015, ANN RHEUM DIS, V74, P1171, DOI 10.1136/annrheumdis-2014-206605; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Deshpande V, 2009, MODERN PATHOL, V22, P1287, DOI 10.1038/modpathol.2009.94; Fajgenbaum DC, 2014, BLOOD, V123, P2924, DOI 10.1182/blood-2013-12-545087; Ferry JA., 2013, DIAGN HISTOPATHOL, V19, P128, DOI [10.1016/j.mpdhp.2013.01.005, DOI 10.1016/J.MPDHP.2013.01.005]; Genereau T, 1999, ARTHRITIS RHEUM, V42, P2674, DOI 10.1002/1529-0131(199912)42:12<2674::AID-ANR25>3.0.CO;2-A; Homann C, 1997, GUT, V40, P544, DOI 10.1136/gut.40.4.544; Khosroshahi A, 2014, ARTHRITIS RHEUMATOL, V66, P213, DOI 10.1002/art.38193; Monach Paul A, 2013, Curr Treat Options Cardiovasc Med, V15, P214, DOI 10.1007/s11936-013-0232-y; Pieri G, 2014, ANN GASTROENTEROL, V27, P113; Sato Y, 2012, INT J RHEUMATOL, V2012, DOI DOI 10.1155/2012/572539; Soumerai JD, 2014, CANCER CONTROL, V21, P266, DOI 10.1177/107327481402100403; Stone JH, 2015, MAYO CLIN PROC, V90, P927, DOI 10.1016/j.mayocp.2015.03.020; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Wallace ZS, 2016, RHEUMATOLOGY, V55, P1000, DOI 10.1093/rheumatology/kev438; Zen Y, 2016, J GASTROENTEROL, V51, P295, DOI 10.1007/s00535-016-1163-7	17	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2017	376	8					775	786		10.1056/NEJMcpc1613461	http://dx.doi.org/10.1056/NEJMcpc1613461			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JO	28225681				2022-12-28	WOS:000395627900012
J	Tzedakis, PC; Crucifix, M; Mitsui, T; Wolff, EW				Tzedakis, P. C. .; Crucifix, M.; Mitsui, T.; Wolff, E. W.			A simple rule to determine which insolation cycles lead to interglacials	NATURE			English	Article							MIDDLE PLEISTOCENE TRANSITION; GLACIAL CYCLES; ICE-SHEET; CLIMATE; EVOLUTION; OBLIQUITY; MODEL; VARIABILITY; PRECESSION; OCEAN	The pacing of glacial-interglacial cycles during the Quaternary period (the past 2.6 million years) is attributed to astronomically driven changes in high-latitude insolation. However, it has not been clear how astronomical forcing translates into the observed sequence of interglacials. Here we show that before one million years ago interglacials occurred when the energy related to summer insolation exceeded a simple threshold, about every 41,000 years. Over the past one million years, fewer of these insolation peaks resulted in deglaciation (that is, more insolation peaks were 'skipped'), implying that the energy threshold for deglaciation had risen, which led to longer glacials. However, as a glacial lengthens, the energy needed for deglaciation decreases. A statistical model that combines these observations correctly predicts every complete deglaciation of the past million years and shows that the sequence of interglacials that has occurred is one of a small set of possibilities. The model accounts for the dominance of obliquity-paced glacial-interglacial cycles early in the Quaternary and for the change in their frequency about one million years ago. We propose that the appearance of larger ice sheets over the past million years was a consequence of an increase in the deglaciation threshold and in the number of skipped insolation peaks.	[Tzedakis, P. C. .] UCL, Dept Geog, Environm Change Res Ctr, London, England; [Crucifix, M.; Mitsui, T.] Catholic Univ Louvain, Earth & Life Inst, Georges Lemaitre Ctr Earth & Climate Res, Louvain La Neuve, Belgium; [Wolff, E. W.] Univ Cambridge, Dept Earth Sci, Cambridge, England	University of London; University College London; Universite Catholique Louvain; University of Cambridge	Tzedakis, PC (corresponding author), UCL, Dept Geog, Environm Change Res Ctr, London, England.	p.c.tzedakis@ucl.ac.uk	Mitsui, Takahito/GLR-6685-2022; Wolff, Eric/AAB-1097-2021; Wolff, Eric W/D-7925-2014	Mitsui, Takahito/0000-0002-2825-3996; Wolff, Eric/0000-0002-5914-8531; Wolff, Eric W/0000-0002-5914-8531; Tzedakis, Polychronis/0000-0001-6072-1166	Leverhulme Trust [RPG-2014-417]; Belgian Policy Office [BR/121/A2/STOCHCLIM]; Royal Society; Directorate For Geosciences [1450657, 1440015] Funding Source: National Science Foundation	Leverhulme Trust(Leverhulme Trust); Belgian Policy Office; Royal Society(Royal Society of London); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank D. A. Hodell, S. J. Crowhurst, M. A. Maslin, L. C. Skinner, L. Cannings and members of the PAGES Working Groups on Past Interglacials (PIGS) and Quaternary Interglacials (QUIGS) for discussions. P.C.T. acknowledges funding from a Leverhulme Trust Research Project Grant (RPG-2014-417). M.C. and T.M. acknowledge support from the Belgian Policy Office under contract BR/121/A2/STOCHCLIM. E.W.W. is funded under a Royal Society Research Professorship and M.C. is a senior research scientist with the Belgian National Fund of Scientific Research. This is a contribution to PAGES QUIGS.	Abe-Ouchi A, 2013, NATURE, V500, P190, DOI 10.1038/nature12374; Ashwin P, 2015, CLIM DYNAM, V45, P2683, DOI 10.1007/s00382-015-2501-9; Berger A, 1999, QUATERNARY SCI REV, V18, P1, DOI 10.1016/S0277-3791(98)00033-X; Berger A, 2016, REV GEOPHYS, V54, P162, DOI 10.1002/2015RG000482; Berger W. H., 1994, GEOPHYS MONOGR SER, V84, P295; BIRCHFIELD GE, 1981, QUATERNARY RES, V15, P126, DOI 10.1016/0033-5894(81)90100-9; Bounceur N, 2015, EARTH SYST DYNAM, V6, P205, DOI 10.5194/esd-6-205-2015; Bouttes N, 2012, CLIM PAST, V8, P149, DOI 10.5194/cp-8-149-2012; Chen MH, 2008, J AM STAT ASSOC, V103, P1659, DOI 10.1198/016214508000000779; Cheng H, 2016, NATURE, V534, P640, DOI 10.1038/nature18591; Clark PU, 2006, QUATERNARY SCI REV, V25, P3150, DOI 10.1016/j.quascirev.2006.07.008; Crucifix M., 2016, PALINSOL INSOLATION; Ehlers J, 2011, DEV QUATER SCI, V15, P1; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; Ganopolski A, 2011, CLIM PAST, V7, P1415, DOI 10.5194/cp-7-1415-2011; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Head MJ, 2015, QUATERN INT, V389, P7, DOI 10.1016/j.quaint.2015.09.042; Hodell DA, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001211; Hodell DA, 2016, CLIM PAST, V12, P1805, DOI 10.5194/cp-12-1805-2016; Huybers P, 2007, QUATERNARY SCI REV, V26, P37, DOI 10.1016/j.quascirev.2006.07.013; Huybers P, 2006, SCIENCE, V313, P508, DOI 10.1126/science.1125249; Huybers P, 2011, NATURE, V480, P229, DOI 10.1038/nature10626; IMBRIE J, 1993, PALEOCEANOGRAPHY, V8, P699, DOI 10.1029/93PA02751; Imbrie JZ, 2011, EARTH PLANET SC LETT, V307, P94, DOI 10.1016/j.epsl.2011.04.018; Lang N, 2011, CLIM PAST, V7, P361, DOI 10.5194/cp-7-361-2011; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lawrence KT, 2010, EARTH PLANET SC LETT, V300, P329, DOI 10.1016/j.epsl.2010.10.013; Lisiecki LE, 2014, PALEOCEANOGRAPHY, V29, P71, DOI 10.1002/2013PA002505; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; MAASCH KA, 1988, CLIM DYNAM, V2, P133; MacAyeal D. R., 1979, J GLACIOL, V24, P245, DOI DOI 10.3189/S0022143000014775; Martinez-Garcia A, 2011, NATURE, V476, P312, DOI 10.1038/nature10310; Maslin MA, 2015, QUATERN INT, V389, P47, DOI 10.1016/j.quaint.2015.01.047; McClymont EL, 2013, EARTH-SCI REV, V123, P173, DOI 10.1016/j.earscirev.2013.04.006; Milankovic M., 1941, KANON ERDBESTRAHLUNG; Naafs BDA, 2012, EARTH PLANET SC LETT, V317, P8, DOI 10.1016/j.epsl.2011.11.026; NINKOVICH D, 1975, EARTH PLANET SC LETT, V27, P20, DOI 10.1016/0012-821X(75)90156-9; Paillard D, 1998, NATURE, V391, P378, DOI 10.1038/34891; Paillard D, 2004, EARTH PLANET SC LETT, V227, P263, DOI 10.1016/j.epsl.2004.08.023; Parrenin F, 2012, CLIM PAST, V8, P2031, DOI 10.5194/cp-8-2031-2012; PISIAS NG, 1981, EARTH PLANET SC LETT, V52, P450, DOI 10.1016/0012-821X(81)90197-7; POLLARD D, 1983, J GEOPHYS RES-OCEANS, V88, P7705, DOI 10.1029/JC088iC12p07705; Raymo ME, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000791; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P577, DOI 10.1029/97PA01169; Robert CP, 2009, AIP CONF PROC, V1193, P251, DOI 10.1063/1.3275622; RUDDIMAN WF, 1986, EARTH PLANET SC LETT, V80, P117, DOI 10.1016/0012-821X(86)90024-5; SALTZMAN B, 1990, T ROY SOC EDIN-EARTH, V81, P315, DOI 10.1017/S0263593300020824; SHACKLETON N, 1967, NATURE, V215, P15, DOI 10.1038/215015a0; Shackleton N. J., 1973, Quaternary Research, V3, P39, DOI 10.1016/0033-5894(73)90052-5; Shackleton N.J., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P337, DOI 10.2973/odp.proc.sr.138.117.1995; Shackleton N.J., 1985, GEOPHYS MONOGR SER, V32, P303; SHACKLETON NJ, 1990, T ROY SOC EDIN-EARTH, V81, P251, DOI 10.1017/S0263593300020782; Shackleton NJ., 1976, GEOLOGICAL SOC AM ME, P449, DOI DOI 10.1130/MEM145-P449; Tzedakis PC, 2012, CLIM PAST, V8, P1473, DOI 10.5194/cp-8-1473-2012; Tziperman E, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000627; Tziperman E, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001241	56	70	73	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2017	542	7642					427	+		10.1038/nature21364	http://dx.doi.org/10.1038/nature21364			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM1RG	28230118	Green Submitted			2022-12-28	WOS:000395094100026
J	Bisson, AW; Hsu, YP; Squyres, GR; Kuru, E; Wu, FB; Jukes, C; Sun, YJ; Dekker, C; Holden, S; VanNieuwenhze, MS; Brun, YV; Garner, EC				Bisson-Filho, Alexandre W.; Hsu, Yen-Pang; Squyres, Georgia R.; Kuru, Erkin; Wu, Fabai; Jukes, Calum; Sun, Yingjie; Dekker, Cees; Holden, Seamus; VanNieuwenhze, Michael S.; Brun, Yves V.; Garner, Ethan C.			Treadmilling by FtsZ filaments drives peptidoglycan synthesis and bacterial cell division	SCIENCE			English	Article							ESCHERICHIA-COLI-CELLS; D-AMINO ACIDS; ASSEMBLY DYNAMICS; IN-VIVO; BACILLUS-SUBTILIS; SUPERRESOLUTION; MICROSCOPY; MACHINERY; PROTEINS; DIVISOME	The mechanism by which bacteria divide is not well understood. Cell division is mediated by filaments of FtsZ and FtsA (FtsAZ) that recruit septal peptidoglycan-synthesizing enzymes to the division site. To understand how these components coordinate to divide cells, we visualized their movements relative to the dynamics of cell wall synthesis during cytokinesis. We found that the division septum was built at discrete sites that moved around the division plane. FtsAZ filaments treadmilled circumferentially around the division ring and drove the motions of the peptidoglycan-synthesizing enzymes. The FtsZ treadmilling rate controlled both the rate of peptidoglycan synthesis and cell division. Thus, FtsZ treadmilling guides the progressive insertion of new cell wall by building increasingly smaller concentric rings of peptidoglycan to divide the cell.	[Bisson-Filho, Alexandre W.; Squyres, Georgia R.; Sun, Yingjie; Garner, Ethan C.] Harvard Univ, Fac Arts, Mol & Cellular Biol, Cambridge, MA 02138 USA; [Bisson-Filho, Alexandre W.; Squyres, Georgia R.; Sun, Yingjie; Garner, Ethan C.] Harvard Univ, Sci Ctr Syst Biol, Cambridge, MA 02138 USA; [Hsu, Yen-Pang; Kuru, Erkin; VanNieuwenhze, Michael S.] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Wu, Fabai; Dekker, Cees] Delft Univ Technol, Kavli Inst Nanosci Delft, Dept Bionanosci, Delft, Netherlands; [Jukes, Calum; Holden, Seamus] Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [VanNieuwenhze, Michael S.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Brun, Yves V.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Kuru, Erkin] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Wu, Fabai] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	Harvard University; Harvard University; Indiana University System; Indiana University Bloomington; Delft University of Technology; Newcastle University - UK; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Harvard University; Harvard Medical School; California Institute of Technology	Garner, EC (corresponding author), Harvard Univ, Fac Arts, Mol & Cellular Biol, Cambridge, MA 02138 USA.; Garner, EC (corresponding author), Harvard Univ, Sci Ctr Syst Biol, Cambridge, MA 02138 USA.; VanNieuwenhze, MS (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA.; Dekker, C (corresponding author), Delft Univ Technol, Kavli Inst Nanosci Delft, Dept Bionanosci, Delft, Netherlands.; Holden, S (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.; VanNieuwenhze, MS (corresponding author), Indiana Univ, Dept Chem, Bloomington, IN 47405 USA.; Brun, YV (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	c.dekker@tudelft.nl; seamus.holden@newcastle.ac.uk; mvannieu@indiana.edu; ybrun@indiana.edu; egarner@g.harvard.edu	VanNieuwenhze, Michael/B-5120-2018; Bisson Filho, Alexandre Wilson/D-4248-2015; Garner, Ethan/J-4025-2014	VanNieuwenhze, Michael/0000-0001-6093-5949; Sun, Yingjie/0000-0002-1309-753X; Bisson Filho, Alexandre Wilson/0000-0002-5940-7230; Wu, Fabai/0000-0001-5812-5621; Garner, Ethan/0000-0003-0141-3555; Holden, Seamus/0000-0002-7169-907X; Squyres, Georgia/0000-0002-8717-2897; Dekker, Cees/0000-0001-6273-071X; Brun, Yves/0000-0002-9289-1909	NIH [GM113172, GM51986, DP2AI117923-01]; Newcastle University Research Fellowship; Royal Society [RG150475]; Science Without Borders Research Fellowship; European Research Council [SynDiv 669598]; NSF Graduate Research Fellowship Program [DGE1144152];  [S10RR028697-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI117923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007598, R01GM113172, R01GM051986, R01GM059618] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Newcastle University Research Fellowship; Royal Society(Royal Society of London); Science Without Borders Research Fellowship; European Research Council(European Research Council (ERC)European Commission); NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Gueiros-Filho, R. Losick, M. Erb, and P. Levin for strains; J. Xiao for discussions; L. Lavis for Janelia Fluor dyes; B. Murphy and E. Pasciak for FDAA synthesis help; F. Gueiros-Filho, R. Daniel, and J. Errington for antibodies; R. Losick, B. LaSarre, and D. Kearns for comments. This work was supported by NIH grants GM113172 to M.S.V. and Y.V.B., GM51986 to Y.V.B., and DP2AI117923-01 to E.C.G.; a Newcastle University Research Fellowship and Royal Society Research Grant RG150475 to S.H.; a Science Without Borders Research Fellowship to A.W.B.-F.; a European Research Council Advanced Grant (SynDiv 669598) to C.D.; and an NSF Graduate Research Fellowship Program (DGE1144152) to G.R.S. SIM was performed in the Indiana University Light Microscopy Imaging Center supported by S10RR028697-01. E.K., Y.V.B., and M.S.V. are inventors on U.S. Patent Application 14/395,815 (PCT Patent Application PCT/US2013/037504), submitted by the Indiana University Research and Technology Corporation, that covers the use of FDAAs for labeling of bacterial cell walls. Data are available in the text and supplementary materials. Movies S1 to S10 are also available at http://garnerlab.fas.harvard.edu/FtsZ/. Code is available at https://bitbucket.org/garnerlab/bisson-2016.	Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Bisson AW, 2015, P NATL ACAD SCI USA, V112, pE2130, DOI 10.1073/pnas.1414242112; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Coltharp C, 2016, P NATL ACAD SCI USA, V113, pE1044, DOI 10.1073/pnas.1514296113; Eberhardt C, 2003, J BACTERIOL, V185, P3726, DOI 10.1128/JB.185.13.3726-3734.2003; Egan AJF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00455; Gamba P, 2009, J BACTERIOL, V191, P4186, DOI 10.1128/JB.01758-08; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Grimm JB, 2015, NAT METHODS, V12, P244, DOI [10.1038/NMETH.3256, 10.1038/nmeth.3256]; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Holden SJ, 2014, P NATL ACAD SCI USA, V111, P4566, DOI 10.1073/pnas.1313368111; Kuru E, 2012, ANGEW CHEM INT EDIT, V51, P12519, DOI 10.1002/anie.201206749; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Loose M, 2014, NAT CELL BIOL, V16, P38, DOI 10.1038/ncb2885; Lupoli TJ, 2011, J AM CHEM SOC, V133, P10748, DOI 10.1021/ja2040656; Ma XL, 1996, P NATL ACAD SCI USA, V93, P12998, DOI 10.1073/pnas.93.23.12998; Niu LL, 2008, BIOPHYS J, V95, P2009, DOI 10.1529/biophysj.108.128751; Osawa M, 2013, P NATL ACAD SCI USA, V110, P11000, DOI 10.1073/pnas.1222254110; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Rowlett VW, 2014, BIOPHYS J, V107, pL17, DOI 10.1016/j.bpj.2014.08.024; Strauss MP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001389; Szwedziak P, 2014, ELIFE, V3, DOI 10.7554/eLife.04601; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048; Yang X., 2016, 101101077610 BIORXIV	24	308	312	9	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					739	743		10.1126/science.aak9973	http://dx.doi.org/10.1126/science.aak9973			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2AC	28209898	Green Submitted, Green Accepted			2022-12-28	WOS:000395117700041
J	Kmietowicz, Z				Kmietowicz, Zosia			Shortlisted teams announced for The BMJ Awards 2017	BMJ-BRITISH MEDICAL JOURNAL			English	News Item															MDDUS; Royal College of Anaesthetists; Alliance Medical; Leo Pharma; Macmillan Cancer Support; GMC; FMLM, Public Health England; Marie Curie and Hospice UK	MDDUS; Royal College of Anaesthetists; Alliance Medical; Leo Pharma(LEO Pharma); Macmillan Cancer Support; GMC; FMLM, Public Health England; Marie Curie and Hospice UK	The major sponsor of The BMJ Awards 2017, and the primary care team award sponsor, is MDDUS, while category sponsors include the Royal College of Anaesthetists, Alliance Medical, Leo Pharma, Macmillan Cancer Support, the GMC and FMLM, Public Health England, and Marie Curie and Hospice UK.		0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2017	356								j854	10.1136/bmj.j854	http://dx.doi.org/10.1136/bmj.j854			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GP	28209564				2022-12-28	WOS:000394580000010
J	Ernberg, I; Karre, K; Wigzell, H				Ernberg, Ingemar; Karre, Klas; Wigzell, Hans			George Klein (1925-2016) A pioneering cancer biologist and Renaissance man OBITUARY	NATURE			English	Biographical-Item									[Ernberg, Ingemar] Karolinska Inst, Tumour Biol, Stockholm, Sweden; [Karre, Klas] Karolinska Inst, Immunol, Stockholm, Sweden; [Wigzell, Hans] Karolinska Inst, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Ernberg, I (corresponding author), Karolinska Inst, Tumour Biol, Stockholm, Sweden.	ingemar.ernberg@ki.se						KLEIN G, PUBLICATION LIST	1	0	0	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					296	296		10.1038/542296a	http://dx.doi.org/10.1038/542296a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2LQ	28202974	Bronze			2022-12-28	WOS:000394451600021
J	Younge, N; Goldstein, RF; Bann, CM; Hintz, SR; Patel, RM; Smith, PB; Bell, EF; Rysavy, MA; Duncan, AF; Vohr, BR; Das, A; Goldberg, RN; Higgins, RD; Cotten, CM				Younge, Noelle; Goldstein, Ricki F.; Bann, Carla M.; Hintz, Susan R.; Patel, Ravi M.; Smith, P. Brian; Bell, Edward F.; Rysavy, Matthew A.; Duncan, Andrea F.; Vohr, Betty R.; Das, Abhik; Goldberg, Ronald N.; Higgins, Rosemary D.; Cotten, C. Michael		Eunice Kennedy Shriver Natl Inst C; Human Dev Neonatal Res Network	Survival and Neurodevelopmental Outcomes among Periviable Infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BIRTH-WEIGHT INFANTS; EXTREMELY PRETERM INFANTS; ACTIVE PERINATAL-CARE; WEEKS GESTATIONAL-AGE; BAYLEY-III; NATIONAL INSTITUTE; CHILDREN BORN; MORTALITY; MORBIDITY; SCALES	BACKGROUND Data reported during the past 5 years indicate that rates of survival have increased among infants born at the borderline of viability, but less is known about how increased rates of survival among these infants relate to early childhood neurodevelopmental outcomes. METHODS We compared survival and neurodevelopmental outcomes among infants born at 22 to 24 weeks of gestation, as assessed at 18 to 22 months of corrected age, across three consecutive birth-year epochs ( 2000-2003 [ epoch 1], 2004-2007 [ epoch 2], and 20082011 [ epoch 3]). The infants were born at 11 centers that participated in the National Institute of Child Health and Human Development Neonatal Research Network. The primary outcome measure was a three-level outcome - survival without neurodevelopmental impairment, survival with neurodevelopmental impairment, or death. After accounting for differences in infant characteristics, including birth center, we used multinomial generalized logit models to compare the relative risk of survival without neurodevelopmental impairment, survival with neurodevelopmental impairment, and death. RESULTS Data on the primary outcome were available for 4274 of 4458 infants ( 96%) born at the 11 centers. The percentage of infants who survived increased from 30% ( 424 of 1391 infants) in epoch 1 to 36% ( 487 of 1348 infants) in epoch 3 ( P<0.001). The percentage of infants who survived without neurodevelopmental impairment increased from 16% ( 217 of 1391) in epoch 1 to 20% ( 276 of 1348) in epoch 3 (P = 0.001), whereas the percentage of infants who survived with neurodevelopmental impairment did not change significantly ( 15% [ 207 of 1391] in epoch 1 and 16% [ 211 of 1348] in epoch 3, P = 0.29). After adjustment for changes in the baseline characteristics of the infants over time, both the rate of survival with neurodevelopmental impairment as compared with death) and the rate of survival without neurodevelopmental impairment ( as compared with death) increased over time ( adjusted relative risks, 1.27 [95% confidence interval {CI}, 1.01 to 1.59] and 1.59 [ 95% CI, 1.28 to 1.99], respectively). CONCLUSIONS The rate of survival without neurodevelopmental impairment increased between 2000 and 2011 in this large cohort of periviable infants. ( Funded by the National Institutes of Health and others; ClinicalTrials.gov numbers, NCT00063063 and NCT00009633.)	[Younge, Noelle; Goldstein, Ricki F.; Smith, P. Brian; Goldberg, Ronald N.; Cotten, C. Michael] Duke Univ, Dept Pediat, DUMC Box 2739, Durham, NC 27710 USA; [Bann, Carla M.; Das, Abhik] RTI Int, Stat & Epidemiol Unit, Res Triangle Pk, NC USA; [Hintz, Susan R.] Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA; [Hintz, Susan R.] Lucile Packard Childrens Hosp, Palo Alto, CA USA; [Patel, Ravi M.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Patel, Ravi M.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Bell, Edward F.; Rysavy, Matthew A.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Rysavy, Matthew A.] Univ Wisconsin, Dept Pediat, Madison, WI USA; [Duncan, Andrea F.] Univ Texas Houston, Sch Med, Dept Pediat, Houston, TX USA; [Vohr, Betty R.] Brown Univ, Women & Infants Hosp, Dept Pediat, Providence, RI 02908 USA; [Higgins, Rosemary D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA	Duke University; Research Triangle Institute; Stanford University; Lucile Packard Children's Hospital (LPCH); Emory University; Children's Healthcare of Atlanta (CHOA); University of Iowa; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Health Science Center Houston; Brown University; Women & Infants Hospital Rhode Island; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Younge, N (corresponding author), Duke Univ, Dept Pediat, DUMC Box 2739, Durham, NC 27710 USA.	noelle.younge@duke.edu	Ambalavanan, Namasivayam/AAI-4088-2020; Das, Abhik/AAF-1883-2020; Patel, Ravi/B-7218-2011	Ambalavanan, Namasivayam/0000-0003-0731-9092; Das, Abhik/0000-0003-2722-0479; Patel, Ravi/0000-0002-7444-5550; D., Sivakumar/0000-0002-3695-5373; Hintz, Susan/0000-0001-7023-4433; Gantz, Marie/0000-0001-8528-0184; Bell, Edward/0000-0002-5568-0889; Lakshminrusimha, Satyan/0000-0001-6098-2155; Rysavy, Matthew/0000-0002-1209-6607; Bann, Carla/0000-0001-9305-8305; Parikh, Nehal/0000-0002-1375-1247	National Institutes of Health [5T32HD043728-10, HD060558-05, 4K12HD043494-14]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Research Resources; National Center for Advancing Translational Sciences for the Neonatal Research Network's Generic Database and Follow-up Studies [U10 HD27904, U10 HD21364, M01 RR80, U10 HD68284, U10 HD27853, M01 RR8084, U10 HD40492, M01 RR30, U10 HD27851, M01 RR39, U10 HD27856, M01 RR750, U10 HD68278, U10 HD36790, U10 HD27880, M01 RR70, UL1 TR93, U10 HD53119, M01 RR54];  [U10 HD68244];  [U10 HD68263];  [U10 HD40521];  [UL1 RR24160];  [M01 RR44];  [UL1 TR42];  [U10 HD21415];  [U10 HD21373];  [U10 HD40689];  [M01 RR633];  [U10 HD53124];  [M01 RR64];  [UL1 TR105];  [U10 HD40498];  [M01 RR7122];  [U10 HD21385];  [U10 HD27871];  [UL1 RR24139];  [M01 RR125];  [UL1 TR142];  [M01 RR59];  [U10 HD21397];  [M01 RR16587];  [U10 HD27881];  [U10 HD53089];  [M01 RR997];  [U10 HD34216];  [M01 RR32];  [U10 HD68270];  [U10 HD40461];  [U10 HD53109]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [UG1HD053089, U10HD036790, U10HD034216, U10HD040689, UG1HD027851, U10HD053119, U10HD040461, U10HD027856, U10HD021373, U10HD027853, U10HD027904, U10HD040492, U10HD027871, UG1HD027853, UG1HD053109, UG1HD027904, T32HD060558, UG1HD068263, U10HD021385, K12HD043494, U10HD053124, U10HD053089, UG1HD021364, U10HD068270, UG1HD027880, U10HD068244, T32HD043728, U10HD027851, UG1HD068278, U10HD027880, UG1HD087229, UG1HD034216, UG1HD087226, U10HD068284, U10HD021364, U10HD021410, U10HD068263, UG1HD040492, U10HD053109, U10HD068278] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD040498, U01HD036790, U10HD021397, U10HD040521] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000093, UL1TR000042, UL1TR000105, UL1TR000142] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000044, M01RR016587, M01RR000125, M01RR000633, M01RR000039, M01RR008084, M01RR000059, M01RR000032, M01RR007122, M01RR000997, M01RR000750, M01RR000054, M01RR000064, UL1RR024160, M01RR000030, UL1RR024139, M01RR000070, M01RR000080] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL128942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences for the Neonatal Research Network's Generic Database and Follow-up Studies; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Institutes of Health ( including grants 5T32HD043728-10, HD060558-05, and 4K12HD043494-14 to Dr. Younge) and from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, grants from the National Center for Research Resources, and cooperative agreements from the National Center for Advancing Translational Sciences for the Neonatal Research Network's Generic Database and Follow-up Studies (U10 HD27904, U10 HD21364, M01 RR80, U10 HD68284, U10 HD27853, M01 RR8084, U10 HD40492, M01 RR30, U10 HD27851, M01 RR39, U10 HD27856, M01 RR750, U10 HD68278, U10 HD36790, U10 HD27880, M01 RR70, UL1 TR93, U10 HD53119, M01 RR54, U10 HD34216, M01 RR32, U10 HD68270, U10 HD40461, U10 HD53109, M01 RR59, U10 HD21397, M01 RR16587, U10 HD27881, U10 HD53089, M01 RR997, U10 HD68244, U10 HD68263, U10 HD40521, UL1 RR24160, M01 RR44, UL1 TR42, U10 HD21415, U10 HD21373, U10 HD40689, M01 RR633, U10 HD53124, M01 RR64, UL1 TR105, U10 HD40498, M01 RR7122, U10 HD21385, U10 HD27871, UL1 RR24139, M01 RR125, and UL1 TR142).	Adams-Chapman I, 2008, PEDIATRICS, V121, pE1167, DOI 10.1542/peds.2007-0423; Anderson PJ, 2010, ARCH PEDIAT ADOL MED, V164, P352, DOI 10.1001/archpediatrics.2010.20; BALLARD JL, 1979, J PEDIATR-US, V95, P769, DOI 10.1016/S0022-3476(79)80734-9; Carlo WA, 2011, JAMA-J AM MED ASSOC, V306, P2348, DOI 10.1001/jama.2011.1752; Claas MJ, 2011, ARCH DIS CHILD-FETAL, V96, pF169, DOI 10.1136/adc.2009.174433; dos Santos ESL, 2013, EARLY HUM DEV, V89, P487, DOI 10.1016/j.earlhumdev.2013.03.008; Doyle LW, 2010, J PEDIATR-US, V156, P49, DOI 10.1016/j.jpeds.2009.07.013; DUBOWITZ LM, 1970, J PEDIATR-US, V77, P1, DOI 10.1016/S0022-3476(70)80038-5; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Hakansson S, 2004, PEDIATRICS, V114, P58, DOI 10.1542/peds.114.1.58; Hintz SR, 2011, PEDIATRICS, V127, P62, DOI 10.1542/peds.2010-1150; Horbar JD, 2012, PEDIATRICS, V129, P1019, DOI 10.1542/peds.2011-3028; Ishii N, 2013, PEDIATRICS, V132, P62, DOI 10.1542/peds.2012-2857; Johnson S, 2014, PEDIATR RES, V75, P670, DOI 10.1038/pr.2014.10; Kusuda S, 2012, PEDIATR RES, V72, P531, DOI 10.1038/pr.2012.114; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Mercier CE, 2010, NEONATOLOGY, V97, P329, DOI 10.1159/000260136; Moore GP, 2013, JAMA PEDIATR, V167, P967, DOI 10.1001/jamapediatrics.2013.2395; Moore T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7961; Moore T, 2012, J PEDIATR-US, V160, P553, DOI 10.1016/j.jpeds.2011.09.047; Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Patel RM, 2015, NEW ENGL J MED, V372, P331, DOI 10.1056/NEJMoa1403489; Raju TNK, 2014, J PERINATOL, V34, P333, DOI 10.1038/jp.2014.70; Rysavy MA, 2015, NEW ENGL J MED, V372, P1801, DOI 10.1056/NEJMoa1410689; Schlapbach LJ, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-198; Serenius F, 2016, JAMA PEDIATR, V170, P954, DOI 10.1001/jamapediatrics.2016.1210; Serenius F, 2015, PEDIATRICS, V135, pE1163, DOI 10.1542/peds.2014-2988; Serenius F, 2013, JAMA-J AM MED ASSOC, V309, P1810, DOI 10.1001/jama.2013.3786; Spencer-Smith MM, 2015, PEDIATRICS, V135, pE1258, DOI 10.1542/peds.2014-3039; Stoll BJ, 2015, JAMA-J AM MED ASSOC, V314, P1039, DOI 10.1001/jama.2015.10244; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059; Vohr BR, 2012, J PEDIATR-US, V161, P222, DOI 10.1016/j.jpeds.2012.01.057; Vohr BR, 2004, PEDIATRICS, V113, P781, DOI 10.1542/peds.113.4.781; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089	39	266	276	2	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2017	376	7					617	628		10.1056/NEJMoa1605566	http://dx.doi.org/10.1056/NEJMoa1605566			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO0QJ	28199816	Green Accepted			2022-12-28	WOS:000396402700013
J	[Anonymous]				[Anonymous]			ECOLOGY Toxic build-up in deep-sea life	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					274	275		10.1038/542274d	http://dx.doi.org/10.1038/542274d			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7YF	28202962	Bronze			2022-12-28	WOS:000454457400004
J	Hawkes, N				Hawkes, Nigel			Merck ends trial of potential Alzheimer's drug verubecestat	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Hawkes N, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6362; Kennedy ME, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9704; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323	3	16	18	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	2017	356								j845	10.1136/bmj.j845	http://dx.doi.org/10.1136/bmj.j845			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GM	28202490				2022-12-28	WOS:000394579700016
J	Wilkes, M				Wilkes, Matt			Productivity in the NHS grows for fifth year running, ONS data show	BMJ-BRITISH MEDICAL JOURNAL			English	News Item												matt@theadventuremedic.com						Bojke C, 2016, PRODUCTIVITY ENGLISH; Health Foundation, 2016, HLTH FDN AN AC HOSP; Office for National Statistics, 2017, PUBL SERV PROD EST H	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2017	356								j786	10.1136/bmj.j786	http://dx.doi.org/10.1136/bmj.j786			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GI	28193607				2022-12-28	WOS:000394579300010
J	Chuang, A				Chuang, Angela			Evolution: Climate	SCIENCE			English	Book Review									[Chuang, Angela] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Chuang, A (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	angelachuang@utk.edu						2016, EVOLUTION CLIMATE	1	3	3	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					587	587		10.1126/science.aam5437	http://dx.doi.org/10.1126/science.aam5437			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK0SF	28183941				2022-12-28	WOS:000393636700032
J	Wadman, M; Stone, R				Wadman, Meredith; Stone, Richard			Grad students, postdocs with US visas face uncertainty	SCIENCE			English	News Item																			0	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					557	558		10.1126/science.355.6325.557	http://dx.doi.org/10.1126/science.355.6325.557			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK0SF	28183918				2022-12-28	WOS:000393636700009
J	Kahan, J; Banner, R; Lutchman-Singh, K				Kahan, Jennifer; Banner, Russell; Lutchman-Singh, Kerryn			SPOT DIAGNOSIS Breathlessness and abdominal swelling: a classic eponymous syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kahan, Jennifer] Singleton Hosp, Oncol, Sketty Lane, Swansea, W Glam, Wales; [Banner, Russell] Singleton Hosp, Sketty Lane, Swansea, W Glam, Wales; [Lutchman-Singh, Kerryn] Singleton Hosp, Obstet & Gynaecol, Sketty Lane, Swansea, W Glam, Wales	Singleton Hospital; Singleton Hospital; Singleton Hospital	Kahan, J (corresponding author), Singleton Hosp, Oncol, Sketty Lane, Swansea, W Glam, Wales.	Jennifer.Kahan@wales.nhs.uk						Ishiko O, 2001, EUR J OBSTET GYN R B, V98, P129, DOI 10.1016/S0301-2115(01)00290-1; MEIGS JV, 1954, AM J OBSTET GYNECOL, V67, P962, DOI 10.1016/0002-9378(54)90258-6; Quirk JT, 2005, GYNECOL ONCOL, V97, P519, DOI 10.1016/j.ygyno.2005.02.007; TIMMERMAN D, 1995, GYNECOL ONCOL, V59, P405, DOI 10.1006/gyno.1995.9952	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2017	356								j382	10.1136/bmj.j382	http://dx.doi.org/10.1136/bmj.j382			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GB	28183705				2022-12-28	WOS:000394578600002
J	Wolfson, RL; Chantranupong, L; Wyant, GA; Gu, X; Orozco, JM; Shen, K; Condon, KJ; Petri, S; Kedir, J; Scaria, SM; Abu-Remaileh, M; Frankel, WN; Sabatini, DM				Wolfson, Rachel L.; Chantranupong, Lynne; Wyant, Gregory A.; Gu, Xin; Orozco, Jose M.; Shen, Kuang; Condon, Kendall J.; Petri, Sabrina; Kedir, Jibril; Scaria, Sonia M.; Abu-Remaileh, Monther; Frankel, Wayne N.; Sabatini, David M.			KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1	NATURE			English	Article							RAG GTPASES; SIGNALING PATHWAY; FOCAL EPILEPSIES; TUMOR-SUPPRESSOR; AMINO-ACIDS; COMPLEX; MUTATIONS; GENE; SZT2; ENCEPHALOPATHY	The mechanistic target of rapamycin complex 1 (mTORC1) is a central regulator of cell growth that responds to diverse environmental signals and is deregulated in many human diseases, including cancer and epilepsy(1-3). Amino acids are a key input to this system, and act through the Rag GTPases to promote the translocation of mTORC1 to the lysosomal surface, its site of activation(4). Multiple protein complexes regulate the Rag GTPases in response to amino acids, including GATOR1, a GTPase activating protein for RAGA, and GATOR2, a positive regulator of unknown molecular function. Here we identify a protein complex (KICSTOR) that is composed of four proteins, KPTN, ITFG2, C12orf66 and SZT2, and that is required for amino acid or glucose deprivation to inhibit mTORC1 in cultured human cells. In mice that lack SZT2, mTORC1 signalling is increased in several tissues, including in neurons in the brain. KICSTOR localizes to lysosomes; binds and recruits GATOR1, but not GATOR2, to the lysosomal surface; and is necessary for the interaction of GATOR1 with its substrates, the Rag GTPases, and with GATOR2. Notably, several KICSTOR components are mutated in neurological diseases associated with mutations that lead to hyperactive mTORC1 signalling(5-10). Thus, KICSTOR is a lysosome-associated negative regulator of mTORC1 signalling, which, like GATOR1, is mutated in human disease11,12.	[Wolfson, Rachel L.; Chantranupong, Lynne; Wyant, Gregory A.; Gu, Xin; Orozco, Jose M.; Shen, Kuang; Condon, Kendall J.; Kedir, Jibril; Scaria, Sonia M.; Abu-Remaileh, Monther; Sabatini, David M.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Wolfson, Rachel L.; Chantranupong, Lynne; Wyant, Gregory A.; Gu, Xin; Orozco, Jose M.; Shen, Kuang; Condon, Kendall J.; Kedir, Jibril; Scaria, Sonia M.; Abu-Remaileh, Monther; Sabatini, David M.] MIT, Dept Biol, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Wolfson, Rachel L.; Chantranupong, Lynne; Wyant, Gregory A.; Gu, Xin; Orozco, Jose M.; Shen, Kuang; Condon, Kendall J.; Kedir, Jibril; Scaria, Sonia M.; Abu-Remaileh, Monther; Sabatini, David M.] MIT, Dept Biol, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Wolfson, Rachel L.; Chantranupong, Lynne; Wyant, Gregory A.; Gu, Xin; Orozco, Jose M.; Shen, Kuang; Condon, Kendall J.; Kedir, Jibril; Scaria, Sonia M.; Abu-Remaileh, Monther; Sabatini, David M.] Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Wolfson, Rachel L.; Chantranupong, Lynne; Wyant, Gregory A.; Gu, Xin; Orozco, Jose M.; Shen, Kuang; Condon, Kendall J.; Kedir, Jibril; Scaria, Sonia M.; Abu-Remaileh, Monther; Sabatini, David M.] Broad Inst Harvard & Massachusetts Inst Technol, 7 Cambridge Ctr, Cambridge, MA 02142 USA; [Petri, Sabrina; Frankel, Wayne N.] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA; [Petri, Sabrina; Frankel, Wayne N.] Columbia Univ, Med Ctr, Inst Genom Med, New York, NY 10032 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Columbia University; Columbia University	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Sabatini, DM (corresponding author), MIT, Dept Biol, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Sabatini, DM (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Sabatini, DM (corresponding author), Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Sabatini, DM (corresponding author), Broad Inst Harvard & Massachusetts Inst Technol, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		Abu-Remaileh, Monther/0000-0003-3772-0477; /0000-0002-1446-7256; /0000-0002-9515-8892	NIH [R01 CA103866, R37 AI47389, R37 NS031348, T32 GM007753, F30 CA189333, F31 CA180271, F30 CA210373]; Department of Defense [W81XWH-07-0448]; NSF [2016197106]; National Defense Science & Engineering Graduate Fellowship (NDSEG) Program; Life Sciences Research Foundation; EMBO Long-Term Fellowship; Paul Gray UROP Fund [3143900]; NATIONAL CANCER INSTITUTE [F30CA210373, F31CA180271, F30CA189333, R01CA103866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031348] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NSF(National Science Foundation (NSF)); National Defense Science & Engineering Graduate Fellowship (NDSEG) Program; Life Sciences Research Foundation; EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Paul Gray UROP Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all members of the Sabatini Laboratory for helpful insights. We thank K. McKinley and I. Cheeseman for providing the retroviral GFP constructs used in this work, C. Mahaffey for technical support with the mouse experiments and J. Xie from Cell Signaling Technology Inc. for providing the DEPDC5, MIOS, NPRL2, WDR24, WDR59, C12orf66, SEH1L and SZT2 antibodies. This work was supported by grants from the NIH to D.M.S. (R01 CA103866 and R37 AI47389) and W.N.F. (R37 NS031348), Department of Defense (W81XWH-07-0448) to D.M.S. and fellowship support from the NIH to R.L.W. (T32 GM007753 and F30 CA189333), L.C. (F31 CA180271) and J.M.O. (T32 GM007753 and F30 CA210373), from NSF to K. J. C. (2016197106), from the National Defense Science & Engineering Graduate Fellowship (NDSEG) Program to G.A.W., from the Life Sciences Research Foundation to K.S. (Pfizer fellow), from the EMBO Long-Term Fellowship to M.A.-R. and from the Paul Gray UROP Fund to S.M.S. (3143900). D.M.S. is an investigator of the Howard Hughes Medical Institute.	Baldassari S, 2016, J MED GENET, V53, P503, DOI 10.1136/jmedgenet-2016-103883; Baple EL, 2014, AM J HUM GENET, V94, P87, DOI 10.1016/j.ajhg.2013.10.001; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Basel-Vanagaite L, 2013, AM J HUM GENET, V93, P524, DOI 10.1016/j.ajhg.2013.07.005; Baulac S, 2016, PROG BRAIN RES, V226, P61, DOI 10.1016/bs.pbr.2016.04.013; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Cai WL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006036; Crino PB, 2011, TRENDS MOL MED, V17, P734, DOI 10.1016/j.molmed.2011.07.008; D'Gama AM, 2015, ANN NEUROL, V77, P720, DOI 10.1002/ana.24357; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Frankel WN, 2009, GENES BRAIN BEHAV, V8, P568, DOI 10.1111/j.1601-183X.2009.00509.x; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Mc Cormack A, 2015, CASE REP GENET, V2015; Pajusalu S, 2015, AM J MED GENET A, V167, P1913, DOI 10.1002/ajmg.a.37105; Petit CS, 2013, J CELL BIOL, V202, P1107, DOI 10.1083/jcb.201307084; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Venkatesan C, 2016, EPILEPTIC DISORD, V18, P195, DOI 10.1684/epd.2016.0828; Wei Y, 2014, CELL DEATH DIFFER, V21, P1460, DOI 10.1038/cdd.2014.63; Wei YH, 2014, P NATL ACAD SCI USA, V111, pE5670, DOI 10.1073/pnas.1419156112; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	28	156	171	3	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					438	+		10.1038/nature21423	http://dx.doi.org/10.1038/nature21423			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28199306	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000396337400054
J	Zhai, Y; Ma, YG; David, SN; Zhao, DL; Lou, RN; Tan, G; Yang, RG; Yin, XB				Zhai, Yao; Ma, Yaoguang; David, Sabrina N.; Zhao, Dongliang; Lou, Runnan; Tan, Gang; Yang, Ronggui; Yin, Xiaobo			Scalable-manufactured randomized glass-polymer hybrid metamaterial for daytime radiative cooling	SCIENCE			English	Article							OPTICS; FILMS	Passive radiative cooling draws heat from surfaces and radiates it into space as infrared radiation to which the atmosphere is transparent. However, the energy density mismatch between solar irradiance and the low infrared radiation flux from a near-ambient-temperature surface requires materials that strongly emit thermal energy and barely absorb sunlight. We embedded resonant polar dielectric microspheres randomly in a polymeric matrix, resulting in a metamaterial that is fully transparent to the solar spectrum while having an infrared emissivity greater than 0.93 across the atmospheric window. When backed with a silver coating, the metamaterial shows a noontime radiative cooling power of 93 watts per square meter under direct sunshine. More critically, we demonstrated high-throughput, economical roll-to-roll manufacturing of the metamaterial, which is vital for promoting radiative cooling as a viable energy technology.	[Zhai, Yao; Ma, Yaoguang; Zhao, Dongliang; Yang, Ronggui; Yin, Xiaobo] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA; [David, Sabrina N.; Yin, Xiaobo] Univ Colorado, Mat Sci & Engn Program, Boulder, CO 80309 USA; [Lou, Runnan] Univ Colorado, Dept Aerosp Engn Sci, Boulder, CO 80309 USA; [Tan, Gang] Univ Wyoming, Dept Civil & Architectural Engn, Laramie, WY 82071 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Wyoming	Yang, RG; Yin, XB (corresponding author), Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.; Yin, XB (corresponding author), Univ Colorado, Mat Sci & Engn Program, Boulder, CO 80309 USA.	ronggui.yang@colorado.edu; xiaobo.yin@colorado.edu	Ma, Yaoguang/K-9357-2013; Zhai, Yao/ABD-2696-2020; Yang, Ronggui/H-1278-2011; Yin, Xiaobo/A-4142-2011; Zhai, Yao/A-4682-2019; Zhao, Dongliang/H-3828-2015	Ma, Yaoguang/0000-0002-8091-611X; Zhai, Yao/0000-0002-0224-0492; Yang, Ronggui/0000-0002-3602-6945; Zhai, Yao/0000-0002-0224-0492; Zhao, Dongliang/0000-0001-8998-9465	U.S. Department of Energy's Advanced Research Projects Agency-Energy (ARPA-E) grant [DE-AR0000580]; Defense Advanced Research Projects Agency (DARPA) [D15AP00106]; Soft Materials Research Center under NSF Materials Research Science and Engineering Center [DMR-1420736]	U.S. Department of Energy's Advanced Research Projects Agency-Energy (ARPA-E) grant; Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Soft Materials Research Center under NSF Materials Research Science and Engineering Center	This research was supported by the U.S. Department of Energy's Advanced Research Projects Agency-Energy (ARPA-E) grant DE-AR0000580. X.Y. also thanks the Defense Advanced Research Projects Agency (DARPA) for the support in Young Faculty Award grant D15AP00106, which enabled the modeling of randomized optical materials, and a seed grant from the Soft Materials Research Center under NSF Materials Research Science and Engineering Center grant DMR-1420736. We have filed a provisional patent application (U.S. Full Patent Application 15/056680) on the work described here. Data are available in the manuscript and supplementary materials.	Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Balin I, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3098360; CATALANOTTI S, 1975, SOL ENERGY, V17, P83, DOI 10.1016/0038-092X(75)90062-6; Gansel JK, 2009, SCIENCE, V325, P1513, DOI 10.1126/science.1177031; Gentle AR, 2015, ADV SCI, V2, DOI 10.1002/advs.201500119; GRANQVIST CG, 1981, J APPL PHYS, V52, P4205, DOI 10.1063/1.329270; Gresillon S, 1999, PHYS REV LETT, V82, P4520, DOI 10.1103/PhysRevLett.82.4520; Hao JP, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4894181; Hart SD, 2002, SCIENCE, V296, P510, DOI 10.1126/science.1070050; Hossain MM, 2016, ADV SCI, V3, DOI 10.1002/advs.201500360; Jung P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4730; Katsidis CC, 2002, APPL OPTICS, V41, P3978, DOI 10.1364/AO.41.003978; Li LF, 1996, J OPT SOC AM A, V13, P1870, DOI 10.1364/JOSAA.13.001870; Liu W, 2014, OPT EXPRESS, V22, P16178, DOI 10.1364/OE.22.016178; Ocelic N, 2004, NAT MATER, V3, P606, DOI 10.1038/nmat1194; OREL B, 1993, SOL ENERGY, V50, P477, DOI 10.1016/0038-092X(93)90108-Z; Palik E D, 1985, HDB OPTICAL CONSTANT; Price H, 2002, J SOL ENERG-T ASME, V124, P109, DOI 10.1115/1.1467922; Raman AP, 2014, NATURE, V515, P540, DOI 10.1038/nature13883; Rasberry RD, 2011, J MATER CHEM, V21, P13902, DOI 10.1039/c1jm12761f; Rephaeli E, 2013, NANO LETT, V13, P1457, DOI 10.1021/nl4004283; Sapienza L, 2010, SCIENCE, V327, P1352, DOI 10.1126/science.1185080; Segev M, 2013, NAT PHOTONICS, V7, P197, DOI [10.1038/NPHOTON.2013.30, 10.1038/nphoton.2013.30]; Seo BJ, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2196871; Shen XP, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4757879; Tureci HE, 2008, SCIENCE, V320, P643, DOI 10.1126/science.1155311; Weber MF, 2000, SCIENCE, V287, P2451, DOI 10.1126/science.287.5462.2451; Wheeler MS, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.073103; Wiersma DS, 2008, NAT PHYS, V4, P359, DOI 10.1038/nphys971; Xu XH, 2016, RENEW SUST ENERG REV, V53, P1106, DOI 10.1016/j.rser.2015.09.015; YABLONOVITCH E, 1982, J OPT SOC AM, V72, P899, DOI 10.1364/JOSA.72.000899; Yates H. W., 1960, NRL5453; Zhao Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1877	33	935	973	191	1428	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI					10.1126/science.aai7899	http://dx.doi.org/10.1126/science.aai7899			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VY	28183998				2022-12-28	WOS:000396348900041
J	Shanafelt, TD; Dyrbye, LN; West, CP				Shanafelt, Tait D.; Dyrbye, Lotte N.; West, Colin P.			Addressing Physician Burnout The Way Forward	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WORK-LIFE BALANCE; SATISFACTION; POPULATION		[Shanafelt, Tait D.; Dyrbye, Lotte N.; West, Colin P.] Mayo Clin, 200 First St, Rochester, MN 55902 USA	Mayo Clinic	Shanafelt, TD (corresponding author), Mayo Clin, 200 First St, Rochester, MN 55902 USA.	shanafelt.tait@mayo.edu			Mayo Clinic Department of Medicine Program on Physician Well-being	Mayo Clinic Department of Medicine Program on Physician Well-being	Funding was provided by the Mayo Clinic Department of Medicine Program on Physician Well-being.	Bodenheimer T, 2014, ANN FAM MED, V12, P573, DOI 10.1370/afm.1713; Shanafelt TD, 2017, MAYO CLIN PROC, V92, P129, DOI 10.1016/j.mayocp.2016.10.004; Shanafelt TD, 2016, MAYO CLIN PROC, V91, P422, DOI 10.1016/j.mayocp.2016.02.001; Shanafelt TD, 2015, MAYO CLIN PROC, V90, P1600, DOI 10.1016/j.mayocp.2015.08.023; Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199; Sinsky C, 2016, ANN INTERN MED, V165, P753, DOI 10.7326/M16-0961; Wallace JE, 2009, LANCET, V374, P1714, DOI 10.1016/S0140-6736(09)61424-0; West CP, 2016, LANCET, V388, P2272, DOI 10.1016/S0140-6736(16)31279-X	8	233	236	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2017	317	9					901	902		10.1001/jama.2017.0076	http://dx.doi.org/10.1001/jama.2017.0076			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM8DM	28196201				2022-12-28	WOS:000395541500005
J	Israel, GL; Belfiore, A; Stella, L; Esposito, P; Casella, P; De Luca, A; Marelli, M; Papitto, A; Perri, M; Puccetti, S; Castillo, GAR; Salvetti, D; Tiengo, A; Zampieri, L; D'Agostino, D; Greiner, J; Haberl, F; Novara, G; Salvaterra, R; Turolla, R; Watson, M; Wilms, J; Wolter, A				Israel, Gian Luca; Belfiore, Andrea; Stella, Luigi; Esposito, Paolo; Casella, Piergiorgio; De Luca, Andrea; Marelli, Martino; Papitto, Alessandro; Perri, Matteo; Puccetti, Simonetta; Rodriguez Castillo, Guillermo A.; Salvetti, David; Tiengo, Andrea; Zampieri, Luca; D'Agostino, Daniele; Greiner, Jochen; Haberl, Frank; Novara, Giovanni; Salvaterra, Ruben; Turolla, Roberto; Watson, Mike; Wilms, Joern; Wolter, Anna			An accreting pulsar with extreme properties drives an ultraluminous x-ray source in NGC 5907	SCIENCE			English	Article							MAGNETIZED NEUTRON-STARS; PHOTON IMAGING CAMERA; XMM-NEWTON; NUSTAR; MASS	Ultraluminous x-ray sources (ULXs) in nearby galaxies shine brighter than any x-ray source in our Galaxy. ULXs are usually modeled as stellar-mass black holes (BHs) accreting at very high rates or intermediate-mass BHs. We present observations showing that NGC 5907 ULX is instead an x-ray accreting neutron star (NS) with a spin period evolving from 1.43 seconds in 2003 to 1.13 seconds in 2014. It has an isotropic peak luminosity of similar to 1000 times the Eddington limit for a NS at 17.1 megaparsec. Standard accretion models fail to explain its luminosity, even assuming beamed emission, but a strong multipolar magnetic field can describe its properties. These findings suggest that other extreme ULXs (x-ray luminosity >= 1041 erg second(-1)) might harbor NSs.	[Israel, Gian Luca; Stella, Luigi; Casella, Piergiorgio; Papitto, Alessandro; Perri, Matteo; Puccetti, Simonetta; Rodriguez Castillo, Guillermo A.] Ist Nazl Astrofis INAF, Osservatorio Astron Roma, I-00078 Monte Porzio Catone, Italy; [Belfiore, Andrea; Esposito, Paolo; De Luca, Andrea; Marelli, Martino; Salvetti, David; Tiengo, Andrea; Novara, Giovanni; Salvaterra, Ruben] INAF, Ist Astrofis Spaziale & Fis Cosm, I-20133 Milan, Italy; [Esposito, Paolo] Univ Amsterdam, Anton Pannekoek Inst Astron, NL-1090 GE Amsterdam, Netherlands; [De Luca, Andrea; Tiengo, Andrea] Ist Nazl Fis Nucl, Sez Pavia, I-27100 Pavia, Italy; [Perri, Matteo; Puccetti, Simonetta] Agenzia Spaziale Italiana Sci Data Ctr, I-00133 Rome, Italy; [Tiengo, Andrea; Novara, Giovanni] Scuola Univ Super IUSS Pavia, I-27100 Pavia, Italy; [Zampieri, Luca] INAF, Osservatorio Astron Padova, I-35122 Padua, Italy; [D'Agostino, Daniele] CNR, Ist Matemat Appl & Tecnol Informat E Magenes, I-16149 Genoa, Italy; [Greiner, Jochen; Haberl, Frank] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Turolla, Roberto] Univ Padua, Dipartimento Fis & Astron, I-35131 Padua, Italy; [Watson, Mike] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Wilms, Joern] Dr Karl Remeis Sternwarte & Erlangen Ctr Astropar, D-96049 Bamberg, Germany; [Wolter, Anna] INAF, Osservatorio Astron Brera, I-20121 Milan, Italy	Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); University of Amsterdam; Istituto Nazionale di Fisica Nucleare (INFN); Agenzia Spaziale Italiana (ASI); IUSS PAVIA; Istituto Nazionale Astrofisica (INAF); University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Matematica Applicata e Tecnologie Informatiche "Enrico Magenes" (IMATI-CNR); Max Planck Society; University of Padua; University of Leicester; University of Erlangen Nuremberg; Istituto Nazionale Astrofisica (INAF)	Israel, GL (corresponding author), Ist Nazl Astrofis INAF, Osservatorio Astron Roma, Via Frascati 33, I-00078 Monte Porzio Catone, Italy.	gianluca@oa-roma.inaf.it	D'Agostino, Daniele/B-8309-2015; Wilms, Joern/C-8116-2013; Esposito, Paolo/Q-2639-2019; Esposito, Paolo/ABE-6389-2020	D'Agostino, Daniele/0000-0003-2649-0071; Wilms, Joern/0000-0003-2065-5410; Esposito, Paolo/0000-0003-4849-5092; Esposito, Paolo/0000-0003-4849-5092; TUROLLA, ROBERTO/0000-0002-5825-8149; De Luca, Andrea/0000-0001-6739-687X; Puccetti, Simonetta/0000-0002-2734-7835; Salvaterra, Ruben/0000-0002-9393-8078; belfiore, andrea/0000-0002-2526-1309; Papitto, Alessandro/0000-0001-6289-7413; Wolter, Anna/0000-0001-5840-9835; Zampieri, Luca/0000-0002-6516-1329; Stella, Luigi/0000-0002-0018-1687; Haberl, Frank/0000-0002-0107-5237; Israel, GianLuca/0000-0001-5480-6438; Rodriguez Castillo, Guillermo Andres/0000-0003-3952-7291; Greiner, Jochen/0000-0002-9875-426X; Perri, Matteo/0000-0003-3613-4409; Casella, Piergiorgio/0000-0002-0752-3301; Marelli, Martino/0000-0002-8017-0338	European Union's (EU) Seventh Framework Programme [607452]; ESA member states; NASA; ASI-INAF [NuSTAR I/037/12/0]; Netherlands Organization for Scientific Research (NWO) Vidi award [A.2320.0076]; EU's Horizon Framework Programme for Research and Innovation under the Marie Sklodowska-Curie grant [660657-TMSP-H2020-MSCA-IF-2014]; UK Space Agency [ST/J004669/1] Funding Source: researchfish	European Union's (EU) Seventh Framework Programme; ESA member states(European Space Agency); NASA(National Aeronautics & Space Administration (NASA)); ASI-INAF(Istituto Nazionale Astrofisica (INAF)Agenzia Spaziale Italiana (ASI)); Netherlands Organization for Scientific Research (NWO) Vidi award(Netherlands Organization for Scientific Research (NWO)); EU's Horizon Framework Programme for Research and Innovation under the Marie Sklodowska-Curie grant; UK Space Agency	EXTraS is funded by the European Union's (EU) Seventh Framework Programme under grant agreement no. 607452. This research is based on observations obtained with XMM-Newton, a European Space Agency (ESA) science mission with instruments and contributions directly funded by ESA member states and NASA. This work also made use of data from NuSTAR, a mission led by the California Institute of Technology, managed by the Jet Propulsion Laboratory, and funded by NASA; and from Swift, which is a NASA mission with participation of the Italian Space Agency and the UK Space Agency. G.L.I., P.C., L.Z., and A.W. acknowledge funding from the ASI-INAF contract NuSTAR I/037/12/0. P.E. acknowledges funding from the Netherlands Organization for Scientific Research (NWO) Vidi award A.2320.0076. A.P. acknowledges funding from the EU's Horizon 2020 Framework Programme for Research and Innovation under the Marie Sklodowska-Curie grant agreement 660657-TMSP-H2020-MSCA-IF-2014. G.L.I. is grateful to T. Tauris for useful comments on an earlier version of the manuscript; P.E. thanks A. Mushtukov for interesting discussions. The EXTraS project acknowledges INAF's Astronomical Observatory of Catania and Astronomical Observatory of Trieste for the use of computing facilities. The data presented here can be found in the supplementary materials; raw x-ray observations can be retrieved through the ESA-XMM-Newton archive interface (www.cosmos.esa.int/web/xmm-newton/xsa) and the NASA archive interfaces for Chandra (http://cda.harvard.edu/chaser/) and Swift (http://heasarc.gsfc.nasa.gov/cgi-bin/W3Browse/swift.pl); see table S1 for the identification number of the observations.	Bachetti M, 2014, NATURE, V514, P202, DOI 10.1038/nature13791; Dall'Osso S, 2015, MON NOT R ASTRON SOC, V449, P2144, DOI 10.1093/mnras/stv170; De Luca A, 2016, ASTROPHYSICS SPACE, V42, P291, DOI 10.1007/978-3-319-19330-4_46; Doroshenko V, 2015, ASTRON ASTROPHYS, V579, DOI 10.1051/0004-6361/201425225; Fabbiano G, 2006, ANNU REV ASTRON ASTR, V44, P323, DOI 10.1146/annurev.astro.44.051905.092519; Fragos T, 2015, ASTROPHYS J LETT, V802, DOI 10.1088/2041-8205/802/1/L5; Furst F, 2016, ASTROPHYS J LETT, V831, DOI 10.3847/2041-8205/831/2/L14; ILLARIONOV AF, 1975, ASTRON ASTROPHYS, V39, P185; Israel GL, 2017, MON NOT R ASTRON SOC, V466, pL48, DOI 10.1093/mnrasl/slw218; Israel GL, 1996, ASTROPHYS J, V468, P369, DOI 10.1086/177697; Lipunov V. M., 1982, Soviet Astronomy, V26, P54; Motch C, 2014, NATURE, V514, P198, DOI 10.1038/nature13730; Mushtukov AA, 2015, MON NOT R ASTRON SOC, V454, P2539, DOI 10.1093/mnras/stv2087; Poutanen J, 2007, MON NOT R ASTRON SOC, V377, P1187, DOI 10.1111/j.1365-2966.2007.11668.x; STELLA L, 1986, ASTROPHYS J, V308, P669, DOI 10.1086/164538; Struder L, 2001, ASTRON ASTROPHYS, V365, pL18, DOI 10.1051/0004-6361:20000066; Sutton AD, 2013, MON NOT R ASTRON SOC, V434, P1702, DOI 10.1093/mnras/stt1133; Sutton AD, 2012, MON NOT R ASTRON SOC, V423, P1154, DOI 10.1111/j.1365-2966.2012.20944.x; THOMPSON C, 1995, MON NOT R ASTRON SOC, V275, P255, DOI 10.1093/mnras/275.2.255; Tiengo A, 2013, NATURE, V500, P312, DOI 10.1038/nature12386; Turner MJL, 2001, ASTRON ASTROPHYS, V365, pL27, DOI 10.1051/0004-6361:20000087; Walton DJ, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/2/122	25	268	270	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					817	819		10.1126/science.aai8635	http://dx.doi.org/10.1126/science.aai8635			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28219970	Green Submitted			2022-12-28	WOS:000395127600036
J	Mogil, JS; Macleod, MR				Mogil, Jeffrey S.; Macleod, Malcolm R.			No publication without confirmation	NATURE			English	Editorial Material									[Mogil, Jeffrey S.] McGill Univ, Montreal, PQ, Canada; [Macleod, Malcolm R.] Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland	McGill University; University of Edinburgh	Mogil, JS (corresponding author), McGill Univ, Montreal, PQ, Canada.	jeffrey.mogil@mcgill.ca; malcolm.macleod@ed.ac.uk	Macleod, Malcolm Robert/B-2052-2010; Mogil, Jeffrey/AAA-9611-2019	Macleod, Malcolm Robert/0000-0001-9187-9839; Mogil, Jeffrey/0000-0003-1359-5720	National Centre for the Replacement, Refinement and Reduction of Animals in Research [NC/L000970/1] Funding Source: Medline; National Centre for the Replacement [NC/L000970/1] Funding Source: researchfish	National Centre for the Replacement, Refinement and Reduction of Animals in Research(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); National Centre for the Replacement		Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cramond F, 2016, SCIENTOMETRICS, V108, P315, DOI 10.1007/s11192-016-1964-8; Head ML, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002106; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kimmelman J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001863; Macleod MR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002273; Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a	7	44	45	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2017	542	7642					409	411		10.1038/542409a	http://dx.doi.org/10.1038/542409a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM1RG	28230138	Bronze			2022-12-28	WOS:000395094100013
J	Gulland, A				Gulland, Anne			BRIEFING Handing NHS data to the Home Office	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Daynes L, 2017, GUARDIAN; Hacker K, 2015, RISK MANAG HEALTHC P, V8, P175, DOI 10.2147/RMHP.S70173; Home Office Department of Health NHS Digital, 2017, MEM UND HLTH SOC CAR; Kalengayi FKN, 2012, J IMMIGR MINOR HEALT, V14, P39, DOI 10.1007/s10903-011-9509-y; NHS Digital, REG APPR DAT REL; Oxford E, 2017, HLTH SERVICE J	6	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2017	356								j911	10.1136/bmj.j911	http://dx.doi.org/10.1136/bmj.j911			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KV	28228374				2022-12-28	WOS:000395631300005
J	Green, A				Green, Andrew			New era for health in The Gambia?	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 18	2017	389	10070					684	684		10.1016/S0140-6736(17)30395-1	http://dx.doi.org/10.1016/S0140-6736(17)30395-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9KK	28229865				2022-12-28	WOS:000394938900011
J	Horton, R				Horton, Richard			Offline: Turning fear into resistance	LANCET			English	Editorial Material												richard.horton@lancet.com							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 18	2017	389	10070					683	683		10.1016/S0140-6736(17)30399-9	http://dx.doi.org/10.1016/S0140-6736(17)30399-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9KK	28229864	Bronze			2022-12-28	WOS:000394938900010
J	Jewell, JA; Hillier, S				Jewell, J. A.; Hillier, Sheila			Kan-Wen Ma OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		MA KW, PUBLICATION LIST, P99767	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2017	356								j810	10.1136/bmj.j810	http://dx.doi.org/10.1136/bmj.j810			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GP	28213350				2022-12-28	WOS:000394580000007
J	Melentijevic, I; Toth, ML; Arnold, ML; Guasp, RJ; Harinath, G; Nguyen, KC; Taub, D; Parker, JA; Neri, C; Gabel, CV; Hall, DH; Driscoll, M				Melentijevic, Ilija; Toth, Marton L.; Arnold, Meghan L.; Guasp, Ryan J.; Harinath, Girish; Nguyen, Ken C.; Taub, Daniel; Parker, J. Alex; Neri, Christian; Gabel, Christopher V.; Hall, David H.; Driscoll, Monica			C-elegans neurons jettison protein aggregates and mitochondria under neurotoxic stress	NATURE			English	Article							TUNNELING NANOTUBES; TRANSMISSION; EXPRESSION; EXOSOMES; MUTANT; CELLS; CED-1; GENE; RNAI	The toxicity of misfolded proteins and mitochondrial dysfunction are pivotal factors that promote age-associated functional neuronal decline and neurodegenerative disease(1,2). Accordingly, neurons invest considerable cellular resources in chaperones, protein degradation, autophagy and mitophagy to maintain proteostasis and mitochondrial quality(3,4). Complicating the challenges of neuroprotection, misfolded human disease proteins and mitochondria can move into neighbouring cells via unknown mechanisms, which may promote pathological spread(5,6). Here we show that adult neurons from Caenorhabditis elegans extrude large (approximately 4 mu m) membrane-surrounded vesicles called exophers that can contain protein aggregates and organelles. Inhibition of chaperone expression, autophagy or the proteasome, in addition to compromising mitochondrial quality, enhances the production of exophers. Proteotoxically stressed neurons that generate exophers subsequently function better than similarly stressed neurons that did not produce exophers. The extruded exopher transits through surrounding tissue in which some contents appear degraded, but some non-degradable materials can subsequently be found in more remote cells, suggesting secondary release. Our observations suggest that exopher-genesis is a potential response to rid cells of neurotoxic components when proteostasis and organelle function are challenged. We propose that exophers are components of a conserved mechanism that constitutes a fundamental, but formerly unrecognized, branch of neuronal proteostasis and mitochondrial quality control, which, when dysfunctional or diminished with age, might actively contribute to pathogenesis in human neurodegenerative disease and brain ageing.	[Melentijevic, Ilija; Toth, Marton L.; Arnold, Meghan L.; Guasp, Ryan J.; Harinath, Girish; Driscoll, Monica] Rutgers State Univ, Nelson Biol Labs, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Nguyen, Ken C.; Hall, David H.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Taub, Daniel; Gabel, Christopher V.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Taub, Daniel; Gabel, Christopher V.] Boston Univ, Photon Ctr, Boston, MA 02215 USA; [Parker, J. Alex] Univ Montreal, CRCHUM, Dept Neurosci, Montreal, PQ H2X 0A9, Canada; [Neri, Christian] CNRS, UMR 8256, Brain Team C, Paris, France; [Neri, Christian] Univ Pierre & Marie Curie UPMC Univ Paris 06, Sorbonnes Univ, Paris, France	Rutgers State University New Brunswick; Yeshiva University; Albert Einstein College of Medicine; Boston University; Boston University; Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Driscoll, M (corresponding author), Rutgers State Univ, Nelson Biol Labs, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.	driscoll@dls.rutgers.edu	Parker, Alex/F-4953-2014; Neri, Christian/F-6729-2013	Parker, Alex/0000-0002-3333-2445; Neri, Christian/0000-0002-3790-2978; Gabel, Christopher/0000-0002-2763-3938; Taub, Daniel/0000-0003-0363-6031	National Institutes of Health [1R01NS086064, 1R01AG046358]; National Institute of General Medical Sciences [T32 GM008339]; NIH [0010943]; Core EM facilities; NICHD [P30 HD71593]; NIH Office of Research Infrastructure Programs [P40 00010440]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD071593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046358, R01AG047101] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010943, P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core EM facilities; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Grant for expert advice, C. Reina for time-lapse microscopy help; N. Kane and J. Kramer for confocal microscopy assistance; and H. Ushakov for construction of some genetic lines. We thank G. Perumal and F. Macaluso for help with HPF fixations, and C. Crocker for the cartoon in Extended Data Fig. 2b. F. Sesti and M. Hilliard supplied C. elegans strains; A. Mendenhall, B. Sands and R. Brent constructed the MOSCI mitoTimer strain. Research was supported by the National Institutes of Health under award numbers 1R01NS086064 and 1R01AG046358. I.M. and R.J.G. were supported by the National Institute of General Medical Sciences under award number T32 GM008339. K.C.N. and D.H.H. were supported by NIH 0010943 (to D.H.H.); Core EM facilities (D.H.H.) NICHD P30 HD71593 for the RFK-IDDRC at Albert Einstein College of Medicine. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 00010440). Content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abounit S, 2012, J CELL SCI, V125, P1089, DOI 10.1242/jcs.083279; Ben-Gedalya T, 2012, TRAFFIC, V13, P635, DOI 10.1111/j.1600-0854.2012.01330.x; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; BRENNER S, 1974, GENETICS, V77, P71; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Cannon Mark B., 2008, V476, P51, DOI 10.1007/978-1-59745-129-1_4; Cocucci E, 2015, TRENDS CELL BIOL, V25, P364, DOI 10.1016/j.tcb.2015.01.004; Costanzo M, 2013, J CELL SCI, V126, P3678, DOI 10.1242/jcs.126086; Craig AL, 2012, METHOD CELL BIOL, V107, P321, DOI 10.1016/B978-0-12-394620-1.00011-4; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; Duan Z., 2013, JOVE-J VIS EXP, V75, P50435; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Gabel CV, 2008, DEVELOPMENT, V135, P1129, DOI 10.1242/dev.013995; Ghose P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004063; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Hong Y, 1998, DEVELOPMENT, V125, P3585; Ji YB, 2011, EXP TOXICOL PATHOL, V63, P69, DOI 10.1016/j.etp.2009.09.010; Kachur TM, 2008, DEV BIOL, V314, P287, DOI 10.1016/j.ydbio.2007.11.028; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kastelowitz N, 2014, CHEMBIOCHEM, V15, P923, DOI 10.1002/cbic.201400043; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Labbadia John, 2014, F1000Prime Rep, V6, P7, DOI 10.12703/P6-7; Labbadia J, 2015, MOL CELL, V59, P639, DOI 10.1016/j.molcel.2015.06.027; Laker RC, 2014, J BIOL CHEM, V289, P12005, DOI 10.1074/jbc.M113.530527; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Liu G, 2011, EMBO J, V30, P2990, DOI 10.1038/emboj.2011.195; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Ma L, 2015, CELL RES, V25, P24, DOI 10.1038/cr.2014.135; Mapes J, 2012, CURR BIOL, V22, P1267, DOI 10.1016/j.cub.2012.05.052; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nath S, 2012, J NEUROSCI, V32, P8767, DOI 10.1523/JNEUROSCI.0615-12.2012; Neumann B, 2015, NATURE, V517, P219, DOI 10.1038/nature14102; Nussbaum-Krammer CI, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003351; Parker JA, 2001, P NATL ACAD SCI USA, V98, P13318, DOI 10.1073/pnas.231476398; Pasquier J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-94; Patton A, 2005, CURR BIOL, V15, P1045, DOI 10.1016/j.cub.2005.04.057; Pearce MMP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7768; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Sarmann J, 2009, J BIOL CHEM, V284, P16482, DOI 10.1074/jbc.M808255200; Scerbak C, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00212; Springer W, 2005, HUM MOL GENET, V14, P3407, DOI 10.1093/hmg/ddi371; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Topalidou I, 2012, CURR BIOL, V22, P1057, DOI 10.1016/j.cub.2012.03.066; Toth ML, 2012, J NEUROSCI, V32, P8778, DOI 10.1523/JNEUROSCI.1494-11.2012; Vayndorf EM, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.1; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	49	165	169	5	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					367	+		10.1038/nature21362	http://dx.doi.org/10.1038/nature21362			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2LQ	28178240	Green Accepted			2022-12-28	WOS:000394451600041
J	Zhang, H; Dasbiswas, K; Ludwig, NB; Han, G; Lee, B; Vaikuntanathan, S; Talapin, DV				Zhang, Hao; Dasbiswas, Kinjal; Ludwig, Nicholas B.; Han, Gang; Lee, Byeongdu; Vaikuntanathan, Suri; Talapin, Dmitri V.			Stable colloids in molten inorganic salts	NATURE			English	Article							SURFACE; NANOCRYSTALS; SEMICONDUCTOR; NANOPARTICLES; STABILITY; HYDRATION; HALIDE; ROUTE	A colloidal solution is a homogeneous dispersion of particles or droplets of one phase (solute) in a second, typically liquid, phase (solvent). Colloids are ubiquitous in biological, chemical and technological processes(1,2), homogenizing highly dissimilar constituents. To stabilize a colloidal system against coalescence and aggregation, the surface of each solute particle is engineered to impose repulsive forces strong enough to overpower van der Waals attraction and keep the particles separated from each other(2). Electrostatic stabilization(3,4) of charged solutes works well in solvents with high dielectric constants, such as water (dielectric constant of 80). In contrast, colloidal stabilization in solvents with low polarity, such as hexane (dielectric constant of about 2), can be achieved by decorating the surface of each particle of the solute with molecules (surfactants) containing flexible, brush-like chains(2,5). Here we report a class of colloidal systems in which solute particles (including metals, semiconductors and magnetic materials) form stable colloids in various molten inorganic salts. The stability of such colloids cannot be explained by traditional electrostatic and steric mechanisms. Screening of many solute-solvent combinations shows that colloidal stability can be traced to the strength of chemical bonding at the solute-solvent interface. Theoretical analysis and molecular dynamics modelling suggest that a layer of surface-bound solvent ions produces long-ranged charge-density oscillations in the molten salt around solute particles, preventing their aggregation. Colloids composed of inorganic particles in inorganic melts offer opportunities for introducing colloidal techniques to solid-state science and engineering applications.	[Zhang, Hao; Dasbiswas, Kinjal; Ludwig, Nicholas B.; Vaikuntanathan, Suri; Talapin, Dmitri V.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Zhang, Hao; Dasbiswas, Kinjal; Ludwig, Nicholas B.; Vaikuntanathan, Suri; Talapin, Dmitri V.] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Han, Gang] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Lee, Byeongdu] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Talapin, Dmitri V.] Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA	University of Chicago; University of Chicago; University of Massachusetts System; University of Massachusetts Worcester; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Talapin, DV (corresponding author), Univ Chicago, Dept Chem, Chicago, IL 60637 USA.; Talapin, DV (corresponding author), Univ Chicago, James Franck Inst, Chicago, IL 60637 USA.; Talapin, DV (corresponding author), Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA.	dvtalapin@uchicago.edu		Dasbiswas, Kinjal/0000-0002-5741-8200; Ludwig, Nicholas/0000-0002-7345-659X	National Science Foundation (NSF) [DMR-1611371]; Air Force Office of Scientific Research (AFOSR) [FA9550-14-1-0367]; Department of Defense (DOD) Office of Naval Research [N00014-13-1-0490]; II-VI Foundation; National Institutes of Health (NIH) [R01 MH103133]; Human Frontier Science Program [RGY-0090/2014]; University of Chicago Research Computing Center; NSF MRSEC [DMR-14-20703]; Center for Nanoscale Materials and Advanced Photon Source; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH103133] Funding Source: NIH RePORTER; Division Of Materials Research [1611371] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Department of Defense (DOD) Office of Naval Research; II-VI Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); University of Chicago Research Computing Center; NSF MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Center for Nanoscale Materials and Advanced Photon Source; DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank P. Guyot-Sionnest for discussions, L. Wang for help with taking photographs, V. Srivastava for providing data on GaAs NCs in molten salts, A. Filatov for discussions and help with XPS measurements, F. Zhai and T.-Y. Zheng for help with NMR measurements, Z. Li and M.H. Hudson for providing UCNP5 and Fe<INF>3</INF>O<INF>4</INF>NCs, and T Shpigel for reading the manuscript. This work was supported by the National Science Foundation (NSF; DMR-1611371), Air Force Office of Scientific Research (AFOSR; FA9550-14-1-0367), Department of Defense (DOD) Office of Naval Research (grant number N00014-13-1-0490), and by the II-VI Foundation. G.H. acknowledges support from the National Institutes of Health (NIH; R01 MH103133) and the Human Frontier Science Program (RGY-0090/2014). N.B.L acknowledges support from the University of Chicago Research Computing Center. The work used facilities supported by the NSF MRSEC (DMR-14-20703), and resources of the Center for Nanoscale Materials and Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory (DE-AC02-06CH11357).	Amgoune A, 2011, CHEM COMMUN, V47, P859, DOI 10.1039/c0cc04109b; Andreu-Cabedo P, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-582; [Anonymous], ACTA PHYSICOCHIM USS; Boles MA, 2016, NAT MATER, V15, P141, DOI [10.1038/NMAT4526, 10.1038/nmat4526]; Chen LY, 2015, NATURE, V528, P539, DOI 10.1038/nature16445; Dong AG, 2011, J AM CHEM SOC, V133, P998, DOI 10.1021/ja108948z; Erwin SC, 2005, NATURE, V436, P91, DOI 10.1038/nature03832; Evans D, 1999, COLLOIDAL DOMAIN PHY, P1; Fafarman AT, 2011, J AM CHEM SOC, V133, P15753, DOI 10.1021/ja206303g; FANNIN AA, 1972, J ELECTROCHEM SOC, V119, P801, DOI 10.1149/1.2404344; Frenkel D., 2002, UNDERSTANDING MOL SI, P165; Gao JS, 2015, ACS NANO, V9, P3243, DOI 10.1021/acsnano.5b00354; Gebbie MA, 2015, P NATL ACAD SCI USA, V112, P7432, DOI 10.1073/pnas.1508366112; Huang J, 2014, ACS NANO, V8, P9388, DOI 10.1021/nn503458y; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; KOHN HW, 1969, SCIENCE, V163, P924, DOI 10.1126/science.163.3870.924; Kovalenko MV, 2009, SCIENCE, V324, P1417, DOI 10.1126/science.1170524; Lanning OJ, 2004, J PHYS CHEM B, V108, P11069, DOI 10.1021/jp048102p; Li CJ, 2014, AIMS ENERGY, V2, P133, DOI 10.3934/energy.2014.2.133; Limmer DT, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.256102; Mezger M, 2008, SCIENCE, V322, P424, DOI 10.1126/science.1164502; Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545; NAPPER DH, 1977, J COLLOID INTERF SCI, V58, P390, DOI 10.1016/0021-9797(77)90150-3; Ning ZJ, 2015, NATURE, V523, P324, DOI 10.1038/nature14563; Ozerinc S, 2010, MICROFLUID NANOFLUID, V8, P145, DOI 10.1007/s10404-009-0524-4; Rodriguez R, 2008, ADV MATER, V20, P4353, DOI 10.1002/adma.200801975; Rosen EL, 2012, ANGEW CHEM INT EDIT, V51, P684, DOI 10.1002/anie.201105996; Schneck E, 2012, P NATL ACAD SCI USA, V109, P14405, DOI 10.1073/pnas.1205811109; Shirts MR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2978177; Smith AM, 2016, J PHYS CHEM LETT, V7, P2157, DOI 10.1021/acs.jpclett.6b00867; Ueno K, 2008, LANGMUIR, V24, P5253, DOI 10.1021/la704066v; Verwey E. J. W., 1948, THEORY STABILITY LYO, P1; Warren SC, 2006, J AM CHEM SOC, V128, P12074, DOI 10.1021/ja064469r; Zhang H, 2014, ACS NANO, V8, P7359, DOI 10.1021/nn502470v; Zobel M, 2015, SCIENCE, V347, P292, DOI 10.1126/science.1261412	37	120	121	19	375	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					328	+		10.1038/nature21041	http://dx.doi.org/10.1038/nature21041			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2LQ	28202966				2022-12-28	WOS:000394451600032
J	Rozemeijer, K; Naber, SK; Penning, C; Overbeek, LIH; Looman, CWN; de Kok, IMCM; Matthijsse, SM; Rebolj, M; van Kemenade, FJ; van Ballegooijen, M				Rozemeijer, Kirsten; Naber, Steffie K.; Penning, Corine; Overbeek, Lucy I. H.; Looman, Caspar W. N.; de Kok, Inge M. C. M.; Matthijsse, Suzette M.; Rebolj, Matejka; van Kemenade, Folkert J.; van Ballegooijen, Marjolein			Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LIQUID-BASED CYTOLOGY; RANDOMIZED-TRIAL; SMEAR; NETHERLANDS; PREVENTION; ACCURACY; SURVIVAL; HISTORY; IMPACT	OBJECTIVE To compare the cumulative incidence of cervical cancer diagnosed within 72 months after a normal screening sample between conventional cytology and liquid based cytology tests SurePath and ThinPrep. DESIGN Retrospective population based cohort study. SETTING Nationwide network and registry of histo-and cytopathology in the Netherlands (PALGA), January 2000 to March 2013. POPULATION Women with 5 924 474 normal screening samples (23 833 123 person years). EXPOSURE Use of SurePath or ThinPrep versus conventional cytology as screening test. MAIN OUTCOME MEASURE 72 month cumulative incidence of invasive cervical cancer after a normal screening sample for each screening test. Cox regression analyses assessed the hazard ratios, adjusted for calendar time, age, screening history, and socioeconomic status and including laboratories as random effects. RESULTS The 72 month cumulative cancer incidence was 58.5 (95% confidence interval 54.6 to 62.7) per 100 000 normal conventional cytology samples, compared with 66.8 (56.7 to 78.7) for ThinPrep and 44.6 (37.8 to 52.6) for SurePath. Compared with conventional cytology, the hazard of invasive cancer was 19% lower (hazard ratio 0.81, 95% confidence interval 0.66 to 0.99) for SurePath, mainly caused by a 27% lower hazard (0.73, 0.57 to 0.93) of a clinically detected cancer. For ThinPrep, the hazard was on average 15% higher (hazard ratio 1.15, 0.95 to 1.38), mainly caused by a 56% higher hazard of a screen detected cancer (1.56, 1.17 to 2.08). CONCLUSIONS These findings should provoke reconsideration of the assumed similarity in sensitivity to detect progressive cervical intraepithelial neoplasia between different types of liquid based cytology and conventional cytology.	[Rozemeijer, Kirsten; Naber, Steffie K.; Penning, Corine; Looman, Caspar W. N.; de Kok, Inge M. C. M.; Matthijsse, Suzette M.; van Ballegooijen, Marjolein] Univ Med Ctr, Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Overbeek, Lucy I. H.] PALGA, Houten, Netherlands; [Rebolj, Matejka] Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark; [Rebolj, Matejka] Copenhagen Univ Hosp, Dept Pathol, Hvidovre, Denmark; [van Kemenade, Folkert J.] Univ Med Ctr, Erasmus MC, Dept Pathol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Copenhagen; University of Copenhagen; Erasmus University Rotterdam; Erasmus MC	Naber, SK (corresponding author), Univ Med Ctr, Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands.	s.naber@erasmusmc.nl	Overbeek, Lucy/AAH-6818-2021; Naber, Steffie/A-9758-2015	Overbeek, Lucy/0000-0002-1776-2787; Manoli, Nandini/0000-0002-6207-7797; Naber, Steffie/0000-0001-8357-1738	Dutch National Institute for Public Health and the Environment (RIVM) [007/12]	Dutch National Institute for Public Health and the Environment (RIVM)	This is an independent report commissioned and funded by the Dutch National Institute for Public Health and the Environment (RIVM, 007/12 V&Z NvdV/EM). The funding source (a non-profit organisation) had no involvement in the study design, data collection, data analysis, interpretation of the data, writing of the report, or the decision to submit the paper for publication.	Albrow R, 2012, CANCER CYTOPATHOL, V120, P87, DOI 10.1002/cncy.20203; [Anonymous], 2016, MORT WHAT IS CURR SI; [Anonymous], 2016, MIGR WHAT IS CURR SI; Arbyn M, 2008, OBSTET GYNECOL, V111, P167, DOI 10.1097/01.AOG.0000296488.85807.b3; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Beerman H, 2009, GYNECOL ONCOL, V112, P572, DOI 10.1016/j.ygyno.2008.12.012; Bigras Gilbert, 2003, J Low Genit Tract Dis, V7, P168, DOI 10.1097/00128360-200307000-00003; Blok M., 2013, DESCRIPTION PALEBA S; Casparie M, 2007, CELL ONCOL, V29, P19; Colgan TJ, 2004, CANCER CYTOPATHOL, V102, P362, DOI 10.1002/cncr.20656; Coste J, 2003, BMJ-BRIT MED J, V326, P733, DOI 10.1136/bmj.326.7392.733; Cox JT, 2009, J CLIN VIROL, V45, pS3, DOI 10.1016/S1386-6532(09)70002-2; Dutch Society for Pathology, 2012, SOC PATHOL; Ferenczy A, 1996, ACTA CYTOL, V40, P1136; Fontaine D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000847; Fremont-Smith M, 2004, CANCER CYTOPATHOL, V102, P269, DOI 10.1002/cncr.20599; Froment MA, 2014, GYNECOL ONCOL, V133, P409, DOI 10.1016/j.ygyno.2014.03.559; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Hussein T, 2005, BJOG-INT J OBSTET GY, V112, P1542, DOI 10.1111/j.1471-0528.2005.00699.x; Jensen KE, 2008, EUR J CANCER, V44, P2003, DOI 10.1016/j.ejca.2008.06.014; Kitchener HC, 2011, LANCET ONCOL, V12, P56, DOI 10.1016/S1470-2045(10)70264-3; Klug SJ, 2013, INT J CANCER, V132, P2849, DOI 10.1002/ijc.27955; Palmer TJ, 2013, CYTOPATHOLOGY, V24, P235, DOI 10.1111/j.1365-2303.2012.00982.x; Public Health England, 2009, CERV SCREEN POCK GUI; Rask J, 2014, INT J CANCER, V134, P2168, DOI 10.1002/ijc.28532; Rebolj M., 2008, RECENT DEV DUTCH CER; Rebolj M, 2008, INT J CANCER, V123, P2632, DOI 10.1002/ijc.23803; Rebolj M, 2015, BRIT J CANCER, V113, P1259, DOI 10.1038/bjc.2015.339; Ronco G, 2007, BRIT MED J, V335, P28, DOI 10.1136/bmj.39196.740995.BE; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Rozemeijer K, 2016, CANCER CAUSE CONTROL, V27, P15, DOI 10.1007/s10552-015-0678-1; Rozemeijer K, 2015, J MED SCREEN, V22, P144, DOI 10.1177/0969141315580836; Siebers AG, 2009, JAMA-J AM MED ASSOC, V302, P1757, DOI 10.1001/jama.2009.1569; Siebers AG, 2008, OBSTET GYNECOL, V112, P1327, DOI 10.1097/AOG.0b013e31818c2b20; Sigurdsson K, 2013, CYTOPATHOLOGY, V24, P254, DOI 10.1111/cyt.12037; Sykes PH, 2008, BJOG-INT J OBSTET GY, V115, P1375, DOI 10.1111/j.1471-0528.2008.01865.x; Taylor S, 2006, INT J CANCER, V118, P957, DOI 10.1002/ijc.21434; The Netherlands Institute for Social Research, 1998, HIGH LOW LOW HIGH SO; Thiryayi SA, 2010, CYTOPATHOLOGY, V21, P223, DOI 10.1111/j.1365-2303.2009.00695.x; Umana A, 2013, CYTOPATHOLOGY, V24, P228, DOI 10.1111/cyt.12029; van der Aa MA, 2008, EUR J OBSTET GYN R B, V139, P204, DOI 10.1016/j.ejogrb.2007.10.017; Vesco KK, 2011, ANN INTERN MED, V155, P698, DOI 10.7326/0003-4819-155-10-201111150-00377; Whitlock EP, 2011, ANN INTERN MED, V155, P687, DOI 10.7326/0003-4819-155-10-201111150-00376; Zhao FH, 2011, CANCER CYTOPATHOL, V119, P387, DOI 10.1002/cncy.20177	44	14	16	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2017	356								j504	10.1136/bmj.j504	http://dx.doi.org/10.1136/bmj.j504			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GL	28196844	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000394579600003
J	Glasner, ME				Glasner, Margaret E.			Finding enzymes in the gut metagenome	SCIENCE			English	Editorial Material							SEQUENCE SIMILARITY NETWORKS; SUPERFAMILIES		[Glasner, Margaret E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Glasner, ME (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	margy.glasner@tamu.edu		Glasner, Margaret/0000-0003-1818-1965				Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Levin BJ, 2017, SCIENCE, V355, DOI 10.1126/science.aai8386; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Methe B. A., 2012, NATURE, V486, P215, DOI DOI 10.1038/NATURE11209; Phang JM, 2010, ANNU REV NUTR, V30, P441, DOI 10.1146/annurev.nutr.012809.104638; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013	9	11	11	4	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					577	578		10.1126/science.aam7446	http://dx.doi.org/10.1126/science.aam7446			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK0SF	28183934				2022-12-28	WOS:000393636700025
J	Mervis, J				Mervis, Jeffrey			DATA FOR ALL?	SCIENCE			English	Editorial Material																			0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					573	573		10.1126/science.355.6325.573	http://dx.doi.org/10.1126/science.355.6325.573			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK0SF	28183932				2022-12-28	WOS:000393636700023
J	Warren, P				Warren, Penny			Adele Francis OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												penny.warren@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2017	356								j728	10.1136/bmj.j728	http://dx.doi.org/10.1136/bmj.j728			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GB	28183695				2022-12-28	WOS:000394578600009
J	Zhang, WG; Liu, Y; Li, CY				Zhang, Weigang; Liu, Yu; Li, Chunying			Generalised nodules in pemphigoid nodularis	LANCET			English	Editorial Material									[Zhang, Weigang; Liu, Yu; Li, Chunying] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Li, CY (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Shaanxi, Peoples R China.	lichying@fmmu.edu.cn							0	3	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2017	389	10082					1930	1930		10.1016/S0140-6736(17)30064-8	http://dx.doi.org/10.1016/S0140-6736(17)30064-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EU4AZ	28215664				2022-12-28	WOS:000400973500028
J	McFarlane, AC				McFarlane, Alexander C.			Is screening for the psychological effects of war useful?	LANCET			English	Editorial Material							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH-CARE; IRAQ; SOLDIERS		[McFarlane, Alexander C.] Univ Adelaide, Ctr Traumat Stress Studies, Adelaide, SA 5000, Australia	University of Adelaide	McFarlane, AC (corresponding author), Univ Adelaide, Ctr Traumat Stress Studies, Adelaide, SA 5000, Australia.	alexander.mcfarlane@adelaide.edu.au			Commonwealth Department of Veterans Affairs in Australia	Commonwealth Department of Veterans Affairs in Australia	I have received research funding from the Commonwealth Department of Veterans Affairs in Australia and act as a senior advisor in psychiatry. I am an adviser to the Australian Defence Force and hold the rank of Group Captain in the Royal Australian Air Force specialist reserves. I provide expert evidence in civil litigation.	Australian Centre for Posttraumatic Mental Health, 2013, AUSTR GUID TREATM AC; Brewin CR, 2008, J TRAUMA STRESS, V21, P3, DOI 10.1002/jts.20310; Bryant RA, 2013, JAMA PSYCHIAT, V70, P839, DOI 10.1001/jamapsychiatry.2013.1137; Hebenstreit CL, 2015, PSYCHIAT RES, V230, P90, DOI 10.1016/j.psychres.2015.08.028; Hines LA, 2014, CAN J PSYCHIAT, V59, P468, DOI 10.1177/070674371405900903; Hoge CW, 2014, PSYCHIAT SERV, V65, P997, DOI 10.1176/appi.ps.201300307; Institute of Medicine, 2014, PREV PSYCH DIS SERV; Iversen AC, 2010, BRIT J PSYCHIAT, V197, P149, DOI 10.1192/bjp.bp.109.075762; Lee DJ, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0467-7; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Rona RJ, 2016, LANCET; Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P380, DOI 10.1001/jama.2015.18392; Thombs BD, 2012, CAN MED ASSOC J, V184, P413, DOI 10.1503/cmaj.111035; Vermetten E, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.23732	14	3	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2017	389	10077					1372	1374		10.1016/S0140-6736(17)30073-9	http://dx.doi.org/10.1016/S0140-6736(17)30073-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EQ8OJ	28215662				2022-12-28	WOS:000398345100007
J	Atlas, SJ				Atlas, Steven J.			Management of Low Back Pain: Getting From Evidence-Based Recommendations to High-Value Care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CLINICAL-PRACTICE GUIDELINE; SOCIETY/AMERICAN COLLEGE; TRENDS		[Atlas, Steven J.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Atlas, SJ (corresponding author), Massachusetts Gen Hosp, Div Gen Internal Med, 50 Staniford St, Boston, MA 02114 USA.	satlas@mgh.harvard.edu			UpToDate; Healthwise	UpToDate; Healthwise	Dr. Atlas reports royalty payments from UpToDate and personal fees from Healthwise. Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M17-0293.	Bigos S, 1994, AHCPR PUBLICATION; Chou R, 2016, COMP EFFECTIVENESS R; Chou R, 2007, ANN INTERN MED, V147, P492, DOI 10.7326/0003-4819-147-7-200710020-00007; Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008; Chou R, 2017, ANN INTERN MED, V166, P493, DOI 10.7326/M16-2459; Chou R, 2017, ANN INTERN MED, V166, P480, DOI 10.7326/M16-2458; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Mafi JN, 2013, JAMA INTERN MED, V173, P1573, DOI 10.1001/jamainternmed.2013.8992; Martin BI, 2009, SPINE, V34, P2077, DOI 10.1097/BRS.0b013e3181b1fad1; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367	10	9	9	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2017	166	7					533	534		10.7326/M17-0293	http://dx.doi.org/10.7326/M17-0293			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ4PT	28192792				2022-12-28	WOS:000398061100015
J	Leucht, S; Davis, JM				Leucht, Stefan; Davis, John M.			Schizophrenia, primary negative symptoms, and soft outcomes in psychiatry	LANCET			English	Editorial Material							EFFICACY; DEFICIT		[Leucht, Stefan] Tech Univ Munich, Klinikum Rechts Isar, Dept Psychiat & Psychotherapy, D-81675 Munich, Germany; [Davis, John M.] Univ Illinois, Inst Psychiat, Chicago, IL USA; [Davis, John M.] Maryland Psychiat Res Ctr, POB 21247, Baltimore, MD 21228 USA	Technical University of Munich; University of Munich; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Leucht, S (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Psychiat & Psychotherapy, D-81675 Munich, Germany.	stefan.leucht@tum.de	Leucht, Stefan/Y-2408-2019	Leucht, Stefan/0000-0002-4934-4352	Janssen; Roche; Lilly; Otsuka; Lundbeck; TEVA Pharmaceuticals	Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Roche(Roche Holding); Lilly(Eli Lilly); Otsuka(Otsuka Pharmaceutical); Lundbeck(Lundbeck Corporation); TEVA Pharmaceuticals(Teva Pharmaceutical Industries)	SL has received honoraria for lectures from Otsuka, Lundbeck, Janssen, ICON, Lilly, Sanofi Aventis, AOP Orphan, and Servier; fees for consulting from Janssen, Roche, Lilly, Otsuka, Lundbeck, and TEVA Pharmaceuticals; and fees for a publication from Roche. JMD declares no conflicts of interest.	Agid O, 2003, ARCH GEN PSYCHIAT, V60, P1228, DOI 10.1001/archpsyc.60.12.1228; Bleuler E., 1908, ALLG Z PSYCHIAT, V65, P436; Buchanan RW, 1998, AM J PSYCHIAT, V155, P751; CARPENTER WT, 1988, AM J PSYCHIAT, V145, P578; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Helfer B, 2016, AM J PSYCHIAT, V173, P876, DOI 10.1176/appi.ajp.2016.15081035; Leucht S, 2002, AM J PSYCHIAT, V159, P180, DOI 10.1176/appi.ajp.159.2.180; Leucht S, 2012, BRIT J PSYCHIAT, V200, P97, DOI 10.1192/bjp.bp.111.096594; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Leucht S, 2009, LANCET, V373, P1249, DOI 10.1016/S0140-6736(09)60723-6; Lindenmayer JP, 2007, J CLIN PSYCHIAT, V68, P368, DOI 10.4088/JCP.v68n0303; McMahon RP, 2008, SCHIZOPHRENIA BULL, V34, P292, DOI 10.1093/schbul/sbm152; Nemeth G, 2017, LANCET	13	13	13	1	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2017	389	10074					1077	1078		10.1016/S0140-6736(17)30181-2	http://dx.doi.org/10.1016/S0140-6736(17)30181-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0SR	28185671				2022-12-28	WOS:000396408700004
J	Ioannidis, JPA				Ioannidis, John P. A.			Acknowledging and Overcoming Nonreproducibility in Basic and Preclinical Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ioannidis, John P. A.] Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Metares Innovat Ctr Stanford METR, Stanford, CA USA	Stanford University; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Univ, Stanford Prevent Res Ctr, Sch Med, Off Bldg,Room X306,1265 Welch Rd, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011	Ioannidis, John P./0000-0003-3118-6859				Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Errington TM, 2014, ELIFE, V3, DOI 10.7554/eLife.04333; Goodman SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5027; Ioannidis JPA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002049; Nosek BA, 2017, ELIFE, V6, DOI 10.7554/eLife.23383; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1	6	42	42	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2017	317	10					1019	1020		10.1001/jama.2017.0549	http://dx.doi.org/10.1001/jama.2017.0549			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO5DO	28192565				2022-12-28	WOS:000396713400011
J	Moore, SJ; Sowa, ST; Schuchardt, C; Deery, E; Lawrence, AD; Ramos, JV; Billig, S; Birkemeyer, C; Chivers, PT; Howard, MJ; Rigby, SEJ; Layer, G; Warren, MJ				Moore, Simon J.; Sowa, Sven T.; Schuchardt, Christopher; Deery, Evelyne; Lawrence, Andrew D.; Ramos, Jose Vazquez; Billig, Susan; Birkemeyer, Claudia; Chivers, Peter T.; Howard, Mark J.; Rigby, Stephen E. J.; Layer, Gunhild; Warren, Martin J.			Elucidation of the biosynthesis of the methane catalyst coenzyme F-430	NATURE			English	Article							YELLOW METAL-FREE; M REDUCTASE; CRYSTAL-STRUCTURE; METHANOGENIC BACTERIA; ANAEROBIC OXIDATION; NICKEL UPTAKE; ENZYME; IDENTIFICATION; HEME; BIOCHEMISTRY	Methane biogenesis in methanogens is mediated by methyl-coenzyme M reductase, an enzyme that is also responsible for the utilization of methane through anaerobic methane oxidation. The enzyme uses an ancillary factor called coenzyme F-430, a nickel-containing modified tetrapyrrole that promotes catalysis through a methyl radical/Ni( ii)-thiolate intermediate. However, it is unclear how coenzyme F-430 is synthesized from the common primogenitor uroporphyrinogen iii, incorporating 11 steric centres into the macrocycle, although the pathway must involve chelation, amidation, macrocyclic ring reduction, lactamization and carbocyclic ring formation. Here we identify the proteins that catalyse the biosynthesis of coenzyme F-430 from sirohydrochlorin, termed CfbA-CfbE, and demonstrate their activity. The research completes our understanding of how the repertoire of tetrapyrrole-based pigments are constructed, permitting the development of recombinant systems to use these metalloprosthetic groups more widely.	[Moore, Simon J.; Deery, Evelyne; Lawrence, Andrew D.; Howard, Mark J.; Warren, Martin J.] Univ Kent, Sch Biosci, Giles Lane, Canterbury CT2 7NJ, Kent, England; [Sowa, Sven T.; Schuchardt, Christopher; Ramos, Jose Vazquez; Layer, Gunhild] Univ Leipzig, Inst Biochem, Bruderstr 34, D-04103 Leipzig, Germany; [Billig, Susan; Birkemeyer, Claudia] Univ Leipzig, Inst Analyt Chem, Linnestr 3, D-04103 Leipzig, Germany; [Chivers, Peter T.] Univ Durham, Dept Chem, Durham DH1 3LE, England; [Chivers, Peter T.] Univ Durham, Dept Biosci, Durham DH1 3LE, England; [Rigby, Stephen E. J.] Univ Manchester, Sch Chem, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England	University of Kent; Leipzig University; Leipzig University; Durham University; Durham University; University of Manchester	Warren, MJ (corresponding author), Univ Kent, Sch Biosci, Giles Lane, Canterbury CT2 7NJ, Kent, England.; Layer, G (corresponding author), Univ Leipzig, Inst Biochem, Bruderstr 34, D-04103 Leipzig, Germany.	gunhild.layer@uni-leipzig.de; m.j.warren@kent.ac.uk	; Birkemeyer, Claudia/L-8687-2015	Billig, Susan/0000-0002-9976-5489; Howard, Mark/0000-0002-0762-2887; Warren, Martin/0000-0002-6028-6456; Sowa, Sven/0000-0001-7411-5925; Birkemeyer, Claudia/0000-0002-8538-8838; Moore, Simon/0000-0002-1968-206X; Chivers, Peter/0000-0002-8779-1452	Boehringer Ingelheim Foundation; Deutsche Forschungsgemeinschaft [LA2412/6-1]; Biotechnology and Biological Sciences Research Council (BBSRC) [68/B19356, BB/I012079]; BBSRC [BB/E013007/1, BB/K009249/1, BB/L010208/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K009249/1, BB/E013007/1, B19356/2, BB/L010208/1] Funding Source: researchfish	Boehringer Ingelheim Foundation(Boehringer Ingelheim); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank M. Honinger, T. Schnitzer and J. Streif for conducting initial experiments with CfbA and CfbC/CfbD. We thank R. Thauer and S. Shima for the gift of the F430 standard. This work was supported by grants from the Boehringer Ingelheim Foundation (Exploration Grant) and the Deutsche Forschungsgemeinschaft (LA2412/6-1) to G.L. and from the Biotechnology and Biological Sciences Research Council (BBSRC; 68/B19356 and BB/I012079) to M.J.W.	Bali S, 2011, P NATL ACAD SCI USA, V108, P18260, DOI 10.1073/pnas.1108228108; Bartolommei G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058615; BATTERSBY AR, 1994, SCIENCE, V264, P1551, DOI 10.1126/science.8202709; Brindley AA, 2003, J BIOL CHEM, V278, P22388, DOI 10.1074/jbc.M302468200; Brocker MJ, 2010, J BIOL CHEM, V285, P8268, DOI 10.1074/jbc.M109.087874; Chivers PT, 2015, METALLOMICS, V7, P590, DOI 10.1039/c4mt00310a; Chivers PT, 2012, METALLOMICS, V4, P1043, DOI 10.1039/c2mt20139a; Dailey HA, 2015, P NATL ACAD SCI USA, V112, P2210, DOI 10.1073/pnas.1416285112; Deery E, 2012, NAT CHEM BIOL, V8, P933, DOI [10.1038/NCHEMBIO.1086, 10.1038/nchembio.1086]; Eitinger T, 2000, ARCH MICROBIOL, V173, P1, DOI 10.1007/s002030050001; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; FARBER G, 1991, HELV CHIM ACTA, V74, P697, DOI 10.1002/hlca.19910740404; FASSLER A, 1982, HELV CHIM ACTA, V65, P812, DOI 10.1002/hlca.19820650319; Fluhe E, 2012, NAT CHEM BIOL, V8, P350, DOI [10.1038/NCHEMBIO.798, 10.1038/nchembio.798]; GILLES H, 1983, EUR J BIOCHEM, V135, P109, DOI 10.1111/j.1432-1033.1983.tb07624.x; Kruger M, 2003, NATURE, V426, P878, DOI 10.1038/nature02207; Kuhner M, 2014, ARCHAEA, V2014, DOI 10.1155/2014/327637; Lee CC, 2014, METAL IONS LIFE SCI, V14, P147, DOI 10.1007/978-94-017-9269-1_7; McGoldrick HM, 2005, J BIOL CHEM, V280, P1086, DOI 10.1074/jbc.M411884200; Moore SJ, 2013, P NATL ACAD SCI USA, V110, P14906, DOI 10.1073/pnas.1308098110; MUCHA H, 1985, FEBS LETT, V190, P169, DOI 10.1016/0014-5793(85)80451-8; Mulrooney SB, 2003, FEMS MICROBIOL REV, V27, P239, DOI 10.1016/S0168-6445(03)00042-1; Muraki N, 2010, NATURE, V465, P110, DOI 10.1038/nature08950; PFALTZ A, 1987, EUR J BIOCHEM, V170, P459, DOI 10.1111/j.1432-1033.1987.tb13722.x; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Ragsdale SW, 2014, METAL IONS LIFE SCI, V14, P125, DOI 10.1007/978-94-017-9269-1_6; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Scheller S, 2010, NATURE, V465, P606, DOI 10.1038/nature09015; SCHLINGMANN G, 1981, LIEBIGS ANN CHEM, P2061; SCHLINGMANN G, 1980, ANGEW CHEM INT EDIT, V19, P321, DOI 10.1002/anie.198003212; Schubert HL, 2002, EMBO J, V21, P2068, DOI 10.1093/emboj/21.9.2068; Shima S, 2012, NATURE, V481, P98, DOI 10.1038/nature10663; Staples CR, 2007, J BACTERIOL, V189, P7392, DOI 10.1128/JB.00876-07; THAUER RK, 1994, CIBA F SYMP, V180, P210; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; WARREN MJ, 1990, TRENDS BIOCHEM SCI, V15, P486, DOI 10.1016/0968-0004(90)90304-T; WON H, 1990, J AM CHEM SOC, V112, P2178, DOI 10.1021/ja00162a020; Wongnate T, 2016, SCIENCE, V352, P953, DOI 10.1126/science.aaf0616; Wongnate T, 2015, J BIOL CHEM, V290, P9322, DOI 10.1074/jbc.M115.636761; Yan YW, 2000, J MOL BIOL, V304, P435, DOI 10.1006/jmbi.2000.4215	42	73	78	2	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					78	+		10.1038/nature21427	http://dx.doi.org/10.1038/nature21427			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0AA	28225763	Green Accepted			2022-12-28	WOS:000395671500035
J	Mayor, S				Mayor, Susan			Statin side effects are strongest predictor of inadequate cholesterol control, study shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Munkhaugen J, 2017, EUR J PREV CARDIOL, V24, P981, DOI 10.1177/2047487317693134	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2017	356								j869	10.1136/bmj.j869	http://dx.doi.org/10.1136/bmj.j869			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KQ	28219883				2022-12-28	WOS:000395630800005
J	Prasad, A; Lakhanpaul, M; Narula, S; Patel, V; Piot, P; Venkatapuram, S				Prasad, Aarathi; Lakhanpaul, Monica; Narula, Surina; Patel, Vikram; Piot, Peter; Venkatapuram, Sridhar			Accounting for the future of health in India	LANCET			English	Editorial Material									[Prasad, Aarathi] UCL, UCL Grand Challenges, London WC1H 0BT, England; [Lakhanpaul, Monica] UCL, UCL Great Ormond Inst Child Hlth, London, England; [Narula, Surina] Difficult Dialogues, Panaji, Goa, India; [Piot, Peter] London Sch Hyg & Trop Med, Off Director, London, England; [Patel, Vikram] London Sch Hyg & Trop Med, Ctr Global Mental Hlth, London, England; [Patel, Vikram] Sangath, Porvorim, Goa, India; [Patel, Vikram] Publ Hlth Fdn India, Ctr Chron Condit, New Delhi, India; [Venkatapuram, Sridhar] Kings Coll London, Dept Global Hlth & Social Med, London, England; [Venkatapuram, Sridhar] Univ Johannesburg, Dept Philosophy, Johannesburg, South Africa	University of London; University College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; University of London; King's College London; University of Johannesburg	Prasad, A (corresponding author), UCL, UCL Grand Challenges, London WC1H 0BT, England.	a.prasad@ucl.ac.uk	Venkatapuram, Sridhar/AAH-2587-2020; Venkatapuram, Sridhar/AAE-6904-2020	Venkatapuram, Sridhar/0000-0003-3076-0783; Lakhanpaul, Monica/0000-0002-9855-2043	Difficult Dialogues	Difficult Dialogues	SN is the founder-sponsor of Difficult Dialogues. ML, AP, and SV are members of the Difficult Dialogues Steering Committee. VP will be a speaker at Difficult Dialogues 2017. PP is a member of the General Body of the Public Health Foundation of India. We declare no other competing interests.	Aiyar Y, 2017, LIVEMINT        0124; [Anonymous], 2017, LANCET, V389, P127; Banerjee Abhiji, 2009, IMPROVING HLTH CARE; Committee on Health and Family Welfare Rajya Sabha, 2016, 96 REP ACT TAK GOV R; Jayakrishnan T, 2016, PHARMACOECONOMICS, V1, P1; Kalra A., 2017, REUTERS; Ministry of Finance, 2017, BUDG SPEECH HONBL FI; Patel V, 2015, LANCET, V386, P2422, DOI 10.1016/S0140-6736(15)00955-1; Prasad A, 2016, BONESETTERS WAITING; Raban MZ, 2013, B WORLD HEALTH ORGAN, V91, P726, DOI 10.2471/BLT.12.113100; WHO, 2010, WOR HEALT REP, P1	11	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 18	2017	389	10070					680	682		10.1016/S0140-6736(17)30324-0	http://dx.doi.org/10.1016/S0140-6736(17)30324-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9KK	28187913	Green Submitted			2022-12-28	WOS:000394938900009
J	Lashuel, HA				Lashuel, Hilal A.			The America I believe in	SCIENCE			English	Editorial Material									[Lashuel, Hilal A.] Swiss Fed Inst Technol, Life Sci, Lausanne, Switzerland	Ecole Polytechnique Federale de Lausanne	Lashuel, HA (corresponding author), Swiss Fed Inst Technol, Life Sci, Lausanne, Switzerland.		Lashuel, Hilal/M-3500-2017						0	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					766	766		10.1126/science.355.6326.766	http://dx.doi.org/10.1126/science.355.6326.766			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2AC	28209903				2022-12-28	WOS:000395117700046
J	Iacobucci, G				Iacobucci, Gareth			Vitamin D supplementation does cut respiratory infections, new study suggests	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Bolland MJ, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j456; Martineau AR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6583	2	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2017	356								j847	10.1136/bmj.j847	http://dx.doi.org/10.1136/bmj.j847			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GN	28209724				2022-12-28	WOS:000394579800010
J	Cox, LS				Cox, Linda S.			Sublingual Immunotherapy for Allergic Rhinitis Is 2-Year Treatment Sufficient for Long-term Benefit?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RESPIRATORY ALLERGY; EFFICACY		[Cox, Linda S.] Univ Miami, Miller Sch Med, Holy Cross Hosp, Ft Lauderdale, FL USA		Cox, LS (corresponding author), 5333 N Dixie Hwy, Ft Lauderdale, FL 33334 USA.	lindaswolfcox@msn.com	Cox, Linda/AAP-1697-2021	Cox, Linda/0000-0002-5258-6870	MedImmune; Novartis; ASIT biotech sa; Circassia; Biotech; Greer-Stallergenes; Genentech	MedImmune(AstraZenecaMedimmune); Novartis(Novartis); ASIT biotech sa; Circassia; Biotech; Greer-Stallergenes; Genentech(Roche HoldingGenentech)	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and reports being on the editorial board for the Journal of Allergy and Clinical Immunology; receipt of personal fees from MedImmune and Novartis for adjudication committee participation; consultation fees from ASIT biotech sa; personal fees from Circassia and Biotech for the safety and data monitoring committee; speaker's fees from Greer-Stallergenes; and personal fees from Genentech for an educational video recording.	Canonica GW, 2007, ALLERGY, V62, P317, DOI 10.1111/j.1398-9995.2006.01312.x; Canonica GW, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-6; Chanez P, 1996, ALLERGY, V51, P850; Cox L, 2007, ANN ALLERG ASTHMA IM, V98, P416, DOI 10.1016/S1081-1206(10)60755-7; Cox L, 2015, CURR OPIN OTOLARYNGO, V23, P247, DOI 10.1097/MOO.0000000000000150; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; Cox LS, 2006, J ALLERGY CLIN IMMUN, V117, P1021, DOI 10.1016/j.jaci.2006.02.040; Didier A, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0057-8; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Durham SR, 2012, J ALLERGY CLIN IMMUN, V129, P717, DOI 10.1016/j.jaci.2011.12.973; Epstein TG, 2017, J ALLER CL IMM-PRACT, V5, P34, DOI 10.1016/j.jaip.2016.09.017; Epstein TG, 2016, ANN ALLERG ASTHMA IM, V116, P354, DOI 10.1016/j.anai.2016.02.001; Meadows A, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17270; Meadows A, 2013, HEALTH TECHNOL ASSES, V17, pxi; Noon L, 1911, LANCET, V1, P1572; Scadding GW, 2015, ALLERGY, V70, P689, DOI 10.1111/all.12608; Scadding GW, 2017, JAMA-J AM MED ASSOC, V317, P615, DOI 10.1001/jama.2016.21040	17	7	9	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2017	317	6					591	593		10.1001/jama.2017.0128	http://dx.doi.org/10.1001/jama.2017.0128			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8LI	28196239				2022-12-28	WOS:000394870900012
J	[Anonymous]				[Anonymous]			Help Patients Have Smoke-Free Life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2017	317	6					577	577		10.1001/jama.2017.0098	http://dx.doi.org/10.1001/jama.2017.0098			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8LI	28196263				2022-12-28	WOS:000394870900005
J	Lin, SX; Yang, XY; Jia, S; Weeks, AM; Hornsby, M; Lee, PS; Nichiporuk, RV; Iavarone, AT; Wells, JA; Toste, FD; Chang, CJ				Lin, Shixian; Yang, Xiaoyu; Jia, Shang; Weeks, Amy M.; Hornsby, Michael; Lee, Peter S.; Nichiporuk, Rita V.; Iavarone, Anthony T.; Wells, James A.; Toste, F. Dean; Chang, Christopher J.			Redox-based reagents for chemoselective methionine bioconjugation	SCIENCE			English	Article							PROTEIN; INHIBITORS; CYSTEINES; CHEMISTRY; DISCOVERY; OXIDATION; PATHWAY; BIOLOGY; TANDEM; DRUG	Cysteine can be specifically functionalized by a myriad of acid-base conjugation strategies for applications ranging from probing protein function to antibody-drug conjugates and proteomics. In contrast, selective ligation to the other sulfur-containing amino acid, methionine, has been precluded by its intrinsically weaker nucleophilicity. Here, we report a strategy for chemoselective methionine bioconjugation through redox reactivity, using oxaziridine-based reagents to achieve highly selective, rapid, and robust methionine labeling under a range of biocompatible reaction conditions. We highlight the broad utility of this conjugation method to enable precise addition of payloads to proteins, synthesis of antibody-drug conjugates, and identification of hyperreactive methionine residues in whole proteomes.	[Lin, Shixian; Yang, Xiaoyu; Jia, Shang; Toste, F. Dean; Chang, Christopher J.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Chang, Christopher J.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Nichiporuk, Rita V.; Iavarone, Anthony T.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Toste, F. Dean; Chang, Christopher J.] Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA USA; [Weeks, Amy M.; Hornsby, Michael; Lee, Peter S.; Wells, James A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Wells, James A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Yang, Xiaoyu] ShanghaiTech Univ, Sch Phys Sci & Technol, Shanghai, Peoples R China	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California San Francisco; University of California System; University of California San Francisco; ShanghaiTech University	Toste, FD; Chang, CJ (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Chang, CJ (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Chang, CJ (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Toste, FD; Chang, CJ (corresponding author), Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA USA.	fdtoste@berkeley.edu; chrischang@berkeley.edu	Yang, Xiaoyu/AAJ-4203-2021; Toste, F. Dean/Y-2556-2019; 贾, 上/P-7344-2019	Yang, Xiaoyu/0000-0002-0756-0671; Toste, F. Dean/0000-0001-8018-2198; 贾, 上/0000-0001-6285-8959; Hornsby, Michael/0000-0002-2304-9961; Weeks, Amy/0000-0003-4700-8256; Lin, Shixian/0000-0001-9718-9986	U.S. Department of Energy/Lawrence Berkeley National Laboratory [101528-002, DE-AC02-05CH11231]; NIH [1S10OD020062-01, F32CA203152]; NATIONAL CANCER INSTITUTE [P41CA196276, F32CA203152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079465] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020062] Funding Source: NIH RePORTER	U.S. Department of Energy/Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the U.S. Department of Energy/Lawrence Berkeley National Laboratory (101528-002 to C.J.C. and DE-AC02-05CH11231 to F.D.T.) for financial support, as well as NIH (GM79465 to C.J.C.) for pilot protein labeling studies. C.J.C. is an Investigator of the Howard Hughes Medical Institute and a Canadian Institute for Advanced Research Senior Fellow. We also thank NIH for grant 1S10OD020062-01 in financial support of University of California (UC) Berkeley QB3 mass spectrometry facilities. We thank A. Killilea (UC Berkeley Tissue Culture Facility) and M. Salemi and B. Phinney (UC Davis Proteomics Core) for expert technical assistance, as well as S. Pollock for the HEK-293T-GFP cell line, V. Yu for yeast genome editing, and D. Nomura for helpful discussions. A.M.W. is a Merck Fellow of the Helen Hay Whitney Foundation. P.S<INF>.</INF>L is supported by a postdoctoral fellowship from NIH (F32CA203152). The experimental data sets used in this study are available as supplementary materials. S.L., X.Y., F.D.T., and C.J.C. are listed as inventors on a patent application describing redox-active reagents for methionine conjugation.	Agarwal P, 2015, BIOCONJUGATE CHEM, V26, P176, DOI 10.1021/bc5004982; Armstrong A, 2003, TETRAHEDRON LETT, V44, P5335, DOI 10.1016/S0040-4039(03)01200-0; Bizet V, 2015, CHEM SOC REV, V44, P3378, DOI 10.1039/c5cs00208g; Bondalapati S, 2016, NAT CHEM, V8, P407, DOI [10.1038/NCHEM.2476, 10.1038/nchem.2476]; Boutureira O, 2015, CHEM REV, V115, P2174, DOI 10.1021/cr500399p; Brewer TF, 2015, ANNU REV BIOCHEM, V84, P765, DOI 10.1146/annurev-biochem-060614-034018; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; FOTHERGILLGILMORE LA, 1993, PROG BIOPHYS MOL BIO, V59, P105, DOI 10.1016/0079-6107(93)90001-Z; Giles NM, 2003, CHEM BIOL, V10, P677, DOI 10.1016/S1074-5521(03)00174-1; GUNDLACH HG, 1959, J BIOL CHEM, V234, P1761; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; KABAT EA, 1977, J BIOL CHEM, V252, P6609; Kaya A, 2015, ANTIOXID REDOX SIGN, V23, P814, DOI 10.1089/ars.2015.6385; Kramer JR, 2013, CHEM COMMUN, V49, P5144, DOI 10.1039/c3cc42214c; Lee BC, 2013, MOL CELL, V51, P397, DOI 10.1016/j.molcel.2013.06.019; Leonard PG, 2016, NAT CHEM BIOL, V12, P1053, DOI [10.1038/NCHEMBIO.2195, 10.1038/nchembio.2195]; Leung D, 2003, NAT BIOTECHNOL, V21, P687, DOI 10.1038/nbt826; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Lewis AK, 2016, NAT CHEM BIOL, V12, P860, DOI [10.1038/NCHEMBIO.2159, 10.1038/nchembio.2159]; Mizukami S, 2014, ACCOUNTS CHEM RES, V47, P247, DOI 10.1021/ar400135f; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Nomura DK, 2010, NAT REV CANCER, V10, P630, DOI 10.1038/nrc2901; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Sanman LE, 2014, ANNU REV BIOCHEM, V83, P249, DOI 10.1146/annurev-biochem-060713-035352; Serafimova IM, 2012, NAT CHEM BIOL, V8, P471, DOI [10.1038/NCHEMBIO.925, 10.1038/nchembio.925]; Shannon DA, 2015, CURR OPIN CHEM BIOL, V24, P18, DOI 10.1016/j.cbpa.2014.10.021; Speers AE, 2005, J AM CHEM SOC, V127, P10018, DOI 10.1021/ja0532842; Spicer CD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5740; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Vidal J, 1997, CHEM-EUR J, V3, P1691, DOI 10.1002/chem.19970031019; Vinogradova EV, 2015, NATURE, V526, P687, DOI 10.1038/nature15739; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Wright TH, 2016, SCIENCE, V354, DOI 10.1126/science.aag1465; Yang A, 2016, SCIENCE, V354, P623, DOI 10.1126/science.aah4428; Zhang C, 2016, NAT CHEM, V8, P120, DOI [10.1038/NCHEM.2413, 10.1038/nchem.2413]	39	241	245	11	333	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					597	602		10.1126/science.aal3316	http://dx.doi.org/10.1126/science.aal3316			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK0SF	28183972	Green Published, Green Accepted			2022-12-28	WOS:000393636700041
J	Martinez-Martin, N; Maldonado, P; Gasparrini, F; Frederico, B; Aggarwal, S; Gaya, M; Tsui, C; Burbage, M; Keppler, SJ; Montaner, B; Jefferies, HBJ; Nair, U; Zhao, YG; Domart, MC; Collinson, L; Bruckbauer, A; Tooze, SA; Batista, FD				Martinez-Martin, Nuria; Maldonado, Paula; Gasparrini, Francesca; Frederico, Bruno; Aggarwal, Shweta; Gaya, Mauro; Tsui, Carlson; Burbage, Marianne; Keppler, Selina Jessica; Montaner, Beatriz; Jefferies, Harold B. J.; Nair, Usha; Zhao, Yan G.; Domart, Marie-Charlotte; Collinson, Lucy; Bruckbauer, Andreas; Tooze, Sharon A.; Batista, Facundo D.			A switch from canonical to noncanonical autophagy shapes B cell responses	SCIENCE			English	Article							LC3; DIFFERENTIATION; MACROAUTOPHAGY; MAINTENANCE; ACTIVATION; PROTEINS	Autophagy is important in a variety of cellular and pathophysiological situations; however, its role in immune responses remains elusive. Here, we show that among B cells, germinal center (GC) cells exhibited the highest rate of autophagy during viral infection. In contrast to mechanistic target of rapamycin complex 1-dependent canonical autophagy, GC B cell autophagy occurred predominantly through a noncanonical pathway. B cell stimulation was sufficient to down-regulate canonical autophagy transiently while triggering noncanonical autophagy. Genetic ablation of WD repeat domain, phosphoinositide-interacting protein 2 in B cells alone enhanced this noncanonical autophagy, resulting in changes of mitochondrial homeostasis and alterations in GC and antibody-secreting cells. Thus, B cell activation prompts a temporal switch from canonical to noncanonical autophagy that is important in controlling B cell differentiation and fate.	[Martinez-Martin, Nuria; Maldonado, Paula; Gasparrini, Francesca; Frederico, Bruno; Aggarwal, Shweta; Gaya, Mauro; Tsui, Carlson; Burbage, Marianne; Keppler, Selina Jessica; Montaner, Beatriz; Bruckbauer, Andreas; Batista, Facundo D.] Francis Crick Inst, Lymphocyte Biol Lab, 1 Midland Rd, London NW1 1AT, England; [Jefferies, Harold B. J.; Tooze, Sharon A.] Francis Crick Inst, Mol Cell Biol Autophagy Lab, 1 Midland Rd, London NW1 1AT, England; [Gaya, Mauro; Nair, Usha; Batista, Facundo D.] MIT, Ragon Inst, Massachusetts Gen Hosp, 400 Technol Sq, Cambridge, MA 02139 USA; [Gaya, Mauro; Nair, Usha; Batista, Facundo D.] Harvard Univ, 400 Technol Sq, Cambridge, MA 02139 USA; [Zhao, Yan G.] Chinese Acad Sci, Inst Biophys, 15 Datun Rd, Beijing 100101, Peoples R China; [Domart, Marie-Charlotte; Collinson, Lucy] Francis Crick Inst, Electron Microscopy Unit, 1 Midland Rd, London NW1 1AT, England; [Bruckbauer, Andreas] Imperial Coll London, FILM, Exhibit Rd, London SW7 2AZ, England	Francis Crick Institute; Francis Crick Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Francis Crick Institute; Imperial College London	Martinez-Martin, N; Batista, FD (corresponding author), Francis Crick Inst, Lymphocyte Biol Lab, 1 Midland Rd, London NW1 1AT, England.; Tooze, SA (corresponding author), Francis Crick Inst, Mol Cell Biol Autophagy Lab, 1 Midland Rd, London NW1 1AT, England.; Batista, FD (corresponding author), MIT, Ragon Inst, Massachusetts Gen Hosp, 400 Technol Sq, Cambridge, MA 02139 USA.; Batista, FD (corresponding author), Harvard Univ, 400 Technol Sq, Cambridge, MA 02139 USA.	nuria.martinezmartin@crick.ac.uk; sharon.tooze@crick.ac.uk; fbatista1@mgh.harvard.edu	Martinez-Martin, Nuria/A-9160-2017; Burbage, Marianne/GLQ-7327-2022	Martinez-Martin, Nuria/0000-0003-2309-8920; Burbage, Marianne/0000-0003-0686-2608; Montaner, Beatriz/0000-0001-9877-7317; Zhao, Yan/0000-0002-4588-6752; Frederico, Bruno/0000-0002-6985-3090; Domart, Marie-Charlotte/0000-0002-5703-2922; Collinson, Lucy/0000-0003-0260-613X; Tooze, Sharon/0000-0002-2182-3116; Keppler, Selina Jessica/0000-0002-9010-8044	Francis Crick Institute - Cancer Research UK [FC001035, FC001187, FC001136]; UK Medical Research Council [FC001035, FC001187, FC001136]; Wellcome Trust [FC001035, FC001187, FC001136]; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery of the National Institutes of Health [UM1AI100663]; Phillip T. and Susan M. Ragon Institute Foundation; Marie Sklodowska-Curie individual postdoctoral fellowship; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT); Institute Pasteur-Fondazione Cenci Bolognetti; European Molecular Biology Organization (EMBO); German Research Foundation; Cancer Research UK [15153] Funding Source: researchfish; The Francis Crick Institute [10187, 10004] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663] Funding Source: NIH RePORTER	Francis Crick Institute - Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery of the National Institutes of Health; Phillip T. and Susan M. Ragon Institute Foundation; Marie Sklodowska-Curie individual postdoctoral fellowship; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Institute Pasteur-Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); German Research Foundation(German Research Foundation (DFG)); Cancer Research UK(Cancer Research UK); The Francis Crick Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the flow cytometry and biological resource units at the Francis Crick Institute for their help. We are grateful to P. Stevenson (University of Queensland, Brisbane, Australia) for the MuHV-4 mice; H. W. Virgin (Washington University School of Medicine, St. Louis, MO, USA); K. Maloy (Sir William Dunn School of Pathology, University of Oxford, UK) for providing the Atg16L1-floxed mice; M. Reth (Max Planck Institute, Freiburg, Germany) for the Mb1-Cre mice; H. Zhang (Institute of Biophysics, Chinese Academy of Sciences, Beijing, China) for providing WIPI2-KO mice; and K. Okkenhaug (Babraham Institute, Cambridge, UK) for Vps34-IN1. We thank all members of the Lymphocyte Biology Laboratory for support and critical discussion. This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001035, FC001187, FC001136), the UK Medical Research Council (FC001035, FC001187, FC001136), and the Wellcome Trust (FC001035, FC001187, FC001136); The Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery of the National Institutes of Health (UM1AI100663); the Phillip T. and Susan M. Ragon Institute Foundation; a Marie Sklodowska-Curie individual postdoctoral fellowship (N.M.-M.); Abroad Doctoral Fellowships; Scholarships Chile granted by Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) (P.M.); the Institute Pasteur-Fondazione Cenci Bolognetti (F.G.); a long-term European Molecular Biology Organization (EMBO) fellowship (N.M.-M. and S.A.); and a German Research Foundation grant (S.J.K.).	Arnold J, 2016, CELL DEATH DIFFER, V23, P853, DOI 10.1038/cdd.2015.149; Chen M, 2014, NAT MED, V20, P507, DOI 10.1038/nm.3521; Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249; Donahue AC, 2007, EUR J IMMUNOL, V37, P2923, DOI 10.1002/eji.200737281; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Florey O, 2015, AUTOPHAGY, V11, P88, DOI 10.4161/15548627.2014.984277; Heise N, 2014, J EXP MED, V211, P2103, DOI 10.1084/jem.20132613; Jang KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7750; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Limon JJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00228; Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192; Pengo N, 2013, NAT IMMUNOL, V14, P298, DOI 10.1038/ni.2524; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Shibutani ST, 2015, NAT IMMUNOL, V16, P1014, DOI 10.1038/ni.3273	16	63	65	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					641	647		10.1126/science.aal3908	http://dx.doi.org/10.1126/science.aal3908			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK0SF	28183981	Green Submitted, Green Accepted			2022-12-28	WOS:000393636700052
J	Sambandan, S; Akbalik, G; Kochen, L; Rinne, J; Kahlstatt, J; Glock, C; Tushev, G; Alvarez-Castelao, B; Heckel, A; Schuman, EM				Sambandan, Sivakumar; Akbalik, Gueney; Kochen, Lisa; Rinne, Jennifer; Kahlstatt, Josefine; Glock, Caspar; Tushev, Georgi; Alvarez-Castelao, Beatriz; Heckel, Alexander; Schuman, Erin M.			Activity-dependent spatially localized miRNA maturation in neuronal dendrites	SCIENCE			English	Article							HIPPOCAMPAL-NEURONS; GENE-EXPRESSION; MICRORNAS; BRAIN; PROBE	MicroRNAs (miRNAs) regulate gene expression by binding to target messenger RNAs (mRNAs) and preventing their translation. In general, the number of potential mRNA targets in a cell is much greater than the miRNA copy number, complicating high-fidelity miRNA-target interactions. We developed an inducible fluorescent probe to explore whether the maturation of a miRNA could be regulated in space and time in neurons. A precursor miRNA (pre-miRNA) probe exhibited an activity-dependent increase in fluorescence, suggesting the stimulation of miRNA maturation. Single-synapse stimulation resulted in a local maturation of miRNA that was associated with a spatially restricted reduction in the protein synthesis of a target mRNA. Thus, the spatially and temporally regulatedmaturation of pre-miRNAs can be used to increase the precision and robustness of miRNA-mediated translational repression.	[Sambandan, Sivakumar; Akbalik, Gueney; Kochen, Lisa; Glock, Caspar; Tushev, Georgi; Alvarez-Castelao, Beatriz; Schuman, Erin M.] Max Planck Inst Brain Res, Max von Laue Str 4, D-60438 Frankfurt, Germany; [Rinne, Jennifer; Kahlstatt, Josefine; Heckel, Alexander] Goethe Univ, Inst Organ Chem & Chem Biol, D-60438 Frankfurt, Germany; [Heckel, Alexander; Schuman, Erin M.] Goethe Univ, Cluster Excellence Macromol Complexes Act, D-60438 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt	Schuman, EM (corresponding author), Max Planck Inst Brain Res, Max von Laue Str 4, D-60438 Frankfurt, Germany.; Heckel, A (corresponding author), Goethe Univ, Inst Organ Chem & Chem Biol, D-60438 Frankfurt, Germany.; Heckel, A; Schuman, EM (corresponding author), Goethe Univ, Cluster Excellence Macromol Complexes Act, D-60438 Frankfurt, Germany.	heckel@uni-frankfurt.de; erin.schuman@brain.mpg.de	Schuman, Erin M/D-6204-2011; Heckel, Alexander/A-8498-2008; alvarez-castelao, beatriz/W-1707-2018; Alvarez-castelao, Beatriz/ABG-8826-2021	Heckel, Alexander/0000-0003-3541-4548; alvarez-castelao, beatriz/0000-0001-7505-1855; Akbalik, Guney/0000-0002-3219-401X; Sambandan, Sivakumar/0000-0001-5471-6141	Max Planck Society; European Research Council; German Research Foundation (DFG) Collaborative Research Centre (CRC) 1080 (Molecular and Cellular Mechanisms of Neural Homeostasis); DFG CRC 902 (Molecular Principles of RNA-based Regulation); DFG Cluster of Excellence "Macromolecular Complexes in Action," Goethe University; Fonds der Chemischen Industrie	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council(European Research Council (ERC)European Commission); German Research Foundation (DFG) Collaborative Research Centre (CRC) 1080 (Molecular and Cellular Mechanisms of Neural Homeostasis); DFG CRC 902 (Molecular Principles of RNA-based Regulation); DFG Cluster of Excellence "Macromolecular Complexes in Action," Goethe University; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	We thank I. Bartnik, N. Fuerst, A. Staab, and C. Thum for the preparation of cultured hippocampal neurons. We thank C. Hanus for assistance with two-photon microscopy. E.M.S. is funded by the Max Planck Society, an Advanced Investigator award from the European Research Council, and German Research Foundation (DFG) Collaborative Research Centre (CRC) 1080 (Molecular and Cellular Mechanisms of Neural Homeostasis). E.M.S. and A.H. are funded by DFG CRC 902 (Molecular Principles of RNA-based Regulation) and by the DFG Cluster of Excellence "Macromolecular Complexes in Action," Goethe University. J.R. and A.H. gratefully acknowledge the stipend support of J.R. by Fonds der Chemischen Industrie. S.S., G.A., L.K., J.R., J.K., C.G., and B.A.-C. designed and conducted experiments and analyzed results. G.T. conducted experiments and analyzed results. A.H. and E.M.S. designed experiments and supervised the project. E.M.S. wrote the manuscript. The authors declare no competing financial interests.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baudet ML, 2012, NAT NEUROSCI, V15, P29, DOI 10.1038/nn.2979; BENNETT MK, 1983, J BIOL CHEM, V258, P2735; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bicker S, 2013, GENE DEV, V27, P991, DOI 10.1101/gad.211243.112; Bissels U, 2009, RNA, V15, P2375, DOI 10.1261/rna.1754109; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Davies BP, 2008, BIOORGAN MED CHEM, V16, P49, DOI 10.1016/j.bmc.2007.04.055; Dieck ST, 2015, NAT METHODS, V12, P411, DOI [10.1038/nmeth.3319, 10.1038/NMETH.3319]; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Ho VM, 2014, MOL CELL NEUROSCI, V61, P1, DOI 10.1016/j.mcn.2014.04.006; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Kye MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024682; Kye MJ, 2007, RNA, V13, P1224, DOI 10.1261/rna.480407; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; Lugli G, 2008, J NEUROCHEM, V106, P650, DOI 10.1111/j.1471-4159.2008.05413.x; Saba R, 2012, MOL CELL BIOL, V32, P619, DOI 10.1128/MCB.05896-11; Sasaki Y, 2014, DEV NEUROBIOL, V74, P397, DOI 10.1002/dneu.22113; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Stubbusch J, 2015, DEV BIOL, V400, P210, DOI 10.1016/j.ydbio.2015.01.026; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; van Spronsen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074907; Wibrand K, 2010, EUR J NEUROSCI, V31, P636, DOI 10.1111/j.1460-9568.2010.07112.x	30	118	122	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					634	637		10.1126/science.aaf8995	http://dx.doi.org/10.1126/science.aaf8995			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK0SF	28183980				2022-12-28	WOS:000393636700050
J	Cui, LJ; Jeong, W; Hur, S; Matt, M; Klockner, JC; Pauly, F; Nielaba, P; Cuevas, JC; Meyhofer, E; Reddy, P				Cui, Longji; Jeong, Wonho; Hur, Sunghoon; Matt, Manuel; Klockner, Jan C.; Pauly, Fabian; Nielaba, Peter; Carlos Cuevas, Juan; Meyhofer, Edgar; Reddy, Pramod			Quantized thermal transport in single-atom junctions	SCIENCE			English	Article							SIZED POINT-CONTACT; MOLECULAR JUNCTIONS; HEAT-FLOW; METALLIC CONTACTS; ROOM-TEMPERATURE; SHOT-NOISE; QUANTUM; CONDUCTANCE; THERMOPOWER; THERMOELECTRICITY	Thermal transport in individual atomic junctions and chains is of great fundamental interest because of the distinctive quantum effects expected to arise in them. By using novel, custom-fabricated, picowatt-resolution calorimetric scanning probes, we measured the thermal conductance of gold and platinum metallic wires down to single-atom junctions. Our work reveals that the thermal conductance of gold single-atom junctions is quantized at room temperature and shows that the Wiedemann-Franz law relating thermal and electrical conductance is satisfied even in single-atom contacts. Furthermore, we quantitatively explain our experimental results within the Landauer framework for quantum thermal transport. The experimental techniques reported here will enable thermal transport studies in atomic and molecular chains, which will be key to investigating numerous fundamental issues that thus far have remained experimentally inaccessible.	[Cui, Longji; Jeong, Wonho; Hur, Sunghoon; Meyhofer, Edgar] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Matt, Manuel; Klockner, Jan C.; Pauly, Fabian; Nielaba, Peter] Univ Konstanz, Dept Phys, D-78457 Constance, Germany; [Carlos Cuevas, Juan] Univ Autonoma Madrid, Dept Fis Teor Mat Condensada, E-28049 Madrid, Spain; [Carlos Cuevas, Juan] Univ Autonoma Madrid, Condensed Matter Phys Ctr IFIMAC, E-28049 Madrid, Spain; [Reddy, Pramod] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Konstanz; Autonomous University of Madrid; Autonomous University of Madrid; University of Michigan System; University of Michigan	Meyhofer, E (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.; Cuevas, JC (corresponding author), Univ Autonoma Madrid, Dept Fis Teor Mat Condensada, E-28049 Madrid, Spain.; Cuevas, JC (corresponding author), Univ Autonoma Madrid, Condensed Matter Phys Ctr IFIMAC, E-28049 Madrid, Spain.; Reddy, P (corresponding author), Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.	juancarlos.cuevas@uam.es; meyhofer@umich.edu; pramodr@umich.edu	hur, sunghoon/HGC-1832-2022; Pauly, Fabian/I-8965-2012; Cuevas, Juan Carlos/B-7813-2012; Cui, Longji/C-8883-2017; Cuevas, Juan Carlos/P-2258-2019	hur, sunghoon/0000-0001-6985-5937; Pauly, Fabian/0000-0001-8017-2379; Cuevas, Juan Carlos/0000-0001-7421-0682; Cui, Longji/0000-0003-0469-3230; Meyhofer, Edgar/0000-0001-5719-6030	U.S. Department of Energy Basic Energy Sciences program [DE-SC0004871]; U.S. Office of Naval Research [N00014-16-1-2672]; U.S. National Science Foundation [CBET 1235691]; Spanish Ministry of Economy, Industry and Competitiveness [FIS2014-53488-P]; German Research Foundation (DFG); Collaborative Research Center (SFB) [767]; Carl Zeiss Foundation; DFG [SFB 767]; Junior Professorship Program of the Baden-Wurttemberg Ministry of Science, Research, and the Arts	U.S. Department of Energy Basic Energy Sciences program(United States Department of Energy (DOE)); U.S. Office of Naval Research(Office of Naval Research); U.S. National Science Foundation(National Science Foundation (NSF)); Spanish Ministry of Economy, Industry and Competitiveness(Spanish Government); German Research Foundation (DFG)(German Research Foundation (DFG)); Collaborative Research Center (SFB)(German Research Foundation (DFG)); Carl Zeiss Foundation; DFG(German Research Foundation (DFG)); Junior Professorship Program of the Baden-Wurttemberg Ministry of Science, Research, and the Arts	P.R. acknowledges support from the U.S. Department of Energy Basic Energy Sciences program (award no. DE-SC0004871). P.R. and E.M. acknowledge support from the U.S. Office of Naval Research (N00014-16-1-2672) and the U.S. National Science Foundation (CBET 1235691). J.C.C. acknowledges funding from the Spanish Ministry of Economy, Industry and Competitiveness (contract no. FIS2014-53488-P) and thanks the German Research Foundation (DFG) and Collaborative Research Center (SFB) 767 for sponsoring his stay at the University of Konstanz as a Mercator Fellow. M.M. and P.N. acknowledge funding from the SFB 767 and computer time granted by the John von Neumann Institute for Computing and the bwHPC framework program of the State of Baden-Wurttemberg, Germany. J.C.K. and F.P. were financially supported by the Carl Zeiss Foundation, the SFB 767 of the DFG, and the Junior Professorship Program of the Baden-Wurttemberg Ministry of Science, Research, and the Arts. We acknowledge the Lurie Nanofabrication Facility for facilitating the fabrication of devices. All of the data are available in the main paper and the supplementary materials.	Agrait N, 2003, PHYS REP, V377, P81, DOI 10.1016/S0370-1573(02)00633-6; Ashcroft N.W., 1976, SOLID STATE PHYS; Balachandran V, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035433; Bergfield JP, 2009, NANO LETT, V9, P3072, DOI 10.1021/nl901554s; Burkle M, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.165419; Cahill DG, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4832615; Chiatti O, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.056601; Crossno J, 2016, SCIENCE, V351, P1058, DOI 10.1126/science.aad0343; Cuevas J. C., 2010, WORLD SCI SERIES NAN; Cui LJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14479; Dreher M, 2005, PHYS REV B, V72, DOI [10.1103/PhysRevB.72.075435, 10.1103/physRevB.72.075435]; Dubi Y, 2011, REV MOD PHYS, V83, P131, DOI 10.1103/RevModPhys.83.131; Evangeli C, 2015, NANO LETT, V15, P1006, DOI 10.1021/nl503853v; Gotsmann B, 2013, NAT MATER, V12, P59, DOI [10.1038/nmat3460, 10.1038/NMAT3460]; Jain A, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.081206; Jezouin S, 2013, SCIENCE, V342, P601, DOI 10.1126/science.1241912; KRANS JM, 1995, PHYS REV LETT, V74, P2146, DOI 10.1103/PhysRevLett.74.2146; Lee W, 2013, NATURE, V498, P209, DOI 10.1038/nature12183; Li NB, 2012, REV MOD PHYS, V84, P1045, DOI 10.1103/RevModPhys.84.1045; Ludoph B, 1999, PHYS REV B, V59, P12290, DOI 10.1103/PhysRevB.59.12290; Meschke M, 2006, NATURE, V444, P187, DOI 10.1038/nature05276; OLESEN L, 1994, PHYS REV LETT, V72, P2251, DOI 10.1103/PhysRevLett.72.2251; OLESEN L, 1995, PHYS REV LETT, V74, P2147, DOI 10.1103/PhysRevLett.74.2147; Partanen M, 2016, NAT PHYS, V12, P460, DOI [10.1038/nphys3642, 10.1038/NPHYS3642]; Pauly F, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/12/125019; Pop E, 2010, NANO RES, V3, P147, DOI 10.1007/s12274-010-1019-z; Reddy P, 2007, SCIENCE, V315, P1568, DOI 10.1126/science.1137149; Sadat S, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4802239; Sadat S, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4744963; Scheer E, 1998, NATURE, V394, P154, DOI 10.1038/28112; Schirm C, 2013, NAT NANOTECHNOL, V8, P645, DOI [10.1038/nnano.2013.170, 10.1038/NNANO.2013.170]; Schwab K, 2000, NATURE, V404, P974, DOI 10.1038/35010065; SIVAN U, 1986, PHYS REV B, V33, P551, DOI 10.1103/PhysRevB.33.551; van den Brom HE, 1999, PHYS REV LETT, V82, P1526, DOI 10.1103/PhysRevLett.82.1526; Wheeler PJ, 2010, NANO LETT, V10, P1287, DOI 10.1021/nl904052r; Xu BQ, 2003, SCIENCE, V301, P1221, DOI 10.1126/science.1087481	36	138	139	12	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1192	1195	eaam6622	10.1126/science.aam6622	http://dx.doi.org/10.1126/science.aam6622			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9WV	28209640	Green Submitted			2022-12-28	WOS:000396351200040
J	Zhou, XX; Fan, LLZ; Li, PP; Shen, K; Lin, MZ				Zhou, Xin X.; Fan, Linlin Z.; Li, Pengpeng; Shen, Kang; Lin, Michael Z.			Optical control of cell signaling by single-chain photoswitchable kinases	SCIENCE			English	Article							PROTEIN-PROTEIN INTERACTIONS; RECEPTOR TYROSINE KINASES; LIVING CELLS; SPATIOTEMPORAL CONTROL; MAMMALIAN-CELLS; GENE-EXPRESSION; OPTOGENETIC CONTROL; MEDIATED INDUCTION; NEGATIVE-FEEDBACK; BLUE-LIGHT	Protein kinases transduce signals to regulate a wide array of cellular functions in eukaryotes. A generalizable method for optical control of kinases would enable fine spatiotemporal interrogation or manipulation of these various functions. We report the design and application of single-chain cofactor-free kinases with photoswitchable activity. We engineered a dimeric protein, pdDronpa, that dissociates in cyan light and reassociates in violet light. Attaching two pdDronpa domains at rationally selected locations in the kinase domain, we created the photoswitchable kinases psRaf1, psMEK1, psMEK2, and psCDK5. Using these photoswitchable kinases, we established an all-optical cell-based assay for screening inhibitors, uncovered a direct and rapid inhibitory feedback loop from ERK to MEK1, and mediated developmental changes and synaptic vesicle transport in vivo using light.	[Zhou, Xin X.; Fan, Linlin Z.; Lin, Michael Z.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Li, Pengpeng; Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Li, Pengpeng; Shen, Kang] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Lin, Michael Z.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Fan, Linlin Z.] Harvard Univ, Program Chem Biol, Cambridge, MA 02138 USA; [Li, Pengpeng] Harvard Med Sch, Boston Childrens Hosp, Boston, MA USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Harvard University; Harvard University; Boston Children's Hospital; Harvard Medical School	Lin, MZ (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Lin, MZ (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	mzlin@stanford.edu		Lin, Michael/0000-0002-0492-1961; Zhou, Xin/0000-0002-8198-2856; Fan, Linlin/0000-0001-6921-2659	Stanford Graduate Fellowship; HHMI International Graduate Student Fellowship; Stanford School of Engineering Undergraduate Visiting Researcher Program; NIH Pioneer Award [5DP1GM111003]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615, DP1GM111003] Funding Source: NIH RePORTER	Stanford Graduate Fellowship(Stanford University); HHMI International Graduate Student Fellowship; Stanford School of Engineering Undergraduate Visiting Researcher Program; NIH Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Colakoglu for assistance with worm experiments; Y. Tao and L. Feng for assistance with crystallographic data collection and analysis; X. Liu and T. Fu for assistance with protein structure refinement; J. Philo for assistance with sedimentation equilibrium analysis; L. Tao and G. Colakoglu for assistance with the worm experiments; T. Kudo, S. Regot, and M. Covert for ERK KTR constructs; K. Zhang and B. Cui for the Raf1 plasmid; R. Tran, X. Bao, and P. Khavari for the MEK1 plasmid; M. Davidson for the Neptune1-fascin plasmid; and members of the Lin laboratory for valuable assistance with experiments and advice on the manuscript. Supported by a Stanford Graduate Fellowship and a HHMI International Graduate Student Fellowship (X.X.Z.), the Stanford School of Engineering Undergraduate Visiting Researcher Program (L.Z.F.), and NIH Pioneer Award 5DP1GM111003 (M.Z.L.). All data are available in the manuscript or supplementary materials. Author contributions: X.X.Z. designed and characterized light-inducible kinases, generated protein crystals, solved x-ray structures, performed worm experiments, engineered pdDronpa1 variants, and co-wrote the manuscript; L.Z.F. characterized light-inducible intersectin and designed and characterized pdDronpaV and pdDronpaM; P. L. performed worm transgenesis and imaging; K. S. provided advice and supervision on worm experiments; and M.Z.L. conceived experiments, provided advice, and co-wrote the manuscript. The authors declare no competing financial interests.	Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Bae D, 2009, BIOCHEM BIOPH RES CO, V385, P523, DOI 10.1016/j.bbrc.2009.05.082; Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Bergeron JJM, 2016, ANNU REV BIOCHEM, V85, P573, DOI 10.1146/annurev-biochem-060815-014659; Bugaj LJ, 2013, NAT METHODS, V10, P249, DOI 10.1038/nmeth.2360; Catalanotti F, 2009, NAT STRUCT MOL BIOL, V16, P294, DOI 10.1038/nsmb.1564; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chang KY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5057; Chen D, 2013, J CELL BIOL, V201, P631, DOI 10.1083/jcb.201210119; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Crefcoeur RP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2800; Cseh B, 2014, FEBS LETT, V588, P2398, DOI 10.1016/j.febslet.2014.06.025; Dagliyan O, 2016, SCIENCE, V354, P1441, DOI 10.1126/science.aah3404; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Evers TH, 2006, BIOCHEMISTRY-US, V45, P13183, DOI 10.1021/bi061288t; Fritsche-Guenther R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.27; Gasser C, 2014, P NATL ACAD SCI USA, V111, P8803, DOI 10.1073/pnas.1321600111; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Grusch M, 2014, EMBO J, V33, P1713, DOI 10.15252/embj.201387695; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; Kawano F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7256; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kim N, 2014, CHEM BIOL, V21, P903, DOI 10.1016/j.chembiol.2014.05.013; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Lee S, 2014, NAT METHODS, V11, P633, DOI [10.1038/nmeth.2940, 10.1038/NMETH.2940]; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Lungu OI, 2012, CHEM BIOL, V19, P507, DOI 10.1016/j.chembiol.2012.02.006; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Motta-Mena LB, 2014, NAT CHEM BIOL, V10, P196, DOI [10.1038/NCHEMBIO.1430, 10.1038/nchembio.1430]; Muller K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt340; Nicholas HR, 2004, CURR BIOL, V14, P1256, DOI 10.1016/j.cub.2004.07.022; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Regot S, 2014, CELL, V157, P1724, DOI 10.1016/j.cell.2014.04.039; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319; Strickland D, 2008, P NATL ACAD SCI USA, V105, P10709, DOI 10.1073/pnas.0709610105; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; Wang X, 2012, NAT METHODS, V9, P266, DOI [10.1038/NMETH.1892, 10.1038/nmeth.1892]; Wend S, 2014, ACS SYNTH BIOL, V3, P280, DOI 10.1021/sb400090s; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569; Zhang K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092917; ZHENG CF, 1994, J BIOL CHEM, V269, P19947; Zhou XX, 2012, SCIENCE, V338, P810, DOI 10.1126/science.1226854	50	104	105	5	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					836	841		10.1126/science.aah3605	http://dx.doi.org/10.1126/science.aah3605			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28232577	Green Accepted			2022-12-28	WOS:000395127600041
J	Geva-Zatorsky, N; Sefik, E; Kua, L; Pasman, L; Tan, TG; Ortiz-Lopez, A; Yanortsang, TB; Yang, L; Jupp, R; Mathis, D; Benoist, C; Kasper, DL				Geva-Zatorsky, Naama; Sefik, Esen; Kua, Lindsay; Pasman, Lesley; Tan, Tze Guan; Ortiz-Lopez, Adriana; Yanortsang, Tsering Bakto; Yang, Liang; Jupp, Ray; Mathis, Diane; Benoist, Christophe; Kasper, Dennis L.			Mining the Human Gut Microbiota for Immunomodulatory Organisms	CELL			English	Article							PLASMACYTOID DENDRITIC CELLS; T-REG CELLS; LYMPHOID-CELLS; IMMUNE-SYSTEM; INTESTINAL HOMEOSTASIS; MAINTAIN HOMEOSTASIS; CYTOKINE PRODUCTION; COMMENSAL BACTERIA; PANETH CELLS; INNATE	Within the human gut reside diverse microbes coexisting with the host in a mutually advantageous relationship. Evidence has revealed the pivotal role of the gut microbiota in shaping the immune system. To date, only a few of these microbes have been shown to modulate specific immune parameters. Herein, we broadly identify the immunomodulatory effects of phylogenetically diverse human gut microbes. We monocolonized mice with each of 53 individual bacterial species and systematically analyzed host immunologic adaptation to colonization. Most microbes exerted several specialized, complementary, and redundant transcriptional and immunomodulatory effects. Surprisingly, these were independent of microbial phylogeny. Microbial diversity in the gut ensures robustness of the microbiota's ability to generate a consistent immunomodulatory impact, serving as a highly important epigenetic system. This study provides a foundation for investigation of gut microbiota-host mutualism, highlighting key players that could identify important therapeutics.	[Geva-Zatorsky, Naama; Sefik, Esen; Kua, Lindsay; Pasman, Lesley; Tan, Tze Guan; Ortiz-Lopez, Adriana; Yanortsang, Tsering Bakto; Yang, Liang; Mathis, Diane; Benoist, Christophe; Kasper, Dennis L.] Harvard Med Sch, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Jupp, Ray] UCB Pharma, Slough SL1 3WE, Berks, England	Harvard University; Harvard Medical School; UCB Pharma SA	Kasper, DL (corresponding author), Harvard Med Sch, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	dennis_kasper@hms.harvard.edu	Geva-Zatorsky, Naama/AAP-9176-2021	Geva-Zatorsky, Naama/0000-0002-7303-854X; Sefik, Esen/0000-0002-6807-3498	NIDDK; UCB; HFSP [LT00079/2012]; EMBO [ALTF 251-2011]; Fulbright Award; UNESCO L'Oreal National and International Women in Science Award; Weizmann Institute of Science-Revson National Postdoctoral Award Program; Boehringer Ingelheim Fonds; National Science Foundation [DGE1144152]; A*STAR Graduate Scholarship fellowship	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); UCB(UCB Pharma SA); HFSP(Human Frontier Science Program); EMBO(European Molecular Biology Organization (EMBO)); Fulbright Award; UNESCO L'Oreal National and International Women in Science Award; Weizmann Institute of Science-Revson National Postdoctoral Award Program; Boehringer Ingelheim Fonds(Boehringer Ingelheim); National Science Foundation(National Science Foundation (NSF)); A*STAR Graduate Scholarship fellowship	We thank A. Onderdonk, L. Bry, A. DuBois, M. Delaney, H. Renz, L. Comstock, J. Mekalanos, A. Sirota-Madi, Y. Benita, A. Madi, and N. Surana for mice, microbial strains, or insightful discussion and J. Ramos, S. Edwards, A. Rhoads, H. Paik, and C. Laplace for help with mice, profiling, and figure designs. Some microbes were obtained through BEI Resources, the NIAID, and the NIH as part of the Human Microbiome Project. Some microbes were from ATCC. Others were obtained from the HDDC center at Harvard-we thank the "Massachusetts Host Microbiome Center'' and P30 Ctr grant from NIDDK. This work was funded by a Sponsored Research Agreement from UCB. N.G.-Z. was supported by HFSP (LT00079/2012) and EMBO (ALTF 251-2011) fellowships, a Fulbright Award, a UNESCO L'Oreal National and International Women in Science Award, and the Weizmann Institute of Science-Revson National Postdoctoral Award Program for Advancing Women in Science; E.S. by a fellowship from the Boehringer Ingelheim Fonds; L.K. by the National Science Foundation (DGE1144152); and T.G.T. by an A*STAR Graduate Scholarship fellowship. R.J. is an employee of UCB Pharma.	An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chao YX, 2014, J LEUKOCYTE BIOL, V96, P1037, DOI 10.1189/jlb.2A0813-465RR; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Dasgupta S, 2014, CELL HOST MICROBE, V15, P413, DOI 10.1016/j.chom.2014.03.006; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051; Fujiwara D, 2008, J IMMUNOL, V180, P5843, DOI 10.4049/jimmunol.180.9.5843; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Knoop KA, 2015, MUCOSAL IMMUNOL, V8, P198, DOI 10.1038/mi.2014.58; Kole A, 2013, J IMMUNOL, V191, P2771, DOI 10.4049/jimmunol.1301093; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Metidji A, 2015, J IMMUNOL, V194, P4265, DOI 10.4049/jimmunol.1500036; Morton AM, 2014, P NATL ACAD SCI USA, V111, P6696, DOI 10.1073/pnas.1405634111; Nakahashi-Oda C, 2016, NAT IMMUNOL, V17, P441, DOI 10.1038/ni.3345; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rakoff-Nahoum S, 2016, NATURE, V533, P255, DOI 10.1038/nature17626; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Schirmer M, 2016, CELL, V167, P1125, DOI 10.1016/j.cell.2016.10.020; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Smith PA, 2015, NATURE, V526, P312, DOI 10.1038/526312a; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; Surana NK, 2014, J CLIN INVEST, V124, P4197, DOI 10.1172/JCI72332; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Tan TG, 2016, P NATL ACAD SCI USA, V113, pE8141, DOI 10.1073/pnas.1617460113; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Wang LR, 2016, CELL HOST MICROBE, V19, P227, DOI 10.1016/j.chom.2016.01.003; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	53	365	380	9	131	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					928	+		10.1016/j.cell.2017.01.022	http://dx.doi.org/10.1016/j.cell.2017.01.022			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28215708	Green Accepted, Bronze			2022-12-28	WOS:000396284800020
J	Spencer, DH; Russler-Germain, DA; Ketkar, S; Helton, NM; Lamprecht, TL; Fulton, RS; Fronick, CC; O'Laughlin, M; Heath, SE; Shinawi, M; Westervelt, P; Payton, JE; Wartman, LD; Welch, JS; Wilson, RK; Walter, MJ; Link, DC; DiPersio, JF; Ley, TJ				Spencer, David H.; Russler-Germain, David A.; Ketkar, Shamika; Helton, Nichole M.; Lamprecht, Tamara L.; Fulton, Robert S.; Fronick, Catrina C.; O'Laughlin, Michelle; Heath, Sharon E.; Shinawi, Marwan; Westervelt, Peter; Payton, Jacqueline E.; Wartman, Lukas D.; Welch, John S.; Wilson, Richard K.; Walter, Matthew J.; Link, Daniel C.; DiPersio, John F.; Ley, Timothy J.			CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression	CELL			English	Article							METHYLTRANSFERASE GENE DNMT3A; HEMATOPOIETIC STEM; DNA METHYLATION; TRANSCRIPTION FACTORS; CLONAL HEMATOPOIESIS; MUTATIONS; HYPOMETHYLATION; EXPANSION; CHROMATIN; PATTERNS	DNMT3A mutations occur in similar to 25% of acute myeloid leukemia (AML) patients. The most common mutation, DNMT3A R882H, has dominant negative activity that reduces DNA methylation activity by similar to 80% in vitro. To understand the contribution of DNMT3A-dependent methylation to leukemogenesis, we performed whole-genome bisulfite sequencing of primary leukemic and non-leukemic cells in patients with or without DNMT3A(R882) mutations. Nonleukemic hematopoietic cells with DNMT3A(R882H) displayed focal methylation loss, suggesting that hypomethylation antedates AML. Although virtually all AMLs with wild-type DNMT3A displayed CpG island hypermethylation, this change was not associated with gene silencing and was essentially absent in AMLs with DNMT3A(R882) mutations. Primary hematopoietic stem cells expanded with cytokines were hypermethylated in a DNMT3A-dependent manner, suggesting that hypermethylation may be a response to, rather than a cause of, cellular proliferation. Our findings suggest that hypomethylation is an initiating phenotype in AMLs with DNMT3A(R882), while DNMT3A-dependent CpG island hypermethylation is a consequence of AML progression.	[Spencer, David H.; Russler-Germain, David A.; Ketkar, Shamika; Helton, Nichole M.; Heath, Sharon E.; Westervelt, Peter; Wartman, Lukas D.; Welch, John S.; Walter, Matthew J.; Link, Daniel C.; DiPersio, John F.; Ley, Timothy J.] Washington Univ, Sch Med, Dept Med, Sect Stem Cell Biol,Div Oncol, St Louis, MO 63110 USA; [Lamprecht, Tamara L.] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Spencer, David H.; Fulton, Robert S.; Fronick, Catrina C.; O'Laughlin, Michelle; Wartman, Lukas D.; Wilson, Richard K.; Ley, Timothy J.] Washington Univ, McDonnell Genome Inst, St Louis, MO 63110 USA; [Shinawi, Marwan] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Payton, Jacqueline E.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); St Jude Children's Research Hospital; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Ley, TJ (corresponding author), Washington Univ, Sch Med, Dept Med, Sect Stem Cell Biol,Div Oncol, St Louis, MO 63110 USA.; Ley, TJ (corresponding author), Washington Univ, McDonnell Genome Inst, St Louis, MO 63110 USA.	timley@wustl.edu	Wilson, Richard K./AAF-4139-2019; Walter, Matthew J/S-7758-2018	Wilson, Richard K./0000-0002-1992-1358; Westover, Tamara/0000-0002-1000-6698; Russler-Germain, David/0000-0003-1009-2247; shinawi, Marwan/0000-0003-1329-4100	ASH Scholar Award [K08CA190815]; NIH [P01CA101937, R35CA197561]; National Cancer Institute Cancer Center [P30CA91842]; NATIONAL CANCER INSTITUTE [K08CA190815, P01CA101937, K08CA166229, R35CA197561, P30CA091842] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128447] Funding Source: NIH RePORTER	ASH Scholar Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We gratefully acknowledge our patients and their families for their participation in this study. Support was provided by grants to D.H.S. (K08CA190815, ASH Scholar Award), and T.J.L. (NIH P01CA101937 and R35CA197561). Technical assistance was provided by the Alvin J. Siteman Cancer Center Tissue Procurement and High Speed Cell Sorting Core at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, MO, which are supported by the National Cancer Institute Cancer Center (P30CA91842).	Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; BAYLIN SB, 1986, CANCER RES, V46, P2917; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Celik H, 2015, BLOOD, V125, P619, DOI 10.1182/blood-2014-08-594564; Challen GA, 2014, CELL STEM CELL, V15, P350, DOI 10.1016/j.stem.2014.06.018; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Cole CB, 2016, J CLIN INVEST, V126, P85, DOI 10.1172/JCI82897; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; FEINBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47, DOI 10.1016/S0006-291X(83)80115-6; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; GREGER V, 1989, HUM GENET, V83, P155, DOI 10.1007/BF00286709; Guryanova OA, 2016, LEUKEMIA, V30, P1133, DOI 10.1038/leu.2015.358; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r83, 10.1186/gb-2012-13-10-R83]; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Heger A, 2013, BIOINFORMATICS, V29, P2046, DOI 10.1093/bioinformatics/btt343; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Juhling F, 2016, GENOME RES, V26, P256, DOI 10.1101/gr.196394.115; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li H., 2013, 13033997V2 ARXIV, V1303, P1; Li Yuting, 2015, ScientificWorldJournal, V2015, P685690, DOI 10.1155/2015/685690; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu YP, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r61; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Rau RE, 2016, BLOOD, V128, P971, DOI 10.1182/blood-2015-11-684225; Russler-Germain DA, 2014, CANCER CELL, V25, P442, DOI 10.1016/j.ccr.2014.02.010; SAKAI T, 1991, AM J HUM GENET, V48, P880; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Song Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081148; Tatton-Brown K, 2014, NAT GENET, V46, P385, DOI 10.1038/ng.2917; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788	46	134	136	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					801	+		10.1016/j.cell.2017.01.021	http://dx.doi.org/10.1016/j.cell.2017.01.021			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28215704	Green Accepted, Bronze			2022-12-28	WOS:000396284800010
J	Mayor, S				Mayor, Susan			Bariatric surgery cuts hyperglycaemia in diabetes more than drugs alone, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Schauer PR, 2017, NEW ENGL J MED, V376, P641, DOI 10.1056/NEJMoa1600869	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2017	356								j857	10.1136/bmj.j857	http://dx.doi.org/10.1136/bmj.j857			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GP	28213612				2022-12-28	WOS:000394580000011
J	Mayor, S				Mayor, Susan			More babies born to mothers with gestational diabetes have adverse outcomes, study shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Billionnet C, 2017, DIABETOLOGIA, V60, P636, DOI 10.1007/s00125-017-4206-6	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2017	356								j846	10.1136/bmj.j846	http://dx.doi.org/10.1136/bmj.j846			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GN	28209565				2022-12-28	WOS:000394579800009
J	Martineau, AR; Jolliffe, DA; Hooper, RL; Greenberg, L; Aloia, JF; Bergman, P; Dubnov-Raz, G; Esposito, S; Ganmaa, D; Ginde, AA; Goodall, EC; Grant, CC; Griffiths, CJ; Janssens, W; Laaksi, I; Manaseki-Holland, S; Mauger, D; Murdoch, DR; Neale, R; Rees, JR; Simpson, S; Stelmach, I; Kumar, GT; Urashima, M; Camargo, CA				Martineau, Adrian R.; Jolliffe, David A.; Hooper, Richard L.; Greenberg, Lauren; Aloia, John F.; Bergman, Peter; Dubnov-Raz, Gal; Esposito, Susanna; Ganmaa, Davaasambuu; Ginde, Adit A.; Goodall, Emma C.; Grant, Cameron C.; Griffiths, Christopher J.; Janssens, Wim; Laaksi, Ilkka; Manaseki-Holland, Semira; Mauger, David; Murdoch, David R.; Neale, Rachel; Rees, Judy R.; Simpson, Steve, Jr.; Stelmach, Iwona; Kumar, Geeta Trilok; Urashima, Mitsuyoshi; Camargo, Carlos A., Jr.			Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DOUBLE-BLIND; RANDOMIZED-TRIAL; INFLUENZA-A; RISK; PNEUMONIA; INFANTS; ASTHMA; ADULTS; KABUL	OBJECTIVES To assess the overall effect of vitamin D supplementation on risk of acute respiratory tract infection, and to identify factors modifying this effect. DESIGN Systematic review and meta-analysis of individual participant data (IPD) from randomised controlled trials. DATA SOURCES Medline, Embase, the Cochrane Central Register of Controlled Trials, Web of Science, ClinicalTrials. gov, and the International Standard Randomised Controlled Trials Number registry from inception to December 2015. ELIGIBILITY CRITERIA FOR STUDY SELECTION Randomised, double blind, placebo controlled trials of supplementation with vitamin D-3 or vitamin D-2 of any duration were eligible for inclusion if they had been approved by a research ethics committee and if data on incidence of acute respiratory tract infection were collected prospectively and prespecified as an efficacy outcome. RESULTS 25 eligible randomised controlled trials (total 11 321 participants, aged 0 to 95 years) were identified. IPD were obtained for 10 933 (96.6%) participants. Vitamin D supplementation reduced the risk of acute respiratory tract infection among all participants (adjusted odds ratio 0.88, 95% confidence interval 0.81 to 0.96; P for heterogeneity < 0.001). In subgroup analysis, protective effects were seen in those receiving daily or weekly vitamin D without additional bolus doses (adjusted odds ratio 0.81, 0.72 to 0.91) but not in those receiving one or more bolus doses (adjusted odds ratio 0.97, 0.86 to 1.10; P for interaction 0.05). Among those receiving daily or weekly vitamin D, protective effects were stronger in those with baseline 25-hydroxyvitamin D levels <25 nmol/L (adjusted odds ratio 0.30, 0.17 to 0.53) than in those with baseline 25-hydroxyvitamin D levels >= 25 nmol/L (adjusted odds ratio 0.75, 0.60 to 0.95; P for interaction = 0.006). Vitamin D did not influence the proportion of participants experiencing at least one serious adverse event (adjusted odds ratio 0.98, 0.80 to 1.20, P = 0.83). The body of evidence contributing to these analyses was assessed as being of high quality. CONCLUSIONS Vitamin D supplementation was safe and it protected against acute respiratory tract infection overall. Patients who were very vitamin D deficient and those not receiving bolus doses experienced the most benefit. SYSTEMATIC REVIEW REGISTRATION PROSPERO CRD42014013953.	[Martineau, Adrian R.; Jolliffe, David A.; Hooper, Richard L.; Greenberg, Lauren; Griffiths, Christopher J.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Primary Care & Publ Hlth, London E1 2AB, England; [Martineau, Adrian R.; Griffiths, Christopher J.] Queen Mary Univ London, Blizard Inst, Asthma UK Ctr Appl Res, London, England; [Aloia, John F.] Winthrop Univ Hosp, Bone Mineral Res Ctr, Mineola, NY 11501 USA; [Bergman, Peter] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Dubnov-Raz, Gal] Edmond & Lily Safra Childrens Hosp, Dept Exercise, Lifestyle & Nutr Clin, Tel Hashomer, Israel; [Esposito, Susanna] Univ Milan, Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Pediat Highly Intens Care Unit, Milan, Italy; [Ganmaa, Davaasambuu] Harvard Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Ginde, Adit A.] Univ Colorado, Sch Med, Dept Emergency Med, Aurora, CO USA; [Goodall, Emma C.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Grant, Cameron C.] Univ Auckland, Fac Med & Hlth Sci, Dept Paediat Child & Youth Hlth, Auckland, New Zealand; [Griffiths, Christopher J.] Queen Mary Univ London, Blizard Inst, MRC & Asthma UK Ctr Allerg Mech Asthma, London, England; [Janssens, Wim] Univ Ziekenhuis Leuven, Leuven, Belgium; [Laaksi, Ilkka] Univ Tampere, Tampere Sch Publ Hlth, Tampere, Finland; [Manaseki-Holland, Semira] Univ Birmingham, Coll Med & Dent Sci, Inst Appl Hlth Sci, Dept Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England; [Mauger, David] Penn State Univ, Dept Stat, Hershey, PA USA; [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand; [Neale, Rachel] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Rees, Judy R.] Geisel Sch Med Dartmouth, Dept Epidemiol, Lebanon, NH USA; [Simpson, Steve, Jr.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Stelmach, Iwona] Med Univ Lodz, Dept Pediat & Allergy, Lodz, Poland; [Kumar, Geeta Trilok] Univ Delhi, Inst Home Econ, New Delhi, India; [Urashima, Mitsuyoshi] Jikei Univ, Sch Med, Div Mol Epidemiol, Tokyo, Japan; [Camargo, Carlos A., Jr.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA USA	University of London; Queen Mary University London; University of London; Queen Mary University London; Winthrop University Hospital; Karolinska Institutet; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Harvard University; Harvard T.H. Chan School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; McMaster University; University of Auckland; University of London; King's College London; Queen Mary University London; KU Leuven; University Hospital Leuven; Tampere University; University of Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Otago; QIMR Berghofer Medical Research Institute; Dartmouth College; University of Tasmania; Menzies Institute for Medical Research; Medical University Lodz; University of Delhi; Jikei University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Martineau, AR (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Primary Care & Publ Hlth, London E1 2AB, England.; Martineau, AR (corresponding author), Queen Mary Univ London, Blizard Inst, Asthma UK Ctr Appl Res, London, England.	a.martineau@qmul.ac.uk	Esposito, Susanna/AAA-8275-2022; Dubnov-Raz, Gal/L-3297-2016; Camargo, Carlos A./C-2145-2008; Trilok-Kumar, Geeta/AAF-5978-2021; Manaseki-Holland, Semira/I-7303-2017; Manaseki-Holland, Semira/AFX-1728-2022; Martineau, Adrian R/A-3083-2010; Murdoch, David/A-2012-2009; Simpson, Steve Jr/J-2454-2013; Neale, Rachel E./I-4427-2018; Esposito, Susanna/K-3475-2016	Dubnov-Raz, Gal/0000-0003-1469-8043; Camargo, Carlos A./0000-0002-5071-7654; Trilok-Kumar, Geeta/0000-0001-8442-2881; Manaseki-Holland, Semira/0000-0001-5827-8855; Manaseki-Holland, Semira/0000-0001-5827-8855; Simpson, Steve Jr/0000-0001-6521-3056; Neale, Rachel E./0000-0001-7162-0854; Janssens, Wim/0000-0003-1830-2982; Esposito, Susanna/0000-0003-4103-2837; Hooper, Richard/0000-0002-1063-0917; Grant, Cameron/0000-0002-4032-7230; Stelmach, Iwona/0000-0002-1475-8221; Bergman, Peter/0000-0003-3306-3713	National Institute for Health Research (NIHR) under its Health Technology Assessment programme [13/03/25]; Medical Research Council [G1000758B, G1000758] Funding Source: researchfish; National Institute for Health Research [13/03/25, RP-PG-0407-10398] Funding Source: researchfish; Asthma UK [MRC-Asthma UK Centre, AUK-AC-2012-01, MRC-AsthmaUKCentre] Funding Source: researchfish	National Institute for Health Research (NIHR) under its Health Technology Assessment programme(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	This study was supported by a grant from the National Institute for Health Research (NIHR) under its Health Technology Assessment programme (reference No 13/03/25, to ARM). The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, or the Department of Health. See the supplementary material for details of sources of support for individual investigators and trials. The NIHR was not involved in the study design; in the collection, analysis, or interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Bergman P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065835; Bergman P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001663; Tran B, 2014, AM J CLIN NUTR, V99, P156, DOI 10.3945/ajcn.113.063271; Camargo CA, 2012, PEDIATRICS, V130, pE561, DOI 10.1542/peds.2011-3029; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Charan J, 2012, J PHARMACOL PHARMACO, V3, P300, DOI 10.4103/0976-500X.103685; Denlinger LC, 2016, AM J RESP CRIT CARE, V193, P634, DOI 10.1164/rccm.201506-1169OC; Department of Health, 1998, DEP HLTH REP HLTH SO, V49; Dubnov-Raz G, 2015, PEDIATR EXERC SCI, V27, P113, DOI 10.1123/pes.2014-0030; Ginde AA, 2017, J AM GERIATR SOC, V65, P496, DOI 10.1111/jgs.14679; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Goodall EC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-273; Grant CC, 2015, ACTA PAEDIATR, V104, P396, DOI 10.1111/apa.12819; Greiller CL, 2015, NUTRIENTS, V7, P4240, DOI 10.3390/nu7064240; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Gysin DV, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0162996, 1]; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hewison M, 2011, NAT REV ENDOCRINOL, V7, P336, DOI 10.1038/nrendo.2010.226; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Jolliffe DA, 2013, J STEROID BIOCHEM, V136, P321, DOI 10.1016/j.jsbmb.2012.11.017; Kumar Geeta Trilok, 2011, BMJ, V342, pd2975, DOI 10.1136/bmj.d2975; Laaksi I, 2010, J INFECT DIS, V202, P809, DOI 10.1086/654881; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; Li-Ng M, 2009, EPIDEMIOL INFECT, V137, P1396, DOI 10.1017/S0950268809002404; Majak P, 2011, J ALLERGY CLIN IMMUN, V127, P1294, DOI 10.1016/j.jaci.2010.12.016; Manaseki-Holland S, 2012, LANCET, V379, P1419, DOI 10.1016/S0140-6736(11)61650-4; Manaseki-Holland S, 2010, TROP MED INT HEALTH, V15, P1148, DOI 10.1111/j.1365-3156.2010.02578.x; Mao S, 2013, SCAND J INFECT DIS, V45, P696, DOI 10.3109/00365548.2013.803293; Marchisio P, 2013, PEDIATR INFECT DIS J, V32, P1055, DOI 10.1097/INF.0b013e31829be0b0; Martineau Adrian R, 2015, Thorax, V70, P953, DOI 10.1136/thoraxjnl-2015-206996; Martineau AR, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011511.pub2; Martineau AR, 2015, THORAX, V70, P451, DOI 10.1136/thoraxjnl-2014-206449; Martineau AR, 2015, LANCET RESP MED, V3, P120, DOI 10.1016/S2213-2600(14)70255-3; Martineau AR, 2012, LANCET, V379, P1373, DOI 10.1016/S0140-6736(12)60405-X; Murdoch DR, 2012, JAMA-J AM MED ASSOC, V308, P1333, DOI 10.1001/jama.2012.12505; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Olliver M, 2013, J INFECT DIS, V208, P1474, DOI 10.1093/infdis/jit355; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Rees JR, 2013, CLIN INFECT DIS, V57, P1384, DOI 10.1093/cid/cit549; Reid IR, 2016, LANCET DIABETES ENDO, V4, P376, DOI 10.1016/S2213-8587(16)00079-6; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Sabetta JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011088; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Simpson S., 2015, BMC NUTR, V1, P7, DOI [10.1186/2055-0928-1-7, DOI 10.1186/2055-0928-1-7]; Steenhoff AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117123; SUN X, 2010, BMJ-BRIT MED J, V340, DOI DOI 10.1136/BMJ.C117; Tachimoto H, 2016, ALLERGY, V71, P1001, DOI 10.1111/all.12856; Urashima M, 2014, FOOD FUNCT, V5, P2365, DOI [10.1039/C4FO00371C, 10.1039/c4fo00371c]; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; Vieth R, 2009, ANTICANCER RES, V29, P3675; Waterhouse M, 2014, J CLIN ENDOCR METAB, V99, pE1332, DOI 10.1210/jc.2013-4101; Xiao LM, 2015, BRIT J NUTR, V114, P1026, DOI 10.1017/S000711451500207X	53	991	1030	9	124	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	2017	356								i6583	10.1136/bmj.i6583	http://dx.doi.org/10.1136/bmj.i6583			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GM	28202713	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000394579700001
J	McCartney, M				McCartney, Margaret			Margaret McCartney: General practice is a long game	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2017	356								j736	10.1136/bmj.j736	http://dx.doi.org/10.1136/bmj.j736			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GI	28193638	Bronze, Green Published			2022-12-28	WOS:000394579300004
J	Lossaint, G; Lingner, J				Lossaint, Gerald; Lingner, Joachim			TZAP or not to zap telomeres	SCIENCE			English	Editorial Material							LENGTH; CHROMATIN; MECHANISM; REVEALS; STATES; CELLS		[Lossaint, Gerald; Lingner, Joachim] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Sch Life Sci, CH-1015 Lausanne, Switzerland	Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Lingner, J (corresponding author), Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Sch Life Sci, CH-1015 Lausanne, Switzerland.	joachim.lingner@epfl.ch		Lingner, Joachim/0000-0002-2853-5803				Bartocci C, 2014, CELL REP, V7, P1320, DOI 10.1016/j.celrep.2014.04.002; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Doksani Y, 2013, CELL, V155, P345, DOI 10.1016/j.cell.2013.09.048; Grolimund L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3848; Li BB, 1996, GENE DEV, V10, P1310, DOI 10.1101/gad.10.11.1310; Li JSZ, 2017, SCIENCE, V355, P638, DOI 10.1126/science.aah6752; Pickett HA, 2011, HUM MOL GENET, V20, P4684, DOI 10.1093/hmg/ddr402; Pickett HA, 2009, EMBO J, V28, P799, DOI 10.1038/emboj.2009.42; Rivera T, 2017, NAT STRUCT MOL BIOL, V24, P30, DOI 10.1038/nsmb.3335; Sarek G, 2015, MOL CELL, V57, P622, DOI 10.1016/j.molcel.2014.12.024; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011	15	3	3	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					578	579		10.1126/science.aam7015	http://dx.doi.org/10.1126/science.aam7015			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK0SF	28183935				2022-12-28	WOS:000393636700026
J	McCarthy, M				McCarthy, Michael			Appeal court upholds stay on Trump's travel ban	BMJ-BRITISH MEDICAL JOURNAL			English	News Item							US											McCarthy M, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j610; McCarthy M, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j545	2	0	0	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2017	356								j758	10.1136/bmj.j758	http://dx.doi.org/10.1136/bmj.j758			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GC	28188137				2022-12-28	WOS:000394578700013
J	Eom, DS; Parichy, DM				Eom, Dae Seok; Parichy, David M.			CELL SIGNALING A macrophage relay for long-distance signaling during postembryonic tissue remodeling	SCIENCE			English	Article							PATTERN-FORMATION; APOPTOTIC CELLS; ZEBRAFISH; REGENERATION; HOMEOSTASIS; FILOPODIA; FISH; FMS	Macrophages have diverse functions in immunity as well as in development and homeostasis. We identified a function for these cells in long-distance communication during postembryonic tissue remodeling. Ablation of macrophages in zebrafish prevented melanophores from coalescing into adult pigment stripes. Melanophore organization depends on signals provided by cells of the yellow xanthophore lineage via airinemes, long filamentous projections with vesicles at their tips. We show that airineme extension from originating cells, as well as vesicle deposition on target cells, depend on interactions with macrophages. These findings identify a role for macrophages in relaying long-range signals between nonimmune cells. This signaling modality may function in the remodeling and homeostasis of other tissues during normal development and disease.	[Eom, Dae Seok] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Parichy, David M.] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA	University of Washington; University of Washington Seattle; University of Virginia	Parichy, DM (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA.	dparichy@virginia.edu		Eom, Dae Seok/0000-0002-0617-8788	NIH [R01 GM096906]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096906, R35GM122471] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Aman, E. Bain, S. Larson, T. Larson, M. Roh-Johnson, and J. Wallingford for discussions, critical reading of the manuscript, or both. Supported by NIH grant R01 GM096906 (D.M.P.). Author contributions: D.S.E. performed experiments; D.S.E. and D.M.P. designed the experiments, analyzed data, and wrote the manuscript.	Budi EH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002044; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Eom DS, 2015, ELIFE, V4, DOI 10.7554/eLife.12401; Fairchild CL, 2014, CURR OPIN GENET DEV, V27, P67, DOI 10.1016/j.gde.2014.03.013; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Hamada H, 2014, DEVELOPMENT, V141, P318, DOI 10.1242/dev.099804; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; Inaba M, 2012, SCIENCE, V335, P677, DOI 10.1126/science.1212821; Inaba M, 2015, NATURE, V523, P329, DOI 10.1038/nature14602; Irion U, 2016, CURR TOP DEV BIOL, V117, P141, DOI 10.1016/bs.ctdb.2015.12.012; Kornberg TB, 2014, DEVELOPMENT, V141, P729, DOI 10.1242/dev.086223; Krahling S, 1999, CELL DEATH DIFFER, V6, P183, DOI 10.1038/sj.cdd.4400473; McKinney MC, 2011, DEV DYNAM, V240, P1391, DOI 10.1002/dvdy.22612; McMenamin SK, 2014, SCIENCE, V345, P1358, DOI 10.1126/science.1256251; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Parichy DM, 2003, DEVELOPMENT, V130, P817, DOI 10.1242/dev.00307; Parichy DM, 2000, DEVELOPMENT, V127, P3031; Patterson LB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003561; Petrie TA, 2014, DEVELOPMENT, V141, P2581, DOI 10.1242/dev.098459; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Stefater JA, 2011, TRENDS MOL MED, V17, P743, DOI 10.1016/j.molmed.2011.07.009; Tauber AI, 2003, NAT REV MOL CELL BIO, V4, P897, DOI 10.1038/nrm1244; van Ham TJ, 2010, FASEB J, V24, P4336, DOI 10.1096/fj.10-161018; Walton EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138949; Watanabe M, 2015, TRENDS GENET, V31, P88, DOI 10.1016/j.tig.2014.11.005; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034	30	61	61	3	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1317	1319		10.1126/science.aal2745	http://dx.doi.org/10.1126/science.aal2745			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28209639	Green Accepted			2022-12-28	WOS:000397082900040
J	Johnson, LM; Du, JM; Ale, CJH; Bischof, S; Feng, SH; Hodavarapu, RKC; Zhong, XH; Marson, G; Pellegrini, M; Segal, DJ; Patel, DJ; Jacobsen, SE				Johnson, Lianna M.; Du, Jiamu; Ale, Christopher J. H.; Bischof, Sylvain; Feng, Suhua; Hodavarapu, Ramakrishna K. C.; Zhong, Xuehua; Marson, Giuseppe; Pellegrini, Matteo; Segal, David J.; Patel, Dinshaw J.; Jacobsen, Steven E.			SRA- and SET-domain-containing proteins link RNA polymerase V occupancy to DNA methylation (vol 507, pg 124, 2014)	NATURE			English	Correction															NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM124806] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Johnson LM, 2014, NATURE, V507, P124, DOI 10.1038/nature12931	1	1	1	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					136	136		10.1038/nature21398	http://dx.doi.org/10.1038/nature21398			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VI0YQ	28178234				2022-12-28	WOS:000459862000001
J	Chi, KR				Chi, Kelly Rae			THE RNA CODE COMES INTO FOCUS As researchers open up to the reality of RNA modification, an expanded epitranscriptomics toolbox takes shape	NATURE			English	Editorial Material							DYNAMIC N-1-METHYLADENOSINE METHYLOME; MESSENGER-RNA; BASE MODIFICATION; TRANSCRIPTOME											Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Dominissini D, 2016, NATURE, V530, P441, DOI 10.1038/nature16998; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Garalde D.R., 2016, PREPRINT; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li XY, 2016, NAT CHEM BIOL, V12, P311, DOI [10.1038/NCHEMBIO.2040, 10.1038/nchembio.2040]; Li XY, 2015, NAT CHEM BIOL, V11, P592, DOI [10.1038/nchembio.1836, 10.1038/NCHEMBIO.1836]; Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017; Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Roost C, 2015, J AM CHEM SOC, V137, P2107, DOI 10.1021/ja513080v; Simpson JT, 2017, NAT METHODS, V14, P407, DOI 10.1038/nmeth.4184; Vilfan ID, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-8; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; Zheng GQ, 2015, NAT METHODS, V12, P835, DOI [10.1038/NMETH.3478, 10.1038/nmeth.3478]	18	9	11	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2017	542	7642					503	506		10.1038/542503a	http://dx.doi.org/10.1038/542503a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM1RG	28230128				2022-12-28	WOS:000395094100042
J	Doms, RW				Doms, Robert W.			What Came First-the Virus or the Egg?	CELL			English	Editorial Material									[Doms, Robert W.] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Doms, Robert W.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Doms, RW (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.; Doms, RW (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.	domsr@email.chop.edu						Blagborough AM, 2009, VACCINE, V27, P5187, DOI 10.1016/j.vaccine.2009.06.069; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Liu YJ, 2008, GENE DEV, V22, P1051, DOI 10.1101/gad.1656508; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Pinello JF, 2017, CURR BIOL, V27, P651, DOI 10.1016/j.cub.2017.01.049; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Valansi C., 2017, J CELL BIOL; Wong JL, 2010, TRENDS CELL BIOL, V20, P134, DOI 10.1016/j.tcb.2009.12.007	9	10	10	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					755	+		10.1016/j.cell.2017.02.012	http://dx.doi.org/10.1016/j.cell.2017.02.012			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28235193	Bronze			2022-12-28	WOS:000396284800005
J	Kaiser, J				Kaiser, Jocelyn			BIOMEDICINE A yellow light for embryo editing	SCIENCE			English	News Item																			0	2	4	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					675	675		10.1126/science.355.6326.675-b	http://dx.doi.org/10.1126/science.355.6326.675-b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2AC	28209849				2022-12-28	WOS:000395117700011
J	Finkelstein, A; Gentzkow, M; Hull, P; Williams, H				Finkelstein, Amy; Gentzkow, Matthew; Hull, Peter; Williams, Heidi			Adjusting Risk Adjustment - Accounting for Variation in Diagnostic Intensity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Finkelstein, Amy; Hull, Peter; Williams, Heidi] MIT, Dept Econ, Cambridge, MA 02139 USA; [Finkelstein, Amy; Gentzkow, Matthew; Williams, Heidi] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Gentzkow, Matthew] Stanford Univ, Dept Econ, Stanford, CA 94305 USA	Massachusetts Institute of Technology (MIT); National Bureau of Economic Research; Stanford University	Finkelstein, A (corresponding author), MIT, Dept Econ, Cambridge, MA 02139 USA.				NATIONAL INSTITUTE ON AGING [R01AG032449, T32AG000186, P01AG019783] Funding Source: NIH RePORTER; NIA NIH HHS [R37 AG032449, R01 AG032449, T32 AG000186, P01 AG019783] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Finkelstein A, 2016, Q J ECON, V131, P1681, DOI 10.1093/qje/qjw023; Gawande A., 2009, THE NEW YORKER  0601; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881	3	30	30	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2017	376	7					608	610		10.1056/NEJMp1613238	http://dx.doi.org/10.1056/NEJMp1613238			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0QJ	28199802	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000396402700010
J	Gassman, AL; Nguyen, CP; Joffe, HV				Gassman, Audrey L.; Nguyen, Christine P.; Joffe, Hylton V.			FDA Regulation of Prescription Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							APPROVAL; RISK		[Gassman, Audrey L.; Nguyen, Christine P.; Joffe, Hylton V.] US FDA, Div Bone Reprod & Urol Prod, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Joffe, HV (corresponding author), US FDA, Div Bone Reprod & Urol Prod, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	hylton.joffe@fda.hhs.gov						[Anonymous], 2009, MIL US FOOD DRUG LAW; [Anonymous], 2016, FDA BAS WEB BRIEF OV; [Anonymous], 2016, ADV COMM; [Anonymous], 2016, PLR REQ PRESCR INF; [Anonymous], 2016, MEDWATCH SAF AL HUM; [Anonymous], 2016, PROD SPEC REC GEN DR; [Anonymous], 2015, GUID IND REV STAFF F; [Anonymous], 2010, SAF LAB CHANG ORD; [Anonymous], 2016, FDAS SENT IN BACK GR; [Anonymous], 2015, ENH BEN RISK ASS REG; [Anonymous], 2016, DRUG SAF COMM; [Anonymous], 2010, MAN POL PROC RES DIF; [Anonymous], 2016, MED GUID; [Anonymous], 2003, FDA DRUG SAF COMM AZ; [Anonymous], 2015, TOT NUMB RET PRESCR; [Anonymous], 2016, POSTM DRUG SAF INF P; [Anonymous], 2014, DRUG APPL CURR GOOD; [Anonymous], 2016, MEDWATCH FDA SAF INF; [Anonymous], 2017, DRUG SAF LAB CHANG S; Ball R, 2016, CLIN PHARMACOL THER, V99, P265, DOI 10.1002/cpt.320; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; Food and Drug Administration, 2013, GUID IND FDA STAFF B; Food and Drug Administration, 2016, UND GEN DRUGS; Food and Drug Administration, 1998, GUID IND PROV CLIN E; Food and Drug Administration, 2009, DRUG SAF NEWS, V2, P21; Food and Drug Administration, 2016, QUEST ANSW FDAS ADV; Food & Drug Administration, 2016, NEW DRUGS FDA CDERS; Generic Pharmaceutical Association, 2015, GEN DRUG SAV US 7 AN; Joffe HV, 2016, NEW ENGL J MED, V374, P101, DOI 10.1056/NEJMp1513686; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Sacks LV, 2014, JAMA-J AM MED ASSOC, V311, P378, DOI 10.1001/jama.2013.282542; Sasinowski FJ, 2015, THER INNOV REGUL SCI, V49, P680, DOI 10.1177/2168479015580383; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Smith JF, 2012, NAT REV DRUG DISCOV, V11, P513, DOI 10.1038/nrd3747; Southworth MR, 2013, NEW ENGL J MED, V368, P1272, DOI 10.1056/NEJMp1302834; Staffa JA, 2012, CLIN PHARMACOL THER, V91, P555, DOI 10.1038/clpt.2011.289; The Food and Drug Administration, 2016, DEV APPR PROC DRUGS	38	21	21	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2017	376	7					674	682		10.1056/NEJMra1602972	http://dx.doi.org/10.1056/NEJMra1602972			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO0QJ	28199811				2022-12-28	WOS:000396402700018
J	Livio, M				Livio, Mario			Winston Churchill's essay on alien life found	NATURE			English	Editorial Material												dr.mario.livio@gmail.com						Churchill W., 1958, NEW SCI, V12; Churchill W., 1931, STRAND MAGAZINE  DEC; Conselice CJ, 2016, ASTROPHYS J, V830, DOI 10.3847/0004-637X/830/2/83; Dressing CD, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/95; Humes J. C., 2012, CHURCHILL PROPHETIC, V82; Jones R. V., 1996, CHURCHILL, P437; Livio M., PHYS TODAY IN PRESS; Way MJ, 2016, GEOPHYS RES LETT, V43, P8376, DOI 10.1002/2016GL069790	8	2	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					289	291		10.1038/542289a	http://dx.doi.org/10.1038/542289a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2LQ	28202987	Bronze			2022-12-28	WOS:000394451600013
J	Altman, DG; Moher, D; Schulz, KF				Altman, Douglas G.; Moher, David; Schulz, Kenneth F.			Harms of outcome switching in reports of randomised trials: CONSORT perspective	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Moher, David] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Moher, David] Univ Ottawa, Canadian EQUATOR Ctr, Ottawa, ON, Canada; [Schulz, Kenneth F.] FHI 360, Durham, NC USA; [Schulz, Kenneth F.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England; [Altman, Douglas G.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, UK EQUATOR Ctr, Oxford, England	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; FHI 360; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Oxford; University of Oxford	Altman, DG (corresponding author), Univ Oxford, Ctr Stat Med, Oxford, England.; Altman, DG (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, UK EQUATOR Ctr, Oxford, England.	doug.altman@csm.ox.ac.uk	Moher, David/I-3408-2019	Moher, David/0000-0003-2434-4206	Medical Research Council [MR/J00488X/1] Funding Source: researchfish; MRC [MR/J00488X/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altman DG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4796; [Anonymous], 2004, NEW ENGLAND J MED; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Doshi P, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5543; Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Goodman SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5027; Hannink G, 2013, ANN SURG, V257, P818, DOI 10.1097/SLA.0b013e3182864fa3; Jones CW, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0520-3; Killeen S, 2014, ANN SURG, V259, P193, DOI 10.1097/SLA.0b013e318299d00b; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Slade E, 2016, ANN INTERN MED, V164, P374, DOI 10.7326/L15-0614; Turner L, 2012, COCHRANE DATABASE SY, V356	16	13	13	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2017	356								j396	10.1136/bmj.j396	http://dx.doi.org/10.1136/bmj.j396			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GL	28196813				2022-12-28	WOS:000394579600001
J	Mayor, S				Mayor, Susan			More than a third with COPD also have asthma symptoms, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Baarnes CB, 2017, NPJ PRIM CARE RESP M, V27, DOI 10.1038/npjpcrm.2016.84	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2017	356								j747	10.1136/bmj.j747	http://dx.doi.org/10.1136/bmj.j747			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GI	28193606				2022-12-28	WOS:000394579300005
J	Barnosky, AD; Hadly, EA; Gonzalez, P; Head, J; Polly, PD; Lawing, AM; Eronen, JT; Ackerly, DD; Alex, K; Biber, E; Blois, J; Brashares, J; Ceballos, G; Davis, E; Dietl, GP; Dirzo, R; Doremus, H; Fortelius, M; Greene, HW; Hellmann, J; Hickler, T; Jackson, ST; Kemp, M; Koch, PL; Kremen, C; Lindsey, EL; Looy, C; Marshall, CR; Mendenhall, C; Mulch, A; Mychajliw, AM; Nowak, C; Ramakrishnan, U; Schnitzler, J; Das Shrestha, K; Solari, K; Stegner, L; Stegner, MA; Stenseth, NC; Wake, MH; Zhang, ZB				Barnosky, Anthony D.; Hadly, Elizabeth A.; Gonzalez, Patrick; Head, Jason; Polly, P. David; Lawing, A. Michelle; Eronen, Jussi T.; Ackerly, David D.; Alex, Ken; Biber, Eric; Blois, Jessica; Brashares, Justin; Ceballos, Gerardo; Davis, Edward; Dietl, Gregory P.; Dirzo, Rodolfo; Doremus, Holly; Fortelius, Mikael; Greene, Harry W.; Hellmann, Jessica; Hickler, Thomas; Jackson, Stephen T.; Kemp, Melissa; Koch, Paul L.; Kremen, Claire; Lindsey, Emily L.; Looy, Cindy; Marshall, Charles R.; Mendenhall, Chase; Mulch, Andreas; Mychajliw, Alexis M.; Nowak, Carsten; Ramakrishnan, Uma; Schnitzler, Jan; Das Shrestha, Kashish; Solari, Katherine; Stegner, Lynn; Stegner, M. Allison; Stenseth, Nils Chr; Wake, Marvalee H.; Zhang, Zhibin			Merging paleobiology with conservation biology to guide the future of terrestrial ecosystems	SCIENCE			English	Review							CLIMATE-CHANGE; MAMMALIAN RESPONSE; ECOLOGY; TRAITS; VULNERABILITY; ASSEMBLAGES; PERSPECTIVE; CHALLENGES; FIDELITY; COLLAPSE	Conservation of species and ecosystems is increasingly difficult because anthropogenic impacts are pervasive and accelerating. Under this rapid global change, maximizing conservation success requires a paradigm shift from maintaining ecosystems in idealized past states toward facilitating their adaptive and functional capacities, even as species ebb and flow individually. Developing effective strategies under this new paradigm will require deeper understanding of the long-term dynamics that govern ecosystem persistence and reconciliation of conflicts among approaches to conserving historical versus novel ecosystems. Integrating emerging information from conservation biology, paleobiology, and the Earth sciences is an important step forward on the path to success. Maintaining nature in all its aspects will also entail immediately addressing the overarching threats of growing human population, overconsumption, pollution, and climate change.	[Barnosky, Anthony D.] Stanford Univ, Jasper Ridge Biol Preserve, Stanford, CA 94305 USA; [Barnosky, Anthony D.; Lindsey, Emily L.; Marshall, Charles R.; Stegner, M. Allison; Wake, Marvalee H.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Barnosky, Anthony D.; Lindsey, Emily L.; Marshall, Charles R.; Stegner, M. Allison; Wake, Marvalee H.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Barnosky, Anthony D.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Hadly, Elizabeth A.] Stanford Univ, Jasper Ridge Biol Preserve, Dept Biol,Ctr Innovat Global Hlth, Dept Geol Sci,Woods Inst Environm, Palo Alto, CA 94303 USA; [Gonzalez, Patrick] Natl Pk Serv, Nat Resource Stewardship & Sci, Berkeley, CA 94720 USA; [Gonzalez, Patrick; Brashares, Justin; Kremen, Claire] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Head, Jason] Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England; [Polly, P. David] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Lawing, A. Michelle] Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX 77845 USA; [Eronen, Jussi T.; Mulch, Andreas; Schnitzler, Jan] Senckenberg Biodivers & Climate Res Ctr BiK F, Senckenberganlage 25, D-60325 Frankfurt, Germany; [Eronen, Jussi T.] Univ Helsinki, Dept Geosci & Geog, POB 64, FIN-00014 Helsinki, Finland; [Eronen, Jussi T.] BIOS Res Unit, Kalliolanrinne 4, Helsinki, Finland; [Ackerly, David D.] Univ Calif Berkeley, Dept Integrat Biol, Univ & Jepson Herbaria, Berkeley, CA 94720 USA; [Alex, Ken] Calif Governors Off Planning & Res, POB 3044, Sacramento, CA 95812 USA; [Biber, Eric; Doremus, Holly] Univ Calif Berkeley, Sch Law, Boalt Hall, Berkeley, CA 94720 USA; [Blois, Jessica] Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA; [Ceballos, Gerardo] Univ Nacl Autonoma Mexico, Inst Ecol, CU, Ap Post 70-275, Mexico City 04510, DF, Mexico; [Davis, Edward] Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA; [Dietl, Gregory P.] Paleontol Res Inst, 1259 Trumansburg Rd, Ithaca, NY 14850 USA; [Dietl, Gregory P.] Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14853 USA; [Dirzo, Rodolfo; Mychajliw, Alexis M.; Solari, Katherine] Stanford Univ, Dept Biol, Stanford, CA 94303 USA; [Fortelius, Mikael] Univ Helsinki, Dept Geosci & Geog, POB 64, FI-00014 Helsinki, Finland; [Fortelius, Mikael] Univ Oslo, Ctr Ecol & Evolutionary Synth, POB 1066 Blindern, NO-0316 Oslo, Norway; [Greene, Harry W.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Hellmann, Jessica] Univ Minnesota, Inst Environm, Minneapolis, MN 55455 USA; [Hickler, Thomas] Goethe Univ Frankfurt, Senckenberg Biodivers & Climate Res Ctr BiK F, Senckenberganlage 25, D-60325 Frankfurt, Germany; [Hickler, Thomas] Goethe Univ Frankfurt, Inst Phys Geog, Senckenberganlage 25, D-60325 Frankfurt, Germany; [Jackson, Stephen T.] US Geol Survey, Dept Interior, Southwest Climate Sci Ctr, 1064 E Lowell St, Tucson, AZ 85721 USA; [Jackson, Stephen T.] Univ Arizona, Dept Geosci, 1064 E Lowell St, Tucson, AZ 85721 USA; [Kemp, Melissa] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA; [Koch, Paul L.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Looy, Cindy] Univ Calif Berkeley, Dept Integrat Biol, Museum Paleontol, Univ & Jepson Herbaria, Berkeley, CA 94720 USA; [Mendenhall, Chase] Stanford Univ, Ctr Conservat Biol, Stanford, CA 94305 USA; [Mendenhall, Chase] Nature Conservancy, Arlington, VA 22203 USA; [Mulch, Andreas] Goethe Univ Frankfurt, Inst Geosci, D-60438 Frankfurt, Germany; [Nowak, Carsten] Senckenberg Res Inst, D-63571 Gelnhausen, Germany; [Nowak, Carsten] Nat Hist Museum Frankfurt, D-63571 Gelnhausen, Germany; [Ramakrishnan, Uma] Tata Inst Fundamental Res GKVK, Natl Ctr Biol Sci, Bellary Rd, Bangalore 560065, Karnataka, India; [Schnitzler, Jan] Univ Leipzig, Inst Biol, Johannisallee 21-23, D-04103 Leipzig, Germany; [Das Shrestha, Kashish] City Museum, Kathmandu 44600, Nepal; [Stegner, Lynn] Stanford Univ, Continuing Studies Program, Stanford, CA 94305 USA; [Stenseth, Nils Chr] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, POB 1066 Blindern, NO-0316 Oslo, Norway; [Zhang, Zhibin] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Insects & Rod, 1 Beichen West Rd, Beijing 100101, Peoples R China; [Lindsey, Emily L.] Brea Tar Pits & Museum, 5801 Wilshire Blvd, Los Angeles, CA 90036 USA; [Stegner, M. Allison] Univ Wisconsin, Dept Zool, 430 Lincoln Dr, Madison, WI 53706 USA	Stanford University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Stanford University; United States Department of the Interior; University of California System; University of California Berkeley; University of Cambridge; Indiana University System; Indiana University Bloomington; Texas A&M University System; Texas A&M University College Station; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); University of Helsinki; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Merced; Universidad Nacional Autonoma de Mexico; University of Oregon; Cornell University; Stanford University; University of Helsinki; University of Oslo; Cornell University; University of Minnesota System; University of Minnesota Twin Cities; Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; United States Department of the Interior; United States Geological Survey; University of Arizona; Harvard University; University of California System; University of California Santa Cruz; University of California System; University of California Berkeley; Stanford University; Nature Conservancy; Goethe University Frankfurt; Senckenberg Gesellschaft fur Naturforschung (SGN); Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Leipzig University; Stanford University; University of Oslo; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Wisconsin System; University of Wisconsin Madison	Barnosky, AD (corresponding author), Stanford Univ, Jasper Ridge Biol Preserve, Stanford, CA 94305 USA.; Barnosky, AD (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.; Barnosky, AD (corresponding author), Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA.; Barnosky, AD (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	tonybarnosky@stanford.edu	Lawing, Michelle/F-7453-2019; Eronen, Jussi T./B-7978-2013; Blois, Jessica/G-5893-2011; Ackerly, David/A-1247-2009; Nowak, Carsten/A-4466-2014; Hickler, Thomas/S-6287-2016; Gonzalez, Patrick/B-9479-2013; Polly, P. David/ABC-6597-2020	Lawing, Michelle/0000-0003-4041-6177; Eronen, Jussi T./0000-0002-0390-8044; Blois, Jessica/0000-0003-4048-177X; Ackerly, David/0000-0002-1847-7398; Nowak, Carsten/0000-0002-3139-1951; Hickler, Thomas/0000-0002-4668-7552; Gonzalez, Patrick/0000-0002-7105-0561; Polly, P. David/0000-0001-7338-8526; Schnitzler, Jan/0000-0002-0843-4503; Head, Jason/0000-0002-2237-6901; Davis, Edward/0000-0002-0918-5852; Ramakrishnan, Uma/0000-0002-5370-5966; Jackson, Stephen/0000-0002-1487-4652; Doremus, Holly/0000-0003-4243-9946; Barnosky, Anthony/0000-0003-0265-7113; Fortelius, Mikael/0000-0002-4851-783X	Integrative Climate Change Biology Group (a scientific program of the International Union of Biological Sciences); Museum of Paleontology, Berkeley Initiative for Global Change Biology; Office of the Vice Chancellor for Research at the University of California, Berkeley; Conservation Paleobiology Group at the Department of Biology, Stanford University; Senckenberg Biodiversity and Climate Research Centre, Frankfurt, Germany; National Science Foundation [NSF EAR-1338028, NSF EAR-13388298]; NSF [EAR-1148181]; Division Of Earth Sciences [1338298, 1338028] Funding Source: National Science Foundation	Integrative Climate Change Biology Group (a scientific program of the International Union of Biological Sciences); Museum of Paleontology, Berkeley Initiative for Global Change Biology; Office of the Vice Chancellor for Research at the University of California, Berkeley(University of California System); Conservation Paleobiology Group at the Department of Biology, Stanford University; Senckenberg Biodiversity and Climate Research Centre, Frankfurt, Germany; National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the financial sponsors of the workshop at which these ideas were formulated: the Integrative Climate Change Biology Group (a scientific program of the International Union of Biological Sciences); the Museum of Paleontology, Berkeley Initiative for Global Change Biology, and Office of the Vice Chancellor for Research at the University of California, Berkeley; the Conservation Paleobiology Group at the Department of Biology, Stanford University; and the Senckenberg Biodiversity and Climate Research Centre, Frankfurt, Germany. J. Head and P.D.P. were additionally funded by National Science Foundation ELT (Earth-Life Transitions) awards NSF EAR-1338028 (J. Head) and NSF EAR-13388298 (P.D.P.). A.D.B. and C.R.M. were partly funded by NSF grant EAR-1148181. We are especially grateful to V. Bowie for logistical support and graduate student helpers A. Poust, S. Elshafie, and P. Kloess. We thank D. Thomas for his production of tiger maps that were modified for Fig. 5 and the Howard Hughes Medical Institute for granting permission to use the maps (original versions are available at www.BioInteractive.org, copyright 2014, all rights reserved). E. Holt, N. Spano, B. Stein, Zixiang Zhang, and anonymous reviewers provided constructive comments.	Ackerly DD, 2000, BIOSCIENCE, V50, P979, DOI 10.1641/0006-3568(2000)050[0979:TEOPET]2.0.CO;2; Alencar AA, 2015, ECOL APPL, V25, P1493, DOI 10.1890/14-1528.1; Anderson CNK, 2005, BIOINFORMATICS, V21, P1733, DOI 10.1093/bioinformatics/bti154; barnosKY a. d., 2014, DODGING EXTINCTION P; Barnosky AD, 2004, P NATL ACAD SCI USA, V101, P9297, DOI 10.1073/pnas.0402592101; Barnosky Elizabeth Hadly, 1994, Historical Biology, V8, P71; Bay RA, 2014, J HERED, V105, P295, DOI 10.1093/jhered/est086; Biber Eric, 2013, AKRON LAW REV, V46, P937; Blois JL, 2010, NATURE, V465, P771, DOI 10.1038/nature09077; Blois JL, 2009, ANNU REV EARTH PL SC, V37, P181, DOI 10.1146/annurev.earth.031208.100055; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Camacho AE, 2010, ISSUES SCI TECHNOL, V26, P21; Camacho Alejandro E., 2015, WASH U L REV, V92, P849; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Chornesky EA, 2015, BIOSCIENCE, V65, P247, DOI 10.1093/biosci/biu233; Cole KL, 2011, ECOL APPL, V21, P137, DOI 10.1890/09-1800.1; Colwell R., 2012, REVISITING LEOPOLD R, P1; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Crees JJ, 2015, BIOL CONSERV, V186, P143, DOI 10.1016/j.biocon.2015.03.007; DAVIES AL, 2010, OPEN J ECOL, V0003; Dearing JA, 2012, P NATL ACAD SCI USA, V109, pE1111, DOI 10.1073/pnas.1118263109; Dietl GP, 2015, ANNU REV EARTH PL SC, V43, P79, DOI 10.1146/annurev-earth-040610-133349; Diffenbaugh NS, 2013, SCIENCE, V341, P486, DOI 10.1126/science.1237123; Donlan Josh, 2014, FRONT BIOGEOGR, V6, P25, DOI DOI 10.21425/F56119504; Ehrlich PR, 2012, NATURE, V486, P68, DOI 10.1038/nature11157; Eigenbrod F, 2015, GLOBAL CHANGE BIOL, V21, P275, DOI 10.1111/gcb.12669; Elias SA, 2015, QUATERNARY SCI REV, V120, P57, DOI 10.1016/j.quascirev.2015.04.026; Ellis EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030535; Eronen JT, 2010, INTEGR ZOOL, V5, P88, DOI 10.1111/j.1749-4877.2010.00192.x; Escudero A, 2016, OECOLOGIA, V180, P919, DOI 10.1007/s00442-016-3578-5; Fanin T, 2015, BIOGEOSCIENCES, V12, P6033, DOI 10.5194/bg-12-6033-2015; Gill JL, 2015, CONSERV BIOL, V29, P640, DOI 10.1111/cobi.12504; Gonzalez P, 2010, GLOBAL ECOL BIOGEOGR, V19, P755, DOI 10.1111/j.1466-8238.2010.00558.x; Greene H. W., 2015, AFTER PRESERVATION S, P105; Hadly EA, 1999, PALAEOGEOGR PALAEOCL, V149, P389, DOI 10.1016/S0031-0182(98)00214-4; Hadly EA, 2004, PLOS BIOL, V2, P1600, DOI 10.1371/journal.pbio.0020290; Hadly EA, 1996, QUATERNARY RES, V46, P298, DOI 10.1006/qres.1996.0068; Hatton IA, 2015, SCIENCE, V349, P1070, DOI 10.1126/science.aac6284; Hellmann JJ, 2011, CONSERV BIOL, V25, P1143, DOI 10.1111/j.1523-1739.2011.01786.x; Hilker T, 2014, P NATL ACAD SCI USA, V111, P16041, DOI 10.1073/pnas.1404870111; HilleRisLambers J, 2010, J ECOL, V98, P1147, DOI 10.1111/j.1365-2745.2010.01706.x; Hobbs RJ, 2014, FRONT ECOL ENVIRON, V12, P557, DOI 10.1890/130300; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; Hooke RL, 2012, GSA TODAY, V22, P4, DOI DOI 10.1130/GSAT151A.1; Huerta MA, 2009, PALAEOGEOGR PALAEOCL, V271, P170, DOI 10.1016/j.palaeo.2008.10.015; Jackson ST, 2012, QUATERNARY SCI REV, V49, P1, DOI 10.1016/j.quascirev.2012.05.020; Jackson ST, 2009, P NATL ACAD SCI USA, V106, P19685, DOI 10.1073/pnas.0901644106; Jeffers ES, 2015, QUATERNARY SCI REV, V112, P17, DOI 10.1016/j.quascirev.2014.12.018; Kareiva P., 2012, BREAKTHROUGH WINTER; Kidwell SM, 2015, P NATL ACAD SCI USA, V112, P4922, DOI 10.1073/pnas.1403660112; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Krausmann F, 2013, P NATL ACAD SCI USA, V110, P10324, DOI 10.1073/pnas.1211349110; Kremen C, 2015, ANN NY ACAD SCI, V1355, P52, DOI 10.1111/nyas.12845; Lawing A. M., 2012, PALEONTOLOGY ECOLOGY, P276; Lawler JJ, 2015, CONSERV BIOL, V29, P618, DOI 10.1111/cobi.12505; Leopold A.S., 1963, WILDLIFE MANAGEMENT; Long Elisabeth, 2014, ENVIRON LAW, V44, P623; Lu YL, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400039; Mace GM, 2014, SCIENCE, V345, P1558, DOI 10.1126/science.1254704; Maguire KC, 2015, ANNU REV ECOL EVOL S, V46, P343, DOI 10.1146/annurev-ecolsys-112414-054441; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Marlon JR, 2012, P NATL ACAD SCI USA, V109, pE535, DOI 10.1073/pnas.1112839109; Mayle FE, 2000, SCIENCE, V290, P2291, DOI 10.1126/science.290.5500.2291; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McGill BJ, 2005, P NATL ACAD SCI USA, V102, P16701, DOI 10.1073/pnas.0504225102; McGuire JL, 2016, P NATL ACAD SCI USA, V113, P7195, DOI 10.1073/pnas.1602817113; McGuire JL, 2014, ECOGRAPHY, V37, P1092, DOI 10.1111/ecog.01337; Meine C, 2006, CONSERV BIOL, V20, P631, DOI 10.1111/j.1523-1739.2006.00449.x; Mendenhall CD, 2014, NATURE, V509, P213, DOI 10.1038/nature13139; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; Mondol S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0496; Morton DC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0163; North MP, 2015, SCIENCE, V349, P1280, DOI 10.1126/science.aab2356; NRC, 2005, GEOL REC EC DYN UND; Oakleaf JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138334; Pires MM, 2015, P ROY SOC B-BIOL SCI, V282, P64, DOI 10.1098/rspb.2015.1367; Polly P. D., 2015, EARTH LIFE TRANSITIO, V21, P21; Polly PD, 2010, CARNIVORAN EVOLUTION; Porder S, 2003, PALEOBIOLOGY, V29, P197, DOI 10.1666/0094-8373(2003)029<0197:MTOOFA>2.0.CO;2; Ramakrishnan U, 2009, MOL ECOL, V18, P1310, DOI 10.1111/j.1365-294X.2009.04092.x; Resilience_ Alliance Key Concepts, 2016, RES ALL KEY CONC; Schepers F., 2014, REWILDING EUROPE, V2014, P1; Schwartz MW, 2012, BIOSCIENCE, V62, P732, DOI 10.1525/bio.2012.62.8.6; Settele J., 2014, INTERGOVERNMENTAL PA; Society for Ecological Restoration International, 2004, EC REST MEANS CONS B; Stegner MA, 2013, PALAEOGEOGR PALAEOCL, V372, P138, DOI 10.1016/j.palaeo.2012.04.019; Stein B.A., 2014, CLIMATE SMART CONSER; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; SWETNAM TW, 1993, SCIENCE, V262, P885, DOI 10.1126/science.262.5135.885; Tallis H, 2014, NATURE, V515, P27, DOI 10.1038/515027a; Terry RC, 2010, PALEOBIOLOGY, V36, P137, DOI 10.1666/0094-8373-36.1.137; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; UNDESA, 2013, WORLD POP PROSP 2012, VII, P439; Webb CT, 2010, ECOL LETT, V13, P267, DOI 10.1111/j.1461-0248.2010.01444.x; Westerling AL, 2011, P NATL ACAD SCI USA, V108, P13165, DOI 10.1073/pnas.1110199108; Willis KJ, 2010, TRENDS ECOL EVOL, V25, P583, DOI 10.1016/j.tree.2010.07.006; Wilson E.O., 2016, HALF EARTH OUR PLANE; Yeakel JD, 2014, P NATL ACAD SCI USA, V111, P14472, DOI 10.1073/pnas.1408471111; Zliobaite I, 2016, P NATL ACAD SCI USA, V113, P12751, DOI 10.1073/pnas.1609409113	99	174	181	10	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325							eaah4787	10.1126/science.aah4787	http://dx.doi.org/10.1126/science.aah4787			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK0SF	28183912	Green Accepted			2022-12-28	WOS:000393636700038
J	Malakoff, D				Malakoff, David			Politics vs. data on needle swaps	SCIENCE			English	Editorial Material																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					565	565		10.1126/science.355.6325.565	http://dx.doi.org/10.1126/science.355.6325.565			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK0SF	28183925				2022-12-28	WOS:000393636700016
J	Ainsworth, C				Ainsworth, Claire			Womb with a view	NATURE			English	News Item							MATERNAL PLASMA; DOWN-SYNDROME; FETAL GENOME; DNA; TRANSCRIPTOME; ANEUPLOIDY; DIAGNOSIS											Bruchova H, 2010, PLACENTA, V31, P186, DOI 10.1016/j.placenta.2009.12.016; Chan KCA, 2016, P NATL ACAD SCI USA, V113, pE8159, DOI 10.1073/pnas.1615800113; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fan HC, 2012, NATURE, V487, P320, DOI 10.1038/nature11251; Guedj F, 2016, SCI REP-UK, V6, DOI 10.1038/srep32353; Hui LS, 2012, HUM GENET, V131, P1751, DOI 10.1007/s00439-012-1195-x; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; Koh W, 2014, P NATL ACAD SCI USA, V111, P7361, DOI 10.1073/pnas.1405528111; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Maccani Jennifer Zj, 2015, Adv Genomics Genet, V2015, P205; Slonim DK, 2009, P NATL ACAD SCI USA, V106, P9425, DOI 10.1073/pnas.0903909106; Tsui NBY, 2014, CLIN CHEM, V60, P954, DOI 10.1373/clinchem.2014.221648; Zwemer LM, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023101	15	3	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					156	158		10.1038/542156a	http://dx.doi.org/10.1038/542156a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK2DJ	28179684				2022-12-28	WOS:000393737500012
J	Kaka, AS; Sarosi, GA				Kaka, Anjum S.; Sarosi, George A.			Disseminated Blastomycosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kaka, Anjum S.; Sarosi, George A.] Minneapolis Vet Affairs Med Ctr, Minneapolis, MN 55417 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Kaka, AS (corresponding author), Minneapolis Vet Affairs Med Ctr, Minneapolis, MN 55417 USA.	anjum.kaka@va.gov							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2017	376	6					E9	E9		10.1056/NEJMicm1606811	http://dx.doi.org/10.1056/NEJMicm1606811			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ8XL	28177861				2022-12-28	WOS:000393510500011
J	Yang, XH				Yang, Xiaohong Helena			Metastasis: Slipping Control	CELL			English	Editorial Material																		Harper KL, 2016, NATURE; Hosseini H., 2016, NATURE; Pascual G, 2017, NATURE, V541, P41, DOI 10.1038/nature20791; van der Weyden L, 2017, NATURE, V541, P233, DOI 10.1038/nature20792	4	2	2	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2017	168	4					547	+		10.1016/j.cell.2017.01.033	http://dx.doi.org/10.1016/j.cell.2017.01.033			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8VJ	28187272	Bronze			2022-12-28	WOS:000396277600002
J	den Boeft, M; Claassen-van Dessel, N; van der Wouden, JC				den Boeft, Madelon; Claassen-van Dessel, Nikki; van der Wouden, Johannes C.			UNCERTAINTIES How should we manage adults with persistent unexplained physical symptoms?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[den Boeft, Madelon; Claassen-van Dessel, Nikki; van der Wouden, Johannes C.] Vrije Univ Amsterdam, Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Gen Practice & Elderly Care Med, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	van der Wouden, JC (corresponding author), Vrije Univ Amsterdam, Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Gen Practice & Elderly Care Med, Amsterdam, Netherlands.	j.vanderwouden@vumc.nl	van der Wouden, Johannes C/O-5109-2019	van der Wouden, Johannes C/0000-0001-6639-6050				Aamland A, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-107; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; [Anonymous], 2013, NHG STAND SOM ONV VE; [Anonymous], 2011, STUURGROEP MULTIDISC; Burton C, 2003, BRIT J GEN PRACT, V53, P231; Creed F, 2010, J PSYCHOSOM RES, V68, P5, DOI 10.1016/j.jpsychores.2009.09.004; Dirkzwager AJE, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-33; Hausteiner-Wiehle C, 2012, 051001 AWMF; Hoedeman R, 2010, COCHRANE DB SYST REV, V356; Jackson JL, 2005, J GEN INTERN MED, V20, P1032, DOI 10.1111/j.1525-1497.2005.0241.x; Kleinstauber M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010628.pub2; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; NHS, 2008, MED UN SYMPT POS PRA; Rosendal M, 2013, COCHRANE DB SYST REV, V356; SMITH GR, 1986, ARCH INTERN MED, V146, P69, DOI 10.1001/archinte.146.1.69; van Dessel N, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011142.pub2; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2	18	7	8	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2017	356								j268	10.1136/bmj.j268	http://dx.doi.org/10.1136/bmj.j268			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4FX	28179237				2022-12-28	WOS:000394578200003
J	Layard, R; Appleby, J				Layard, Richard; Appleby, John			Is it time for a dedicated tax to fund the NHS?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Layard, Richard] London Sch Econ, London, England; [Appleby, John] Nuffield Trust, London, England	University of London; London School Economics & Political Science	Layard, R (corresponding author), London Sch Econ, London, England.; Appleby, J (corresponding author), Nuffield Trust, London, England.	R.Layard@lse.ac.uk; john.appleby@nuffieldtrust.org.uk						Appleby J., 2016, DOES NHS SPENDING CO; Appleby J, 2016, NATCEN; Commission on Taxation and Citizenship, 2000, PAY PROGR NEW POL TA; Commission on the Future of Health and Social Care in England, 2014, NEW SETTL HLTH SOC C; King's Fund, 2010, MUCH HAS BEEN SPENT; Murphy R., 2014, HYPOTHECATION IS ANS; Nuffield Trust King's Fund Health Foundation, 2015, SPEND REV 2015 WHAT	7	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2017	356								j471	10.1136/bmj.j471	http://dx.doi.org/10.1136/bmj.j471			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4FX	28179269	Green Accepted			2022-12-28	WOS:000394578200005
J	Chatterjee, S; Khunti, K; Davies, MJ				Chatterjee, Sudesna; Khunti, Kamlesh; Davies, Melanie J.			Type 2 diabetes	LANCET			English	Review							LIFE-STYLE INTERVENTION; GLUCOSE-LOWERING DRUGS; BETA-CELL FUNCTION; LOW-CALORIE-DIET; ALL-CAUSE MORTALITY; CARDIOVASCULAR OUTCOMES; GLYCEMIC CONTROL; WEIGHT-LOSS; INSULIN GLARGINE; FOLLOW-UP	415 million people live with diabetes worldwide, and an estimated 193 million people have undiagnosed diabetes. Type 2 diabetes accounts for more than 90% of patients with diabetes and leads to microvascular and macrovascular complications that cause profound psychological and physical distress to both patients and carers and put a huge burden on health-care systems. Despite increasing knowledge regarding risk factors for type 2 diabetes and evidence for successful prevention programmes, the incidence and prevalence of the disease continues to rise globally. Early detection through screening programmes and the availability of safe and effective therapies reduces morbidity and mortality by preventing or delaying complications. Increased understanding of specific diabetes phenotypes and genotypes might result in more specific and tailored management of patients with type 2 diabetes, as has been shown in patients with maturity onset diabetes of the young. In this Seminar, we describe recent developments in the diagnosis and management of type 2 diabetes, existing controversies, and future directions of care.	[Chatterjee, Sudesna; Khunti, Kamlesh; Davies, Melanie J.] Univ Leicester, Leicester Gen Hosp, Leicester Diabet Ctr, Leicester LE5 4PW, Leics, England; [Chatterjee, Sudesna; Khunti, Kamlesh; Davies, Melanie J.] Univ Leicester, Diabet Res Ctr, Coll Med Biol Sci & Psychol, Leicester, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; University of Leicester	Davies, MJ (corresponding author), Univ Leicester, Leicester Gen Hosp, Leicester Diabet Ctr, Leicester LE5 4PW, Leics, England.	melanie.davies@uhl-tr.nhs.uk	Chatterjee, Sudesna/AAN-9580-2020; /ABC-9527-2021	Chatterjee, Sudesna/0000-0003-4391-6732; Davies, Melanie/0000-0002-9987-9371	Janssen; Eli Lilly; Novo Nordisk; AstraZeneca; Boehringer Ingelheim; Sanofi-Aventis; Lilly; Merck Sharp Dohme; Mitsubishi Tanabe Pharma Corporation; Takeda Pharmaceuticals International; Novartis; Roche	Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Eli Lilly(Eli Lilly); Novo Nordisk(Novo Nordisk); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Sanofi-Aventis(Sanofi-Aventis); Lilly(Eli Lilly); Merck Sharp Dohme(Merck & Company); Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation); Takeda Pharmaceuticals International(Takeda Pharmaceutical Company Ltd); Novartis(Novartis); Roche(Roche Holding)	SC declares speaker fees, educational funding, or both, from Janssen, Eli Lilly, Novo Nordisk, AstraZeneca, and Boehringer Ingelheim, and grants in support of investigator-initiated trials from Boehringer Ingelheim and Janssen. MJD declares personal fees from Novo Nordisk, Sanofi-Aventis, Lilly, Merck Sharp & Dohme, Boehringer Ingelheim, AstraZeneca, Janssen, Mitsubishi Tanabe Pharma Corporation, and Takeda Pharmaceuticals International, and grants from Novo Nordisk, Sanofi-Aventis, Lilly, Boehringer Ingelheim, and Janssen. KK has acted as a consultant and speaker for AstraZeneca, Novartis, Novo Nordisk, Sanofi-Aventis, Lilly, Merck Sharp & Dohme, Janssen, and Boehringer Ingelheim. KK declares grants in support of investigator and investigator initiated trials from AstraZeneca, Novartis, Novo Nordisk, Sanofi-Aventis, Lilly, Boehringer Ingelheim, Merck Sharp & Dohme, and Roche. KK has served on advisory boards for AstraZeneca, Novartis, Novo Nordisk, Sanofi-Aventis, Lilly, Merck Sharp & Dohme, Janssen, and Boehringer Ingelheim.	Abdelmoneim AS, 2015, DIABETES OBES METAB, V17, P523, DOI 10.1111/dom.12456; Amiel SA, 2015, DIABETES CARE, V38, P1583, DOI 10.2337/dc15-0279; AstraZeneca, 2015, MULT TRIAL INV EFF D; Bailey CJ, 2016, LANCET DIABETES ENDO, V4, P350, DOI 10.1016/S2213-8587(15)00462-3; Barnett AH, 2013, ADV THER, V30, P557, DOI 10.1007/s12325-013-0039-y; Belalcazar LM, 2010, DIABETES CARE, V33, P2297, DOI 10.2337/dc10-0728; Black C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004654.pub2; Bray GA, 2016, LANCET, V387, P1947, DOI 10.1016/S0140-6736(16)00271-3; Butler PC, 2013, DIABETES CARE, V36, P2118, DOI 10.2337/dc12-2713; Cardona-Morrell M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-653; Cefalu WT, 2008, NEW ENGL J MED, V358, P2633, DOI 10.1056/NEJMe0803831; Ceriello A, 2011, DIABETES CARE, V34, P697, DOI 10.2337/dc10-1949; Colagiuri S, 2011, DIABETES CARE, V34, P145, DOI 10.2337/dc10-1206; Constantino MI, 2013, DIABETES CARE, V36, P3863, DOI 10.2337/dc12-2455; Copeland KC, 2011, J CLIN ENDOCR METAB, V96, P159, DOI 10.1210/jc.2010-1642; Cox DJ, 2016, DIABETES CARE, V39, pE71, DOI 10.2337/dc15-2836; Crasto W, 2009, POSTGRAD MED J, V85, P219, DOI 10.1136/pgmj.2008.073379; Cryer PE, 2014, DIABETES, V63, P2188, DOI 10.2337/db14-0059; Davies MJ, 2008, BMJ-BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE; Davies MJ, 2013, DIABETIC MED, V30, P512, DOI 10.1111/dme.12128; Davies MJ, 2015, JAMA-J AM MED ASSOC, V314, P687, DOI 10.1001/jama.2015.9676; de Jager J, 2014, J INTERN MED, V275, P59, DOI 10.1111/joim.12128; DeFronzo RA, 2016, DIABETOLOGIA, V59, P1645, DOI 10.1007/s00125-016-3992-6; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Distiller Larry A, 2016, J Diabetes Sci Technol, V10, P1294; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Dunkley AJ, 2014, DIABETES CARE, V37, P922, DOI 10.2337/dc13-2195; Elwen FR, 2015, BMJ OPEN DIAB RES CA, V3, DOI [10.1136/bmjdrc-2015000094, 10.1136/bmjdrc-2015-000094]; Eng C, 2014, LANCET, V384, P2228, DOI 10.1016/S0140-6736(14)61335-0; Erickson J, 1993, AAPPO J, V3, P33; Erickson J., 1993, J AM ASS PREFERRED P, V3, P38; Finan B, 2015, NAT MED, V21, P27, DOI 10.1038/nm.3761; Fox CS, 2015, DIABETES CARE, V38, P1777, DOI 10.2337/dci15-0012; Fuhlendorff J, 1998, DIABETES, V47, P345, DOI 10.2337/diabetes.47.3.345; Gaede P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Garber AJ, 2012, LANCET, V379, P1498, DOI 10.1016/S0140-6736(12)60205-0; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gori M, 2016, DIABETES CARE, V39, P677, DOI 10.2337/dc15-1760; Grarup N, DIABETOLOGICAL; Greco D, 2010, EXP CLIN ENDOCR DIAB, V118, P215, DOI 10.1055/s-0029-1241823; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Gruber K, 2015, LANCET DIABETES ENDO, V3, P171, DOI 10.1016/S2213-8587(15)00010-8; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Heine RJ, 2005, ANN INTERN MED, V143, P559, DOI 10.7326/0003-4819-143-8-200510180-00006; Hemmingsen B, 2014, CMAJ OPEN; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2014, LANCET, V383, P2008, DOI 10.1016/S0140-6736(14)60794-7; Holman RR, 2009, NEW ENGL J MED, V361, P1736, DOI 10.1056/NEJMoa0905479; Horvath K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005613.pub3; Huang ES, 2014, JAMA INTERN MED, V174, P251, DOI 10.1001/jamainternmed.2013.12956; International Diabetes Federation (IDF), 2015, IDF DIABETES ATLAS, V7th, DOI DOI 10.1214/AOMS/1177699147; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Inzucchi SE, 2014, JAMA-J AM MED ASSOC, V312, P2668, DOI 10.1001/jama.2014.15298; Janssen Research and Development LLC, 2015, CANVAS CANAGLIFLOZIN; Jenkinson CP, 2016, GENOM DATA, V8, P25, DOI 10.1016/j.gdata.2015.12.001; Kahn SE, 2011, DIABETES, V60, P1552, DOI 10.2337/db10-1392; Kazierad DJ, 2016, DIABETES OBES METAB, V18, P795, DOI 10.1111/dom.12672; Khunti K, 2016, DIABETES OBES METAB, V18, P907, DOI 10.1111/dom.12689; Khunti K, 2016, DIABETES OBES METAB, V18, P401, DOI 10.1111/dom.12626; Khunti K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135702; Khunti K, 2013, DIABETES CARE, V36, P3411, DOI 10.2337/dc13-0331; Khunti K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2333; Knowler WC, 2014, LANCET DIABETES ENDO, V2, P801, DOI 10.1016/S2213-8587(14)70156-1; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kohlroser J, 2000, AM J GASTROENTEROL, V95, P272; Leong A, 2016, DIABETES CARE, V39, P539, DOI 10.2337/dc15-2080; Lewis JD, 2015, JAMA-J AM MED ASSOC, V314, P265, DOI 10.1001/jama.2015.7996; Lipska KJ, 2015, JAMA INTERN MED, V175, P356, DOI 10.1001/jamainternmed.2014.7345; Loke YK, 2009, CAN MED ASSOC J, V180, P32, DOI 10.1503/cmaj.080486; Lorber D, 2014, DIABETES CARE, V37, pS97, DOI 10.2337/dc14-S097; Mahaffey KW, 2013, AM HEART J, V166, P240, DOI 10.1016/j.ahj.2013.05.004; Mari A, 2015, ENDOCR PRACT, V21, P1344, DOI 10.4158/EP15898.OR; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Maruthappu M, 2015, LANCET DIABETES ENDO, V3, P312, DOI 10.1016/S2213-8587(15)00079-0; Merlotti C, 2014, DIABETES OBES METAB, V16, P719, DOI 10.1111/dom.12270; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Miwa S, 2004, ENDOCR J, V51, P393, DOI 10.1507/endocrj.51.393; Monami M, 2014, DIABETES OBES METAB, V16, P833, DOI 10.1111/dom.12287; Monami M, 2008, DIABETES RES CLIN PR, V81, P184, DOI 10.1016/j.diabres.2008.04.007; Nathan DM, 2015, LANCET DIABETES ENDO, V3, P866, DOI 10.1016/S2213-8587(15)00291-0; Nathan DM, 2013, DIABETES CARE, V36, P2254, DOI 10.2337/dc13-0356; Nauck MA, 2016, LANCET DIABETES ENDO, V4, P525, DOI 10.1016/S2213-8587(15)00482-9; Nauck MA, 2011, DIABETES CARE, V34, P2015, DOI 10.2337/dc11-0606; NCD Risk Factor Collaboration (NCD-RisC), 2016, Lancet, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Norris SL, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004096.pub2, 10.1002/14651858.CD004095.pub2, 10.1002/14651858.CD005270]; Oram RA, 2016, DIABETES CARE, V39, P337, DOI 10.2337/dc15-1111; Orozco LJ, 2008, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003054.PUB3; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Perreault L, 2014, DIABETES CARE, V37, P2622, DOI 10.2337/dc14-0656; Peters AL, 2015, DIABETES CARE, V38, P1687, DOI 10.2337/dc15-0843; Pfeffer MA, 2015, ADA SCI SESS; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Redelmeier DA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000192; Reznik Y, 2014, LANCET, V384, P1265, DOI 10.1016/S0140-6736(14)61037-0; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278; Rosenstock J, 2013, DIABETES, V62, pA285; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Salpeter SR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002967.pub3; Sarafidis PA, 2016, NEW ENGL J MED, V374, P1092, DOI 10.1056/NEJMc1600827; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Schwartz SS, 2016, DIABETES CARE, V39, P179, DOI 10.2337/dc15-1585; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480; Setty SG, 2016, POSTGRAD MED J, V92, P152, DOI 10.1136/postgradmedj-2015-133716; Seuring T, 2015, PHARMACOECONOMICS, V33, P811, DOI 10.1007/s40273-015-0268-9; Simmons RK, 2012, LANCET, V380, P1741, DOI 10.1016/S0140-6736(12)61422-6; Sinclair A, 2015, LANCET DIABETES ENDO, V3, P275, DOI 10.1016/S2213-8587(14)70176-7; Skyler JS, 2009, J AM COLL CARDIOL, V53, P298, DOI [10.1016/j.jacc.2008.10.008, 10.2337/dc08-9026]; Stamler J, 1993, DIABETES CARE; Steinstraesser A, 2014, DIABETES OBES METAB, V16, P873, DOI 10.1111/dom.12283; Steven S, 2015, DIABETIC MED, V32, P1149, DOI 10.1111/dme.12722; Steven S, 2015, DIABETIC MED, V32, P47, DOI 10.1111/dme.12567; Steven S, 2016, DIABETES CARE, V39, P808, DOI 10.2337/dc15-1942; Swinnen SG, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006383.pub2; Tahrani AA, 2013, LANCET DIABETES ENDO, V1, P140, DOI 10.1016/S2213-8587(13)70050-0; Tamborlane WV, 2016, DIABETES CARE, V39, P323, DOI 10.2337/dc15-1649; Tancredi M, 2015, NEW ENGL J MED, V373, P1720, DOI 10.1056/NEJMoa1504347; Thanabalasingham G, 2012, DIABETES CARE, V35, P1206, DOI 10.2337/dc11-1243; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; Trujillo JM, 2015, THER ADV ENDOCRINOL, V6, P19, DOI 10.1177/2042018814559725; Tuccori M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1541; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Udell JA, 2015, LANCET DIABETES ENDO, V3, P356, DOI 10.1016/S2213-8587(15)00044-3; US Food and Drug Administration, 2016, DIAB MED CONT SAX AL; Vasilakou D, 2013, ANN INTERN MED, V159, P262, DOI 10.7326/0003-4819-159-4-201308200-00007; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Wadden TA, 2013, INT J OBESITY, V37, pS1, DOI 10.1038/ijo.2013.89; Wadden TA, 2014, DIABETES CARE, V37, P1544, DOI 10.2337/dc13-1928; Webb DR, 2011, DIABETOLOGIA, V54, P2237, DOI 10.1007/s00125-011-2189-2; Welsh KJ, 2016, DIABETES CARE, V39, P1299, DOI 10.2337/dc15-2727; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Wilding JPH, 2014, METABOLISM, V63, P1228, DOI 10.1016/j.metabol.2014.06.018; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Wing RR, 2013, DIABETES CARE, V36, P2937, DOI 10.2337/dc13-0315; Wong MG, 2016, DIABETES CARE, V39, P694, DOI 10.2337/dc15-2322; Wong ND, 2016, DIABETES CARE, V39, P668, DOI 10.2337/dc15-2439; Woo VC, 2015, CAN J DIABETES, V39, P335, DOI 10.1016/j.jcjd.2015.04.006; World Health Organization, 2014, NONC DIS COUNTR PROF; Xie ZY, 2016, STEM CELLS, V34, P627, DOI 10.1002/stem.2238; Zaccardi F, 2016, ANN INTERN MED, V164, P102, DOI 10.7326/M15-1432; Zafar A, 2010, PRIM CARE DIABETES, V4, P203, DOI 10.1016/j.pcd.2010.07.003; Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	151	1029	1070	60	624	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2017	389	10085					2239	2251		10.1016/S0140-6736(17)30058-2	http://dx.doi.org/10.1016/S0140-6736(17)30058-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW5JC	28190580				2022-12-28	WOS:000402540800032
J	Keller, A; Gerkin, RC; Guan, YF; Dhurandhar, A; Turu, G; Szalai, B; Mainland, JD; Ihara, Y; Yu, CW; Wolfinger, R; Vens, C; Schietgat, L; De Grave, K; Norel, R; Stolovitzky, G; Cecchi, GA; Vosshall, LB; Meyer, P				Keller, Andreas; Gerkin, Richard C.; Guan, Yuanfang; Dhurandhar, Amit; Turu, Gabor; Szalai, Bence; Mainland, Joel D.; Ihara, Yusuke; Yu, Chung Wen; Wolfinger, Russ; Vens, Celine; Schietgat, Leander; De Grave, Kurt; Norel, Raquel; Stolovitzky, Gustavo; Cecchi, Guillermo A.; Vosshall, Leslie B.; Meyer, Pablo		DREAM Olfaction Prediction	Predicting human olfactory perception from chemical features of odor molecules	SCIENCE			English	Article							PLEASANTNESS; PROFILES	It is still not possible to predict whether a given molecule will have a perceived odor or what olfactory percept it will produce. We therefore organized the crowd-sourced DREAM Olfaction Prediction Challenge. Using a large olfactory psychophysical data set, teams developed machine-learning algorithms to predict sensory attributes of molecules based on their chemoinformatic features. The resulting models accurately predicted odor intensity and pleasantness and also successfully predicted 8 among 19 rated semantic descriptors ("garlic," "fish," "sweet," "fruit," "burnt," "spices," "flower," and "sour"). Regularized linear models performed nearly as well as random forest-based ones, with a predictive accuracy that closely approaches a key theoretical limit. These models help to predict the perceptual qualities of virtually any molecule with high accuracy and also reverse-engineer the smell of a molecule.	[Keller, Andreas; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [Gerkin, Richard C.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA; [Guan, Yuanfang] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Dhurandhar, Amit; Norel, Raquel; Stolovitzky, Gustavo; Cecchi, Guillermo A.; Meyer, Pablo] IBM Corp, Thomas J Watson Computat Biol Ctr, Yorktown Hts, NY 10598 USA; [Turu, Gabor; Szalai, Bence] Semmelweis Univ, Fac Med, Dept Physiol, H-1085 Budapest, Hungary; [Turu, Gabor; Szalai, Bence] Semmelweis Univ MTA SE, Hungarian Acad Sci, Lab Mol Physiol, H-1085 Budapest, Hungary; [Mainland, Joel D.; Ihara, Yusuke; Yu, Chung Wen] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA; [Mainland, Joel D.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Ihara, Yusuke] Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa 2108681, Japan; [Wolfinger, Russ] SAS Inst Inc, Cary, NC 27513 USA; [Vens, Celine] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, B-8500 Kortrijk, Belgium; [Schietgat, Leander; De Grave, Kurt] Katholieke Univ Leuven, Dept Comp Sci, B-3001 Leuven, Belgium; [De Grave, Kurt] Flanders Make, B-3920 Lommel, Belgium; [Vosshall, Leslie B.] Howard Hughes Med Inst, New York, NY 10065 USA; [Stolovitzky, Gustavo; Meyer, Pablo] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA	Rockefeller University; Arizona State University; Arizona State University-Tempe; University of Michigan System; University of Michigan; International Business Machines (IBM); Semmelweis University; Hungarian Academy of Sciences; Monell Chemical Senses Center; University of Pennsylvania; Ajinomoto Co Inc; SAS Institute Inc; KU Leuven; KU Leuven; Howard Hughes Medical Institute; Icahn School of Medicine at Mount Sinai	Meyer, P (corresponding author), IBM Corp, Thomas J Watson Computat Biol Ctr, Yorktown Hts, NY 10598 USA.; Meyer, P (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.	pmeyerr@us.ibm.com	Golińska, Agnieszka Kitlas/V-9677-2018; Saiz, Leonor/I-3557-2015; Norel, Raquel/ABB-3422-2021; Raghava, Gajendra P.S./AAA-2413-2022; Rudnicki, Witold R/B-6670-2012; Falcao, Andre O./A-3545-2010; Panwar, Bharat/H-9790-2019; Mainland, Joel/C-5171-2009; Vilar, Jose MG/A-9069-2013; Kazanov, Marat D/D-6381-2013; Polewko-Klim, Aneta/T-1045-2018	Golińska, Agnieszka Kitlas/0000-0001-8737-765X; Saiz, Leonor/0000-0002-6866-9400; Norel, Raquel/0000-0001-7737-4172; Raghava, Gajendra P.S./0000-0002-8902-2876; Rudnicki, Witold R/0000-0002-7928-4944; Falcao, Andre O./0000-0002-3588-8746; Mainland, Joel/0000-0002-5056-4598; Vilar, Jose MG/0000-0003-4037-0746; Kazanov, Marat D/0000-0002-2314-5507; Polewko-Klim, Aneta/0000-0003-1987-7374; Vosshall, Leslie/0000-0002-6060-8099; Turu, Gabor/0000-0002-4421-3812; Guan, Yuanfang/0000-0001-8275-2852; Gerkin, Richard C/0000-0002-2940-3378; Szalai, Bence/0000-0002-9320-5704; Dhurandhar, Amit/0000-0002-3579-1450; Lesinski, Wojciech/0000-0001-6628-9466; CHEN, CHIEN-YU/0000-0002-6940-6389; Kumar, Ritesh/0000-0003-4284-5311	NIH [R01DC013339, R01MH106674, R01EB021711, UL1RR024143]; Russian Science Foundation [14-24-00155]; Slovenian Research Agency [P2-0209]; Research Fund KU Leuven; Flemish Agency for Innovation by Science and Technology-Flanders-Strategic Basic Research Project (IWT-SBO) NEMOA; Branco Weiss Science in Society Fellowship; Hungarian Academy of Sciences; Ontario Institute for Cancer Research - Government of Ontario; Terry Fox Research Institute New Investigator Award; Canadian Institutes of Health Research New Investigator Award; Council of Scientific and Industrial Research-Central Scientific Instruments Organisation, Chandigarh, India; Flemish Council of Scientific and Industrial Research (IWT) "InSPECtor"; European Research Council (ERC) Proof of Concept "SNIPER"; DREAM Olfaction Prediction Challenge; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB021711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013339] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Science Foundation(Russian Science Foundation (RSF)); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Research Fund KU Leuven(KU Leuven); Flemish Agency for Innovation by Science and Technology-Flanders-Strategic Basic Research Project (IWT-SBO) NEMOA; Branco Weiss Science in Society Fellowship; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Ontario Institute for Cancer Research - Government of Ontario; Terry Fox Research Institute New Investigator Award; Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Council of Scientific and Industrial Research-Central Scientific Instruments Organisation, Chandigarh, India; Flemish Council of Scientific and Industrial Research (IWT) "InSPECtor"; European Research Council (ERC) Proof of Concept "SNIPER"; DREAM Olfaction Prediction Challenge; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported in part by grants from the NIH (R01DC013339 to J.D.M., R01MH106674 and R01EB021711 to R.C.G., UL1RR024143 to The Rockefeller University); the Russian Science Foundation (#14-24-00155 to M.D.K. of the DREAM Olfaction Prediction Consortium [see supplementary materials (SM)]; the Slovenian Research Agency (P2-0209 to B.Z. of the DREAM Olfaction Prediction Consortium); the Research Fund KU Leuven (C.V.); and Flemish Agency for Innovation by Science and Technology-Flanders-Strategic Basic Research Project (IWT-SBO) NEMOA (L.S.). A.K. was supported by a Branco Weiss Science in Society Fellowship. G.S. is an employee of IBM Research. G.T. is partly funded by the Hungarian Academy of Sciences. L.B.V. is an investigator of the Howard Hughes Medical Institute. P.C.B. of the DREAM Olfaction Prediction Consortium has the support of the Ontario Institute for Cancer Research through funding provided by the Government of Ontario and a Terry Fox Research Institute New Investigator Award and a Canadian Institutes of Health Research New Investigator Award. R.K. is supported by a grant from the Council of Scientific and Industrial Research-Central Scientific Instruments Organisation, Chandigarh, India, K.D.G by the Flemish Council of Scientific and Industrial Research (IWT) "InSPECtor" and European Research Council (ERC) Proof of Concept "SNIPER." L.B.V. is a member of the scientific advisory board of International Flavors & Fragrances, Inc. (IFF), and receives compensation for these activities. IFF was one of the corporate sponsors of the DREAM Olfaction Prediction Challenge. Y.I. is employed by Ajinomoto Co., Inc. J.D.M. is a member of the scientific advisory board of Aromyx and receives compensation and stock for these activities. Web links for data and models are provided below. On the website pages, individual predictions are known as "Subchallenge 1," and population prediction as "Subchallenge 2." Model details and code from the best-performing team for individual prediction (Team GuanLab; authors Y.G. and B.P. of the DREAM Olfaction Prediction Consortium): https://www.synapse.org/#!Synapse:syn3354800/wiki/; model details and code for the best-performing team for population prediction (Team IKW Allstars and author R.C.G.): https://www.synapse.org/#!Synapse:syn3822692/wiki/231036. DREAM Olfaction challenge description, participants, leaderboards, and data sets: https://www.synapse.org/#!Synapse:syn2811262/wiki/78368; model descriptions and predictions: https://www.synapse.org/#!Synapse:syn2811262/wiki/78388; code and details to reproduce analysis for scoring and to reproduce all the analysis for the figures: http://dream-olfaction.github.io.	BOELENS H, 1983, TRENDS PHARMACOL SCI, V4, P421, DOI 10.1016/0165-6147(83)90475-3; Boesveldt S, 2010, BEHAV BRAIN RES, V215, P110, DOI 10.1016/j.bbr.2010.07.007; Castro JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073289; Costa Fabrizio, 2010, INT C MACHINE LEARNI, P255, DOI DOI 10.1016/J.NEUROPHARM.2007.07.003; DRAVNIEKS A, 1982, SCIENCE, V218, P799, DOI 10.1126/science.7134974; Dravnieks A., 1985, ATLAS ODOR CHARACTER; EDWARDS PA, 1989, CHEM SENSES, V14, P281, DOI 10.1093/chemse/14.2.281; Gupta P, 2015, NAT NEUROSCI, V18, P272, DOI 10.1038/nn.3913; Keller A, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0287-2; Kermen F, 2011, SCI REP-UK, V1, DOI 10.1038/srep00206; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; Koulakov AA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00065; Laska M, 1999, CHEM SENSES, V24, P263, DOI 10.1093/chemse/24.3.263; Prill RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125777; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Sell CS, 2006, ANGEW CHEM INT EDIT, V45, P6254, DOI 10.1002/anie.200600782; Snitz K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003184; U. S. Environmental Protection Agency, 2014, EST PROGR INT SUIT M; Zarzo M, 2011, SENSORS-BASEL, V11, P3667, DOI 10.3390/s110403667	19	119	127	12	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					820	+		10.1126/science.aal2014	http://dx.doi.org/10.1126/science.aal2014			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28219971	Green Accepted, Green Submitted			2022-12-28	WOS:000395127600037
J	Lieu, TA; Platt, R				Lieu, Tracy A.; Platt, Richard			Applied Research and Development in Health Care - Time for a Frameshift	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lieu, Tracy A.] Kaiser Permanente Northern Calif, Div Res, Oakland, CA 94612 USA; [Platt, Richard] Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA USA; [Platt, Richard] Harvard Med Sch, Boston, MA USA	Kaiser Permanente; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School	Lieu, TA (corresponding author), Kaiser Permanente Northern Calif, Div Res, Oakland, CA 94612 USA.							Corley DA, 2014, NEW ENGL J MED, V370, P1298, DOI 10.1056/NEJMoa1309086; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; Office for Human Research Protections Department of Health and Human Services, 2017, QUAL IMPR ACT FAQS, DOI [10.1056/NEJMp1611611, DOI 10.1056/NEJMP1611611]; Yokoe DS, 2014, INFECT CONT HOSP EP, V35, P967, DOI 10.1086/677216; Yoon SS, 2015, HYPERTENSION PREVALE	5	20	20	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2017	376	8					710	713		10.1056/NEJMp1611611	http://dx.doi.org/10.1056/NEJMp1611611			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JO	28225671				2022-12-28	WOS:000395627900003
J	Hibble, A				Hibble, Arthur			Bob Berrington OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		BERRINGTON B, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2017	356								j871	10.1136/bmj.j871	http://dx.doi.org/10.1136/bmj.j871			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KQ	28219907				2022-12-28	WOS:000395630800007
J	Barnett, ML; Olenski, AR; Jena, AB				Barnett, Michael L.; Olenski, Andrew R.; Jena, Anupam B.			Opioid-Prescribing Patterns of Emergency Physicians and Risk of Long-Term Use	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OLDER-ADULTS; CHRONIC PAIN; ANALGESICS; CARE	BACKGROUND Increasing overuse of opioids in the United States may be driven in part by physician prescribing. However, the extent to which individual physicians vary in opioid prescribing and the implications of that variation for long-term opioid use and adverse outcomes in patients are unknown. METHODS We performed a retrospective analysis involving Medicare beneficiaries who had an index emergency department visit in the period from 2008 through 2011 and had not received prescriptions for opioids within 6 months before that visit. After identifying the emergency physicians within a hospital who cared for the patients, we categorized the physicians as being high-intensity or low-intensity opioid prescribers according to relative quartiles of prescribing rates within the same hospital. We compared rates of long-term opioid use, defined as 6 months of days supplied, in the 12 months after a visit to the emergency department among patients treated by high-intensity or low-intensity prescribers, with adjustment for patient characteristics. RESULTS Our sample consisted of 215,678 patients who received treatment from low-intensity prescribers and 161,951 patients who received treatment from high-intensity prescribers. Patient characteristics, including diagnoses in the emergency department, were similar in the two treatment groups. Within individual hospitals, rates of opioid prescribing varied widely between low-intensity and high-intensity prescribers (7.3% vs. 24.1%). Long-term opioid use was significantly higher among patients treated by high-intensity prescribers than among patients treated by lowintensity prescribers (adjusted odds ratio, 1.30; 95% confidence interval, 1.23 to 1.37; P< 0.001); these findings were consistent across multiple sensitivity analyses. CONCLUSIONS Wide variation in rates of opioid prescribing existed among physicians practicing within the same emergency department, and rates of long-term opioid use were increased among patients who had not previously received opioids and received treatment from high-intensity opioid prescribers.	[Barnett, Michael L.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Kresge Bldg,4th Fl,677 Huntington Ave, Boston, MA 02115 USA; [Olenski, Andrew R.; Jena, Anupam B.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA; [Barnett, Michael L.] Brigham & Womens Hosp, Dept Med, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Jena, Anupam B.] NBER, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; National Bureau of Economic Research	Barnett, ML (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Kresge Bldg,4th Fl,677 Huntington Ave, Boston, MA 02115 USA.	mbarnett@hsph.harvard.edu	Barnett, Michael/ABA-4159-2021; Barnett, Michael/AAF-4017-2019	Barnett, Michael/0000-0002-4884-6609; Barnett, Michael/0000-0002-4884-6609; Olenski, Andrew/0000-0002-7461-0536	National Institutes of Health; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by the National Institutes of Health.	Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Braden JB, 2010, ARCH INTERN MED, V170, P1425, DOI 10.1001/archinternmed.2010.273; Buckeridge D, 2010, J AM GERIATR SOC, V58, P1664, DOI 10.1111/j.1532-5415.2010.03015.x; Butler MM, 2016, ANN EMERG MED, V68, P202, DOI 10.1016/j.annemergmed.2015.11.033; Centers for Disease Control and Prevention, 2016, PRESCR OP OV DAT; Department of Health and Human Services Behavioral Health Coordinating Committee, 2014, ADDR PRESCR DRUG AB; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Dufour R, 2014, PAIN PRACT, V14, pE106, DOI 10.1111/papr.12148; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Frank R., 2015, HLTH AFFAIRS BLOG; Healthcare Cost and Utilization Project, 2014, HOSP INP UT REL OP O; Hoppe JA, 2015, ANN EMERG MED, V66, P253, DOI 10.1016/j.annemergmed.2015.03.026; Jena AB, 2016, JAMA INTERN MED, V176, P990, DOI 10.1001/jamainternmed.2016.2737; Jena Anupam B, 2014, BMJ, V348, pg1393, DOI 10.1136/bmj.g1393; Kuo YF, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2015.10.002; Makris UE, 2014, JAMA-J AM MED ASSOC, V312, P825, DOI 10.1001/jama.2014.9405; Meara E, 2016, NEW ENGL J MED, V375, P44, DOI 10.1056/NEJMsa1514387; Miller M, 2011, J AM GERIATR SOC, V59, P430, DOI 10.1111/j.1532-5415.2011.03318.x; National Institute of Standards and Technology, 2013, KOLM SMIRN GOODN OF; National Institute on Drug Abuse, 2014, AM ADD OP HER PRESCR; O'Neil CK, 2012, AM J GERIATR PHARMAC, V10, P331, DOI 10.1016/j.amjopharm.2012.09.004; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Pletcher MJ, 2008, JAMA-J AM MED ASSOC, V299, P70, DOI 10.1001/jama.2007.64; Poon SJ, 2014, ANN EMERG MED, V64, P490, DOI 10.1016/j.annemergmed.2014.06.016; Solomon DH, 2010, ARCH INTERN MED, V170, P1968, DOI 10.1001/archinternmed.2010.391; Tamayo-Sarver JH, 2004, ANN EMERG MED, V43, P483, DOI 10.1016/j.annemergmed.2003.10.043; Vestal C., 2016, OLDER ADDICTS SQUEEZ; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934	28	347	348	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2017	376	7					663	673		10.1056/NEJMsa1610524	http://dx.doi.org/10.1056/NEJMsa1610524			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO0QJ	28199807	Green Accepted			2022-12-28	WOS:000396402700017
J	Wise, J				Wise, Jacqui			Offer radiotherapy to all patients with painful bone metastases, say researchers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		McDonald R, 2017, JAMA ONCOL, V3, P953, DOI 10.1001/jamaoncol.2016.6770	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2017	356								j732	10.1136/bmj.j732	http://dx.doi.org/10.1136/bmj.j732			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GC	28188125				2022-12-28	WOS:000394578700006
J	Mayor, S				Mayor, Susan			Feedback to doctors cuts unnecessary antibiotic use in hospitals, review finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Davey P, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003543.pub4, 10.1002/14651858.CD003543.pub2, 10.1002/14651858.CD003543.pub3]	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2017	356								j713	10.1136/bmj.j713	http://dx.doi.org/10.1136/bmj.j713			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GB	28183692				2022-12-28	WOS:000394578600008
J	Seymour, M; Morton, A				Seymour, Matthew; Morton, Adam			CASE REVIEW Unilateral facial swelling in a thyrotoxic patient	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Seymour, Matthew; Morton, Adam] Mater Misericordiae Hlth Serv Brisbane Ltd, Queensland Diabet & Endocrine Ctr, South Brisbane, Qld, Australia		Morton, A (corresponding author), Mater Misericordiae Hlth Serv Brisbane Ltd, Queensland Diabet & Endocrine Ctr, South Brisbane, Qld, Australia.	Adam.Morton@mater.org.au	morton, adam/I-1771-2013	morton, adam/0000-0001-9887-714X; Seymour, Matthew/0000-0003-4293-0997				Bogazzi F, 2003, J ENDOCRINOL INVEST, V26, P635, DOI 10.1007/BF03347021; Bogazzi F, 2010, J CLIN ENDOCR METAB, V95, P2529, DOI 10.1210/jc.2010-0180; Bogazzi F, 2009, J CLIN ENDOCR METAB, V94, P3757, DOI 10.1210/jc.2009-0940; Dickstein G, 1997, AM J MED, V102, P454, DOI 10.1016/S0002-9343(97)00047-8; Hasegawa J, 2011, AURIS NASUS LARYNX, V38, P101, DOI 10.1016/j.anl.2010.06.001; Lampropoulos P, 2012, SURG INFECT, V13, P266, DOI 10.1089/sur.2011.015; Loy M, 2007, ACTA RADIOL, V48, P628, DOI 10.1080/02841850701342138; Martino E, 2001, ENDOCR REV, V22, P240, DOI 10.1210/er.22.2.240; Mercado M, 1996, J CLIN ENDOCR METAB, V81, P3191, DOI 10.1210/jc.81.9.3191; Nakamura H, 2013, J CLIN ENDOCR METAB, V98, P4776, DOI 10.1210/jc.2013-2569; Narayana SK, 2011, THER ADV ENDOCRINOL, V2, P115, DOI 10.1177/2042018811398516; Pierret C, 2012, J LARYNGOL OTOL, V126, P701, DOI 10.1017/S0022215112000722; Robinson J, 2014, EUR THYROID J, V3, P245, DOI 10.1159/000367990; Tajiri J, 2005, THYROID, V15, P292, DOI 10.1089/thy.2005.15.292; Takata K, 2009, THYROID, V19, P559, DOI 10.1089/thy.2008.0364; Tomisti L, 2012, J CLIN ENDOCR METAB, V97, P3515, DOI 10.1210/jc.2012-1797	16	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2017	356								j534	10.1136/bmj.j534	http://dx.doi.org/10.1136/bmj.j534			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GB	28183855				2022-12-28	WOS:000394578600003
J	Lo, NC; Barry, M				Lo, Nathan C.; Barry, Michele			The Perils of Trumping Science in Global Health - The Mexico City Policy and Beyond	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lo, Nathan C.] Stanford Univ, Sch Med, Div Epidemiol, Stanford, CA 94305 USA; [Barry, Michele] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Barry, Michele] Stanford Univ, Ctr Innovat Global Hlth, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Lo, NC (corresponding author), Stanford Univ, Sch Med, Div Epidemiol, Stanford, CA 94305 USA.		Finkelstein, Mikal/AAF-7278-2021					Bendavid E, 2012, JAMA-J AM MED ASSOC, V307, P2060, DOI 10.1001/jama.2012.2001; Bendavid E, 2011, B WORLD HEALTH ORGAN, V89, P873, DOI 10.2471/BLT.11.091660; Glasier A, 2006, LANCET, V368, P1595, DOI 10.1016/S0140-6736(06)69478-6; Jones KM., 2011, EVALUATING MEXICO CI; Lo NC, 2016, HEALTH AFFAIR, V35, P856, DOI 10.1377/hlthaff.2015.0828	5	6	6	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 13	2017	376	15					1399	1401		10.1056/NEJMp1701294	http://dx.doi.org/10.1056/NEJMp1701294			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ER6EX	28225666				2022-12-28	WOS:000398899200002
J	Chow, CK; Thakkar, J; Bennett, A; Hillis, G; Burke, M; Usherwood, T; Vo, K; Rogers, K; Atkins, E; Webster, R; Chou, M; Dehbi, HM; Salam, A; Patel, A; Neal, B; Peiris, D; Krum, H; Chalmers, J; Nelson, M; Reid, CM; Woodward, M; Hilmer, S; Thom, S; Rodgers, A				Chow, Clara K.; Thakkar, Jay; Bennett, Alex; Hillis, Graham; Burke, Michael; Usherwood, Tim; Vo, Kha; Rogers, Kris; Atkins, Emily; Webster, Ruth; Chou, Michael; Dehbi, Hakim-Moulay; Salam, Abdul; Patel, Anushka; Neal, Bruce; Peiris, David; Krum, Henry; Chalmers, John; Nelson, Mark; Reid, Christopher M.; Woodward, Mark; Hilmer, Sarah; Thom, Simon; Rodgers, Anthony			Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review	LANCET			English	Article							BLOOD-PRESSURE CONTROL; RENAL-DISEASE; USUAL CARE; METAANALYSIS; MANAGEMENT; RISK; NEPHROPATHY; PROGRESSION	Background Globally, most patients with hypertension are treated with monotherapy, and control rates are poor because monotherapy only reduces blood pressure by around 9/5 mm Hg on average. There is a pressing need for blood pressure-control strategies with improved efficacy and tolerability. We aimed to assess whether ultra-low-dose combination therapy could meet these needs. Methods We did a randomised, placebo-controlled, double-blind, crossover trial of a quadpill-a single capsule containing four blood pressure-lowering drugs each at quarter-dose (irbesartan 37.5 mg, amlodipine 1.25 mg, hydrochlorothiazide 6.25 mg, and atenolol 12.5 mg). Participants with untreated hypertension were enrolled from four centres in the community of western Sydney, NSW, Australia, mainly by general practitioners. Participants were randomly allocated by computer to either the quadpill or matching placebo for 4 weeks; this treatment was followed by a 2-week washout, then the other study treatment was administered for 4 weeks. Study staff and participants were unaware of treatment allocations, and masking was achieved by use of identical opaque capsules. The primary outcome was placebo-corrected 24-h systolic ambulatory blood pressure reduction after 4 weeks and analysis was by intention to treat. We also did a systematic review of trials evaluating the efficacy and safety of quarter-standard-dose blood pressure-lowering therapy against placebo. This trial is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12614001057673. The trial ended after 1 year and this report presents the final analysis. Findings Between November, 2014, and December, 2015, 55 patients were screened for our randomised trial, of whom 21 underwent randomisation. Mean age of participants was 58 years (SD 11) and mean baseline office and 24-h systolic and diastolic blood pressure levels were 154 (14)/90 (11) mm Hg and 140 (9)/87 (8) mm Hg, respectively. One individual declined participation after randomisation and two patients dropped out for administrative reasons. The placebo-corrected reduction in systolic 24-h blood pressure with the quadpill was 19 mm Hg (95% CI 14-23), and office blood pressure was reduced by 22/13 mm Hg (p<0.0001). During quadpill treatment, 18 (100%) of 18 participants achieved office blood pressure less than 140/90 mm Hg, compared with six (33%) of 18 during placebo treatment (p=0.0013). There were no serious adverse events and all patients reported that the quadpill was easy to swallow. Our systematic review identified 36 trials (n=4721 participants) of one drug at quarter-dose and six trials (n=312) of two drugs at quarter-dose, against placebo. The pooled placebo-corrected blood pressure-lowering effects were 5/2 mm Hg and 7/5 mm Hg, respectively (both p<0.0001), and there were no side-effects from either regimen. Interpretation The findings of our small trial in the context of previous randomised evidence suggest that the benefits of quarter-dose therapy could be additive across classes and might confer a clinically important reduction in blood pressure. Further examination of the quadpill concept is needed to investigate effectiveness against usual treatment options and longer term tolerability.	[Chow, Clara K.; Thakkar, Jay; Bennett, Alex; Hillis, Graham; Rogers, Kris; Atkins, Emily; Webster, Ruth; Salam, Abdul; Patel, Anushka; Neal, Bruce; Peiris, David; Chalmers, John; Woodward, Mark; Rodgers, Anthony] Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia; [Chow, Clara K.; Thakkar, Jay] Westmead Hosp, Sydney, NSW, Australia; [Burke, Michael] Kildare Rd Med Ctr, Sydney, NSW, Australia; [Usherwood, Tim; Hilmer, Sarah; Rodgers, Anthony] Univ Sydney, Sydney, NSW, Australia; [Hillis, Graham] Univ Western Australia, Perth, WA, Australia; [Chou, Michael] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Dehbi, Hakim-Moulay; Neal, Bruce; Thom, Simon] Imperial Coll, London, England; [Krum, Henry] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Nelson, Mark] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Reid, Christopher M.] Curtin Univ, Perth, WA, Australia; [Chow, Clara K.; Neal, Bruce] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia; [Patel, Anushka; Neal, Bruce] Royal Prince Alfred Hosp, Sydney, NSW, Australia	George Institute for Global Health; University of Sydney; University of Sydney; University of Sydney; University of Western Australia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Imperial College London; Monash University; University of Tasmania; Menzies Institute for Medical Research; Curtin University; University of Sydney; University of Sydney	Chow, CK (corresponding author), George Inst Global Hlth Australia, Camperdown, NSW 2050, Australia.	cchow@georgeinstitute.org.au	Dehbi, Hakim-Moulay/AAU-4736-2020; Salam, Abdul/GWC-1029-2022; Hilmer, Sarah N/AAW-8554-2020; Reid, Christopher M/AAP-8135-2021; Woodward, Mark/L-6817-2017; Atkins, Emily R/J-5504-2013	Atkins, Emily R/0000-0003-2522-3510; Patel, Anushka/0000-0003-3825-4092; Woodward, Mark/0000-0001-9800-5296; Peiris, David/0000-0002-6898-3870; Neal, Bruce/0000-0002-0490-7465; Reid, Christopher/0000-0001-9173-3944; Chalmers, John/0000-0002-9931-0580; Hilmer, Sarah/0000-0002-5970-1501; Webster, Ruth/0000-0002-7444-3037; Abdul Salam, Mohammad/0000-0002-5870-7936; Rodgers, Anthony/0000-0003-1282-1896	National Heart Foundation, Australia; University of Sydney; National Health and Medical Research Council of Australia	National Heart Foundation, Australia(National Heart Foundation of Australia); University of Sydney(University of Sydney); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	National Heart Foundation, Australia; University of Sydney; and National Health and Medical Research Council of Australia.	Brayfield A., MARTINDALE COMPLETE; Byrd JB, 2011, AM HEART J, V162, P340, DOI 10.1016/j.ahj.2011.05.010; Chang SW, 2016, CTS-CLIN TRANSL SCI, V9, P114, DOI 10.1111/cts.12389; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Drawz PE, 2017, HYPERTENSION, V69, P42, DOI 10.1161/HYPERTENSIONAHA.116.08076; Feldman RD, 2009, HYPERTENSION, V53, P646, DOI 10.1161/HYPERTENSIONAHA.108.123455; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Keane WF, 2003, KIDNEY INT, V63, P1499, DOI 10.1046/j.1523-1755.2003.00885.x; Kenward MG, 2010, BIOSTATISTICS, V11, P1, DOI 10.1093/biostatistics/kxp046; Kenward MG, 2009, COMPUT STAT DATA AN, V53, P2583, DOI 10.1016/j.csda.2008.12.013; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mahmud A, 2007, HYPERTENSION, V49, P272, DOI 10.1161/01.HYP.0000254479.66645.a3; National Heart Foundation of Australia, 2010, GUID MAN HYP 2008 AS; Peralta CA, 2016, CIRCULATION, V133, P584, DOI 10.1161/CIRCULATIONAHA.115.019657; Peterzan MA, 2012, HYPERTENSION, V59, P1104, DOI 10.1161/HYPERTENSIONAHA.111.190637; Salam A, 2014, AM HEART J, V167, P127, DOI 10.1016/j.ahj.2013.10.020; Sever PS, 2011, EUR HEART J, V32, P2499, DOI 10.1093/eurheartj/ehr177; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X; Turnbull F, 2003, LANCET, V362, P1527; Wald DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041297; Wald DS, 2009, AM J MED, V122, P290, DOI 10.1016/j.amjmed.2008.09.038; Webster R, 2016, INT J CARDIOL, V205, P147, DOI 10.1016/j.ijcard.2015.12.015; Wright JT, 2016, NEW ENGL J MED, V374, P2294, DOI 10.1056/NEJMc1602668; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3	30	72	75	1	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2017	389	10073					1035	1042		10.1016/S0140-6736(17)30260-X	http://dx.doi.org/10.1016/S0140-6736(17)30260-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EN9UN	28190578	Green Submitted			2022-12-28	WOS:000396345200025
J	Shen, HZ; Zhou, Q; Pan, XJ; Li, ZQ; Wu, JP; Yan, N				Shen, Huaizong; Zhou, Qiang; Pan, Xiaojing; Li, Zhangqiang; Wu, Jianping; Yan, Nieng			Structure of a eukaryotic voltage-gated sodium channel at near-atomic resolution	SCIENCE			English	Article							AMINO-ACID-RESIDUES; C-TYPE INACTIVATION; SWISS-MODEL; SLOW INACTIVATION; CRYSTAL-STRUCTURE; GATING CHARGE; K+ CHANNEL; MOLECULAR DETERMINANTS; ORGANIC CATIONS; PROTEIN	Voltage-gated sodium (Nav) channels are responsible for the initiation and propagation of action potentials. They are associated with a variety of channelopathies and are targeted by multiple pharmaceutical drugs and natural toxins. Here, we report the cryogenic electron microscopy structure of a putative Nav channel from American cockroach (designated NavPaS) at 3.8 angstrom resolution. The voltage-sensing domains (VSDs) of the four repeats exhibit distinct conformations. The entrance to the asymmetric selectivity filter vestibule is guarded by heavily glycosylated and disulfide bond-stabilized extracellular loops. On the cytoplasmic side, a conserved amino-terminal domain is placed below VSDI, and a carboxy-terminal domain binds to the III-IV linker. The structure of NavPaS establishes an important foundation for understanding function and disease mechanism of Nav and related voltage-gated calcium channels.	[Shen, Huaizong; Zhou, Qiang; Pan, Xiaojing; Li, Zhangqiang; Wu, Jianping; Yan, Nieng] Tsinghua Univ, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Shen, Huaizong; Zhou, Qiang; Pan, Xiaojing; Li, Zhangqiang; Wu, Jianping; Yan, Nieng] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China; [Zhou, Qiang; Li, Zhangqiang; Wu, Jianping; Yan, Nieng] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Zhou, Qiang; Li, Zhangqiang; Wu, Jianping; Yan, Nieng] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Yan, N (corresponding author), Tsinghua Univ, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn	Bourinet, Emmanuel/S-4396-2017	Bourinet, Emmanuel/0000-0001-8021-0419; Yan, Nieng/0000-0003-4829-7416; Wu, Jianping/0000-0001-9869-7691; Shen, Huaizong/0000-0002-1216-5393	Ministry of Science and Technology of China [2015CB910101, 2016YFA0500402, 2014ZX09507003-006]; National Natural Science Foundation of China [31621092, 31630017, 31611130036]; Howard Hughes Medical Institute; Bayer Healthcare	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals)	We thank J. Lei, X. Li, and X. Li for technical support during EM image acquisition. We thank K. Wu, J. Chen, S. Fu, X. Zhu, H. Qi, W. Xiong, B. Xiao, C. Canessa, and Q. Tao at Tsinghua University for technical support and critical discussions. We thank the Tsinghua University Branch of China National Center for Protein Sciences (Beijing) for providing the cryo-EM facility support. We thank the computational facility support on the cluster of Bio-Computing Platform (Tsinghua University Branch of China National Center for Protein Sciences Beijing) and the "Explorer 100" cluster system of Tsinghua National Laboratory for Information Science and Technology. This work was supported by funds from the Ministry of Science and Technology of China (2015CB910101, 2016YFA0500402, and 2014ZX09507003-006) and the National Natural Science Foundation of China (projects 31621092, 31630017, and 31611130036). N.Y. was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute and an endowed professorship from Bayer Healthcare. The atomic coordinates have been deposited in the Protein Data Bank (PDB) with accession code 5X0M, and the EM map has been deposited in the Electron Microscopy Data Bank with accession code EMD-6698.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2008, CIRC RES, V102, P86, DOI 10.1161/CIRCRESAHA.107.160663; Ahern CA, 2016, J GEN PHYSIOL, V147, P1, DOI 10.1085/jgp.201511492; Ahuja S, 2015, SCIENCE, V350, DOI 10.1126/science.aac5464; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bagal SK, 2015, CHANNELS, V9, P360, DOI 10.1080/19336950.2015.1079674; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bourdin CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067290; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Capes DL, 2013, J GEN PHYSIOL, V142, P101, DOI 10.1085/jgp.201310998; CATTERALL WA, 1984, SCIENCE, V223, P653, DOI 10.1126/science.6320365; Catterall WA, 2014, ANNU REV PHARMACOL, V54, P317, DOI 10.1146/annurev-pharmtox-011112-140232; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen YA, 2006, NEURON, V49, P409, DOI 10.1016/j.neuron.2006.01.009; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Das S, 2016, ELIFE, V5, DOI 10.7554/eLife.10960; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeCaen PG, 2008, P NATL ACAD SCI USA, V105, P15142, DOI 10.1073/pnas.0806486105; DeLano WL, 2002, THE PYMOL MOLECULAR; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; ELLINOR PT, 1995, NEURON, V15, P1121, DOI 10.1016/0896-6273(95)90100-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; FENG GP, 1995, CELL, V82, P1001, DOI 10.1016/0092-8674(95)90279-1; Finol-Urdaneta RK, 2014, J GEN PHYSIOL, V143, P157, DOI 10.1085/jgp.201311037; Goldenberg O, 2009, NUCLEIC ACIDS RES, V37, pD323, DOI 10.1093/nar/gkn822; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Goldschen-Ohm MP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2356; Gong X, 2016, CELL, V165, P1467, DOI 10.1016/j.cell.2016.05.022; Grant T, 2015, J STRUCT BIOL, V192, P204, DOI 10.1016/j.jsb.2015.08.006; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; HILLE B, 1971, J GEN PHYSIOL, V58, P599, DOI 10.1085/jgp.58.6.599; Hille B, 2001, ION CHANNELS OF EXCI; Hite RK, 2017, NATURE, V541, P52, DOI 10.1038/nature20775; HODGKIN AL, 1945, J PHYSIOL-LONDON, V104, P176, DOI 10.1113/jphysiol.1945.sp004114; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huang WY, 2017, PROTEIN CELL, V8, P401, DOI 10.1007/s13238-017-0372-z; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Kass Robert S, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS21, DOI 10.1111/j.1540-8167.2006.00381.x; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Lee CH, 2017, CELL, V168, P111, DOI 10.1016/j.cell.2016.12.023; Li MH, 2017, NATURE, V542, P60, DOI 10.1038/nature20819; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lipkind GM, 2005, MOL PHARMACOL, V68, P1611, DOI 10.1124/mol.105.014803; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; Moignot B, 2009, INSECT BIOCHEM MOLEC, V39, P814, DOI 10.1016/j.ibmb.2009.09.006; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; O'Malley HA, 2015, ANNU REV PHYSIOL, V77, P481, DOI 10.1146/annurev-physiol-021014-071846; Ogielska EM, 1995, BIOPHYS J, V69, P2449, DOI 10.1016/S0006-3495(95)80114-1; Onwuli DO, 2016, AMINO ACIDS, V48, P641, DOI 10.1007/s00726-015-2122-y; Pavlov E, 2005, BIOPHYS J, V89, P232, DOI 10.1529/biophysj.104.056994; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pineda SS, 2014, FUTURE MED CHEM, V6, P1699, DOI [10.4155/FMC.14.103, 10.4155/fmc.14.103]; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Rohl CA, 1999, BIOCHEMISTRY-US, V38, P855, DOI 10.1021/bi9823380; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Shen PS, 2016, CELL, V167, P763, DOI 10.1016/j.cell.2016.09.048; Slowik D, 2015, BBA-BIOMEMBRANES, V1848, P1545, DOI 10.1016/j.bbamem.2015.03.021; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; STRONG M, 1993, MOL BIOL EVOL, V10, P221; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Sun YM, 1997, J GEN PHYSIOL, V110, P693, DOI 10.1085/jgp.110.6.693; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Todt H, 1999, BIOPHYS J, V76, P1335, DOI 10.1016/S0006-3495(99)77296-6; Ulbricht W, 2005, PHYSIOL REV, V85, P1271, DOI 10.1152/physrev.00024.2004; VASSILEV P, 1989, P NATL ACAD SCI USA, V86, P8147, DOI 10.1073/pnas.86.20.8147; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; Wang CJ, 2012, STRUCTURE, V20, P1167, DOI 10.1016/j.str.2012.05.001; Wang SY, 1997, BIOPHYS J, V72, P1633, DOI 10.1016/S0006-3495(97)78809-X; Watanabe E, 2000, J NEUROSCI, V20, P7743; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Whicher JR, 2016, SCIENCE, V353, P664, DOI 10.1126/science.aaf8070; Wu JP, 2016, NATURE, V537, P191, DOI 10.1038/nature19321; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Yarov-Yarovoy V, 2002, J BIOL CHEM, V277, P35393, DOI 10.1074/jbc.M206126200; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; Yue LX, 2002, J GEN PHYSIOL, V120, P845, DOI 10.1085/jgp.20028699; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zheng S., 2016, BIORXIV, DOI [10.1101/061960, DOI 10.1101/061960]	105	236	251	11	257	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2017	355	6328							eaal4326	10.1126/science.aal4326	http://dx.doi.org/10.1126/science.aal4326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2YM	28183995				2022-12-28	WOS:000395181700032
J	Neri, F; Rapelli, S; Krepelova, A; Incarnato, D; Parlato, C; Basile, G; Maldotti, M; Anselmi, F; Oliviero, S				Neri, Francesco; Rapelli, Stefania; Krepelova, Anna; Incarnato, Danny; Parlato, Caterina; Basile, Giulia; Maldotti, Mara; Anselmi, Francesca; Oliviero, Salvatore			Intragenic DNA methylation prevents spurious transcription initiation	NATURE			English	Article							GENOME-WIDE ANALYSIS; RNA-POLYMERASE-II; METHYLTRANSFERASES DNMT3A; TUMOR-SUPPRESSOR; SP1 BINDING; HALF-LIFE; GENE; STEM; REVEALS; SETD2	In mammals, DNA methylation occurs mainly at CpG dinucleotides. Methylation of the promoter suppresses gene expression, but the functional role of gene-body DNA methylation in highly expressed genes has yet to be clarified. Here we show that, in mouse embryonic stem cells, Dnmt3b-dependent intragenic DNA methylation protects the gene body from spurious RNA polymerase II entry and cryptic transcription initiation. Using different genome-wide approaches, we demonstrate that this Dnmt3b function is dependent on its enzymatic activity and recruitment to the gene body by H3K36me3. Furthermore, the spurious transcripts can either be degraded by the RNA exosome complex or capped, polyadenylated, and delivered to the ribosome to produce aberrant proteins. Elongating RNA polymerase II therefore triggers an epigenetic crosstalk mechanism that involves SetD2, H3K36me3, Dnmt3b and DNA methylation to ensure the fidelity of gene transcription initiation, with implications for intragenic hypomethylation in cancer.	[Neri, Francesco; Krepelova, Anna; Incarnato, Danny; Parlato, Caterina; Basile, Giulia; Maldotti, Mara; Anselmi, Francesca; Oliviero, Salvatore] Human Genet Fdn HuGeF, Via Nizza 52, I-10126 Turin, Italy; [Neri, Francesco] Leibniz Inst Aging FLI, Beutenbergstr 11, D-07745 Jena, Germany; [Rapelli, Stefania; Krepelova, Anna; Maldotti, Mara; Anselmi, Francesca; Oliviero, Salvatore] Univ Torino, Dipartimento Sci Vita & Biol Sistemi, Via Accademia Albertina 13, I-10123 Turin, Italy	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Turin	Anselmi, F; Oliviero, S (corresponding author), Human Genet Fdn HuGeF, Via Nizza 52, I-10126 Turin, Italy.; Anselmi, F; Oliviero, S (corresponding author), Univ Torino, Dipartimento Sci Vita & Biol Sistemi, Via Accademia Albertina 13, I-10123 Turin, Italy.	francesco.neri@leibniz-fli.de; salvatore.oliviero@unito.it	oliviero, salvatore/R-6657-2019; Neri, Francesco/A-3321-2014	oliviero, salvatore/0000-0002-3405-765X; Neri, Francesco/0000-0003-3903-1974; Maldotti, Mara/0000-0002-3299-9053; PARLATO, CATERINA/0000-0001-5304-3117; Krepelova, Anna/0000-0002-2775-1336	Associazione Italiana Ricerca sul Cancro (AIRC) [IG 2014 Id15217]	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	We thank T. Baubec and D. Schubeler for providing the Dnmt3b construct. We thank S. Yamanaka for anti-Dnmt3l antibody. We thank E. Guccione, R. Calogero and T. Bates for helpful suggestions and critical reading of the manuscript. This work was supported by the Associazione Italiana Ricerca sul Cancro (AIRC) IG 2014 Id15217.	Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; BOCHNIG P, 1987, EUR J BIOCHEM, V168, P461, DOI 10.1111/j.1432-1033.1987.tb13439.x; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Carvalho S, 2013, NUCLEIC ACIDS RES, V41, P2881, DOI 10.1093/nar/gks1472; Chen CYA, 2008, METHOD ENZYMOL, V448, P335, DOI 10.1016/S0076-6879(08)02617-7; Chen ZX, 2011, J BIOL CHEM, V286, P18347, DOI 10.1074/jbc.R110.205286; Clark SJ, 1997, GENE, V195, P67, DOI 10.1016/S0378-1119(97)00164-9; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Douet V, 2007, BIOCHEM BIOPH RES CO, V354, P66, DOI 10.1016/j.bbrc.2006.12.151; Duns G, 2010, CANCER RES, V70, P4287, DOI 10.1158/0008-5472.CAN-10-0120; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gowher H, 2002, J BIOL CHEM, V277, P20409, DOI 10.1074/jbc.M202148200; Hogart A, 2012, GENOME RES, V22, P1407, DOI 10.1101/gr.132878.111; Incarnato D, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0491-2; Incarnato D, 2014, GENOMICS, V104, P121, DOI 10.1016/j.ygeno.2014.06.007; Incarnato D, 2013, NUCLEIC ACIDS RES, V41, P8421, DOI 10.1093/nar/gkt629; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jeltsch A, 2014, TRENDS BIOCHEM SCI, V39, P310, DOI 10.1016/j.tibs.2014.05.002; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kanu N, 2015, ONCOGENE, V34, P5699, DOI 10.1038/onc.2015.24; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; MADERIOUS A, 1984, P NATL ACAD SCI-BIOL, V81, P5931, DOI 10.1073/pnas.81.19.5931; Maunakea AK, 2013, CELL RES, V23, P1256, DOI 10.1038/cr.2013.110; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morselli M, 2015, ELIFE, V4, DOI 10.7554/eLife.06205; Neri F, 2015, ONCOGENE, V34, P4168, DOI 10.1038/onc.2014.356; Neri F, 2015, CELL REP, V10, P674, DOI 10.1016/j.celrep.2015.01.008; Neri F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r91; Neri F, 2013, CELL, V155, P121, DOI 10.1016/j.cell.2013.08.056; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Tani H, 2012, RNA BIOL, V9, P1233, DOI 10.4161/rna.22036; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Uchiumi F, 2011, CELL MOL LIFE SCI, V68, P2039, DOI 10.1007/s00018-011-0674-x; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; YANKULOV K, 1995, J BIOL CHEM, V270, P23922, DOI 10.1074/jbc.270.41.23922; Yearim A, 2015, CELL REP, V10, P1122, DOI 10.1016/j.celrep.2015.01.038; Yoh SM, 2008, GENE DEV, V22, P3422, DOI 10.1101/gad.1720008; Yu M, 1997, J BIOL CHEM, V272, P29060, DOI 10.1074/jbc.272.46.29060; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	55	352	367	6	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					72	+		10.1038/nature21373	http://dx.doi.org/10.1038/nature21373			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0AA	28225755	Green Submitted			2022-12-28	WOS:000395671500034
J	Loukola, OJ; Solvi, C; Coscos, L; Chittka, L				Loukola, Olli J.; Solvi, Cwyn; Coscos, Louie; Chittka, Lars			Bumblebees show cognitive flexibility by improving on an observed complex behavior	SCIENCE			English	Article								We explored bees' behavioral flexibility in a task that required transporting a small ball to a defined location to gain a reward. Bees were pretrained to know the correct location of the ball. Subsequently, to obtain a reward, bees had to move a displaced ball to the defined location. Bees that observed demonstration of the technique from a live or model demonstrator learned the task more efficiently than did bees observing a "ghost" demonstration (ball moved via magnet) or without demonstration. Instead of copying demonstrators moving balls over long distances, observers solved the task more efficiently, using the ball positioned closest to the target, even if it was of a different color than the one previously observed. Such unprecedented cognitive flexibility hints that entirely novel behaviors could emerge relatively swiftly in species whose lifestyle demands advanced learning abilities, should relevant ecological pressures arise.	[Loukola, Olli J.; Solvi, Cwyn; Coscos, Louie; Chittka, Lars] Queen Mary Univ London, Sch Biol & Chem Sci, Dept Biol & Expt Psychol, London E1 4NS, England	University of London; Queen Mary University London	Loukola, OJ (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Dept Biol & Expt Psychol, London E1 4NS, England.	o.loukola@qmul.ac.uk	Chittka, Lars/C-3110-2012	Chittka, Lars/0000-0001-8153-1732; Solvi, Cwyn/0000-0003-2517-6179	Jenny and Antti Wihuri Foundation; Marie Curie Postdoctoral Fellowship; European Research Council Advanced Grant; Royal Society Wolfson Research Merit Award	Jenny and Antti Wihuri Foundation; Marie Curie Postdoctoral Fellowship(European Commission); European Research Council Advanced Grant(European Research Council (ERC)); Royal Society Wolfson Research Merit Award(Royal Society of London)	We thank E. Sovik and H. MaBouDi for their help with statistical analyses. We also thank L. Baciadonna, N. Emery, and V. Vasas for discussions on earlier drafts and three anonymous reviewers for their helpful critical feedback. O.J.L. was funded by the Jenny and Antti Wihuri Foundation. C.J.P. was funded by a Marie Curie Postdoctoral Fellowship. L. Chittka was funded by a European Research Council Advanced Grant and a Royal Society Wolfson Research Merit Award. O.J.L. and L. Chittka conceived the study. O.J.L. and C.J.P. designed the experiments. O.J.L., C.J.P., and L. Coscos conducted the experiments. O.J.L. and C.J.P. carried out behavioral data analysis. The manuscript was written by O.J.L., C.J.P., and L. Chittka. The authors declare no conflicts of interest. The data reported in this paper are archived at the Dryad.	Abramson CI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162347; Alem S, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002564; Avargues-Weber A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088415; CHITTKA L, 1995, ANIM BEHAV, V49, P159, DOI 10.1016/0003-3472(95)80163-4; Chittka L, 2011, CURR BIOL, V21, pR116, DOI 10.1016/j.cub.2010.12.045; Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; Dawson EH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031444; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Giurfa M, 2013, TRENDS NEUROSCI, V36, P285, DOI 10.1016/j.tins.2012.12.011; LAVERTY TM, 1994, ANIM BEHAV, V47, P531, DOI 10.1006/anbe.1994.1077; Leadbeater E, 2005, CURR BIOL, V15, pR447, DOI 10.1016/j.cub.2005.06.011; Leadbeater E, 2007, CURR BIOL, V17, pR703, DOI 10.1016/j.cub.2007.06.012; Mirwan HB, 2015, INSECT SOC, V62, P365, DOI 10.1007/s00040-015-0414-6; Roth G, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0049; Shumaker R. W., 2011, ANIMAL TOOL BEHAV US; Thorndike E. L, 1965, ANIMAL INTELLIGENCE; Worden BD, 2005, BIOL LETT-UK, V1, P504, DOI 10.1098/rsbl.2005.0368	17	89	91	9	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					834	+		10.1126/science.aag2360	http://dx.doi.org/10.1126/science.aag2360			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28232576	Green Published, Green Submitted			2022-12-28	WOS:000395127600040
J	Zeckhauser, R				Zeckhauser, Richard			RETROSPECTIVE Thomas Crombie Schelling (1921-2016) A pioneering game theorist who made the world a safer place	SCIENCE			English	Biographical-Item									[Zeckhauser, Richard] Harvard Univ, Polit Econ, Boston, MA 02115 USA	Harvard University	Zeckhauser, R (corresponding author), Harvard Univ, Polit Econ, Boston, MA 02115 USA.	richard_zeckhauser@hks.harvard.edu							0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					800	800		10.1126/science.aam9079	http://dx.doi.org/10.1126/science.aam9079			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28232540				2022-12-28	WOS:000395127600022
J	Thomou, T; Mori, MA; Dreyfuss, JM; Konishi, M; Sakaguchi, M; Wolfrum, C; Rao, TN; Winnay, JN; Garcia-Martin, R; Grinspoon, SK; Gorden, P; Kahn, CR				Thomou, Thomas; Mori, Marcelo A.; Dreyfuss, Jonathan M.; Konishi, Masahiro; Sakaguchi, Masaji; Wolfrum, Christian; Rao, Tata Nageswara; Winnay, Jonathon N.; Garcia-Martin, Ruben; Grinspoon, Steven K.; Gorden, Phillip; Kahn, C. Ronald			Adipose-derived circulating miRNAs regulate gene expression in other tissues	NATURE			English	Article							EXTRACELLULAR VESICLES; MICRORNA BIOGENESIS; MEMBRANE-VESICLES; EXOSOMES; RNA; PROTEINS; CELLS; DYSREGULATION; ADIPOGENESIS; METABOLISM	Adipose tissue is a major site of energy storage and has a role in the regulation of metabolism through the release of adipokines. Here we show that mice with an adipose-tissue-specific knockout of the microRNA (miRNA)-processing enzyme Dicer (ADicerKO), as well as humans with lipodystrophy, exhibit a substantial decrease in levels of circulating exosomal miRNAs. Transplantation of both white and brown adipose tissue-brown especially-into ADicerKO mice restores the level of numerous circulating miRNAs that are associated with an improvement in glucose tolerance and a reduction in hepatic Fgf21 mRNA and circulating FGF21. This gene regulation can be mimicked by the administration of normal, but not ADicerKO, serum exosomes. Expression of a human-specific miRNA in the brown adipose tissue of one mouse in vivo can also regulate its 3'UTR reporter in the liver of another mouse through serum exosomal transfer. Thus, adipose tissue constitutes an important source of circulating exosomal miRNAs, which can regulate gene expression in distant tissues and thereby serve as a previously undescribed form of adipokine.	[Thomou, Thomas; Konishi, Masahiro; Sakaguchi, Masaji; Rao, Tata Nageswara; Winnay, Jonathon N.; Garcia-Martin, Ruben; Kahn, C. Ronald] Joslin Diabet Ctr, Sect Integrat Physiol & Metab, Boston, MA 02215 USA; [Thomou, Thomas; Dreyfuss, Jonathan M.; Konishi, Masahiro; Sakaguchi, Masaji; Rao, Tata Nageswara; Winnay, Jonathon N.; Garcia-Martin, Ruben; Grinspoon, Steven K.; Kahn, C. Ronald] Harvard Med Sch, Boston, MA 02115 USA; [Mori, Marcelo A.] Univ Estadual Campinas, Dept Biochem & Tissue Biol, Campinas, SP, Brazil; [Dreyfuss, Jonathan M.] Joslin Diabet Ctr, Bioinformat Core, Boston, MA 02215 USA; [Dreyfuss, Jonathan M.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Wolfrum, Christian] ETHZ, Dept Hlth Sci & Metab, Zurich, Switzerland; [Rao, Tata Nageswara] Univ Basel Hosp, Dept Biomed, Expt Hematol, Basel, Switzerland; [Grinspoon, Steven K.] Massachusetts Gen Hosp, MGH Program Nutr Metab, Boston, MA 02114 USA; [Gorden, Phillip] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Universidade Estadual de Campinas; Harvard University; Joslin Diabetes Center, Inc.; Boston University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Kahn, CR (corresponding author), Joslin Diabet Ctr, Sect Integrat Physiol & Metab, Boston, MA 02215 USA.; Kahn, CR (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	c.ronald.kahn@joslin.harvard.edu	Mori, Marcelo A/R-2881-2018; Kahn, Ronald/AAY-2435-2021; Martin, Ruben Garcia/AAA-8538-2021	Mori, Marcelo A/0000-0001-7112-5263; Kahn, Ronald/0000-0002-7583-9228; Martin, Ruben Garcia/0000-0003-2049-4960; Wolfrum, Christian/0000-0002-3862-6805; Tata, Nageswara Rao/0000-0002-9928-5944; Dreyfuss, Jonathan/0000-0001-7242-3991	NIH [R01 DK082659, R01 DK033201, P30 DK040561]; Mary K. Iacocca Professorship; Joslin Diabetes Center DRC [P30DK036836]; FAPESP [2010/52557-0, 2015/01316-7]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031036, R01DK033201, P30DK040561, T32DK007260, P30DK036836, R01DK082659] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary K. Iacocca Professorship; Joslin Diabetes Center DRC; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Torriani and K. V. Fitch for assistance with HIV lipodystrophy samples; M. Lynnes, S. Kasif, and A. M. Cypess for help with reagents and discussions; and the Joslin Histology, Media and Physiology Core Facilities for help with experiments. This study was supported by grants from the NIH R01 DK082659 and R01 DK033201, the Mary K. Iacocca Professorship, and the Joslin Diabetes Center DRC Grant P30DK036836. S.K.G. was funded by grants from the NIH (P30 DK040561). M.A.M. was funded by grants from FAPESP (2010/52557-0 and 2015/01316-7).	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Arner E, 2012, DIABETES, V61, P1986, DOI 10.2337/db11-1508; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Atai NA, 2013, J NEURO-ONCOL, V115, P343, DOI 10.1007/s11060-013-1235-y; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bluher M, 2014, MOL METAB, V3, P230, DOI 10.1016/j.molmet.2014.01.005; Capobianco V, 2012, J PROTEOME RES, V11, P3358, DOI 10.1021/pr300152z; Caroli A, 2013, J CARDIOL, V61, P315, DOI 10.1016/j.jjcc.2013.01.012; Chou WW, 2013, CELL PHYSIOL BIOCHEM, V32, P127, DOI 10.1159/000350131; Dumortier O, 2013, CELL METAB, V18, P312, DOI 10.1016/j.cmet.2013.06.004; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Guay C, 2011, TRANSL RES, V157, P253, DOI 10.1016/j.trsl.2011.01.009; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hata A, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005825; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793; Keller P, 2011, BMC ENDOCR DISORD, V11, DOI 10.1186/1472-6823-11-7; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; McGregor RA, 2011, CURR MOL MED, V11, P304; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Mori MA, 2014, J CLIN INVEST, V124, P3339, DOI 10.1172/JCI73468; Mori MA, 2012, CELL METAB, V16, P336, DOI 10.1016/j.cmet.2012.07.017; Oger F, 2014, J CLIN ENDOCR METAB, V99, P2821, DOI 10.1210/jc.2013-4259; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tian YH, 2014, BIOMATERIALS, V35, P2383, DOI 10.1016/j.biomaterials.2013.11.083; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Uhrig-Schmidt S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116288; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Vos KE, 2016, NEURO-ONCOLOGY, V18, P58, DOI 10.1093/neuonc/nov244; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zech D, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-37; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610	50	787	819	19	372	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2017	542	7642					450	+		10.1038/nature21365	http://dx.doi.org/10.1038/nature21365			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM1RG	28199304	Green Accepted			2022-12-28	WOS:000395094100030
J	Wiesenfeld, HC				Wiesenfeld, Harold C.			Screening for Chlamydia trachomatis Infections in Women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PELVIC-INFLAMMATORY-DISEASE; GENITAL-TRACT INFECTION; ECTOPIC PREGNANCY; VAGINAL SWABS; GONORRHEA; RISK; AZITHROMYCIN; DOXYCYCLINE; PREVENTION; DIAGNOSIS	A 19-year-old woman visits her physician for a preventive health examination. Her medical history is unremarkable. She is sexually active with her boyfriend, and they use condoms inconsistently. She had one prior sexual partner and reports no symptoms of vaginal infections or sexually transmitted diseases. Results from her gynecologic examination are normal. Should this woman be screened for chlamydia, and if so, how?	[Wiesenfeld, Harold C.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Wiesenfeld, Harold C.] Allegheny Cty Hlth Dept, Sexually Transmitted Dis Program, Pittsburgh, PA USA; [Wiesenfeld, Harold C.] UPMC, Magee Womens Hosp, Dept Obstet Gynecol & Reprod Sci, 300 Halket St,Suite 2333, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wiesenfeld, HC (corresponding author), UPMC, Magee Womens Hosp, Dept Obstet Gynecol & Reprod Sci, 300 Halket St,Suite 2333, Pittsburgh, PA 15213 USA.	hwiesenfeld@mail.magee.edu						American Academy of Family Physicians, 2017, SUMM REC CLIN PREV S; American Academy of Pediatrics and American College of Obstetricians and Gynecologists, 2012, GUID PER CAR; Andersen B, 2006, SEX TRANSM DIS, V33, P407, DOI 10.1097/01.olq.0000200609.77577.3f; [Anonymous], 2011, CONTRACEPTION, V83, P295, DOI 10.1016/j.contraception.2010.11.006; [Anonymous], 2014, FIN REC STAT CHLAM G; [Anonymous], 2014, GUIDELINES WOMENS HL; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Briere EC, 2014, MMWR RECOMM REP, V63, P1; BRUNHAM RC, 1985, J INFECT DIS, V152, P1275, DOI 10.1093/infdis/152.6.1275; Brunham RC, 2005, J INFECT DIS, V192, P1836, DOI 10.1086/497341; BUCHAN H, 1993, BRIT J OBSTET GYNAEC, V100, P558, DOI 10.1111/j.1471-0528.1993.tb15308.x; Chesson HW, 2012, SEX TRANSM DIS, V39, P458, DOI 10.1097/OLQ.0b013e318248e3eb; Darville T, 2010, J INFECT DIS, V201, pS114, DOI 10.1086/652397; Department of Health and Human Services . Centers for Disease Control and Prevention, 2015, SEX TRANSM DIS SURV; Egger M, 1998, BRIT MED J, V316, P1776, DOI 10.1136/bmj.316.7147.1776; Gaydos CA, 2006, SEX TRANSM DIS, V33, P451, DOI 10.1097/01.olq.0000200497.14326.fb; Geisler WM, 2015, NEW ENGL J MED, V373, P2512, DOI 10.1056/NEJMoa1502599; Geisler WM, 2013, J INFECT DIS, V207, P1850, DOI 10.1093/infdis/jit094; Gottlieb SL, 2010, J INFECT DIS, V201, pS156, DOI 10.1086/652396; Graseck AS, 2010, OBSTET GYNECOL, V116, P1311, DOI 10.1097/AOG.0b013e3181fae60d; Hillis SD, 1997, AM J OBSTET GYNECOL, V176, P103, DOI 10.1016/S0002-9378(97)80020-8; HOOK EW, 1994, JAMA-J AM MED ASSOC, V272, P867, DOI 10.1001/jama.272.11.867; Hu D, 2004, ANN INTERN MED, V141, P501, DOI 10.7326/0003-4819-141-7-200410050-00006; Huang W, 2011, SEX TRANSM DIS, V38, P815, DOI 10.1097/OLQ.0b013e31821b0f50; Johnson LF, 2008, SEX TRANSM DIS, V35, P946, DOI 10.1097/OLQ.0b013e3181812d15; Kamwendo F, 1996, SEX TRANSM DIS, V23, P384, DOI 10.1097/00007435-199609000-00007; Kong FYS, 2015, J ANTIMICROB CHEMOTH, V70, P1290, DOI 10.1093/jac/dku574; LAGA M, 1993, AIDS, V7, P95, DOI 10.1097/00002030-199301000-00015; LeFevre ML, 2014, ANN INTERN MED, V161, P902, DOI 10.7326/M14-1981; MARTIN DH, 1982, JAMA-J AM MED ASSOC, V247, P1585, DOI 10.1001/jama.247.11.1585; Murray PJ, 2014, PEDIATRICS, V134, pE302, DOI 10.1542/peds.2014-1024; Nelson HD., 2014, SCREENING GONORRHEA; Ness RB, 2002, AM J OBSTET GYNECOL, V186, P929, DOI 10.1067/mob.2002.121625; Oakeshott P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1642; Quinn TC, 1996, JAMA-J AM MED ASSOC, V276, P1737, DOI 10.1001/jama.276.21.1737; Rekart ML, 2013, J INFECT DIS, V207, P30, DOI 10.1093/infdis/jis644; RYAN GM, 1990, AM J OBSTET GYNECOL, V162, P34, DOI 10.1016/0002-9378(90)90815-O; Schachter J, 2003, J CLIN MICROBIOL, V41, P3784, DOI 10.1128/JCM.41.8.3784-3789.2003; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103; Singh D, 2011, AM J PUBLIC HEALTH, V101, P1284, DOI 10.2105/AJPH.2009.169631; SVENSSON L, 1985, FERTIL STERIL, V44, P313; Torrone E, 2014, MMWR-MORBID MORTAL W, V63, P834; Trebach JD, 2015, SEX TRANSM DIS, V42, P233, DOI 10.1097/OLQ.0000000000000248; WESTROM L, 1992, SEX TRANSM DIS, V19, P185, DOI 10.1097/00007435-199207000-00001; WESTROM L, 1975, AM J OBSTET GYNECOL, V121, P707, DOI 10.1016/0002-9378(75)90477-9; Wiesenfeld HC, 2012, OBSTET GYNECOL, V120, P37, DOI 10.1097/AOG.0b013e31825a6bc9; Wiesenfeld HC, 2002, OBSTET GYNECOL, V100, P456, DOI 10.1016/S0029-7844(02)02118-X; Wiesenfeld HC, 2001, SEX TRANSM DIS, V28, P321, DOI 10.1097/00007435-200106000-00003; Wiesenfeld HC, 1996, AM J OBSTET GYNECOL, V174, P1542, DOI 10.1016/S0002-9378(96)70603-8; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1	50	43	46	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2017	376	8					765	773		10.1056/NEJMcp1412935	http://dx.doi.org/10.1056/NEJMcp1412935			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JO	28225683				2022-12-28	WOS:000395627900009
J	Peterson, SS; Liljestrand, J; Claeson, M; Nordenstedt, H				Peterson, Stefan Swartling; Liljestrand, Jerker; Claeson, Mariam; Nordenstedt, Helena			Friends and colleagues remember Hans Rosling	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		Nordenstedt H, 2016, LANCET, V388, P1864, DOI 10.1016/S0140-6736(16)31793-7	1	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2017	356								j891	10.1136/bmj.j891	http://dx.doi.org/10.1136/bmj.j891			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KS	28223276				2022-12-28	WOS:000395631000011
J	Glass, J				Glass, Jonathan			Irrational numbers in surgical training	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Glass, Jonathan] Guys & St Thomas Fdn Trust, London, England		Glass, J (corresponding author), Guys & St Thomas Fdn Trust, London, England.								0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2017	356								j883	10.1136/bmj.j883	http://dx.doi.org/10.1136/bmj.j883			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KQ	28219899				2022-12-28	WOS:000395630800011
J	Crowston, J; Trounce, I				Crowston, Jonathan; Trounce, Ian			Relief for retinal neurons under pressure	SCIENCE			English	Editorial Material							OPEN-ANGLE GLAUCOMA; MITOCHONDRIAL		[Crowston, Jonathan; Trounce, Ian] Univ Melbourne, Ctr Eye Res Australia Ophthalmol, Dept Surg, Melbourne, Vic, Australia	Centre for Eye Research Australia; University of Melbourne	Trounce, I (corresponding author), Univ Melbourne, Ctr Eye Res Australia Ophthalmol, Dept Surg, Melbourne, Vic, Australia.	i.trounce@unimelb.edu.au	Trounce, Ian A/F-8338-2010	Trounce, Ian A/0000-0002-1070-8892				Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001; Garway-Heath DF, 2015, LANCET, V385, P1295, DOI 10.1016/S0140-6736(14)62111-5; Guarente L, 2016, SCIENCE, V352, P1396, DOI 10.1126/science.aag1718; Lee S, 2012, INVEST OPHTH VIS SCI, V53, P2431, DOI 10.1167/iovs.12-9596; Sanchez MIGL, 2016, PHARMACOL THERAPEUT, V165, P132, DOI 10.1016/j.pharmthera.2016.06.004; Titov DV, 2016, SCIENCE, V352, P231, DOI 10.1126/science.aad4017; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Weinreb RN, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.67; Williams PA, 2017, SCIENCE, V355, P756, DOI 10.1126/science.aal0092; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693	10	2	2	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					688	689		10.1126/science.aam7935	http://dx.doi.org/10.1126/science.aam7935			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2AC	28209856				2022-12-28	WOS:000395117700018
J	Mervis, J				Mervis, Jeffrey			US HIGHER EDUCATION Drop in foreign applicants worries engineering schools	SCIENCE			English	News Item																			0	1	1	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					676	677		10.1126/science.355.6326.676	http://dx.doi.org/10.1126/science.355.6326.676			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2AC	28209850				2022-12-28	WOS:000395117700012
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Hotel chains are no answer to hospital bed crises	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						BMA, 2016, PRIM CAR I RES HOM; Brindle D., 2015, GUARDIAN; British Geriatrics Society, 2013, COMM GUID HIGH QUAL; Edwards N., 2017, WHATS DELAYED TRANSF; Ellis G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006211.pub2; Imison C, 2016, NUFFIELD TRUST RESHA; Knight John, 2009, Nurs Times, V105, P16; Lilley R., 2017, NHS MANAGERS BL 0105; Lilley R., 2017, NHS MANAGERS BL 0116; NHS Benchmarking, 2015, NAT AUD INT CAR SUMM; Oliver D., 2016, BMJ-BRIT MED J, V356, pi458; Oliver D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2948	12	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2017	356								j730	10.1136/bmj.j730	http://dx.doi.org/10.1136/bmj.j730			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GP	28213363	Bronze, Green Published			2022-12-28	WOS:000394580000002
J	Jarvis, DE; Ho, YS; Lightfoot, DJ; Schmockel, SM; Li, B; Borm, TJA; Ohyanagi, H; Mineta, K; Michell, CT; Saber, N; Kharbatia, NM; Rupper, RR; Sharp, AR; Dally, N; Boughton, BA; Woo, YH; Gao, G; Schijlen, EGWM; Guo, XJ; Momin, AA; Negrao, S; Al-Babili, S; Gehring, C; Roessner, U; Jung, C; Murphy, K; Arold, ST; Gojobori, T; van der Linden, CG; van Loo, EN; Jellen, EN; Maughan, PJ; Tester, M				Jarvis, David E.; Ho, Yung Shwen; Lightfoot, Damien J.; Schmockel, Sandra M.; Li, Bo; Borm, Theo J. A.; Ohyanagi, Hajime; Mineta, Katsuhiko; Michell, Craig T.; Saber, Noha; Kharbatia, Najeh M.; Rupper, Ryan R.; Sharp, Aaron R.; Dally, Nadine; Boughton, Berin A.; Woo, Yong H.; Gao, Ge; Schijlen, Elio G. W. M.; Guo, Xiujie; Momin, Afaque A.; Negrao, Sonia; Al-Babili, Salim; Gehring, Christoph; Roessner, Ute; Jung, Christian; Murphy, Kevin; Arold, Stefan T.; Gojobori, Takashi; van der Linden, C. Gerard; van Loo, Eibertus N.; Jellen, Eric N.; Maughan, Peter J.; Tester, Mark			The genome of Chenopodium quinoa	NATURE			English	Article							FLOWERING-LOCUS-T; READ ALIGNMENT; FT HOMOLOGS; SEQUENCE; WILLD.; ANNOTATION; RNA; QUANTIFICATION; IDENTIFICATION; BIOSYNTHESIS	Chenopodium quinoa (quinoa) is a highly nutritious grain identified as an important crop to improve world food security. Unfortunately, few resources are available to facilitate its genetic improvement. Here we report the assembly of a high-quality, chromosome-scale reference genome sequence for quinoa, which was produced using single-molecule real-time sequencing in combination with optical, chromosome-contact and genetic maps. We also report the sequencing of two diploids from the ancestral gene pools of quinoa, which enables the identification of sub-genomes in quinoa, and reduced-coverage genome sequences for 22 other samples of the allotetraploid goosefoot complex. The genome sequence facilitated the identification of the transcription factor likely to control the production of anti-nutritional triterpenoid saponins found in quinoa seeds, including a mutation that appears to cause alternative splicing and a premature stop codon in sweet quinoa strains. These genomic resources are an important first step towards the genetic improvement of quinoa.	[Jarvis, David E.; Ho, Yung Shwen; Lightfoot, Damien J.; Schmockel, Sandra M.; Li, Bo; Saber, Noha; Woo, Yong H.; Gao, Ge; Guo, Xiujie; Negrao, Sonia; Gehring, Christoph; Tester, Mark] KAUST, Biol & Environm Sci & Engn Div BESE, Thuwal 239556900, Saudi Arabia; [Borm, Theo J. A.; van der Linden, C. Gerard; van Loo, Eibertus N.] Wageningen Univ & Res, Wageningen UR Plant Breeding, Wageningen, Netherlands; [Ohyanagi, Hajime; Momin, Afaque A.; Arold, Stefan T.; Gojobori, Takashi] KAUST, CBRC, Biol & Environm Sci & Engn Div BESE, Thuwal 239556900, Saudi Arabia; [Mineta, Katsuhiko] KAUST, CBRC, Comp Elect & Math Sci & Engn Div CEMSE, Thuwal 239556900, Saudi Arabia; [Michell, Craig T.] KAUST, RSRC, Biol & Environm Sci & Engn Div BESE, Thuwal 239556900, Saudi Arabia; [Kharbatia, Najeh M.] KAUST, Analyt Core Lab, Thuwal 239556900, Saudi Arabia; [Rupper, Ryan R.; Sharp, Aaron R.; Jellen, Eric N.; Maughan, Peter J.] Brigham Young Univ, Dept Plant & Wildlife Sci, Coll Life Sci, Provo, UT 84602 USA; [Dally, Nadine; Jung, Christian] Christian Albrechts Univ Kiel, Plant Breeding Inst, Olshausenstr 40, D-24118 Kiel, Germany; [Boughton, Berin A.; Roessner, Ute] Univ Melbourne, Metabol Australia, Sch Biosci, Parkville, Vic 3010, Australia; [Schijlen, Elio G. W. M.] Wageningen UR, Plant Res Int, PRI Biosci, Wageningen, Netherlands; [Murphy, Kevin] Washington State Univ, Dept Crop & Soil Sci, Coll Agr Human & Nat Resource Sci, Pullman, WA 99164 USA	King Abdullah University of Science & Technology; Wageningen University & Research; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; Brigham Young University; University of Kiel; University of Melbourne; Wageningen University & Research; Washington State University	Tester, M (corresponding author), KAUST, Biol & Environm Sci & Engn Div BESE, Thuwal 239556900, Saudi Arabia.	mark.tester@kaust.edu.sa	Tester, Mark/J-2368-2017; Arold, Stefan/T-2612-2019; Jellen, Eric/K-4443-2019; Negrao, Sonia/F-4787-2016; Jellen, Eric/S-1166-2019; Mineta, Katsuhiko/A-5455-2012; Roessner, Ute/E-9446-2015	Tester, Mark/0000-0002-5085-8801; Negrao, Sonia/0000-0001-8059-5240; Jellen, Eric/0000-0002-7906-4845; Mineta, Katsuhiko/0000-0002-4727-045X; Roessner, Ute/0000-0002-6482-2615; Al-Babili, Salim/0000-0003-4823-2882; Lightfoot, Damien/0000-0003-3824-8856; Schmoeckel, Sandra Manuela/0000-0001-5974-5136; Arold, Stefan T/0000-0001-5278-0668; Gehring, Christoph/0000-0003-4355-4591; Boughton, Berin/0000-0001-6342-9814; Michell, Craig/0000-0003-4706-7256; Momin, Afaque Ahmad/0000-0002-5058-9445	King Abdullah University of Science and Technology (KAUST); USDA/NIFA-REEIS [2012-51300-20100]; NSF [1339412]; German Research Foundation, DFG [JU205/24-1]; Direct For Biological Sciences [1339412] Funding Source: National Science Foundation	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); USDA/NIFA-REEIS; NSF(National Science Foundation (NSF)); German Research Foundation, DFG(German Research Foundation (DFG)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Research reported in this publication was supported by the King Abdullah University of Science and Technology (KAUST), by USDA/NIFA-REEIS grant #2012-51300-20100 (WSU/BYU), by NSF grant #1339412, and by a grant from the German Research Foundation, DFG (grant no. JU205/24-1). We thank T Ramaraj from the National Center for Genomic Resources (Santa Fe) for his bioinformatics assistance, O. Mohammed Eid Alharbi at the KAUST Imaging and Characterization Laboratory for generating SEM images, K. Zemmouri at the KAUST Greenhouse for plant care, and H. Ho (Heno) Hwang and I. D. Gromicho at the KAUST Academic Writing Department for assistance with quinoa illustrations and photographs. We also thank H. Storchova, F. Morton, D. Bertero, F. Fuentes and D. Brenner of USDA-ARS-NPGS for their assistance in providing seeds.	Adolf VI, 2012, PLANT SOIL, V357, P117, DOI 10.1007/s11104-012-1133-7; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown D. C., 2014, PLANT GENOME, V8, P1; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Chab D, 2008, PLANTA, V228, P929, DOI 10.1007/s00425-008-0792-3; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; De Geyter E., 2007, PEST TECHNOLOGY, V1, P96; Dohm JC, 2014, NATURE, V505, P546, DOI 10.1038/nature12817; Eilbeck K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-67; Felsenstein J., PHYLOGENY INFERENCE; Giavalisco P, 2009, ANAL CHEM, V81, P6546, DOI 10.1021/ac900979e; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gordillo-Bastidas E., 2016, Journal of Nutrition and Food Sciences, V6, P497; Hariadi Y, 2011, J EXP BOT, V62, P185, DOI 10.1093/jxb/erq257; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jacobsen SE, 2003, FOOD REV INT, V19, P99, DOI 10.1081/FRI-120018872; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kallberg M, 2014, METHODS MOL BIOL, V1137, P17, DOI 10.1007/978-1-4939-0366-5_2; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Kolano B, 2011, GENOME, V54, P710, DOI 10.1139/G11-035; Kolano B, 2016, MOL PHYLOGENET EVOL, V100, P109, DOI 10.1016/j.ympev.2016.04.009; Kolano B, 2012, PLANT SYST EVOL, V298, P251, DOI 10.1007/s00606-011-0534-z; Konishi Y, 2004, BIOSCI BIOTECH BIOCH, V68, P231, DOI 10.1271/bbb.68.231; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuljanabhagavad T, 2008, PHYTOCHEMISTRY, V69, P1919, DOI 10.1016/j.phytochem.2008.03.001; Kuljanabhagavad T, 2009, PHYTOCHEM REV, V8, P473, DOI 10.1007/s11101-009-9121-0; Lam ET, 2012, NAT BIOTECHNOL, V30, P771, DOI 10.1038/nbt.2303; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Lee TH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-162; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lyons E., 2008, Tropical Plant Biology, V1, P181, DOI 10.1007/s12042-008-9017-y; Lyons E, 2008, PLANT J, V53, P661, DOI 10.1111/j.1365-313X.2007.03326.x; Madl T, 2006, J AM SOC MASS SPECTR, V17, P795, DOI 10.1016/j.jasms.2006.02.013; Massawe F, 2016, TRENDS PLANT SCI, V21, P365, DOI 10.1016/j.tplants.2016.02.006; Mastebroek HD, 2000, J SCI FOOD AGR, V80, P152, DOI [10.1002/(SICI)1097-0010(20000101)80:1<152::AID-JSFA503>3.3.CO;2-G, 10.1002/(SICI)1097-0010(20000101)80:1&lt;152::AID-JSFA503&gt;3.0.CO;2-P]; Maughan PJ, 2012, PLANT GENOME-US, V5, P114, DOI 10.3835/plantgenome2012.06.0011; Mertens J, 2016, PLANT PHYSIOL, V170, P194, DOI 10.1104/pp.15.01645; Palomino G, 2008, EUPHYTICA, V164, P221, DOI 10.1007/s10681-008-9711-8; Pin PA, 2012, PLANT CELL ENVIRON, V35, P1742, DOI 10.1111/j.1365-3040.2012.02558.x; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Putnam NH, 2016, GENOME RES, V26, P342, DOI 10.1101/gr.193474.115; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Revanna KV, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-190; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Risi C. J., 1984, Advances in Applied Biology, V10, P145; Rodriguez-Concepcion M, 2015, CURR OPIN PLANT BIOL, V25, P17, DOI 10.1016/j.pbi.2015.04.001; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smit A.F.A., 2008, 2015 REPEATMODELER O; Smit AF., 2018, REPEATMASKER; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Storchova H, 2015, GENET RESOUR CROP EV, V62, P913, DOI 10.1007/s10722-014-0200-8; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vega-Galvez A, 2010, J SCI FOOD AGR, V90, P2541, DOI 10.1002/jsfa.4158; Walsh BM, 2015, AM J BOT, V102, P533, DOI 10.3732/ajb.1400344; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Ward SM, 2001, J HERED, V92, P83, DOI 10.1093/jhered/92.1.83; WILSON HD, 1988, ECON BOT, V42, P478, DOI 10.1007/BF02862792; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; XU YQ, 2016, BIOMED RES INT, V2016, DOI DOI 10.1155/2016/7823429; Yandell M, 2012, NAT REV GENET, V13, P329, DOI 10.1038/nrg3174; Yasui Y, 2016, DNA RES, V23, P535, DOI 10.1093/dnares/dsw037; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zurita-Silva A, 2014, MOL BREEDING, V34, P13, DOI 10.1007/s11032-014-0023-5	79	348	384	14	174	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					307	+		10.1038/nature21370	http://dx.doi.org/10.1038/nature21370			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2LQ	28178233	Green Published, hybrid			2022-12-28	WOS:000394451600028
J	Brito, JP; Montori, VM; Davis, AM				Brito, Juan P.; Montori, Victor M.; Davis, Andrew M.			Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes A Joint Statement by International Diabetes Organizations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BARIATRIC SURGERY; OUTCOMES		[Brito, Juan P.] Mayo Clin, Rochester, MN USA; [Montori, Victor M.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN USA; [Davis, Andrew M.] Univ Chicago, Gen Internal Med Sect, 4124 N LeClaire Ave, Chicago, IL 60637 USA	Mayo Clinic; Mayo Clinic; University of Chicago	Davis, AM (corresponding author), Univ Chicago, Gen Internal Med Sect, 4124 N LeClaire Ave, Chicago, IL 60637 USA.	adavis@medicine.bsd.uchicago.edu			NIDDK NIH HHS [P30 DK092949] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092949] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams TD, 2016, DIABETES CARE, V39, P912, DOI 10.2337/dc16-0157; Chang SH, 2014, JAMA SURG, V149, P275, DOI 10.1001/jamasurg.2013.3654; Garcia-Perez LE, 2013, DIABETES THER, V4, P175, DOI 10.1007/s13300-013-0034-y; Hargraves I, 2016, HEALTH AFFAIR, V35, P627, DOI 10.1377/hlthaff.2015.1354; Keating C, 2015, LANCET DIABETES ENDO, V3, P855, DOI 10.1016/S2213-8587(15)00290-9; Lewis KH, 2016, CURR OBES REP, V5, P282, DOI 10.1007/s13679-016-0211-1; Maciejewski ML, 2016, JAMA SURG, V151, P1046, DOI 10.1001/jamasurg.2016.2317; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Rubino F, 2016, DIABETES CARE, V39, P861, DOI 10.2337/dc16-0236; Tran VT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0356-x	10	32	37	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2017	317	6					635	636		10.1001/jama.2016.20563	http://dx.doi.org/10.1001/jama.2016.20563			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8LI	28196240	Green Accepted			2022-12-28	WOS:000394870900018
J	Iacobucci, G				Iacobucci, Gareth			Briefing: GPs and private work	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		BMA, 2009, INT NHS PRIV TREATM; Campbell D, 2017, GUARDIAN; Madsen M, 2017, PULSE; Roberts N, 2017, NHS ENGLAND INVESTIG; Torjesen I, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i823	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2017	356								j774	10.1136/bmj.j774	http://dx.doi.org/10.1136/bmj.j774			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GL	28196835				2022-12-28	WOS:000394579600007
J	Nangia, J; Wang, T; Osborne, C; Niravath, P; Otte, K; Papish, S; Holmes, F; Abraham, J; Lacouture, M; Courtright, J; Paxman, R; Rude, M; Hilsenbeck, S; Osborne, CK; Rimawi, M				Nangia, Julie; Wang, Tao; Osborne, Cynthia; Niravath, Polly; Otte, Kristen; Papish, Steven; Holmes, Frankie; Abraham, Jame; Lacouture, Mario; Courtright, Jay; Paxman, Richard; Rude, Mari; Hilsenbeck, Susan; Osborne, C. Kent; Rimawi, Mothaffar			Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer The SCALP Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INDUCED HAIR LOSS; BODY-IMAGE; PREVENTION; HYPOTHERMIA	Importance Chemotherapy may induce alopecia. Although scalp cooling devices have been used to prevent this alopecia, efficacy has not been assessed in a randomized clinical trial. Objectives To assess whether a scalp cooling device is effective at reducing chemotherapy-induced alopecia and to assess adverse treatment effects. Design, Setting, and Participants Multicenter randomized clinical trial of women with breast cancer undergoing chemotherapy. Patients were enrolled from December 9, 2013, to September 30, 2016. One interim analysis was planned to allow the study to stop early for efficacy. Data reported are from the interim analysis. This study was conducted at 7 sites in the United States, and 182 women with breast cancer requiring chemotherapy were enrolled and randomized. Interventions Participants were randomized to scalp cooling (n = 119) or control (n = 63). Scalp cooling was done using a scalp cooling device. Main Outcomes and Measures The primary efficacy end points were successful hair preservation assessed using the Common Terminology Criteria for Adverse Events version 4.0 scale (grade 0 [no hair loss] or grade 1 [<50% hair loss not requiring a wig] were considered to have hair preservation) at the end of 4 cycles of chemotherapy by a clinician unaware of treatment assignment, and device safety. Secondary end points included wig use and scores on the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30, Hospital Anxiety and Depression Scale, and a summary scale of the Body Image Scale. Results At the time of the interim analysis, 142 participants were evaluable. The mean (SD) age of the patients was 52.6 (10.1) years; 36% (n = 51) received anthracycline-based chemotherapy and 64% (n = 91) received taxane-based chemotherapy. Successful hair preservation was found in 48 of 95 women with cooling (50.5%; 95% CI, 40.7%-60.4%) compared with 0 of 47 women in the control group (0%; 95% CI, 0%-7.6%) (success rate difference, 50.5%; 95% CI, 40.5%-60.6%). Because the 1-tailed P value from the Fisher exact test was <.001, which crossed the superiority boundary (P = .0061), the data and safety monitoring board recommended study termination on September 26, 2016. There were no statistically significant differences in changes in any of the scales of quality of life from baseline to chemotherapy cycle 4 among the scalp cooling and control groups. Only adverse events related to device use were collected; 54 adverse events were reported in the cooling group, all grades 1 and 2. There were no serious adverse device events. Conclusions and Relevance Among women with stage I to II breast cancer receiving chemotherapy with a taxane, anthracycline, or both, those who underwent scalp cooling were significantly more likely to have less than 50% hair loss after the fourth chemotherapy cycle compared with those who received no scalp cooling. Further research is needed to assess longer-term efficacy and adverse effects.	[Nangia, Julie; Wang, Tao; Niravath, Polly; Otte, Kristen; Rude, Mari; Hilsenbeck, Susan; Osborne, C. Kent; Rimawi, Mothaffar] Baylor Coll Med, One Baylor Plaza,BCM 660, Houston, TX 77030 USA; [Osborne, Cynthia; Holmes, Frankie; Courtright, Jay] US Oncol, Texas Oncol, Dallas, TX USA; [Niravath, Polly] Methodist Hosp, 6535 Fannin, Houston, TX 77030 USA; [Papish, Steven] Univ Texas MD Anderson Canc Ctr, Summit Med Grp, Morristown, NJ USA; [Abraham, Jame] Cleveland Clin, Cleveland, OH 44106 USA; [Lacouture, Mario] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Paxman, Richard] Paxman Coolers Ltd, Huddersfield, W Yorkshire, England	Baylor College of Medicine; Texas Oncology; US Oncology Network; The Methodist Hospital System; The Methodist Hospital - Houston; University of Texas System; UTMD Anderson Cancer Center; Cleveland Clinic Foundation; Memorial Sloan Kettering Cancer Center	Nangia, J (corresponding author), Baylor Coll Med, One Baylor Plaza,BCM 660, Houston, TX 77030 USA.	nangia@bcm.edu	Rimawi, Mothaffar/AAI-3520-2020	Rimawi, Mothaffar/0000-0002-4284-5656; Lacouture, Mario/0000-0002-4818-3710	Paxman Coolers Ltd; Baylor College of Medicine; National Cancer Institute [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Paxman Coolers Ltd; Baylor College of Medicine; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Paxman Coolers Ltd, which contracted with Baylor College of Medicine to conduct the study. Dr Lacouture is supported in part by grant P30 CA008748 from the National Cancer Institute.	Breed W. P. M., 2011, EXPERT REV DERMATOLO, DOI [10.1586/edm.10.76, DOI 10.1586/EDM.10.76]; Christodoulou C, 2006, Ann Oncol, V17, P350, DOI 10.1093/annonc/mdj008; EDELSTYN GA, 1977, LANCET, V2, P253; Fayers P, 2001, EORTC QLQ C30 SCORIN; GIACCONE G, 1988, CANCER NURS, V11, P170; Hopwood P, 2001, EUR J CANCER, V37, P189, DOI 10.1016/S0959-8049(00)00353-1; Kennedy M, 1983, Oncol Nurs Forum, V10, P19; Komen MMC, 2013, ONCOLOGIST, V18, P885, DOI 10.1634/theoncologist.2012-0332; Kornblith A., 1998, PSYCHO-ONCOLOGY, V1, P223; Lemieux J, 2008, PSYCHO-ONCOLOGY, V17, P317, DOI 10.1002/pon.1245; Lemieux J, 2011, BREAST CANCER RES TR, V128, P563, DOI 10.1007/s10549-011-1453-y; Lemieux J, 2009, BREAST CANCER RES TR, V118, P547, DOI 10.1007/s10549-009-0342-0; Macduff C, 2003, EUR J CANCER CARE, V12, P154, DOI 10.1046/j.1365-2354.2003.00382.x; Massey Carolyn S, 2004, Eur J Oncol Nurs, V8, P121, DOI 10.1016/j.ejon.2003.10.006; Mols F, 2009, SUPPORT CARE CANCER, V17, P181, DOI 10.1007/s00520-008-0475-4; Munstedt K, 1997, SUPPORT CARE CANCER, V5, P139, DOI 10.1007/s005200050056; Parker R, 1987, Oncol Nurs Forum, V14, P49; Peerbooms M, 2011, 34 ANN CTRC AACR SAN; Pozo-Kaderman C, 1999, NURS PRACT FORUM, V10, P165; Ron IG, 1997, SUPPORT CARE CANCER, V5, P136, DOI 10.1007/s005200050055; Rugo HS, 2015, 2015 ASCO ANN M MAY; SATTERWHITE B, 1984, CANCER, V54, P34, DOI 10.1002/1097-0142(19840701)54:1<34::AID-CNCR2820540109>3.0.CO;2-W; Shin H, 2015, INT J CANCER, V136, pE442, DOI 10.1002/ijc.29115; SNEEUW KCA, 1992, RADIOTHER ONCOL, V25, P160, DOI 10.1016/0167-8140(92)90262-S; Spaeth D, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.9564; Trusson D, 2017, CANCER NURS, V40, pE9, DOI 10.1097/NCC.0000000000000373; van de Sande Mariska A E, 2010, Ned Tijdschr Geneeskd, V154, pA2134; van den Hurk CJG, 2013, BREAST, V22, P1001, DOI 10.1016/j.breast.2013.07.039; van den Hurk CJ, 2013, SAFETY EFFECTIVENESS; van den Hurk CJ, 2012, ACTA ONCOL, V51, P497, DOI 10.3109/0284186X.2012.658966; van den Hurk CJG, 2010, PSYCHO-ONCOLOGY, V19, P701, DOI 10.1002/pon.1615; Zdenkowski N, 2016, MED J AUSTRALIA, V205, P471, DOI 10.5694/mja16.00947	32	114	115	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2017	317	6					596	605		10.1001/jama.2016.20939	http://dx.doi.org/10.1001/jama.2016.20939			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8LI	28196254				2022-12-28	WOS:000394870900014
J	Malakoff, D				Malakoff, David			A MATTER OF FACT	SCIENCE			English	Editorial Material																			0	6	6	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					562	563		10.1126/science.355.6325.562	http://dx.doi.org/10.1126/science.355.6325.562			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK0SF	28183923				2022-12-28	WOS:000393636700014
J	Turner, PJ; Campbell, DE				Turner, Paul J.; Campbell, Dianne E.			Implementing Primary Prevention for Peanut Allergy at a Population Level	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Turner, Paul J.] Imperial Coll London, Paediat Sect, London, England; [Turner, Paul J.] Univ Sydney, Discipline Child & Adolescent Hlth, Sydney, NSW, Australia; [Campbell, Dianne E.] Univ Sydney, Discipline Child & Adolescent Hlth, Sydney, NSW, Australia; [Campbell, Dianne E.] Childrens Hosp Westmead, Sydney, NSW, Australia	Imperial College London; University of Sydney; University of Sydney; University of Sydney	Campbell, DE (corresponding author), Univ Sydney, Sydney, NSW, Australia.	dianne.campbell1@health.nsw.gov.au		Campbell, Dianne/0000-0002-0907-6963; Turner, Paul/0000-0001-9862-5161	UK Medical Research Council [MR/K010468/1]; National Institute for Health Research (NIHR) Biomedical Research Centre based at the Imperial College Healthcare NHS Trust and Imperial College London; MRC [MR/K010468/1] Funding Source: UKRI; Medical Research Council [MR/K010468/1] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Centre based at the Imperial College Healthcare NHS Trust and Imperial College London(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Dr Turner is in receipt of a Clinician Scientist award funded by the UK Medical Research Council (reference MR/K010468/1), and is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at the Imperial College Healthcare NHS Trust and Imperial College London.	Du Toit G, 2016, NEW ENGL J MED, V374, P1435, DOI 10.1056/NEJMoa1514209; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Greenhawt M, 2016, ALLERGY, P13100; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Koplin JJ, 2016, J ALLERGY CLIN IMMUN, V138, P1131, DOI 10.1016/j.jaci.2016.04.011; O'Connor C, 2016, J ALLERGY CLIN IMMUN, V137, P1263, DOI 10.1016/j.jaci.2015.11.029; Osborne NJ, 2011, J ALLERGY CLIN IMMUN, V127; Perkin MR, 2016, NEW ENGL J MED, V374, P1733, DOI 10.1056/NEJMoa1514210; Togias A, 2017, J ALLERGY CLIN IMMUN, V139, P29, DOI 10.1016/j.jaci.2016.10.010; Turner PJ, 2016, CURR OPIN ALLERGY CL, V16, P441, DOI 10.1097/ACI.0000000000000305	10	31	31	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2017	317	11					1111	1112		10.1001/jama.2017.0922	http://dx.doi.org/10.1001/jama.2017.0922			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9CQ	28192569	Green Published			2022-12-28	WOS:000396987200010
J	Gradman, AH				Gradman, Alan H.			A quarter-dose quadpill for initial treatment of hypertension	LANCET			English	Editorial Material							COMBINATION THERAPY; BLOOD-PRESSURE; MONOTHERAPY; EVENTS		[Gradman, Alan H.] Temple Univ, Sch Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Gradman, AH (corresponding author), Temple Univ, Sch Med, Philadelphia, PA 19140 USA.	gradmanmd@aol.com						Bangalore S, 2007, AM J MED, V120, P713, DOI 10.1016/j.amjmed.2006.08.033; Brown MJ, 2011, LANCET, V377, P312, DOI 10.1016/S0140-6736(10)62003-X; Chow CK, 2017, LANCET, V389, P1035, DOI 10.1016/S0140-6736(17)30260-X; Chrysant SG, 2008, CLIN THER, V30, P587, DOI 10.1016/j.clinthera.2008.04.002; Corrao G, 2011, HYPERTENSION, V58, P566, DOI 10.1161/HYPERTENSIONAHA.111.177592; Egan BM, 2012, HYPERTENSION, V59, P1124, DOI 10.1161/HYPERTENSIONAHA.112.194167; Ezzati M, 2008, CIRCULATION, V117, P905, DOI 10.1161/CIRCULATIONAHA.107.732131; Gradman AH, 2013, HYPERTENSION, V61, P309, DOI 10.1161/HYPERTENSIONAHA.112.201566; Gradman AH, 2010, J AM SOC HYPERTENS, V4, P90, DOI [10.1016/j.jash.2010.03.001, 10.1016/j.jash.2010.02.005]; Mancia G, 2013, EUR HEART J; Weber MA, 2004, LANCET, V363, P2049, DOI 10.1016/S0140-6736(04)16456-8; Weir MR, 2007, AM J HYPERTENS, V20, P807, DOI 10.1016/j.amjhyper.2007.02.017; Yu JM, 2015, J THORAC DIS, V7, P881, DOI 10.3978/j.issn.2072-1439.2015.04.41	13	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2017	389	10073					989	+		10.1016/S0140-6736(17)30331-8	http://dx.doi.org/10.1016/S0140-6736(17)30331-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EN9UN	28190581				2022-12-28	WOS:000396345200003
J	Peeler, K				Peeler, Katherine			Protecting the Tired, the Poor, the Huddled Masses	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Peeler, Katherine] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Peeler, Katherine] Boston Childrens Hosp, Div Med Crit Care, Boston, MA 02115 USA; [Peeler, Katherine] Phys Human Rights, Asylum Network, New York, NY 10018 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Peeler, K (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.; Peeler, K (corresponding author), Boston Childrens Hosp, Div Med Crit Care, Boston, MA 02115 USA.; Peeler, K (corresponding author), Phys Human Rights, Asylum Network, New York, NY 10018 USA.		Peeler, Katherine Ratzan/H-9184-2019						0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2017	376	10							e17	10.1056/NEJMp1701684	http://dx.doi.org/10.1056/NEJMp1701684			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JA	28225667				2022-12-28	WOS:000395626500007
J	Gudipaty, SA; Lindblom, J; Loftus, PD; Redd, MJ; Edes, K; Davey, CF; Krishnegowda, V; Rosenblatt, J				Gudipaty, S. A.; Lindblom, J.; Loftus, P. D.; Redd, M. J.; Edes, K.; Davey, C. F.; Krishnegowda, V.; Rosenblatt, J.			Mechanical stretch triggers rapid epithelial cell division through Piezo1	NATURE			English	Article							PARADOXICAL COMPONENTS; G(2)/M TRANSITION; PATHWAY; CHANNEL; ACTIVATION; CIRCUITS; PROTEINS; GENES; CYCLE; CA2+	Despite acting as a barrier for the organs they encase, epithelial cells turn over at some of the fastest rates in the body. However, epithelial cell division must be tightly linked to cell death to preserve barrier function and prevent tumour formation. How does the number of dying cells match those dividing to maintain constant numbers? When epithelial cells become too crowded, they activate the stretch-activated channel Piezo1 to trigger extrusion of cells that later die(1). However, it is unclear how epithelial cell division is controlled to balance cell death at the steady state. Here we show that mammalian epithelial cell division occurs in regions of low cell density where cells are stretched. By experimentally stretching epithelia, we find that mechanical stretch itself rapidly stimulates cell division through activation of the Piezo1 channel. To stimulate cell division, stretch triggers cells that are paused in early G2 phase to activate calcium-dependent phosphorylation of ERK1/2, thereby activating the cyclin B transcription that is necessary to drive cells into mitosis. Although both epithelial cell division and cell extrusion require Piezo1 at the steady state, the type of mechanical force controls the outcome: stretch induces cell division, whereas crowding induces extrusion. How Piezo1-dependent calcium transients activate two opposing processes may depend on where and how Piezo1 is activated, as it accumulates in different subcellular sites with increasing cell density. In sparse epithelial regions in which cells divide, Piezo1 localizes to the plasma membrane and cytoplasm, whereas in dense regions in which cells extrude, it forms large cytoplasmic aggregates. Because Piezo1 senses both mechanical crowding and stretch, it may act as a homeostatic sensor to control epithelial cell numbers, triggering extrusion and apoptosis in crowded regions and cell division in sparse regions.	[Gudipaty, S. A.; Lindblom, J.; Loftus, P. D.; Redd, M. J.; Edes, K.; Davey, C. F.; Krishnegowda, V.; Rosenblatt, J.] Univ Utah, Huntsman Canc Inst, 2000 Circle Hope, Salt Lake City, UT 84102 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Rosenblatt, J (corresponding author), Univ Utah, Huntsman Canc Inst, 2000 Circle Hope, Salt Lake City, UT 84102 USA.	jody.rosenblatt@hci.utah.edu	Rosenblatt, Jody/AAD-4260-2019	Rosenblatt, Jody/0000-0001-9460-5868; Aravind Gudipaty, Swapna/0000-0003-1050-2285	National Institute of Health [1DP2OD002056-01, R01GM102169]; University of Utah [P30 CA042014]; NCRR [1S10RR024761-01]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102169] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002056] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Utah; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Wright for design consultation and printing our new stretch device prototypes, M. Yoshigi for the previous stretch device, L. Zinn-Bjorkman for video analysis, A. Patapoutian for a GFP-Piezo1 construct, D. Morgan and B. Edgar for cell cycle experimental advice and B. Edgar for comments on the manuscript. A National Institute of Health Director's New Innovator Award 1DP2OD002056-01, R01GM102169, and University of Utah Funding Incentive Seed Grant to J.R. and P30 CA042014 awarded to Huntsman Cancer Institute core facilities supported this work. We thank the Fluorescence Microscopy and Mutation Generation and Detection Cores in the Health Sciences Cores at the University of Utah. An NCRR Shared Equipment Grant 1S10RR024761-01 paid for microscopy equipment.	Abend M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039103; Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Benham-Pyle BW, 2015, SCIENCE, V348, P1024, DOI 10.1126/science.aaa4559; Cheng Y, 2014, ONCOL LETT, V7, P1021, DOI 10.3892/ol.2014.1838; Chuderland D, 2008, J BIOL CHEM, V283, P11176, DOI 10.1074/jbc.M709030200; Chuderland Dana, 2008, Commun Integr Biol, V1, P4; Coste B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8223; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Donnard E, 2014, ONCOTARGET, V5, P9199, DOI 10.18632/oncotarget.2374; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; Ge JP, 2015, NATURE, V527, P64, DOI 10.1038/nature15247; Hart Y, 2014, CELL, V158, P1022, DOI 10.1016/j.cell.2014.07.033; Hart Y, 2013, MOL CELL, V49, P213, DOI 10.1016/j.molcel.2013.01.004; Hart Y, 2012, P NATL ACAD SCI USA, V109, P8346, DOI 10.1073/pnas.1117475109; Hayne C, 2000, J BIOL CHEM, V275, P31876, DOI 10.1074/jbc.M002766200; Held M, 2010, NAT METHODS, V7, P747, DOI 10.1038/nmeth.1486; Pathak MM, 2014, P NATL ACAD SCI USA, V111, P16148, DOI 10.1073/pnas.1409802111; Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109; Shah AN, 2016, METHOD CELL BIOL, V135, P89, DOI 10.1016/bs.mcb.2016.01.008; Shah AN, 2015, NAT METHODS, V12, P535, DOI 10.1038/nmeth.3360; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; Spier I, 2016, FAM CANCER, V15, P281, DOI 10.1007/s10689-016-9870-z; Wright JH, 1999, P NATL ACAD SCI USA, V96, P11335, DOI 10.1073/pnas.96.20.11335; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	27	340	348	14	182	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					118	+		10.1038/nature21407	http://dx.doi.org/10.1038/nature21407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0AA	28199303	Green Submitted, Green Accepted			2022-12-28	WOS:000395671500044
J	Burgess, MR; Hwang, E; Mroue, R; Bielski, CM; Wandler, AM; Huang, BJ; Firestone, AJ; Young, A; Lacap, JA; Crocker, L; Asthana, S; Davis, EM; Xu, J; Akagi, K; Le Beau, MM; Li, Q; Haley, B; Stokoe, D; Sampath, D; Taylor, BS; Evangelista, M; Shannon, K				Burgess, Michael R.; Hwang, Eugene; Mroue, Rana; Bielski, Craig M.; Wandler, Anica M.; Huang, Benjamin J.; Firestone, Ari J.; Young, Amy; Lacap, Jennifer A.; Crocker, Lisa; Asthana, Saurabh; Davis, Elizabeth M.; Xu, Jin; Akagi, Keiko; Le Beau, Michelle M.; Li, Qing; Haley, Benjamin; Stokoe, David; Sampath, Deepak; Taylor, Barry S.; Evangelista, Marie; Shannon, Kevin			KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer	CELL			English	Article							ACUTE MYELOID-LEUKEMIA; ORAL MEK INHIBITOR; COPY NUMBER; K-RAS; LUNG-CANCER; DEVELOPMENTAL DEFECTS; TUMOR PROGRESSION; MUTATIONS; RESISTANCE; ONCOGENE	Investigating therapeutic "outliers'' that show exceptional responses to anti-cancer treatmentcanuncover biomarkers of drug sensitivity. We performed preclinical trials investigating primary murine acute myeloid leukemias (AMLs) generated by retroviral insertional mutagenesis in Kras(G12D) "knockin'' mice with the MEK inhibitor PD0325901 (PD901). One outlier AML responded and exhibited intrinsic drug resistance at relapse. Loss of wild-type (WT) Kras enhanced the fitness of thedominant clone and rendered it sensitive to MEK inhibition. Similarly, human colorectal cancer cell lines with increasedKRASmutant allele frequency were more sensitive to MAP kinase inhibition, and CRISPR-Cas9-mediated replacement of WT KRAS with a mutant allele sensitized heterozygous mutant HCT116 cells to treatment. In a prospectively characterized cohort of patients with advanced cancer, 642 of 1,168 (55%) with KRAS mutations exhibited allelic imbalance. These studies demonstrate that serial genetic changes at the Kras/KRAS locus are frequent in cancer and modulate competitive fitness and MEK dependency.	[Burgess, Michael R.; Asthana, Saurabh] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Hwang, Eugene; Wandler, Anica M.; Huang, Benjamin J.; Firestone, Ari J.; Xu, Jin; Shannon, Kevin] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Mroue, Rana; Stokoe, David; Evangelista, Marie] Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA; [Bielski, Craig M.; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, New York, NY 10065 USA; [Young, Amy; Lacap, Jennifer A.; Crocker, Lisa; Sampath, Deepak] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Davis, Elizabeth M.; Le Beau, Michelle M.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Akagi, Keiko] Ohio State Univ, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [Li, Qing] Univ Michigan, Dept Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA; [Haley, Benjamin] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Shannon, Kevin] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Roche Holding; Genentech; Memorial Sloan Kettering Cancer Center; Roche Holding; Genentech; University of Chicago; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; Roche Holding; Genentech; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Shannon, K (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.; Evangelista, M (corresponding author), Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA.; Shannon, K (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	evangelista.marie@gene.com; kevin.shannon@ucsf.edu		Huang, Benjamin/0000-0001-6996-0833; Firestone, Ari/0000-0001-9902-443X	NIH [R01 CA180037, R37 CA72614, T32 CA108462, T32 CA128583, R01 CA207244, U54 OD202355, P30 CA0088748]; DOD NF1 Research Program grant [W81XWH-12-1-0157]; Rally Foundation for Childhood Cancer Research; Truth 365; Leukemia and Lymphoma Society Specialized Center of Research grant LLS [7019-04]; Ohio Supercomputer Center [PAS0425]; Cycle for Survival; Josie Robertson Foundation; American Cancer Society - Hillcrest Committee [PF-14-146-01-LIB]; American Cancer Society [PF-14-070-01-TBG]; Damon Runyon Cancer Research Foundation Fellowship [DRG-2149-13]; NATIONAL CANCER INSTITUTE [R01CA072614, T32CA108462, R01CA204749, T32CA128583, R01CA207244, P30CA008748, R37CA072614, R01CA180037] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U54OD020355] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD NF1 Research Program grant; Rally Foundation for Childhood Cancer Research; Truth 365; Leukemia and Lymphoma Society Specialized Center of Research grant LLS; Ohio Supercomputer Center; Cycle for Survival; Josie Robertson Foundation; American Cancer Society - Hillcrest Committee; American Cancer Society(American Cancer Society); Damon Runyon Cancer Research Foundation Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to the members of the Molecular Diagnostics Service in the Department of Pathology and the Marie-Josee and Henry R. Kravis Center for Molecular Oncology at Memorial Sloan Kettering Cancer Center; David Adams at the Sanger Centre; Byron Hahn and the Preclinical Therapeutics Core at the UCSF Helen Diller Family Cancer Center; and members of the gCSI Cell line screening group at Genentech. We obtained Kras G12D mice from David Tuveson and Tyler Jacks, and Linda Wolff provided the MOL4070LTR retrovirus. This work was supported by the NIH (R01 CA180037 and R37 CA72614 to K.S.; T32 CA108462 to M.R.B.; T32 CA128583 to B.J.H.; and R01 CA207244, U54 OD202355, and P30 CA0088748 to B.S.T.), a DOD NF1 Research Program grant (W81XWH-12-1-0157) (to K.S.), the Rally Foundation for Childhood Cancer Research and The Truth 365, a Leukemia and Lymphoma Society Specialized Center of Research grant LLS (7019-04) (to K.S. and M.M.L.B.), the Ohio Supercomputer Center (PAS0425) (to K.A.), and the Cycle for Survival and the Josie Robertson Foundation (to B.S.T.). M.R.B. was supported by a Postdoctoral Fellowship (PF-14-146-01-LIB) from the American Cancer Society - Hillcrest Committee. A.M.W. was supported by a Postdoctoral Fellowship (PF-14-070-01-TBG) from the American Cancer Society, including a supplement from the Hillcrest Committee. A.J.F. was supported by a Damon Runyon Cancer Research Foundation Fellowship (DRG-2149-13). K.S. is an American Cancer Society Research Professor (RP 10-078-01-TBE). Michael R. Burgess is an employee and shareholder of Celgene. Rana Mroue, Amy Young, Jennifer A. LaCap, Lisa Crocker, Jin Xu, Ben Haley, David Stokoe, Deepak Sampath, and Marie Evangelista are employees and shareholders of Genentech. Ari J. Firestone is an employee of Calico Life Sciences. The remaining authors of this manuscript declare no financial interest related to this work.	Al-Ahmadie H, 2014, CANCER DISCOV, V4, P1014, DOI 10.1158/2159-8290.CD-14-0380; Bengtsson H., 2008, AROMA AFFYMETRIX GEN; Bentley C, 2013, BIOCHEM J, V452, P313, DOI 10.1042/BJ20121578; BREMNER R, 1990, CELL, V61, P407, DOI 10.1016/0092-8674(90)90523-H; Brown AP, 2007, CANCER CHEMOTH PHARM, V59, P671, DOI 10.1007/s00280-006-0323-5; Burgess MR, 2014, BLOOD, V124, P3947, DOI 10.1182/blood-2014-05-574582; Chen X, 2009, P NATL ACAD SCI USA, V106, P7979, DOI 10.1073/pnas.0900343106; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Dail M, 2014, NATURE, V513, P512, DOI 10.1038/nature13495; Dail M, 2010, P NATL ACAD SCI USA, V107, P5106, DOI 10.1073/pnas.1001064107; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Haura EB, 2010, CLIN CANCER RES, V16, P2450, DOI 10.1158/1078-0432.CCR-09-1920; Haverty PM, 2016, NATURE, V533, P333, DOI 10.1038/nature17987; Infante JR, 2012, LANCET ONCOL, V13, P773, DOI 10.1016/S1470-2045(12)70270-X; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Kerr EM, 2016, NATURE, V531, P110, DOI 10.1038/nature16967; Lauchle JO, 2009, NATURE, V461, P411, DOI 10.1038/nature08279; Le Beau MM, 2002, BLOOD, V99, P2985, DOI 10.1182/blood.V99.8.2985; LeBeau MM, 1996, BLOOD, V88, P1930; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Q, 2011, BLOOD, V117, P2022, DOI 10.1182/blood-2010-04-280750; Lindsley RC, 2015, BLOOD, V125, P1367, DOI 10.1182/blood-2014-11-610543; Lindsley RC, 2013, BLOOD, V122, P3741, DOI 10.1182/blood-2013-06-460295; Mainardi S, 2014, P NATL ACAD SCI USA, V111, P255, DOI 10.1073/pnas.1320383110; Modrek B, 2009, MOL CANCER RES, V7, P1244, DOI 10.1158/1541-7786.MCR-08-0532; Nan XL, 2013, P NATL ACAD SCI USA, V110, P18519, DOI 10.1073/pnas.1318188110; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Shen RL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw520; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Soh J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007464; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; To MD, 2006, NAT GENET, V38, P926, DOI 10.1038/ng1836; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Uren AG, 2005, ONCOGENE, V24, P7656, DOI 10.1038/sj.onc.1209043; Wagle N, 2014, CANCER DISCOV, V4, P546, DOI 10.1158/2159-8290.CD-13-0353; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	50	102	104	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					817	+		10.1016/j.cell.2017.01.020	http://dx.doi.org/10.1016/j.cell.2017.01.020			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28215705	Green Accepted, Bronze			2022-12-28	WOS:000396284800011
J	Clemmensen, C; Muller, TD; Woods, SC; Berthoud, HR; Seeley, RJ; Tschop, MH				Clemmensen, Christoffer; Mueller, Timo D.; Woods, Stephen C.; Berthoud, Hans-Rudolf; Seeley, Randy J.; Tschoep, Matthias H.			Gut-Brain Cross-Talk in Metabolic Control	CELL			English	Review							GLUCAGON-LIKE PEPTIDE-1; Y GASTRIC BYPASS; VERTICAL SLEEVE GASTRECTOMY; INTRAGANGLIONIC LAMINAR ENDINGS; RESTING ENERGY-EXPENDITURE; SERUM BILE-ACIDS; BODY-MASS INDEX; MELANOCORTIN-4 RECEPTOR; FOOD-INTAKE; WEIGHT-LOSS	Because human energy metabolism evolved to favor adiposity over leanness, the availability of palatable, easily attainable, and calorically dense foods has led to unprecedented levels of obesity and its associated metabolic co-morbidities that appear resistant to traditional lifestyle interventions. However, recent progress identifying the molecular signaling pathways through which the brain and the gastrointestinal system communicate to govern energy homeostasis, combined with emerging insights on the molecular mechanisms underlying successful bariatric surgery, gives reason to be optimistic that novel precision medicines that mimic, enhance, and/or modulate gut-brain signaling can have unprecedented potential for stopping the obesity and type 2 diabetes pandemics.	[Clemmensen, Christoffer; Mueller, Timo D.; Tschoep, Matthias H.] German Res Ctr Environm Hlth GmbH, Inst Diabet & Obes, Helmholtz Diabet Ctr, D-85764 Neuherberg, Germany; [Clemmensen, Christoffer; Mueller, Timo D.; Tschoep, Matthias H.] German Res Ctr Environm Hlth GmbH, German Ctr Diabet Res DZD, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Clemmensen, Christoffer; Mueller, Timo D.; Tschoep, Matthias H.] Tech Univ Munich, Dept Med, Div Metab Dis, D-80333 Munich, Germany; [Woods, Stephen C.] Univ Cincinnati, Dept Psychiat & Behav Neurosci, Cincinnati, OH 45220 USA; [Berthoud, Hans-Rudolf] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA; [Seeley, Randy J.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Seeley, Randy J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Seeley, Randy J.] Univ Michigan, Dept Nutr Sci, Ann Arbor, MI 48109 USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University System of Ohio; University of Cincinnati; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Tschop, MH (corresponding author), German Res Ctr Environm Hlth GmbH, Inst Diabet & Obes, Helmholtz Diabet Ctr, D-85764 Neuherberg, Germany.; Tschop, MH (corresponding author), German Res Ctr Environm Hlth GmbH, German Ctr Diabet Res DZD, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany.; Tschop, MH (corresponding author), Tech Univ Munich, Dept Med, Div Metab Dis, D-80333 Munich, Germany.	tschoep@helmholtz-muenchen.de	Clemmensen, Christoffer/N-4680-2017; Müller, Timo D./AAZ-4445-2020; Clemmensen, Christoffer/AAM-3347-2020; Berthoud, Hans-Rudolf/N-1950-2017	Clemmensen, Christoffer/0000-0003-2456-9667; Clemmensen, Christoffer/0000-0003-2456-9667; Seeley, Randy/0000-0002-3721-5625; Muller, Timo/0000-0002-0624-9339	Alfred Benzon Foundation; Lundbeck Foundation; Helmholtz Alliance ICEMED; Helmholtz Initiative on Personalized Medicine iMed; Helmholtz crossprogram topic "Metabolic Dysfunction''; Alexander von Humboldt Foundation; German Research Foundation DFG [SFB1123]; European Research Council ERC (AdG HypoFlam) [695054]; NIH [R01 DK047348, R01DK107652]; Ethicon Surgical Care; Novo Nordisk; Novartis; Daiichi Sankyo; Janssen/Johnson Johnson; Zafgen; Paul Hastings Law Firm; Takeda; Boehringer-Ingelheim; Sanofi; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK047348, R01DK107652] Funding Source: NIH RePORTER; Lundbeck Foundation [R210-2015-4001] Funding Source: researchfish	Alfred Benzon Foundation; Lundbeck Foundation(Lundbeckfonden); Helmholtz Alliance ICEMED; Helmholtz Initiative on Personalized Medicine iMed; Helmholtz crossprogram topic "Metabolic Dysfunction''; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Research Foundation DFG(German Research Foundation (DFG)); European Research Council ERC (AdG HypoFlam); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ethicon Surgical Care; Novo Nordisk(Novo Nordisk); Novartis(Novartis); Daiichi Sankyo(Daiichi Sankyo Company Limited); Janssen/Johnson Johnson(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Zafgen; Paul Hastings Law Firm; Takeda(Takeda Pharmaceutical Company Ltd); Boehringer-Ingelheim(Boehringer Ingelheim); Sanofi; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Lundbeck Foundation(Lundbeckfonden)	We would like to acknowledge and thank the numerous colleagues and collaborators with whom we have interacted over the years. C.C. received support from the Alfred Benzon Foundation and the Lundbeck Foundation. T.D.M. and M.H.T. received support from Helmholtz Alliance ICEMED, the Helmholtz Initiative on Personalized Medicine iMed, and the Helmholtz crossprogram topic "Metabolic Dysfunction''. M.H.T. received support from the Alexander von Humboldt Foundation, the German Research Foundation DFG (SFB1123) and the European Research Council ERC (AdG HypoFlam no. 695054). H.R.B. was supported by NIH grant R01 DK047348. R.J.S. was supported by NIH grant R01DK107652 and is a paid consultant for Ethicon Surgical Care, Novo Nordisk, Novartis, Daiichi Sankyo, Janssen/Johnson & Johnson, Zafgen, Paul Hastings Law Firm, Takeda, Boehringer-Ingelheim, and Sanofi.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Barrera JG, 2011, NAT REV ENDOCRINOL, V7, P507, DOI 10.1038/nrendo.2011.77; Batterham RL, 2007, NATURE, V450, P106, DOI 10.1038/nature06212; Baxter JD, 2009, NAT REV DRUG DISCOV, V8, P308, DOI 10.1038/nrd2830; Berthoud HR, 2008, NEUROGASTROENT MOTIL, V20, P64, DOI 10.1111/j.1365-2982.2008.01104.x; Berthoud HR, 2008, REGUL PEPTIDES, V149, P15, DOI 10.1016/j.regpep.2007.08.024; Berthoud HR, 2008, ANNU REV PSYCHOL, V59, P55, DOI 10.1146/annurev.psych.59.103006.093551; Berthoud HR, 1996, ACTA ANAT, V156, P123; BERTHOUD HR, 1995, ANAT EMBRYOL, V191, P203; Berthoud HR, 1997, ANAT EMBRYOL, V195, P183, DOI 10.1007/s004290050037; BERTHOUD HR, 1992, J COMP NEUROL, V319, P261, DOI 10.1002/cne.903190206; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; BLACKSHAW LA, 1990, J AUTONOM NERV SYST, V31, P191, DOI 10.1016/0165-1838(90)90185-L; Branco T, 2016, CELL, V165, P1749, DOI 10.1016/j.cell.2016.05.019; Brandsma E, 2015, CURR OPIN LIPIDOL, V26, P73, DOI 10.1097/MOL.0000000000000154; BRAY GA, 1969, LANCET, V2, P397; Brennan IM, 2005, AM J PHYSIOL-REG I, V288, pR1477, DOI 10.1152/ajpregu.00732.2004; BROBECK JR, 1946, PHYSIOL REV, V26, P541, DOI 10.1152/physrev.1946.26.4.541; Broeders EPM, 2015, CELL METAB, V22, P418, DOI 10.1016/j.cmet.2015.07.002; CABANAC M, 1983, PHYSIOL BEHAV, V31, P249, DOI 10.1016/0031-9384(83)90128-2; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Cegla J, 2014, DIABETES, V63, P3711, DOI 10.2337/db14-0242; Cello AC, 2016, SURG CLIN N AM, V96, P655, DOI 10.1016/j.suc.2016.03.001; Chakravarthy MV, 2004, J APPL PHYSIOL, V96, P3, DOI 10.1152/japplphysiol.00757.2003; Chambers AP, 2013, GASTROENTEROLOGY, V144, P50, DOI 10.1053/j.gastro.2012.09.009; Chambers AP, 2011, GASTROENTEROLOGY, V141, P950, DOI 10.1053/j.gastro.2011.05.050; Chan JL, 2006, OBESITY, V14, P194, DOI 10.1038/oby.2006.25; Chen KY, 2015, J CLIN ENDOCR METAB, V100, P1639, DOI 10.1210/jc.2014-4024; Clemmensen C, 2016, HANDB EXP PHARMACOL, V233, P437, DOI 10.1007/164_2015_7; Clemmensen C, 2015, EMBO MOL MED, V7, P288, DOI 10.15252/emmm.201404508; Clemmensen C, 2014, DIABETES, V63, P1422, DOI 10.2337/db13-1609; COLEMAN DL, 1969, AM J PHYSIOL, V217, P1298; COLEMAN DL, 1973, DIABETOLOGIA, V9, P294, DOI 10.1007/BF01221857; Colquitt JL, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub4; Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908; Cynthia K., 2010, MUSONIUS RUFUS LECT; D'Agostino G, 2016, ELIFE, V5, DOI 10.7554/eLife.12225; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; de Jonge L, 1997, OBES RES, V5, P622, DOI 10.1002/j.1550-8528.1997.tb00584.x; de Lartigue G, 2014, MOL METAB, V3, P855, DOI 10.1016/j.molmet.2014.09.009; De Silva A, 2011, CELL METAB, V14, P700, DOI 10.1016/j.cmet.2011.09.010; Degirolamo C, 2014, CELL REP, V7, P12, DOI 10.1016/j.celrep.2014.02.032; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Dickson SL, 2012, J NEUROSCI, V32, P4812, DOI 10.1523/JNEUROSCI.6326-11.2012; Dirksen C, 2013, INT J OBESITY, V37, P1452, DOI 10.1038/ijo.2013.15; Dossat AM, 2011, J NEUROSCI, V31, P14453, DOI 10.1523/JNEUROSCI.3262-11.2011; Dunn JP, 2010, BRAIN RES, V1350, P123, DOI 10.1016/j.brainres.2010.03.064; Ernst B, 2009, OBES SURG, V19, P274, DOI 10.1007/s11695-008-9769-3; Falken Y, 2011, J CLIN ENDOCR METAB, V96, P2227, DOI 10.1210/jc.2010-2876; Fang S, 2015, NAT MED, V21, P159, DOI 10.1038/nm.3760; Fani L, 2014, INT J OBESITY, V38, P163, DOI 10.1038/ijo.2013.80; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Figlewicz DP, 2016, BRAIN RES, V1645, P68, DOI 10.1016/j.brainres.2015.12.041; Finan B, 2016, CELL, V167, P843, DOI 10.1016/j.cell.2016.09.014; Finan B, 2016, TRENDS MOL MED, V22, P359, DOI 10.1016/j.molmed.2016.03.005; Finan B, 2015, MOL CELL ENDOCRINOL, V418, P42, DOI 10.1016/j.mce.2015.07.003; Finan B, 2015, NAT MED, V21, P27, DOI 10.1038/nm.3761; Finan B, 2012, NAT MED, V18, P1847, DOI 10.1038/nm.3009; Fosgerau K, 2013, DIABETES OBES METAB, V15, P62, DOI 10.1111/j.1463-1326.2012.01676.x; Frank S, 2014, INT J OBESITY, V38, P341, DOI 10.1038/ijo.2013.60; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Garcia-Caceres C, 2016, CELL, V166, P867, DOI 10.1016/j.cell.2016.07.028; Gautron L, 2015, CELL, V161, P133, DOI 10.1016/j.cell.2015.02.023; Gerhard GS, 2013, DIABETES CARE, V36, P1859, DOI 10.2337/dc12-2255; GIBBS J, 1973, NATURE, V245, P323, DOI 10.1038/245323a0; Grayson BE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006505; GREEN ED, 1995, GENOME RES, V5, P5, DOI 10.1101/gr.5.1.5; Gribble FM, 2016, ANNU REV PHYSIOL, V78, P277, DOI 10.1146/annurev-physiol-021115-105439; Gribble FM, 2012, P NUTR SOC, V71, P456, DOI 10.1017/S0029665112000705; Grill HJ, 2012, CELL METAB, V16, P296, DOI 10.1016/j.cmet.2012.06.015; Grunddal KV, 2016, ENDOCRINOLOGY, V157, P176, DOI 10.1210/en.2015-1600; Gutzwiller JP, 2004, AM J PHYSIOL-REG I, V287, pR562, DOI 10.1152/ajpregu.00599.2003; Habegger KM, 2013, DIABETES, V62, P1453, DOI 10.2337/db12-1116; Habegger KM, 2010, NAT REV ENDOCRINOL, V6, P689, DOI 10.1038/nrendo.2010.187; Hamilton MK, 2015, AM J PHYSIOL-GASTR L, V308, pG840, DOI 10.1152/ajpgi.00029.2015; Han WF, 2016, CELL METAB, V23, P103, DOI 10.1016/j.cmet.2015.10.009; Hasler WL, 2009, NEUROGASTROENT MOTIL, V21, P229, DOI 10.1111/j.1365-2982.2009.01277.x; Henry FE, 2015, ELIFE, V4, DOI 10.7554/eLife.09800; HERBERT H, 1990, J COMP NEUROL, V293, P581, DOI 10.1002/cne.902930405; HERVEY GR, 1959, J PHYSIOL-LONDON, V145, P336, DOI 10.1113/jphysiol.1959.sp006145; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Huypens P, 2016, NAT GENET, V48, P497, DOI 10.1038/ng.3527; Ikramuddin S, 2014, JAMA-J AM MED ASSOC, V312, P915, DOI 10.1001/jama.2014.10540; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jacobsen SH, 2012, OBES SURG, V22, P1084, DOI 10.1007/s11695-012-0621-4; Jansen PLM, 2011, DIGEST DIS, V29, P48, DOI 10.1159/000324128; Jiang CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10166; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; KENNEDY GC, 1953, PROC R SOC SER B-BIO, V140, P578, DOI 10.1098/rspb.1953.0009; KENNEDY GC, 1966, BRIT MED BULL, V22, P216, DOI 10.1093/oxfordjournals.bmb.a070476; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; Kharitonenkov A, 2015, TRENDS ENDOCRIN MET, V26, P608, DOI 10.1016/j.tem.2015.09.007; Kievit P, 2013, DIABETES, V62, P490, DOI 10.2337/db12-0598; Koch M, 2015, NATURE, V519, P45, DOI 10.1038/nature14260; Kohli R, 2013, ENDOCRINOLOGY, V154, P2341, DOI 10.1210/en.2012-2069; Korner J, 2007, SURG OBES RELAT DIS, V3, P597, DOI 10.1016/j.soard.2007.08.004; Krashes MJ, 2016, NAT NEUROSCI, V19, P206, DOI 10.1038/nn.4202; Kuhnen P, 2016, NEW ENGL J MED, V375, P240, DOI 10.1056/NEJMoa1512693; Larsen PJ, 1997, NEUROSCIENCE, V77, P257, DOI 10.1016/S0306-4522(96)00434-4; le Roux CW, 2014, EXP PHYSIOL, V99, P1128, DOI 10.1113/expphysiol.2014.078378; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Leonard WR, 2007, ANNU REV NUTR, V27, P311, DOI 10.1146/annurev.nutr.27.061406.093659; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; LUCAS F, 1989, PHYSIOL BEHAV, V46, P403, DOI 10.1016/0031-9384(89)90011-5; Lynch L, 2016, CELL METAB, V24, P510, DOI 10.1016/j.cmet.2016.08.003; Madara J. L., 2011, HDB PHYSL GASTROINTE; Madsbad S, 2014, LANCET DIABETES ENDO, V2, P152, DOI 10.1016/S2213-8587(13)70218-3; MAFFEI M, 1995, P NATL ACAD SCI USA, V92, P6957, DOI 10.1073/pnas.92.15.6957; Makaronidis JM, 2016, ENDOCRIN METAB CLIN, V45, P539, DOI 10.1016/j.ecl.2016.04.006; McGavigan AK, 2017, GUT, V66, P226, DOI 10.1136/gutjnl-2015-309871; Mikkelsen KH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142352; Mingrone G, 2015, LANCET, V386, P964, DOI 10.1016/S0140-6736(15)00075-6; Morton GJ, 2013, J CLIN INVEST, V123, P4799, DOI 10.1172/JCI70710; Muller TD, 2012, J PEPT SCI, V18, P383, DOI 10.1002/psc.2408; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Myronovych A, 2014, OBESITY, V22, P390, DOI 10.1002/oby.20548; Naslund E, 1998, OBES SURG, V8, P253, DOI 10.1381/096089298765554449; Neary NM, 2005, ENDOCRINOLOGY, V146, P5120, DOI 10.1210/en.2005-0237; Ochner CN, 2012, NEUROSCI RES, V74, P138, DOI 10.1016/j.neures.2012.08.002; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Oswald KD, 2011, INT J EAT DISORDER, V44, P203, DOI 10.1002/eat.20808; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Penney NC, 2015, INT J OBESITY, V39, P1565, DOI 10.1038/ijo.2015.115; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Pocai A, 2009, DIABETES, V58, P2258, DOI 10.2337/db09-0278; Powley TL, 2011, J COMP NEUROL, V519, P644, DOI 10.1002/cne.22541; Quarta C, 2016, DIABETOLOGIA, V59, P920, DOI 10.1007/s00125-016-3906-7; Ramsay DS, 2014, PSYCHOL REV, V121, P225, DOI 10.1037/a0035942; Ratner C, 2016, ENDOCRINOLOGY, V157, P3482, DOI 10.1210/en.2016-1329; Rehfeld JF, 1998, PHYSIOL REV, V78, P1087, DOI 10.1152/physrev.1998.78.4.1087; Reijnders D, 2016, CELL METAB, V24, P341, DOI 10.1016/j.cmet.2016.07.008; Reimann F, 2012, CELL METAB, V15, P421, DOI 10.1016/j.cmet.2011.12.019; RISING R, 1992, AM J CLIN NUTR, V55, P343, DOI 10.1093/ajcn/55.2.343; Romero F, 2012, SURG ENDOSC, V26, P2231, DOI 10.1007/s00464-012-2166-y; Rosenbaum M, 2000, AM J CLIN NUTR, V71, P1421; Rubino F, 2016, DIABETES CARE, V39, P861, DOI 10.2337/dc16-0236; Ryan KK, 2014, NATURE, V509, P183, DOI 10.1038/nature13135; Ryan KK, 2013, ENDOCRINOLOGY, V154, P9, DOI 10.1210/en.2012-1891; Salehi M, 2011, DIABETES, V60, P2308, DOI 10.2337/db11-0203; Sanchez-Garrido MA, 2016, MOL METAB, V5, P1015, DOI 10.1016/j.molmet.2016.07.003; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Scarlett JM, 2016, NAT MED, V22, P800, DOI 10.1038/nm.4101; Schauer PR, 2014, NEW ENGL J MED, V370, P2002, DOI [10.1056/NEJMoa1401329, 10.1056/NEJMc1407393]; Scholtz S, 2014, GUT, V63, P891, DOI 10.1136/gutjnl-2013-305008; Schultes B, 2010, AM J CLIN NUTR, V92, P277, DOI 10.3945/ajcn.2009.29007; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; SCLAFANI A, 1976, PHYSIOL BEHAV, V17, P461, DOI 10.1016/0031-9384(76)90109-8; Sclafani A, 2004, PHYSIOL BEHAV, V81, P773, DOI 10.1016/j.physbeh.2004.04.031; Sclafani A, 2003, PHYSIOL BEHAV, V78, P285, DOI 10.1016/S0031-9384(02)00968-X; Sclafani A, 2016, AM J PHYSIOL-REG I, V310, pR631, DOI 10.1152/ajpregu.00432.2015; Sclafani A, 2015, PHYSIOL BEHAV, V149, P14, DOI 10.1016/j.physbeh.2015.05.016; Sclafani A, 2013, AM J PHYSIOL-REG I, V305, pR1490, DOI 10.1152/ajpregu.00440.2013; Sclafani A, 2013, APPETITE, V71, P454, DOI 10.1016/j.appet.2012.05.024; Sclafani A, 2012, AM J PHYSIOL-REG I, V302, pR1119, DOI 10.1152/ajpregu.00038.2012; Seeley RJ, 2015, CELL METAB, V21, P369, DOI 10.1016/j.cmet.2015.01.001; Shin AC, 2011, INT J OBESITY, V35, pS40, DOI 10.1038/ijo.2011.147; Shin AC, 2011, INT J OBESITY, V35, P642, DOI 10.1038/ijo.2010.174; Skibicka KP, 2012, ADDICT BIOL, V17, P95, DOI 10.1111/j.1369-1600.2010.00294.x; Smith GP, 1996, NEUROSCI BIOBEHAV R, V20, P41, DOI 10.1016/0149-7634(95)00038-G; Speakman JR, 2014, PHYSIOLOGY, V29, P88, DOI 10.1152/physiol.00053.2013; Stanley SA, 2016, NATURE, V531, P647, DOI 10.1038/nature17183; Stearns AT, 2012, DIGEST DIS SCI, V57, P1281, DOI 10.1007/s10620-011-1968-4; Steculorum SM, 2015, CELL, V162, P1404, DOI 10.1016/j.cell.2015.08.032; Steele KE, 2010, OBES SURG, V20, P369, DOI 10.1007/s11695-009-0015-4; Stefater MA, 2010, GASTROENTEROLOGY, V138, P2426, DOI 10.1053/j.gastro.2010.02.059; Steinert RE, 2013, OBESITY, V21, pE660, DOI 10.1002/oby.20522; Sternson SM, 2014, ANNU REV NEUROSCI, V37, DOI 10.1146/annurev-neuro-071013-014048; Suarez-Pinzon WL, 2008, DIABETES, V57, P3281, DOI 10.2337/db08-0688; Suh JM, 2014, NATURE, V513, P436, DOI 10.1038/nature13540; Tamaki M, 2010, J DIABETES INVEST, V1, P172, DOI 10.1111/j.2040-1124.2010.00044.x; Tan CL, 2016, CELL, V167, P47, DOI 10.1016/j.cell.2016.08.028; Tan TM, 2013, DIABETES, V62, P1131, DOI 10.2337/db12-0797; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Teixeira TFS, 2012, NUTR RES, V32, P637, DOI 10.1016/j.nutres.2012.07.003; Tellez LA, 2016, NAT NEUROSCI, V19, P465, DOI 10.1038/nn.4224; Tichansky DS, 2011, SURG ENDOSC, V25, P1176, DOI 10.1007/s00464-010-1335-0; Trevaskis JL, 2010, TRENDS ENDOCRIN MET, V21, P473, DOI 10.1016/j.tem.2010.03.006; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583; Tschop MH, 2016, CELL METAB, V24, P51, DOI 10.1016/j.cmet.2016.06.021; Udit S, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00134; Ullrich J, 2013, OBES SURG, V23, P50, DOI 10.1007/s11695-012-0754-5; Unniappan S, 2008, AM J PHYSIOL-REG I, V295, pR51, DOI 10.1152/ajpregu.00234.2007; Valdearcos M, 2015, ANNU REV PHYSIOL, V77, P131, DOI 10.1146/annurev-physiol-021014-071656; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang LX, 2000, REGUL PEPTIDES, V92, P79, DOI 10.1016/S0167-0115(00)00153-1; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Waterson MJ, 2015, CELL METAB, V22, P962, DOI 10.1016/j.cmet.2015.09.026; Wilson-Perez HE, 2013, INT J OBESITY, V37, P288, DOI 10.1038/ijo.2012.18; Wilson-Perez HE, 2013, DIABETES, V62, P2380, DOI 10.2337/db12-1498; Wouterlood FG, 2014, J NEUROSCI METH, V235, P331, DOI 10.1016/j.jneumeth.2014.07.021; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xue Y, 2014, J NUTR BIOCHEM, V25, P758, DOI 10.1016/j.jnutbio.2014.03.009; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; Zagorodnyuk VP, 2001, J PHYSIOL-LONDON, V534, P255, DOI 10.1111/j.1469-7793.2001.00255.x; Zelissen PMJ, 2005, DIABETES OBES METAB, V7, P755, DOI 10.1111/j.1463-1326.2005.00468.x; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	201	140	146	5	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					758	774		10.1016/j.cell.2017.01.025	http://dx.doi.org/10.1016/j.cell.2017.01.025			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28235194	Bronze, Green Accepted			2022-12-28	WOS:000396284800007
J	Lees, JA; Messa, M; Sun, EW; Wheeler, H; Torta, F; Wenk, MR; De Camilli, P; Reinisch, KM				Lees, Joshua A.; Messa, Mirko; Sun, Elizabeth Wen; Wheeler, Heather; Torta, Federico; Wenk, Markus R.; De Camilli, Pietro; Reinisch, Karin M.			Lipid transport by TMEM24 at ER-plasma membrane contacts regulates pulsatile insulin secretion	SCIENCE			English	Article							BINDING PROTEINS; PHOSPHATIDYLSERINE TRANSPORT; CALCIUM OSCILLATIONS; TULIP SUPERFAMILY; SMP DOMAINS; EXCHANGE; PHOSPHOLIPIDS; SITES; PHOSPHORYLATION; IDENTIFICATION	Insulin is released by beta cells in pulses regulated by calcium and phosphoinositide signaling. Here, we describe how transmembrane protein 24 (TMEM24) helps coordinate these signaling events. We showed that TMEM24 is an endoplasmic reticulum (ER)-anchored membrane protein whose reversible localization to ER-plasma membrane (PM) contacts is governed by phosphorylation and dephosphorylation in response to oscillations in cytosolic calcium. A lipid-binding module in TMEM24 transports the phosphatidylinositol 4,5-bisphosphate [PI(4,5)P-2] precursor phosphatidylinositol between bilayers, allowing replenishment of PI(4,5)P-2 hydrolyzed during signaling. In the absence of TMEM24, calcium oscillations are abolished, leading to a defect in triggered insulin release. Our findings implicate direct lipid transport between the ER and the PM in the control of insulin secretion, a process impaired in patients with type II diabetes.	[Lees, Joshua A.; Messa, Mirko; Sun, Elizabeth Wen; Wheeler, Heather; De Camilli, Pietro; Reinisch, Karin M.] Yale Univ, Dept Cell Biol, Sch Med, New Haven, CT 06520 USA; [Messa, Mirko; Sun, Elizabeth Wen; Wheeler, Heather; De Camilli, Pietro] Yale Univ, Dept Neurosci, Sch Med, New Haven, CT 06510 USA; [Messa, Mirko; Sun, Elizabeth Wen; Wheeler, Heather; De Camilli, Pietro] Yale Univ, Howard Hughes Med Inst, Sch Med, New Haven, CT 06510 USA; [Messa, Mirko; Sun, Elizabeth Wen; Wheeler, Heather; De Camilli, Pietro] Yale Univ, Program Cellular Neurosci Neurodegenerat & Repair, Sch Med, New Haven, CT 06510 USA; [De Camilli, Pietro] Yale Univ, Kavli Inst Neurosci, Sch Med, New Haven, CT 06510 USA; [Torta, Federico; Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117599, Singapore	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University; National University of Singapore	Reinisch, KM (corresponding author), Yale Univ, Dept Cell Biol, Sch Med, New Haven, CT 06520 USA.	pietro.decamilli@yale.edu; karin.reinisch@yale.edu	De Camilli, Pietro/T-7229-2017	De Camilli, Pietro/0000-0001-9045-0723; Torta, Federico/0000-0001-7545-7484	National Institute of General Medical Sciences [P41 GM103403]; NIH [R37NS036251, DK45735, DA018343, DK082700, R01GM80616, 5T32GM007223-38/39]; National University of Singapore via the Life Sciences Institute (LSI); Biochemical Research Council [BMRC-SERC Diag-034]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, R01DK082700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223, P41GM103403, R01GM080616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036251, R37NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National University of Singapore via the Life Sciences Institute (LSI); Biochemical Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank T. Levine (University College London, London, UK) for valuable scientific discussion. We also thank F. Wilson, L. Lucast, L. Liu, and C. Schauder for superb technical assistance. X-ray data were collected at Northeastern Collaborative Access Team beamline 24-ID-E, funded by National Institute of General Medical Sciences (P41 GM103403), and we are grateful to NE-CAT staff for their assistance. P.D.C. was supported in part by NIH (R37NS036251, DK45735, DA018343, and DK082700); K.M.R. was supported by NIH (R01GM80616); E.W.S. was supported in part by NIH 5T32GM007223-38/39; M.R.W. and F.T. were supported by grants from the National University of Singapore via the Life Sciences Institute (LSI) and the Biochemical Research Council (BMRC-SERC Diag-034). Data and coordinates for the TMEM24 SMP domain have been deposited in the Protein Data Bank (accession number 5TOD).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AhYoung AP, 2015, P NATL ACAD SCI USA, V112, pE3179, DOI 10.1073/pnas.1422363112; Alva V, 2016, BBA-MOL CELL BIOL L, V1861, P913, DOI 10.1016/j.bbalip.2016.01.016; Bratanova-Tochkova TK, 2002, DIABETES, V51, pS83, DOI 10.2337/diabetes.51.2007.S83; Caberoy NB, 2009, BIOCHEM BIOPH RES CO, V386, P197, DOI 10.1016/j.bbrc.2009.06.010; Chang CL, 2015, J BIOL CHEM, V290, P14289, DOI 10.1074/jbc.M114.621375; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; Daniel S, 1999, DIABETES, V48, P1686, DOI 10.2337/diabetes.48.9.1686; Dong R, 2016, CELL, V166, P408, DOI 10.1016/j.cell.2016.06.037; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; EBERHARD DA, 1990, BIOCHEM J, V268, P15, DOI 10.1042/bj2680015; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gaspers LD, 2014, CELL REP, V9, P1209, DOI 10.1016/j.celrep.2014.10.033; Gatta AT, 2015, ELIFE, V4, DOI 10.7554/eLife.07253; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; HAROOTUNIAN AT, 1991, SCIENCE, V251, P75, DOI 10.1126/science.1986413; HAY JC, 1993, NATURE, V366, P572, DOI 10.1038/366572a0; Hille B, 2015, BBA-MOL CELL BIOL L, V1851, P844, DOI 10.1016/j.bbalip.2014.09.010; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Hou JCQ, 2009, VITAM HORM, V80, P473, DOI 10.1016/S0083-6729(08)00616-X; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Idevall-Hagren O, 2014, METHODS MOL BIOL, V1148, P109, DOI 10.1007/978-1-4939-0470-9_8; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; James Declan J, 2013, Front Endocrinol (Lausanne), V4, P187, DOI 10.3389/fendo.2013.00187; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kameshita I, 1999, FEBS LETT, V456, P249, DOI 10.1016/S0014-5793(99)00958-8; Kang LJ, 2006, CELL METAB, V3, P463, DOI 10.1016/j.cmet.2006.04.012; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kim YJ, 2015, DEV CELL, V33, P549, DOI 10.1016/j.devcel.2015.04.028; Kim YJ, 2013, TRENDS CELL BIOL, V23, P270, DOI 10.1016/j.tcb.2013.01.009; Kopec KO, 2010, BIOINFORMATICS, V26, P1927, DOI 10.1093/bioinformatics/btq326; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Martin TFJ, 2015, BBA-MOL CELL BIOL L, V1851, P785, DOI 10.1016/j.bbalip.2014.09.017; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nasuhoglu C, 2002, ANAL BIOCHEM, V301, P243, DOI 10.1006/abio.2001.5489; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Pottekat A, 2013, CELL REP, V4, P921, DOI 10.1016/j.celrep.2013.07.050; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Saheki Y, 2016, NAT CELL BIOL, V18, P504, DOI 10.1038/ncb3339; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Schauder CM, 2014, NATURE, V510, P552, DOI 10.1038/nature13269; Schikorski T, 2007, J NEUROSCI METH, V165, P210, DOI 10.1016/j.jneumeth.2007.06.004; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Stefan CJ, 2013, CURR OPIN CELL BIOL, V25, P434, DOI 10.1016/j.ceb.2013.02.020; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Tavassoli S, 2013, EMBO REP, V14, P434, DOI 10.1038/embor.2013.36; Thore S, 2007, DIABETES, V56, P818, DOI 10.2337/db06-0843; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Toulmay A, 2012, J CELL SCI, V125, P49, DOI 10.1242/jcs.085118; von Filseck JM, 2015, SCIENCE, V349, P432, DOI 10.1126/science.aab1346; Wuttke A, 2010, J CELL SCI, V123, P1492, DOI 10.1242/jcs.060525; Xie BC, 2016, CELL CHEM BIOL, V23, P816, DOI 10.1016/j.chembiol.2016.06.009; Yu HJ, 2016, P NATL ACAD SCI USA, V113, P4362, DOI 10.1073/pnas.1517259113	68	112	113	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326							eaah6171	10.1126/science.aah6171	http://dx.doi.org/10.1126/science.aah6171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2AC	28209843	Green Accepted, Green Submitted			2022-12-28	WOS:000395117700032
J	Vakil, S				Vakil, Stephen			Alice Vakil OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2017	356								j814	10.1136/bmj.j814	http://dx.doi.org/10.1136/bmj.j814			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GP	28213345				2022-12-28	WOS:000394580000009
J	Cockbain, BC; Bharucha, T; Irish, D; Jacobs, M				Cockbain, Beatrice Clare; Bharucha, Tehmina; Irish, Dianne; Jacobs, Michael			EASILY MISSED? Measles in older children and adults	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cockbain, Beatrice Clare; Irish, Dianne] Royal Free Hosp, London, England; [Bharucha, Tehmina] Royal Free Hosp, Combined Infect Training, London, England; [Jacobs, Michael] Royal Free Hosp, Infect Dis, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Cockbain, BC (corresponding author), Royal Free Hosp, London, England.	beatricecockbain@nhs.net						[Anonymous], 2015, IMMUNISATION STAT EN; ARISTA S, 1995, RES VIROLOGY, V146, P225, DOI 10.1016/0923-2516(96)80583-8; Public Health England, 2013, GREEN BOOK; Public Health England, 2016, MEASL MUMPS RUB LAB; Thomas B, 2007, J MED VIROL, V79, P1587, DOI 10.1002/jmv.20997; Young MK, 2014, COCHRANE DB SYST REV, V4; Zenner D, 2012, J INFECT DEV COUNTR, V6, P271, DOI 10.3855/jidc.1756	7	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2017	356								j426	10.1136/bmj.j426	http://dx.doi.org/10.1136/bmj.j426			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GN	28209781				2022-12-28	WOS:000394579800001
J	Basler, MH				Basler, Michael H.			COMMENTARY Could we see a prescription opioid epidemic in the UK?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Basler, Michael H.] Glasgow Royal Infirm, Anaesthesia & Pain Med, Glasgow, Lanark, Scotland	University of Glasgow	Basler, MH (corresponding author), Glasgow Royal Infirm, Anaesthesia & Pain Med, Glasgow, Lanark, Scotland.	michael.basler@ggc.scot.nhs.uk						Alvarez-Madrazo S, 2016, INT J EPIDEMIOL, V45, P714, DOI 10.1093/ije/dyw060; Shapiro H, 2017, HIGHWAYS BUYWAYS SNA; Zee AV, 2009, AM J PUBLIC HEALTH, V99, P221, DOI 10.2105/AJPH.2007.131714	3	4	4	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	2017	356								j790	10.1136/bmj.j790	http://dx.doi.org/10.1136/bmj.j790			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL4GM	28202445				2022-12-28	WOS:000394579700010
J	Mohammadi, D				Mohammadi, Dara			Scientists vigilant over circulating avian influenza viruses	LANCET			English	Editorial Material																			0	0	0	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2017	389	10069					587	587		10.1016/S0140-6736(17)30328-8	http://dx.doi.org/10.1016/S0140-6736(17)30328-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9AF	28195046				2022-12-28	WOS:000394910800011
J	McGranahan, N; Swanton, C				McGranahan, Nicholas; Swanton, Charles			Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future	CELL			English	Review							PAIRED EXOME ANALYSIS; WHOLE-GENOME; MUTATIONAL PROCESSES; CANCER EVOLUTION; COPY NUMBER; INTRATUMOR HETEROGENEITY; COLLATERAL SENSITIVITY; ACQUIRED-RESISTANCE; ESOPHAGEAL ADENOCARCINOMA; CHROMOSOMAL INSTABILITY	Intratumor heterogeneity, which fosters tumor evolution, is a key challenge in cancer medicine. Here, we review data and technologies that have revealed intra-tumor heterogeneity across cancer types and the dynamics, constraints, and contingencies inherent to tumor evolution. We emphasize the importance of macro-evolutionary leaps, often involving large-scale chromosomal alterations, in driving tumor evolution and metastasis and consider the role of the tumor microenvironment in engendering heterogeneity and drug resistance. We suggest that bold approaches to drug development, harnessing the adaptive properties of the immune-microenvironment while limiting those of the tumor, combined with advances in clinical trial-design, will improve patient outcome.	[McGranahan, Nicholas; Swanton, Charles] UCL, Inst Canc, Canc Res UK Lung Canc Ctr Excellence, Paul OGorman Bldg,72 Huntley St, London WC1E 6BT, England; [McGranahan, Nicholas; Swanton, Charles] Francis Crick Inst, Translat Canc Therapeut Lab, 1 Midland Rd, London NW1 1AT, England; [Swanton, Charles] Univ Coll London Hosp, Dept Med Oncol, 235 Euston Rd, London NW1 2BU, England	Cancer Research UK; University of London; University College London; Francis Crick Institute; University College London Hospitals NHS Foundation Trust; University of London; University College London	Swanton, C (corresponding author), UCL, Inst Canc, Canc Res UK Lung Canc Ctr Excellence, Paul OGorman Bldg,72 Huntley St, London WC1E 6BT, England.; Swanton, C (corresponding author), Francis Crick Inst, Translat Canc Therapeut Lab, 1 Midland Rd, London NW1 1AT, England.; Swanton, C (corresponding author), Univ Coll London Hosp, Dept Med Oncol, 235 Euston Rd, London NW1 2BU, England.	charles.swanton@crick.ac.uk	McGranahan, Nicholas/ABD-6561-2021	McGranahan, Nicholas/0000-0001-9537-4045; Swanton, Charles/0000-0002-4299-3018	Francis Crick Institute - Cancer Research UK [FC001169]; UK Medical Research Council [FC001169, MR/FC001169/1]; Wellcome Trust [FC001169]; Cancer Research UK (TRACERx); CRUK Lung Cancer Centre of Excellence; Stand Up 2 Cancer (SU2C); Rosetrees Trust; NovoNordisk Foundation [16584]; Prostate Cancer Foundation; Breast Cancer Research Foundation; European Research Council (THESEUS); National Institute for Health Research; University College London (UCL) Hospitals Biomedical Research Centre; Cancer Research UK UCL Experimental Cancer Medicine Centre; Cancer Research UK [20466, 17786, 23896] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0016584] Funding Source: researchfish; Rosetrees Trust [M179, M630] Funding Source: researchfish; The Francis Crick Institute [10359] Funding Source: researchfish	Francis Crick Institute - Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK (TRACERx); CRUK Lung Cancer Centre of Excellence; Stand Up 2 Cancer (SU2C); Rosetrees Trust(Rosetrees Trust); NovoNordisk Foundation(Novo Nordisk FoundationNovocure Limited); Prostate Cancer Foundation; Breast Cancer Research Foundation; European Research Council (THESEUS)(European Research Council (ERC)); National Institute for Health Research(National Institute for Health Research (NIHR)); University College London (UCL) Hospitals Biomedical Research Centre; Cancer Research UK UCL Experimental Cancer Medicine Centre; Cancer Research UK(Cancer Research UK); Novo Nordisk Fonden(Novo Nordisk Foundation); Rosetrees Trust(Rosetrees Trust); The Francis Crick Institute	We thank Erik Sahai, Samra Turajlic and Gareth Wilson for their input and discussions regarding the manuscript. We thank Poppy Swanton and Kip Lyall for artistic help with the figures. C.S. is a Royal Society Napier Research Professor. This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001169), the UK Medical Research Council (FC001169), and the Wellcome Trust (FC001169) and by the UK Medical Research Council (grant reference MR/FC001169/1). C.S. is funded by Cancer Research UK (TRACERx), the CRUK Lung Cancer Centre of Excellence, Stand Up 2 Cancer (SU2C), the Rosetrees Trust, NovoNordisk Foundation (ID 16584), the Prostate Cancer Foundation, the Breast Cancer Research Foundation, and the European Research Council (THESEUS). Support was provided to C.S. by the National Institute for Health Research, the University College London (UCL) Hospitals Biomedical Research Centre, and the Cancer Research UK UCL Experimental Cancer Medicine Centre. C.S. reports personal fees from Pfizer, Boehringer Ingelheim, Novartis, Celgene, Servier, Eli Lily and Glazo Smithkline outside the submitted work, and stock options: 1. Achilles Therapeutics, 2. Epic Biosciences, 3. GRAIL, 4. Apogen Biotech.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Alexandrov LB, 2015, NAT GENET, V47, P1402, DOI 10.1038/ng.3441; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Anagnostou V., 2016, CANC DISCOV; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Andor N, 2016, NAT MED, V22, P105, DOI 10.1038/nm.3984; [Anonymous], 1861, ORIGIN SPECIES MEANS; Aryee MJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005211; Bashashati A, 2013, J PATHOL, V231, P21, DOI 10.1002/path.4230; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bhang HEC, 2015, NAT MED, V21, P440, DOI 10.1038/nm.3841; Birkbak NJ, 2011, CANCER RES, V71, P3447, DOI 10.1158/0008-5472.CAN-10-3667; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Bozic I, 2014, P NATL ACAD SCI USA, V111, P15964, DOI 10.1073/pnas.1412075111; Bozic I, 2013, ELIFE, V2, DOI 10.7554/eLife.00747; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carreira S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009448; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chen GB, 2015, CELL, V160, P771, DOI 10.1016/j.cell.2015.01.026; Chen H, 2016, MOL BIOL EVOL, V33, P4, DOI 10.1093/molbev/msv212; Cheung KJ, 2016, P NATL ACAD SCI USA, V113, pE854, DOI 10.1073/pnas.1508541113; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; Conway Morris S., 2003, LIFES SOLUTION INEVT; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Deshwar AG, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0602-8; Dewhurst SM, 2014, CANCER DISCOV, V4, P175, DOI 10.1158/2159-8290.CD-13-0285; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Eckert MA, 2016, CANCER DISCOV, V6, P1342, DOI 10.1158/2159-8290.CD-16-0607; Eleveld TF, 2015, NAT GENET, V47, P864, DOI 10.1038/ng.3333; Enriquez-Navas PM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7842; Faltas BM, 2016, NAT GENET, V48, P1490, DOI 10.1038/ng.3692; Fedorenko IV, 2016, ONCOGENE, V35, P1225, DOI 10.1038/onc.2015.188; Fischer A, 2014, CELL REP, V7, P1740, DOI 10.1016/j.celrep.2014.04.055; Fisher R, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0433-z; Fojo T, 2014, JAMA OTOLARYNGOL, V140, P1225, DOI 10.1001/jamaoto.2014.1570; Francis JM, 2014, CANCER DISCOV, V4, P956, DOI 10.1158/2159-8290.CD-13-0879; Fu F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004142; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Gao RL, 2016, NAT GENET, V48, P1119, DOI 10.1038/ng.3641; Gatenby RA, 2009, CANCER RES, V69, P4894, DOI 10.1158/0008-5472.CAN-08-3658; Gerlinger M, 2014, ANNU REV GENET, V48, P215, DOI 10.1146/annurev-genet-120213-092314; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Gould SJ, 2000, WONDERFUL LIFE BURGE; Greaves M, 2015, CANCER DISCOV, V5, P806, DOI 10.1158/2159-8290.CD-15-0439; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Ha G, 2014, GENOME RES, V24, P1881, DOI 10.1101/gr.180281.114; Haber DA, 2014, CANCER DISCOV, V4, P650, DOI 10.1158/2159-8290.CD-13-1014; Hao JJ, 2016, NAT GENET, V48, P1500, DOI 10.1038/ng.3683; Harbst K, 2016, CANCER RES, V76, P4765, DOI 10.1158/0008-5472.CAN-15-3476; Hartkopf AD, 2014, BREAST CANCER RES TR, V147, P345, DOI 10.1007/s10549-014-3113-5; Hata AN, 2016, NAT MED, V22, P262, DOI 10.1038/nm.4040; HILL BT, 1986, DRUG EXP CLIN RES, V12, P293; Hirata E, 2015, CANCER CELL, V27, P574, DOI 10.1016/j.ccell.2015.03.008; Hobor S, 2014, CLIN CANCER RES, V20, P6429, DOI 10.1158/1078-0432.CCR-14-0774; Humphries A, 2013, P NATL ACAD SCI USA, V110, pE2490, DOI 10.1073/pnas.1220353110; Huxley Julian, 1958, BIOL ASPECTS CANC; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jamal-Hanjani M, 2016, ANN ONCOL, V27, P862, DOI 10.1093/annonc/mdw037; Jensen PB, 1997, BRIT J CANCER, V75, P869, DOI 10.1038/bjc.1997.154; Jiang YC, 2016, P NATL ACAD SCI USA, V113, pE5528, DOI 10.1073/pnas.1522203113; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Ju YS, 2014, ELIFE, V3, DOI 10.7554/eLife.02935; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Juric D, 2015, NATURE, V518, P240, DOI 10.1038/nature13948; Kim H, 2015, GENOME RES, V25, P316, DOI 10.1101/gr.180612.114; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kostadinov RL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003553; Kumar A, 2016, NAT MED, V22, P369, DOI 10.1038/nm.4053; Lalonde E, 2014, LANCET ONCOL, V15, P1521, DOI 10.1016/S1470-2045(14)71021-6; Lamy P, 2016, CANCER RES, V76, P5894, DOI 10.1158/0008-5472.CAN-16-0436; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Law EK, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601737; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Ling SP, 2015, P NATL ACAD SCI USA, V112, pE6496, DOI 10.1073/pnas.1519556112; Lipinski KA, 2016, TRENDS CANCER, V2, P49, DOI 10.1016/j.trecan.2015.11.003; Lord CJ, 2016, NAT REV CANCER, V16, P110, DOI 10.1038/nrc.2015.21; Maddipati R, 2015, CANCER DISCOV, V5, P1086, DOI 10.1158/2159-8290.CD-15-0120; Makohon-Moore A.P., 2017, NAT GENET; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Malhotra A, 2013, GENOME RES, V23, P762, DOI 10.1101/gr.143677.112; Mao Q, 2013, J CANCER RES CLIN, V139, P211, DOI 10.1007/s00432-012-1310-3; Martinez P, 2013, J PATHOL, V230, P356, DOI 10.1002/path.4214; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; Mayers JR, 2016, SCIENCE, V353, P1161, DOI 10.1126/science.aaf5171; Mazor T, 2016, CANCER CELL, V29, P440, DOI 10.1016/j.ccell.2016.03.009; Mazor T, 2015, CANCER CELL, V28, P307, DOI 10.1016/j.ccell.2015.07.012; McDermott DH, 2015, CELL, V160, P686, DOI 10.1016/j.cell.2015.01.014; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; McPherson A, 2016, NAT GENET, V48, P758, DOI 10.1038/ng.3573; Medema JP, 1999, J EXP MED, V190, P1033, DOI 10.1084/jem.190.7.1033; Mehine M, 2013, NEW ENGL J MED, V369, P43, DOI 10.1056/NEJMoa1302736; Melchor L, 2014, LEUKEMIA, V28, P1705, DOI 10.1038/leu.2014.13; Merlo LMF, 2010, CANCER PREV RES, V3, P1388, DOI 10.1158/1940-6207.CAPR-10-0108; Miller CA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003665; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Monajemi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093428; Morrison CD, 2014, P NATL ACAD SCI USA, V111, pE672, DOI 10.1073/pnas.1313580111; Morrissy AS, 2016, NATURE, V529, P351, DOI 10.1038/nature16478; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Murugaesu N, 2015, CANCER DISCOV, V5, P821, DOI 10.1158/2159-8290.CD-15-0412; Nadeu F, 2016, BLOOD, V127, P2122, DOI 10.1182/blood-2015-07-659144; Natrajan R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001961; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nikbakht H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11185; Nones K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6224; Notta F, 2016, NATURE, V538, P378, DOI 10.1038/nature19823; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Okosun J, 2014, NAT GENET, V46, P176, DOI 10.1038/ng.2856; Ortmann CA, 2015, NEW ENGL J MED, V372, P601, DOI 10.1056/NEJMoa1412098; Pallasch CP, 2014, CELL, V156, P590, DOI 10.1016/j.cell.2013.12.041; Park S, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156102; Pearson A, 2016, CANCER DISCOV, V6, P838, DOI 10.1158/2159-8290.CD-15-1246; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rosenthal R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0893-4; Roth A, 2016, NAT METHODS, V13, P573, DOI [10.1038/NMETH.3867, 10.1038/nmeth.3867]; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Russo M, 2016, CANCER DISCOV, V6, P147, DOI 10.1158/2159-8290.CD-15-1283; Schwarz RF, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001789; Selmecki AM, 2015, NATURE, V519, P349, DOI 10.1038/nature14187; Shaw AT, 2016, NEW ENGL J MED, V374, P54, DOI 10.1056/NEJMoa1508887; Shen RL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw520; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siravegna G, 2015, NAT MED, V21, P795, DOI 10.1038/nm.3870; Smith MP, 2014, CANCER DISCOV, V4, P1214, DOI 10.1158/2159-8290.CD-13-1007; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Stachler MD, 2015, NAT GENET, V47, P1047, DOI 10.1038/ng.3343; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Su KY, 2012, J CLIN ONCOL, V30, P433, DOI 10.1200/JCO.2011.38.3224; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Tavora B, 2014, NATURE, V514, P112, DOI 10.1038/nature13541; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Tomasetti C, 2013, P NATL ACAD SCI USA, V110, P1999, DOI 10.1073/pnas.1221068110; Turajlic S, 2016, SCIENCE, V352, P169, DOI 10.1126/science.aaf2784; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Uchi R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005778; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Verdegaal EME, 2016, NATURE, V536, P91, DOI 10.1038/nature18945; Voss MH, 2014, CLIN CANCER RES, V20, P1955, DOI 10.1158/1078-0432.CCR-13-2345; Waclaw B, 2015, NATURE, V525, P261, DOI 10.1038/nature14971; Wallace A. R., 1867, WESTMINSTER REV; Wang JG, 2016, NAT GENET, V48, P768, DOI 10.1038/ng.3590; Williams MJ, 2016, NAT GENET, V48, P238, DOI 10.1038/ng.3489; Xue RD, 2016, GASTROENTEROLOGY, V150, P998, DOI 10.1053/j.gastro.2015.12.033; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886; Yuan YY, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004330; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930; Zhao BY, 2016, CELL, V165, P234, DOI 10.1016/j.cell.2016.01.045	162	1284	1319	18	314	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2017	168	4					613	628		10.1016/j.cell.2017.01.018	http://dx.doi.org/10.1016/j.cell.2017.01.018			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8VJ	28187284	Green Submitted, Bronze			2022-12-28	WOS:000396277600013
J	Rampinelli, C; De Marco, P; Origgi, D; Maisonneuve, P; Casiraghi, M; Veronesi, G; Spaggiari, L; Bellomi, M				Rampinelli, Cristiano; De Marco, Paolo; Origgi, Daniela; Maisonneuve, Patrick; Casiraghi, Monica; Veronesi, Giulia; Spaggiari, Lorenzo; Bellomi, Massimo			Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ITERATIVE RECONSTRUCTION; RADIATION RISKS; CT; SMOKERS; NODULES	OBJECTIVE To estimate the cumulative radiation exposure and lifetime attributable risk of cancer incidence associated with lung cancer screening using annual low dose computed tomography (CT). Design Secondary analysis of data from a lung cancer screening trial and risk-benefit analysis. Setting 10 year, non-randomised, single centre, low dose CT, lung cancer screening trial (COSMOS study) which took place in Milan, Italy in 2004-15 (enrolment in 2004-05). Secondary analysis took place in 2015-16. Participants High risk asymptomatic smokers aged 50 and older, who were current or former smokers (>= 20 pack years), and had no history of cancer in the previous five years. Main outcome measures Cumulative radiation exposure from low dose CT and positron emission tomography (PET) CT scans, calculated by dosimetry software; and lifetime attributable risk of cancer incidence, calculated from the Biological Effects of Ionizing Radiation VII (BEIR VII) report. Results Over 10 years, 5203 participants (3439 men, 1764 women) underwent 42 228 low dose CT and 635 PET CT scans. The median cumulative effective dose at the 10th year of screening was 9.3 mSv for men and 13.0 mSv for women. According to participants' age and sex, the lifetime attributable risk of lung cancer and major cancers after 10 years of CT screening ranged from 5.5 to 1.4 per 10 000 people screened, and from 8.1 to 2.6 per 10 000 people screened, respectively. In women aged 50-54, the lifetime attributable risk of lung cancer and major cancers was about fourfold and threefold higher than for men aged 65 and older, respectively. The numbers of lung cancer and major cancer cases induced by 10 years of screening in our cohort were 1.5 and 2.4, respectively, which corresponded to an additional risk of induced major cancers of 0.05% (2.4/5203). 259 lung cancers were diagnosed in 10 years of screening; one radiation induced major cancer would be expected for every 108 (259/2.4) lung cancers detected through screening. Conclusion Radiation exposure and cancer risk from low dose CT screening for lung cancer, even if non-negligible, can be considered acceptable in light of the substantial mortality reduction associated with screening.	[Rampinelli, Cristiano; Bellomi, Massimo] European Inst Oncol, Dept Med Imaging & Radiat Sci, Milan, Italy; [De Marco, Paolo] Univ Milan, Med Phys Sch, Milan, Italy; [Origgi, Daniela] European Inst Oncol, Div Med Phys, Milan, Italy; [Maisonneuve, Patrick] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy; [Casiraghi, Monica; Veronesi, Giulia; Spaggiari, Lorenzo] European Inst Oncol, Div Thorac Surg, Milan, Italy; [Veronesi, Giulia] Humanitas Res Hosp, Div Thorac Surg, Rozzano, Italy; [Spaggiari, Lorenzo; Bellomi, Massimo] Univ Milan, Dept Oncol & Hematol Oncol, Milan, Italy	IRCCS European Institute of Oncology (IEO); University of Milan; IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS Humanitas Research Hospital; University of Milan	Rampinelli, C (corresponding author), European Inst Oncol, Dept Med Imaging & Radiat Sci, Milan, Italy.	cristiano.rampinelli@ieo.it	Origgi, Daniela/AAQ-7871-2020; De Marco, Paolo/AAA-2755-2021; Rampinelli, Cristiano/AAR-1232-2020; Bellomi, Massimo/AAM-4352-2020; Veronesi, Giulia/AAA-6327-2021; Maisonneuve, Patrick/U-9789-2018; Casiraghi, Monica/K-2777-2019	Veronesi, Giulia/0000-0001-9032-1278; Maisonneuve, Patrick/0000-0002-5309-4704; Casiraghi, Monica/0000-0001-5986-7811; Spaggiari, Lorenzo/0000-0002-1068-3541; origgi, daniela/0000-0003-1338-312X	Italian Association for Cancer Research	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	The COSMOS study was supported by the Italian Association for Cancer Research. The study sponsor was not involved in the study design, collection, analysis, and interpretation of data, or the writing of the article or the decision to submit it for publication. The authors were independent from study sponsor. The secondary analysis was not funded.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; American College of Radiology, LUNG CT SCREEN REP D; [Anonymous], 1991, Ann ICRP, V21, P1; [Anonymous], 2014, RAD ENT PLATF DOS MA; [Anonymous], 2010, RAD RISK PERSP POS H; [Anonymous], 2013, UNC RISK ASS POS HLT; Brenner DJ, 2012, RADIOLOGY, V265, P330, DOI 10.1148/radiol.12121248; Brenner DJ, 2004, RADIOLOGY, V231, P440, DOI 10.1148/radiol.2312030880; Brooks AL, 2014, SEMIN NUCL MED, V44, P179, DOI 10.1053/j.semnuclmed.2014.03.004; Calabrese EJ, 2014, RADIAT RES, V182, P463, DOI 10.1667/RR13829.1; Centers for Medicare & Medicaid Services, 2015, CAG00439N CENTR MED; Christy M, 1987, SPECIFIC ABSORBED FR; Clement C. H., 2008, Annals of the ICRP, V38, P1, DOI 10.1016/j.icrp.2008.08.003; de Wiel JCMV, 2007, EUR RADIOL, V17, P1474, DOI 10.1007/s00330-006-0532-7; den Harder AM, 2015, EUR J RADIOL, V84, P2307, DOI 10.1016/j.ejrad.2015.07.011; Harrison J. D., 2016, Annals of the ICRP, V45, P215, DOI 10.1177/0146645316634566; Hendee WR, 2013, RADIOLOGY, V267, P326, DOI 10.1148/radiol.13130567; Hendee WR, 2012, RADIOLOGY, V264, P312, DOI 10.1148/radiol.12112678; Larke FJ, 2011, AM J ROENTGENOL, V197, P1165, DOI 10.2214/AJR.11.6533; Maisonneuve P, 2011, CANCER PREV RES, V4, P1778, DOI 10.1158/1940-6207.CAPR-11-0026; Mascalchi M, 2012, BRIT J RADIOL, V85, P1134, DOI 10.1259/bjr/20711289; Mathieu KB, 2014, J APPL CLIN MED PHYS, V15, P271, DOI 10.1120/jacmp.v15i2.4515; McCollough CH, 2010, AM J ROENTGENOL, V194, P890, DOI 10.2214/AJR.09.4179; McCunney RJ, 2014, CHEST, V145, P618, DOI 10.1378/chest.13-1420; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; National Council on Radiation Protection and Measurements, 2009, 160 NCRP; National Research Council, 2006, HLTH RISKS EXP LOW L, DOI DOI 10.17226/11340; Osei EK, 2012, ISRN RADIOL, V2013; Rampinelli C, 2015, RADIOL MED, V120, P611, DOI 10.1007/s11547-015-0505-5; Rampinelli C, 2011, RADIOLOGY, V261, P293, DOI 10.1148/radiol.11102231; Scott BR, 2008, HUM EXP TOXICOL, V27, P163, DOI 10.1177/0960327107083410; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Tammemagi MC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2253; Tubiana M, 2005, INT J RADIAT ONCOL, V63, P317, DOI 10.1016/j.ijrobp.2005.06.013; United Nations Scientific Committee on the Effects of Atomic Radiation, 2010, UNSCEAR 2008 GEN ASS; Veronesi G, 2008, LUNG CANCER, V61, P340, DOI 10.1016/j.lungcan.2008.01.001; Veronesi G, 2007, ANN THORAC SURG, V84, P959, DOI 10.1016/j.athoracsur.2007.04.058; Yamada Y, 2012, INVEST RADIOL, V47, P482, DOI 10.1097/RLI.0b013e3182562a89	38	140	150	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2017	356								j347	10.1136/bmj.j347	http://dx.doi.org/10.1136/bmj.j347			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4FX	28179230	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000394578200004
J	Wise, J				Wise, Jacqui			Heavy lifting and shift work are linked to reduced fertility	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Minguez-Alarcon L, 2017, OCCUP ENVIRON MED, V74, P426, DOI 10.1136/oemed-2016-103953	1	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2017	356								j681	10.1136/bmj.j681	http://dx.doi.org/10.1136/bmj.j681			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4FX	28179262				2022-12-28	WOS:000394578200013
J	Lu, W; Du, J; Goehring, A; Gouaux, E				Lu, Wei; Du, Juan; Goehring, April; Gouaux, Eric			ION CHANNELS Cryo-EM structures of the triheteromeric NMDA receptor and its allosteric modulation	SCIENCE			English	Article							AFFINITY ZINC INHIBITION; D-ASPARTATE RECEPTOR; X-RAY STRUCTURES; SUBUNIT ARRANGEMENT; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; MECHANISM; ACTIVATION; DYNAMICS; COMPLEXES	N-methyl-D-aspartate receptors (NMDARs) are heterotetrameric ion channels assembled as diheteromeric or triheteromeric complexes. Here, we report structures of the triheteromeric GluN1/GluN2A/GluN2B receptor in the absence or presence of the GluN2B-specific allosteric modulator Ro 25-6981 (Ro), determined by cryogenic electron microscopy (cryo-EM). In the absence of Ro, the GluN2A and GluN2B amino-terminal domains (ATDs) adopt "closed" and "open" clefts, respectively. Upon binding Ro, the GluN2B ATD clamshell transitions from an open to a closed conformation. Consistent with a predominance of the GluN2A subunit in ion channel gating, the GluN2A subunit interacts more extensively with GluN1 subunits throughout the receptor, in comparison with the GluN2B subunit. Differences in the conformation of the pseudo-2-fold-related GluN1 subunits further reflect receptor asymmetry. The triheteromeric NMDAR structures provide the first view of the most common NMDA receptor assembly and show how incorporation of two different GluN2 subunits modifies receptor symmetry and subunit interactions, allowing each subunit to uniquely influence receptor structure and function, thus increasing receptor complexity.	[Lu, Wei; Du, Juan; Goehring, April; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, 3181 Southwest Sam Jackson Pk Rd, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, 3181 Southwest Sam Jackson Pk Rd, Portland, OR USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 Southwest Sam Jackson Pk Rd, Portland, OR 97239 USA.; Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, 3181 Southwest Sam Jackson Pk Rd, Portland, OR USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360	Multiscale Microscopy Core [Oregon Health and Science University (OHSU)]; FEI Company; National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R01NS038631]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038631] Funding Source: NIH RePORTER	Multiscale Microscopy Core [Oregon Health and Science University (OHSU)]; FEI Company; National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Multiscale Microscopy Core [Oregon Health and Science University (OHSU)] and FEI Company for the support with microscopy and the Advanced Computing Center (OHSU) and Intel for computational support. We are grateful to L. Vaskalis for help with illustrations and H. Owen for proofreading. We thank all Gouaux and Baconguis laboratory members, and C. Yoshioka, for helpful discussions. This work was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R01NS038631 (to E.G.). E.G. is an investigator with the Howard Hughes Medical Institute. The cryo-EM density maps and coordinates of non-Ro-bound and Ro-bound triNMDARs in complex with Fab 11D1 have been deposited in the Electron Microscopy Data Bank (EMDB) under accession numbers EMD-8579 and EMD-8581 and in the Research Collaboratory for Structural Bioinformatics Protein Data Bank under accession codes 5UOW and 5UP2, respectively. The cryo-EM density maps of non-Ro-bound triNMDAR-G610 in complex with Fab 11D1 and Ro-bound triNMDAR have been deposited in the EMDB under accession numbers EMD-8580 and EMD-8583.	Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; [Anonymous], PYMOL MOL GRAPH SYST; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Balu DT, 2016, ADV PHARMACOL, V76, P351, DOI 10.1016/bs.apha.2016.01.006; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Chazot PL, 1997, J NEUROCHEM, V69, P2138; Chen L, 2014, SCIENCE, V345, P1021, DOI 10.1126/science.1258409; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheriyan J, 2016, NEUROSCI LETT, V617, P240, DOI 10.1016/j.neulet.2016.02.032; Coleman JA, 2016, JOVE-J VIS EXP, DOI 10.3791/54792; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Durr KL, 2014, CELL, V158, P778, DOI 10.1016/j.cell.2014.07.023; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2012, J PHYSIOL-LONDON, V590, P63, DOI 10.1113/jphysiol.2011.213850; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Grigorieff N, 2016, METHOD ENZYMOL, V579, P191, DOI 10.1016/bs.mie.2016.04.013; Hansen KB, 2014, NEURON, V81, P1084, DOI 10.1016/j.neuron.2014.01.035; Hansen KB, 2010, MOL PHARMACOL, V78, P535, DOI 10.1124/mol.110.067157; Hatton CJ, 2005, NEURON, V46, P261, DOI 10.1016/j.neuron.2005.03.005; Herguedas B, 2016, SCIENCE, V352, DOI 10.1126/science.aad3873; Hu C, 2016, J PHARMACOL SCI, V132, P115, DOI 10.1016/j.jphs.2016.10.002; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kazi R, 2014, NAT NEUROSCI, V17, P914, DOI 10.1038/nn.3724; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McKeage K, 2009, CNS DRUGS, V23, P881, DOI 10.2165/11201020-000000000-00000; Meyerson JR, 2016, NATURE, V537, P567, DOI 10.1038/nature19352; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Moskal JR, 2014, EXPERT OPIN INV DRUG, V23, P243, DOI 10.1517/13543784.2014.852536; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Paoletti P, 2011, EUR J NEUROSCI, V33, P1351, DOI 10.1111/j.1460-9568.2011.07628.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rauner C, 2011, J BIOL CHEM, V286, P7558, DOI 10.1074/jbc.M110.182600; Romero-Hernandez A, 2016, NEURON, V92, P1324, DOI 10.1016/j.neuron.2016.11.006; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sirrieh RE, 2013, J BIOL CHEM, V288, P22555, DOI 10.1074/jbc.M113.482356; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Stroebel D, 2014, J NEUROSCI, V34, P16630, DOI 10.1523/JNEUROSCI.2736-14.2014; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tajima N, 2016, NATURE, V534, P63, DOI 10.1038/nature17679; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tovar KR, 2013, J NEUROSCI, V33, P9150, DOI 10.1523/JNEUROSCI.0829-13.2013; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Williams K, 1996, NEUROSCI LETT, V215, P9, DOI 10.1016/S0304-3940(96)12924-4; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Wyllie DJA, 2013, NEUROPHARMACOLOGY, V74, P4, DOI 10.1016/j.neuropharm.2013.01.016; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng S., 2016, BIORXIV, DOI [10.1101/061960, DOI 10.1101/061960]; Zhu SJ, 2016, CELL, V165, P704, DOI 10.1016/j.cell.2016.03.028; Zhu SJ, 2013, NAT STRUCT MOL BIOL, V20, P477, DOI 10.1038/nsmb.2522	67	91	91	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331							eaal3729	10.1126/science.aal3729	http://dx.doi.org/10.1126/science.aal3729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28232581	Green Accepted			2022-12-28	WOS:000397082900029
J	Berger, JB; Wadley, HNG; Mcmeeking, RM				Berger, J. B.; Wadley, H. N. G.; Mcmeeking, R. M.			Mechanical metamaterials at the theoretical limit of isotropic elastic stiffness	NATURE			English	Article							STRENGTH; BEHAVIOR; DESIGN	A wide variety of high-performance applications(1) require materials for which shape control is maintained under substantial stress, and that have minimal density. Bio-inspired hexagonal and square honeycomb structures and lattice materials based on repeating unit cells composed of webs or trusses(2), when made from materials of high elastic stiffness and low density(3), represent some of the lightest, stiffest and strongest materials available today(4). Recent advances in 3D printing and automated assembly have enabled such complicated material geometries to be fabricated at low (and declining) cost. These mechanical metamaterials have properties that are a function of their mesoscale geometry as well as their constituents(3,5-12), leading to combinations of properties that are unobtainable in solid materials; however, a material geometry that achieves the theoretical upper bounds for isotropic elasticity and strain energy storage (the Hashin-Shtrikman upper bounds) has yet to be identified. Here we evaluate the manner in which strain energy distributes under load in a representative selection of material geometries, to identify the morphological features associated with high elastic performance. Using finite-element models, supported by analytical methods, and a heuristic optimization scheme, we identify a material geometry that achieves the Hashin-Shtrikman upper bounds on isotropic elastic stiffness. Previous work has focused on truss networks and anisotropic honeycombs, neither of which can achieve this theoretical limit(13). We find that stiff but well distributed networks of plates are required to transfer loads efficiently between neighbouring members. The resulting low-density mechanical metamaterials have many advantageous properties: their mesoscale geometry can facilitate large crushing strains with high energy absorption(2,14,15), optical bandgaps(16-19) and mechanically tunable acoustic bandgaps(20), high thermal insulation(21), buoyancy, and fluid storage and transport. Our relatively simple design can be manufactured using origami-like sheet folding(22) and bonding methods.	[Berger, J. B.; Mcmeeking, R. M.] Univ Calif, Dept Mat, Santa Barbara, CA 93106 USA; [Berger, J. B.; Mcmeeking, R. M.] Univ Calif, Dept Mech Engn, Santa Barbara, CA 93106 USA; [Wadley, H. N. G.] Univ Virginia, Sch Engn & Appl Sci, Dept Mat Sci & Engn, Charlottesville, VA 22904 USA; [Mcmeeking, R. M.] Univ Aberdeen, Kings Coll, Sch Engn, Aberdeen AB24 3UE, Scotland; [Mcmeeking, R. M.] INM Leibniz Inst New Mat, Campus D22, D-66123 Saarbrucken, Germany	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Virginia; University of Aberdeen; Leibniz Institut fur Neue Materialien (INM)	Berger, JB (corresponding author), Univ Calif, Dept Mat, Santa Barbara, CA 93106 USA.; Berger, JB (corresponding author), Univ Calif, Dept Mech Engn, Santa Barbara, CA 93106 USA.	berger@engineering.ucsb.edu			ONR [N00014-15-1-2933]; DARPA MCMA programme [W91CRB-10-1-005]	ONR(Office of Naval Research); DARPA MCMA programme	H.N.G.W. is grateful for support for this work by the ONR (grant number N00014-15-1-2933), managed by D. Shifler, and the DARPA MCMA programme (grant number W91CRB-10-1-005), managed by J. Goldwasser.	[Anonymous], 2010, CELLULAR MAT NATURE; Ashby M. F., 2000, METAL FOAMS DESIGN G; Ashby M, 2011, J AM CERAM SOC, V94, pS3, DOI 10.1111/j.1551-2916.2011.04559.x; Babaee S, 2015, J APPL PHYS, V117, DOI 10.1063/1.4923032; Bauer J, 2016, NAT MATER, V15, P438, DOI [10.1038/NMAT4561, 10.1038/nmat4561]; Berger J., 2015, US patent application, Patent No. [15/110,402, 15110402]; Bertoldi K, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.052105; Bertoldi K, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.184107; Danielsson M, 2002, J MECH PHYS SOLIDS, V50, P351, DOI 10.1016/S0022-5096(01)00060-6; Deshpande VS, 2001, J MECH PHYS SOLIDS, V49, P1747, DOI 10.1016/S0022-5096(01)00010-2; do Rosario JJ, 2015, ADV ENG MATER, V17, P1420, DOI 10.1002/adem.201500118; George T, 2014, COMPOS PART A-APPL S, V65, P135, DOI 10.1016/j.compositesa.2014.06.011; Gibson L. J, 2014, CELLULAR SOLIDS, P175, DOI [DOI 10.1017/CBO9781139878326.007, 10.1017/cbo9781139878326.007]; GIBSON LJ, 1989, MAT SCI ENG A-STRUCT, V110, P1, DOI 10.1016/0921-5093(89)90154-8; Grenestedt JL, 1999, INT J SOLIDS STRUCT, V36, P1471, DOI 10.1016/S0020-7683(98)00048-1; Gurtner G, 2014, P ROY SOC A-MATH PHY, V470, DOI 10.1098/rspa.2013.0611; HASHIN Z, 1963, J MECH PHYS SOLIDS, V11, P127, DOI 10.1016/0022-5096(63)90060-7; Jang DC, 2013, NAT MATER, V12, P893, DOI [10.1038/NMAT3738, 10.1038/nmat3738]; Montemayor L, 2015, MRS BULL, V40, P1122, DOI 10.1557/mrs.2015.263; Moongkhamklang P, 2010, ADV ENG MATER, V12, P1111, DOI 10.1002/adem.201000145; Mousanezhad D, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.104304; Roberts AP, 2001, ACTA MATER, V49, P189, DOI 10.1016/S1359-6454(00)00314-1; Spadaccini C. M., 2016, FRONTIERS ENG, P85; Steeves CA, 2011, J AM CERAM SOC, V94, pS55, DOI 10.1111/j.1551-2916.2011.04447.x; Thomson W. S., 1887, ACTA MATH-DJURSHOLM, V11, P121, DOI DOI 10.1007/BF02612322; United States National Research Council, 2012, APPL LIGHTW TECHN MI; Valdevit L, 2011, J AM CERAM SOC, V94, P1, DOI 10.1111/j.1551-2916.2011.04599.x; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Wadley HNG, 2006, PHILOS T R SOC A, V364, P31, DOI 10.1098/rsta.2005.1697; Zheng XY, 2014, SCIENCE, V344, P1373, DOI 10.1126/science.1252291; Zok FW, 2004, INT J SOLIDS STRUCT, V41, P6249, DOI 10.1016/j.ijsolstr.2004.05.045	31	312	314	62	540	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					533	+		10.1038/nature21075	http://dx.doi.org/10.1038/nature21075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO9OM	28219078	Green Submitted			2022-12-28	WOS:000397018000047
J	Andropoulos, DB; Greene, MF				Andropoulos, Dean B.; Greene, Michael F.			Anesthesia and Developing Brains - Implications of the FDA Warning	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GENERAL-ANESTHESIA; EXPOSURE; AGE		[Andropoulos, Dean B.] Texas Childrens Hosp, Dept Anesthesiol, Houston, TX 77030 USA; [Andropoulos, Dean B.] Baylor Coll Med, Houston, TX 77030 USA; [Greene, Michael F.] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA	Baylor College of Medicine; Baylor College of Medicine; Harvard University; Massachusetts General Hospital	Andropoulos, DB (corresponding author), Texas Childrens Hosp, Dept Anesthesiol, Houston, TX 77030 USA.; Andropoulos, DB (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.							Davidson AJ, 2016, LANCET, V387, P239, DOI 10.1016/S0140-6736(15)00608-X; Pinyavat T, 2016, J NEUROSURG ANESTH, V28, P356, DOI 10.1097/ANA.0000000000000347; Sanders RD, 2013, BRIT J ANAESTH, V110, P53, DOI 10.1093/bja/aet054; Sun LS, 2016, JAMA-J AM MED ASSOC, V315, P2312, DOI 10.1001/jama.2016.6967; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d	5	205	212	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2017	376	10					905	907		10.1056/NEJMp1700196	http://dx.doi.org/10.1056/NEJMp1700196			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JA	28177852				2022-12-28	WOS:000395626500001
J	Eagan, JM; Xu, J; Di Girolamo, R; Thurber, CM; Macosko, CW; LaPointe, AM; Bates, FS; Coates, GW				Eagan, James M.; Xu, Jun; Di Girolamo, Rocco; Thurber, Christopher M.; Macosko, Christopher W.; LaPointe, Anne M.; Bates, Frank S.; Coates, Geoffrey W.			Combining polyethylene and polypropylene: Enhanced performance with PE/iPP multiblock polymers	SCIENCE			English	Article							ISOTACTIC POLYPROPYLENE; PROPENE POLYMERIZATION; BLOCK-COPOLYMERS; COMPATIBILIZATION; INTERFACES; CATALYSTS	Polyethylene (PE) and isotactic polypropylene (iPP) constitute nearly two-thirds of the world's plastic. Despite their similar hydrocarbon makeup, the polymers are immiscible with one another. Thus, common grades of PE and iPP do not adhere or blend, creating challenges for recycling these materials. We synthesized PE/iPP multiblock copolymers using an isoselective alkene polymerization initiator. These polymers can weld common grades of commercial PE and iPP together, depending on the molecular weights and architecture of the block copolymers. Interfacial compatibilization of phase-separated PE and iPP with tetrablock copolymers enables morphological control, transforming brittle materials into mechanically tough blends.	[Eagan, James M.; Di Girolamo, Rocco; LaPointe, Anne M.; Coates, Geoffrey W.] Cornell Univ, Baker Lab, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Xu, Jun; Thurber, Christopher M.; Macosko, Christopher W.; Bates, Frank S.] Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA; [Di Girolamo, Rocco] Univ Napoli Federico II, Dipartimento Sci Chim, Complesso Monte S Angelo,Via Cintia, I-80126 Naples, Italy	Cornell University; University of Minnesota System; University of Minnesota Twin Cities; University of Naples Federico II	LaPointe, AM; Coates, GW (corresponding author), Cornell Univ, Baker Lab, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.; Bates, FS (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	lapointe@cornell.edu; bates001@umn.edu; coates@cornell.edu		Eagan, James/0000-0003-4010-9353; Coates, Geoffrey/0000-0002-3400-2552; LaPointe, Anne/0000-0002-7830-0922; DI GIROLAMO, Rocco/0000-0001-8815-2997	Center for Sustainable Polymers, an NSF Center for Chemical Innovation [CHE-1413862]; Cariplo Foundation ("Crystalline Elastomers Project"); Direct For Mathematical & Physical Scien [1413862] Funding Source: National Science Foundation	Center for Sustainable Polymers, an NSF Center for Chemical Innovation; Cariplo Foundation ("Crystalline Elastomers Project"); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Financial support for this work was provided by the Center for Sustainable Polymers, an NSF Center for Chemical Innovation (grant CHE-1413862). The Cariplo Foundation ("Crystalline Elastomers Project") provided funding to R.D.G. We thank N. Chen, S. Hayrapetyan, and M. Silberstein for assistance with melt-blend and tensile studies and I. Keresztes for assistance with NMR spectroscopy. J.M.E., A.M.L., and G.W.C. are inventors on U.S. patent applications 62/421,680 and 62/342,583, submitted by Cornell University, which cover welds and compatibilization of polyolefin materials. All data are available in the supplementary materials. Author contributions: G.W.C. conceived the project. G.W.C., J.M.E., R.D.G., and A.M.L. designed and conducted experiments related to polymer synthesis. J.M.E., J.X., and C.M.T. designed and conducted experiments related to adhesion and blends. G.W.C., A.M.L., C.W.M., and F.S.B. designed experiments and directed research. J.M.E., G.W.C., A.M.L., J.X., and F.S.B. wrote the manuscript. All authors commented on the manuscript.	Arriola DJ, 2006, SCIENCE, V312, P714, DOI 10.1126/science.1125268; Bates FS, 2012, SCIENCE, V336, P434, DOI 10.1126/science.1215368; Benkoski JJ, 2003, MACROMOLECULES, V36, P3289, DOI 10.1021/ma034013j; Boussie TR, 2006, ANGEW CHEM INT EDIT, V45, P3278, DOI 10.1002/anie.200600240; Busico V, 2004, MACROMOLECULES, V37, P8201, DOI 10.1021/ma048144b; Busico V, 2003, MACROMOLECULES, V36, P3806, DOI 10.1021/ma0342527; Chaffin KA, 2000, SCIENCE, V288, P2187, DOI 10.1126/science.288.5474.2187; Chanda M., 2009, PLASTICS ENG SERIES; Coates G. W., 2008, [No title captured], Patent No. [WO 2008112133A2, 2008112133]; Colbeaux A, 2005, J APPL POLYM SCI, V95, P312, DOI 10.1002/app.21226; Domski GJ, 2007, PROG POLYM SCI, V32, P30, DOI 10.1016/j.progpolymsci.2006.11.001; Ellen MacArthur Foundation, 2016, NEW PLAST EC RETH FU; Hustad PD, 2009, SCIENCE, V325, P704, DOI 10.1126/science.1174927; Kaminsky W., 2013, ADV POLYMER SCI SERI, VI; Laurens C, 2004, MACROMOLECULES, V37, P6814, DOI 10.1021/ma0400259; Lin YJ, 2009, J APPL POLYM SCI, V113, P1945, DOI 10.1002/app.30190; Malpass D.B., 2012, INTRO IND POLYPROPYL, P1; Nwabunma D., 2008, POLYOLEFIN BLENDS; Phatak A, 2006, MACROMOLECULES, V39, P6221, DOI 10.1021/ma0611319; Resconi L, 2000, CHEM REV, V100, P1253, DOI 10.1021/cr9804691; Sturzel M, 2016, CHEM REV, V116, P1398, DOI 10.1021/acs.chemrev.5b00310; TEH JW, 1994, ADV POLYM TECH, V13, P1, DOI 10.1002/adv.1994.060130101; WEBSTER OW, 1991, SCIENCE, V251, P887, DOI 10.1126/science.251.4996.887; Xanthos M, 2012, SCIENCE, V337, P700, DOI 10.1126/science.1221806	24	273	286	59	566	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					814	816		10.1126/science.aah5744	http://dx.doi.org/10.1126/science.aah5744			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28232574	Green Submitted			2022-12-28	WOS:000395127600035
J	Compagno, M; Wang, Q; Pighi, C; Cheong, TC; Meng, FL; Poggio, T; Yeap, LS; Karaca, E; Blasco, RB; Langellotto, F; Ambrogio, C; Voena, C; Wiestner, A; Kasar, SN; Brown, JR; Sun, J; Wu, CJ; Gostissa, M; Alt, FW; Chiarle, R				Compagno, Mara; Wang, Qi; Pighi, Chiara; Cheong, Taek-Chin; Meng, Fei-Long; Poggio, Teresa; Yeap, Leng-Siew; Karaca, Elif; Blasco, Rafael B.; Langellotto, Fernanda; Ambrogio, Chiara; Voena, Claudia; Wiestner, Adrian; Kasar, Siddha N.; Brown, Jennifer R. .; Sun, Jing; Wu, Catherine J.; Gostissa, Monica; Alt, Frederick W.; Chiarle, Roberto			Phosphatidylinositol 3-kinase delta blockade increases genomic instability in B cells	NATURE			English	Article							INDUCED CYTIDINE DEAMINASE; CLASS-SWITCH RECOMBINATION; SEQUENCING REVEALS; SUPER-ENHANCERS; TARGETING BTK; AID; DNA; TRANSCRIPTION; MECHANISMS; IBRUTINIB	Activation-induced cytidine deaminase (AID) is a B-cell-specific enzyme that targets immunoglobulin genes to initiate class switch recombination and somatic hypermutation(1). In addition, through off-target activity, AID has a much broader effect on genomic instability by initiating oncogenic chromosomal translocations and mutations involved in the development and progression of lymphoma(2). AID expression is tightly regulated in B cells and its overexpression leads to enhanced genomic instability and lymphoma formation3. The phosphatidylinositol 3-kinase delta (PI3K delta) pathway regulates AID by suppressing its expression in B cells4. Drugs for leukaemia or lymphoma therapy such as idelalisib, duvelisib and ibrutinib block PI3K delta activity directly or indirectly(5-8), potentially affecting AID expression and, consequently, genomic stability in B cells. Here we show that treatment of primary mouse B cells with idelalisib or duvelisib, and to a lesser extent ibrutinib, enhanced the expression of AID and increased somatic hypermutation and chromosomal translocation frequency to the Igh locus and to several AID off-target sites. Both of these effects were completely abrogated in AID-deficient B cells. PI3K delta inhibitors or ibrutinib increased the formation of AID-dependent tumours in pristane-treated mice. Consistently, PI3K delta inhibitors enhanced AID expression and translocation frequency to IGH and AID off-target sites in human chronic lymphocytic leukaemia and mantle cell lymphoma cell lines, and patients treated with idelalisib, but not ibrutinib, showed increased somatic hypermutation in AID off-targets. In summary, we show that PI3K delta or Bruton's tyrosine kinase inhibitors increase genomic instability in normal and neoplastic B cells by an AID-dependent mechanism. This effect should be carefully considered, as such inhibitors can be administered to patients for years.	[Compagno, Mara; Wang, Qi; Pighi, Chiara; Cheong, Taek-Chin; Karaca, Elif; Blasco, Rafael B.; Langellotto, Fernanda; Voena, Claudia; Chiarle, Roberto] Childrens Hosp Boston, Dept Pathol, Boston, MA 02115 USA; [Compagno, Mara; Wang, Qi; Pighi, Chiara; Cheong, Taek-Chin; Karaca, Elif; Blasco, Rafael B.; Langellotto, Fernanda; Voena, Claudia; Chiarle, Roberto] Harvard Med Sch, Boston, MA 02115 USA; [Meng, Fei-Long; Yeap, Leng-Siew; Gostissa, Monica; Alt, Frederick W.] Boston Childrens Hosp, Howard Hughes Med Inst, Program Cellular & Mol Med, Boston, MA 02115 USA; [Meng, Fei-Long; Yeap, Leng-Siew; Gostissa, Monica; Alt, Frederick W.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Poggio, Teresa; Voena, Claudia; Chiarle, Roberto] Univ Torino, Dept Mol Biotechnol & Hlth Sci, I-10126 Turin, Italy; [Kasar, Siddha N.; Brown, Jennifer R. .; Sun, Jing] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wiestner, Adrian] Natl Heart Lung & Blood Inst, Hematol Branch, Bethesda, MD USA; [Meng, Fei-Long] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Yeap, Leng-Siew] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200025, Peoples R China; [Langellotto, Fernanda; Gostissa, Monica] Agenus Inc, 3 Forbes Rd, Lexington, MA 02421 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of Turin; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University; Agenus Inc	Chiarle, R (corresponding author), Childrens Hosp Boston, Dept Pathol, Boston, MA 02115 USA.; Chiarle, R (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Chiarle, R (corresponding author), Univ Torino, Dept Mol Biotechnol & Hlth Sci, I-10126 Turin, Italy.	roberto.chiarle@childrens.harvard.edu	VOENA, Claudia/ADJ-6244-2022	Voena, Claudia/0000-0002-1324-1431; Meng, Feilong/0000-0003-0333-6872; CHIARLE, Roberto/0000-0003-1564-8531; Wang, Qi/0000-0002-4306-3293; Poggio, Teresa/0000-0003-2560-8488	NIH [R01 CA196703-01, 1U10CA180861-01, R01AI077595]; Associazione Italiana per la Ricerca sul Cancro [IG-12023, MFAG 10708]; Worldwide Cancer Research grant [12-0216]; Compagnia di San Paolo-Comitato Gigi Ghirotti; American Cancer Society [RSG-13-002-01-CCE]; National Research Foundation of Korea(NRF); PhRMA Foundation; NHLBI, NIH; NATIONAL CANCER INSTITUTE [R01CA184922, R01CA182461, P01CA206978, U10CA180861, R01CA216273, R01CA196703] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077595, R37AI077595] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Worldwide Cancer Research grant; Compagnia di San Paolo-Comitato Gigi Ghirotti(Compagnia di San Paolo); American Cancer Society(American Cancer Society); National Research Foundation of Korea(NRF)(National Research Foundation of Korea); PhRMA Foundation; NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Okkenhaug and F. Garcon for providing wild-type and mutated PI3K delta constructs, F. Zhang for providing CRISPR/Cas9 plasmids. We thank M. Fleming and M. M. Awad for critically reading the manuscript. This work was supported by NIH grants R01 CA196703-01 to R.C.; 1U10CA180861-01 to C.J.W., R01AI077595 to F.W.A; Associazione Italiana per la Ricerca sul Cancro grant IG-12023 to R.C. and MFAG 10708 to M.C.; Worldwide Cancer Research grant 12-0216 to R.C.; Compagnia di San Paolo-Comitato Gigi Ghirotti to M.C.; American Cancer Society Grant RSG-13-002-01-CCE to J.R.B.; T.C.C. is supported by a National Research Foundation of Korea(NRF) fellowship; L.S.Y. was a Cancer Research Institute postdoctoral fellow; F.M. was a Lymphoma Research Foundation postdoctoral fellow; J.S. is a recipient of a PhRMA Foundation Research Fellowship; C.J.W. is Scholar of the Leukemia and Lymphoma Society; F.W.A. is an investigator of the Howard Hughes Medical Institute. A.W. is supported by the intramural program of NHLBI, NIH.	Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; Brown JR, 2014, BLOOD, V123, P3390, DOI 10.1182/blood-2013-11-535047; Burger JA, 2013, TRENDS IMMUNOL, V34, P592, DOI 10.1016/j.it.2013.07.002; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Camps J, 2006, LEUKEMIA RES, V30, P923, DOI 10.1016/j.leukres.2005.11.013; Cato MH, 2011, NAT PROTOC, V6, P953, DOI 10.1038/nprot.2011.344; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Dong S, 2014, BLOOD, V124, P3583, DOI 10.1182/blood-2014-07-587279; Gopal AK, 2014, NEW ENGL J MED, V370, P1008, DOI 10.1056/NEJMoa1314583; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu JZ, 2014, P NATL ACAD SCI USA, V111, P10269, DOI 10.1073/pnas.1410112111; Kasar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9866; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Klemm L, 2009, CANCER CELL, V16, P232, DOI 10.1016/j.ccr.2009.07.030; Kovalchuk AL, 1997, ONCOGENE, V15, P2369, DOI 10.1038/sj.onc.1201409; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lucas CL, 2014, NAT IMMUNOL, V15, P88, DOI 10.1038/ni.2771; Meng FL, 2014, CELL, V159, P1538, DOI 10.1016/j.cell.2014.11.014; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Omori SA, 2006, IMMUNITY, V25, P545, DOI 10.1016/j.immuni.2006.08.015; Palacios F, 2010, BLOOD, V115, P4488, DOI 10.1182/blood-2009-12-257758; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Pefanis E, 2014, NATURE, V514, P389, DOI 10.1038/nature13580; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; Puente XS, 2015, NATURE, V526, P519, DOI 10.1038/nature14666; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rush JS, 2005, P NATL ACAD SCI USA, V102, P13242, DOI 10.1073/pnas.0502779102; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Yeap LS, 2015, CELL, V163, P1124, DOI 10.1016/j.cell.2015.10.042; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340	43	89	92	3	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2017	542	7642					489	+		10.1038/nature21406	http://dx.doi.org/10.1038/nature21406			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM1RG	28199309	Green Accepted, Green Submitted			2022-12-28	WOS:000395094100039
J	del Rio, CM; Dillon, ME				del Rio, Carlos Martinez; Dillon, Michael E.			Sweet relief for pollinators	SCIENCE			English	Editorial Material							MECHANISMS		[del Rio, Carlos Martinez; Dillon, Michael E.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [del Rio, Carlos Martinez; Dillon, Michael E.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming	del Rio, CM (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.; del Rio, CM (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	cmdelrio@uwyo.edu			NSF-DEB [1457659]	NSF-DEB(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank S. McWilliams for useful comments. H. Sease contributed to the drawings in the figure. M.E.D. was funded by NSF-DEB 1457659.	Karelis AD, 2010, SPORTS MED, V40, P747, DOI 10.2165/11533080-000000000-00000; Levin E, 2017, SCIENCE, V355, P733, DOI 10.1126/science.aah4634; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Skrip MM, 2015, ECOL EVOL, V5, P3198, DOI 10.1002/ece3.1601; Stincone A, 2015, BIOL REV, V90, P927, DOI 10.1111/brv.12140; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X	6	2	2	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					686	687		10.1126/science.aam5323	http://dx.doi.org/10.1126/science.aam5323			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2AC	28209855				2022-12-28	WOS:000395117700017
J	McCarthy, M				McCarthy, Michael			Non-drug therapies should be first line treatment for low back pain, US guidance says	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Chou R, 2017, ANN INTERN MED, V166, P493, DOI 10.7326/M16-2459; Chou R, 2017, ANN INTERN MED, V166, P480, DOI 10.7326/M16-2458; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	2017	356								j840	10.1136/bmj.j840	http://dx.doi.org/10.1136/bmj.j840			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GM	28202436				2022-12-28	WOS:000394579700015
J	Lyon, J				Lyon, Jeff			Uncertain Future for Preexisting Conditions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2017	317	6					576	576		10.1001/jama.2017.0506	http://dx.doi.org/10.1001/jama.2017.0506			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4NG	28196234				2022-12-28	WOS:000426800900001
J	Stokstad, E				Stokstad, Erik			HOW TO BE HEARD	SCIENCE			English	Editorial Material																			0	2	2	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					572	572		10.1126/science.355.6325.572-b	http://dx.doi.org/10.1126/science.355.6325.572-b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK0SF	28183931				2022-12-28	WOS:000393636700022
J	Lindsley, RC; Saber, W; Mar, BG; Redd, R; Wang, T; Haagenson, MD; Grauman, PV; Hu, ZH; Spellman, SR; Lee, SJ; Verneris, MR; Hsu, K; Fleischhauer, K; Cutler, C; Antin, JH; Neuberg, D; Ebert, BL				Lindsley, R. C.; Saber, W.; Mar, B. G.; Redd, R.; Wang, T.; Haagenson, M. D.; Grauman, P. V.; Hu, Z. -H.; Spellman, S. R.; Lee, S. J.; Verneris, M. R.; Hsu, K.; Fleischhauer, K.; Cutler, C.; Antin, J. H.; Neuberg, D.; Ebert, B. L.			Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLONAL HEMATOPOIESIS; SOMATIC MUTATIONS; TP53; PREDISPOSITION; CLASSIFICATION; BLOOD; PPM1D; GAIN	BACKGROUND Genetic mutations drive the pathogenesis of the myelodysplastic syndrome (MDS) and are closely associated with clinical phenotype. Therefore, genetic mutations may predict clinical outcomes after allogeneic hematopoietic stem-cell transplantation. METHODS We performed targeted mutational analysis on samples obtained before transplantation from 1514 patients with MDS who were enrolled in the Center for International Blood and Marrow Transplant Research Repository between 2005 and 2014. We evaluated the association of mutations with transplantation outcomes, including overall survival, relapse, and death without relapse. RESULTS TP53 mutations were present in 19% of the patients and were associated with shorter survival and a shorter time to relapse than was the absence of TP53 mutations, after adjustment for significant clinical variables (P<0.001 for both comparisons). Among patients 40 years of age or older who did not have TP53 mutations, the presence of RAS pathway mutations was associated with shorter survival than was the absence of RAS pathway mutations (P = 0.004), owing to a high risk of relapse, and the presence of JAK2 mutations was associated with shorter survival than was the absence of JAK2 mutations (P = 0.001), owing to a high risk of death without relapse. The adverse prognostic effect of TP53 mutations was similar in patients who received reduced-intensity conditioning regimens and those who received myeloablative conditioning regimens. By contrast, the adverse effect of RAS pathway mutations on the risk of relapse, as compared with the absence of RAS pathway mutations, was evident only with reduced-intensity conditioning (P<0.001). In young adults, 4% of the patients had compound heterozygous mutations in the Shwachman-Diamond syndrome-associated SBDS gene with concurrent TP53 mutations and a poor prognosis. Mutations in the p53 regulator PPM1D were more common among patients with therapy-related MDS than those with primary MDS (15% vs. 3%, P<0.001). CONCLUSIONS Genetic profiling revealed that molecular subgroups of patients undergoing allogeneic hematopoietic stem-cell transplantation for MDS may inform prognostic stratification and the selection of conditioning regimen.	[Lindsley, R. C.; Cutler, C.; Antin, J. H.] Dana Farber Canc Inst, Dept Med Oncol, Div Hematol Malignancies, Boston, MA 02115 USA; [Mar, B. G.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Redd, R.; Neuberg, D.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Grauman, P. V.; Ebert, B. L.] Harvard Med Sch, Brigham & Womens Hosp, Div Hematol, Boston, MA USA; [Saber, W.; Wang, T.; Hu, Z. -H.; Lee, S. J.] Med Coll Wisconsin, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA; [Haagenson, M. D.; Spellman, S. R.] Univ Minnesota, Ctr Int Blood & Marrow Transplant Res, Natl Marrow Donor Program Be Match, Minneapolis, MN USA; [Verneris, M. R.] Univ Minnesota, Pediat Blood & Marrow Transplantat Ctr, Minneapolis, MN USA; [Lee, S. J.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Hsu, K.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Fleischhauer, K.] Univ Hosp Essen, Inst Expt Cellular Therapy, Essen, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Center for International Blood & Marrow Transplant Research; Medical College of Wisconsin; Center for International Blood & Marrow Transplant Research; National Marrow Donor Program; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Fred Hutchinson Cancer Center; Memorial Sloan Kettering Cancer Center; University of Duisburg Essen	Ebert, BL (corresponding author), Brigham & Womens Hosp, 1 Blackfan Circle,Karp Res Bldg 5-211, Boston, MA 02115 USA.	bebert@partners.org	Lindsley, Coleman/AAA-3040-2021	Mar, Brenton/0000-0002-3857-9324	Edward P. Evans Foundation; Harvard Catalyst KL2-CMeRIT Award; National Marrow Donor Program Immunobiology Research Study Grant; NIH [R01HL082945, R24DK099808, 5P30 CA006516]; Leukemia and Lymphoma Society; Public Health Service grant from the National Cancer Institute (NCI) [5U24-CA076518]; National Heart, Lung, and Blood Institute (NHLBI); National Institute of Allergy and Infectious Diseases; NHLBI [5U10HL069294]; NCI; Health Resources and Services Administration [HHSH250201200016C]; Office of Naval Research [N00014-14-10028, N00014-15-1-0848]; Alexion; Be the Match Foundation; Celgene; Chimerix; Fred Hutchinson Cancer Research Center; Gamida Cell; Genentech; Genzyme; Gilead Sciences; Health Research; Roswell Park Cancer Institute; HistoGenetics; Incyte; Jazz Pharmaceuticals; Jeff Gordon Children's Foundation; Medical College of Wisconsin; Merck; Mesoblast; Millennium; Miltenyi Biotec; National Marrow Donor Program; Neovii Biotech; Novartis Pharmaceuticals; Onyx Pharmaceuticals; Optum Healthcare Solutions; Otsuka America Pharmaceutical; Otsuka Pharmaceutical Japan; Oxford Immunotec; Perkin Elmer; Pharmacyclics; Sanofi U.S.; Seattle Genetics; Sigma-Tau Pharmaceuticals; Spectrum Pharmaceuticals; St. Baldrick's Foundation; Sunesis Pharmaceuticals; Swedish Orphan Biovitrum; Telomere Diagnostics; Terumo BCT; Therakos; University of Minnesota; Wellpoint; Amgen; Bristol-Myers Squibb Oncology; NATIONAL CANCER INSTITUTE [P30CA006516, P01CA066996, U24CA076518, K08CA204734] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082945, U10HL069294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK094746, R24DK099808] Funding Source: NIH RePORTER	Edward P. Evans Foundation; Harvard Catalyst KL2-CMeRIT Award; National Marrow Donor Program Immunobiology Research Study Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Public Health Service grant from the National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Office of Naval Research(Office of Naval Research); Alexion; Be the Match Foundation; Celgene(Bristol-Myers SquibbCelgene Corporation); Chimerix; Fred Hutchinson Cancer Research Center; Gamida Cell; Genentech(Roche HoldingGenentech); Genzyme(Sanofi-AventisGenzyme Corporation); Gilead Sciences(Gilead Sciences); Health Research; Roswell Park Cancer Institute; HistoGenetics; Incyte; Jazz Pharmaceuticals(Jazz Pharmaceuticals); Jeff Gordon Children's Foundation; Medical College of Wisconsin(General Electric); Merck(Merck & Company); Mesoblast; Millennium(Takeda Pharmaceutical Company Ltd); Miltenyi Biotec; National Marrow Donor Program; Neovii Biotech; Novartis Pharmaceuticals(Novartis); Onyx Pharmaceuticals; Optum Healthcare Solutions; Otsuka America Pharmaceutical(Otsuka Pharmaceutical); Otsuka Pharmaceutical Japan(Otsuka Pharmaceutical); Oxford Immunotec; Perkin Elmer; Pharmacyclics; Sanofi U.S.; Seattle Genetics; Sigma-Tau Pharmaceuticals; Spectrum Pharmaceuticals; St. Baldrick's Foundation; Sunesis Pharmaceuticals; Swedish Orphan Biovitrum; Telomere Diagnostics; Terumo BCT; Therakos; University of Minnesota(University of Minnesota System); Wellpoint; Amgen(Amgen); Bristol-Myers Squibb Oncology(Bristol-Myers Squibb); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by a grant from the Edward P. Evans Foundation (to Drs. Lindsley and Ebert), a Harvard Catalyst KL2-CMeRIT Award (to Dr. Lindsley), and a National Marrow Donor Program Immunobiology Research Study Grant (to Dr. Lindsley), by grants from the NIH (R01HL082945, R24DK099808, and 5P30 CA006516, to Dr. Ebert), and by a grant from the Leukemia and Lymphoma Society (to Dr. Ebert). The Center for International Blood and Marrow Transplant Research is supported by a Public Health Service grant (5U24-CA076518) from the National Cancer Institute (NCI), the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute of Allergy and Infectious Diseases, by a grant (5U10HL069294) from the NHLBI and NCI, by a contract (HHSH250201200016C) with the Health Resources and Services Administration, by grants (N00014-14-10028 and N00014-15-1-0848) from the Office of Naval Research, by grants from Alexion and Amgen, by an anonymous donation to the Medical College of Wisconsin, and by grants from the Be the Match Foundation, Bristol-Myers Squibb Oncology, Celgene, Chimerix, Fred Hutchinson Cancer Research Center, Gamida Cell, Genentech, Genzyme, Gilead Sciences, Health Research, Roswell Park Cancer Institute, HistoGenetics, Incyte, Jazz Pharmaceuticals, Jeff Gordon Children's Foundation, the Leukemia and Lymphoma Society, the Medical College of Wisconsin, Merck, Mesoblast, Millennium (Takeda Oncology), Miltenyi Biotec, National Marrow Donor Program, Neovii Biotech, Novartis Pharmaceuticals, Onyx Pharmaceuticals, Optum Healthcare Solutions, Otsuka America Pharmaceutical, Otsuka Pharmaceutical Japan, Oxford Immunotec, Perkin Elmer, Pharmacyclics, Sanofi U.S., Seattle Genetics, Sigma-Tau Pharmaceuticals, Spectrum Pharmaceuticals, St. Baldrick's Foundation, Sunesis Pharmaceuticals, Swedish Orphan Biovitrum, Telomere Diagnostics, Terumo BCT, Therakos, the University of Minnesota, and Wellpoint.	Ali AY, 2012, ONCOGENE, V31, P2175, DOI 10.1038/onc.2011.399; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Babushok DV, 2015, BEST PRACT RES CL HA, V28, P55, DOI 10.1016/j.beha.2014.11.004; Bally C, 2014, LEUKEMIA RES, V38, P751, DOI 10.1016/j.leukres.2014.03.012; Bejar R, 2014, J CLIN ONCOL, V32, P2691, DOI 10.1200/JCO.2013.52.3381; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Boocock GRB, 2003, NAT GENET, V33, P97, DOI 10.1038/ng1062; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Cutler CS, 2004, BLOOD, V104, P579, DOI 10.1182/blood-2004-01-0338; Della Porta MG, 2014, BLOOD, V123, P2333, DOI 10.1182/blood-2013-12-542720; Della Porta MG, 2016, J CLIN ONCOL; Donadieu J, 2012, HAEMATOL-HEMATOL J, V97, P1312, DOI 10.3324/haematol.2011.057489; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Kleiblova P, 2013, J CELL BIOL, V201, P511, DOI 10.1083/jcb.201210031; Lindsley RC, 2015, BLOOD, V125, P1367, DOI 10.1182/blood-2014-11-610543; Murphy DM, 2013, LEUKEMIA, V27, P2077, DOI 10.1038/leu.2013.160; Myers KC, 2014, J PEDIATR-US, V164, P866, DOI 10.1016/j.jpeds.2013.11.039; Ostergaard P, 2011, NAT GENET, V43, P929, DOI 10.1038/ng.923; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Scott BL, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.LBA-8.LBA-8; Shaffer BC, 2016, J CLIN ONCOL, V34, P1864, DOI 10.1200/JCO.2015.65.0515; Swisher EM, 2016, JAMA ONCOL, V2, P370, DOI 10.1001/jamaoncol.2015.6053; Wong TN, 2015, NATURE, V518, P552, DOI 10.1038/nature13968; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yoshizato T, 2015, NEW ENGL J MED, V373, P35, DOI 10.1056/NEJMoa1414799	27	384	400	2	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2017	376	6					536	547		10.1056/NEJMoa1611604	http://dx.doi.org/10.1056/NEJMoa1611604			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8XL	28177873	Green Accepted			2022-12-28	WOS:000393510500008
J	Rona, RJ; Burdett, H; Khondoker, M; Chesnokov, M; Green, K; Pernet, D; Jones, N; Greenberg, N; Wessely, S; Fear, NT				Rona, Roberto J.; Burdett, Howard; Khondoker, Mizanur; Chesnokov, Melanie; Green, Kevin; Pernet, David; Jones, Norman; Greenberg, Neil; Wessely, Simon; Fear, Nicola T.			Post-deployment screening for mental disorders and tailored advice about help-seeking in the UK military: a cluster randomised controlled trial	LANCET			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; HEALTH PROBLEMS; ARMED-FORCES; PRIMARY-CARE; IRAQ; PERSONNEL; PTSD; AFGHANISTAN; SYMPTOMS	Background The effectiveness of post-deployment screening for mental disorders has not been assessed in a randomised controlled trial. We aimed to assess whether post-deployment screening for post-traumatic stress disorder (PTSD), depression, anxiety, or alcohol misuse was effective. We defined screening as the presumptive identification of a previously unrecognised disorder using tests to distinguish those who probably had the disorder from those who probably did not so that those people with a probable disorder could be referred appropriately, and assessed effectiveness and consequences for help-seeking by the odds ratio at follow-up between those receiving tailored help-seeking advice and those who received general mental health advice. Methods We did a cluster randomised controlled trial among Royal Marines and Army personnel in the UK military after deployment to Afghanistan. Platoons were randomly assigned (1: 1 initially, then 2: 1) by stratified block randomisation with randomly varying block sizes of two and four to the screening group, which received tailored help-seeking advice, or the control group, which received general mental health advice. Initial assessment took place 6-12 weeks after deployment; follow-up assessments were done 10-24 months later. Follow-up measures were the PTSD Checklist-Civilian Version, Patient Health Questionnaire-9, Generalised Anxiety Disorder-7 scale, Alcohol Use Disorder Identification Test (AUDIT), and self-reported help-seeking from clinical and welfare providers comparing those receiving tailored advice and those receiving only general advice. All participants and all investigators other than the person who analysed the data were masked to allocation. The primary outcomes were PTSD, depression or generalised anxiety disorder, and alcohol misuse at follow-up. A key secondary outcome was assessment of whether post-deployment screening followed by tailored advice would modify help-seeking behaviour. Comparisons were made between screening and control groups, with primary analyses by intention to treat. This trial is registered with the ISRCTN Registry, number ISRCTN19965528. Findings Between Oct 24, 2011, and Oct 31, 2014, 434 platoons comprising 10 190 personnel were included: 274 (6350 personnel) in the screening group and 160 (3840 personnel) in the control group. 5577 (88%) of 6350 personnel received screening and 3996 (63%) completed follow-up, whereas 3149 (82%) of 3840 received the control questionnaire and 2369 (62%) completed follow-up. 1958 (35%) of 5577 personnel in the screening group declined to see the tailored advice, but those with PTSD (83%) or anxiety or depression (84%) were more likely than non-cases (64%) to view the advice (both p<0.0001). At follow-up, there were no significant differences in prevalence between groups for PTSD (adjusted odds ratio 0.92, 95% CI 0.75-1.14), depression or anxiety (0.91, 0.71-1.16), alcohol misuse (0.88, 0.73-1.06), or seeking support for mental disorders (0.92, 0.78-1. 08). Interpretation Post-deployment screening for mental disorders based on tailored advice was not effective at reducing prevalence of mental health disorders nor did it increase help-seeking. Countries that have implemented post-deployment screening programmes for mental disorders should consider monitoring the outcomes of their programmes.	[Rona, Roberto J.; Burdett, Howard; Chesnokov, Melanie; Green, Kevin; Pernet, David; Wessely, Simon] Kings Coll London, Kings Ctr Mil Hlth Res, Dept Psychol Med, London, England; [Jones, Norman; Greenberg, Neil; Fear, Nicola T.] Kings Coll London, Acad Dept Mil Mental Hlth, Dept Psychol Med, London, England; [Khondoker, Mizanur] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England; [Green, Kevin] Command Headquarter Operat Stress Management Trau, Portsmouth, Hants, England	University of London; King's College London; University of London; King's College London; University of East Anglia	Rona, RJ (corresponding author), Kings Coll London, Weston Educ Ctr, Kings Ctr Mil Hlth Res, Dept Psychol Med, London SE5 9RJ, England.	roberto.rona@kcl.ac.uk	Khondoker, Mizanur/A-9860-2011; Wessely, Simon C/A-8713-2008; Khondoker, Mizanur/O-2656-2019	Khondoker, Mizanur/0000-0002-1801-1635; Khondoker, Mizanur/0000-0002-1801-1635; Wessely, Simon Charles/0000-0002-6743-9929; Fear, Nicola/0000-0002-5792-2925; Chesnokov, Melanie/0000-0001-6674-422X; Burdett, Howard/0000-0002-8127-8981; greenberg, neil/0000-0003-4550-2971	US Army Medical Research and Materiel Command-Military Operational Medicine Research Program (USAMRMC-MOMRP)	US Army Medical Research and Materiel Command-Military Operational Medicine Research Program (USAMRMC-MOMRP)	The US Army Medical Research and Materiel Command-Military Operational Medicine Research Program (USAMRMC-MOMRP).	Adler AB, 2015, BRIT J PSYCHIAT, V207, P346, DOI 10.1192/bjp.bp.114.146506; Babor T. F, 2001, GUIDELINES USE PRIMA; Berntsen D, 2012, PSYCHOL SCI, V23, P1557, DOI 10.1177/0956797612457389; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bonanno GA, 2012, BRIT J PSYCHIAT, V200, P317, DOI 10.1192/bjp.bp.111.096552; Burdett H, 2016, INT J METH PSYCH RES, V25, P168, DOI 10.1002/mpr.1501; Casualty Monitor, 2013, MON AN DAT CIV BRIT; Committee on the Assessment of Ongoing Efforts in the Treatment of Posttraumatic Stress Disorder Board on the Health of Select Populations Institute of Medicine, 2014, TREATM POSTTR STRESS; Eekhout I, 2016, LANCET PSYCHIAT, V3, P58, DOI 10.1016/S2215-0366(15)00368-5; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; Hines LA, 2014, PSYCHIAT SERV, V65, P98, DOI 10.1176/appi.ps.004972012; Hoge CW, 2014, PSYCHIAT SERV, V65, P997, DOI 10.1176/appi.ps.201300307; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Jones M, 2013, PSYCHOL MED, V43, P1703, DOI 10.1017/S0033291712002619; Keeling M, 2012, J MED SCREEN, V19, P206, DOI 10.1258/jms.2012.012054; Kehle-Forbes SM, 2016, PSYCHOL TRAUMA-US, V8, P107, DOI 10.1037/tra0000065; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Lee DJ, 2016, DEPRESS ANXIETY, V33, P792, DOI 10.1002/da.22511; Lee DJ, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0467-7; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Ministry of Defence, 2014, DEF STAT TRI SERV; Ministry of Defence, 2014, OP HERR CAS FAT TABL; Rabe-Hesketh S., 2012, MULTILEVEL LONGITUDI; Rona RJ, 2004, J MED SCREEN, V11, P148, DOI 10.1258/0969141041732193; Rona RJ, 2007, BRIT MED J, V335, P603, DOI 10.1136/bmj.39274.585752.BE; Rona RJ, 2006, BMJ-BRIT MED J, V333, P991, DOI 10.1136/BMJ.38985.610949.55; Rona RJ, 2014, LANCET PSYCHIAT, V1, P531, DOI 10.1016/S2215-0366(14)00062-5; Rona RJ, 2012, J PSYCHIATR RES, V46, P1191, DOI 10.1016/j.jpsychires.2012.05.009; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Seal KH, 2008, AM J PUBLIC HEALTH, V98, P714, DOI 10.2105/AJPH.2007.115519; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Steenkamp MM, 2016, JAMA PSYCHIAT, V73, P431, DOI 10.1001/jamapsychiatry.2015.2879; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; Torgerson DJ, 1998, BRIT MED J, V316, P606, DOI 10.1136/bmj.316.7131.606; Tran US, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0979-2; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vermetten E, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.23732; Ware JE, 1993, SF36 HLTH SURVEY MAN; Warner CH, 2011, ARCH GEN PSYCHIAT, V68, P1065, DOI 10.1001/archgenpsychiatry.2011.112; Warner CH, 2011, AM J PSYCHIAT, V168, P378, DOI 10.1176/appi.ajp.2010.10091303; White IR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d40; Wong E. C, 2015, EVALUATING IMPLEMENT; Zamorski MA, 2014, CAN J PSYCHIAT, V59, P319, DOI 10.1177/070674371405900605	46	39	39	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2017	389	10077					1410	1423		10.1016/S0140-6736(16)32398-4	http://dx.doi.org/10.1016/S0140-6736(16)32398-4			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EQ8OJ	28215661	Green Submitted, Green Accepted			2022-12-28	WOS:000398345100033
J	Banerji, A; Busse, P; Shennak, M; Lumry, W; Davis-Lorton, M; Wedner, HJ; Jacobs, J; Baker, J; Bernstein, JA; Lockey, R; Li, HH; Craig, T; Cicardi, M; Riedl, M; Al-Ghazawi, A; Soo, C; Iarrobino, R; Sexton, DJ; TenHoor, C; Kenniston, JA; Faucette, R; Still, JG; Kushner, H; Mensah, R; Stevens, C; Biedenkapp, JC; Chyung, Y; Adelman, B				Banerji, A.; Busse, P.; Shennak, M.; Lumry, W.; Davis-Lorton, M.; Wedner, H. J.; Jacobs, J.; Baker, J.; Bernstein, J. A.; Lockey, R.; Li, H. H.; Craig, T.; Cicardi, M.; Riedl, M.; Al-Ghazawi, A.; Soo, C.; Iarrobino, R.; Sexton, D. J.; TenHoor, C.; Kenniston, J. A.; Faucette, R.; Still, J. G.; Kushner, H.; Mensah, R.; Stevens, C.; Biedenkapp, J. C.; Chyung, Y.; Adelman, B.			Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERNATIONAL WORKING GROUP; BRADYKININ-FORMING CASCADE; CONSENSUS REPORT; DEFICIENCY; MANAGEMENT; DANAZOL; RECOMMENDATIONS; ATTACKS; BURDEN	BACKGROUND Hereditary angioedema with C1 inhibitor deficiency is characterized by recurrent, unpredictable swelling episodes caused by uncontrolled plasma kallikrein generation and excessive bradykinin release resulting from cleavage of high-molecular-weight kininogen. Lanadelumab (DX-2930) is a new kallikrein inhibitor with the potential for prophylactic treatment of hereditary angioedema with C1 inhibitor deficiency. METHODS We conducted a phase 1b, multicenter, double-blind, placebo-controlled, multiple-ascending- dose trial. Patients with hereditary angioedema with C1 inhibitor deficiency were randomly assigned in a 2: 1 ratio to receive either lanadelumab (24 patients) or placebo (13 patients), in two administrations 14 days apart. Patients assigned to lanadelumab were enrolled in sequential dose groups: total dose of 30 mg (4 patients), 100 mg (4 patients), 300 mg (5 patients), or 400 mg (11 patients). The pharmacodynamic profile of lanadelumab was assessed by measurement of plasma levels of cleaved high-molecular-weight kininogen, and efficacy was assessed by the rate of attacks of angioedema during a prespecified period (day 8 to day 50) in the 300-mg and 400-mg groups as compared with the placebo group. RESULTS No discontinuations occurred because of adverse events, serious adverse events, or deaths in patients who received lanadelumab. The most common adverse events that emerged during treatment were attacks of angioedema, injection-site pain, and headache. Dose-proportional increases in serum concentrations of lanadelumab were observed; the mean elimination half-life was approximately 2 weeks. Lanadelumab at a dose of 300 mg or 400 mg reduced cleavage of high-molecular-weight kininogen in plasma from patients with hereditary angioedema with C1 inhibitor deficiency to levels approaching that from patients without the disorder. From day 8 to day 50, the 300-mg and 400-mg groups had 100% and 88% fewer attacks, respectively, than the placebo group. All patients in the 300-mg group and 82% (9 of 11) in the 400-mg group were attack-free, as compared with 27% (3 of 11) in the placebo group. CONCLUSIONS In this small trial, administration of lanadelumab to patients with hereditary angioedema with C1 inhibitor deficiency reduced cleavage of high-molecular-weight kininogen and attacks of angioedema.	[Banerji, A.] Massachusetts Gen Hosp, Harvard Med Sch, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; [Soo, C.; Iarrobino, R.; Sexton, D. J.; TenHoor, C.; Kenniston, J. A.; Faucette, R.; Kushner, H.; Mensah, R.; Stevens, C.; Biedenkapp, J. C.; Chyung, Y.; Adelman, B.] Dyax, Burlington, MA USA; [Still, J. G.] ICON Clin Res, Marlborough, MA USA; [Busse, P.] Icahn Sch Med Mt Sinai, Dept Med, Div Clin Immunol & Allergy, New York, NY 10029 USA; [Davis-Lorton, M.] Winthrop Univ Hosp, Mineola, NY, Jordan; [Shennak, M.; Al-Ghazawi, A.] Triumpharma, Amman, Jordan; [Lumry, W.] Asthma & Allergy Res Associates, Dallas, TX USA; [Wedner, H. J.] Washington Univ, Sch Med, Div Allergy & Immunol, St Louis, MO USA; [Jacobs, J.] Allergy & Asthma Med Grp, Walnut Creek, CA USA; [Riedl, M.] Univ Calif San Diego, Dept Rheumatol Allergy & Immunol, San Diego, CA 92103 USA; [Baker, J.] Baker Allergy Asthma & Dermatol, Lake Oswego, OR USA; [Bernstein, J. A.] Univ Cincinnati, Coll Med, Dept Internal Med, Allergy Sect Cincinnati, Cincinnati, OH USA; [Lockey, R.] Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, Tampa, FL USA; [Li, H. H.] Inst Asthma & Allergy, Chevy Chase, MD USA; [Craig, T.] Penn State Hershey Allergy Asthma & Immunol, Dept Med & Pediat, Hershey, PA USA; [Cicardi, M.] Univ Milan, Dept Biomed & Clin Sci Luigi Sacco, I-20122 Milan, Italy; [Cicardi, M.] Luigi Sacco Hosp Milan, Milan, Italy	Harvard University; Harvard Medical School; Massachusetts General Hospital; ICON plc; Icahn School of Medicine at Mount Sinai; Washington University (WUSTL); University of California System; University of California San Diego; University System of Ohio; University of Cincinnati; State University System of Florida; University of South Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital	Banerji, A (corresponding author), Massachusetts Gen Hosp, Harvard Med Sch, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA.		Banerji, Aleena/ABG-1245-2021; cicardi, marco/K-9219-2016	cicardi, marco/0000-0003-1251-225X; Bernstein, Jonathan/0000-0002-3476-1196	Dyax; Alnylam Pharmaceuticals; Shire; CSL Behring; Salix Pharmaceuticals; BioCryst Pharmaceuticals; Salix Pharmaceuticals/Pharming Group; Swedish Orphan Biovitrum; Ionis Pharmaceuticals; Global Blood Therapeutics; Arrowhead Pharmaceuticals; Pharming Group; Relypsa; Arsanis; Forum Pharmaceuticals; Seres Therapeutics	Dyax; Alnylam Pharmaceuticals; Shire; CSL Behring; Salix Pharmaceuticals; BioCryst Pharmaceuticals; Salix Pharmaceuticals/Pharming Group; Swedish Orphan Biovitrum; Ionis Pharmaceuticals; Global Blood Therapeutics; Arrowhead Pharmaceuticals; Pharming Group; Relypsa; Arsanis; Forum Pharmaceuticals; Seres Therapeutics	Supported by Dyax.; Dr. Banerji reports receiving fees for serving on an advisory board from Alnylam Pharmaceuticals and grant support from Shire, CSL Behring, and Dyax; Dr. Busse, receiving consulting fees from CSL Behring, Shire, and Dyax; Dr. Lumry, receiving consulting fees (paid to his institution) from ViroPharma (now Shire), Valeant Pharmaceuticals (now Salix Pharmaceuticals), BioCryst Pharmaceuticals, and CSL Behring, lecture fees from ViroPharma (now Shire) and CSL Behring, and grant support from ViroPharma (now Shire), BioCryst Pharmaceuticals, and CSL Behring; Dr. Jacobs, receiving lecture fees and fees for serving on advisory boards from Dyax and Shire and grant support from Shire, CSL Behring, and BioCryst Pharmaceuticals; Dr. Baker, receiving grant support from Dyax, Shire, Pharming Group, and CSL Behring; Dr. Bernstein, receiving consulting fees from Shire, CSL Behring, and Salix Pharmaceuticals, lecture fees from Shire and CSL Behring, and grant and travel support from Dyax, Shire, CSL Behring, and BioCryst Pharmaceuticals; Dr. Li, receiving consulting fees from Dyax, ViroPharma (now Shire), CSL Behring, and Salix Pharmaceuticals/Pharming Group, lecture fees from ViroPharma (now Shire) and CSL Behring, and travel and grant support from Dyax, ViroPharma (now Shire), CSL Behring, Salix Pharmaceuticals/Pharming Group, and BioCryst Pharmaceuticals; Dr. Cicardi, receiving fees for board membership from Dyax (now Shire), CSL Behring, Alnylam Pharmaceuticals, and the Swedish Orphan Biovitrum, lecture fees from Dyax (now Shire), CSL Behring, and the Swedish Orphan Biovitrum, fees for the development of educational presentations from Dyax (now Shire), and grant support from Shire; Dr. Riedl, receiving consulting fees from Shire, Dyax, CSL Behring, BioCryst Pharmaceuticals, Salix Pharmaceuticals, Ionis Pharmaceuticals, Global Blood Therapeutics, and Arrowhead Pharmaceuticals, lecture fees from Shire, Dyax, CSL Behring, and Salix Pharmaceuticals, and grant support from Shire, Dyax, CSL Behring, BioCryst Pharmaceuticals, Pharming Group, and Ionis Pharmaceuticals; Dr. Kushner, receiving consulting fees from Dyax; Dr. Stevens, receiving fees for serving on an advisory board from Relypsa, receiving consulting fees from Dyax, Shire, Intarcia Therapeutics, Arsanis, Forum Pharmaceuticals, and Seres Therapeutics, and being chief medical officer for Arsanis; Dr. Soo, Dr. Sexton, Dr. Kenniston, Mr. Faucette, and Dr. Biedenkapp, being employees of Dyax; and Mr. Iarrobino, Dr. TenHoor, Dr. Mensah, Dr. Chyung, and Dr. Adelman, being former employees of Dyax. In addition, Dr. Sexton, Dr. TenHoor, Dr. Kenniston, Mr. Faucette, and Dr. Adelman are named inventors on a pending patent related to assays for determining plasma kallikrein system biomarkers (WO/2015/061183); Dr. Kenniston is a named inventor on a pending patent related to anti-plasma kallikrein antibodies (WO/2014/152232 and US 20160017055); Dr. Sexton is a named inventor on a patent related to plasma kallikrein binding proteins (20160102150); Dr. Sexton, Dr. TenHoor, Dr. Kenniston, Mr. Faucette, Dr. Chyung, and Dr. Adelman are named inventors on a pending patent related to the evaluation and treatment of bradykinin-mediated disorders (20150362493 and WO/2014/113712); and Mr. Iarrobino, Dr. Sexton, Dr. TenHoor, Dr. Kenniston, Mr. Faucette, Dr. Biedenkapp, Dr. Chyung, and Dr. Adelman are named inventors on a pending patent related to plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema (WO/2015/112578); all these patents are held by Dyax (now Shire).; No other potential conflict of interest relevant to this article was reported.	Banerji A, 2015, ALLERGY ASTHMA PROC, V36, P213, DOI 10.2500/aap.2015.36.3824; Banerji A, 2013, ANN ALLERG ASTHMA IM, V111, P329, DOI 10.1016/j.anai.2013.08.019; Bork K, 2008, ANN ALLERG ASTHMA IM, V100, P153, DOI 10.1016/S1081-1206(10)60424-3; Bork K, 2012, J ALLERGY CLIN IMMUN, V130, P692, DOI 10.1016/j.jaci.2012.05.055; Chyung Y, 2014, ANN ALLERG ASTHMA IM, V113, P460, DOI 10.1016/j.anai.2014.05.028; Cicardi M, 2014, ALLERGY, V69, P602, DOI 10.1111/all.12380; Cicardi M, 1997, J ALLERGY CLIN IMMUN, V99, P194, DOI 10.1016/S0091-6749(97)70095-2; Cicardi M, 2012, ALLERGY, V67, P147, DOI 10.1111/j.1398-9995.2011.02751.x; Cicardi M, 2010, NEW ENGL J MED, V363, P523, DOI 10.1056/NEJMoa0905079; GELFAND JA, 1976, NEW ENGL J MED, V295, P1444, DOI 10.1056/NEJM197612232952602; Girolami A, 2010, EXPERT REV HEMATOL, V3, P685, DOI [10.1586/ehm.10.69, 10.1586/EHM.10.69]; Joseph K, 2013, J ALLERGY CLIN IMMUN, V132, P470, DOI 10.1016/j.jaci.2013.03.026; Kaplan AP, 2010, ANN ALLERG ASTHMA IM, V104, P193, DOI 10.1016/j.anai.2010.01.007; Kenniston JA, 2014, J BIOL CHEM, V289, P23596, DOI 10.1074/jbc.M114.569061; Lumry WR, 2010, ALLERGY ASTHMA PROC, V31, P407, DOI 10.2500/aap.2010.31.3394; Renne T, 2012, THROMB HAEMOSTASIS, V107, P1012, DOI 10.1160/TH12-04-0264; Renne T, 2012, SEMIN IMMUNOPATHOL, V34, P31, DOI 10.1007/s00281-011-0288-2; Riedl MA, 2015, ANN ALLERG ASTHMA IM, V114, P281, DOI 10.1016/j.anai.2015.01.003; Silverberg M, 1995, BLOOD PRINCIPLES PRA, P1127; Suffritti C, 2014, CLIN EXP ALLERGY, V44, P1503, DOI 10.1111/cea.12293; Szeplaki G, 2005, J ALLERGY CLIN IMMUN, V115, P864, DOI 10.1016/j.jaci.2004.12.1130; Zuraw BL, 2008, NEW ENGL J MED, V359, P1027, DOI 10.1056/NEJMcp0803977; Zuraw BL, 2013, J ALLER CL IMM-PRACT, V1, P458, DOI 10.1016/j.jaip.2013.07.002; Zuraw BL, 2010, NEW ENGL J MED, V363, P513, DOI 10.1056/NEJMoa0805538	24	111	117	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2017	376	8					717	728		10.1056/NEJMoa1605767	http://dx.doi.org/10.1056/NEJMoa1605767			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JO	28225674				2022-12-28	WOS:000395627900005
J	Israel, L; Wang, Y; Bulek, K; Della Mina, E; Zhang, Z; Pedergnana, V; Chrabieh, M; Lemmens, NA; Sancho-Shimizu, V; Descatoire, M; Lasseau, T; Israelsson, E; Lorenzo, L; Yun, L; Belkadi, A; Moran, A; Weisman, LE; Vandenesch, F; Batteux, F; Weller, S; Levin, M; Herberg, J; Abhyankar, A; Prando, C; Itan, Y; van Wamel, WJB; Picard, C; Abel, L; Chaussabel, D; Li, XX; Beutler, B; Arkwright, PD; Casanova, JL; Puel, A				Israel, Laura; Wang, Ying; Bulek, Katarzyna; Della Mina, Erika; Zhang, Zhao; Pedergnana, Vincent; Chrabieh, Maya; Lemmens, Nicole A.; Sancho-Shimizu, Vanessa; Descatoire, Marc; Lasseau, Theo; Israelsson, Elisabeth; Lorenzo, Lazaro; Yun, Ling; Belkadi, Aziz; Moran, Andrew; Weisman, Leonard E.; Vandenesch, Francois; Batteux, Frederic; Weller, Sandra; Levin, Michael; Herberg, Jethro; Abhyankar, Avinash; Prando, Carolina; Itan, Yuval; van Wamel, Willem J. B.; Picard, Capucine; Abel, Laurent; Chaussabel, Damien; Li, Xiaoxia; Beutler, Bruce; Arkwright, Peter D.; Casanova, Jean-Laurent; Puel, Anne			Human Adaptive Immunity Rescues an Inborn Error of Innate Immunity	CELL			English	Article							PYOGENIC BACTERIAL-INFECTIONS; STAPHYLOCOCCUS-AUREUS; PRIMARY IMMUNODEFICIENCIES; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; MYD88 DEFICIENCY; CUTTING EDGE; TIR DOMAIN; TLR2; GENE	The molecular basis of the incomplete penetrance of monogenic disorders is unclear. We describe here eight related individuals with autosomal recessive TIRAP deficiency. Life-threatening staphylococcal disease occurred during childhood in the proband, but not in the other seven homozygotes. Responses to all Toll-like receptor 1/2 (TLR1/2), TLR2/6, and TLR4 agonists were impaired in the fibroblasts and leukocytes of all TIRAP-deficient individuals. However, the whole-blood response to the TLR2/6 agonist staphylococcal lipoteichoic acid (LTA) was abolished only in the index case individual, the only family member lacking LTA-specific antibodies (Abs). This defective response was reversed in the patient, but not in interleukin-1 receptor-associated kinase 4 (IRAK-4)deficient individuals, by anti-LTA monoclonal anti-body (mAb). Anti-LTA mAb also rescued the macrophage response in mice lacking TIRAP, but not TLR2 or MyD88. Thus, acquired anti-LTA Abs rescue TLR2-dependent immunity to staphylococcal LTA in individuals with inherited TIRAP deficiency, accounting for incomplete penetrance. Combined TIRAP and anti-LTA Ab deficiencies underlie staphylococcal disease in this patient.	[Israel, Laura; Della Mina, Erika; Pedergnana, Vincent; Chrabieh, Maya; Sancho-Shimizu, Vanessa; Lasseau, Theo; Lorenzo, Lazaro; Yun, Ling; Belkadi, Aziz; Picard, Capucine; Abel, Laurent; Casanova, Jean-Laurent; Puel, Anne] INSERM, U1163, Necker Branch, Lab Human Genet Infect Dis, F-75015 Paris, France; [Israel, Laura; Della Mina, Erika; Pedergnana, Vincent; Chrabieh, Maya; Sancho-Shimizu, Vanessa; Lasseau, Theo; Lorenzo, Lazaro; Yun, Ling; Belkadi, Aziz; Picard, Capucine; Abel, Laurent; Casanova, Jean-Laurent; Puel, Anne] Paris Descartes Univ, Imagine Inst, F-75015 Paris, France; [Wang, Ying; Zhang, Zhao; Beutler, Bruce] Univ Texas Southwestern Med Ctr Dallas, Ctr Genet Host Def, Dallas, TX 75390 USA; [Bulek, Katarzyna; Li, Xiaoxia] Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44106 USA; [Lemmens, Nicole A.; van Wamel, Willem J. B.] Erasmus MC, Med Microbiol & Infect Dis, NL-3015 Rotterdam, Netherlands; [Sancho-Shimizu, Vanessa] Imperial Coll London, Dept Virol, Norfolk Pl, London W21 PG, England; [Sancho-Shimizu, Vanessa; Levin, Michael; Herberg, Jethro] Imperial Coll London, Dept Med, Paediat Sect, London W21 PG, England; [Descatoire, Marc; Weller, Sandra] Paris Descartes Univ, INSERM, U1151, CNRS,UMR 8253,Necker Enfants Malad Med Sch Brouss, F-75014 Paris, France; [Israelsson, Elisabeth; Chaussabel, Damien] Virginia Mason, Benaroya Res Inst, Seattle, WA 98101 USA; [Moran, Andrew] Manchester Royal Infirm, Greater Manchester Immunol Serv, Manchester M13 9WL, Lancs, England; [Weisman, Leonard E.] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; [Vandenesch, Francois] Hosp Civils Lyon, French Natl Reference Ctr Staphylococci, F-69677 Bron, France; [Batteux, Frederic] Cochin Hosp, Dept Biol Immunol, F-75679 Paris, France; [Abhyankar, Avinash; Prando, Carolina; Itan, Yuval; Abel, Laurent; Casanova, Jean-Laurent; Puel, Anne] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10065 USA; [Picard, Capucine; Casanova, Jean-Laurent] Hop Necker Enfants Malad, AP HP, Pediat Hematol Immunol Unit, F-75015 Paris, France; [Picard, Capucine] Hop Necker Enfants Malad, AP HP, Study Ctr Primary Immunodeficiencies, F-75015 Paris, France; [Arkwright, Peter D.] Univ Manchester, Royal Manchester Childrens Hosp, Manchester M13 9WL, Lancs, England; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY 10065 USA; [Bulek, Katarzyna] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Immunol, PL-30387 Krakow, Poland; [Israelsson, Elisabeth] AstraZeneca Gothenburg, Resp Inflammat & Autoimmun Unit, Innovat Med & Early Dev, SE-43183 Molndal, Sweden; [Prando, Carolina] Pele Pequeno Principe Res Inst, BR-80250060 Curitiba, Parana, Brazil; [Chaussabel, Damien] Sidra Med & Res Ctr, Doha, Qatar	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cleveland Clinic Foundation; Erasmus University Rotterdam; Erasmus MC; Imperial College London; Imperial College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Benaroya Research Institute; Virginia Mason Medical Center; University of Manchester; Baylor College of Medicine; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Royal Manchester Children's Hospital; University of Manchester; Howard Hughes Medical Institute; Jagiellonian University; AstraZeneca; Hospital Pequeno Principe; Sidra Medical & Research Center	Casanova, JL; Puel, A (corresponding author), INSERM, U1163, Necker Branch, Lab Human Genet Infect Dis, F-75015 Paris, France.; Casanova, JL; Puel, A (corresponding author), Paris Descartes Univ, Imagine Inst, F-75015 Paris, France.; Casanova, JL; Puel, A (corresponding author), Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10065 USA.; Casanova, JL (corresponding author), Hop Necker Enfants Malad, AP HP, Pediat Hematol Immunol Unit, F-75015 Paris, France.; Casanova, JL (corresponding author), Howard Hughes Med Inst, New York, NY 10065 USA.	jean-laurent.casanova@rockefeller.edu; anne.puel@inserm.fr	Vandenesch, Francois/C-7209-2014; Weller, Sandra/N-1947-2018; Chaussabel, Damien/AAX-1909-2020; Puel, Anne/H-7305-2017; Prando, Carolina/C-4689-2015; chrabieh, maya/H-7370-2017; Lorenzo, Lazaro/H-7902-2017; Batteux, Frederic/O-7889-2017; Casanova, Jean-Laurent/I-3418-2017; Abel, Laurent/H-8888-2017	Vandenesch, Francois/0000-0001-9412-7106; Weller, Sandra/0000-0003-4725-2793; Puel, Anne/0000-0003-2603-0323; Prando, Carolina/0000-0002-9570-9770; chrabieh, maya/0000-0003-0772-4805; Lorenzo, Lazaro/0000-0001-6648-8684; Batteux, Frederic/0000-0002-1265-7996; Zhang, Zhao/0000-0001-9345-3663; van Wamel, Willem/0000-0001-9145-9121; Ling, Yun/0000-0002-0203-3637; Casanova, Jean-Laurent/0000-0002-7782-4169; Abel, Laurent/0000-0001-7016-6493; Pedergnana, Vincent/0000-0002-7852-5339; Yun, Ling/0000-0002-4289-3594; Levin, Michael/0000-0003-2767-6919; Herberg, Jethro/0000-0001-6941-6491	INSERM; Paris Descartes University; Imagine Institute [ANR-10-LABX-62-IBEID, ANR-2012-BSV3-0003-02, ANR-10-IAHU-01]; St. Giles Foundation; National Center for Research Resources; National Center for Advancing Sciences (NCATS) from the NIH [8UL1TR000043]; Rockefeller University; Innovative Medicines Initiative Joint Undertaking [115523]; COMBACTE; European Union; EFPIA; Fondation pour la Recherche Medicale; Thrasher Research Fund; AXA Research Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001866, UL1TR000043] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582, P01HL103453] Funding Source: NIH RePORTER; Medical Research Foundation [C0483] Funding Source: researchfish	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paris Descartes University; Imagine Institute; St. Giles Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Sciences (NCATS) from the NIH; Rockefeller University; Innovative Medicines Initiative Joint Undertaking; COMBACTE; European Union(European Commission); EFPIA; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Thrasher Research Fund; AXA Research Fund(AXA Research Fund); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the patient and her family for participating in the study and all the members of both branches of the laboratory for discussions. We thank J. Bustamante and S.Y. Zhang for providing the plasma samples and S. Fahy, J. Flatot, M. Courat, L. Amar, and Y. Nemiroskaya for their assistance. We also thank R. Desvaux and N. Goudin for their help at the imaging platform. We thank Biosynexus for providing us with pagibaximab (anti-LTA Ab). The Laboratory of Human Genetics of Infectious Diseases is supported by INSERM, Paris Descartes University, the Imagine Institute, ANR-10-LABX-62-IBEID, ANR-2012-BSV3-0003-02, ANR-10-IAHU-01, the St. Giles Foundation, the National Center for Research Resources, the National Center for Advancing Sciences (NCATS) grant number 8UL1TR000043 from the NIH, and The Rockefeller University. This work was partly supported by the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115523, COMBACTE, from the European Union's FP7/2007-2013 and EFPIA. L.I. was supported by Fondation pour la Recherche Medicale. C. Prando was supported by the Thrasher Research Fund, and Y.I. was supported by the AXA Research Fund.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Bousfiha A, 2015, J CLIN IMMUNOL, V35, P727, DOI 10.1007/s10875-015-0198-5; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Casanova JL, 2015, P NATL ACAD SCI USA, V112, pE7118, DOI 10.1073/pnas.1521644112; Casanova JL, 2015, P NATL ACAD SCI USA, V112, pE7128, DOI 10.1073/pnas.1521651112; Casanova JL, 2014, J EXP MED, V211, P2137, DOI 10.1084/jem.20140520; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Cole LE, 2010, J LEUKOCYTE BIOL, V87, P275, DOI 10.1189/jlb.0909619; Conley ME, 2009, ANNU REV IMMUNOL, V27, P199, DOI 10.1146/annurev.immunol.021908.132649; den Reijer PM, 2017, MED MICROBIOL IMMUN, V206, P11, DOI 10.1007/s00430-016-0476-8; Dryla A, 2005, CLIN DIAGN LAB IMMUN, V12, P387, DOI 10.1128/CDLI.12.3.387-398.2005; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Itan Y, 2016, NAT METHODS, V13, P109, DOI 10.1038/nmeth.3739; Itan Y, 2015, P NATL ACAD SCI USA, V112, P13615, DOI 10.1073/pnas.1518646112; Jimenez-Dalmaroni MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007411; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kurokawa K, 2009, J BIOL CHEM, V284, P8406, DOI 10.1074/jbc.M809618200; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li ZG, 2015, PATHOGENS, V4, P793, DOI 10.3390/pathogens4040793; Lin ZJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034202, 10.1371/journal.pone.0040262]; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mulcahy ME, 2016, TRENDS MICROBIOL, V24, P872, DOI 10.1016/j.tim.2016.06.012; Nada M, 2012, MOL IMMUNOL, V52, P108, DOI 10.1016/j.molimm.2012.05.003; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Takahashi Masazumi, 2003, J Bioinform Comput Biol, V1, P253, DOI 10.1142/S021972000300006X; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; von Bernuth H, 2006, PEDIATRICS, V118, P2498, DOI 10.1542/peds.2006-1845; von Bernuth H, 2012, EUR J IMMUNOL, V42, P3126, DOI 10.1002/eji.201242683; WERGELAND HI, 1989, J CLIN MICROBIOL, V27, P1286, DOI 10.1128/JCM.27.6.1286-1291.1989; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhang Y, 2015, NAT IMMUNOL, V16, P1001, DOI 10.1038/ni.3275	51	52	53	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					789	+		10.1016/j.cell.2017.01.039	http://dx.doi.org/10.1016/j.cell.2017.01.039			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28235196	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000396284800009
J	Adashi, EY; Cohen, IG				Adashi, Eli Y.; Cohen, I. Glenn			Mitochondrial Replacement Therapy: Unmade in the USA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Med Sci, Providence, RI 02912 USA; [Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Med & Biol Sci, Providence, RI 02912 USA; [Cohen, I. Glenn] Harvard Law Sch, Law, Cambridge, MA USA; [Cohen, I. Glenn] Harvard Law Sch, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA USA	Brown University; Brown University; Harvard University; Harvard University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, Med Sci, Providence, RI 02912 USA.; Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, Med & Biol Sci, Providence, RI 02912 USA.	Eli_Adashi@Brown.edu							0	14	14	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2017	317	6					574	575		10.1001/jama.2016.20935	http://dx.doi.org/10.1001/jama.2016.20935			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8LI	28196242				2022-12-28	WOS:000394870900003
J	Lyon, J				Lyon, Jeff			Concerns Over Newborn Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2017	317	6					576	576		10.1001/jama.2017.0080	http://dx.doi.org/10.1001/jama.2017.0080			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8LI	28196233				2022-12-28	WOS:000394870900004
J	Rugo, HS; Klein, P; Melin, SA; Hurvitz, SA; Melisko, ME; Moore, A; Park, G; Mitchel, J; Bageman, E; D'Agostino, RB; Ver Hoeve, ES; Esserman, L; Cigler, T				Rugo, Hope S.; Klein, Paula; Melin, Susan Anitra; Hurvitz, Sara A.; Melisko, Michelle E.; Moore, Anne; Park, Glen; Mitchel, Jules; Bageman, Erika; D'Agostino, Ralph B., Jr.; Ver Hoeve, Elizabeth S.; Esserman, Laura; Cigler, Tessa			Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INDUCED HAIR LOSS; QUALITY-OF-LIFE; ADJUVANT CHEMOTHERAPY; PREVENTION; EFFICACY; DOCETAXEL; IMPACT; HYPOTHERMIA; SYSTEM; WOMEN	Importance Chemotherapy-induced alopecia is a common and distressing adverse effect. In previous studies of scalp cooling to prevent chemotherapy-induced alopecia, conclusions have been limited. Objectives To evaluate whether use of a scalp cooling system is associated with a lower amount of hair loss among women receiving specific chemotherapy regimens for early-stage breast cancer and to assess related changes in quality of life. Design, Setting, and Participants A prospective cohort study conducted at 5 US medical centers of women with stage I or II breast cancer receiving adjuvant or neoadjuvant chemotherapy regimens excluding sequential or combination anthracycline and taxane (106 patients in the scalp cooling group and 16 in the control group; 14 matched by both age and chemotherapy regimen). The study was conducted between August 2013 and October 2014 with ongoing annual follow-up for 5 years. Exposures Use of a scalp cooling system. Scalp cooling was initiated 30 minutes prior to each chemotherapy cycle, with scalp temperature maintained at 3 degrees C (37 degrees F) throughout chemotherapy and for 90 minutes to 120 minutes afterward. Main Outcomes and Measures Self-estimated hair loss using the Dean scale was assessed 4 weeks after the last dose of chemotherapy by unblinded patient review of 5 photographs. A Dean scale score of 0 to 2 (<= 50% hair loss) was defined as treatment success. A positive association between scalp cooling and reduced risk of hair loss would be demonstrated if 50% or more of patients in the scalp cooling group achieved treatment success, with the lower bound of the 95% CI greater than 40% of the success proportion. Quality of life was assessed at baseline, at the start of the last chemotherapy cycle, and 1 month later. Median follow-up was 29.5 months. Results Among the 122 patients in the study, the mean age was 53 years (range, 28-77 years); 77.0% were white, 9.0% were black, and 10.7% were Asian; and the mean duration of chemotherapy was 2.3 months (median, 2.1 months). No participants in the scalp cooling group received anthracyclines. Hair loss of 50% or less (Dean score of 0-2) was seen in 67 of 101 patients (66.3%; 95% CI, 56.2%-75.4%) evaluable for alopecia in the scalp cooling group vs 0 of 16 patients (0%) in the control group (P < .001). Three of 5 quality-of-life measures were significantly better 1 month after the end of chemotherapy in the scalp cooling group. Of patients who underwent scalp cooling, 27.3% (95% CI, 18.0%-36.6%) reported feeling less physically attractive compared with 56.3% (95% CI, 31.9%-80.6%) of patients in the control group (P = .02). Of the 106 patients in the scalp cooling group, 4 (3.8%) experienced the adverse event of mild headache and 3 (2.8%) discontinued scalp cooling due to feeling cold. Conclusions and Relevance Among women undergoing nonanthracycline-based adjuvant chemotherapy for early-stage breast cancer, the use of scalp cooling vs no scalp cooling was associated with less hair loss at 4 weeks after the last dose of chemotherapy. Further research is needed to assess outcomes after patients receive anthracycline regimens, longer-term measures of alopecia, and adverse effects.	[Rugo, Hope S.; Melisko, Michelle E.; Esserman, Laura] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Klein, Paula] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Melin, Susan Anitra] Wake Forest Sch Med, Wake Forest Baptist Hlth Med Ctr, Winston Salem, NC USA; [Hurvitz, Sara A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Moore, Anne; Cigler, Tessa] Weill Cornell Med Coll, New York, NY USA; [Park, Glen; Mitchel, Jules] Target Hlth Inc, New York, NY USA; [Bageman, Erika] Dignitana AB, Lund, Sweden; [D'Agostino, Ralph B., Jr.] Wake Forest Sch Med, Winston Salem, NC USA; [Ver Hoeve, Elizabeth S.] Columbia Univ, New York, NY USA; [Ver Hoeve, Elizabeth S.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Icahn School of Medicine at Mount Sinai; Wake Forest University; Wake Forest Baptist Medical Center; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Cornell University; Wake Forest University; Columbia University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Rugo, HS (corresponding author), Helen Diller Family Comprehens Canc Ctr, 1600 Divisidero St,POB 1710, San Francisco, CA 94115 USA.	hope.rugo@ucsf.edu			Dignitana AB; Lazlo Tauber Family Foundation; Anne Moore Breast Cancer Research Fund; Friedman Family Foundation; NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER	Dignitana AB; Lazlo Tauber Family Foundation; Anne Moore Breast Cancer Research Fund; Friedman Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded partially by Dignitana AB, the Lazlo Tauber Family Foundation (awarded to the University of California, San Francisco), the Anne Moore Breast Cancer Research Fund (awarded to the Weil Cornell Medical College), and the Friedman Family Foundation (awarded to Mount Sinai Beth Israel).	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Batchelor D, 2001, EUR J CANCER CARE, V10, P147, DOI 10.1046/j.1365-2354.2001.00272.x; Betticher DC, 2013, SUPPORT CARE CANCER, V21, P2565, DOI 10.1007/s00520-013-1804-9; Breed W. P. M., 2011, EXPERT REV DERMATOLO, DOI [10.1586/edm.10.76, DOI 10.1586/EDM.10.76]; BULOW J, 1985, SCAND J CLIN LAB INV, V45, P505, DOI 10.3109/00365518509155250; Cigler T, 2015, CLIN BREAST CANCER, V15, P332, DOI 10.1016/j.clbc.2015.01.003; DEAN JC, 1979, NEW ENGL J MED, V301, P1427, DOI 10.1056/NEJM197912273012605; Ekwall EM, 2013, MOL CLIN ONCOL, V1, P1065, DOI 10.3892/mco.2013.178; Friedrichs K, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-500; Giordano SH, 2012, J CLIN ONCOL, V30, P2232, DOI 10.1200/JCO.2011.40.1273; Grevelman EG, 2005, ANN ONCOL, V16, P352, DOI 10.1093/annonc/mdi088; Hesketh PJ, 2004, SUPPORT CARE CANCER, V12, P543, DOI 10.1007/s00520-003-0562-5; Janssen FPEM, 2007, PHYSIOL MEAS, V28, P829, DOI 10.1088/0967-3334/28/8/006; Kargar M, 2011, J ADV NURS, V67, P2473, DOI 10.1111/j.1365-2648.2011.05668.x; Komen MMC, 2013, ONCOLOGIST, V18, P885, DOI 10.1634/theoncologist.2012-0332; Lemieux J, 2015, BREAST CANCER RES TR, V149, P263, DOI 10.1007/s10549-014-3231-0; Lemieux J, 2008, PSYCHO-ONCOLOGY, V17, P317, DOI 10.1002/pon.1245; Lemieux J, 2009, BREAST CANCER RES TR, V118, P547, DOI 10.1007/s10549-009-0342-0; McAndrews PJ, DEGREE OF HAIR LOSS; Nangia J, 2017, JAMA-J AM MED ASSOC, V317, P596, DOI 10.1001/jama.2016.20939; Protiere C, 2002, SUPPORT CARE CANCER, V10, P529, DOI 10.1007/s00520-002-0375-y; Ridderheim M, 2003, SUPPORT CARE CANCER, V11, P371, DOI 10.1007/s00520-003-0451-y; Roe Helen, 2011, Br J Nurs, V20, pS4; Rugo H.S., 2013, ST GALL 13 INT BREAS; Rugo HS, 2012, CANC RES S, V72, pA2; Shin H, 2015, INT J CANCER, V136, pE442, DOI 10.1002/ijc.29115; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Trueb RM, 2009, SEMIN CUTAN MED SURG, V28, P11, DOI 10.1016/j.sder.2008.12.001; van den Hurk CJG, 2015, SUPPORT CARE CANCER, V23, P1197, DOI 10.1007/s00520-015-2647-3; van den Hurk CJG, 2013, BREAST, V22, P1001, DOI 10.1016/j.breast.2013.07.039; van den Hurk CJG, 2013, EUR J ONCOL NURS, V17, P536, DOI 10.1016/j.ejon.2013.02.004; van den Hurk CJG, 2012, SUPPORT CARE CANCER, V20, P3255, DOI 10.1007/s00520-012-1465-0; van den Hurk CJ, 2012, ACTA ONCOL, V51, P497, DOI 10.3109/0284186X.2012.658966; van den Hurk CJG, 2010, PSYCHO-ONCOLOGY, V19, P701, DOI 10.1002/pon.1615	34	84	88	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2017	317	6					606	614		10.1001/jama.2016.21038	http://dx.doi.org/10.1001/jama.2016.21038			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8LI	28196257	Green Accepted			2022-12-28	WOS:000394870900015
J	Russo, RJ; Costa, HS; Silva, PD; Anderson, JL; Arshad, A; Biederman, RWW; Boyle, NG; Frabizzio, JV; Birgersdotter-Green, U; Higgins, SL; Lampert, R; Machado, CE; Martin, ET; Rivard, AL; Rubenstein, JC; Schaerf, RHM; Schwartz, JD; Shah, DJ; Tomassoni, GF; Tominaga, GT; Tonkin, AE; Uretsky, S; Wolff, SD				Russo, Robert J.; Costa, Heather S.; Silva, Patricia D.; Anderson, Jeffrey L.; Arshad, Aysha; Biederman, Robert W. W.; Boyle, Noel G.; Frabizzio, Jennifer V.; Birgersdotter-Green, Ulrika; Higgins, Steven L.; Lampert, Rachel; Machado, Christian E.; Martin, Edward T.; Rivard, Andrew L.; Rubenstein, Jason C.; Schaerf, Raymond H. M.; Schwartz, Jennifer D.; Shah, Dipan J.; Tomassoni, Gery F.; Tominaga, Gail T.; Tonkin, Allison E.; Uretsky, Seth; Wolff, Steven D.			Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPLANTABLE-CARDIOVERTER-DEFIBRILLATORS; LEAD EXTRACTION; 1.5 TESLA; PERMANENT PACEMAKERS; CARDIAC-PACEMAKERS; DEPENDENT PATIENTS; SAFE; DEVICES; PROTOCOL; REGISTRY	BACKGROUND The presence of a cardiovascular implantable electronic device has long been a contraindication for the performance of magnetic resonance imaging (MRI). We established a prospective registry to determine the risks associated with MRI at a magnetic field strength of 1.5 tesla for patients who had a pacemaker or implantable cardioverterdefibrillator (ICD) that was "non-MRI-conditional" (i.e., not approved by the Food and Drug Administration for MRI scanning). METHODS Patients in the registry were referred for clinically indicated nonthoracic MRI at a field strength of 1.5 tesla. Devices were interrogated before and after MRI with the use of a standardized protocol and were appropriately reprogrammed before the scanning. The primary end points were death, generator or lead failure, induced arrhythmia, loss of capture, or electrical reset during the scanning. The secondary end points were changes in device settings. RESULTS MRI was performed in 1000 cases in which patients had a pacemaker and in 500 cases in which patients had an ICD. No deaths, lead failures, losses of capture, or ventricular arrhythmias occurred during MRI. One ICD generator could not be interrogated after MRI and required immediate replacement; the device had not been appropriately programmed per protocol before the MRI. We observed six cases of self-terminating atrial fibrillation or flutter and six cases of partial electrical reset. Changes in lead impedance, pacing threshold, battery voltage, and P-wave and R-wave amplitude exceeded prespecified thresholds in a small number of cases. Repeat MRI was not associated with an increase in adverse events. CONCLUSIONS In this study, device or lead failure did not occur in any patient with a non-MRIconditional pacemaker or ICD who underwent clinically indicated nonthoracic MRI at 1.5 tesla, was appropriately screened, and had the device reprogrammed in accordance with the prespecified protocol.	[Russo, Robert J.; Silva, Patricia D.] Cardiovasc Res Inst, La Jolla, CA USA; [Birgersdotter-Green, Ulrika] Univ Calif San Diego, San Diego, CA 92103 USA; [Higgins, Steven L.; Tominaga, Gail T.] Scripps Mem Hosp, San Diego, CA USA; [Boyle, Noel G.] Univ Calif Los Angeles, Los Angeles, CA USA; [Schaerf, Raymond H. M.] Prov St Joseph Med Ctr, Burbank, CA USA; [Costa, Heather S.] Univ Arizona, Dept Entomol, Tucson, AZ USA; [Anderson, Jeffrey L.; Tonkin, Allison E.] Intermt Med Ctr, Salt Lake City, UT USA; [Arshad, Aysha] Inova Heart & Vasc inst, Falls Church, VA USA; [Biederman, Robert W. W.] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA; [Frabizzio, Jennifer V.] Abington Mem Hosp, Abington, PA 19001 USA; [Lampert, Rachel] Yale Univ, Sch Med, New Haven, CT USA; [Machado, Christian E.] Prov Heart Inst, Southfield, MI USA; [Martin, Edward T.] Oklahoma Heart Inst, Tulsa, OK USA; [Rivard, Andrew L.] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Rubenstein, Jason C.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Schwartz, Jennifer D.] Bassett Med Ctr, Cooperstown, NY USA; [Uretsky, Seth; Wolff, Steven D.] Adv Cardiovasc Imaging, Carnegie Hill Radiol, New York, NY USA; [Shah, Dipan J.] Methodist DeBakey Heart & Vasc Ctr, Houston, TX USA; [Tomassoni, Gery F.] Baptist Hlth, Lexington, KY USA; [Russo, Robert J.] Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of Arizona; Intermountain Healthcare; Intermountain Medical Center; Inova Fairfax Hospital; Allegheny General Hospital; Abington Memorial Hospital; Yale University; University of Mississippi; University of Mississippi Medical Center; Medical College of Wisconsin; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Central Baptist Hospital; Scripps Research Institute	Russo, RJ (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	russo@scripps.edu	Tominaga, Gail/ABE-6303-2021; Russo, Robert J/AAG-2751-2020		St. Jude Medical; Biotronik; Boston Scientific; Hewitt Foundation for Medical Research	St. Jude Medical(St. Jude Medical); Biotronik; Boston Scientific(Boston Scientific); Hewitt Foundation for Medical Research	Supported by grants from St. Jude Medical, Biotronik, Boston Scientific, and the Hewitt Foundation for Medical Research, and by philanthropic gifts from Mr. and Mrs. Richard H. Deihl, Evelyn F. and Louis S. Grubb, Roscoe E. Hazard, Jr., and the Shultz Steel Company.	American College of Radiology, 2016, APPR CRIT; Anfinsen OG, 2002, PACE, V25, P1400, DOI 10.1046/j.1460-9592.2002.01400.x; Beinart R, 2013, CIRCULATION, V128, P2799, DOI 10.1161/CIRCULATIONAHA.113.005697; Boilson BA, 2012, J INTERV CARD ELECTR, V33, P59, DOI 10.1007/s10840-011-9615-8; Burke PT, 2010, J INTERV CARD ELECTR, V28, P59, DOI 10.1007/s10840-009-9463-y; Centers for Medicare & Medicaid Services, 2011, CAG00399R2 CENT MED; CHAN CC, 1994, PACE, V17, P1873, DOI 10.1111/j.1540-8159.1994.tb03766.x; Cohen JD, 2012, AM J CARDIOL, V110, P1631, DOI 10.1016/j.amjcard.2012.07.030; Danilovic D, 1999, PACE, V22, P567, DOI 10.1111/j.1540-8159.1999.tb00498.x; Gimbel JR, 2013, HEART RHYTHM, V10, P685, DOI 10.1016/j.hrthm.2013.01.022; Gimbel JR, 2009, EUROPACE, V11, P1241, DOI 10.1093/europace/eup162; Gimbel JR, 2005, EUR HEART J, V26, P1683, DOI 10.1093/eurheartj/ehi360; Gimbel JR, 2004, J AM COLL CARDIOL, V43, P1325, DOI 10.1016/j.jacc.2004.02.009; Gimbel JR, 2005, PACE, V28, P1041, DOI 10.1111/j.1540-8159.2005.00230.x; Hauser RG, 2010, EUROPACE, V12, P395, DOI 10.1093/europace/eup375; Irnich W, 2010, EUROPACE, V12, P918, DOI 10.1093/europace/euq144; Jones SO, 2008, HEART RHYTHM, V5, P520, DOI 10.1016/j.hrthm.2008.01.009; Kalin R, 2005, PACE, V28, P326, DOI 10.1111/j.1540-8159.2005.50024.x; Langman DA, 2012, MAGN RESON MED, V68, P606, DOI 10.1002/mrm.23235; Luechinger R, 2005, EUR HEART J, V26, P376, DOI 10.1093/eurheartj/ehi009; Lundqvist CB, 2013, EUROPACE, V15, P927, DOI 10.1093/europace/eut084; Maisel WH, 2006, JAMA-J AM MED ASSOC, V295, P1901, DOI 10.1001/jama.295.16.1901; Martin ET, 2004, J AM COLL CARDIOL, V43, P1315, DOI 10.1016/j.jacc.2003.12.016; Mollerus M, 2008, PACE, V31, P1241, DOI 10.1111/j.1540-8159.2008.01172.x; Naehle CP, 2009, J AM COLL CARDIOL, V54, P549, DOI 10.1016/j.jacc.2009.04.050; Nazarian S, 2011, ANN INTERN MED, V155, P415, DOI 10.7326/0003-4819-155-7-201110040-00004; Nazarian S, 2006, CIRCULATION, V114, P1277, DOI 10.1161/CIRCULATIONAHA.105.607655; Poole JE, 2010, CIRCULATION, V122, P1553, DOI 10.1161/CIRCULATIONAHA.110.976076; Roguin A, 2004, CIRCULATION, V110, P475, DOI 10.1161/01.CIR.0000137121.28722.33; Russo RJ, 2013, AM HEART J, V165, P266, DOI 10.1016/j.ahj.2012.12.004; Sharif MN, 1998, AM J CARDIOL, V82, P600, DOI 10.1016/S0002-9149(98)00414-7; Sommer T, 2005, J AM COLL CARDIOL, V46, P561, DOI 10.1016/j.jacc.2005.05.018; Sommer T, 2006, CIRCULATION, V114, P1285, DOI 10.1161/CIRCULATIONAHA.105.597013; Team RC., 2013, R LANG ENV STAT COMP; Verma A, 2014, CAN J CARDIOL, V30, P1131, DOI 10.1016/j.cjca.2014.07.010; Wazni O, 2010, J AM COLL CARDIOL, V55, P579, DOI 10.1016/j.jacc.2009.08.070; Wilkoff BL, 1999, J AM COLL CARDIOL, V33, P1671, DOI 10.1016/S0735-1097(99)00074-1; Wilkoff BL, 2011, HEART RHYTHM, V8, P65, DOI 10.1016/j.hrthm.2010.10.002	38	216	219	2	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2017	376	8					755	764		10.1056/NEJMoa1603265	http://dx.doi.org/10.1056/NEJMoa1603265			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JO	28225684	Green Published, Bronze			2022-12-28	WOS:000395627900008
J	Hawkes, N				Hawkes, Nigel			Sixty seconds on ... the full course	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Saam M, EVALUATION ANTIBIOTI	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2017	356								j894	10.1136/bmj.j894	http://dx.doi.org/10.1136/bmj.j894			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KS	28223272				2022-12-28	WOS:000395631000012
J	Hurley, R				Hurley, Richard			WAR ON DRUGS US surgeon general: doctors have central role in solving opioid epidemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rhurley@bmj.com						Godlee F, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6067; Office of the Surgeon General, 2016, FAC ADD AM SURG GEN; US Surgeon General's Advisory Committee on Smoking and Health, 1964, SMOK AND HLTH	3	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	2017	356								j715	10.1136/bmj.j715	http://dx.doi.org/10.1136/bmj.j715			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GM	28202432				2022-12-28	WOS:000394579700005
J	Yek, C; Gupta, A; Mauskar, M				Yek, Christina; Gupta, Arjun; Mauskar, Melissa			Fever and a Pustular Rash	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GENERALIZED EXANTHEMATOUS PUSTULOSIS; AGEP; PSORIASIS; SPECTRUM		[Yek, Christina; Gupta, Arjun] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Mauskar, Melissa] Univ Texas Southwestern Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gupta, A (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	guptaarjun90@gmail.com						Britschgi M, 2002, CURR OPIN ALLERGY CL, V2, P325, DOI 10.1097/00130832-200208000-00006; Choudhary Sonal, 2013, J Clin Aesthet Dermatol, V6, P31; Halevy S, 2010, BRIT J DERMATOL, V163, P1245, DOI 10.1111/j.1365-2133.2010.09967.x; Hotz C, 2013, BRIT J DERMATOL, V169, P1223, DOI 10.1111/bjd.12502; Kardaun SH, 2010, J CUTAN PATHOL, V37, P1220, DOI 10.1111/j.1600-0560.2010.01612.x; Navarini AA, 2013, J INVEST DERMATOL, V133, P1904, DOI 10.1038/jid.2013.44; Robinson A, 2012, J AM ACAD DERMATOL, V67, P279, DOI 10.1016/j.jaad.2011.01.032; Sidoroff A, 2007, BRIT J DERMATOL, V157, P989, DOI 10.1111/j.1365-2133.2007.08156.x; Sidoroff A, 2001, J CUTAN PATHOL, V28, P113, DOI 10.1034/j.1600-0560.2001.028003113.x; Thienvibul C, 2015, DERMAT RES PRACT, V2015, DOI 10.1155/2015/260928	10	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2017	317	6					637	638		10.1001/jama.2016.18020	http://dx.doi.org/10.1001/jama.2016.18020			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8LI	28196232				2022-12-28	WOS:000394870900019
J	Cho, A				Cho, Adrian			Debate heats up over black holes as dark matter	SCIENCE			English	News Item																			0	2	2	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					560	560		10.1126/science.355.6325.560	http://dx.doi.org/10.1126/science.355.6325.560			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK0SF	28183921				2022-12-28	WOS:000393636700012
J	Aravanis, AM; Lee, M; Klausner, RD				Aravanis, Alexander M.; Lee, Mark; Klausner, Richard D.			Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection	CELL			English	Editorial Material							SERVICES TASK-FORCE; PLASMA	Curative therapies are most successful when cancer is diagnosed and treated at an early stage. We advocate that technological advances in next-generation sequencing of circulating, tumor-derived nucleic acids hold promise for addressing the challenge of developing safe and effective cancer screening tests.	[Aravanis, Alexander M.; Lee, Mark; Klausner, Richard D.] GRAIL, Menlo Pk, CA 94402 USA		Klausner, RD (corresponding author), GRAIL, Menlo Pk, CA 94402 USA.	klausner.rick@gmail.com						Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Alexandrov LB, 2015, NAT GENET, V47, P1402, DOI 10.1038/ng.3441; Berry DA, 2014, CANCER-AM CANCER SOC, V120, P2784, DOI 10.1002/cncr.28795; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Chan KCA, 2013, P NATL ACAD SCI USA, V110, P18761, DOI 10.1073/pnas.1313995110; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Cho Hyunsoon, 2014, Journal of the National Cancer Institute Monographs, P187, DOI 10.1093/jncimonographs/lgu014; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Nelson HD, 2016, ANN INTERN MED, V164, P256, DOI 10.7326/M15-0970; Nelson HD, 2016, ANN INTERN MED, V164, P226, DOI 10.7326/M15-0971; Thress KS, 2015, LUNG CANCER, V90, P509, DOI 10.1016/j.lungcan.2015.10.004; Tie J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6219; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764	15	219	230	3	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2017	168	4					571	574		10.1016/j.cell.2017.01.030	http://dx.doi.org/10.1016/j.cell.2017.01.030			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8VJ	28187279	Bronze			2022-12-28	WOS:000396277600008
J	Rosen, J				Rosen, Julia			Arctic 2.0: What happens after all the ice goes?	NATURE			English	News Item							SEA-ICE											Bronen Robin, 2013, CLIMATE INDUCED DISP; Desch S.J., 2017, EARTHS FUTURE; Hamilton SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113746; Huard D., 2013, WWF LAST ICE AREA TE; Lam VWY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32607; Li C, 2013, J CLIMATE, V26, P5624, DOI 10.1175/JCLI-D-12-00492.1; Newton R, 2016, EARTHS FUTURE, V4, P396, DOI 10.1002/2016EF000356; Overland JE, 2013, GEOPHYS RES LETT, V40, P2097, DOI 10.1002/grl.50316; Polyak L, 2010, QUATERNARY SCI REV, V29, P1757, DOI 10.1016/j.quascirev.2010.02.010; Vihma T, 2014, SURV GEOPHYS, V35, P1175, DOI 10.1007/s10712-014-9284-0	10	11	11	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					152	154		10.1038/542152a	http://dx.doi.org/10.1038/542152a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK2DJ	28179679	Bronze			2022-12-28	WOS:000393737500011
J	Paz-Bailey, G; Rosenberg, ES; Doyle, K; Munoz-Jordan, J; Santiago, GA; Klein, L; Perez-Padilla, J; Medina, FA; Waterman, SH; Adams, LE; Lozier, MJ; Bertran-Pasarell, J; Gubern, CG; Alvarado, LI; Sharp, TM				Paz-Bailey, Gabriela; Rosenberg, Eli S.; Doyle, Kate; Munoz-Jordan, Jorge; Santiago, Gilberto A.; Klein, Liore; Perez-Padilla, Janice; Medina, Freddy A.; Waterman, Stephen H.; Adams, Laura E.; Lozier, Matthew J.; Bertran-Pasarell, Jorge; Garcia Gubern, Carlos; Alvarado, Luisa, I; Sharp, Tyler M.			Persistence of Zika Virus in Body Fluids-Final Report	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MALE SEXUAL TRANSMISSION; UNITED-STATES; INFECTION; SEMEN; PREVENTION; TRAVELERS; DISEASE; AREAS; BORNE; RISK	BACKGROUND To estimate the frequency and duration of detectable Zika virus (ZIKV) RNA in human body fluids, we prospectively assessed a cohort of recently infected participants in Puerto Rico. METHODS We evaluated samples obtained from 295 participants (including 94 men who provided semen specimens) in whom ZIKV RNA was detected on reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay in urine or blood at an enhanced arboviral clinical surveillance site. We collected serum, urine, saliva, semen, and vaginal secretions weekly for the first month and at 2, 4, and 6 months. All specimens were tested by means of RT-PCR, and serum was tested with the use of anti-ZIKV IgM enzyme-linked immunosorbent assay. Among the participants with ZIKV RNA in any specimen at week 4, collection continued every 2 weeks thereafter until all specimens tested negative. We used parametric Weibull regression models to estimate the time until the loss of ZIKV RNA detection in each body fluid and reported the findings in medians and 95th percentiles. RESULTS The medians and 95th percentiles for the time until the loss of ZIKV RNA detection were 15 days (95% confidence interval [CI], 14 to 17) and 41 days (95% CI, 37 to 44), respectively, in serum; 11 days (95% CI, 9 to 12) and 34 days (95% CI, 30 to 38) in urine; and 42 days (95% CI, 35 to 50) and 120 days (95% CI, 100 to 139) in semen. Less than 5% of participants had detectable ZIKV RNA in saliva or vaginal secretions. CONCLUSIONS The prolonged time until ZIKV RNA clearance in serum in this study may have implications for the diagnosis and prevention of ZIKV infection. In 95% of the men in this study, ZIKV RNA was cleared from semen after approximately 4 months.	[Paz-Bailey, Gabriela; Munoz-Jordan, Jorge; Santiago, Gilberto A.; Perez-Padilla, Janice; Medina, Freddy A.; Waterman, Stephen H.; Adams, Laura E.; Lozier, Matthew J.; Sharp, Tyler M.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Doyle, Kate] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis Sexually Transm, Atlanta, GA USA; [Rosenberg, Eli S.] SUNY Albany, Sch Publ Hlth, Dept Epidemiol & Biostat, Albany, NY USA; [Klein, Liore] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Bertran-Pasarell, Jorge] Auxilio Mutuo Hosp, San Juan, PR 00919 USA; [Garcia Gubern, Carlos; Alvarado, Luisa, I] Ponce Hlth Sci Univ, Sch Med, St Lukes Episcopal Hosp Consortium, Ponce, PR USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; Ponce Health Sciences University	Paz-Bailey, G (corresponding author), Ctr Dis Control & Prevent, 1324 Calle Canada, San Juan, PR 00920 USA.	gmb5@cdc.gov			Centers for Disease Control and Prevention; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the Centers for Disease Control and Prevention.	[Anonymous], 2016, ZIK VIR EM AUTH EM U; [Anonymous], 2016, ZIK VIR EM US AUTH E; Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6; Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967; Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2; Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2; Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2; Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Centers for Disease Control and Prevention, 2017, GUID US LAB TEST ZIK; Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611; D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449; Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2; Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3; Duggal NK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22840-6; Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3; Feldmann H, 2018, NEW ENGL J MED, V378, P1440, DOI 10.1056/NEJMe1803212; Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254; Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618; Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070; Garcia-Bujalance S, 2017, J CLIN VIROL, V96, P110, DOI 10.1016/j.jcv.2017.10.006; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2; Huits R, 2017, B WORLD HEALTH ORGAN, V95, P802, DOI [10.2471/BLT.17.181370, 10.2471/blt.17.181370]; Hunsperger EA, 2016, J INFECT DIS, V214, P836, DOI 10.1093/infdis/jiw103; Iannetta M, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.34.30600; Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9; Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]; Medina FA, 2018, J INFECT DIS; Mohammed H, 2012, TRANSFUSION, V52, P1652, DOI 10.1111/j.1537-2995.2011.03492.x; Munoz-Jordan JL, 2017, J INFECT DIS, V216, pS951, DOI 10.1093/infdis/jix502; Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761; Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021; Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314; Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280; Perez S, 2016, EUROSURVEILLANCE, V21, P1, DOI 10.2807/1560-7917.ES.2016.21.24.30261; Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769; Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2; Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6; Roze Benoit, 2016, Euro Surveill, V21, P30154, DOI 10.2807/1560-7917.ES.2016.21.9.30154; Sanchez-Montalva A, 2018, TROP MED INT HEALTH, V23, P92, DOI 10.1111/tmi.13019; Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1; Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476; TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053; Tomashek KM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005859; Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9; Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148; Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3	53	85	87	0	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2018	379	13					1234	1243		10.1056/NEJMoa1613108	http://dx.doi.org/10.1056/NEJMoa1613108			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV1KS	28195756	Green Accepted, Bronze			2022-12-28	WOS:000445835100008
J	Pan, YD; Tian, T; Park, CO; Lofftus, SY; Mei, SL; Liu, X; Luo, C; O'Malley, JT; Gehad, A; Teague, JE; Divito, SJ; Fuhlbrigge, R; Puigserver, P; Krueger, JG; Hotamisligil, GS; Clark, RA; Kupper, TS				Pan, Youdong; Tian, Tian; Park, Chang Ook; Lofftus, Serena Y.; Mei, Shenglin; Liu, Xing; Luo, Chi; O'Malley, John T.; Gehad, Ahmed; Teague, Jessica E.; Divito, Sherrie J.; Fuhlbrigge, Robert; Puigserver, Pere; Krueger, James G.; Hotamisligil, Goekhan S.; Clark, Rachael A.; Kupper, Thomas S.			Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism	NATURE			English	Article							FATTY-ACID OXIDATION; SKIN; IMMUNITY; INFECTION; IMMUNIZATION; RESPONSES; TRIGGER; VIRUS; IL-15	Tissue-resident memory T (T-RM) cells persist indefinitely in epithelial barrier tissues and protect the host against pathogens(1-4). However, the biological pathways that enable the long-term survival of T-RM cells are obscure(4,5). Here we show that mouse CD8(+) T-RM cells generated by viral infection of the skin differentially express high levels of several molecules that mediate lipid uptake and intracellular transport, including fatty-acid-binding proteins 4 and 5 (FABP4 and FABP5). We further show that T-cell-specific deficiency of Fabp4 and Fabp5 (Fabp4/Fabp5) impairs exogenous free fatty acid (FFA) uptake by CD8(+) T-RM cells and greatly reduces their long-term survival in vivo, while having no effect on the survival of central memory T (T-CM) cells in lymph nodes. In vitro, CD8(+) T-RM cells, but not CD8(+) T-CM cells, demonstrated increased mitochondrial oxidative metabolism in the presence of exogenous FFAs; this increase was not seen in Fabp4/Fabp5 double-knockout CD8(+) T-RM cells. The persistence of CD8(+) T-RM cells in the skin was strongly diminished by inhibition of mitochondrial FFA beta-oxidation in vivo. Moreover, skin CD8(+) T-RM cells that lacked Fabp4/Fabp5 were less effective at protecting mice from cutaneous viral infection, and lung Fabp4/Fabp5 double-knockout CD8(+) T-RM cells generated by skin vaccinia virus (VACV) infection were less effective at protecting mice from a lethal pulmonary challenge with VACV. Consistent with the mouse data, increased FABP4 and FABP5 expression and enhanced extracellular FFA uptake were also demonstrated in human CD8(+) T-RM cells in normal and psoriatic skin. These results suggest that FABP4 and FABP5 have a critical role in the maintenance, longevity and function of CD8(+) T-RM cells, and suggest that CD8(+) T-RM cells use exogenous FFAs and their oxidative metabolism to persist in tissue and to mediate protective immunity.	[Pan, Youdong; Tian, Tian; Park, Chang Ook; Lofftus, Serena Y.; O'Malley, John T.; Gehad, Ahmed; Teague, Jessica E.; Divito, Sherrie J.; Fuhlbrigge, Robert; Clark, Rachael A.; Kupper, Thomas S.] Harvard Med Sch Boston, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Pan, Youdong; Tian, Tian; Park, Chang Ook; Lofftus, Serena Y.; Mei, Shenglin; O'Malley, John T.; Gehad, Ahmed; Teague, Jessica E.; Divito, Sherrie J.; Fuhlbrigge, Robert; Clark, Rachael A.; Kupper, Thomas S.] Harvard Med Sch, Brigham & Womens Hosp, Harvard Skin Dis Res Ctr, Boston, MA 02115 USA; [Mei, Shenglin] Dana Farber Canc Inst, Ctr Funct Epigenet, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Liu, Xing] Harvard Med Sch, Boston Childrens Hosp, Dept Pediat, Program Cellular & Mol Med, Boston, MA USA; [Luo, Chi; Puigserver, Pere] Harvard Med Sch, Dana Farber Canc Inst, Dept Cell Biol, Dept Canc Biol, Boston, MA USA; [Krueger, James G.] Rockefeller Univ, Dept Dermatol, New York, NY USA; [Hotamisligil, Goekhan S.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Clark, Rachael A.; Kupper, Thomas S.] Dana Farber Brigham & Womens Canc Ctr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Rockefeller University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute	Kupper, TS (corresponding author), Harvard Med Sch Boston, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA.; Kupper, TS (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Harvard Skin Dis Res Ctr, Boston, MA 02115 USA.; Kupper, TS (corresponding author), Dana Farber Brigham & Womens Canc Ctr, Boston, MA 02115 USA.	tkupper@bwh.harvard.edu	Kupper, Thomas/O-4962-2019; Mei, Shenglin/O-6108-2019	LUO, CHI/0000-0001-7669-9506	NIH [R01AI041707, R01AI127654, TR01AI097128, R01AR063962]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C1799]; NATIONAL CANCER INSTITUTE [R01CA203721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097128, R01AI041707, R01AI127654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR069625, R01AR063962, P30AR042689, R01AR065807] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD023091] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Moss (US National Institute of Health (NIH)) for providing rVACV expressing the OT-I T cell epitope OVA257-264, as well as WR-VACV. This work was supported by NIH grants R01AI041707 (T.S.K.), R01AI127654 (T.S.K.), TR01AI097128 (T.S.K. and R.A.C.) and R01AR063962 (R.A.C.). C.O.P. was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI14C1799).	Adachi T, 2015, NAT MED, V21, P1272, DOI 10.1038/nm.3962; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Cheuk S, 2014, J IMMUNOL, V192, P3111, DOI 10.4049/jimmunol.1302313; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Clark RA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010641; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; Gaide O, 2015, NAT MED, V21, P647, DOI 10.1038/nm.3860; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Hotamisligil GS, 2015, NAT REV ENDOCRINOL, V11, P592, DOI 10.1038/nrendo.2015.122; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kantor PF, 2000, CIRC RES, V86, P580, DOI 10.1161/01.RES.86.5.580; Khnykin D, 2011, DERM-ENDOCRINOL, V3, P53, DOI 10.4161/derm.3.2.14816; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Nomura M, 2016, NAT IMMUNOL, V17, P216, DOI 10.1038/ni.3366; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; Rogue A, 2010, PPAR RES, V2010, DOI 10.1155/2010/325183; Sanz P, 1999, P NATL ACAD SCI USA, V96, P2692, DOI 10.1073/pnas.96.6.2692; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; van der Windt Gerritje J W, 2016, Curr Protoc Immunol, V113, DOI 10.1002/0471142735.im0316bs113; Zhang YW, 2015, IMMUNITY, V42, P953, DOI 10.1016/j.immuni.2015.04.016	30	358	367	12	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					252	+		10.1038/nature21379	http://dx.doi.org/10.1038/nature21379			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0GQ	28219080	Green Accepted			2022-12-28	WOS:000395688700041
J	Mordmuller, B; Surat, G; Lagler, H; Chakravarty, S; Ishizuka, AS; Lalremruata, A; Gmeiner, M; Campo, JJ; Esen, M; Ruben, AJ; Held, J; Calle, CL; Mengue, JB; Gebru, T; Ibanez, J; Sulyok, M; James, ER; Billingsley, PF; Kc, N; Manoj, A; Murshedkar, T; Gunasekera, A; Appen, AGE; Li, T; Stafford, RE; Li, ML; Felgner, PL; Seder, RA; Richie, TL; Sim, BKL; Hoffman, SL; Kremsner, PG				Mordmueller, Benjamin; Surat, Guezin; Lagler, Heimo; Chakravarty, Sumana; Ishizuka, Andrew S.; Lalremruata, Albert; Gmeiner, Markus; Campo, Joseph J.; Esen, Meral; Ruben, Adam J.; Held, Jana; Calle, Carlos Lamsfus; Mengue, Juliana B.; Gebru, Tamirat; Ibanez, Javier; Sulyok, Mihaly; James, Eric R.; Billingsley, Peter F.; Kc, Natasha; Manoj, Anita; Murshedkar, Tooba; Gunasekera, Anusha; Appen, Abraham G. E.; Li, Tao; Stafford, Richard E.; Li, Minglin; Felgner, Phil L.; Seder, Robert A.; Richie, Thomas L.; Sim, B. Kim Lee; Hoffman, Stephen L.; Kremsner, Peter G.			Sterile protection against human malaria by chemoattenuated PfSPZ vaccine	NATURE			English	Article							PLASMODIUM-FALCIPARUM SPOROZOITES; DIRECT VENOUS INOCULATION; CD8+ T-CELLS; LIVER-STAGE; CHLOROQUINE PROPHYLAXIS; HUMAN VOLUNTEERS; IMMUNIZATION; IMMUNITY; INFECTION; ANTIBODIES	A highly protective malaria vaccine would greatly facilitate the prevention and elimination of malaria and containment of drug-resistant parasites(1). A high level (more than 90%) of protection against malaria in humans has previously been achieved only by immunization with radiation-attenuated Plasmodium falciparum (Pf) sporozoites (PfSPZ) inoculated by mosquitoes(2-4); by intravenous injection of aseptic, purified, radiation-attenuated, cryopreserved PfSPZ ('PfSPZ Vaccine')(5,6); or by infectious PfSPZ inoculated by mosquitoes to volunteers taking chloroquine(7-10) or mefloquine(11) (chemoprophylaxis with sporozoites). We assessed immunization by direct venous inoculation of aseptic, purified, cryopreserved, non-irradiated PfSPZ ('PfSPZ Challenge'(12,13)) to malaria-naive, healthy adult volunteers taking chloroquine for antimalarial chemoprophylaxis (vaccine approach denoted as PfSPZ-CVac)(14). Three doses of 5.12 x 10(4) PfSPZ of PfSPZ Challenge(12,13) at 28-day intervals were well tolerated and safe, and prevented infection in 9 out of 9 (100%) volunteers who underwent controlled human malaria infection ten weeks after the last dose (group III). Protective efficacy was dependent on dose and regimen. Immunization with 3.2 x 10(3) (group I) or 1.28 x 10(4) (group II) PfSPZ protected 3 out of 9 (33%) or 6 out of 9 (67%) volunteers, respectively. Three doses of 5.12 x 10(4) PfSPZ at five-day intervals protected 5 out of 8 (63%) volunteers. The frequency of Pf-specific polyfunctional CD4 memory T cells was associated with protection. On a 7,455 peptide Pf proteome array, immune sera from at least 5 out of 9 group III vaccinees recognized each of 22 proteins. PfSPZ-CVac is a highly efficacious vaccine candidate; when we are able to optimize the immunization regimen (dose, interval between doses, and drug partner), this vaccine could be used for combination mass drug administration and a mass vaccination program approach to eliminate malaria from geographically defined areas.	[Mordmueller, Benjamin; Surat, Guezin; Lagler, Heimo; Lalremruata, Albert] Univ Tubingen, Inst Trop Med, Partner Site, D-72074 Tubingen, Germany; [Gmeiner, Markus; Held, Jana; Gebru, Tamirat; James, Eric R.] German Ctr Infect Res, Partner Site, D-72074 Tubingen, Germany; [Chakravarty, Sumana; Billingsley, Peter F.; Murshedkar, Tooba; Hoffman, Stephen L.] Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med, A-1090 Vienna, Austria; [Seder, Robert A.] Sanaria Inc, Rockville, MD 20850 USA; [Gmeiner, Markus; Ibanez, Javier; James, Eric R.; Kc, Natasha] NIAID, NIH, Vaccine Res Ctr VRC, Bethesda, MD 20892 USA; [Billingsley, Peter F.; Kc, Natasha] Antigen Discovery Inc, Irvine, CA 92618 USA; [Campo, Joseph J.; Mengue, Juliana B.; James, Eric R.; Manoj, Anita] Protein Potential LLC, Rockville, MD 20850 USA; [Ishizuka, Andrew S.; Calle, Carlos Lamsfus; Appen, Abraham G. E.; Li, Tao] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA	Eberhard Karls University of Tubingen; German Center for Infection Research; Medical University of Vienna; Sanaria Inc.; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California Irvine	Hoffman, SL (corresponding author), Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med, A-1090 Vienna, Austria.	slhoffman@sanaria.com	Mordmüller, Benjamin/A-5749-2010; Lalremruata, Albert/S-6453-2019; Held, Jana/AAO-5823-2021; Held, Jana/L-7827-2013	Mordmüller, Benjamin/0000-0001-9101-2768; Lalremruata, Albert/0000-0002-4692-7835; Held, Jana/0000-0002-7970-1429; Held, Jana/0000-0002-7970-1429; Lagler, Heimo/0000-0003-3240-7385; Lamsfus Calle, Carlos/0000-0002-6766-1765; Ishizuka, Andrew/0000-0002-3024-7536; Woldearegai, Tamirat Gebru/0000-0001-9508-1787; Sulyok, Mihaly/0000-0002-6960-5126; Gmeiner, Markus/0000-0002-1450-2955; Richie, Thomas/0000-0002-2946-5456; Ibanez, Javier/0000-0001-6215-6332	German Federal Ministry of Education and Research (BMBF) through the German Center for Infection Research (DZIF); National Institute of Allergy and Infectious Diseases of the National Institutes of Health under SBIR [5R44AI058375, 5R44AI055229]; intramural research program of the VRC, NIAID, NIH; NIAID SBIR [5R44AI066791]; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI058375, R43AI055229, ZIAAI005107] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research (BMBF) through the German Center for Infection Research (DZIF); National Institute of Allergy and Infectious Diseases of the National Institutes of Health under SBIR; intramural research program of the VRC, NIAID, NIH; NIAID SBIR; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the vaccine trial participants for their contribution and commitment to vaccine research. We thank F. Adomat, S. Adukpo, M. Aldejohann, S. Bolte, S. Borrmann, A. Bouyoukou Hounkpatin, S. Bruckner, E. Bruske, J. Fernandes, P. Granados Bayon, J. Hass, S. Jeyaraj, J. Keim, A. Knoblich, R. Kollner, A. Kreidenweiss, D. N. Ndungu, R. Ritter, J. A. Selvaraj, Z. Sulyok, S. Theil, N. Theurer, and I. Westermann for support in conducting the trial, and P. Darrah and M. Roederer for assistance with the interpretation of the T-cell data. We thank the Sanaria and Protein Potential teams for manufacture and shipping of investigational products, PfSPZ Challenge and diluents, regulatory, quality, and clinical site activities, and legal and administrative support, including especially D. Cheney (nee Padilla), Y. Abebe, E. Saverino, Y. Wu, E. Fomumbod, A. Awe, M. King, M. Orozco, A. Patil, Y. Wen, K. Nelson, J. Overby, S. Matheny, V. Pitch, B. Jiang, L. Gao, R. Xu, T. T. Wai, S. Monsheimer, P. De La Vega, M. Laskowski, H. Huang, M. Marquette, J. Jackson, F. Beams, R. Douglas, R. C. Thompson, D. Dolberg and A. Hoffman. We thank J. Inglese and P. Dranchak of the National Center for Advancing Translational Sciences (NCATS), NIH for support with the automated immunofluorescence assay and inhibition of sporozoite invasion assays. We appreciate the expert reviews of the Safety Monitoring Committee (W. Chen, P. Coyne and P. Zanger). The clinical trial was funded by the German Federal Ministry of Education and Research (BMBF) through the German Center for Infection Research (DZIF). Manufacture of investigational product by Sanaria was supported in part by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under SBIR award numbers 5R44AI058375 and 5R44AI055229. T cell studies were supported by the intramural research program of the VRC, NIAID, NIH. Proteome microarray studies were supported by NIAID SBIR grant 5R44AI066791 and funding from the Bill & Melinda Gates Foundation.	Bastiaens GJH, 2016, AM J TROP MED HYG, V94, P663, DOI 10.4269/ajtmh.15-0621; BEAUDOIN RL, 1977, EXP PARASITOL, V42, P1, DOI 10.1016/0014-4894(77)90054-6; Behet MC, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-136; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Bijker EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112910; Bijker EM, 2014, J INFECT DIS, V210, P1605, DOI 10.1093/infdis/jiu293; Bijker EM, 2013, P NATL ACAD SCI USA, V110, P7862, DOI 10.1073/pnas.1220360110; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; EGAN JE, 1993, AM J TROP MED HYG, V49, P166, DOI 10.4269/ajtmh.1993.49.166; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Epstein JE, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89154; FAIRLEY BNH, 1945, T ROY SOC TROP MED H, V38, P311, DOI 10.1016/0035-9203(45)90038-1; Felgner PL, 2013, SCI REP-UK, V3, DOI 10.1038/srep03549; Fernandez-Ruiz D, 2016, IMMUNITY, V45, P889, DOI 10.1016/j.immuni.2016.08.011; Gomez-Perez GP, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0817-x; GUERINMARCHAND C, 1987, NATURE, V329, P164, DOI 10.1038/329164a0; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Ishizuka AS, 2016, NAT MED, V22, P614, DOI 10.1038/nm.4110; Kamau E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071539; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Lyke K., P NATL ACAD IN PRESS; malERA Consultative Group on Vaccines, 2011, PLoS Med, V8, pe1000398, DOI 10.1371/journal.pmed.1000398; Mordmuller B, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0628-0; Orito Y, 2013, MOL MICROBIOL, V87, P66, DOI 10.1111/mmi.12083; Planche T, 2001, AM J TROP MED HYG, V65, P599, DOI 10.4269/ajtmh.2001.65.599; Richie TL, 2015, VACCINE, V33, P7452, DOI 10.1016/j.vaccine.2015.09.096; RIECKMANN KH, 1974, T ROY SOC TROP MED H, V68, P258, DOI 10.1016/0035-9203(74)90129-1; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Roestenbeng M, 2013, AM J TROP MED HYG, V88, P5, DOI 10.4269/ajtmh.2012.12-0613; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Sahu T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00283; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; Schats R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124243; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Sissoko M. S., LANCET INFE IN PRESS; SUHRBIER A, 1990, INFECT IMMUN, V58, P2834, DOI 10.1128/IAI.58.9.2834-2839.1990; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; Team RC., 2013, R LANG ENV STAT COMP; Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573	45	238	242	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2017	542	7642					445	+		10.1038/nature21060	http://dx.doi.org/10.1038/nature21060			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM1RG	28199305				2022-12-28	WOS:000395094100029
J	Westhorpe, F; Tiengwe, C; Hunsberger, H; Jain, G; Wells, M; Yu, MG; Bogdanovic, O; Absalon, S; Sen, P; Madrigal, P; Natarajan, K				Westhorpe, Frederic; Tiengwe, Calvin; Hunsberger, Holly; Jain, Gaurav; Wells, Michael; Yu, Megan; Bogdanovic, Ozren; Absalon, Sabrina; Sen, Payel; Madrigal, Pedro; Natarajan, Kedar			Postdocs, What Would You Tell Your Younger Self?	CELL			English	Editorial Material									[Westhorpe, Frederic] Stanford Univ, Stanford, CA 94305 USA; [Tiengwe, Calvin] SUNY Buffalo, Buffalo, NY USA; [Hunsberger, Holly] Columbia Univ, Med Ctr, New York, NY 10027 USA; [Jain, Gaurav] NYU, New York, NY 10003 USA; [Yu, Megan] Univ Virginia, Charlottesville, VA 22903 USA; [Bogdanovic, Ozren] Univ Western Australia, Nedlands, WA, Australia; [Absalon, Sabrina] Boston Childrens Hosp, Boston, MA USA; [Absalon, Sabrina] Harvard Med Sch, Boston, MA USA; [Sen, Payel] Univ Penn, Philadelphia, PA 19104 USA; [Madrigal, Pedro] Univ Cambridge, Cambridge, England; [Natarajan, Kedar] Wellcome Trust Sanger Inst, Hinxton, England; [Natarajan, Kedar] European Bioinformat Inst, Hinxton, England	Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Columbia University; New York University; University of Virginia; University of Western Australia; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Pennsylvania; University of Cambridge; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL)	Westhorpe, F (corresponding author), Stanford Univ, Stanford, CA 94305 USA.		Bogdanovic, Ozren/ABG-9527-2020; Sen, Payel/AAY-6834-2020; Madrigal, Pedro/AAG-8543-2019; Tiengwe, Calvin/AAH-6658-2020; Hunsberger, Holly/GON-5793-2022	Bogdanovic, Ozren/0000-0001-5680-0056; Tiengwe, Calvin/0000-0002-3742-6502; Madrigal, Pedro/0000-0003-1959-8199; Natarajan, Kedar Nath/0000-0002-9264-1280					0	0	0	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					745	748						4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28235189	Bronze			2022-12-28	WOS:000396284800002
J	Aldridge, S				Aldridge, Stephen			Michael John Aldridge OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2017	356								j808	10.1136/bmj.j808	http://dx.doi.org/10.1136/bmj.j808			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GP	28213535				2022-12-28	WOS:000394580000005
J	Emdin, CA; Khera, AV; Natarajan, P; Klarin, D; Zekavat, SM; Hsiao, AJ; Kathiresan, S				Emdin, Connor A.; Khera, Amit V.; Natarajan, Pradeep; Klarin, Derek; Zekavat, Seyedeh M.; Hsiao, Allan J.; Kathiresan, Sekar			Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; GENOME-WIDE ASSOCIATION; MENDELIAN RANDOMIZATION; LARGE-SCALE; CARDIOVASCULAR-DISEASE; COMPUTED-TOMOGRAPHY; BIOLOGICAL PATHWAYS; FAT DISTRIBUTION; ARTERY-DISEASE; RISK	Importance In observational studies, abdominal adiposity has been associated with type 2 diabetes and coronary heart disease (CHD). Whether these associations represent causal relationships remains uncertain. Objective To test the association of a polygenic risk score for waist-to-hip ratio (WHR) adjusted for body mass index (BMI), a measure of abdominal adiposity, with type 2 diabetes and CHD through the potential intermediates of blood lipids, blood pressure, and glycemic phenotypes. Design, Setting, and Participants A polygenic risk score for WHR adjusted for BMI, a measure of genetic predisposition to abdominal adiposity, was constructed with 48 single-nucleotide polymorphisms. The association of this score with cardiometabolic traits, type 2 diabetes, and CHD was tested in a mendelian randomization analysis that combined case-control and cross-sectional data sets. Estimates for cardiometabolic traits were based on a combined data set consisting of summary results from 4 genome-wide association studies conducted from 2007 to 2015, including up to 322 154 participants, as well as individual-level, cross-sectional data from the UK Biobank collected from 2007-2011, including 111 986 individuals. Estimates for type 2 diabetes and CHD were derived from summary statistics of 2 separate genome-wide association studies conducted from 2007 to 2015 and including 149 821 individuals and 184 305 individuals, respectively, combined with individual-level data from the UK Biobank. Exposures Genetic predisposition to increased WHR adjusted for BMI. Main Outcomes and Measures Type 2 diabetes and CHD. Results Among 111 986 individuals in the UK Biobank, the mean age was 57 (SD, 8) years, 58 845 participants (52.5%) were women, and mean WHR was 0.875. Analysis of summary-level genome-wide association study results and individual-level UK Biobank data demonstrated that a 1-SD increase in WHR adjusted for BMI mediated by the polygenic risk score was associated with 27-mg/dL higher triglyceride levels, 4.1-mg/dL higher 2-hour glucose levels, and 2.1-mm Hg higher systolic blood pressure (each P < .001). A 1-SD genetic increase in WHR adjusted for BMI was also associated with a higher risk of type 2 diabetes (odds ratio, 1.77 [95% CI, 1.57-2.00]; absolute risk increase per 1000 participant-years, 6.0 [95% CI, CI, 4.4-7.8]; number of participants with type 2 diabetes outcome, 40 530) and CHD (odds ratio, 1.46 [95% CI, 1.32-1.62]; absolute risk increase per 1000 participant-years, 1.8 [95% CI, 1.3-2.4]; number of participants with CHD outcome, 66 440). Conclusions and Relevance A genetic predisposition to higher waist-to-hip ratio adjusted for body mass index was associated with increased risk of type 2 diabetes and coronary heart disease. These results provide evidence supportive of a causal association between abdominal adiposity and these outcomes.	[Emdin, Connor A.; Khera, Amit V.; Natarajan, Pradeep; Klarin, Derek; Zekavat, Seyedeh M.; Kathiresan, Sekar] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA USA; [Emdin, Connor A.; Khera, Amit V.; Natarajan, Pradeep; Klarin, Derek; Zekavat, Seyedeh M.; Kathiresan, Sekar] Harvard Med Sch, Massachusetts Gen Hosp, Div Cardiol, Boston, MA USA; [Emdin, Connor A.; Khera, Amit V.; Natarajan, Pradeep; Klarin, Derek; Zekavat, Seyedeh M.; Kathiresan, Sekar] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Hsiao, Allan J.] MIT, Dept Econ, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Ctr Genom Med, 185 Cambridge St,CPZN 5-830, Boston, MA 02114 USA.	skathiresan1@mgh.harvard.edu	Zekavat, Seyedeh M/N-7570-2018; Natarajan, Pradeep/H-9764-2019	Zekavat, Seyedeh M/0000-0003-4026-8944; Natarajan, Pradeep/0000-0001-8402-7435; Klarin, Derek/0000-0002-4636-5780	Rhodes Trust; ACCF/Merck Cardiovascular Research Fellowship; John S. LaDue Memorial Fellowship in Cardiology; National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) [T32 HL007734]; Massachusetts General Hospital; Donovan Family Foundation; NIH [R01HL127564]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007734, R01HL127564] Funding Source: NIH RePORTER; Medical Research Council [MC_qA137853] Funding Source: researchfish	Rhodes Trust; ACCF/Merck Cardiovascular Research Fellowship; John S. LaDue Memorial Fellowship in Cardiology; National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Massachusetts General Hospital(General Electric); Donovan Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Dr Emdin is funded by the Rhodes Trust. Dr Khera is funded by an ACCF/Merck Cardiovascular Research Fellowship and a John S. LaDue Memorial Fellowship in Cardiology. Dr Klarin is supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) under award T32 HL007734. Dr Kathiresan is supported by the Ofer and Shelly Nemirovsky Research Scholar award from the Massachusetts General Hospital, the Donovan Family Foundation, and R01HL127564 from the NIH.	ASHWELL M, 1985, BRIT MED J, V290, P1692, DOI 10.1136/bmj.290.6483.1692; BarrettConnor E, 1997, CIRCULATION, V95, P252, DOI 10.1161/01.CIR.95.1.252; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Burgess S, 2014, EPIDEMIOLOGY, V25, P877, DOI 10.1097/EDE.0000000000000161; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Gupta M, 2006, CIRCULATION, V113, pE924, DOI 10.1161/CIRCULATIONAHA.105.583815; Han TS, 1998, INT J EPIDEMIOL, V27, P422, DOI 10.1093/ije/27.3.422; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6; Nordestgaard BG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001212; Pattaro C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10023; Pierce BL, 2011, INT J EPIDEMIOL, V40, P740, DOI 10.1093/ije/dyq151; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rodgers RJ, 2012, DIS MODEL MECH, V5, P621, DOI 10.1242/dmm.009621; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; SEIDELL JC, 1989, INT J OBESITY, V13, P289; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Stitziel NO, 2016, NEW ENGL J MED, V374, P1134, DOI 10.1056/NEJMoa1507652; Stock JH, 2002, J BUS ECON STAT, V20, P518, DOI 10.1198/073500102288618658; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; von Hinke S, 2016, J HEALTH ECON, V45, P131, DOI 10.1016/j.jhealeco.2015.10.007; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	32	205	211	4	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2017	317	6					626	634		10.1001/jama.2016.21042	http://dx.doi.org/10.1001/jama.2016.21042			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8LI	28196256	Green Accepted, Bronze			2022-12-28	WOS:000394870900017
J	Cohen, D				Cohen, Deborah			Roche asks WHO to remove Avastin from essential medicines list	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2017	356								j779	10.1136/bmj.j779	http://dx.doi.org/10.1136/bmj.j779			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GI	28193603				2022-12-28	WOS:000394579300009
J	Holder, CD				Holder, Curtis D.			Coping with class in science	SCIENCE			English	Editorial Material									[Holder, Curtis D.] Univ Colorado, Dept Geog & Environm Studies, Colorado Springs, CO 80907 USA	University of Colorado System; University of Colorado at Colorado Springs	Holder, CD (corresponding author), Univ Colorado, Dept Geog & Environm Studies, Colorado Springs, CO 80907 USA.			Holder, Curtis D./0000-0002-9149-8996					0	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					658	658		10.1126/science.355.6325.658	http://dx.doi.org/10.1126/science.355.6325.658			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK0SF	28183983				2022-12-28	WOS:000393636700053
J	Loken, E; Gelman, A				Loken, Eric; Gelman, Andrew			Measurement error and the replication crisis	SCIENCE			English	Editorial Material							NONDIFFERENTIAL MISCLASSIFICATION		[Loken, Eric] Univ Connecticut, Dept Educ Psychol, Storrs, CT 06269 USA; [Gelman, Andrew] Columbia Univ, Dept Stat, New York, NY 10027 USA; [Gelman, Andrew] Columbia Univ, Dept Polit Sci, New York, NY 10027 USA	University of Connecticut; Columbia University; Columbia University	Gelman, A (corresponding author), Columbia Univ, Dept Stat, New York, NY 10027 USA.; Gelman, A (corresponding author), Columbia Univ, Dept Polit Sci, New York, NY 10027 USA.	gelman@stat.columbia.edu			Office of Naval Research [N00014-15-1-2541]	Office of Naval Research(Office of Naval Research)	We thank the Office of Naval Research for grant N00014-15-1-2541.	[Anonymous], 2012, BOSTON REV; Gelman A, 2014, PERSPECT PSYCHOL SCI, V9, P641, DOI 10.1177/1745691614551642; Gelman A, 2014, AM SCI, V102, P460, DOI 10.1511/2014.111.460; Hausman J, 2001, J ECON PERSPECT, V15, P57, DOI 10.1257/jep.15.4.57; Jurek AM, 2005, INT J EPIDEMIOL, V34, P680, DOI 10.1093/ije/dyi060; Maner JK, 2016, J EXP SOC PSYCHOL, V66, P100, DOI 10.1016/j.jesp.2015.09.018; Messick S, 1987, ETS RES REPORT SERIE; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; WACHOLDER S, 1995, OCCUP ENVIRON MED, V52, P557, DOI 10.1136/oem.52.8.557	11	279	281	0	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					584	585		10.1126/science.aal3618	http://dx.doi.org/10.1126/science.aal3618			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK0SF	28183939				2022-12-28	WOS:000393636700030
J	Pala, C				Pala, Christopher			New Zealand's endemic dolphins are hanging by a thread	SCIENCE			English	News Item																			0	3	3	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					559	559		10.1126/science.355.6325.559	http://dx.doi.org/10.1126/science.355.6325.559			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK0SF	28183920				2022-12-28	WOS:000393636700011
J	Cubillos-Ruiz, JR; Bettigole, SE; Glimcher, LH				Cubillos-Ruiz, Juan R.; Bettigole, Sarah E.; Glimcher, Laurie H.			Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer	CELL			English	Review							UNFOLDED PROTEIN RESPONSE; PLASMA-CELL DIFFERENTIATION; TRANSCRIPTION FACTOR XBP1; ER-STRESS; BREAST-CANCER; DENDRITIC CELLS; MESSENGER-RNA; TUMOR-CELLS; INHIBITOR RESISTANCE; SIGNALING PATHWAYS	Malignant cells utilize diverse strategies that enable them to thrive under adverse conditions while simultaneously inhibiting the development of anti-tumor immune responses. Hostile microenvironmental conditions within tumor masses, such as nutrient deprivation, oxygen limitation, high metabolic demand, and oxidative stress, disturb the protein-folding capacity of the endoplasmic reticulum (ER), thereby provoking a cellular state of "ER stress." Sustained activation of ER stress sensors endows malignant cells with greater tumorigenic, metastatic, and drug-resistant capacity. Additionally, recent studies have uncovered that ER stress responses further impede the development of protective anti-cancer immunity by manipulating the function of myeloid cells in the tumor microenvironment. Here, we discuss the tumorigenic and immunoregulatory effects of ER stress in cancer, and we explore the concept of targeting ER stress responses to enhance the efficacy of standard chemotherapies and evolving cancer immunotherapies in the clinic.	[Cubillos-Ruiz, Juan R.] Weill Cornell Med, Dept Obstet & Gynecol, New York, NY 10065 USA; [Cubillos-Ruiz, Juan R.] Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA; [Bettigole, Sarah E.] Quentis Therapeut Inc, New York, NY 10016 USA; [Glimcher, Laurie H.] Harvard Med Sch, Dept Med, Boston, MA 02215 USA; [Glimcher, Laurie H.] Brigham & Womens Hosp, Boston, MA 02215 USA; [Glimcher, Laurie H.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02215 USA	Cornell University; Cornell University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute	Cubillos-Ruiz, JR (corresponding author), Weill Cornell Med, Dept Obstet & Gynecol, New York, NY 10065 USA.; Cubillos-Ruiz, JR (corresponding author), Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA.; Glimcher, LH (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02215 USA.; Glimcher, LH (corresponding author), Brigham & Womens Hosp, Boston, MA 02215 USA.; Glimcher, LH (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02215 USA.	jur2016@med.cornell.edu; laurie_glimcher@dfci.harvard.edu			Irvington Institute Fellowship Program of the Cancer Research Institute; Ann Schreiber Mentored Investigator Award of the Ovarian Cancer Research Fund Alliance; Ovarian Cancer Academy Early-Career Investigator Award of the Department of Defense [W81XWH-16-1-0438]; Stand Up to Cancer Innovative Research Grant [SU2C-AACR-1RG-03-16]; Clinic and Laboratory Integration Program of the Cancer Research Institute; Weill Cornell Medical College Funds; NIH [R01CA112663]; NATIONAL CANCER INSTITUTE [R01CA112663] Funding Source: NIH RePORTER	Irvington Institute Fellowship Program of the Cancer Research Institute; Ann Schreiber Mentored Investigator Award of the Ovarian Cancer Research Fund Alliance; Ovarian Cancer Academy Early-Career Investigator Award of the Department of Defense; Stand Up to Cancer Innovative Research Grant; Clinic and Laboratory Integration Program of the Cancer Research Institute; Weill Cornell Medical College Funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Our research was supported by the Irvington Institute Fellowship Program of the Cancer Research Institute (J.R.C.-R.), the Ann Schreiber Mentored Investigator Award of the Ovarian Cancer Research Fund Alliance (J.R.C.-R.), the Ovarian Cancer Academy Early-Career Investigator Award of the Department of Defense (W81XWH-16-1-0438 to J.R.C.-R.), Stand Up to Cancer Innovative Research Grant (SU2C-AACR-1RG-03-16 to J.R.C.-R.), the Clinic and Laboratory Integration Program of the Cancer Research Institute (J.R.C.-R.), Weill Cornell Medical College Funds (L.H.G.), and NIH grant R01CA112663 (L.H.G.). We apologize to colleagues whose work was not cited in this review due to space limitations. J.R.C.-R. and L.H.G. are co-founders of and scientific advisors for Quentis Therapeutics. S.E.B. is co-founder and employee of Quentis Therapeutics. L.H.G. also serves on the board of directors of and holds equity in Bristol-Myers Squibb.	Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Atkins C, 2013, CANCER RES, V73, P1993, DOI 10.1158/0008-5472.CAN-12-3109; Auf G, 2010, P NATL ACAD SCI USA, V107, P15553, DOI 10.1073/pnas.0914072107; Avivar-Valderas A, 2011, MOL CELL BIOL, V31, P3616, DOI 10.1128/MCB.05164-11; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Bartkowiak K, 2015, CANCER RES, V75, P5367, DOI 10.1158/0008-5472.CAN-14-3728; Bartkowiak K, 2010, J PROTEOME RES, V9, P3158, DOI 10.1021/pr100039d; Beck D, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003057; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bettigole SE, 2015, NAT IMMUNOL, V16, P829, DOI 10.1038/ni.3225; Bettigole SE, 2015, ANNU REV IMMUNOL, V33, P107, DOI 10.1146/annurev-immunol-032414-112116; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; Cao W, 2014, J IMMUNOL, V192, P2920, DOI 10.4049/jimmunol.1302801; Cerezo M, 2016, CANCER CELL, V29, P805, DOI 10.1016/j.ccell.2016.04.013; Chen L, 2009, BIOCHEM PHARMACOL, V78, P70, DOI 10.1016/j.bcp.2009.03.022; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Chitnis NS, 2012, MOL CELL, V48, P353, DOI 10.1016/j.molcel.2012.08.025; Condamine T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8943; Condamine T, 2014, J CLIN INVEST, V124, P2626, DOI 10.1172/JCI74056; Conejo-Garcia JR, 2016, PHARMACOL THERAPEUT, V164, P97, DOI 10.1016/j.pharmthera.2016.04.003; Corazzari M, 2015, CELL DEATH DIFFER, V22, P946, DOI 10.1038/cdd.2014.183; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Cubillos-Ruiz JR, 2012, CANCER RES, V72, P1683, DOI 10.1158/0008-5472.CAN-11-3160; Cubillos-Ruiz JR, 2009, FUTURE ONCOL, V5, P1189, DOI 10.2217/FON.09.101; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Dalton LE, 2013, BRIT J CANCER, V108, P1340, DOI 10.1038/bjc.2013.66; Davies MPA, 2008, INT J CANCER, V123, P85, DOI 10.1002/ijc.23479; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Dey S, 2015, J CLIN INVEST, V125, P2592, DOI 10.1172/JCI78031; Feng YX, 2014, CANCER DISCOV, V4, P702, DOI 10.1158/2159-8290.CD-13-0945; Fucikova J, 2016, CANCER RES, V76, P1746, DOI 10.1158/0008-5472.CAN-15-1142; Gallagher CM, 2016, ELIFE, V5, DOI 10.7554/eLife.11880; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Ghosh R, 2010, PLOS ONE, V5, pA104, DOI 10.1371/journal.pone.0009575; Gomez-Cadena A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.134; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Herrera ACS, 2014, CLIN BREAST CANCER, V14, P451, DOI 10.1016/j.clbc.2014.05.002; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hossain F, 2015, CANCER IMMUNOL RES, V3, P1236, DOI 10.1158/2326-6066.CIR-15-0036; Hu R, 2015, J IMMUNOL, V195, P4802, DOI 10.4049/jimmunol.1500073; Huber AL, 2013, MOL CELL, V49, P1049, DOI 10.1016/j.molcel.2013.01.009; Iwakoshi NN, 2007, J EXP MED, V204, P2267, DOI 10.1084/jem.20070525; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Jabouille A, 2015, ONCOTARGET, V6, P24922, DOI 10.18632/oncotarget.4679; Jeon YJ, 2015, CANCER CELL, V27, P354, DOI 10.1016/j.ccell.2015.02.006; Kandalaft LE, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22664; Karali E, 2014, MOL CELL, V54, P559, DOI 10.1016/j.molcel.2014.03.022; Kepp O, 2013, CYTOKINE GROWTH F R, V24, P311, DOI 10.1016/j.cytogfr.2013.05.001; Kitai Y, 2013, GENES CELLS, V18, P798, DOI 10.1111/gtc.12074; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Krishnamoorthy J, 2014, CELL CYCLE, V13, P801, DOI 10.4161/cc.27726; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lee BR, 2014, ONCOTARGET, V5, P12331, DOI 10.18632/oncotarget.2589; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Leung-Hagesteijn C, 2013, CANCER CELL, V24, P289, DOI 10.1016/j.ccr.2013.08.009; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu Y, 2015, J HEPATOL, V62, P590, DOI 10.1016/j.jhep.2014.10.022; Lu YY, 2014, MOL CELL, V55, P758, DOI 10.1016/j.molcel.2014.06.032; Ma XH, 2014, J CLIN INVEST, V124, P1406, DOI 10.1172/JCI70454; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Mahadevan NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051845; Mahadevan NR, 2011, P NATL ACAD SCI USA, V108, P6561, DOI 10.1073/pnas.1008942108; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marada S, 2013, MOL CELL BIOL, V33, P2375, DOI 10.1128/MCB.01445-12; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Matsuo K, 2013, GYNECOL ONCOL, V128, P552, DOI 10.1016/j.ygyno.2012.11.024; Mimura N, 2012, BLOOD, V119, P5772, DOI 10.1182/blood-2011-07-366633; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Mujcic H, 2013, CLIN CANCER RES, V19, P6126, DOI 10.1158/1078-0432.CCR-13-0526; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Namba T, 2015, ONCOTARGET, V6, P19990, DOI 10.18632/oncotarget.4598; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Oh J, 2012, J BIOL CHEM, V287, P11629, DOI 10.1074/jbc.M111.338673; Olson OC, 2015, NAT REV CANCER, V15, P712, DOI 10.1038/nrc4027; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Pereira ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012521; Pol J, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1008866; Pozzi C, 2016, NAT MED, V22, P624, DOI 10.1038/nm.4078; Qiu Q, 2013, EMBO J, V32, P2477, DOI 10.1038/emboj.2013.183; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ri M, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.26; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Rouschop KM, 2013, P NATL ACAD SCI USA, V110, P4622, DOI 10.1073/pnas.1210633110; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sahu N, 2016, CELL METAB, V24, P753, DOI 10.1016/j.cmet.2016.08.008; Scarlett UK, 2012, J EXP MED, V209, P495, DOI 10.1084/jem.20111413; Schewe DM, 2008, P NATL ACAD SCI USA, V105, P10519, DOI 10.1073/pnas.0800939105; Schindler AJ, 2009, P NATL ACAD SCI USA, V106, P17775, DOI 10.1073/pnas.0910342106; Senovilla L, 2012, SCIENCE, V337, P1678, DOI 10.1126/science.1224922; Shi YH, 2011, AUTOPHAGY, V7, P1159, DOI 10.4161/auto.7.10.16818; Shimizu A., 2016, PATHOL ONCOL RES; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.05033; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Tam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045078; Tang CHA, 2014, J CLIN INVEST, V124, P2585, DOI 10.1172/JCI73448; Thevenot PT, 2014, IMMUNITY, V41, P389, DOI 10.1016/j.immuni.2014.08.015; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Uruena C, 2015, INTEGR CANCER THER, V14, P468, DOI 10.1177/1534735415596425; VAUPEL P, 1989, CANCER RES, V49, P6449; Velez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018005; Vladykovskaya E, 2012, J BIOL CHEM, V287, P11398, DOI 10.1074/jbc.M111.320416; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wang YG, 2012, CANCER RES, V72, P5396, DOI 10.1158/0008-5472.CAN-12-0474; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Xie WY, 2015, EXP CELL RES, V339, P270, DOI 10.1016/j.yexcr.2015.11.005; Yaari-Stark S, 2010, INT J CANCER, V126, P2268, DOI 10.1002/ijc.25102; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Yan DY, 2016, CELL REP, V16, P2914, DOI 10.1016/j.celrep.2016.08.035; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Young RM, 2013, GENE DEV, V27, P1115, DOI 10.1101/gad.198630.112	129	429	450	11	176	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2017	168	4					692	706		10.1016/j.cell.2016.12.004	http://dx.doi.org/10.1016/j.cell.2016.12.004			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8VJ	28187289	Green Accepted, Bronze			2022-12-28	WOS:000396277600018
J	Lyon, J				Lyon, Jeff			Alzheimer Outlook Far From Bleak	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	6	8	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2017	317	9					896	898		10.1001/jama.2017.0276	http://dx.doi.org/10.1001/jama.2017.0276			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM8DM	28199483				2022-12-28	WOS:000395541500002
J	O'Brien, E; Holt, ME; Thompson, MK; Salay, LE; Ehlinger, AC; Chazin, WJ; Barton, JK				O'Brien, Elizabeth; Holt, Marilyn E.; Thompson, Matthew K.; Salay, Lauren E.; Ehlinger, Aaron C.; Chazin, Walter J.; Barton, Jacqueline K.			The [4Fe4S] cluster of human DNA primase functions as a redox switch using DNA charge transport	SCIENCE			English	Article							IRON-SULFUR CLUSTER; POLYMERASE ALPHA-PRIMASE; C-TERMINAL DOMAIN; POL ALPHA; ELECTRON-TRANSFER; CRYSTAL-STRUCTURE; ENDONUCLEASE-III; PRIMER SYNTHESIS; 4FE-4S CLUSTERS; REPAIR PROTEINS	DNA charge transport chemistry offers a means of long-range, rapid redox signaling. We demonstrate that the [4Fe4S] cluster in human DNA primase can make use of this chemistry to coordinate the first steps of DNA synthesis. Using DNA electrochemistry, we found that a change in oxidation state of the [4Fe4S] cluster acts as a switch for DNA binding. Single-atom mutations that inhibit this charge transfer hinder primase initiation without affecting primase structure or polymerization. Generating a single base mismatch in the growing primer duplex, which attenuates DNA charge transport, inhibits primer truncation. Thus, redox signaling by [4Fe4S] clusters using DNA charge transport regulates primase binding to DNA and illustrates chemistry that may efficiently drive substrate handoff between polymerases during DNA replication.	[O'Brien, Elizabeth; Barton, Jacqueline K.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Holt, Marilyn E.; Thompson, Matthew K.; Salay, Lauren E.; Ehlinger, Aaron C.; Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Struct Biol Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA; [Holt, Marilyn E.; Thompson, Matthew K.; Salay, Lauren E.; Ehlinger, Aaron C.; Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Struct Biol Ctr, Box 1583, Nashville, TN 37235 USA	California Institute of Technology; Vanderbilt University; Vanderbilt University	Barton, JK (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.; Chazin, WJ (corresponding author), Vanderbilt Univ, Dept Biochem, Struct Biol Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA.; Chazin, WJ (corresponding author), Vanderbilt Univ, Dept Chem, Struct Biol Ctr, Box 1583, Nashville, TN 37235 USA.	walter.j.chazin@vanderbilt.edu; jkbarton@caltech.edu		Chazin, Walter/0000-0002-2180-0790	NIH [GM61077, GM120087, GM65484, GM118089, T32 GM07616, T32 GM08230, T32 CA009582, S10 RR025677]; Moore Foundation; NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008120, R01GM065484, R01GM120087, T32GM007616, R01GM061077, R35GM118089, T32GM008320] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023680] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by NIH operating grants GM61077 and GM120087 (J.K.B.); NIH operating grants GM65484 and GM118089 (W.J.C.); NIH training grants T32 GM07616 (E.O'B.), T32 GM08230 (M.E.H. and L.E.S.), and T32 CA009582 (A.C.E.); NIH grant S10 RR025677 in support of NMR instrumentation; and the Moore Foundation. Crystallographic data for the p58C Y345F and Y347F mutants have been deposited in the Protein Data Bank under accession numbers PDB 517M and PDB 5DQO, respectively.	Agarkar VB, 2011, CELL CYCLE, V10, P926, DOI 10.4161/cc.10.6.15010; Arezi B, 2000, TRENDS BIOCHEM SCI, V25, P572, DOI 10.1016/S0968-0004(00)01680-7; Baranovskiy AG, 2016, J BIOL CHEM, V291, P10006, DOI 10.1074/jbc.M116.717405; Baranovskiy AG, 2015, J BIOL CHEM, V290, P5635, DOI 10.1074/jbc.M114.624742; Boal AK, 2005, BIOCHEMISTRY-US, V44, P8397, DOI 10.1021/bi047494n; Boal AK, 2009, P NATL ACAD SCI USA, V106, P15237, DOI 10.1073/pnas.0908059106; Boon EM, 2003, BIOCONJUGATE CHEM, V14, P1140, DOI 10.1021/bc034139l; CUNNINGHAM RP, 1989, BIOCHEMISTRY-US, V28, P4450, DOI 10.1021/bi00436a049; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Fuss JO, 2015, BBA-MOL CELL RES, V1853, P1253, DOI 10.1016/j.bbamcr.2015.01.018; Garcia-Diaz M, 2007, DNA REPAIR, V6, P1333, DOI 10.1016/j.dnarep.2007.03.005; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Georgescu RE, 2015, ELIFE, V4, DOI 10.7554/eLife.04988; Gorodetsky AA, 2006, J AM CHEM SOC, V128, P12082, DOI 10.1021/ja064784d; Gray HB, 2010, BBA-BIOENERGETICS, V1797, P1563, DOI 10.1016/j.bbabio.2010.05.001; Grodick MA, 2015, BIOCHEMISTRY-US, V54, P962, DOI 10.1021/bi501520w; Grodick MA, 2014, J AM CHEM SOC, V136, P6470, DOI 10.1021/ja501973c; HOLMES AM, 1985, J BIOL CHEM, V260, P840; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Kilkenny ML, 2012, J BIOL CHEM, V287, P23740, DOI 10.1074/jbc.M112.368951; Kilkenny ML, 2013, P NATL ACAD SCI USA, V110, P15961, DOI 10.1073/pnas.1311185110; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Liu LL, 2015, PROTEIN CELL, V6, P194, DOI 10.1007/s13238-015-0134-8; Lue NF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6762; Mui TP, 2011, J AM CHEM SOC, V133, P16378, DOI 10.1021/ja207222t; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Nunez-Ramirez R, 2011, NUCLEIC ACIDS RES, V39, P8187, DOI 10.1093/nar/gkr534; O'Donnell M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010108; O'Neill MA, 2003, ANGEW CHEM INT EDIT, V42, P5896, DOI 10.1002/anie.200352831; O'Neill MA, 2002, J AM CHEM SOC, V124, P13053, DOI 10.1021/ja0208198; O'Neill MA, 2004, J AM CHEM SOC, V126, P13234, DOI 10.1021/ja0455897; Perera RL, 2013, ELIFE, V2, DOI 10.7554/eLife.00482; Pheeney CG, 2013, J AM CHEM SOC, V135, P11869, DOI 10.1021/ja4041779; Plekan O, 2008, MOL PHYS, V106, P1143, DOI 10.1080/00268970801974875; Rees DC, 2003, SCIENCE, V300, P929, DOI 10.1126/science.1083075; Rouault TA, 2015, NAT REV MOL CELL BIO, V16, P45, DOI 10.1038/nrm3909; Sauguet L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010083; SHEAFF RJ, 1994, BIOCHEMISTRY-US, V33, P2247, DOI 10.1021/bi00174a035; SHEAFF RJ, 1994, J BIOL CHEM, V269, P19225; Shih C, 2008, SCIENCE, V320, P1760, DOI 10.1126/science.1158241; Slinker JD, 2011, NAT CHEM, V3, P228, DOI 10.1038/NCHEM.982; Slinker JD, 2010, J AM CHEM SOC, V132, P2769, DOI 10.1021/ja909915m; Sontz PA, 2012, P NATL ACAD SCI USA, V109, P1856, DOI 10.1073/pnas.1120063109; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; SUZUKI M, 1993, BIOCHEMISTRY-US, V32, P12782, DOI 10.1021/bi00210a030; Vaithiyalingam S, 2014, J MOL BIOL, V426, P558, DOI 10.1016/j.jmb.2013.11.007; Vaithiyalingam S, 2010, P NATL ACAD SCI USA, V107, P13684, DOI 10.1073/pnas.1002009107; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Winkler JR, 2014, J AM CHEM SOC, V136, P2930, DOI 10.1021/ja500215j; Zerbe LK, 2002, BIOCHEMISTRY-US, V41, P4891, DOI 10.1021/bi016030b	54	72	73	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327							eaag1789	10.1126/science.aag1789	http://dx.doi.org/10.1126/science.aag1789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28232525	Green Submitted, Green Accepted			2022-12-28	WOS:000395127600034
J	Akita, C; Saikawa, Y				Akita, Chisato; Saikawa, Yutaka			Gastric Gyri - Pediatric Menetrier's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Akita, Chisato; Saikawa, Yutaka] Kanazawa Med Univ, Kanazawa, Ishikawa, Japan	Kanazawa Medical University	Saikawa, Y (corresponding author), Kanazawa Med Univ, Kanazawa, Ishikawa, Japan.	saikawa@kanazawa-med.ac.jp							0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2017	376	8					774	774		10.1056/NEJMicm1605473	http://dx.doi.org/10.1056/NEJMicm1605473			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JO	28225680				2022-12-28	WOS:000395627900010
J	Gillon, M; Triaud, AHMJ; Demory, BO; Jehin, E; Agol, E; Deck, KM; Lederer, SM; de Wit, J; Burdanov, A; Ingalls, JG; Bolmont, E; Leconte, J; Raymond, SN; Selsis, F; Turbet, M; Barkaoui, K; Burgasser, A; Burleigh, MR; Carey, SJ; Chaushev, A; Copperwheat, CM; Delrez, L; Fernandes, CS; Holdsworth, DL; Kotze, EJ; Van Grootel, V; Almleaky, Y; Benkhaldoun, Z; Magain, P; Queloz, D				Gillon, Michael; Triaud, Amaury H. M. J.; Demory, Brice-Olivier; Jehin, Emmanuel; Agol, Eric; Deck, Katherine M.; Lederer, Susan M.; de Wit, Julien; Burdanov, Artem; Ingalls, James G.; Bolmont, Emeline; Leconte, Jeremy; Raymond, Sean N.; Selsis, Franck; Turbet, Martin; Barkaoui, Khalid; Burgasser, Adam; Burleigh, Matthew R.; Carey, Sean J.; Chaushev, Aleksander; Copperwheat, Chris M.; Delrez, Laetitia; Fernandes, Catarina S.; Holdsworth, Daniel L.; Kotze, Enrico J.; Van Grootel, Valerie; Almleaky, Yaseen; Benkhaldoun, Zouhair; Magain, Pierre; Queloz, Didier			Seven temperate terrestrial planets around the nearby ultracool dwarf star TRAPPIST-1	NATURE			English	Article							MAIN-SEQUENCE STARS; TRANSITING PLANETS; HABITABLE ZONES; SUPER-EARTHS; SYSTEMS; STELLAR; MODELS; ECCENTRICITY; RESONANCES; INVERSION	One aim of modern astronomy is to detect temperate, Earth-like exoplanets that are well suited for atmospheric characterization. Recently, three Earth-sized planets were detected that transit (that is, pass in front of) a star with a mass just eight per cent that of the Sun, located 12 parsecs away(1). The transiting configuration of these planets, combined with the Jupiter-like size of their host star-named TRAPPIST-1-makes possible in-depth studies of their atmospheric properties with present-day and future astronomical facilities(1-3). Here we report the results of a photometric monitoring campaign of that star from the ground and space. Our observations reveal that at least seven planets with sizes and masses similar to those of Earth revolve around TRAPPIST-1. The six inner planets form a near-resonant chain, such that their orbital periods (1.51, 2.42, 4.04, 6.06, 9.1 and 12.35 days) are near-ratios of small integers. This architecture suggests that the planets formed farther from the star and migrated inwards(4,5). Moreover, the seven planets have equilibrium temperatures low enough to make possible the presence of liquid water on their surfaces(6-8).	[Gillon, Michael; Jehin, Emmanuel; Burdanov, Artem; Magain, Pierre] Univ Liege, Space Sci Technol & Astrophys Res STAR Inst, Allee 6 Auot 19C,Bat B5C, B-4000 Liege, Belgium; [Triaud, Amaury H. M. J.] Inst Astron, Madingley Rd, Cambridge CB3 0HA, England; [Demory, Brice-Olivier] Univ Bern, Ctr Space & Habitabil, Sidlerstr 5, CH-3012 Bern, Switzerland; [Demory, Brice-Olivier] Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England; [Agol, Eric] Univ Washington, Dept Astron, Seattle, WA 98195 USA; [Agol, Eric] NASA, Astrobiol Inst, Virtual Planetary Lab, Seattle, WA 98195 USA; [Deck, Katherine M.] CALTECH, Dept Geol & Planetary Sci, Pasadena, CA 91125 USA; [Lederer, Susan M.] NASA, Johnson Space Ctr, 2101 NASA Pkwy, Houston, TX 77058 USA; [de Wit, Julien] MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Ingalls, James G.; Carey, Sean J.] CALTECH, Spitzer Sci Ctr, 1200 E Calif Blvd,Mail Code 314-6, Pasadena, CA 91125 USA; [Bolmont, Emeline] Univ Namur, Dept Math, NaXys, 8 Rempart La Vierge, B-5000 Namur, Belgium; [Bolmont, Emeline] Univ Paris Diderot, CNRS, Ctr Saclay, IRFU,SAp,DRF,CEA,Lab AIM Paris Saclay, F-91191 Gif Sur Yvette, France; [Leconte, Jeremy; Raymond, Sean N.; Selsis, Franck] Univ Bordeaux, CNRS, Lab Astrophys Bordeaux, B18N Allee Geoffroy St Hilaire, F-33615 Pessac, France; [Turbet, Martin; Delrez, Laetitia] Univ Paris 06, Sorbonne Univ, CNRS, Lab Meteorol Dynam, 4 Pl Jussieu, F-75005 Paris, France; [Barkaoui, Khalid; Benkhaldoun, Zouhair] Cadi Ayyad Univ, FSSM, Lab LPHEA, Oukaimeden Observ, BP 2390, Marrakech, Morocco; [Burgasser, Adam] Univ Calif San Diego, Ctr Astrophys & Space Sci, La Jolla, CA 92093 USA; [Burleigh, Matthew R.; Chaushev, Aleksander] Univ Leicester, Dept Phys & Astron, Leicester Inst Space & Earth Observ, Leicester LE1 7RH, Leics, England; [Copperwheat, Chris M.] Liverpool John Moores Univ, Astrophys Res Inst, Liverpool L3 5RF, Merseyside, England; [Holdsworth, Daniel L.] Univ Cent Lancashire, Jeremiah Horrocks Inst, Preston PR1 2HE, Lancs, England; [Kotze, Enrico J.] South African Astron Observ, Observ, POB 9, ZA-7935 Cape Town, South Africa; [Almleaky, Yaseen] King Abdulaziz Univ, Fac Sci, Space & Astron Dept, Jeddah 21589, Saudi Arabia; [Almleaky, Yaseen] King Abdullah Ctr Crescent Observat & Astron, Makkah Clock, Mecca 24231, Saudi Arabia; [Queloz, Didier] Univ Geneva, Observ Geneva, 51 Chemin Maillettes, CH-1290 Sauverny, Switzerland	University of Liege; University of Cambridge; University of Bern; University of Cambridge; University of Washington; University of Washington Seattle; National Aeronautics & Space Administration (NASA); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Massachusetts Institute of Technology (MIT); California Institute of Technology; University of Namur; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Cadi Ayyad University of Marrakech; University of California System; University of California San Diego; University of Leicester; Liverpool John Moores University; University of Central Lancashire; National Research Foundation - South Africa; South African Astronomical Observatory; King Abdulaziz University; University of Geneva	Gillon, M (corresponding author), Univ Liege, Space Sci Technol & Astrophys Res STAR Inst, Allee 6 Auot 19C,Bat B5C, B-4000 Liege, Belgium.	michael.gillon@ulg.ac.be	Triaud, Amaury/AAT-5603-2021; Ingalls, James/AAK-6875-2021; Demory, Brice-Olivier/ABG-1063-2020; Benkhaldoun, Zouhair/F-2620-2012	Triaud, Amaury/0000-0002-5510-8751; Ingalls, James/0000-0003-4714-1364; Demory, Brice-Olivier/0000-0002-9355-5165; Benkhaldoun, Zouhair/0000-0001-6285-9847; Turbet, Martin/0000-0003-2260-9856; Burleigh, Matthew/0000-0003-0684-7803; Carey, Sean/0000-0002-0221-6871; Bolmont, Emeline/0000-0001-5657-4503; Barkaoui, Khalid/0000-0003-1464-9276; Gillon, Michael/0000-0003-1462-7739; Agol, Eric/0000-0002-0802-9145; /0000-0002-0351-2429; Queloz, Didier/0000-0002-3012-0316; Kotze, Enrico/0000-0003-4802-7985; Burgasser, Adam J./0000-0002-6523-9536; Copperwheat, Christopher/0000-0001-7983-8698; Holdsworth, Daniel/0000-0003-2002-896X; Raymond, Sean/0000-0001-8974-0758; Selsis, Franck/0000-0001-9619-5356	NASA; NASA [NNX15AI75G, NNX13AF62G, NNH05ZDA001C]; Belgian Fonds (National) de la Recherche Scientifique (F.R.S.-FNRS) [FRFC 2.5.594.09.F]; University of Liege; European Research Council (ERC) [336480, 679030]; Actions de Recherche Concertee (ARC) grant - Wallonia-Brussels Federation; UK Science and Technology Facilities Council; Swiss National Science Foundation [PP00P2_163967]; National Science Foundation (NSF) [AST-1615315]; European Research Council through ERC [SPIRE 647383]; Agence Nationale pour la Recherche (ANR) [ANR-13-BS05-0003-002];  [296.C-5010(A)]; STFC [ST/P002218/1, ST/N001524/1, ST/J001465/1, ST/N000757/1, ST/P006892/1, ST/M003035/1, ST/L00061X/1, ST/L001306/1] Funding Source: UKRI; Science and Technology Facilities Council [1362676, ST/N000757/1, ST/P006892/1, ST/M003035/1, ST/P002218/1, ST/N001524/1, ST/L001306/1] Funding Source: researchfish; Direct For Mathematical & Physical Scien [1615315] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); Belgian Fonds (National) de la Recherche Scientifique (F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS); University of Liege(University of Liege); European Research Council (ERC)(European Research Council (ERC)European Commission); Actions de Recherche Concertee (ARC) grant - Wallonia-Brussels Federation; UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Science Foundation (NSF)(National Science Foundation (NSF)); European Research Council through ERC(European Research Council (ERC)); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); ; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work is based in part on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. The material presented here is based on work supported in part by NASA under contract no. NNX15AI75G. TRAPPIST-South is a project funded by the Belgian Fonds (National) de la Recherche Scientifique (F.R.S.-FNRS) under grant FRFC 2.5.594.09.F, with the participation of the Swiss National Science Foundation (FNS/SNSF). TRAPPIST-North is a project funded by the University of Liege, and performed in collaboration with Cadi Ayyad University of Marrakesh. The research leading to these results has received funding from the European Research Council (ERC) under the FP/2007-2013 ERC grant agreement no. 336480, and under the H2020 ERC grant agreement no. 679030; and from an Actions de Recherche Concertee (ARC) grant, financed by the Wallonia-Brussels Federation. The VLT data used in this work were taken under program 296.C-5010(A). UKIRT is supported by NASA and operated under an agreement among the University of Hawaii, the University of Arizona, and Lockheed Martin Advanced Technology Center; operations are enabled through the cooperation of the East Asian Observatory. The Liverpool Telescope is operated on the island of La Palma by Liverpool John Moores University (JMU) in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias, with financial support from the UK Science and Technology Facilities Council. This paper uses observations made at the South African Astronomical Observatory (SAAO). M.G., E.J. and V.V.G. are F.R.S.-FNRS research associates. B.-O.D. acknowledges support from the Swiss National Science Foundation in the form of a SNSF Professorship (PP00P2_163967). E.A. acknowledges support from National Science Foundation (NSF) grant AST-1615315, and NASA grants NNX13AF62G and NNH05ZDA001C. E.B. acknowledges that this work is part of the F.R.S.-FNRS ExtraOrDynHa research project and acknowledges funding by the European Research Council through ERC grant SPIRE 647383. S.N.R. thanks the Agence Nationale pour la Recherche (ANR) for support via grant ANR-13-BS05-0003-002 (project MOJO). D.L.H. acknowledges financial support from the UK Science and Technology Facilities Council. The authors thank C. Owen, C. Wolf and the rest of the SkyMapper team for their attempts to monitor the star from Australia; from UKIRT, the director R. Green and the staff scientists W. Varricatt and T. Kerr; the ESO staff at Paranal for their support with the HAWK-I observations; JMU and their flexibility as regards the Liverpool Telescope schedule, which allowed us to search actively for the planets, and to extend our time allocation in the face of amazing results; for the William Herschel Telescope, C. Farina, F. Riddick, F. Jimenez and O. Vaduvescu for their help and kindness during observations; and for SAAO, the telescopes operations manager R. Sefako for his support.	Agol E, 2005, MON NOT R ASTRON SOC, V359, P567, DOI 10.1111/j.1365-2966.2005.08922.x; Agol E, 2016, ASTROPHYS J, V818, DOI 10.3847/0004-637X/818/2/177; Alibert Y, 2017, ASTRON ASTROPHYS, V598, DOI 10.1051/0004-6361/201629671; Barnes R, 2009, ASTROPHYS J LETT, V700, pL30, DOI 10.1088/0004-637X/700/1/L30; Benn C, 2008, PROC SPIE, V7014, DOI 10.1117/12.788694; Bolmont E, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201525909; Bolmont E, 2014, ASTROPHYS J, V793, DOI 10.1088/0004-637X/793/1/3; Casali M, 2001, ASTR SOC P, V232, P357; Chambers JE, 1999, MON NOT R ASTRON SOC, V304, P793, DOI 10.1046/j.1365-8711.1999.02379.x; Chiang E, 2013, MON NOT R ASTRON SOC, V431, P3444, DOI 10.1093/mnras/stt424; Claret A, 2000, ASTRON ASTROPHYS, V363, P1081; Claret A, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201116451; Cresswell P, 2006, ASTRON ASTROPHYS, V450, P833, DOI 10.1051/0004-6361:20054551; Deck KM, 2016, ASTROPHYS J, V821, DOI 10.3847/0004-637X/821/2/96; Deck KM, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/2/132; Deck KM, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/2/129; Filippazzo JC, 2015, ASTROPHYS J, V810, DOI 10.1088/0004-637X/810/2/158; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gillon M, 2014, ASTRON ASTROPHYS, V563, DOI 10.1051/0004-6361/201322362; Gillon M, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201218817; Hanno R., 2015, MON NOT R ASTRON SOC, V452, P376; Holman MJ, 2005, SCIENCE, V307, P1288, DOI 10.1126/science.1107822; Ingalls JG, 2012, PROC SPIE, V8442, DOI 10.1117/12.926947; Jehin E., 2011, MESSENGER, V145, P2; Kane SR, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/5/122; Kopparapu RK, 2016, ASTROPHYS J, V819, DOI 10.3847/0004-637X/819/1/84; Leconte J, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201321042; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI 10.1090/qam/10666; MacDonald MG, 2016, ASTRON J, V152, DOI 10.3847/0004-6256/152/4/105; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Papaloizou JCB, 2005, MON NOT R ASTRON SOC, V363, P153, DOI 10.1111/j.1365-2966.2005.09427.x; Pirard JF, 2004, P SOC PHOTO-OPT INS, V5492, P1763, DOI 10.1117/12.578293; Pu BN, 2016, ASTROPHYS J, V819, DOI 10.3847/0004-637X/819/2/170; Ribas I, 2016, ASTRON ASTROPHYS, V596, DOI 10.1051/0004-6361/201629576; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stevenson DJ, 1999, NATURE, V400, P32, DOI 10.1038/21811; Terquem C, 2007, ASTROPHYS J, V654, P1110, DOI 10.1086/509497; Turbet M, 2016, ASTRON ASTROPHYS, V596, DOI 10.1051/0004-6361/201629577; Wordsworth RD, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/201015053; Zeng L, 2016, ASTROPHYS J, V819, DOI 10.3847/0004-637X/819/2/127	58	824	827	19	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2017	542	7642					456	+		10.1038/nature21360	http://dx.doi.org/10.1038/nature21360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM1RG	28230125	Green Submitted			2022-12-28	WOS:000395094100031
J	Mayor, S				Mayor, Susan			Asking older people two simple questions accurately detects depression risk, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Tsoi KKF, 2017, BRIT J PSYCHIAT, V210, P255, DOI 10.1192/bjp.bp.116.186932	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2017	356								j874	10.1136/bmj.j874	http://dx.doi.org/10.1136/bmj.j874			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KQ	28219894				2022-12-28	WOS:000395630800010
J	Hazlett, HC; Gu, HB; Munsell, BC; Kim, SH; Styner, M; Wolff, JJ; Elison, JT; Swanson, MR; Zhu, HT; Otteron, KNB; Collins, DL; Constantino, JN; Dager, SR; Estes, AM; Evans, AC; Fonov, VS; Gerig, G; Kostopoulos, P; McKinstry, RC; Pandey, J; Paterson, S; Pruett, JR; Schultz, RT; Shaw, DW; Zwaigenbaum, L; Piven, J				Hazlett, Heather Cody; Gu, Hongbin; Munsell, Brent C.; Kim, Sun Hyung; Styner, Martin; Wolff, Jason J.; Elison, Jed T.; Swanson, Meghan R.; Zhu, Hongtu; Otteron, Kelly N. B.; Collins, D. Louis; Constantino, John N.; Dager, Stephen R.; Estes, Annette M.; Evans, Alan C.; Fonov, Vladimir S.; Gerig, Guido; Kostopoulos, Penelope; McKinstry, Robert C.; Pandey, Juhi; Paterson, Sarah; Pruett, John R., Jr.; Schultz, Robert T.; Shaw, Dennis W.; Zwaigenbaum, Lonnie; Piven, Joseph		IBIS Network	Early brain development in infants at high risk for autism spectrum disorder	NATURE			English	Article							CORTICAL SURFACE-AREA; HUMAN CEREBRAL-CORTEX; AGE 2 YEARS; 16P11.2 DELETION; GRAY-MATTER; SIZE; EXPANSION; CHILDREN; BIRTH; LIFE	Brain enlargement has been observed in children with autism spectrum disorder (ASD), but the timing of this phenomenon, and the relationship between ASD and the appearance of behavioural symptoms, are unknown. Retrospective head circumference and longitudinal brain volume studies of two-year olds followed up at four years of age have provided evidence that increased brain volume may emerge early in development(1,2). Studies of infants at high familial risk of autism can provide insight into the early development of autism and have shown that characteristic social deficits in ASD emerge during the latter part of the first and in the second year of life(3,4). These observations suggest that prospective brain-imaging studies of infants at high familial risk of ASD might identify early postnatal changes in brain volume that occur before an ASD diagnosis. In this prospective neuroimaging study of 106 infants at high familial risk of ASD and 42 low-risk infants, we show that hyperexpansion of the cortical surface area between 6 and 12 months of age precedes brain volume overgrowth observed between 12 and 24 months in 15 high-risk infants who were diagnosed with autism at 24 months. Brain volume overgrowth was linked to the emergence and severity of autistic social deficits. A deep-learning algorithm that primarily uses surface area information from magnetic resonance imaging of the brain of 6-12-month-old individuals predicted the diagnosis of autism in individual high-risk children at 24 months (with a positive predictive value of 81% and a sensitivity of 88%). These findings demonstrate that early brain changes occur during the period in which autistic behaviours are first emerging.	[Hazlett, Heather Cody; Gu, Hongbin; Kim, Sun Hyung; Styner, Martin; Piven, Joseph] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [Hazlett, Heather Cody; Swanson, Meghan R.; Piven, Joseph] Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA; [Munsell, Brent C.] Coll Charleston, Charleston, SC 29424 USA; [Wolff, Jason J.] Univ Minnesota, Dept Educ Psychol, Minneapolis, MN 55455 USA; [Elison, Jed T.] Univ Minnesota, Inst Child Dev, Minneapolis, MN 55455 USA; [Zhu, Hongtu] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Otteron, Kelly N. B.; Constantino, John N.; Pruett, John R., Jr.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Dager, Stephen R.; Shaw, Dennis W.] Univ Washington, Dept Radiol, Seattle, WA 98105 USA; [Dager, Stephen R.; Estes, Annette M.; Shaw, Dennis W.] Univ Washington, Ctr Human Dev & Disabil, Seattle, WA 98105 USA; [Estes, Annette M.] Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98105 USA; [Collins, D. Louis; Evans, Alan C.; Fonov, Vladimir S.; Kostopoulos, Penelope] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 0G4, Canada; [Gerig, Guido] NYU, Tandon Sch Engn, New York, NY 10003 USA; [McKinstry, Robert C.] Washington Univ, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Pandey, Juhi; Schultz, Robert T.] Childrens Hosp Philadelphia, Ctr Autism Res, Philadelphia, PA 19104 USA; [Pandey, Juhi; Schultz, Robert T.] Univ Penn, Philadelphia, PA 19104 USA; [Paterson, Sarah] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA; [Zwaigenbaum, Lonnie] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2R3, Canada	University of North Carolina; University of North Carolina Chapel Hill; College of Charleston; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; New York University; New York University Tandon School of Engineering; Washington University (WUSTL); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Alberta	Hazlett, HC (corresponding author), Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA.; Hazlett, HC (corresponding author), Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA.	hcody@med.unc.edu	Styner, Martin/AAS-9949-2020; Collins, D. Louis/ABD-7708-2021; Evans, Alan C/B-2373-2013; Fonov, Vladimir/AAG-9572-2019; Pike, Bruce/K-5562-2014	Styner, Martin/0000-0002-8747-5118; Collins, D. Louis/0000-0002-8432-7021; Evans, Alan C/0000-0003-3841-6098; Fonov, Vladimir/0000-0003-3402-7749; Pike, Bruce/0000-0001-8924-683X; Swanson, Meghan/0000-0001-8474-3458; Gerig, Guido/0000-0002-9547-6233; Estes, Annette/0000-0003-2687-4155	NIH [HD055741, 054 EB005149]; NIH Autism Center of Excellence grant (NIMH and NICHD) [HD055741]; Autism Speaks [6020]; Simons Foundation [140209]; National Alliance for Medical Image Computing (NA-MIC); IDDRC Imaging and Participant Registry cores (NICHD) [HD003110];  [R01 MH093510]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055741, U54HD083091, U54HD079124, U54HD087011, U54HD086984, P30HD003110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB005149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH108700, R01MH086633, R01MH093510] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Autism Center of Excellence grant (NIMH and NICHD); Autism Speaks; Simons Foundation; National Alliance for Medical Image Computing (NA-MIC); IDDRC Imaging and Participant Registry cores (NICHD); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The IBIS (Infant Brain Imaging Study) Network is an NIH funded Autism Center of Excellence (HD055741) and consists of a consortium of 8 Universities in the US and Canada. This work was supported by an NIH Autism Center of Excellence grant (NIMH and NICHD HD055741 to J.Pi.), Autism Speaks (6020) and the Simons Foundation (140209). Further support was provided by the National Alliance for Medical Image Computing (NA-MIC), funded by the NIH through grant 054 EB005149, the IDDRC Imaging and Participant Registry cores (NICHD HD003110 to J.Pi.) and R01 MH093510 (to J.R.P.Jr). We thank M. Burchinal and K. Y. Truong for their consultation on the statistical methods and approach. Given the large commitment of time and effort required by this study, we extend our appreciation to the families who have participated in this study and the numerous research assistants and staff who have contributed to this work.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Casanova MF, 2006, ACTA NEUROPATHOL, V112, P287, DOI 10.1007/s00401-006-0085-5; Charman T, 2014, INT J SPEECH-LANG PA, V16, P15, DOI 10.3109/17549507.2013.859732; Chawarska K, 2011, ARCH GEN PSYCHIAT, V68, P1021, DOI 10.1001/archgenpsychiatry.2011.106; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cotney J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7404; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Elison JT, 2013, AM J PSYCHIAT, V170, P899, DOI 10.1176/appi.ajp.2012.12091150; Estes A, 2015, J NEURODEV DISORD, V7, DOI 10.1186/s11689-015-9117-6; Fang WQ, 2014, CELL REP, V9, P1635, DOI 10.1016/j.celrep.2014.11.003; Georgiades S, 2013, JAMA PSYCHIAT, V70, P42, DOI 10.1001/2013.jamapsychiatry.1; Gilmore JH, 2007, J NEUROSCI, V27, P1255, DOI 10.1523/JNEUROSCI.3339-06.2007; Gilmore JH, 2012, CEREB CORTEX, V22, P2478, DOI 10.1093/cercor/bhr327; Guthrie W, 2013, J CHILD PSYCHOL PSYC, V54, P582, DOI 10.1111/jcpp.12008; Hazlett HC, 2005, ARCH GEN PSYCHIAT, V62, P1366, DOI 10.1001/archpsyc.62.12.1366; Hazlett HC, 2012, AM J PSYCHIAT, V169, P601, DOI 10.1176/appi.ajp.2012.11091425; Hazlett HC, 2011, ARCH GEN PSYCHIAT, V68, P467, DOI 10.1001/archgenpsychiatry.2011.39; Hill J, 2010, P NATL ACAD SCI USA, V107, P13135, DOI 10.1073/pnas.1001229107; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Im K, 2008, CEREB CORTEX, V18, P2181, DOI 10.1093/cercor/bhm244; Kim SH, 2013, J NEUROSCI METH, V212, P43, DOI 10.1016/j.jneumeth.2012.09.018; Landa RJ, 2013, CHILD DEV, V84, P429, DOI 10.1111/j.1467-8624.2012.01870.x; Li G, 2014, CEREB CORTEX, V24, P1289, DOI 10.1093/cercor/bhs413; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C., 2000, AUTISM DIGANOSTIC OB; Marchetto M.C, 2016, MOL PSYCHIAT; Messinger D, 2013, J AM ACAD CHILD PSY, V52, P300, DOI 10.1016/j.jaac.2012.12.011; Mullen E.M., 1995, MULLEN SCALES EARLY; Nonaka-Kinoshita M, 2013, EMBO J, V32, P1817, DOI 10.1038/emboj.2013.96; Ozonoff S., J AM ACAD CHILD ADOL, V49, P256; Ozonoff S, 2014, J AM ACAD CHILD PSY, V53, P398, DOI 10.1016/j.jaac.2013.12.020; Packer A, 2016, NEUROSCI BIOBEHAV R, V64, P185, DOI 10.1016/j.neubiorev.2016.03.002; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; PIVEN J, 1995, AM J PSYCHIAT, V152, P1145; Pucilowska J, 2015, J NEUROSCI, V35, P3190, DOI 10.1523/JNEUROSCI.4864-13.2015; Qureshi AY, 2014, J NEUROSCI, V34, P11199, DOI 10.1523/JNEUROSCI.1366-14.2014; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Shaw P, 2012, BIOL PSYCHIAT, V72, P191, DOI 10.1016/j.biopsych.2012.01.031; Shen MD, 2013, BRAIN, V136, P2825, DOI 10.1093/brain/awt166; Sparks BF, 2002, NEUROLOGY, V59, P184, DOI 10.1212/WNL.59.2.184; Sparrow SS., 1984, VINELAND ADAPTIVE BE; Sugathan A, 2014, P NATL ACAD SCI USA, V111, pE4468, DOI 10.1073/pnas.1405266111; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang JH, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00007; Wetherby A. M, 2002, COMMUNICATION SYMBOL, DOI 10.1037/t11529-000; Zwaigenbaum L, 2005, INT J DEV NEUROSCI, V23, P143, DOI 10.1016/j.ijdevneu.2004.05.001	51	517	549	15	343	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					348	+		10.1038/nature21369	http://dx.doi.org/10.1038/nature21369			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2LQ	28202961	Green Accepted, Green Submitted			2022-12-28	WOS:000394451600037
J	Thomson, M; El Sakr, F				Thomson, Mary; El Sakr, Fredy			Gas in the Left Atrium and Ventricle	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Thomson, Mary; El Sakr, Fredy] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Thomson, M (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	maryjt@med.umich.edu							0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2017	376	7					683	683		10.1056/NEJMicm1604787	http://dx.doi.org/10.1056/NEJMicm1604787			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0QJ	28199804				2022-12-28	WOS:000396402700019
J	[Anonymous]				[Anonymous]			CLIMATE CHANGE The high cost of keeping cool	NATURE			English	Editorial Material																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					275	275		10.1038/542275d	http://dx.doi.org/10.1038/542275d			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7YF	28202963	Bronze			2022-12-28	WOS:000454457400008
J	McCall, C				McCall, Chris			Alcohol industry looks to boost drinks sales in Africa	LANCET			English	Editorial Material																			0	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2017	389	10069					589	590		10.1016/S0140-6736(17)30330-6	http://dx.doi.org/10.1016/S0140-6736(17)30330-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9AF	28195048				2022-12-28	WOS:000394910800013
J	Mckay, E				Mckay, Erin			The Inkblots Hermann Rorschach, His Iconic Test, and the Power of Seeing	SCIENCE			English	Book Review									[Mckay, Erin] Michigan State Univ, Dept Translat Sci & Mol Med, Grand Rapids, MI 49503 USA	Michigan State University	Mckay, E (corresponding author), Michigan State Univ, Dept Translat Sci & Mol Med, Grand Rapids, MI 49503 USA.	erin.mckay@hc.msu.edu						Searls D, 2017, INKBLOTS HERMANN ROR	1	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					588	588		10.1126/science.aal2877	http://dx.doi.org/10.1126/science.aal2877			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK0SF	28183942				2022-12-28	WOS:000393636700034
J	DeVries, T; Holzer, M; Primeau, F				DeVries, Tim; Holzer, Mark; Primeau, Francois			Recent increase in oceanic carbon uptake driven by weaker upper-ocean overturning	NATURE			English	Article							ANTHROPOGENIC CARBON; CO2 SINK; TRENDS; VARIABILITY; STORAGE; DISTRIBUTIONS	The ocean is the largest sink for anthropogenic carbon dioxide (CO2), having absorbed roughly 40 per cent of CO2 emissions since the beginning of the industrial era(1,2). Recent data show that oceanic CO2 uptake rates have been growing over the past decade(3-7), reversing a trend of stagnant or declining carbon uptake during the 1990(8-14). Here we show that ocean circulation variability is the primary driver of these changes in oceanic CO2 uptake over the past several decades. We use a global inverse model to quantify the mean ocean circulation during the 1980s, 1990s and 2000s, and then estimate the impact of decadal circulation changes on the oceanic CO2 sink using a carbon cycling model. We find that during the 1990s an enhanced upper-ocean overturning circulation drove increased outgassing of natural CO2, thus weakening the global CO2 sink. This trend reversed during the 2000s as the overturning circulation weakened. Continued weakening of the upper-ocean overturning is likely to strengthen the CO2 sink in the near future by trapping natural CO2 in the deep ocean, but ultimately may limit oceanic uptake of anthropogenic CO2.	[DeVries, Tim] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; [DeVries, Tim] Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA; [Holzer, Mark] Univ New South Wales, Sch Math & Stat, Sydney, NSW 2052, Australia; [Holzer, Mark] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA; [Primeau, Francois] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of New South Wales Sydney; Columbia University; University of California System; University of California Irvine	DeVries, T (corresponding author), Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA.; DeVries, T (corresponding author), Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA.	tdevries@geog.ucsb.edu	Primeau, Francois W/A-7310-2011; Holzer, Mark/E-8735-2011	Primeau, Francois W/0000-0001-7452-9415; Holzer, Mark/0000-0002-9568-1763; DeVries, Tim/0000-0002-7771-9430	University of California; NASA [NNX16A122G]; Australian Research Council [DP120100674]; National Science Foundation [OCE 1436992]; Division Of Ocean Sciences [1436922] Funding Source: National Science Foundation	University of California(University of California System); NASA(National Aeronautics & Space Administration (NASA)); Australian Research Council(Australian Research Council); National Science Foundation(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	T.D. acknowledges support from a University of California Regents Junior Faculty Fellowship, and from NASA grant NNX16A122G. M.H. acknowledges support from Australian Research Council grant DP120100674. F.P. acknowledges funding from the National Science Foundation award OCE 1436992. We thank all of the scientists who collected the oceanographic tracer data used in this study.	Bernardello R., J CLIM, V27, P2033; Bernardello R, 2014, GEOPHYS RES LETT, V41, P7262, DOI 10.1002/2014GL061313; Bopp L, 2015, GEOPHYS RES LETT, V42, P6416, DOI 10.1002/2015GL065073; DeVries T, 2014, GLOBAL BIOGEOCHEM CY, V28, P631, DOI 10.1002/2013GB004739; DeVries T, 2011, J PHYS OCEANOGR, V41, P2381, DOI 10.1175/JPO-D-10-05011.1; DiNezio P. N., US CLIVAR VAR, V13, P12; England MH, 2014, NAT CLIM CHANGE, V4, P222, DOI [10.1038/NCLIMATE2106, 10.1038/nclimate2106]; Fay AR, 2013, GLOBAL BIOGEOCHEM CY, V27, P541, DOI 10.1002/gbc.20051; Frajka-Williams E, 2015, GEOPHYS RES LETT, V42, P3458, DOI 10.1002/2015GL063220; Ito T, 2015, GEOPHYS RES LETT, V42, P4516, DOI 10.1002/2015GL064320; Khatiwala S, 2013, BIOGEOSCIENCES, V10, P2169, DOI 10.5194/bg-10-2169-2013; Landschutzer P, 2014, GLOBAL BIOGEOCHEM CY, V28, P927, DOI 10.1002/2014GB004853; Landschutzer P, 2016, GLOBAL BIOGEOCHEM CY, V30, P1396, DOI 10.1002/2015GB005359; Landschutzer P, 2015, SCIENCE, V349, P1221, DOI 10.1126/science.aab2620; Le Quere C, 2007, SCIENCE, V316, P1735, DOI 10.1126/science.1136188; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Lovenduski NS, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003139; Majkut JD, 2014, GLOBAL BIOGEOCHEM CY, V28, P335, DOI 10.1002/2013GB004585; McKinley GA, 2016, NATURE, V530, P469, DOI 10.1038/nature16958; McKinley GA, 2011, NAT GEOSCI, V4, P606, DOI 10.1038/ngeo1193; McNeil BI, 2013, BIOGEOSCIENCES, V10, P2219, DOI 10.5194/bg-10-2219-2013; Munro DR, 2015, GEOPHYS RES LETT, V42, P7623, DOI 10.1002/2015GL065194; Nakano H, 2015, GLOBAL BIOGEOCHEM CY, V29, P1706, DOI 10.1002/2015GB005128; Perez FF, 2013, NAT GEOSCI, V6, P146, DOI [10.1038/ngeo1680, 10.1038/NGEO1680]; Rodenbeck C, 2015, BIOGEOSCIENCES, V12, P7251, DOI 10.5194/bg-12-7251-2015; Rodenbeck C, 2014, BIOGEOSCIENCES, V11, P4599, DOI 10.5194/bg-11-4599-2014; Sarmiento JL, 2010, BIOGEOSCIENCES, V7, P2351, DOI 10.5194/bg-7-2351-2010; Schuster U, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003941; Thomas H, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003167	29	156	167	34	209	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					215	218		10.1038/nature21068	http://dx.doi.org/10.1038/nature21068			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK2DJ	28179663				2022-12-28	WOS:000393737500037
J	Wang, ZL				Wang, Zhong Lin			New wave power	NATURE			English	Editorial Material							ENERGY		[Wang, Zhong Lin] Chinese Acad Sci, Beijing Inst Nanoenergy & Nanosyst, Beijing 100864, Peoples R China; [Wang, Zhong Lin] Georgia Inst Technol, Atlanta, GA 30332 USA	Chinese Academy of Sciences; Beijing Institute of Nanoenergy & Nanosystems, CAS; University System of Georgia; Georgia Institute of Technology	Wang, ZL (corresponding author), Chinese Acad Sci, Beijing Inst Nanoenergy & Nanosyst, Beijing 100864, Peoples R China.; Wang, ZL (corresponding author), Georgia Inst Technol, Atlanta, GA 30332 USA.	zlwang@gatech.edu	Wang, Zhong Lin/E-2176-2011; wang, jie/GRS-0942-2022	Wang, Zhong Lin/0000-0002-5530-0380; 				Chen J, 2015, ACS NANO, V9, P3324, DOI 10.1021/acsnano.5b00534; Tollefson J, 2014, NATURE, V508, P302, DOI 10.1038/508302a; Wang XF, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201501467; Wang ZL, 2015, ENERG ENVIRON SCI, V8, P2250, DOI 10.1039/c5ee01532d; Wang ZL, 2016, GREEN ENERGY TECHNOL, P1, DOI 10.1007/978-3-319-40039-6; Zi YL, 2016, ACS NANO, V10, P4797, DOI 10.1021/acsnano.6b01569	6	359	364	20	283	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					159	160		10.1038/542159a	http://dx.doi.org/10.1038/542159a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK2DJ	28179678	Bronze			2022-12-28	WOS:000393737500013
J	Pares, A				Pares, Albert			An appealing new agent for treating cholestatic pruritus	LANCET			English	Editorial Material							ACID TRANSPORTER INHIBITOR; BILE-ACIDS		[Pares, Albert] Univ Barcelona, Hosp Clin Barcelona, CIBERehd, Liver Unit,IDIBAPS, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Pares, A (corresponding author), Univ Barcelona, Hosp Clin Barcelona, CIBERehd, Liver Unit,IDIBAPS, Barcelona, Spain.	pares@ub.edu	Pares, Albert/M-6268-2019; Pares, Albert/G-1328-2011	Pares, Albert/0000-0002-5413-9687; Pares, Albert/0000-0002-5413-9687	Intercept Pharmaceuticals; Novartis	Intercept Pharmaceuticals; Novartis(Novartis)	I declare receiving personal fees from Intercept Pharmaceuticals and Novartis, related to liver disease advisory boards.	BACHS L, 1992, GASTROENTEROLOGY, V102, P2077, DOI 10.1016/0016-5085(92)90335-V; Beuers U, 2014, HEPATOLOGY, V60, P399, DOI 10.1002/hep.26909; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Dawson PA, 2003, J BIOL CHEM, V278, P33920, DOI 10.1074/jbc.M306370200; Graffner H, 2016, ALIMENT PHARM THER, V43, P303, DOI 10.1111/apt.13457; Hegade VS, 2016, ALIMENT PHARM THER, V43, P294, DOI 10.1111/apt.13449; Hegade VS, 2017, LANCET; Mayo MJ, 2016, J HEPATOL, V64, pS197, DOI 10.1016/S0168-8278(16)00146-X; Pares A, 2014, J HEPATOL, V60, pS192, DOI 10.1016/S0168-8278(14)60535-3; Pares A, 2010, J HEPATOL, V53, P307, DOI 10.1016/j.jhep.2010.02.031	10	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2017	389	10074					1078	1080		10.1016/S0140-6736(17)30320-3	http://dx.doi.org/10.1016/S0140-6736(17)30320-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0SR	28187916				2022-12-28	WOS:000396408700005
J	Eyquem, J; Mansilla-Soto, J; Giavridis, T; van der Stegen, SJC; Hamieh, M; Cunanan, KM; Odak, A; Gonen, M; Sadelain, M				Eyquem, Justin; Mansilla-Soto, Jorge; Giavridis, Theodoros; van der Stegen, Sjoukje J. C.; Hamieh, Mohamad; Cunanan, Kristen M.; Odak, Ashlesha; Goenen, Mithat; Sadelain, Michel			Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection	NATURE			English	Article							CHIMERIC ANTIGEN RECEPTORS; T-CELL EXHAUSTION; LYMPHOCYTES; EXPRESSION; DESIGN; PROLIFERATION; INTEGRATION; THERAPY; CD8(+); SITE	Chimeric antigen receptors (CARs) are synthetic receptors that redirect and reprogram T cells to mediate tumour rejection(1). The most successful CARs used to date are those targeting CD19 (ref. 2), which offer the prospect of complete remission in patients with chemorefractory or relapsed B-cell malignancies(3). CARs are typically transduced into the T cells of a patient using gamma-retroviral(4) vectors or other randomly integrating vectors(5), which may result in clonal expansion, oncogenic transformation, variegated transgene expression and transcriptional silencing(6-8). Recent advances in genome editing enable efficient sequence-specific interventions in human cells(9,10), including targeted gene delivery to the CCR5 and AAVS1 loci(11,12). Here we show that directing a CD19-specific CAR to the T-cell receptor a constant (TRAC) locus not only results in uniform CAR expression in human peripheral blood T cells, but also enhances T-cell potency, with edited cells vastly outperforming conventionally generated CAR T cells in a mouse model of acute lymphoblastic leukaemia. We further demonstrate that targeting the CAR to the TRAC locus averts tonic CAR signalling and establishes effective internalization and re-expression of the CAR following single or repeated exposure to antigen, delaying effector T-cell differentiation and exhaustion. These findings uncover facets of CAR immunobiology and underscore the potential of CRISPR/Cas9 genome editing to advance immunotherapies.	[Eyquem, Justin; Mansilla-Soto, Jorge; Giavridis, Theodoros; van der Stegen, Sjoukje J. C.; Hamieh, Mohamad; Odak, Ashlesha; Sadelain, Michel] Sloan Kettering Inst, Ctr Cell Engn, New York, NY 10065 USA; [Eyquem, Justin; Mansilla-Soto, Jorge; Giavridis, Theodoros; van der Stegen, Sjoukje J. C.; Hamieh, Mohamad; Odak, Ashlesha; Sadelain, Michel] Sloan Kettering Inst, Program Immunol, New York, NY 10065 USA; [Cunanan, Kristen M.; Goenen, Mithat] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Sadelain, M (corresponding author), Sloan Kettering Inst, Ctr Cell Engn, New York, NY 10065 USA.; Sadelain, M (corresponding author), Sloan Kettering Inst, Program Immunol, New York, NY 10065 USA.	m-sadelain@ski.mskcc.org	Eyquem, Justin/AAW-5753-2020; Gonen, Mithat/E-4826-2012; Odak, Ashlesha/ABH-1532-2021; Hamieh, Mohamad/AAX-3056-2020	Gonen, Mithat/0000-0001-8683-8477; Odak, Ashlesha/0000-0001-5595-0394; Giavridis, Theodoros/0000-0002-8716-781X; Eyquem, Justin/0000-0001-8262-1190	Lake Road Foundation; Commonwealth Foundation for Cancer Research; Stand Up To Cancer/American Association for Cancer Research; Lymphoma and Leukemia Society; NYSTEM; NYSCF; MSK Cancer Center [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Lake Road Foundation; Commonwealth Foundation for Cancer Research; Stand Up To Cancer/American Association for Cancer Research; Lymphoma and Leukemia Society(Leukemia and Lymphoma Society); NYSTEM; NYSCF; MSK Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank I. Riviere (MSKCC) for helpful discussion and for reviewing the manuscript. We thank the SKI Flow Cytometry core facility and animal facility for excellent support. This work was in part supported by the Lake Road Foundation, the Mr. William H. and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research, Stand Up To Cancer/American Association for Cancer Research (a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research), the Lymphoma and Leukemia Society, NYSTEM, NYSCF and the MSK Cancer Center Support Grant/Core Grant (P30 CA008748).	Allison KA, 2016, ELIFE, V5, DOI 10.7554/eLife.10134; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Corthay A, 2001, J AUTOIMMUN, V16, P423, DOI 10.1006/jaut.2001.0504; de Vree PJP, 2014, NAT BIOTECHNOL, V32, P1019, DOI 10.1038/nbt.2959; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; Frigault MJ, 2015, CANCER IMMUNOL RES, V3, P356, DOI 10.1158/2326-6066.CIR-14-0186; Gade TPF, 2005, CANCER RES, V65, P9080, DOI 10.1158/0008-5472.CAN-05-0436; Gallardo HF, 1997, GENE THER, V4, P1115, DOI 10.1038/sj.gt.3300506; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gong Michael C., 1999, Neoplasia (New York), V1, P123, DOI 10.1038/sj.neo.7900018; Hubbard N, 2016, BLOOD, V127, P2513, DOI 10.1182/blood-2015-11-683235; Jensen MC, 2015, CURR OPIN IMMUNOL, V33, P9, DOI 10.1016/j.coi.2015.01.002; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; RIVIERE I, 1995, P NATL ACAD SCI USA, V92, P6733, DOI 10.1073/pnas.92.15.6733; Riviere I, 2012, BLOOD, V119, P1107, DOI 10.1182/blood-2011-09-349993; Sadelain M., 1992, 9 INT IMM C BUD, V88, P34; Sadelain M, 2015, J CLIN INVEST, V125, P3392, DOI 10.1172/JCI80010; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Schrum AG, 2003, IMMUNOL REV, V196, P7, DOI 10.1046/j.1600-065X.2003.00083.x; Sommermeyer D, 2016, LEUKEMIA, V30, P492, DOI 10.1038/leu.2015.247; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; von Kalle C, 2014, HUM GENE THER, V25, P475, DOI 10.1089/hum.2014.2525; Wang JB, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1121; Wang XY, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.15; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Zhao ZG, 2015, CANCER CELL, V28, P415, DOI 10.1016/j.ccell.2015.09.004	34	874	994	12	513	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					113	+		10.1038/nature21405	http://dx.doi.org/10.1038/nature21405			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0AA	28225754	Green Accepted			2022-12-28	WOS:000395671500043
J	Cartlidge, E				Cartlidge, Edwin			Eastern Europe's laser centers will debut without a star	SCIENCE			English	News Item																			0	12	12	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					785	785		10.1126/science.355.6327.785	http://dx.doi.org/10.1126/science.355.6327.785			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28232531				2022-12-28	WOS:000395127600013
J	Johnson, NF				Johnson, Neil F.			SCIENCE AND BUSINESS To slow or not? Challenges in subsecond networks Advancing understanding of extreme behaviors beyond human response times is vital to our electronics-driven world	SCIENCE			English	Editorial Material									[Johnson, Neil F.] Univ Miami, Dept Phys, Coral Gables, FL 33126 USA	University of Miami	Johnson, NF (corresponding author), Univ Miami, Dept Phys, Coral Gables, FL 33126 USA.	njohnson@physics.miami.edu			National Science Foundation [CNS1522693]; Air Force (AFOSR) [FA9550-16-1-0247]; Division Of Computer and Network Systems [1522693] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Air Force (AFOSR); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	N.F.J. acknowledges funding from the National Science Foundation grant CNS1522693 and Air Force (AFOSR) grant FA9550-16-1-0247 and thanks E. Hunsader and P. Manrique for their assistance with the figure.	[Anonymous], 2016, BBC NEWS; Bain B., 2016, BLOOMBERG; Cartlidge J., 2012, P ICAART 2012, V2, P126; CFTC-SEC, 2010, FIND REG MARK EV MAY; Conway B, 2011, WALL STREET J, V14; Division of Trading and Markets, 2014, EQ MARK STR LIT REV; Eagleman D. M., 2010, SPACE TIME PERCEPTIO, P216; Government Office for Science, 2012, FUT COMP TRAD FIN MA; Johnson N, 2013, SCI REP-UK, V3, DOI 10.1038/srep02627; Kasthuri N, 2003, NATURE, V424, P426, DOI 10.1038/nature01836; Kramer D., 2016, PHYS TODAY; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; McCoy K, 2016, US TODAY; Pappalardo J., 2011, POPULAR MECH; Preis T, 2011, P NATL ACAD SCI USA, V108, P7674, DOI 10.1073/pnas.1019484108; Saariluoma P., 1995, CHESS PLAYERS THINKI, P43; Unit K., 2009, HUMAN REACTION TIMES; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990	18	7	7	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					801	802		10.1126/science.aai8618	http://dx.doi.org/10.1126/science.aai8618			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28232541	Green Submitted			2022-12-28	WOS:000395127600023
J	Tayeb-Fligelman, E; Tabachnikov, O; Moshe, A; Goldshmidt-Tran, O; Sawaya, MR; Coquelle, N; Colletier, JP; Landau, M				Tayeb-Fligelman, Einav; Tabachnikov, Orly; Moshe, Asher; Goldshmidt-Tran, Orit; Sawaya, Michael R.; Coquelle, Nicolas; Colletier, Jacques-Philippe; Landau, Meytal			The cytotoxic Staphylococcus aureus PSM alpha a3 reveals a cross-alpha amyloid-like fibril	SCIENCE			English	Article							RESOLUTION STRUCTURE; FUNCTIONAL AMYLOIDS; BETA; SYNUCLEIN; STATE; OLIGOMERS; CORE; RICH	Amyloids are ordered protein aggregates, found in all kingdoms of life, and are involved in aggregation diseases as well as in physiological activities. In microbes, functional amyloids are often key virulence determinants, yet the structural basis for their activity remains elusive. We determined the fibril structure and function of the highly toxic, 22-residue phenol-soluble modulin alpha 3 (PSM alpha 3) peptide secreted by Staphylococcus aureus. PSMa3 formed elongated fibrils that shared the morphological and tinctorial characteristics of canonical cross-beta eukaryotic amyloids. However, the crystal structure of full-length PSMa3, solved de novo at 1.45 angstrom resolution, revealed a distinctive "cross-alpha" amyloid-like architecture, in which amphipathic a helices stacked perpendicular to the fibril axis into tight self-associating sheets. The cross-alpha fibrillation of PSM alpha 3 facilitated cytotoxicity, suggesting that this assembly mode underlies function in S. aureus.	[Tayeb-Fligelman, Einav; Tabachnikov, Orly; Moshe, Asher; Goldshmidt-Tran, Orit; Landau, Meytal] Technion Israel Inst Technol, Dept Biol, IL-3200003 Haifa, Israel; [Sawaya, Michael R.] Univ Calif Los Angeles, Dept Biol Chem, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Sawaya, Michael R.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Coquelle, Nicolas; Colletier, Jacques-Philippe] Univ Grenoble Alpes, IBS, CEA, CNRS,UMR 5075, F-38044 Grenoble, France	Technion Israel Institute of Technology; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Landau, M (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-3200003 Haifa, Israel.	mlandau@technion.ac.il	Landau, Meytal/J-3075-2012; Landau, Meytal/AAF-3479-2021	Landau, Meytal/0000-0002-1743-3430; Landau, Meytal/0000-0002-1743-3430; Tayeb-Fligelman, Einav/0000-0001-9318-5400; Coquelle, Nicolas/0000-0002-8501-4908; Colletier, Jacques-Philippe/0000-0003-1819-4686; Sawaya, Michael/0000-0003-0874-9043	U.S.-Israel Binational Science Foundation (BSF) [2013254]; Alon Fellowships for Outstanding Young Researchers by the Israeli Council for Higher Education; David and Inez Mayers Career Advancement Chair in Life Sciences; J. and A. Taub Biological Research Fund; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation, Center of Excellence in Integrated Structural Cell Biology [1775/12]; Support for Training and Career Development of Researchers (Marie Curie Career Integration Grants), Seventh Framework Program (FP7) of the European Commission, Single Beneficiary [334260]; BioStruct-X - FP7; France Alzheimer Foundation [FA-AAP-2013-65-101349]; Agence Nationale de la Recherche [ANR-12-BS07-0008-03]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	U.S.-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Alon Fellowships for Outstanding Young Researchers by the Israeli Council for Higher Education; David and Inez Mayers Career Advancement Chair in Life Sciences; J. and A. Taub Biological Research Fund; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation, Center of Excellence in Integrated Structural Cell Biology; Support for Training and Career Development of Researchers (Marie Curie Career Integration Grants), Seventh Framework Program (FP7) of the European Commission, Single Beneficiary; BioStruct-X - FP7; France Alzheimer Foundation; Agence Nationale de la Recherche(French National Research Agency (ANR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to D. Eisenberg for discussions and for his insight. We acknowledge S. Fleishman, R. Diskin, and N. Ben-Tal for helpful comments. M.L. thanks the U.S.-Israel Binational Science Foundation (BSF) (grant no. 2013254); Alon Fellowships for Outstanding Young Researchers by the Israeli Council for Higher Education; David and Inez Mayers Career Advancement Chair in Life Sciences; the J. and A. Taub Biological Research Fund; the I-CORE Program of the Planning and Budgeting Committee and the Israel Science Foundation, Center of Excellence in Integrated Structural Cell Biology (grant no. 1775/12); the Support for Training and Career Development of Researchers (Marie Curie Career Integration Grants), Seventh Framework Program (FP7) of the European Commission, Single Beneficiary (grant no. 334260), and BioStruct-X funded by FP7. J.-P.C. gratefully acknowledges the support of the France Alzheimer Foundation (FA-AAP-2013-65-101349) and the Agence Nationale de la Recherche (ANR-12-BS07-0008-03). M. R. S. acknowledges support from the Howard Hughes Medical Institute. We acknowledge Y. Pazy-Benhar, H. Dvir, and D. Hiya (Technion Center for Structural Biology). We thank M. Baskin (Technion) for support with CD experiments. This work is based on research conducted at the Northeastern Collaborative Access Team beamlines of the Advanced Photon Source (APS), Argonne National Laboratory, and the ID13 and ID23-EH2 beamlines at the European Synchrotron Radiation Facility (ESRF). We appreciatively acknowledge ESRF and APS for beamtime and assistance during data collection. Coordinates and structure factors for the x-ray crystal structures of PSMa3 have been deposited in the Protein Data Bank (PDB) with accession code 5I55.	Bousset L, 2002, EMBO J, V21, P2903, DOI 10.1093/emboj/cdf303; Brunette TJ, 2015, NATURE, V528, P580, DOI 10.1038/nature16162; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chen SW, 2015, P NATL ACAD SCI USA, V112, pE1994, DOI 10.1073/pnas.1421204112; Cheung GYC, 2014, FASEB J, V28, P153, DOI 10.1096/fj.13-232041; Colletier JP, 2011, P NATL ACAD SCI USA, V108, P16938, DOI 10.1073/pnas.1112600108; Colvin MT, 2016, J AM CHEM SOC, V138, P9663, DOI 10.1021/jacs.6b05129; DePas WH, 2012, RES MICROBIOL, V163, P592, DOI 10.1016/j.resmic.2012.10.009; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Ghosh D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09228; Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010; Laabei M, 2014, BBA-BIOMEMBRANES, V1838, P3153, DOI 10.1016/j.bbamem.2014.08.026; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Mondal S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9615; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Prive GG, 1999, PROTEIN SCI, V8, P1400, DOI 10.1110/ps.8.7.1400; Rodriguez DD, 2009, NAT METHODS, V6, P651, DOI [10.1038/NMETH.1365, 10.1038/nmeth.1365]; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schmidt M, 2015, P NATL ACAD SCI USA, V112, P11858, DOI 10.1073/pnas.1503455112; Schubeis T, 2015, ANGEW CHEM INT EDIT, V54, P14669, DOI 10.1002/anie.201506772; Schwartz K, 2016, MOL MICROBIOL, V99, P123, DOI 10.1111/mmi.13219; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Shewmaker F, 2009, J BIOL CHEM, V284, P25065, DOI 10.1074/jbc.M109.007054; Stefani M, 2012, PROG NEUROBIOL, V99, P226, DOI 10.1016/j.pneurobio.2012.03.002; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Taylor KS, 1996, PROTEIN SCI, V5, P414; Towle KM, 2016, BIOCHEMISTRY-US, V55, P4798, DOI 10.1021/acs.biochem.6b00615; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991	33	163	170	4	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					831	833		10.1126/science.aaf4901	http://dx.doi.org/10.1126/science.aaf4901			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28232575	Green Accepted, Green Submitted			2022-12-28	WOS:000395127600039
J	Genovese, G; Carugo, A; Tepper, J; Robinson, FS; Li, LR; Svelto, M; Nezi, L; Corti, D; Minelli, R; Pettazzoni, P; Gutschner, T; Wu, CC; Seth, S; Akdemir, KC; Leo, E; Amin, S; Dal Molin, M; Ying, HQ; Kwong, LN; Colla, S; Takahashi, K; Ghosh, P; Giuliani, V; Muller, F; Dey, P; Jiang, S; Garvey, J; Liu, CG; Zhang, JH; Heffernan, TP; Toniatti, C; Fleming, JB; Goggins, MG; Wood, LD; Sgambato, A; Agaimy, A; Maitra, A; Roberts, CWM; Wang, HM; Viale, A; DePinho, RA; Draetta, GF; Chin, L				Genovese, Giannicola; Carugo, Alessandro; Tepper, James; Robinson, Frederick Scott; Li, Liren; Svelto, Maria; Nezi, Luigi; Corti, Denise; Minelli, Rosalba; Pettazzoni, Piergiorgio; Gutschner, Tony; Wu, Chia-Chin; Seth, Sahil; Akdemir, Kadir Caner; Leo, Elisabetta; Amin, Samirkumar; Dal Molin, Marco; Ying, Haoqiang; Kwong, Lawrence N.; Colla, Simona; Takahashi, Koichi; Ghosh, Papia; Giuliani, Virginia; Muller, Florian; Dey, Prasenjit; Jiang, Shan; Garvey, Jill; Liu, Chang-Gong; Zhang, Jianhua; Heffernan, Timothy P.; Toniatti, Carlo; Fleming, Jason B.; Goggins, Michael G.; Wood, Laura D.; Sgambato, Alessandro; Agaimy, Abbas; Maitra, Anirban; Roberts, Charles W. M.; Wang, Huamin; Viale, Andrea; DePinho, Ronald A.; Draetta, Giulio F.; Chin, Lynda			Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer	NATURE			English	Article							RNA INTERFERENCE; TUMOR XENOGRAFTS; GENE-EXPRESSION; PROTEIN-KINASE; CELL FATE; P53 LOSS; REVEALS; EMT; ADENOCARCINOMA; PROGRESSION	Malignant neoplasms evolve in response to changes in oncogenic signalling(1). Cancer cell plasticity in response to evolutionary pressures is fundamental to tumour progression and the development of therapeutic resistance(2,3). Here we determine the molecular and cellular mechanisms of cancer cell plasticity in a conditional oncogenic Kras mouse model of pancreatic ductal adenocarcinoma (PDAC), a malignancy that displays considerable phenotypic diversity and morphological heterogeneity. In this model, stochastic extinction of oncogenic Kras signalling and emergence of Kras-independent escaper populations (cells that acquire oncogenic properties) are associated with de-differentiation and aggressive biological behaviour. Transcriptomic and functional analyses of Kras-independent escapers reveal the presence of Smarcb1-Myc-network-driven mesenchymal reprogramming and independence from MAPK signalling. A somatic mosaic model of PDAC, which allows time-restricted perturbation of cell fate, shows that depletion of Smarcb1 activates the Myc network, driving an anabolic switch that increases protein metabolism and adaptive activation of endoplasmic-reticulum-stress-induced survival pathways. Increased protein turnover renders mesenchymal sub-populations highly susceptible to pharmacological and genetic perturbation of the cellular proteostatic machinery and the IRE1-alpha-MKK4 arm of the endoplasmic-reticulum-stress-response pathway. Specifically, combination regimens that impair the unfolded protein responses block the emergence of aggressive mesenchymal subpopulations in mouse and patient-derived PDAC models. These molecular and biological insights inform a potential therapeutic strategy for targeting aggressive mesenchymal features of PDAC.	[Genovese, Giannicola; Carugo, Alessandro; Tepper, James; Robinson, Frederick Scott; Li, Liren; Svelto, Maria; Nezi, Luigi; Corti, Denise; Minelli, Rosalba; Pettazzoni, Piergiorgio; Gutschner, Tony; Wu, Chia-Chin; Seth, Sahil; Akdemir, Kadir Caner; Amin, Samirkumar; Takahashi, Koichi; Viale, Andrea; Draetta, Giulio F.; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Carugo, Alessandro; Robinson, Frederick Scott; Leo, Elisabetta; Giuliani, Virginia; Garvey, Jill; Zhang, Jianhua; Heffernan, Timothy P.; Draetta, Giulio F.; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Carugo, Alessandro] European Inst Oncol, I-20141 Milan, Italy; [Li, Liren] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China; [Svelto, Maria; Sgambato, Alessandro] Univ Cattolica Sacro Cuore, Ist Patol Gen, I-00168 Rome, Italy; [Amin, Samirkumar] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Dal Molin, Marco; Goggins, Michael G.; Wood, Laura D.] Johns Hopkins Univ, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21287 USA; [Ying, Haoqiang] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Kwong, Lawrence N.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Colla, Simona; Takahashi, Koichi] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Ghosh, Papia] Univ Texas MD Anderson Canc Ctr, Off Technol Commercializat, Houston, TX 77030 USA; [Muller, Florian] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA; [Dey, Prasenjit; Jiang, Shan; DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Liu, Chang-Gong] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Toniatti, Carlo] Univ Texas MD Anderson Canc Ctr, ORBIT Platform, Houston, TX 77030 USA; [Fleming, Jason B.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Agaimy, Abbas] Friedrich Alexander Univ Erlangen Nuremberg, Univ Hosp, Dept Pathol, D-91054 Erlangen, Germany; [Maitra, Anirban; Wang, Huamin] Friedrich Alexander Univ Erlangen Nuremberg, Dept Pathol, D-91054 Erlangen, Germany; [Maitra, Anirban] Friedrich Alexander Univ Erlangen Nuremberg, Sheikh Ahmed Bin Zayed Nahyan Ctr Pancreat Canc R, D-91054 Erlangen, Germany; [Roberts, Charles W. M.] St Jude Childrens Res Hosp, Ctr Comprehens Canc, Memphis, TN 77027 USA; [Roberts, Charles W. M.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 77027 USA; [Heffernan, Timothy P.] C4 Therapeut, Cambridge, MA 02142 USA; [Chin, Lynda] Univ Texas Syst, Inst Hlth Transformat, Austin, TX 78701 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; IRCCS European Institute of Oncology (IEO); State Key Lab Oncology South China; Sun Yat Sen University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Baylor College of Medicine; Johns Hopkins University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Texas System; University of Texas Austin	Genovese, G; Draetta, GF; Chin, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA.; Draetta, GF; Chin, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA.	ggenovese@mdanderson.org; gdraetta@mdanderson.org; lchin@mdanderson.org	Nezi, Luigi/AAB-1957-2019; Ying, Haoqiang/AAK-4325-2020; Wu, Chia-Chin/ABD-5516-2021; Pettazzoni, Piergiorgio/GRJ-3011-2022; Roberts, Charles/N-2541-2018; Wood, Laura/ABF-1531-2020; Gutschner, Tony/I-3944-2019; Seth, Sahil/I-5809-2019; Amin, Samirkumar B/H-3184-2019	Nezi, Luigi/0000-0002-4670-7656; Wu, Chia-Chin/0000-0002-5208-6016; Roberts, Charles/0000-0003-1135-1896; Gutschner, Tony/0000-0002-1722-3134; Seth, Sahil/0000-0003-4579-3959; Amin, Samirkumar B/0000-0002-3207-9505; Colla, Simona/0000-0001-6583-8910; Pettazzoni, Piergiorgio/0000-0001-9039-2463; Genovese, Giannicola/0000-0003-1392-9954; DePinho, Ronald/0000-0002-5625-577X; Carugo, Alessandro/0000-0001-5182-3320; Toniatti, Carlo/0000-0001-9493-344X; Robinson, Frederick/0000-0003-1188-0376; Muller, Florian/0000-0001-7568-2948	High Resolution Electron Microscopy Facility at MDACC for TEM (Cancer Center Core Grant) [CA16672]; CPRIT [R1204]; NIH [5 U01 CA141508]; AACR [14-90-25]; Sheikh Ahmed Bin Zayed Al Nahyan Center for Pancreatic Cancer Grant; FIRC (Fondazione Italiana per la Ricerca sul Cancro) Fellowship; FIRC fellowship; NATIONAL CANCER INSTITUTE [R00CA218891, K99CA218891, U01CA141508, P30CA016672, P50CA062924] Funding Source: NIH RePORTER	High Resolution Electron Microscopy Facility at MDACC for TEM (Cancer Center Core Grant); CPRIT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AACR; Sheikh Ahmed Bin Zayed Al Nahyan Center for Pancreatic Cancer Grant; FIRC (Fondazione Italiana per la Ricerca sul Cancro) Fellowship(Fondazione AIRC per la ricerca sul cancro); FIRC fellowship(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Spring, A. Futreal, P Jones, J. Marszalek, I. Watson, Y. Lissanu Deribe, K. Rai and J. Horner for discussions and suggestions We thank A. Petrocchi, E. Di Francesco, E. Paul and T lieu for providing reagents We wish to thank the members of the Chin, DePinho and Draetta labs for discussions and reagents; K. Dunner, Jr. and the High Resolution Electron Microscopy Facility at MDACC for TEM (Cancer Center Core Grant CA16672); M. Keith, C. Kingsley, the MDACC Small Animals Imaging Facility, the UTMDACC Microarray Core Facility, the MDACC Department of Veterinary Medicine and the UTMDACC Flow Facility. L.C. was supported by the CPRIT R1204 and NIH 5 U01 CA141508. G.F.D. was supported by the AACR 14-90-25 and by the Sheikh Ahmed Bin Zayed Al Nahyan Center for Pancreatic Cancer Grant. A.C. was supported by the FIRC (Fondazione Italiana per la Ricerca sul Cancro) Fellowship. G.G. was supported by the FIRC fellowship.	Agaimy A, 2015, MODERN PATHOL, V28, P248, DOI 10.1038/modpathol.2014.100; Agaimy A, 2014, ADV ANAT PATHOL, V21, P394, DOI 10.1097/PAP.0000000000000038; Agaimy A, 2014, AM J SURG PATHOL, V38, P910, DOI 10.1097/PAS.0000000000000173; Agbunag C, 2006, METHOD ENZYMOL, V407, P703, DOI 10.1016/S0076-6879(05)07055-2; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Aparicio S, 2015, NAT REV CANCER, V15, P311, DOI 10.1038/nrc3944; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Beerling E, 2016, CELL REP, V14, P2281, DOI 10.1016/j.celrep.2016.02.034; Bonnefoix T, 1996, J IMMUNOL METHODS, V194, P113, DOI 10.1016/0022-1759(96)00077-4; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Carugo A, 2016, CELL REP, V16, P133, DOI 10.1016/j.celrep.2016.05.063; Chen YN, 2013, TRENDS CELL BIOL, V23, P547, DOI 10.1016/j.tcb.2013.06.005; Cheung AF, 2008, CANCER RES, V68, P9459, DOI 10.1158/0008-5472.CAN-08-2634; Chien WW, 2014, ONCOTARGET, V5, P4881, DOI 10.18632/oncotarget.2051; Chiou SH, 2015, GENE DEV, V29, P1576, DOI 10.1101/gad.264861.115; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Creighton CJ, 2006, CANCER RES, V66, P3903, DOI 10.1158/0008-5472.CAN-05-4363; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Genovese G, 2012, CANCER DISCOV, V2, P736, DOI 10.1158/2159-8290.CD-12-0111; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Isakoff MS, 2005, P NATL ACAD SCI USA, V102, P17745, DOI 10.1073/pnas.0509014102; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kim MP, 2012, ANN SURG ONCOL, V19, pS395, DOI 10.1245/s10434-011-1839-4; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Kissler S, 2006, NAT GENET, V38, P479, DOI 10.1038/ng1766; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Lao ZM, 2012, CELL REP, V2, P386, DOI 10.1016/j.celrep.2012.07.004; Lee CL, 2012, DIS MODEL MECH, V5, P397, DOI 10.1242/dmm.009084; Lee KE, 2010, CANCER CELL, V18, P448, DOI 10.1016/j.ccr.2010.10.020; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Ma YH, 2002, ARCH BIOCHEM BIOPHYS, V399, P212, DOI 10.1006/abbi.2002.2761; Marino S, 2000, GENE DEV, V14, P994; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Noll EM, 2016, NAT MED, V22, P278, DOI 10.1038/nm.4038; Pisco AO, 2015, BRIT J CANCER, V112, P1725, DOI 10.1038/bjc.2015.146; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reichert M, 2013, NAT PROTOC, V8, P1354, DOI 10.1038/nprot.2013.079; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Rudalska R, 2014, NAT MED, V20, P1138, DOI 10.1038/nm.3679; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Young NP, 2011, CANCER RES, V71, P4040, DOI 10.1158/0008-5472.CAN-10-4563; Young NP, 2010, P NATL ACAD SCI USA, V107, P10184, DOI 10.1073/pnas.1004796107	58	72	74	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					362	+		10.1038/nature21064	http://dx.doi.org/10.1038/nature21064			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2LQ	28178232	Green Accepted			2022-12-28	WOS:000394451600040
J	Payne, D				Payne, David			Rosamund Snow OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												davidrpayne@gmail.com							0	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2017	356								j850	10.1136/bmj.j850	http://dx.doi.org/10.1136/bmj.j850			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GN	28209635	Green Published, Bronze			2022-12-28	WOS:000394579800011
J	Taylor, PC; Keystone, EC; van der Heijde, D; Weinblatt, ME; Morales, LD; Gonzaga, JR; Yakushin, S; Ishii, T; Emoto, K; Beattie, S; Arora, V; Gaich, C; Rooney, T; Schlichting, D; Macias, WL; de Bono, S; Tanaka, Y				Taylor, Peter C.; Keystone, Edward C.; van der Heijde, Desiree; Weinblatt, Michael E.; del Carmen Morales, Liliana; Reyes Gonzaga, Jaime; Yakushin, Sergey; Ishii, Taeko; Emoto, Kahaku; Beattie, Scott; Arora, Vipin; Gaich, Carol; Rooney, Terence; Schlichting, Douglas; Macias, William L.; de Bono, Stephanie; Tanaka, Yoshiya			Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE-ACTIVITY INDEX; PLUS METHOTREXATE; DOUBLE-BLIND; EFFICACY; THERAPY; VALIDATION; SAFETY; HAD	BACKGROUND Baricitinib is an oral, reversible inhibitor of the Janus kinases JAK1 and JAK2 that may have therapeutic value in patients with rheumatoid arthritis. METHODS We conducted a 52-week, phase 3, double-blind, placebo-and active-controlled trial in which 1307 patients with active rheumatoid arthritis who were receiving background therapy with methotrexate were randomly assigned to one of three regimens in a 3: 3: 2 ratio: placebo (switched to baricitinib after 24 weeks), 4 mg of baricitinib once daily, or 40 mg of adalimumab (an anti-tumor necrosis factor a monoclonal antibody) every other week. End-point measures evaluated after adjustment for multiplicity included 20% improvement according to the criteria of the American College of Rheumatology (ACR20 response) (the primary end point), the Disease Activity Score for 28 joints (DAS28), the Health Assessment Questionnaire-Disability Index, and the Simplified Disease Activity Index at week 12, as well as radiographic progression of joint damage as measured by the van der Heijde modification of the total Sharp score (mTSS) (range, 0 to 448, with higher scores indicating greater structural joint damage) at week 24. RESULTS More patients had an ACR20 response at week 12 with baricitinib than with placebo (primary end point, 70% vs. 40%, P< 0.001). All major secondary objectives were met, including inhibition of radiographic progression of joint damage, according to the mTSS at week 24 with baricitinib versus placebo (mean change from baseline, 0.41 vs. 0.90; P< 0.001) and an increased ACR20 response rate at week 12 with baricitinib versus adalimumab (70% vs. 61%, P = 0.014). Adverse events, including infections, were more frequent through week 24 with baricitinib and adalimumab than with placebo. Cancers were reported in five patients (two who received baricitinib and three who received placebo). Baricitinib was associated with reductions in neutrophil counts and increases in levels of creatinine and low-density lipoprotein cholesterol. CONCLUSIONS In patients with rheumatoid arthritis who had had an inadequate response to methotrexate, baricitinib was associated with significant clinical improvements as compared with placebo and adalimumab.	[Taylor, Peter C.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskel S, Oxford, England; [Taylor, Peter C.] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Keystone, Edward C.] Univ Toronto, Mt Sinai Hosp, Rebecca MacDonald Ctr, Toronto, ON, Canada; [van der Heijde, Desiree] Leiden Univ, Med Ctr, Leiden, Netherlands; [Weinblatt, Michael E.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [del Carmen Morales, Liliana] Inst Reumatol Strusberg, Cordoba, Argentina; [Reyes Gonzaga, Jaime] Ctr Invest Clin Especializada, Mexico City, DF, Mexico; [Yakushin, Sergey] Ryazan Reg Clin Cardiol Dispensary, Ryazan, Russia; [Ishii, Taeko; Beattie, Scott; Arora, Vipin; Gaich, Carol; Rooney, Terence; Schlichting, Douglas; Macias, William L.; de Bono, Stephanie] Eli Lilly, Indianapolis, IN USA; [Emoto, Kahaku] AstraZeneca KK, Osaka, Japan; [Tanaka, Yoshiya] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Kitakyushu, Fukuoka, Japan	University of Oxford; University of Oxford; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Brigham & Women's Hospital; Eli Lilly; AstraZeneca; University of Occupational & Environmental Health - Japan	Taylor, PC (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Windmill Rd, Oxford OX3 7LD, England.	peter.taylor@kennedy.ox.ac.uk	van der Heijde, Désirée/I-6774-2019; Yakushin, Sergey/N-4165-2013	van der Heijde, Désirée/0000-0002-5781-158X; Gomez-Reino, Juan/0000-0001-5229-6294; Beattie, Scott/0000-0003-2710-1234; Yakushin, Sergey/0000-0001-7202-742X	Eli Lilly; Incyte [NCT01710358]	Eli Lilly(Eli Lilly); Incyte	Funded by Eli Lilly and Incyte; ClinicalTrials.gov number, NCT01710358.	Aletaha D, 2005, CLIN EXP RHEUMATOL, V23, pS100; Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; Alosh M, 2014, STAT MED, V33, P693, DOI 10.1002/sim.5974; [Anonymous], 2016, DIS ACT SCOR RHEUM A; [Anonymous], 2015, ANN RHEUM DIS; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Bretz F, 2009, STAT MED, V28, P586, DOI 10.1002/sim.3495; Curtis JR, 2011, CLIN THER, V33, P679, DOI 10.1016/j.clinthera.2011.05.044; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; FRIES JF, 1982, J RHEUMATOL, V9, P789; Genovese MC, 2016, NEW ENGL J MED, V374, P1243, DOI 10.1056/NEJMoa1507247; Jones G, 2010, ANN RHEUM DIS, V69, P88, DOI 10.1136/ard.2008.105197; Keystone EC, 2015, ANN RHEUM DIS, V74, P333, DOI 10.1136/annrheumdis-2014-206478; Moreland LW, 2012, ARTHRITIS RHEUM-US, V64, P2824, DOI 10.1002/art.34498; Nam JL, 2014, ANN RHEUM DIS, V73, P516, DOI 10.1136/annrheumdis-2013-204577; O'Shea JJ, 2013, ANN RHEUM DIS, V72, P111, DOI 10.1136/annrheumdis-2012-202576; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Tanaka Y, 2016, J RHEUMATOL, V43, P504, DOI 10.3899/jrheum.150613; van der Heijde D, 2000, J RHEUMATOL, V27, P261; Van der Heijde DMFM, 2004, J RHEUMATOL, V31, P46; Weinblatt ME, 2013, ARTHRITIS RHEUM-US, V65, P28, DOI 10.1002/art.37711	24	450	470	7	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2017	376	7					652	662		10.1056/NEJMoa1608345	http://dx.doi.org/10.1056/NEJMoa1608345			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO0QJ	28199814	Green Published			2022-12-28	WOS:000396402700016
J	[Anonymous]				[Anonymous]			MATERIALS Hybrid film cools in the Sun	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					274	274		10.1038/542274c	http://dx.doi.org/10.1038/542274c			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7YF	28202957	Bronze			2022-12-28	WOS:000454457400002
J	Hasuwa, H; Siomi, H				Hasuwa, Hidetoshi; Siomi, Haruhiko			Mobile elements control stem cell potency	SCIENCE			English	Editorial Material									[Hasuwa, Hidetoshi; Siomi, Haruhiko] Keio Univ, Sch Med, Dept Mol Biol, Tokyo 1608582, Japan	Keio University	Hasuwa, H (corresponding author), Keio Univ, Sch Med, Dept Mol Biol, Tokyo 1608582, Japan.	awa403@keio.jp	Siomi, Haruhiko/A-7020-2015	Siomi, Haruhiko/0000-0001-8690-3822				Choi YJ, 2017, SCIENCE, V355, DOI 10.1126/science.aag1927; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Fedoroff NV, 2012, SCIENCE, V338, P758, DOI 10.1126/science.338.6108.758; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Schlesinger S, 2015, MOL CELL BIOL, V35, P770, DOI 10.1128/MCB.01293-14; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Takahashi K, 2015, DEVELOPMENT, V142, P3274, DOI 10.1242/dev.114249; Wang JC, 2014, NATURE, V516, P405, DOI 10.1038/nature13804	10	0	0	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					581	582		10.1126/science.aam6589	http://dx.doi.org/10.1126/science.aam6589			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK0SF	28183937				2022-12-28	WOS:000393636700028
J	Sreekantan, BV; Cowsik, R				Sreekantan, Badanaval Venkatasubba; Cowsik, Ram			M. G. K. Menon (1928-2016)	SCIENCE			English	Biographical-Item									[Sreekantan, Badanaval Venkatasubba] Natl Inst Adv Studies, Bangalore, Karnataka, India; [Cowsik, Ram] Washington Univ, Dept Phys, St Louis, MO 63130 USA	Washington University (WUSTL)	Cowsik, R (corresponding author), Washington Univ, Dept Phys, St Louis, MO 63130 USA.	cowsik@physics.wustl.edu						MENON MGK, PUBLICATION LIST	1	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					586	586		10.1126/science.aam8130	http://dx.doi.org/10.1126/science.aam8130			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK0SF	28183940				2022-12-28	WOS:000393636700031
J	Chen, Z; Chen, SJ				Chen, Zhu; Chen, Sai-Juan			Poisoning the Devil	CELL			English	Editorial Material									[Chen, Zhu; Chen, Sai-Juan] St Louis Hosp Paris, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Chen, Z (corresponding author), St Louis Hosp Paris, Paris, France.								0	17	18	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2017	168	4					556	560		10.1016/j.cell.2017.01.029	http://dx.doi.org/10.1016/j.cell.2017.01.029			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8VJ	28187275	Bronze			2022-12-28	WOS:000396277600004
J	[Anonymous]				[Anonymous]			Cancer: The Road Ahead	CELL			English	Editorial Material																			0	4	4	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2017	168	4					545	546		10.1016/j.cell.2017.01.036	http://dx.doi.org/10.1016/j.cell.2017.01.036			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8VJ	28187271	Bronze			2022-12-28	WOS:000396277600001
J	Weintraub, RG; Semsarian, C; Macdonald, P				Weintraub, Robert G.; Semsarian, Christopher; Macdonald, Peter			Dilated cardiomyopathy	LANCET			English	Review							LEFT-VENTRICULAR NONCOMPACTION; CHRONIC-HEART-FAILURE; CARDIAC-RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MAGNETIC-RESONANCE; CARDIOLOGY WORKING GROUP; PEDIATRIC CARDIOMYOPATHY; INTERNATIONAL SOCIETY; MUSCULAR-DYSTROPHY; POSITION STATEMENT; ACUTE MYOCARDITIS	Dilated cardiomyopathy is defined by the presence of left ventricular dilatation and contractile dysfunction. Genetic mutations involving genes that encode cytoskeletal, sarcomere, and nuclear envelope proteins, among others, account for up to 35% of cases. Acquired causes include myocarditis and exposure to alcohol, drugs and toxins, and metabolic and endocrine disturbances. The most common presenting symptoms relate to congestive heart failure, but can also include circulatory collapse, arrhythmias, and thromboembolic events. Secondary neurohormonal changes contribute to reverse remodelling and ongoing myocyte damage. The prognosis is worst for individuals with the lowest ejection fractions or severe diastolic dysfunction. Treatment of chronic heart failure comprises medications that improve survival and reduce hospital admission-namely, angiotensin converting enzyme inhibitors and beta blockers. Other interventions include enrolment in a multidisciplinary heart failure service, and device therapy for arrhythmia management and sudden death prevention. Patients who are refractory to medical therapy might benefit from mechanical circulatory support and heart transplantation. Treatment of preclinical disease and the potential role of stem-cell therapy are being investigated.	[Weintraub, Robert G.] Royal Childrens Hosp, Dept Cardiol, Melbourne, Vic 3052, Australia; [Weintraub, Robert G.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Weintraub, Robert G.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Semsarian, Christopher] Agnes Ginges Ctr Mol Cardiol, Centenary Inst, Sydney, NSW, Australia; [Semsarian, Christopher] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Semsarian, Christopher] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia; [Macdonald, Peter] St Vincents Hosp, Sydney, NSW, Australia; [Macdonald, Peter] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia	Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Melbourne; University of Sydney; Centenary Institute; University of Sydney; University of Sydney; St Vincents Hospital Sydney; Victor Chang Cardiac Research Institute	Weintraub, RG (corresponding author), Royal Childrens Hosp, Dept Cardiol, Melbourne, Vic 3052, Australia.	robert.weintraub@rch.org.au			National Health and Medical Research Council [1059156]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	CS is the recipient of a National Health and Medical Research Council Practitioner Fellowship (1059156). We thank Andrew Davis who supplied the electrocardiograms and Andrew Jabbour who supplied the MRI image.	Aaronson KD, 2012, CIRCULATION, V125, P3191, DOI 10.1161/CIRCULATIONAHA.111.058412; Abdel-Aty H, 2005, J AM COLL CARDIOL, V45, P1815, DOI 10.1016/j.jacc.2004.11.069; Acker MA, 2011, J THORAC CARDIOV SUR, V142, P569, DOI 10.1016/j.jtcvs.2010.10.051; Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1016/j.hrthm.2011.05.020, 10.1093/europace/eur245]; Afonso L, 2007, AM J CARDIOL, V100, P1040, DOI 10.1016/j.amjcard.2007.04.049; Alexander PMA, 2013, CIRCULATION, V128, P2039, DOI 10.1161/CIRCULATIONAHA.113.002767; Alter P, 2012, INT J CARDIOL, V157, P233, DOI 10.1016/j.ijcard.2011.07.092; Apple FS, 2007, CIRCULATION, V116, pE95, DOI 10.1161/CIRCULATIONAHA.107.185266; Arbustini E, 2014, J AM COLL CARDIOL, V64, P1840, DOI 10.1016/j.jacc.2014.08.030; Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3; Ashford MW, 2005, CIRCULATION, V112, P2462, DOI 10.1161/CIRCULATIONAHA.104.516716; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Baughman KL, 2006, CIRCULATION, V113, P593, DOI 10.1161/CIRCULATIONAHA.105.589663; Beckermann TM, 2014, HEART RHYTHM, V11, P1446, DOI 10.1016/j.hrthm.2014.04.042; BERKO BA, 1987, NEW ENGL J MED, V316, P1186, DOI 10.1056/NEJM198705073161904; Bharucha T, 2015, J AM COLL CARDIOL, V65, P2302, DOI 10.1016/j.jacc.2015.03.552; BIONE S, 1995, HUM MOL GENET, V4, P1859; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Blume ED, 2016, J HEART LUNG TRANSPL; Bolli R, 2015, EUR HEART J, V36, P2905, DOI 10.1093/eurheartj/ehv454; Bowles NE, 2000, HERZ, V25, P168, DOI 10.1007/s000590050003; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Castagno D, 2012, EUR HEART J, V33, P1137, DOI 10.1093/eurheartj/ehs004; CETTA F, 1995, CURR OPIN CARDIOL, V10, P332, DOI 10.1097/00001573-199505000-00015; Charron P, 2010, EUR HEART J, V31, P2715, DOI 10.1093/eurheartj/ehq271; Chen HH, 2013, JAMA-J AM MED ASSOC, V310, P2533, DOI 10.1001/jama.2013.282190; CHOW LH, 1989, J AM COLL CARDIOL, V14, P915, DOI 10.1016/0735-1097(89)90465-8; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cooper LT, 2007, J AM COLL CARDIOL, V50, P1914, DOI 10.1016/j.jacc.2007.09.008; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Cowie MR, 2015, NEW ENGL J MED, V373, P1095, DOI 10.1056/NEJMoa1506459; D'Ambrosio A, 2001, HEART, V85, P499, DOI 10.1136/heart.85.5.499; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Dipchand AI, 2015, J HEART LUNG TRANSPL, V34, P1233, DOI 10.1016/j.healun.2015.08.002; DRUCKER NA, 1994, CIRCULATION, V89, P252, DOI 10.1161/01.CIR.89.1.252; Duboc D, 2005, J AM COLL CARDIOL, V45, P855, DOI 10.1016/j.jacc.2004.09.078; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Fabre A, 2006, HEART, V92, P316, DOI 10.1136/hrt.2004.045518; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Fatkin D, 2011, CIRC-CARDIOVASC GENE, V4, P342, DOI 10.1161/CIRCGENETICS.110.958918; Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419; Fernandez-Sola J, 2015, NAT REV CARDIOL, V12, P576, DOI 10.1038/nrcardio.2015.91; Finsterer J, 2008, SCAND CARDIOVASC J, V42, P25, DOI 10.1080/14017430701744451; Flynn KE, 2009, JAMA-J AM MED ASSOC, V301, P1451, DOI 10.1001/jama.2009.457; Foerster SR, 2010, CIRC-HEART FAIL, V3, P689, DOI 10.1161/CIRCHEARTFAILURE.109.902833; Friedrich MG, 2013, CIRC-CARDIOVASC IMAG, V6, P833, DOI 10.1161/CIRCIMAGING.113.000416; Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007; Frustaci A, 2003, CIRCULATION, V107, P857, DOI 10.1161/01.CIR.0000048147.15962.31; Gati S, 2013, INT J CARDIOL, V168, P1658, DOI 10.1016/j.ijcard.2013.03.039; Gati S, 2014, CIRCULATION, V130, P475, DOI 10.1161/CIRCULATIONAHA.114.008554; Gati S, 2013, HEART, V99, P401, DOI 10.1136/heartjnl-2012-303418; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Giatrakos N, 2006, HEART, V92, P840, DOI 10.1136/hrt.2005.067710; Givertz MM, 2013, J CARD FAIL, V19, P371, DOI 10.1016/j.cardfail.2013.04.002; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105; Hershberger RE, 2009, J CARD FAIL, V15, P83, DOI 10.1016/j.cardfail.2009.01.006; Hilfiker-Kleiner D, 2008, TRENDS CARDIOVAS MED, V18, P173, DOI 10.1016/j.tcm.2008.05.002; Hjalmarson A, 1999, LANCET, V353, P2001; Hsiao R, 2016, PROG CARDIOVASC DIS, V58, P367, DOI 10.1016/j.pcad.2015.12.005; Hsu Daphne T, 2010, Heart Fail Clin, V6, P415, DOI 10.1016/j.hfc.2010.05.003; Ichida F, 1999, J AM COLL CARDIOL, V34, P233, DOI 10.1016/S0735-1097(99)00170-9; Ingles J, 2014, TRENDS CARDIOVAS MED, V24, P217, DOI 10.1016/j.tcm.2014.05.009; Jasseron C, 2016, TRANSPLANTATION, V100, P1979, DOI 10.1097/TP.0000000000001265; Jefferies JL, 2015, J CARD FAIL, V21, P877, DOI 10.1016/j.cardfail.2015.06.381; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; KEOGH AM, 1990, AM J CARDIOL, V65, P903, DOI 10.1016/0002-9149(90)91434-8; Kindermann I, 2008, CIRCULATION, V118, P639, DOI 10.1161/CIRCULATIONAHA.108.769489; Kindermann I, 2012, J AM COLL CARDIOL, V59, P779, DOI 10.1016/j.jacc.2011.09.074; Kirk R, 2014, J HEART LUNG TRANSPL, V33, P888, DOI 10.1016/j.healun.2014.06.002; Klatsky Arthur L, 2009, Expert Rev Cardiovasc Ther, V7, P499, DOI 10.1586/erc.09.22; Kober L, 2016, NEW ENGL J MED, V375, P1221, DOI 10.1056/NEJMoa1608029; Krum H, 2011, MED J AUSTRALIA, V194, P405, DOI 10.5694/j.1326-5377.2011.tb03031.x; Kuhl U, 2005, CIRCULATION, V111, P887, DOI 10.1161/01.CIR.0000155616.07901.35; Lakdawala NK, 2013, CIRC-ARRHYTHMIA ELEC, V6, P228, DOI 10.1161/CIRCEP.111.962050; Laonigro I, 2009, EUR J HEART FAIL, V11, P453, DOI 10.1093/eurjhf/hfp037; Laurent G, 2012, J AM COLL CARDIOL, V60, P144, DOI 10.1016/j.jacc.2012.02.052; Lechat P, 1999, LANCET, V353, P9; LEWIS JF, 1993, J AM COLL CARDIOL, V21, P649, DOI 10.1016/0735-1097(93)90097-K; Lipshultz SE, 2005, J CLIN ONCOL, V23, P2629, DOI 10.1200/JCO.2005.12.121; Lipshultz SE, 2004, NEW ENGL J MED, V351, P145, DOI 10.1056/NEJMoa035153; Lipshultz SE, 2003, NEW ENGL J MED, V348, P1647, DOI 10.1056/NEJMoa021715; Lipshultz SE, 2013, CIRCULATION, V128, P1927, DOI 10.1161/CIR.0b013e3182a88099; Lund LH, 2015, J HEART LUNG TRANSPL, V34, P1244, DOI 10.1016/j.healun.2015.08.003; Mahon NG, 2005, ANN INTERN MED, V143, P108, DOI 10.7326/0003-4819-143-2-200507190-00009; Mahrholdt H, 2004, CIRCULATION, V109, P1250, DOI 10.1161/01.CIR.0000118493.13323.81; Maisch B, 2013, HEART FAIL REV, V18, P761, DOI 10.1007/s10741-012-9362-7; Maisch B, 2012, HEART FAIL CLIN, V8, P53, DOI 10.1016/j.hfc.2011.08.014; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Mann SA, 2012, J AM COLL CARDIOL, V60, P1566, DOI 10.1016/j.jacc.2012.05.050; MANOLIO TA, 1992, AM J CARDIOL, V69, P1458, DOI 10.1016/0002-9149(92)90901-A; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Martino H, 2015, EUR HEART J, V36, P2898, DOI 10.1093/eurheartj/ehv477; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; McCarthy RE, 2000, NEW ENGL J MED, V342, P690, DOI 10.1056/NEJM200003093421003; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; McNair WP, 2011, J AM COLL CARDIOL, V57, P2160, DOI 10.1016/j.jacc.2010.09.084; McNally EM, 2013, J CLIN INVEST, V123, P19, DOI 10.1172/JCI62862; McNamara DM, 2001, CIRCULATION, V103, P2254; Mehra MR, 2016, J HEART LUNG TRANSPL, V35, P1, DOI 10.1016/j.healun.2015.10.023; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Mohapatra B, 2003, MOL GENET METAB, V80, P207, DOI 10.1016/S1096-7192(03)00142-2; Morales A, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0375-1; MUNTONI F, 1993, NEW ENGL J MED, V329, P921, DOI 10.1056/NEJM199309233291304; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; Nugent AW, 2003, NEW ENGL J MED, V348, P1639, DOI 10.1056/NEJMoa021737; Obadia JF, 2015, EUROINTERVENTION, V10, P1354, DOI 10.4244/EIJV10I11A232; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Otomo J, 2005, J CARDIOVASC ELECTR, V16, P137, DOI 10.1046/j.1540-8167.2004.40096.x; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Pahl E, 2012, J AM COLL CARDIOL, V59, P607, DOI 10.1016/j.jacc.2011.10.878; Paratz ED, 2016, HEART LUNG CIRC, V25, P325, DOI 10.1016/j.hlc.2015.10.019; Parks SB, 2008, AM HEART J, V156, P161, DOI 10.1016/j.ahj.2008.01.026; PARRILLO JE, 1989, NEW ENGL J MED, V321, P1061, DOI 10.1056/NEJM198910193211601; Pearson GD, 2000, JAMA-J AM MED ASSOC, V283, P1183, DOI 10.1001/jama.283.9.1183; Pinto YM, 2016, EUR HEART J, V37, P1850, DOI 10.1093/eurheartj/ehv727; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Porepa LF, 2014, CAN J CARDIOL, V30, P296, DOI 10.1016/j.cjca.2013.12.017; Price JF, 2006, CIRCULATION, V114, P1063, DOI 10.1161/CIRCULATIONAHA.105.608869; Probst S, 2011, CIRC-CARDIOVASC GENE, V4, P367, DOI 10.1161/CIRCGENETICS.110.959270; Puntmann VO, 2016, JACC-CARDIOVASC IMAG, V9, P40, DOI 10.1016/j.jcmg.2015.12.001; Raman SV, 2015, LANCET NEUROL, V14, P153, DOI 10.1016/S1474-4422(14)70318-7; RIHAL CS, 1994, CIRCULATION, V90, P2772, DOI 10.1161/01.CIR.90.6.2772; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Santangeli P, 2011, J INTERV CARD ELECTR, V32, P125, DOI 10.1007/s10840-011-9584-y; Sasse-Klaassen S, 2003, AM J MED GENET A, V119A, P162, DOI 10.1002/ajmg.a.20075; Sayer G, 2014, CARDIOL CLIN, V32, P21, DOI 10.1016/j.ccl.2013.09.002; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Shaddy RE, 2007, JAMA-J AM MED ASSOC, V298, P1171, DOI 10.1001/jama.298.10.1171; Shan L, 2008, MOL GENET METAB, V93, P468, DOI 10.1016/j.ymgme.2007.10.009; Shehab S, 2016, J HEART LUNG TRANSPL, V35, P466, DOI 10.1016/j.healun.2015.12.001; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; Sochalski J, 2009, HEALTH AFFAIR, V28, P179, DOI 10.1377/hlthaff.28.1.179; Sorensen K, 2003, CANCER-AM CANCER SOC, V97, P1991, DOI 10.1002/cncr.11274; Stewart S, 2012, J AM COLL CARDIOL, V60, P1239, DOI 10.1016/j.jacc.2012.06.025; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Taylor MRG, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-27; Taylor MRG, 2007, CIRCULATION, V115, P1244, DOI 10.1161/CIRCULATIONAHA.106.646778; Teekakirikul P, 2013, J MOL DIAGN, V15, P158, DOI 10.1016/j.jmoldx.2012.09.002; Towbin JA, 2002, NATURE, V415, P227, DOI 10.1038/415227a; TOWBIN JA, 1993, CIRCULATION, V87, P1854, DOI 10.1161/01.CIR.87.6.1854; Towbin JA, 2006, JAMA-J AM MED ASSOC, V296, P1867, DOI 10.1001/jama.296.15.1867; Towbin Jeffrey A, 2010, Heart Fail Clin, V6, P453, DOI 10.1016/j.hfc.2010.06.005; Towbin JA, 2015, LANCET, V386, P813, DOI 10.1016/S0140-6736(14)61282-4; Tsujii N, 2016, CIRC J, V80, P1251, DOI 10.1253/circj.CJ-15-1122; van Dalen EC, 2006, EUR J CANCER, V42, P3191, DOI 10.1016/j.ejca.2006.08.005; van der Pal HJ, 2010, ARCH INTERN MED, V170, P1247, DOI 10.1001/archinternmed.2010.233; van Tintelen JP, 2007, AM HEART J, V154, P1130, DOI 10.1016/j.ahj.2007.07.038; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Ware JS, 2016, NEW ENGL J MED, V374, P233, DOI 10.1056/NEJMoa1505517; Wilkoff BL, 2002, JAMA-J AM MED ASSOC, V288, P3115; Wojnicz R, 2001, CIRCULATION, V104, P39, DOI 10.1161/01.CIR.104.1.39; XIE GY, 1994, J AM COLL CARDIOL, V24, P132, DOI 10.1016/0735-1097(94)90553-3; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yeo KK, 2007, AM J MED, V120, P165, DOI 10.1016/j.amjmed.2006.01.024; Yeoh T, 2011, HEART LUNG CIRC, V20, P566, DOI 10.1016/j.hlc.2011.06.004; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	170	268	290	10	70	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 22	2017	390	10092					400	414		10.1016/S0140-6736(16)31713-5	http://dx.doi.org/10.1016/S0140-6736(16)31713-5			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB1NU	28190577				2022-12-28	WOS:000405911300029
J	Ma, C; Meyers, SR; Sageman, BB				Ma, Chao; Meyers, Stephen R.; Sageman, Bradley B.			Theory of chaotic orbital variations confirmed by Cretaceous geological evidence	NATURE			English	Article							WESTERN INTERIOR BASIN; SOLAR-SYSTEM; INSOLATION QUANTITIES; CONIACIAN; EARTH; BIOSTRATIGRAPHY; MILANKOVITCH; BEHAVIOR; CYCLES; USA	Variations in the Earth's orbit and spin vector are a primary control on insolation and climate; their recognition in the geological record has revolutionized our understanding of palaeoclimate dynamics(1), and has catalysed improvements in the accuracy and precision of the geological timescale(2). Yet the secular evolution of the planetary orbits beyond 50 million years ago remains highly uncertain, and the chaotic dynamical nature of the Solar System predicted by theoretical models has yet to be rigorously confirmed by well constrained (radioisotopically calibrated and anchored) geological data(2-4). Here we present geological evidence for a chaotic resonance transition associated with interactions between the orbits of Mars and the Earth, using an integrated radioisotopic and astronomical timescale from the Cretaceous Western Interior Basin of what is now North America(5). This analysis confirms the predicted chaotic dynamical behaviour of the Solar System, and provides a constraint for refining numerical solutions for insolation, which will enable a more precise and accurate geological timescale to be produced.	[Ma, Chao; Meyers, Stephen R.] Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA; [Sageman, Bradley B.] Northwestern Univ, Dept Earth & Planetary Sci, Evanston, IL USA	University of Wisconsin System; University of Wisconsin Madison; Northwestern University	Meyers, SR (corresponding author), Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA.	smeyers@geology.wisc.edu	Sageman, Bradley B/E-6363-2010; Super, Super/AAC-8569-2020	Super, Super/0000-0002-0122-5696; Meyers, Stephen/0000-0003-4422-720X	NSF [EAR-1151438, EAR-0959108]; Directorate For Geosciences [1151438] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was supported by NSF grants EAR-1151438 (S.R.M.) and EAR-0959108 (S.R.M. and B.B.S.). We thank R. Locklair for his cyclostratigraphic studies of the Libsack core, upon which this work builds. The Libsack core was donated to Northwestern University by EnCana, Inc., thanks to G. Gustason.	Agterberg FP, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P269, DOI 10.1016/B978-0-444-59425-9.00014-7; [Anonymous], 2021, LANG ENV STAT COMP; Fienga A, 2008, ASTRON ASTROPHYS, V477, P315, DOI 10.1051/0004-6361:20066607; Fienga A, 2011, CELEST MECH DYN ASTR, V111, P363, DOI 10.1007/s10569-011-9377-8; Fienga A, 2009, ASTRON ASTROPHYS, V507, P1675, DOI 10.1051/0004-6361/200911755; Fischer A. G., 1980, SPEC PAP GEOL SOC AM, V183, P93; GILBERT G. K., 1895, J GEOL, V3, P121, DOI DOI 10.1086/607150; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Herbert TD, 1997, P NATL ACAD SCI USA, V94, P8362, DOI 10.1073/pnas.94.16.8362; Hinnov LA, 2013, GEOL SOC AM BULL, V125, P1703, DOI 10.1130/B30934.1; Jenkyns HC, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002788; LASKAR J, 1989, NATURE, V338, P237, DOI 10.1038/338237a0; Laskar J, 2011, ASTRON ASTROPHYS, V532, DOI [10.1051/0004-6361/201116836, 10.1051/0004-6361/201117504]; Laskar J, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201117504; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; LASKAR J, 1993, ASTRON ASTROPHYS, V270, P522; Leckie RM, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000623; Locklair R, 2011, SEDIMENT GEOL, V235, P38, DOI 10.1016/j.sedgeo.2010.06.026; Locklair RE, 2008, EARTH PLANET SC LETT, V269, P539, DOI 10.1016/j.epsl.2008.03.021; Meyers S., 2014, ASTROCHRON R PACKAGE; Meyers SR, 2008, AM J SCI, V308, P770, DOI 10.2475/06.2008.02; Meyers SR, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002286; Meyers SR, 2012, GEOLOGY, V40, P7, DOI 10.1130/G32261.1; Mitchell RN, 2008, EARTH PLANET SC LETT, V267, P1, DOI 10.1016/j.epsl.2007.11.026; Palike H, 2006, SCIENCE, V314, P1894, DOI 10.1126/science.1133822; Sabatino N, 2015, PALAEOGEOGR PALAEOCL, V426, P319, DOI 10.1016/j.palaeo.2015.03.009; Sageman BB, 2014, GEOL SOC AM BULL, V126, P956, DOI 10.1130/B30929.1; TANER MT, 1979, GEOPHYSICS, V44, P1041, DOI 10.1190/1.1440994; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Wagreich M, 2012, CLIM PAST, V8, P1447, DOI 10.5194/cp-8-1447-2012; Walaszczyk I, 2007, CRETACEOUS RES, V28, P132, DOI 10.1016/j.cretres.2006.05.024; Walaszczyk I, 2006, ACTA GEOL POL, V56, P241; Walaszczyk Ireneusz, 2000, Special Papers in Palaeontology, V64, P1; Westerhold T, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004096; Wu HC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3452; Wu HC, 2013, PALAEOGEOGR PALAEOCL, V385, P55, DOI 10.1016/j.palaeo.2012.09.004	37	63	69	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2017	542	7642					468	+		10.1038/nature21402	http://dx.doi.org/10.1038/nature21402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM1RG	28230127				2022-12-28	WOS:000395094100034
J	Chan, CKF; Longaker, MT				Chan, Charles K. F.; Longaker, Michael T.			Fibroblasts become fat to reduce scarring	SCIENCE			English	Editorial Material							STEM-CELLS; WOUND REPAIR; REGENERATION; SKIN		[Chan, Charles K. F.; Longaker, Michael T.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Longaker, Michael T.] Stanford Univ, Hagey Lab Pediat Regenerat Med, Stanford, CA 94305 USA; [Longaker, Michael T.] Stanford Univ, Dept Surg, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Chan, CKF (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	chazchan@stanford.edu; longaker@stanford.edu			NATIONAL INSTITUTE ON AGING [R00AG049958, K99AG049958] Funding Source: NIH RePORTER; NIA NIH HHS [R00 AG049958, K99 AG049958] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barretto RPJ, 2011, NAT MED, V17, P223, DOI 10.1038/nm.2292; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Chan CKF, 2015, CELL, V160, P285, DOI 10.1016/j.cell.2014.12.002; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Murray IR, 2014, CELL MOL LIFE SCI, V71, P1353, DOI 10.1007/s00018-013-1462-6; Plikus MV, 2017, SCIENCE, V355, P748, DOI 10.1126/science.aai8792; Rinkevich Y, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2151; Roy E, 2014, STEM CELLS, V32, P3046, DOI 10.1002/stem.1804; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Shaw TJ, 2016, CURR OPIN CELL BIOL, V42, P29, DOI 10.1016/j.ceb.2016.04.001; Zielins ER, 2014, REGEN MED, V9, P817, DOI [10.2217/RME.14.54, 10.2217/rme.14.54]	15	9	10	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					693	694		10.1126/science.aam6748	http://dx.doi.org/10.1126/science.aam6748			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2AC	28209860	Green Accepted			2022-12-28	WOS:000395117700022
J	De Sanctis, MC; Ammannito, E; McSween, HY; Raponi, A; Marchi, S; Capaccioni, F; Capria, MT; Carrozzo, FG; Ciarniello, M; Fonte, S; Formisano, M; Frigeri, A; Giardino, M; Longobardo, A; Magni, G; McFadden, LA; Palomba, E; Pieters, CM; Tosi, F; Zambon, F; Raymond, CA; Russell, CT				De Sanctis, M. C.; Ammannito, E.; McSween, H. Y.; Raponi, A.; Marchi, S.; Capaccioni, F.; Capria, M. T.; Carrozzo, F. G.; Ciarniello, M.; Fonte, S.; Formisano, M.; Frigeri, A.; Giardino, M.; Longobardo, A.; Magni, G.; McFadden, L. A.; Palomba, E.; Pieters, C. M.; Tosi, F.; Zambon, F.; Raymond, C. A.; Russell, C. T.			Localized aliphatic organic material on the surface of Ceres	SCIENCE			English	Article							WATER-ICE; MATTER; EVOLUTION; ORIGIN; SPECTROSCOPY	Organic compounds occur in some chondritic meteorites, and their signatures on solar system bodies have been sought for decades. Spectral signatures of organics have not been unambiguously identified on the surfaces of asteroids, whereas they have been detected on cometary nuclei. Data returned by the Visible and InfraRed Mapping Spectrometer on board the Dawn spacecraft show a clear detection of an organic absorption feature at 3.4 micrometers on dwarf planet Ceres. This signature is characteristic of aliphatic organic matter and is mainly localized on a broad region of similar to 1000 square kilometers close to the similar to 50-kilometer Ernutet crater. The combined presence on Ceres of ammonia-bearing hydrated minerals, water ice, carbonates, salts, and organic material indicates a very complex chemical environment, suggesting favorable environments to prebiotic chemistry.	[De Sanctis, M. C.; Ammannito, E.; Raponi, A.; Marchi, S.; Capaccioni, F.; Capria, M. T.; Carrozzo, F. G.; Ciarniello, M.; Fonte, S.; Formisano, M.; Frigeri, A.; Giardino, M.; Longobardo, A.; Magni, G.; Palomba, E.; Tosi, F.; Zambon, F.] Ist Nazl Astrofis, Ist Astrofis & Planetol Spaziali, I-00133 Rome, Italy; [Ammannito, E.; Russell, C. T.] Univ Calif Los Angeles, Earth Planetary & Space Sci, 603 Charles Young Dr, Los Angeles, CA 90095 USA; [McSween, H. Y.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; [Marchi, S.] Southwest Res Inst, Boulder, CO 80302 USA; [McFadden, L. A.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Pieters, C. M.] Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA; [Raymond, C. A.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Istituto Nazionale Astrofisica (INAF); University of California System; University of California Los Angeles; University of Tennessee System; University of Tennessee Knoxville; Southwest Research Institute; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Brown University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	De Sanctis, MC (corresponding author), Ist Nazl Astrofis, Ist Astrofis & Planetol Spaziali, I-00133 Rome, Italy.	mariacristina.desanctis@iaps.inafit	Frigeri, Alessandro/K-9679-2019; Tosi, Federico/F-2321-2018; Palomba, Ernesto/E-8287-2017; Russell, Christopher T/E-7745-2012; Zambon, Francesca/J-2855-2018; Formisano, Michelangelo/AAJ-2719-2020; McFadden, Lucy/I-4902-2013; De Sanctis, Maria Cristina/G-5232-2013	Frigeri, Alessandro/0000-0002-9140-3977; Tosi, Federico/0000-0003-4002-2434; Palomba, Ernesto/0000-0002-9101-6774; Russell, Christopher T/0000-0003-1639-8298; Zambon, Francesca/0000-0002-4190-6592; Formisano, Michelangelo/0000-0003-3236-1604; Capaccioni, Fabrizio/0000-0003-1631-4314; Carrozzo, Filippo Giacomo/0000-0002-0391-6407; Giardino, Marco/0000-0002-6983-6346; McFadden, Lucy/0000-0002-0537-9975; ammannito, eleonora/0000-0001-6671-2690; capria, maria teresa/0000-0002-9814-9588; Raponi, Andrea/0000-0003-4996-0099; Longobardo, Andrea/0000-0002-1797-2741; Ciarniello, Mauro/0000-0002-7498-5207; De Sanctis, Maria Cristina/0000-0002-3463-4437; Marchi, Simone/0000-0003-2548-3291	Italian Space Agency (ASI); NASA; VIR instrument	Italian Space Agency (ASI)(Agenzia Spaziale Italiana (ASI)); NASA(National Aeronautics & Space Administration (NASA)); VIR instrument	We thank the Italian Space Agency (ASI) and NASA for supporting this work. The VIR instrument was funded and coordinated by the ASI and built by Selex ES, with the scientific leadership of the Institute for Space Astrophysics and Planetology, Italian National Institute for Astrophysics, Italy. The VIR is operated byte Institute for Space Astrophysics and Planetology, Rome, Italy. A portion of this work was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under contract to NASA. Dawn data are archived in NASA's Planetary Data System; VIR spectral data may be obtained at http://sbn.psi.edu/pds/resource/dwncvir.html. We thank E. Quirico for providing the IOM data.	Ammannito E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4279; Bradley JP, 2005, TREATISE GEOCHEM, V1, P689; Brown RH, 2006, SCIENCE, V311, P1425, DOI 10.1126/science.1121031; Campins H, 2010, NATURE, V464, P1320, DOI 10.1038/nature09029; Capaccioni F, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0628; Caselli P, 2012, ASTRON ASTROPHYS REV, V20, DOI 10.1007/s00159-012-0056-x; Clark RN, 2005, NATURE, V435, P66, DOI 10.1038/nature03558; Combe JP, 2016, SCIENCE, V353, DOI 10.1126/science.aaf3010; Cruikshank DP, 2008, ICARUS, V193, P334, DOI 10.1016/j.icarus.2007.04.036; De Sanctis MC, 2016, NATURE, V536, P54, DOI 10.1038/nature18290; De Sanctis MC, 2011, SPACE SCI REV, V163, P329, DOI 10.1007/s11214-010-9668-5; GREENBERG JM, 1995, ASTROPHYS J, V455, pL177, DOI 10.1086/309834; Herd CDK, 2011, SCIENCE, V332, P1304, DOI 10.1126/science.1203290; HOYLE F, 1982, ASTROPHYS SPACE SCI, V83, P405, DOI 10.1007/BF00648568; Kebukawa Y, 2010, METEORIT PLANET SCI, V45, P99, DOI 10.1111/j.1945-5100.2009.01008.x; Licandro J, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201015339; Marchi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12257; McCord TB, 2011, SPACE SCI REV, V163, P63, DOI 10.1007/s11214-010-9729-9; Moroz LV, 1998, ICARUS, V134, P253, DOI 10.1006/icar.1998.5955; Orthous-Daunay FR, 2013, ICARUS, V223, P534, DOI 10.1016/j.icarus.2013.01.003; Pearson VK, 2002, METEORIT PLANET SCI, V37, P1829, DOI 10.1111/j.1945-5100.2002.tb01166.x; Pendleton YJ, 2002, ASTROPHYS J SUPPL S, V138, P75, DOI 10.1086/322999; Pierazzo E, 2000, METEORIT PLANET SCI, V35, P117, DOI 10.1111/j.1945-5100.2000.tb01979.x; Pizzarello S, 2013, P NATL ACAD SCI USA, V110, P15614, DOI 10.1073/pnas.1309113110; Pizzarello S, 2011, P NATL ACAD SCI USA, V108, P4303, DOI 10.1073/pnas.1014961108; Pizzarello S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002105; Rivkin AS, 2010, NATURE, V464, P1322, DOI 10.1038/nature09028; Roatsch T, 2016, PLANET SPACE SCI, V121, P115, DOI 10.1016/j.pss.2015.12.005; Takir D, 2013, METEORIT PLANET SCI, V48, P1618, DOI 10.1111/maps.12171; Williams LB, 2005, GEOLOGY, V33, P913, DOI 10.1130/G21751.1	32	112	112	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					719	+		10.1126/science.aaj2305	http://dx.doi.org/10.1126/science.aaj2305			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2AC	28209893				2022-12-28	WOS:000395117700035
J	Goossens, H				Goossens, Herman			Shout about the European Union's success	NATURE			English	Editorial Material									[Goossens, Herman] Univ Antwerp, Med Microbiol, Antwerp, Belgium; [Goossens, Herman] Univ Antwerp Hosp, Med Microbiol, Edegem, Belgium	University of Antwerp; University of Antwerp	Goossens, H (corresponding author), Univ Antwerp, Med Microbiol, Antwerp, Belgium.; Goossens, H (corresponding author), Univ Antwerp Hosp, Med Microbiol, Edegem, Belgium.	herman.goossens@uza.be							0	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					273	273		10.1038/542273a	http://dx.doi.org/10.1038/542273a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2LQ	28202984				2022-12-28	WOS:000394451600004
J	Schmidtko, S; Stramma, L; Visbeck, M				Schmidtko, Sunke; Stramma, Lothar; Visbeck, Martin			Decline in global oceanic oxygen content during the past five decades	NATURE			English	Article							NORTH PACIFIC OXYGEN; WATER; ZONES	Ocean models predict a decline in the dissolved oxygen inventory of the global ocean of one to seven per cent by the year 2100, caused by a combination of a warming-induced decline in oxygen solubility and reduced ventilation of the deep ocean(1,2). It is thought that such a decline in the oceanic oxygen content could affect ocean nutrient cycles and the marine habitat, with potentially detrimental consequences for fisheries and coastal economies(3-6). Regional observational data indicate a continuous decrease in oceanic dissolved oxygen concentrations in most regions of the global ocean(1,7-10), with an increase reported in a few limited areas, varying by study(1,10). Prior work attempting to resolve variations in dissolved oxygen concentrations at the global scale reported a global oxygen loss of 550 +/- 130 teramoles (10(12) mol) per decade between 100 and 1,000 metres depth based on a comparison of data from the 1970s and 1990s(10). Here we provide a quantitative assessment of the entire ocean oxygen inventory by analysing dissolved oxygen and supporting data for the complete oceanic water column over the past 50 years. We find that the global oceanic oxygen content of 227.4 +/- 1.1 petamoles (10(15) mol) has decreased by more than two per cent (4.8 +/- 2.1 petamoles) since 1960, with large variations in oxygen loss in different ocean basins and at different depths. We suggest that changes in the upper water column are mostly due to a warming-induced decrease in solubility and biological consumption. Changes in the deeper ocean may have their origin in basin-scale multi-decadal variability, oceanic overturning slow-down and a potential increase in biological consumption(11,12).	[Schmidtko, Sunke; Stramma, Lothar; Visbeck, Martin] GEOMAR Helmholtz Ctr Ocean Res Kiel, Dsternbrooker Weg 20, D-24105 Kiel, Germany; [Visbeck, Martin] Univ Kiel, D-24098 Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel	Schmidtko, S (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Dsternbrooker Weg 20, D-24105 Kiel, Germany.	sschmidtko@geomar.de	Schmidtko, Sunke/F-3355-2011; Visbeck, Martin H/B-6541-2016	Schmidtko, Sunke/0000-0003-3272-7055; Visbeck, Martin H/0000-0002-0844-834X; Stramma, Lothar/0000-0003-1391-4808	German Federal Ministry of Education and Research project MIKLIP; German Research Foundation (DFG) [SFB-754]	German Federal Ministry of Education and Research project MIKLIP; German Research Foundation (DFG)(German Research Foundation (DFG))	S.S. was supported by the German Federal Ministry of Education and Research project MIKLIP and L.S. and M.V. by the German Research Foundation (DFG) as part of research project SFB-754. We thank R. Keeling for providing expertise on chemical processes of oxygen measurements and calculating impacts on carbon budgeting.	Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; Bianchi D, 2013, NAT GEOSCI, V6, P545, DOI 10.1038/NGEO1837; Biastoch A, 2008, J CLIMATE, V21, P6599, DOI 10.1175/2008JCLI2404.1; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Bopp L, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001445; Broecker WS, 1999, SCIENCE, V286, P1132, DOI 10.1126/science.286.5442.1132; CARPENTER JAMES H., 1965, LIMNOL OCEANOGR, V10, P135; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cocco V, 2013, BIOGEOSCIENCES, V10, P1849, DOI 10.5194/bg-10-1849-2013; Codispoti LA, 2010, SCIENCE, V327, P1339, DOI 10.1126/science.1184945; Deutsch C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023190; Deutsch C, 2011, SCIENCE, V333, P336, DOI 10.1126/science.1202422; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Frolicher TL, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003316; Helm KP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049513; Keeling R. F., 2000, CARBON CYCLE, P134; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Keeling RF, 2002, P NATL ACAD SCI USA, V99, P7848, DOI 10.1073/pnas.122154899; Keeling RF., 2014, TREATISE GEOCHEMISTR, P385, DOI [DOI 10.1016/B978-0-08-095975-7.00420-4, 10.1016/B978-0-08-095975-7.00420-4]; Keller DP, 2016, GEOPHYS RES LETT, V43, P6469, DOI 10.1002/2016GL069630; Khatiwala S, 2009, NATURE, V462, P346, DOI 10.1038/nature08526; KNAPP GP, 1991, DEEP-SEA RES, V38, P121, DOI 10.1016/0198-0149(91)90057-M; Kwok R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039035; Kwon EY, 2016, J CLIMATE, V29, P61, DOI 10.1175/JCLI-D-14-00157.1; Long MC, 2016, GLOBAL BIOGEOCHEM CY, V30, P381, DOI 10.1002/2015GB005310; Morison J, 2012, NATURE, V481, P66, DOI 10.1038/nature10705; Purkey SG, 2012, J CLIMATE, V25, P5830, DOI 10.1175/JCLI-D-11-00612.1; Santoro AE, 2011, SCIENCE, V333, P1282, DOI 10.1126/science.1208239; Schmidtko S, 2014, SCIENCE, V346, P1227, DOI 10.1126/science.1256117; Schmidtko S, 2013, J GEOPHYS RES-OCEANS, V118, P1658, DOI 10.1002/jgrc.20122; Stendardo I, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC007909; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Stramma L, 2012, NAT CLIM CHANGE, V2, P33, DOI 10.1038/NCLIMATE1304; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Watanabe YW, 2001, GEOPHYS RES LETT, V28, P3289, DOI 10.1029/2001GL013212; Whitney FA, 2007, PROG OCEANOGR, V75, P179, DOI 10.1016/j.pocean.2007.08.007; WILCOCK RJ, 1981, WATER RES, V15, P321, DOI 10.1016/0043-1354(81)90035-X; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; WYRTKI K, 1961, DEEP-SEA RES, V8, P39, DOI 10.1016/0146-6313(61)90014-4	40	510	524	38	421	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					335	+		10.1038/nature21399	http://dx.doi.org/10.1038/nature21399			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2LQ	28202958				2022-12-28	WOS:000394451600034
J	Lane, R				Lane, Richard			Patricia Walker: pioneer in refugee health	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2017	389	10069					593	593		10.1016/S0140-6736(17)30274-X	http://dx.doi.org/10.1016/S0140-6736(17)30274-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL9AF	28195049				2022-12-28	WOS:000394910800015
J	Morell, V				Morell, Virginia			World's most endangered marine mammal down to 30	SCIENCE			English	News Item																			0	6	6	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					558	559		10.1126/science.355.6325.558	http://dx.doi.org/10.1126/science.355.6325.558			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK0SF	28183919				2022-12-28	WOS:000393636700010
J	Nielsen, PB; Skjoth, F; Sogaard, M; Kjaeldgaard, JN; Lip, GYH; Larsen, TB				Nielsen, Peter Bronnum; Skjoth, Flemming; Sogaard, Mette; Kjaeldgaard, Jette Nordstrom; Lip, Gregory Y. H.; Larsen, Torben Bjerregaard			Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							STROKE PREVENTION; RENAL-FUNCTION; ESC GUIDELINES; BLEEDING RISK; DABIGATRAN; EFFICACY; APIXABAN; KIDNEY; METAANALYSIS; RIVAROXABAN	OBJECTIVE To examine clinical effectiveness and safety of apixaban 2.5 mg, dabigatran 110 mg, and rivaroxaban 15 mg compared with warfarin among patients with atrial fibrillation who had not previously taken an oral anticoagulant. DESIGN Propensity weighted (inverse probability of treatment weighted) nationwide cohort study. SETTING Individual linked data from three nationwide registries in Denmark. PARTICIPANTS Patients with non-valvular atrial fibrillation filling a first prescription for an oral anticoagulant from August 2011 to February 2016. Patients who filled a prescription for a standard dose non-vitamin K antagonist oral anticoagulant (novel oral anticoagulants, NOACs) were excluded. To control for baseline differences in the population, a propensity score for receipt of either of the four treatment alternatives was calculated to apply an inverse probability treatment weight. INTERVENTION Initiated anticoagulant treatment (dabigatran 110 mg, rivaroxaban 15 mg, apixaban 2.5 mg, and warfarin). MAIN OUTCOME MEASURES Patients were followed in the registries from onset of treatment for the primary effectiveness outcome of ischaemic stroke/systemic embolism and for the principal safety outcome of any bleeding events. RESULTS Among 55 644 patients with atrial fibrillation who met inclusion criteria, the cohort was distributed according to treatment: apixaban n=4400; dabigatran n=8875; rivaroxaban n=3476; warfarin n=38 893. The overall mean age was 73.9 (SD 12.7), ranging from a mean of 71.0 (warfarin) to 83.9 (apixaban). During one year of follow-up, apixaban was associated with higher (weighted) event rate of ischaemic stroke/systemic embolism (4.8%), while dabigatran, rivaroxaban, and warfarin had event rates of 3.3%, 3.5%, and 3.7%, respectively. In the comparison between a non-vitamin K antagonist oral anticoagulant and warfarin in the inverse probability of treatment weighted analyses and investigation of the effectiveness outcome, the hazard ratios were 1.19 (95% confidence interval 0.95 to 1.49) for apixaban, 0.89 (0.77 to 1.03) for dabigatran, and 0.89 (0.69 to 1.16) for rivaroxaban. For the principal safety outcome versus warfarin, the hazard ratios were 0.96 (0.73 to 1.27) for apixaban, 0.80 (0.70 to 0.92) for dabigatran, and 1.06 (0.87 to 1.29) for rivaroxaban. CONCLUSION In this propensity weighted nationwide study of reduced dose non-vitamin K antagonist oral anticoagulant regimens, apixaban 2.5 mg twice a day was associated with a trend towards higher rates of ischaemic stroke/systemic embolism compared with warfarin, while rivaroxaban 15 mg once a day and dabigatran 110 mg twice a day showed a trend towards lower thromboembolic rates. The results were not significantly different. Rates of bleeding (the principal safety outcome) were significantly lower for dabigatran, but not significantly different for apixaban and rivaroxaban compared with warfarin.	[Nielsen, Peter Bronnum; Skjoth, Flemming; Sogaard, Mette; Kjaeldgaard, Jette Nordstrom; Lip, Gregory Y. H.; Larsen, Torben Bjerregaard] Aalborg Univ, Fac Hlth, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark; [Skjoth, Flemming] Aalborg Univ Hosp, Unit Clin Biostat, Aalborg, Denmark; [Sogaard, Mette; Kjaeldgaard, Jette Nordstrom; Larsen, Torben Bjerregaard] Aalborg Univ Hosp, Dept Cardiol, DK-9000 Aalborg, Denmark; [Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Inst Cardiovasc Sci, Birmingham, W Midlands, England	Aalborg University; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; University of Birmingham	Larsen, TB (corresponding author), Aalborg Univ, Fac Hlth, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark.; Larsen, TB (corresponding author), Aalborg Univ Hosp, Dept Cardiol, DK-9000 Aalborg, Denmark.	tobl@rn.dk	Skjøth, Flemming/AAI-9954-2020	Sogaard, Mette/0000-0002-2830-4968; Skjoth, Flemming/0000-0003-2975-647X; Nielsen, Peter Bronnum/0000-0003-2922-6970	Obel Family Foundation	Obel Family Foundation	The Obel Family Foundation partly funded this research by an unrestricted grant. The sponsor had no role the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488; Avgil-Tsadok M, 2016, THROMB HAEMOSTASIS, V115, P152, DOI 10.1160/TH15-03-0247; Camm AJ, 2012, EUR HEART J, V33; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Diener HC, 2017, EUR HEART J, V38, P860, DOI 10.1093/eurheartj/ehw069; Frost C, 2013, BRIT J CLIN PHARMACO, V76, P776, DOI 10.1111/bcp.12106; Glassock RJ, 2012, KIDNEY INT, V82, P270, DOI 10.1038/ki.2012.65; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Gorst-Rasmussen A, 2016, PHARMACOEPIDEM DR S, V25, P1236, DOI 10.1002/pds.4034; Grams ME, 2011, AM J KIDNEY DIS, V57, P44, DOI 10.1053/j.ajkd.2010.05.013; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Halvorsen S, 2014, EUR HEART J, V35, P1864, DOI 10.1093/eurheartj/ehu046; Harel Z, 2014, J AM SOC NEPHROL, V25, P431, DOI 10.1681/ASN.2013040361; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Heidbuchel H, 2015, EUROPACE, V17, P1467, DOI 10.1093/europace/euv309; Hijazi Z, 2016, JAMA CARDIOL, V1, P451, DOI 10.1001/jamacardio.2016.1170; Hijazi Z, 2014, CIRCULATION, V129, P961, DOI 10.1161/CIRCULATIONAHA.113.003628; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; LaHaye S, 2014, THROMB HAEMOSTASIS, V111, P465, DOI 10.1160/TH13-05-0424; Lane DA, 2014, THROMB HAEMOSTASIS, V111, P381, DOI 10.1160/TH14-01-0063; Larsen TB, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3189; Larsen TB, 2013, J AM COLL CARDIOL, V61, P2264, DOI 10.1016/j.jacc.2013.03.020; Lip GYH, 2015, JAMA-J AM MED ASSOC, V313, P1950, DOI 10.1001/jama.2015.4369; Lip GYH, 2014, THROMB HAEMOSTASIS, V111, P933, DOI 10.1160/TH13-09-0734; McCaffrey DF, 2013, STAT MED, V32, P3388, DOI 10.1002/sim.5753; Nielsen PB, 2015, CLIN RES CARDIOL, V104, P418, DOI 10.1007/s00392-014-0797-9; Olesen JB, 2012, NEW ENGL J MED, V367, P625, DOI 10.1056/NEJMoa1105594; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Petersen ML, 2012, STAT METHODS MED RES, V21, P31, DOI 10.1177/0962280210386207; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Schaeffner ES, 2012, ANN INTERN MED, V157, P471, DOI 10.7326/0003-4819-157-7-201210020-00003; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schneeweiss S, 2011, CLIN PHARMACOL THER, V90, P777, DOI 10.1038/clpt.2011.235; Sturmer T, 2014, J INTERN MED, V275, P570, DOI 10.1111/joim.12197; Sturmer T, 2006, PHARMACOEPIDEM DR S, V15, P698, DOI 10.1002/pds.1231; Vestergaard AS, 2016, STROKE, V47, P979, DOI 10.1161/STROKEAHA.115.012338	41	224	226	2	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2017	356								j510	10.1136/bmj.j510	http://dx.doi.org/10.1136/bmj.j510			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GC	28188243	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000394578700001
J	Limb, M				Limb, Matt			Joyce Lilian Thomas OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												limb@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2017	356								j697	10.1136/bmj.j697	http://dx.doi.org/10.1136/bmj.j697			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GB	28183719				2022-12-28	WOS:000394578600006
J	Chou, R; Deyo, R; Friedly, J; Skelly, A; Hashimoto, R; Weimer, M; Fu, R; Dana, T; Kraegel, P; Griffin, J; Grusing, S; Brodt, ED				Chou, Roger; Deyo, Richard; Friedly, Janna; Skelly, Andrea; Hashimoto, Robin; Weimer, Melissa; Fu, Rochelle; Dana, Tracy; Kraegel, Paul; Griffin, Jessica; Grusing, Sara; Brodt, Erika D.			Nonpharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED-CONTROLLED-TRIAL; NONSPECIFIC LOW-BACK; COGNITIVE-BEHAVIORAL THERAPY; MOTOR CONTROL EXERCISES; MIND-BODY PROGRAM; SELF-CARE BOOK; SPINAL MANIPULATION; FOLLOW-UP; SWEDISH MASSAGE; MCKENZIE METHOD	Background: A 2007 American College of Physicians guideline addressed nonpharmacologic treatment options for low back pain. New evidence is now available. Purpose: To systematically review the current evidence on nonpharmacologic therapies for acute or chronic nonradicular or radicular low back pain. Data Sources: Ovid MEDLINE (January 2008 through February 2016), Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and reference lists. Study Selection: Randomized trials of 9 nonpharmacologic options versus sham treatment, wait list, or usual care, or of 1 nonpharmacologic option versus another. Data Extraction: One investigator abstracted data, and a second checked abstractions for accuracy; 2 investigators independently assessed study quality. Data Synthesis: The number of trials evaluating nonpharmacologic therapies ranged from 2 (tai chi) to 121 (exercise). New evidence indicates that tai chi (strength of evidence [SOE], low) and mindfulness-based stress reduction (SOE, moderate) are effective for chronic low back pain and strengthens previous find-ings regarding the effectiveness of yoga (SOE, moderate). Evidence continues to support the effectiveness of exercise, psychological therapies, multidisciplinary rehabilitation, spinal manipulation, massage, and acupuncture for chronic low back pain (SOE, low to moderate). Limited evidence shows that acupuncture is modestly effective for acute low back pain (SOE, low). The magnitude of pain benefits was small to moderate and generally short term; effects on function generally were smaller than effects on pain. Limitation: Qualitatively synthesized new trials with prior metaanalyses, restricted to English-language studies; heterogeneity in treatment techniques; and inability to exclude placebo effects. Conclusion: Several nonpharmacologic therapies for primarily chronic low back pain are associated with small to moderate, usually short-term effects on pain; findings include new evidence on mind-body interventions.	Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Kraegel, Paul] Univ Washington, Dept Pharm, Box 357630, Seattle, WA 98195 USA; Spectrum Res, Tacoma, WA USA; [Chou, Roger; Fu, Rochelle; Dana, Tracy; Griffin, Jessica; Grusing, Sara] Mail Code BICC, 3181 Southwest Sam Jackson Pk Rd, Portland, OR 97239 USA; [Deyo, Richard] Mail Code FM, 3181 Southwest Sam Jackson Pk Rd, Portland, OR 97239 USA; [Friedly, Janna] 325 Ninth Ave,Box 359612, Seattle, WA 98104 USA; [Skelly, Andrea; Hashimoto, Robin; Brodt, Erika D.] 705 South 9th St,Suite 203, Tacoma, WA 98405 USA; [Weimer, Melissa] 3181 Southwest Sam Jackson Pk Rd,Mail Code L-475, Portland, OR 97239 USA	Oregon Health & Science University; University of Washington; University of Washington Seattle	Chou, R (corresponding author), Mail Code BICC, 3181 Southwest Sam Jackson Pk Rd, Portland, OR 97239 USA.	chour@ohsu.edu	Weimer, Melissa/M-5599-2019	Chou, Roger/0000-0001-9889-8610; Weimer, Melissa/0000-0002-5624-2434	Agency for Healthcare Research and Quality [PROSPERO: CRD42014014735]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality. (PROSPERO: CRD42014014735)	Aboagye E, 2015, J REHABIL MED, V47, P167, DOI 10.2340/16501977-1910; Agency for Healthcare Research and Quality, 2015, METH GUID IN PRESS, P1; Agency for Healthcare Research and Quality, 2014, AHRQ PUBLICATION, V10; Ajimsha MS, 2014, J BODYW MOV THER, V18, P273, DOI 10.1016/j.jbmt.2013.05.007; Albaladejo C, 2010, SPINE, V35, P483, DOI 10.1097/BRS.0b013e3181b9c9a7; Albert HB, 2012, SPINE, V37, P531, DOI 10.1097/BRS.0b013e31821ace7f; Balthazard P, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-162; Basford JR, 1999, ARCH PHYS MED REHAB, V80, P647, DOI 10.1016/S0003-9993(99)90167-3; Bicalho E, 2010, MANUAL THER, V15, P469, DOI 10.1016/j.math.2010.03.012; Borges TP, 2014, REV ESC ENFERM USP, V48, P670, DOI 10.1590/S0080-623420140000400014; Bronfort G, 2004, J MANIP PHYSIOL THER, V27, P503, DOI 10.1016/j.jmpt.2004.08.002; Bronfort G, 2014, ANN INTERN MED, V161, P381, DOI 10.7326/M14-0006; Bronfort G, 2011, SPINE J, V11, P585, DOI 10.1016/j.spinee.2011.01.036; Brosseau L, 2012, J BODYW MOV THER, V16, P424, DOI 10.1016/j.jbmt.2012.04.002; Burton AK, 2000, EUR SPINE J, V9, P202, DOI 10.1007/s005869900113; Bystrom MG, 2013, SPINE, V38, pE350, DOI 10.1097/BRS.0b013e31828435fb; Cecchi F, 2010, CLIN REHABIL, V24, P26, DOI 10.1177/0269215509342328; Chatchawan U, 2005, J BODYW MOV THER, V9, P298, DOI 10.1016/j.jbmt.2005.02.001; Cherkin DC, 2016, JAMA-J AM MED ASSOC, V315, P1240, DOI 10.1001/jama.2016.2323; Cherkin DC, 2011, ANN INTERN MED, V155, P1, DOI 10.7326/0003-4819-155-1-201107050-00002; Cho YJ, 2013, SPINE, V38, P549, DOI 10.1097/BRS.0b013e318275e601; Chou R, 2016, 16EHC004EF AG HEALTH; Chou R, 2009, GUIDELINE USE CHRONI; Chou R, 2007, GUIDELINE EVALUATION; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008; Chou R, 2017, ANN INTERN MED, V166, P480, DOI 10.7326/M16-2458; Chuter V, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-140; Cleary-Guida MB, 2001, J ALTERN COMPLEM MED, V7, P269, DOI 10.1089/107555301300328142; Cramer H, 2013, CLIN J PAIN, V29, P450, DOI 10.1097/AJP.0b013e31825e1492; Dahm KT, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007612.pub2; de Oliveira RF, 2013, PHYS THER, V93, P748, DOI 10.2522/ptj.20120256; Dupeyron A., 2011, Annals of Physical and Rehabilitation Medicine, V54, P319, DOI 10.1016/j.rehab.2011.06.001; Eghbali Maryam, 2012, Iran J Nurs Midwifery Res, V17, P239; Eisenberg DM, 2012, J ALTERN COMPLEM MED, V18, P354, DOI 10.1089/acm.2011.0408; Ferreira ML, 2010, PHYS THER, V90, P1383, DOI 10.2522/ptj.20090332; Franke A, 2000, FORSCH KOMP KLAS NAT, V7, P286, DOI 10.1159/000057176; Furlan Andrea D, 2010, Evid Rep Technol Assess (Full Rep), P1; Furlan AD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001929.pub2; Garcia AN, 2013, PHYS THER, V93, P729, DOI 10.2522/ptj.20120414; Gatchel RJ, 2003, J OCCUP REHABIL, V13, P1, DOI 10.1023/A:1021823505774; Gatchel RJ, 2014, AM PSYCHOL, V69, P119, DOI 10.1037/a0035514; George SZ, 2008, PAIN, V140, P145, DOI 10.1016/j.pain.2008.07.029; Goertz CM, 2012, J ELECTROMYOGR KINES, V22, P670, DOI 10.1016/j.jelekin.2012.03.006; Goertz CM, 2013, SPINE, V38, P627, DOI 10.1097/BRS.0b013e31827733e7; Haake M, 2007, ARCH INTERN MED, V167, P1892, DOI 10.1001/archinte.167.17.1892; Haas M, 2014, SPINE J, V14, P1106, DOI 10.1016/j.spinee.2013.07.468; Hagen EM, 2010, SCAND J PUBLIC HEALT, V38, P731, DOI 10.1177/1403494810382472; Hall AM, 2011, ARTHRIT CARE RES, V63, P1576, DOI 10.1002/acr.20594; Hartvigsen J, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-30; Hasegawa TM, 2014, ACUPUNCT MED, V32, P109, DOI 10.1136/acupmed-2013-010333; Helmhout PH, 2008, ARCH PHYS MED REHAB, V89, P1675, DOI 10.1016/j.apmr.2007.12.050; Henchoz Yves, 2010, Swiss Med Wkly, V140, pw13133, DOI 10.4414/smw.2010.13133; Henschke N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002014.pub3; Hidalgo B, 2014, J MAN MANIP THER, V22, P59, DOI 10.1179/2042618613Y.0000000041; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Hofstee DJ, 2002, J NEUROSURG, V96, P45, DOI 10.3171/spi.2002.96.1.0045; Hoiriis KT, 2004, J MANIP PHYSIOL THER, V27, P388, DOI 10.1016/j.jmpt.2004.05.003; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Hurley DA, 2015, PAIN, V156, P131, DOI 10.1016/j.pain.0000000000000013; Hutchinson AJP, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-36; Inani SB, 2013, J BACK MUSCULOSKELET, V26, P37, DOI 10.3233/BMR-2012-0348; Jensen RK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-22; Kalauokalani D, 2001, SPINE, V26, P1418, DOI 10.1097/00007632-200107010-00005; Kamper SJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000963.pub3; Kell RT, 2011, J STRENGTH COND RES, V25, P1052, DOI 10.1519/JSC.0b013e3181d09df7; Kennedy S, 2008, COMPLEMENT THER MED, V16, P139, DOI 10.1016/j.ctim.2007.03.001; Khan M, 2014, PAK J PHARM SCI, V27, P1113; Kong LJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/695726; Kumnerddee Wipoo, 2009, J Med Assoc Thai, V92 Suppl 1, pS117; Lam M, 2013, SPINE, V38, P2124, DOI 10.1097/01.brs.0000435025.65564.b7; Lamb SE, 2012, PAIN, V153, P494, DOI 10.1016/j.pain.2011.11.016; Lamb SE, 2010, LANCET, V375, P916, DOI 10.1016/S0140-6736(09)62164-4; Lee JH, 2013, CLIN J PAIN, V29, P172, DOI 10.1097/AJP.0b013e31824909f9; Leibing E, 2002, PAIN, V96, P189, DOI 10.1016/S0304-3959(01)00444-4; Licciardone JC, 2013, MANUAL THER, V18, P533, DOI 10.1016/j.math.2013.05.006; Linde K, 2007, PAIN, V128, P264, DOI 10.1016/j.pain.2006.12.006; Little P, 2008, BRIT J SPORT MED, V42, P965; Macedo LG, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012085; Macedo LG, 2012, PHYS THER, V92, P363, DOI 10.2522/ptj.20110290; Machado LAC, 2009, RHEUMATOLOGY, V48, P520, DOI 10.1093/rheumatology/ken470; Machado LAC, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-10; Monticone M, 2014, EUR SPINE J, V23, P2105, DOI 10.1007/s00586-014-3478-5; Moore RA, 2013, BRIT J ANAESTH, V111, P38, DOI 10.1093/bja/aet126; Morone NE, 2016, JAMA INTERN MED, V176, P329, DOI 10.1001/jamainternmed.2015.8033; Morone NE, 2009, PAIN MED, V10, P1395, DOI 10.1111/j.1526-4637.2009.00746.x; Nambi Gopal S, 2014, Int J Yoga, V7, P48, DOI 10.4103/0973-6131.123481; Oesch P, 2010, J REHABIL MED, V42, P193, DOI 10.2340/16501977-0524; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Paatelma M, 2008, J REHABIL MED, V40, P858, DOI 10.2340/16501977-0262; Pengel LHM, 2007, ANN INTERN MED, V146, P787, DOI 10.7326/0003-4819-146-11-200706050-00007; Petersen T, 2011, SPINE, V36, P1999, DOI 10.1097/BRS.0b013e318201ee8e; Poole H, 2007, EUR J PAIN, V11, P878, DOI 10.1016/j.ejpain.2007.01.006; Quinn F, 2008, COMPLEMENT THER MED, V16, P3, DOI 10.1016/j.ctim.2007.05.001; Romanowski M, 2012, STUD HEALTH TECHNOL, V176, P411, DOI 10.3233/978-1-61499-067-3-411; Rubinstein SM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008112.pub2; Rubinstein SM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008880.pub2; Santilli Valter, 2006, Spine J, V6, P131, DOI 10.1016/j.spinee.2005.08.001; Saper RB, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/658030; Saragiotto BT, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012004; Sator-Katzenschlager SM, 2004, ANESTH ANALG, V98, P1359, DOI 10.1213/01.ANE.0000107941.16173.F7; Schneider M, 2015, SPINE, V40, P209, DOI 10.1097/BRS.0000000000000724; Searle A, 2015, CLIN REHABIL, V29, P1155, DOI 10.1177/0269215515570379; Senna MK, 2011, SPINE, V36, P1427, DOI 10.1097/BRS.0b013e3181f5dfe0; Shaheed CA, 2014, J PAIN, V15, P2, DOI 10.1016/j.jpain.2013.09.016; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Sherman KJ, 2011, ARCH INTERN MED, V171, P2019, DOI 10.1001/archinternmed.2011.524; Sherman KJ, 2005, ANN INTERN MED, V143, P849, DOI 10.7326/0003-4819-143-12-200512200-00003; Siemonsma PC, 2013, PHYS THER, V93, P435, DOI 10.2522/ptj.20110150; Soriano Fernando, 1998, Laser Therapy, V10, P175; Sritoomma N, 2014, COMPLEMENT THER MED, V22, P26, DOI 10.1016/j.ctim.2013.11.002; Stankovic A, 2012, TURK FIZ TIP REHAB D, V58, P177, DOI 10.4274/tftr.22438; Tekur P, 2012, COMPLEMENT THER MED, V20, P107, DOI 10.1016/j.ctim.2011.12.009; Toya Shigeo, 1994, Laser Therapy, V6, P143; U.S. Preventive Services Task Force. U.S. Preventive Services Task Force Procedure Manual, 2015, AHRQ PUBLICATION; van Geen JW, 2007, SPINE, V32, P249, DOI 10.1097/01.brs.0000251745.00674.08; van Middelkoop M, 2010, BEST PRACT RES CL RH, V24, P193, DOI 10.1016/j.berh.2010.01.002; Vas J, 2012, PAIN, V153, P1883, DOI 10.1016/j.pain.2012.05.033; von Heymann WJ, 2013, SPINE, V38, P540, DOI 10.1097/BRS.0b013e318275d09c; Vong SK, 2011, ARCH PHYS MED REHAB, V92, P176, DOI 10.1016/j.apmr.2010.10.016; Weiss J, 2013, J ALTERN COMPLEM MED, V19, P935, DOI 10.1089/acm.2012.0338; Whitlock EP, 2008, ANN INTERN MED, V148, P776, DOI 10.7326/0003-4819-148-10-200805200-00010; Williams K, 2009, SPINE, V34, P2066, DOI 10.1097/BRS.0b013e3181b315cc; Wu WF, 2013, J MUSCULOSKELET PAIN, V21, P37, DOI 10.3109/10582452.2013.763394; Xu M, 2013, AM J CHINESE MED, V41, P1, DOI 10.1142/S0192415X13500018; Yeh CH, 2016, BEHAV SLEEP MED, V14, P279, DOI 10.1080/15402002.2014.981820; Yoon YS, 2012, ANN REHABIL MED-ARM, V36, P55, DOI 10.5535/arm.2012.36.1.55; Yun MD, 2012, J MUSCULOSKELET PAIN, V20, P107, DOI 10.3109/10582452.2012.673544; Zhang YJ, 2015, COMPLEMENT THER MED, V23, P1, DOI 10.1016/j.ctim.2014.12.005; Zheng ZX, 2012, J TRADIT CHIN MED, V32, P534, DOI 10.1016/S0254-6272(13)60066-7	130	366	386	21	202	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2017	166	7					493	+		10.7326/M16-2459	http://dx.doi.org/10.7326/M16-2459			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ4PT	28192793				2022-12-28	WOS:000398061100011
J	Potpara, TS; Lip, GYH				Potpara, Tatjana S.; Lip, Gregory Y. H.			Postapproval Observational Studies of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DABIGATRAN; RIVAROXABAN; WARFARIN; SAFETY; METAANALYSIS; COHORT; RISK		[Potpara, Tatjana S.; Lip, Gregory Y. H.] Univ Belgrade, Sch Med, Belgrade, Serbia; [Potpara, Tatjana S.] Clin Ctr Serbia, Cardiol Clin, Belgrade, Serbia; [Lip, Gregory Y. H.] Univ Birmingham, Inst Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England	University of Belgrade; Clinical Centre of Serbia; University of Birmingham	Lip, GYH (corresponding author), Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Dudley Rd, Birmingham B18 7QH, W Midlands, England.	g.y.h.lip@bham.ac.uk			Pfizer; Bayer; Boehringer Ingelheim	Pfizer(Pfizer); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim)	Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Potpara reports receipt of speaker fees from Pfizer, Bayer, and Boehringer Ingelheim. Dr Lip reports consulting for Bayer/Janssen, BMS/Pfizer, Biotronik, Medtronic, Boehringer Ingelheim, Microlife, and Daiichi-Sankyo; and being a speaker for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Microlife, Roche, and Daiichi-Sankyo. No fees were received personally. Consultancy and speaker honoraria were received into a group private practice limited company.	Carmo J, 2016, THROMB HAEMOSTASIS, V116, P754, DOI 10.1160/TH16-03-0203; Gorst-Rasmussen A, 2016, PHARMACOEPIDEM DR S, V25, P1236, DOI 10.1002/pds.4034; Graham DJ, 2016, JAMA INTERN MED, V176, P1662, DOI 10.1001/jamainternmed.2016.5954; Larsen TB, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3189; Lip GYH, 2016, THROMB HAEMOSTASIS, V116, P975, DOI 10.1160/TH16-05-0403; Maura G, 2015, CIRCULATION, V132, P1252, DOI 10.1161/CIRCULATIONAHA.115.015710; Raparelli V, 2017, THROMB HAEMOSTASIS, V117, P209, DOI 10.1160/TH16-10-0757; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Staerk L, 2017, EUR HEART J, V38, P907, DOI 10.1093/eurheartj/ehw496; Yao XX, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003725	10	31	32	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2017	317	11					1115	1116		10.1001/jama.2017.1152	http://dx.doi.org/10.1001/jama.2017.1152			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9CQ	28208176				2022-12-28	WOS:000396987200012
J	Schwietzke, S; Sherwood, OA; Bruhwiler, LMP; Miller, JB; Etiope, G; Dlugokencky, EJ; Michel, SE; Arling, VA; Vaughn, BH; White, JWC; Tans, PP				Schwietzke, Stefan; Sherwood, Owen A.; Bruhwiler, Lori M. P.; Miller, John B.; Etiope, Giuseppe; Dlugokencky, Edward J.; Michel, Sylvia Englund; Arling, Victoria A.; Vaughn, Bruce H.; White, James W. C.; Tans, Pieter P.			Upward revision of global fossil fuel methane emissions based on isotope database (vol 538, pg 88, 2016)	NATURE			English	Correction													Miller, John B./AAE-7714-2019; Dlugokencky, Edward/AAN-8746-2020; Bruhwiler, Lori/AAQ-8502-2020; Etiope, Giuseppe/H-3343-2011; Vaughn, Bruce/AAO-8867-2020; Tans, Pieter/AAG-8273-2019; Michel, Sylvia Englund/AAQ-2028-2020; White, James W.C./A-7845-2009	Miller, John B./0000-0001-8630-1610; Dlugokencky, Edward/0000-0003-0612-6985; Bruhwiler, Lori/0000-0002-3554-9250; Etiope, Giuseppe/0000-0001-8614-4221; Tans, Pieter/0000-0002-9883-0787; Michel, Sylvia Englund/0000-0002-5651-1163; White, James W.C./0000-0001-6041-4684				Schwietzke S, 2016, NATURE, V538, P88, DOI 10.1038/nature19797	1	2	2	3	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					452	452		10.1038/nature21422	http://dx.doi.org/10.1038/nature21422			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28199311	Bronze			2022-12-28	WOS:000396337400057
J	Brusatte, SL				Brusatte, Stephen L.			PALEONTOLOGY A Mesozoic aviary Biomechanical models are key to understanding how dinosaurs experimented with different ways of flying	SCIENCE			English	Editorial Material							EVOLUTION; FLIGHT; HYPOTHESES; FEATHERS; ORIGINS; WINGS; BIRD		[Brusatte, Stephen L.] Univ Edinburgh, Sch GeoSci, Grant Inst, James Hutton Rd, Edinburgh EH9 3FE, Midlothian, Scotland	University of Edinburgh	Brusatte, SL (corresponding author), Univ Edinburgh, Sch GeoSci, Grant Inst, James Hutton Rd, Edinburgh EH9 3FE, Midlothian, Scotland.	stephen.brusatte@ed.ac.uk						Brusatte SL, 2014, CURR BIOL, V24, P2386, DOI 10.1016/j.cub.2014.08.034; Chiappe LM, 2016, BIRDS OF STONE: CHINESE AVIAN FOSSILS FROM THE AGE OF DINOSAURS, P3; Clarke J, 2013, SCIENCE, V340, P690, DOI 10.1126/science.1235463; Dececchi TA, 2016, PEERJ, V4, DOI 10.7717/peerj.2159; Dyke G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3489; Evangelista D, 2014, PEERJ, V2, DOI 10.7717/peerj.632; Foth C, 2014, NATURE, V511, P79, DOI 10.1038/nature13467; Li QG, 2014, NATURE, V507, P350, DOI 10.1038/nature12973; Vinther J, 2016, CURR BIOL, V26, P2456, DOI 10.1016/j.cub.2016.06.065; Xing LD, 2016, CURR BIOL, V26, P3352, DOI 10.1016/j.cub.2016.10.008; Xu X, 2015, NATURE, V521, P70, DOI 10.1038/nature14423; Xu X, 2014, SCIENCE, V346, P1341, DOI 10.1126/science.1253293; Zelenitsky DK, 2012, SCIENCE, V338, P510, DOI 10.1126/science.1225376	13	10	10	4	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					792	794		10.1126/science.aal2397	http://dx.doi.org/10.1126/science.aal2397			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28232535				2022-12-28	WOS:000395127600017
J	Spiegel, P; Rubenstein, L				Spiegel, Paul; Rubenstein, Leonard			The academic case for repealing Trump's refugee and travel ban	LANCET			English	Editorial Material							HEALTH		[Spiegel, Paul; Rubenstein, Leonard] Johns Hopkins Univ, Ctr Humanitarian Hlth, Baltimore, MD 21205 USA; [Rubenstein, Leonard] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Spiegel, P (corresponding author), Johns Hopkins Univ, Ctr Humanitarian Hlth, Baltimore, MD 21205 USA.	pbspiegel@jhu.edu	Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661				Al-Mowafak HM, 2017, NY TIMES; Doocy S, 2016, CONFL HEALTH, V10, DOI 10.1186/s13031-016-0088-3; Doocy S, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0399-4; Hassan G, 2016, EPIDEMIOL PSYCH SCI, V25, P129, DOI 10.1017/S2045796016000044; Johns Hopkins Bloomberg School of Public Health, 2017, EX ORD REF EM PUBL H; Klag MJ, 2017, LETT FACULTY JOHNS H; Maxmen A., 2017, SCI AM; Nowrasteh A, 2016, POLCY ANAL      0913; Verme P., 2015, WELFARE SYRIAN REFUG; White House, 2017, EXECUTIVE ORDER PROT; Yasmine R, 2016, REPROD HEALTH MATTER, V24, P27, DOI 10.1016/j.rhm.2016.04.008	11	6	6	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 18	2017	389	10070					679	680		10.1016/S0140-6736(17)30332-X	http://dx.doi.org/10.1016/S0140-6736(17)30332-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9KK	28190579				2022-12-28	WOS:000394938900008
J	Frank, RG; Pollack, HA				Frank, Richard G.; Pollack, Harold A.			Addressing the Fentanyl Threat to Public Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Drug Enforcement Agency, 2016, DEA WARN POL PUBL FE; Drug Enforcement Agency, 2016, NAT HER THREAT ASS S; Gladden RM, 2016, MMWR-MORBID MORTAL W, V65, P837, DOI 10.15585/mmwr.mm6533a2; Kleiman MAR, 2012, ISSUES SCI TECHNOL, V28, P79; Schumann H, 2008, CLIN TOXICOL, V46, P501, DOI 10.1080/15563650701877374	5	144	148	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2017	376	7					605	607		10.1056/NEJMp1615145	http://dx.doi.org/10.1056/NEJMp1615145			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0QJ	28199808				2022-12-28	WOS:000396402700009
J	Workman, P; Draetta, GF; Schellens, JHM; Bernards, R				Workman, Paul; Draetta, Giulio F.; Schellens, Jan H. M.; Bernards, Rene			How Much Longer Will We Put Up With $100,000 Cancer Drugs?	CELL			English	Editorial Material							LUNG-CANCER; DISCOVERY; CRIZOTINIB; MARKET; COSTS	The spiraling cost of new drugs mandates a fundamentally different approach to keep lifesaving therapies affordable for cancer patients. We call here for the formation of new relationships between academic drug discovery centers and commercial partners, which can accelerate the development of truly transformative drugs at sustainable prices.	[Workman, Paul] Inst Canc Res, Canc Res UK Canc Therapeut Unit, London, England; [Draetta, Giulio F.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Draetta, Giulio F.] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Schellens, Jan H. M.] Netherlands Canc Inst, Div Clin Pharmacol, NL-1066 CX Amsterdam, Netherlands; [Schellens, Jan H. M.] Univ Utrecht, UIPS, Utrecht, Netherlands; [Bernards, Rene] Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; [Bernards, Rene] Netherlands Canc Inst, Canc Genom Ctr Netherlands, NL-1066 CX Amsterdam, Netherlands	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Netherlands Cancer Institute; Utrecht University; Netherlands Cancer Institute; Netherlands Cancer Institute	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands.; Bernards, R (corresponding author), Netherlands Canc Inst, Canc Genom Ctr Netherlands, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl			Cancer Research UK [11566] Funding Source: Medline; Cancer Research UK [22897] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)		Avorn J, 2015, NEW ENGL J MED, V372, P1877, DOI 10.1056/NEJMp1500848; Banerji U, 2016, SEMIN ONCOL, V43, P436, DOI 10.1053/j.seminoncol.2016.06.001; Brawley L, 2016, CANC LETT, V42, P2; DiMasi JA, 2001, CLIN PHARMACOL THER, V69, P297, DOI 10.1067/mcp.2001.115446; Frye S, 2011, NAT REV DRUG DISCOV, V10, P409, DOI 10.1038/nrd3462; Hoelder S, 2012, MOL ONCOL, V6, P155, DOI 10.1016/j.molonc.2012.02.004; Howard DH, 2015, J ECON PERSPECT, V29, P139, DOI 10.1257/jep.29.1.139; Jaffe S, 2015, LANCET, V386, P2127, DOI 10.1016/S0140-6736(15)01098-3; Kirkegaard HS, 2014, DRUG DISCOV TODAY, V19, P1699, DOI 10.1016/j.drudis.2014.06.011; Light DW, 2013, CANCER-AM CANCER SOC, V119, P3900, DOI 10.1002/cncr.28321; Mailankody S, 2015, JAMA ONCOL, V1, P539, DOI 10.1001/jamaoncol.2015.0373; Shaw AT, 2014, NEW ENGL J MED, V371, P1963, DOI 10.1056/NEJMoa1406766; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; van Harten WH, 2016, LANCET ONCOL, V17, P18, DOI 10.1016/S1470-2045(15)00486-6	14	54	54	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2017	168	4					579	583		10.1016/j.cell.2017.01.034	http://dx.doi.org/10.1016/j.cell.2017.01.034			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8VJ	28187281	Green Published, hybrid			2022-12-28	WOS:000396277600010
J	Mayor, S				Mayor, Susan			Care home residents show higher incidence of venous thromboembolism	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Apenteng PN, 2017, BRIT J GEN PRACT, V67, pE130, DOI 10.3399/bjgp17X688873	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2017	356								j694	10.1136/bmj.j694	http://dx.doi.org/10.1136/bmj.j694			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4FX	28179236				2022-12-28	WOS:000394578200014
J	Rimmer, A				Rimmer, Abi			Half of doctors don't go straight into specialty training	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Rimmer A., 2017, BMJ CAREERS	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2017	356								j672	10.1136/bmj.j672	http://dx.doi.org/10.1136/bmj.j672			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4FX	28179234				2022-12-28	WOS:000394578200011
J	Paramsothy, S; Kamm, MA; Kaakoush, NO; Walsh, AJ; van den Bogaerde, J; Samuel, D; Leong, RWL; Connor, S; Ng, W; Paramsothy, R; Xuan, W; Lin, E; Mitchell, HM; Borody, TJ				Paramsothy, Sudarshan; Kamm, Michael A.; Kaakoush, Nadeem O.; Walsh, Alissa J.; van den Bogaerde, Johan; Samuel, Douglas; Leong, Rupert W. L.; Connor, Susan; Ng, Watson; Paramsothy, Ramesh; Xuan, Wei; Lin, Enmoore; Mitchell, Hazel M.; Borody, Thomas J.			Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial	LANCET			English	Article							INFLAMMATORY-BOWEL-DISEASE; DONOR; REMISSION; FROZEN	Background The intestinal microbiota is implicated in the pathogenesis of ulcerative colitis. Faecal microbiota transplantation is a novel form of therapeutic microbial manipulation, but its efficacy in ulcerative colitis is uncertain. We aimed to establish the efficacy of intensive-dosing, multidonor, faecal microbiota transplantation in active ulcerative colitis. Methods We conducted a multicentre, double-blind, randomised, placebo-controlled trial at three hospitals in Australia. We randomly allocated patients with active ulcerative colitis (Mayo score 4-10) in a 1: 1 ratio, using a preestablished randomisation list, to either faecal microbiota transplantation or placebo colonoscopic infusion, followed by enemas 5 days per week for 8 weeks. Patients, treating clinicians, and other study staff were unaware of the assigned treatment. Faecal microbiota transplantation enemas were each derived from between three and seven unrelated donors. The primary outcome was steroid-free clinical remission with endoscopic remission or response (Mayo score <= 2, all subscores <= 1, and <= 1 point reduction in endoscopy subscore) at week 8. Analysis was by modified intention-to-treat and included all patients receiving one study dose. We performed 16S rRNA stool analysis to assess associated microbial changes. This trial is registered with ClinicalTrials.gov, number NCT01896635. The trial has ended; this report presents the final analysis. Findings From November, 2013, to May, 2015, 85 patients were enrolled to our trial, of whom 42 were randomly assigned faecal microbiota transplantation and 43 were allocated placebo. One patient assigned faecal microbiota transplantation and three allocated placebo did not receive study treatment and were excluded from the analysis. The primary outcome was achieved in 11 (27%) of 41 patients allocated faecal microbiota transplantation versus three (8%) of 40 who were assigned placebo (risk ratio 3.6, 95% CI 1.1-11.9; p=0.021). Adverse events were reported by 32 (78%) of 41 patients allocated faecal microbiota transplantation and 33 (83%) of 40 who were assigned placebo; most were self-limiting gastrointestinal complaints, with no significant difference in number or type of adverse events between treatment groups. Serious adverse events occurred in two patients assigned faecal microbiota transplantation and in one allocated placebo. Microbial diversity increased with and persisted after faecal microbiota transplantation. Several bacterial taxa were associated with clinical outcome; in particular, the presence of Fusobacterium spp was associated with lack of remission. Interpretation Intensive-dosing, multidonor, faecal microbiota transplantation induces clinical remission and endoscopic improvement in active ulcerative colitis and is associated with distinct microbial changes that relate to outcome. Faecal microbiota transplantation is, thus, a promising new therapeutic option for ulcerative colitis. Future work should focus on precisely defining the optimum treatment intensity and the role of donor-recipient matching based on microbial profiles.	[Paramsothy, Sudarshan] Univ New South Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Kaakoush, Nadeem O.] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia; [Connor, Susan; Ng, Watson; Xuan, Wei] Univ New South Wales, South Western Sydney Clin Sch, Sydney, NSW, Australia; [Paramsothy, Ramesh; Mitchell, Hazel M.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Kamm, Michael A.] St Vincents Hosp, Dept Gastroenterol, Melbourne, Vic, Australia; [Kamm, Michael A.] St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [Kamm, Michael A.] Univ Melbourne, Melbourne, Vic, Australia; [Paramsothy, Sudarshan; Walsh, Alissa J.] St Vincents Hosp, Dept Gastroenterol, Sydney, NSW, Australia; [Paramsothy, Sudarshan; van den Bogaerde, Johan] Nambour Gen Hosp, Dept Gastroenterol, Nambour, Qld, Australia; [Paramsothy, Sudarshan; Samuel, Douglas; Leong, Rupert W. L.] Bankstown Lidcombe Hosp, Dept Gastroenterol, Sydney, NSW, Australia; [Connor, Susan; Ng, Watson; Paramsothy, Ramesh] Liverpool Hosp, Dept Gastroenterol, Sydney, NSW, Australia; [Connor, Susan; Xuan, Wei] Ingham Inst, Sydney, NSW, Australia; [Lin, Enmoore; Borody, Thomas J.] Ctr Digest Dis, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; St Vincent's Hospital Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; St Vincents Hospital Sydney; Liverpool Hospital; Ingham Institute for Applied Medical Research	Kamm, MA (corresponding author), St Vincents Hosp, Melbourne, Vic 3065, Australia.	mkamm@unimelb.edu.au	Leong, Rupert WL/J-7839-2012; Connor, Susan/ABF-5155-2020; Paramsothy, Sudarshan/AAN-3096-2020; Kaakoush, Nadeem/ABG-9499-2020	Leong, Rupert WL/0000-0001-5944-3488; Connor, Susan/0000-0001-5606-0270; Borody, Thomas/0000-0002-0519-4698; Lin, Enmoore/0000-0002-8584-7627; Paramsothy, Sudarshan/0000-0002-9097-6028; Walsh, Alissa/0000-0002-8994-1186; Kaakoush, Nadeem Omar/0000-0003-4017-1077	Broad Medical Research Program; Gastroenterological Society of Australia; Mount Sinai (New York) SUCCESS fund; University of New South Wales	Broad Medical Research Program; Gastroenterological Society of Australia; Mount Sinai (New York) SUCCESS fund; University of New South Wales	Broad Medical Research Program, Gastroenterological Society of Australia, Mount Sinai (New York) SUCCESS fund, University of New South Wales.	Alang N, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv004; Anderson JL, 2012, ALIMENT PHARM THER, V36, P503, DOI 10.1111/j.1365-2036.2012.05220.x; Angelberger S, 2013, AM J GASTROENTEROL, V108, P1620, DOI 10.1038/ajg.2013.257; Borody TJ, 2014, CURR OPIN GASTROEN, V30, P97, DOI 10.1097/MOG.0000000000000027; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; GUYATT G, 1989, GASTROENTEROLOGY, V96, P804, DOI 10.1016/0016-5085(89)90905-0; Hamilton MJ, 2013, GUT MICROBES, V4, P125, DOI 10.4161/gmic.23571; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Kump PK, 2013, INFLAMM BOWEL DIS, V19, P2155, DOI 10.1097/MIB.0b013e31829ea325; Kump PK, 2013, UNITED EUR GASTRO S1, V1, pA57, DOI DOI 10.1177/2050640613502899]; Lee CH, 2016, JAMA-J AM MED ASSOC, V315, P142, DOI 10.1001/jama.2015.18098; Li SS, 2016, SCIENCE, V352, P586, DOI 10.1126/science.aad8852; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; Ohkusa T, 2003, GUT, V52, P79, DOI 10.1136/gut.52.1.79; Paramsothy S, 2015, INFLAMM BOWEL DIS, V21, P1600, DOI 10.1097/MIB.0000000000000405; Rossen NG, 2015, GASTROENTEROLOGY, V149, P110, DOI 10.1053/j.gastro.2015.03.045; Sartor RB, 2010, GASTROENTEROLOGY, V139, P1816, DOI 10.1053/j.gastro.2010.10.036; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shanahan F, 2014, GASTROENTEROLOGY, V146, P1554, DOI 10.1053/j.gastro.2014.01.050; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; Travis SPL, 2012, GUT, V61, P535, DOI 10.1136/gutjnl-2011-300486; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vermeire S, 2016, J CROHNS COLITIS, V10, P387, DOI 10.1093/ecco-jcc/jjv203; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Youngster I, 2014, JAMA-J AM MED ASSOC, V312, P1772, DOI 10.1001/jama.2014.13875	29	652	695	7	125	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2017	389	10075					1218	1228		10.1016/S0140-6736(17)30182-4	http://dx.doi.org/10.1016/S0140-6736(17)30182-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP1KL	28214091				2022-12-28	WOS:000397143700034
J	Hirose, K; Morard, G; Sinmyo, R; Umemoto, K; Hernlund, J; Helffrich, G; Labrosse, S				Hirose, Kei; Morard, Guillaume; Sinmyo, Ryosuke; Umemoto, Koichio; Hernlund, John; Helffrich, George; Labrosse, Stephane			Crystallization of silicon dioxide and compositional evolution of the Earth's core	NATURE			English	Article							X-RAY-DIFFRACTION; DEEP MAGMA-OCEAN; LIQUID-IRON; PRESSURES IMPLICATIONS; SYSTEM; MANTLE; ACCRETION; GEODYNAMO; DYNAMO; NI	The Earth's core is about ten per cent less dense than pure iron (Fe), suggesting that it contains light elements as well as iron. Modelling of core formation at high pressure (around 40-60 gigapascals) and high temperature (about 3,500 kelvin) in a deep magma ocean(1-5) predicts that both silicon (Si) and oxygen (O) are among the impurities in the liquid outer core(6-9). However, only the binary systems Fe-Si and Fe-O have been studied in detail at high pressures, and little is known about the compositional evolution of the Fe-Si-O ternary alloy under core conditions. Here we performed melting experiments on liquid Fe-Si-O alloy at core pressures in a laser-heated diamond-anvil cell. Our results demonstrate that the liquidus field of silicon dioxide (SiO2) is unexpectedly wide at the iron-rich portion of the Fe-Si-O ternary, such that an initial Fe-Si-O core crystallizes SiO2 as it cools. If crystallization proceeds on top of the core, the buoyancy released should have been more than sufficient to power core convection and a dynamo, in spite of high thermal conductivity(10,11), from as early on as the Hadean eon(12). SiO2 saturation also sets limits on silicon and oxygen concentrations in the present-day outer core.	[Hirose, Kei; Sinmyo, Ryosuke; Umemoto, Koichio; Hernlund, John; Helffrich, George] Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528550, Japan; [Morard, Guillaume] Univ Paris 06, Sorbonne Univ, CNRS,Inst Mineral Phys Mat & Cosmochim, Museum Natl Hist Natl,IRD,UMR 7590, 4 Pl Jussieu, F-75005 Paris, France; [Labrosse, Stephane] Univ Lyon 1, Ecole Normale Super Lyon, CNRS, UMR 5276 LGL TPE, F-69364 Lyon, France	Tokyo Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Hirose, K (corresponding author), Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528550, Japan.	kei@elsi.jp	Hirose, Kei/C-2165-2009; Labrosse, Stéphane/C-8665-2012; Labrosse, Stéphane/M-5990-2019; Umemoto, Koichiro/A-2800-2014; Morard, Guillaume/AAX-8454-2020; Sinmyo, Ryosuke/M-9534-2019; Hernlund, John/A-8931-2014	Hirose, Kei/0000-0003-4366-7721; Labrosse, Stéphane/0000-0002-7620-4363; Labrosse, Stéphane/0000-0002-7620-4363; Umemoto, Koichiro/0000-0003-2410-4042; Sinmyo, Ryosuke/0000-0001-5799-3400; Morard, Guillaume/0000-0002-4225-0767; Helffrich, George/0000-0002-7363-4552; Hernlund, John/0000-0003-1008-0182	Grants-in-Aid for Scientific Research [16H06285, 15H05834] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Akahama Y, 2006, J APPL PHYS, V100, DOI 10.1063/1.2335683; Andrault D, 1998, EUR J MINERAL, V10, P931; [Anonymous], 1988, JAPAN SOC PROMOTIO 2; Anzellini S, 2013, SCIENCE, V340, P464, DOI 10.1126/science.1233514; Badro J, 2016, NATURE, V536, P326, DOI 10.1038/nature18594; Badro J, 2014, P NATL ACAD SCI USA, V111, P7542, DOI 10.1073/pnas.1316708111; Bouhifd MA, 2011, EARTH PLANET SC LETT, V307, P341, DOI 10.1016/j.epsl.2011.05.006; Boukare CE, 2015, J GEOPHYS RES-SOL EA, V120, P6085, DOI 10.1002/2015JB011929; Buffett BA, 2000, SCIENCE, V290, P1338, DOI 10.1126/science.290.5495.1338; Christensen UR, 2010, SPACE SCI REV, V152, P565, DOI 10.1007/s11214-009-9553-2; Christensen UR, 2004, NATURE, V429, P169, DOI 10.1038/nature02508; Fischer RA, 2015, GEOCHIM COSMOCHIM AC, V167, P177, DOI 10.1016/j.gca.2015.06.026; Fischer RA, 2013, EARTH PLANET SC LETT, V373, P54, DOI 10.1016/j.epsl.2013.04.035; Fu RR, 2012, SCIENCE, V338, P238, DOI 10.1126/science.1225648; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Gonzalez-Cataldo F, 2016, SCI REP-UK, V6, DOI 10.1038/srep26537; Helffrich G, 2014, EARTH PLANET SC LETT, V391, P256, DOI 10.1016/j.epsl.2014.01.039; Hernlund JW, 2007, PHYS EARTH PLANET IN, V162, P149, DOI 10.1016/j.pepi.2007.04.005; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Ichikawa H, 2014, J GEOPHYS RES-SOL EA, V119, P240, DOI 10.1002/2013JB010732; Kato C, 2016, EARTH PLANET SC LETT, V440, P56, DOI 10.1016/j.epsl.2016.02.011; Komabayashi T., 2014, J GEOPHYS RES SOLID, V119; Konopkova Z, 2016, NATURE, V534, P99, DOI 10.1038/nature18009; Kuwayama Y, 2005, SCIENCE, V309, P923, DOI 10.1126/science.1114879; Labrosse S, 2007, NATURE, V450, P866, DOI 10.1038/nature06356; Labrosse S, 2015, PHYS EARTH PLANET IN, V247, P36, DOI 10.1016/j.pepi.2015.02.002; Ma ZT, 2001, METALL MATER TRANS B, V32, P87, DOI 10.1007/s11663-001-0011-0; Morard G, 2011, PHYS CHEM MINER, V38, P767, DOI 10.1007/s00269-011-0449-9; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; O'Neill HS, 1998, J GEOPHYS RES-SOL EA, V103, P12239, DOI 10.1029/97JB02601; O'Rourke JG, 2016, NATURE, V529, P387, DOI 10.1038/nature16495; Ohta K, 2016, NATURE, V534, P95, DOI 10.1038/nature17957; Ozawa H, 2016, EARTH PLANET SC LETT, V456, P47, DOI 10.1016/j.epsl.2016.08.042; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Righter K, 2011, EARTH PLANET SC LETT, V304, P158, DOI 10.1016/j.epsl.2011.01.028; Rubie DC, 2015, ICARUS, V248, P89, DOI 10.1016/j.icarus.2014.10.015; Rubie DC, 2011, EARTH PLANET SC LETT, V301, P31, DOI 10.1016/j.epsl.2010.11.030; Siebert J, 2013, SCIENCE, V339, P1194, DOI 10.1126/science.1227923; Siebert J, 2012, EARTH PLANET SC LETT, V321, P189, DOI 10.1016/j.epsl.2012.01.013; Sinmyo R, 2010, PHYS EARTH PLANET IN, V180, P172, DOI 10.1016/j.pepi.2009.10.011; Sun T, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.094109; Takafuji N, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022773; Tarduno JA, 2015, SCIENCE, V349, P521, DOI 10.1126/science.aaa9114; Tsuno K, 2013, GEOPHYS RES LETT, V40, P66, DOI 10.1029/2012GL054116; Umemoto K, 2014, GEOPHYS RES LETT, V41, P6712, DOI 10.1002/2014GL061233; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Wade J, 2005, EARTH PLANET SC LETT, V236, P78, DOI 10.1016/j.epsl.2005.05.017; Wood BJ, 2006, NATURE, V441, P825, DOI 10.1038/nature04763	48	137	140	8	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					99	+		10.1038/nature21367	http://dx.doi.org/10.1038/nature21367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0AA	28225759				2022-12-28	WOS:000395671500040
J	Cook, PJ				Cook, Philip J.			When Police Kill	SCIENCE			English	Book Review									[Cook, Philip J.] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA	Duke University	Cook, PJ (corresponding author), Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA.	pcook@duke.edu		Cook, Philip/0000-0001-5094-9052				Police Foundation and Major Cities Chiefs Association, 2017, RED VIOL CRIM AM CIT; Zimring Franklin E., 2017, WHEN POLICE KILL	2	1	1	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					803	803		10.1126/science.aam5966	http://dx.doi.org/10.1126/science.aam5966			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2DW	28232542				2022-12-28	WOS:000395127600024
J	Mejia, R				Mejia, Robin			Stephen E. Fienberg (1942-2016) OBITUARY	NATURE			English	Biographical-Item									[Mejia, Robin] Carnegie Mellons Ctr Human Rights Sci, Stat & Human Rights Program, Pittsburgh, PA 15213 USA		Mejia, R (corresponding author), Carnegie Mellons Ctr Human Rights Sci, Stat & Human Rights Program, Pittsburgh, PA 15213 USA.	rmejia@andrew.cmu.edu						FIENBERG SE, PUBLICATION LIST	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2017	542	7642					415	415		10.1038/542415a	http://dx.doi.org/10.1038/542415a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM1RG	28230130	Bronze			2022-12-28	WOS:000395094100019
J	Bayton, EA				Bayton, Evan Aled			David Howel Bayton OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2017	356								j870	10.1136/bmj.j870	http://dx.doi.org/10.1136/bmj.j870			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KQ	28219905				2022-12-28	WOS:000395630800006
J	Stafford, N				Stafford, Ned			Hans Rosling OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												ns@europefn.de						Fleck F, 2013, B WORLD HEALTH ORGAN, V91, P904, DOI 10.2471/BLT.13.031213; Gates B, 2017, OUR MEMORIES H ROSLI; HOWLETT WP, 1990, BRAIN, V113, P223, DOI 10.1093/brain/113.1.223; Karolinska Institute, 2017, MEM H ROSL; Kupferschmidt K, 2014, STAR STAT H ROSLING; Maxmen A, 2016, 3 MINUTES H ROSLING; Rosling H, 1993, LAKARTIDNINGEN, V356, P4069; Rosling H, 2006, BEST STATS YOUVE EVE; ROSLING H, PUBLICATION LIST; TYLLESKAR T, 1991, B WORLD HEALTH ORGAN, V69, P581; TYLLESKAR T, 1993, J NEUROL NEUROSUR PS, V56, P638, DOI 10.1136/jnnp.56.6.638; TYLLESKAR T, 1992, LANCET, V339, P208, DOI 10.1016/0140-6736(92)90006-O; UNICEF, 2017, H ROSL UNICEF MEM FU	13	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2017	356								j888	10.1136/bmj.j888	http://dx.doi.org/10.1136/bmj.j888			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KQ	28219885				2022-12-28	WOS:000395630800012
J	Baudard, M; Yavchitz, A; Ravaud, P; Perrodeau, E; Boutron, I				Baudard, Marie; Yavchitz, Amelie; Ravaud, Philippe; Perrodeau, Elodie; Boutron, Isabelle			Impact of searching clinical trial registries in systematic reviews of pharmaceutical treatments: methodological systematic review and reanalysis of meta-analyses	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REPORTING BIAS; PUBLICATION; CLINICALTRIALS.GOV; REGISTRATION; WASTE	OBJECTIVE To evaluate the impact of searching clinical trial registries in systematic reviews. Design Methodological systematic review and reanalyses of meta-analyses. Data sources Medline was searched to identify systematic reviews of randomised controlled trials (RCTs) assessing pharmaceutical treatments published between June 2014 and January 2015. For all systematic reviews that did not report a trial registry search but reported the information to perform it, the World Health Organization International Trials Registry Platform (WHO ICTRP search portal) was searched for completed or terminated RCTs not originally included in the systematic review. Data extraction For each systematic review, two researchers independently extracted the outcomes analysed, the number of patients included, and the treatment effect estimated. For each RCT identified, two researchers independently determined whether the results were available (ie, posted, published, or available on the sponsor website) and extracted the data. When additional data were retrieved, we reanalysed meta-analyses and calculated the weight of the additional RCTs and the change in summary statistics by comparison with the original meta-analysis. Results Among 223 selected systematic reviews, 116 (52%) did not report a search of trial registries; 21 of these did not report the information to perform the search (key words, search date). A search was performed for 95 systematic reviews; for 54 (57%), no additional RCTs were found and for 41 (43%) 122 additional RCTs were identified. The search allowed for increasing the number of patients by more than 10% in 19 systematic reviews, 20% in 10, 30% in seven, and 50% in four. Moreover, 63 RCTs had results available; the results for 45 could be included in a meta-analysis. 14 systematic reviews including 45 RCTs were reanalysed. The weight of the additional RCTs in the recalculated metaanalyses ranged from 0% to 58% and was greater than 10% in five of 14 systematic reviews, 20% in three, and 50% in one. The change in summary statistics ranged from 0% to 29% and was greater than 10% for five of 14 systematic reviews and greater than 20% for two. However, none of the changes to summary effect estimates led to a qualitative change in the interpretation of the results once the new trials were added. Conclusions Trial registries are an important source for identifying additional RCTs. The additional number of RCTs and patients included if a search were performed varied across systematic reviews.	[Baudard, Marie; Yavchitz, Amelie; Ravaud, Philippe; Perrodeau, Elodie; Boutron, Isabelle] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Baudard, Marie; Yavchitz, Amelie; Ravaud, Philippe; Perrodeau, Elodie; Boutron, Isabelle] INSERM, Ctr Rech Epidemiol & Stat, U1153, Paris, France; [Yavchitz, Amelie; Ravaud, Philippe; Perrodeau, Elodie; Boutron, Isabelle] Cochrane France, Paris, France; [Ravaud, Philippe; Perrodeau, Elodie; Boutron, Isabelle] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75004 Paris, France; [Ravaud, Philippe] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Columbia University	Yavchitz, A (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.; Yavchitz, A (corresponding author), INSERM, Ctr Rech Epidemiol & Stat, U1153, Paris, France.; Yavchitz, A (corresponding author), Cochrane France, Paris, France.	amelie.yavchitz@aphp.fr	ravaud, philippe/C-1694-2009	Boutron, Isabelle/0000-0002-5263-6241; Ravaud, Philippe/0000-0001-8264-9206				Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Cook DJ, 1997, ANN INTERN MED, V126, P376, DOI 10.7326/0003-4819-126-5-199703010-00006; Cortes J, 2014, J CLIN EPIDEMIOL, V67, P1172, DOI 10.1016/j.jclinepi.2014.05.017; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Dechartres A, 2011, ANN INTERN MED, V155, P39, DOI 10.7326/0003-4819-155-1-201107050-00006; Dwan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066844; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Ebrahim S, 2016, J CLIN EPIDEMIOL, V70, P155, DOI 10.1016/j.jclinepi.2015.08.021; Glanville JM, 2014, J MED LIBR ASSOC, V102, P177, DOI 10.3163/1536-5050.102.3.007; Golder S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002127; Groves T, 2008, BRIT MED J, V336, P170, DOI 10.1136/bmj.39469.465139.80; Hart B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7202; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Jefferson Tom, 2009, BMJ, V339, pb5106, DOI 10.1136/bmj.b5106; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]; Jones CW, 2014, SYST REV, V3, DOI 10.1186/2046-4053-3-126; Keil LG, 2015, ANN EMERG MED, V66, P424, DOI 10.1016/j.annemergmed.2014.10.001; Laine C, 2007, NEW ENGL J MED, V356, P2734, DOI 10.1056/NEJMe078110; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Maruani A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5579; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Page MJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002028; Potthast R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092067; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Riveros C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001566; Schmucker C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114023; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Strom BL, 2014, NEW ENGL J MED, V371, P2052, DOI 10.1056/NEJMp1411794; van Enst WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042812; Zarin DA, 2016, NEW ENGL J MED, V375, P1998, DOI 10.1056/NEJMsr1611785	36	58	59	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2017	356								j448	10.1136/bmj.j448	http://dx.doi.org/10.1136/bmj.j448			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GP	28213479	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000394580000001
J	Ramsay, L				Ramsay, Lauren			SPOT DIAGNOSIS Sharp shoulder pain, getting worse, after a fall	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ramsay, Lauren] Royal Surrey Cty Hosp, Guildford, Surrey, England	Royal Surrey County Hospital	Ramsay, L (corresponding author), Royal Surrey Cty Hosp, Guildford, Surrey, England.	laurie.ramsay@gmail.com						Callister M E J, 2015, Thorax, V70 Suppl 2, pii1, DOI 10.1136/thoraxjnl-2015-207168; Hollings N, 2002, EUR RESPIR J, V19, P722, DOI 10.1183/09031936.02.00280002; Lee CS, 2013, AM J ROENTGENOL, V201, P611, DOI 10.2214/AJR.12.10375; Lumbreras B, 2010, BRIT J RADIOL, V83, P276, DOI 10.1259/bjr/98067945	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2017	356								j571	10.1136/bmj.j571	http://dx.doi.org/10.1136/bmj.j571			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GN	28209586				2022-12-28	WOS:000394579800002
J	Hawkes, N				Hawkes, Nigel			Professional football may be linked to brain injuries usually seen in boxing	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ling H, 2017, ACTA NEUROPATHOL	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	2017	356								j811	10.1136/bmj.j811	http://dx.doi.org/10.1136/bmj.j811			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GM	28202442				2022-12-28	WOS:000394579700012
J	[Anonymous]				[Anonymous]			Football's Toll on Student Athletes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2017	317	6					577	577		10.1001/jama.2017.0100	http://dx.doi.org/10.1001/jama.2017.0100			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4NG	28196264				2022-12-28	WOS:000426800900003
J	Mervis, J				Mervis, Jeffrey			NO EASY ANSWERS	SCIENCE			English	Editorial Material																			0	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					568	571		10.1126/science.355.6325.568	http://dx.doi.org/10.1126/science.355.6325.568			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK0SF	28183927				2022-12-28	WOS:000393636700018
J	Bradner, JE; Hnisz, D; Young, RA				Bradner, James E.; Hnisz, Denes; Young, Richard A.			Transcriptional Addiction in Cancer	CELL			English	Review							ACUTE PROMYELOCYTIC LEUKEMIA; BET BROMODOMAIN INHIBITION; ACUTE LYMPHOBLASTIC-LEUKEMIA; COVALENT CDK7 INHIBITOR; NEGATIVE BREAST-CANCER; MLL-FUSION LEUKEMIA; CELL IDENTITY GENES; RNA-POLYMERASE-II; SUPER-ENHANCER; C-MYC	Cancer arises from genetic alterations that invariably lead to dysregulated transcriptional programs. These dysregulated programs can cause cancer cells to become highly dependent on certain regulators of gene expression. Here, we discuss how transcriptional control is disrupted by genetic alterations in cancer cells, why transcriptional dependencies can develop as a consequence of dysregulated programs, and how these dependencies provide opportunities for novel therapeutic interventions in cancer.	[Bradner, James E.] Novartis Inst Biomed Res, 181 Massachusetts Ave, Cambridge, MA 02139 USA; [Hnisz, Denes; Young, Richard A.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Young, Richard A.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Novartis; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Young, RA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	young@wi.mit.edu	Hnisz, Denes/AAE-9592-2019; Young, Richard A/F-6495-2012	Hnisz, Denes/0000-0002-6256-1693; Young, Richard A/0000-0001-8855-8647	NIH [HG002668]; Erwin Schrodinger Fellowship from the Austrian Science Fund [J3490]; Margaret and Herman Sokol Postdoctoral Award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Erwin Schrodinger Fellowship from the Austrian Science Fund; Margaret and Herman Sokol Postdoctoral Award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful to Brian Abraham, Brad Bernstein, Daniel Day, Matthew Fearer, Isaac Klein, Nick Kwiatkowski, Charles Lin, Marc Mansour, Peter Rahl, Jussi Taipale, William Tansey, Marc Timmers, Chris Vakoc, and Robert Weinberg for critical comments. Supported by an NIH Grant HG002668 (R.A.Y.), an Erwin Schrodinger Fellowship (J3490) from the Austrian Science Fund (D.H.), and a Margaret and Herman Sokol Postdoctoral Award (D.H.). R.A.Y. and J.E.B are a founders and shareholders of Syros Pharmaceuticals. R.A.Y. is a founder and shareholder of Marauder Therapeutics. J.E.B. is a shareholder and executive of Novartis Pharmaceuticals, and a shareholder of Acetylon Pharmaceuticals. Syros, Novartis, and Acetylon are discovering and developing therapeutics directed at transcriptional pathways in cancer.	Affer M, 2014, LEUKEMIA, V28, P1725, DOI 10.1038/leu.2014.70; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Baubec T, 2013, CELL, V153, P480, DOI 10.1016/j.cell.2013.03.011; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bhagwat AS, 2016, CELL REP, V15, P519, DOI 10.1016/j.celrep.2016.03.054; Bhagwat AS, 2015, TRENDS CANCER, V1, P53, DOI 10.1016/j.trecan.2015.07.001; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Bywater MJ, 2013, NAT REV CANCER, V13, P299, DOI 10.1038/nrc3496; Cai SF, 2015, MOL CELL, V60, P561, DOI 10.1016/j.molcel.2015.10.042; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Chen CW, 2015, EXP HEMATOL, V43, P673, DOI 10.1016/j.exphem.2015.05.012; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Christensen CL, 2014, CANCER CELL, V26, P909, DOI 10.1016/j.ccell.2014.10.019; Clarke VE, 2016, NAT GENET, V48, P1253, DOI 10.1038/ng.3651; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Drier Y, 2016, NAT GENET, V48, P265, DOI 10.1038/ng.3502; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Geng FQ, 2012, ANNU REV BIOCHEM, V81, P177, DOI 10.1146/annurev-biochem-052110-120012; Ghirlando R, 2016, GENE DEV, V30, P881, DOI 10.1101/gad.277863.116; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Gorkin DU, 2014, CELL STEM CELL, V14, P762, DOI 10.1016/j.stem.2014.05.017; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Guenther MG, 2008, GENE DEV, V22, P3403, DOI 10.1101/gad.1741408; Hah N, 2015, P NATL ACAD SCI USA, V112, pE297, DOI 10.1073/pnas.1424028112; Hay D, 2016, NAT GENET, V48, P895, DOI 10.1038/ng.3605; Hnisz D, 2016, CELL, V167, P1188, DOI 10.1016/j.cell.2016.10.024; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Inaba H, 2010, LANCET ONCOL, V11, P1096, DOI 10.1016/S1470-2045(10)70114-5; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Ji X, 2016, CELL STEM CELL, V18, P262, DOI 10.1016/j.stem.2015.11.007; Jiang TT, 2016, NUCLEIC ACIDS RES, V44, P8714, DOI 10.1093/nar/gkw568; Jones PA, 2016, NAT REV GENET, V17, P630, DOI 10.1038/nrg.2016.93; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Joo JY, 2016, NAT NEUROSCI, V19, P75, DOI 10.1038/nn.4170; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Li WB, 2016, NAT REV GENET, V17, P207, DOI 10.1038/nrg.2016.4; Lin CY, 2016, NATURE, V530, P57, DOI 10.1038/nature16546; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Morris SA, 2013, CELL RES, V23, P33, DOI 10.1038/cr.2013.1; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nabet B, 2015, CELL REP, V12, P1300, DOI 10.1016/j.celrep.2015.06.078; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pelish HE, 2015, NATURE, V526, P273, DOI 10.1038/nature14904; Phillips-Cremins JE, 2013, MOL CELL, V50, P461, DOI 10.1016/j.molcel.2013.04.018; Piunti A, 2016, SCIENCE, V352, DOI 10.1126/science.aad9780; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; ROWLEY JD, 1977, LANCET, V1, P549; Sancho-Martinez I, 2012, NAT CELL BIOL, V14, P892, DOI 10.1038/ncb2567; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Shin HY, 2016, NAT GENET, V48, P904, DOI 10.1038/ng.3606; Shu SK, 2016, NATURE, V529, P413, DOI 10.1038/nature16508; Soshnev AA, 2016, MOL CELL, V62, P681, DOI 10.1016/j.molcel.2016.05.004; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Soucek L, 2013, GENE DEV, V27, P504, DOI 10.1101/gad.205542.112; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stathis A, 2016, CANCER DISCOV, V6, P492, DOI 10.1158/2159-8290.CD-15-1335; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Stuart D, 2009, CURR OPIN CELL BIOL, V21, P304, DOI 10.1016/j.ceb.2009.02.001; Sur I, 2016, NAT REV CANCER, V16, P483, DOI 10.1038/nrc.2016.62; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; Thomas D, 2000, CURR BIOL, V10, pR341, DOI 10.1016/S0960-9822(00)00462-0; Tomazou EM, 2015, CELL REP, V10, P1082, DOI 10.1016/j.celrep.2015.01.042; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vierbuchen T, 2012, MOL CELL, V47, P827, DOI 10.1016/j.molcel.2012.09.008; Viny AD, 2015, J EXP MED, V212, P1819, DOI 10.1084/jem.20151317; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Walker BA, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.13; Wang YB, 2015, CELL, V163, P174, DOI 10.1016/j.cell.2015.08.063; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Watson IR, 2013, NAT REV GENET, V14, P703, DOI 10.1038/nrg3539; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Yang H, 2015, ELIFE, V4, DOI 10.7554/eLife.10870; Yashiro-Ohtani Y, 2014, P NATL ACAD SCI USA, V111, pE4946, DOI 10.1073/pnas.1407079111; Zhang TH, 2016, NAT CHEM BIOL, V12, P876, DOI 10.1038/nchembio.2166; Zhang XY, 2016, NAT GENET, V48, P176, DOI 10.1038/ng.3470; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	129	531	542	10	112	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2017	168	4					629	643		10.1016/j.cell.2016.12.013	http://dx.doi.org/10.1016/j.cell.2016.12.013			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8VJ	28187285	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000396277600014
J	Jost, TS; Lazarus, S				Jost, Timothy Stoltzfus; Lazarus, Simon			Trump's Executive Order on Health Care - Can It Undermine the ACA if Congress Fails to Act?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jost, Timothy Stoltzfus] Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA; [Lazarus, Simon] Constitut Accountabil Ctr, Washington, DC USA	Washington & Lee University	Jost, TS (corresponding author), Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA.							Jost TS, 2014, NEW ENGL J MED, V370, P1970, DOI 10.1056/NEJMp1403294; Obama BH, 2017, NEW ENGL J MED, V376, P297, DOI 10.1056/NEJMp1616577	2	5	5	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2017	376	13					1201	1203		10.1056/NEJMp1701340	http://dx.doi.org/10.1056/NEJMp1701340			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EP8KS	28225665				2022-12-28	WOS:000397624900001
J	Gostin, LO; Hodge, JG				Gostin, Lawrence O.; Hodge, James G.			Reforming Federal Public Health Powers Responding to National and Global Threats	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, Oneill Inst Global & Natl Hlth Law, Washington, DC USA; [Hodge, James G.] Arizona State Univ, Sandra Day Oconnor Coll Law, Publ Hlth Law & Policy Program, Phoenix, AZ USA	Georgetown University; Arizona State University; Arizona State University-Downtown Phoenix	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW,McDonough 568, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Control of Communicable Diseases, 2017, FED REGISTER, V82, P6890; Gostin LO, 2017, HEALTH AFFAIR, V36, P159, DOI 10.1377/hlthaff.2016.1492; O'Donnell J., 2017, US TODAY	3	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1211	1212		10.1001/jama.2017.1021	http://dx.doi.org/10.1001/jama.2017.1021			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP7KX	28208169				2022-12-28	WOS:000397557800013
J	Cameron, D; Piccart-Gebhart, MJ; Gelber, RD; Procter, M; Goldhirsch, A; de Azambuja, E; Castro, G; Untch, M; Smith, I; Gianni, L; Baselga, J; Al-Sakaff, N; Lauer, S; McFadden, E; Leyland-Jones, B; Bell, R; Dowsett, M; Jackisch, C				Cameron, David; Piccart-Gebhart, Martine J.; Gelber, Richard D.; Procter, Marion; Goldhirsch, Aron; de Azambuja, Evandro; Castro, Gilberto, Jr.; Untch, Michael; Smith, Ian; Gianni, Luca; Baselga, Jose; Al-Sakaff, Nedal; Lauer, Sabine; McFadden, Eleanor; Leyland-Jones, Brian; Bell, Richard; Dowsett, Mitch; Jackisch, Christian		Herceptin Adjuvant HERA Trial	11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIAL; OPEN-LABEL; PHASE-3 TRIAL; MULTICENTER; PERTUZUMAB; SYSTEM	Background Clinical trials have shown that trastuzumab, a recombinant monoclonal antibody against HER2 receptor, significantly improves overall survival and disease-free survival in women with HER2-positive early breast cancer, but long-term follow-up data are needed. We report the results of comparing observation with two durations of trastuzumab treatment at a median follow-up of 11 years, for patients enrolled in the HERA (HERceptin Adjuvant) trial. Methods HERA (BIG 1-01) is an international, multicentre, open-label, phase 3 randomised trial of 5102 women with HER2-positive early breast cancer, who were enrolled from hospitals in 39 countries between Dec 7, 2001, and June 20, 2005. After completion of all primary therapy (including, surgery, chemotherapy, and radiotherapy as indicated), patients were randomly assigned (1: 1: 1) to receive trastuzumab for 1 year (once at 8 mg/kg of bodyweight intravenously, then 6 mg/kg once every 3 weeks) or for 2 years (with the same dose schedule), or to the observation group. Primary endpoint is disease-free survival, and analyses are in the intention-to-treat population. Hazard ratios (HRs) were estimated from Cox models, and survival curves were estimated by the Kaplan-Meier method. Comparison of 2 years versus 1 year of trastuzumab is based on 366-day landmark analyses. This study is registered with ClinicalTrials.gov (NCT00045032). Findings Of the 5102 women randomly assigned in the HERA trial, three patients had no evidence of having provided written informed consent to participate. We followed up the intention-to-treat population of 5099 patients (1697 in observation, 1702 in 1-year trastuzumab, and 1700 in 2-years trastuzumab groups). After a median follow-up of 11 years (IQR 10.09-11.53), random assignment to 1 year of trastuzumab significantly reduced the risk of a disease-free survival event (HR 0.76, 95% CI 0.68-0.86) and death (0.74, 0.64-0.86) compared with observation. 2 years of adjuvant trastuzumab did not improve disease free-survival outcomes compared with 1 year of this drug (HR 1.02, 95% CI 0.89-1.17). Estimates of 10-year disease-free survival were 63% for observation, 69% for 1 year of trastuzumab, and 69% for 2 years of trastuzumab. 884 (52%) patients assigned to the observation group selectively crossed over to receive trastuzumab. Cardiac toxicity remained low in all groups and occurred mostly during the treatment phase. The incidence of secondary cardiac endpoints was 122 (7.3%) in the 2-years trastuzumab group, 74 (4.4%) in the 1-year trastuzumab group, and 15 (0.9%) in the observation group. Interpretation 1 year of adjuvant trastuzumab after chemotherapy for patients with HER2-positive early breast cancer significantly improves long-term disease-free survival, compared with observation. 2 years of trastuzumab had no additional benefit.	[Cameron, David] Univ Edinburgh, Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; [Piccart-Gebhart, Martine J.] Univ Libre Bruxelles, Dept Med, Brussels, Belgium; [de Azambuja, Evandro] Univ Libre Bruxelles, Med Oncol Clin, Brussels, Belgium; Univ Libre Bruxelles, BrEAST Data Ctr, Inst Jules Bordet, Brussels, Belgium; [Gelber, Richard D.] Harvard TH Chan Sch Publ Hlth, Dept Biostat & Computat Biol, Dana Farber Canc Inst, Harvard Med Sch, Boston, MA USA; [Gelber, Richard D.] Frontier Sci & Technol Res Fdn Inc, Boston, MA USA; [Procter, Marion] Frontier Sci Scotland Ltd, Kincraig, Kingussie, Scotland; [Goldhirsch, Aron] European Inst Oncol, Milan, Italy; [Castro, Gilberto, Jr.] Univ Sao Paulo, Clin Oncol, Inst Canc Estado Sao Paulo, Fac Med, Sao Paulo, Brazil; [Untch, Michael] Helios Klinikum Berlin Buch, Multidisciplinary Breast Canc Ctr, Berlin, Germany; [Smith, Ian; Dowsett, Mitch] Royal Marsden Hosp, Breast Unit, London, England; [Smith, Ian; Dowsett, Mitch] Inst Canc Res, London, England; [Gianni, Luca] Hosp San Raffaele, Dept Med Oncol, Inst Sci, Milan, Italy; [Baselga, Jose] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Al-Sakaff, Nedal; Lauer, Sabine] F Hoffmann La Roche, Basel, Switzerland; [McFadden, Eleanor] Frontier Sci Scotland Ltd, Kincraig, Kingussie, Scotland; [Leyland-Jones, Brian] Avera Canc Inst, Ctr Precis Oncol, Sioux Falls, SD USA; [Bell, Richard] Deakin Univ, Waurn Ponds, Vic, Australia; [Jackisch, Christian] Sana Klinikum Offenbach, Dept Gynecol & Obstet, Offenbach, Germany	University of Edinburgh; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Institut Jules Bordet; Universite Libre de Bruxelles; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard T.H. Chan School of Public Health; Frontier Science Foundation; IRCCS European Institute of Oncology (IEO); Universidade de Sao Paulo; Helios Kliniken; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Memorial Sloan Kettering Cancer Center; Roche Holding; Deakin University; Sana Klinikum Offenbach	Cameron, D (corresponding author), Univ Edinburgh, Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland.	d.cameron@ed.ac.uk	de Castro, Gilberto/C-1627-2013	de Castro, Gilberto/0000-0001-8765-3044; de Azambuja, Evandro/0000-0001-9501-4509; GIANNI, LUCA/0000-0002-2372-9625	F Hoffmann-La Roche (Roche); National Institute for Health Research [NF-SI-0512-10122] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	F Hoffmann-La Roche (Roche)(Hoffmann-La RocheRoche Holding); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	F Hoffmann-La Roche (Roche).	Bianchini G, 2014, LANCET ONCOL, V15, pE58, DOI 10.1016/S1470-2045(13)70477-7; Chan A, 2016, LANCET ONCOL, V17, P367, DOI 10.1016/S1470-2045(15)00551-3; COX DR, 1972, J R STAT SOC B, V34, P187; de Azambuja E, 2014, LANCET ONCOL, V15, P1137, DOI 10.1016/S1470-2045(14)70320-1; de Azambuja E, 2014, J CLIN ONCOL, V32, P2159, DOI 10.1200/JCO.2013.53.9288; Gianni L, 2016, LANCET ONCOL, V17, P791, DOI 10.1016/S1470-2045(16)00163-7; Gianni L, 2011, LANCET ONCOL, V12, P236, DOI 10.1016/S1470-2045(11)70033-X; Goldhirsch A, 2013, LANCET, V382, P1021, DOI 10.1016/S0140-6736(13)61094-6; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Kalbfleisch JD, 2002, STAT ANAL FAILURE TI, P193; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Perez EA, 2011, J CLIN ONCOL, V29, P3366, DOI 10.1200/JCO.2011.35.0868; Piccart-Gebhart M, 2016, J CLIN ONCOL, V34, P1034, DOI 10.1200/JCO.2015.62.1797; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Swain SM, 2015, NEW ENGL J MED, V372, P724, DOI 10.1056/NEJMoa1413513	18	511	546	8	90	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2017	389	10075					1195	1205		10.1016/S0140-6736(16)32616-2	http://dx.doi.org/10.1016/S0140-6736(16)32616-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP1KL	28215665	Green Accepted			2022-12-28	WOS:000397143700032
J	Bellmunt, J; de Wit, R; Vaughn, DJ; Fradet, Y; Lee, JL; Fong, L; Vogelzang, NJ; Climent, MA; Petrylak, DP; Choueiri, TK; Necchi, A; Gerritsen, W; Gurney, H; Quinn, DI; Culine, S; Sternberg, CN; Mai, Y; Poehlein, CH; Perini, RF; Bajorin, DF				Bellmunt, J.; de Wit, R.; Vaughn, D. J.; Fradet, Y.; Lee, J. -L.; Fong, L.; Vogelzang, N. J.; Climent, M. A.; Petrylak, D. P.; Choueiri, T. K.; Necchi, A.; Gerritsen, W.; Gurney, H.; Quinn, D. I.; Culine, S.; Sternberg, C. N.; Mai, Y.; Poehlein, C. H.; Perini, R. F.; Bajorin, D. F.		KEYNOTE-045 Investigators	Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSITIONAL-CELL CARCINOMA; PHASE-III TRIAL; VINFLUNINE PLUS; SUPPORTIVE CARE; NIVOLUMAB; CHEMOTHERAPY; FAILURE; CANCER	BACKGROUND Patients with advanced urothelial carcinoma that progresses after platinum-based chemotherapy have a poor prognosis and limited treatment options. METHODS In this open-label, international, phase 3 trial, we randomly assigned 542 patients with advanced urothelial cancer that recurred or progressed after platinum-based chemotherapy to receive pembrolizumab (a highly selective, humanized monoclonal IgG kappa. isotype antibody against programmed death 1 [PD-1]) at a dose of 200 mg every 3 weeks or the investigator's choice of chemotherapy with paclitaxel, docetaxel, or vinflunine. The coprimary end points were overall survival and progression-free survival, which were assessed among all patients and among patients who had a tumor PD-1 ligand (PD-L1) combined positive score (the percentage of PD-L1-expressing tumor and infiltrating immune cells relative to the total number of tumor cells) of 10% or more. RESULTS The median overall survival in the total population was 10.3 months (95% confidence interval [CI], 8.0 to 11.8) in the pembrolizumab group, as compared with 7.4 months (95% CI, 6.1 to 8.3) in the chemotherapy group (hazard ratio for death, 0.73; 95% CI, 0.59 to 0.91; P = 0.002). The median overall survival among patients who had a tumor PD-L1 combined positive score of 10% or more was 8.0 months (95% CI, 5.0 to 12.3) in the pembrolizumab group, as compared with 5.2 months (95% CI, 4.0 to 7.4) in the chemotherapy group (hazard ratio, 0.57; 95% CI, 0.37 to 0.88; P = 0.005). There was no significant between-group difference in the duration of progression-free survival in the total population (hazard ratio for death or disease progression, 0.98; 95% CI, 0.81 to 1.19; P = 0.42) or among patients who had a tumor PD-L1 combined positive score of 10% or more (hazard ratio, 0.89; 95% CI, 0.61 to 1.28; P = 0.24). Fewer treatment-related adverse events of any grade were reported in the pembrolizumab group than in the chemotherapy group (60.9% vs. 90.2%); there were also fewer events of grade 3, 4, or 5 severity reported in the pembrolizumab group than in the chemotherapy group (15.0% vs. 49.4%). CONCLUSIONS Pembrolizumab was associated with significantly longer overall survival (by approximately 3 months) and with a lower rate of treatment-related adverse events than chemotherapy as second-line therapy for platinum-refractory advanced urothelial carcinoma.Funded by Merck; KEYNOTE- 045 ClinicalTrials. gov number, NCT02256436.)	[Bellmunt, J.; Choueiri, T. K.] Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA; [Bellmunt, J.] Hosp Mar, Med Res Inst, Parc Salut Mar, Barcelona, Spain; [Climent, M. A.] Fdn Inst Valenciano Oncol, Valencia, Spain; [de Wit, R.] Erasmus MC Canc Inst, Rotterdam, Netherlands; [Gerritsen, W.] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands; [Vaughn, D. J.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Fradet, Y.] Univ Laval, Ctr Hosp Univ Quebec, Quebec City, PQ, Canada; [Lee, J. -L.] Asan Med Ctr, Seoul, South Korea; [Lee, J. -L.] Univ Ulsan, Coll Med, Seoul, South Korea; [Fong, L.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Vogelzang, N. J.] Comprehens Canc Ctr Nevada, Las Vegas, NV USA; [Petrylak, D. P.] Yale Univ, Smilow Canc Hosp, New Haven, CT USA; [Necchi, A.] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Gurney, H.] Westmead Hosp, Sydney, NSW, Australia; [Gurney, H.] Macquarie Univ, Sydney, NSW, Australia; [Quinn, D. I.] Univ Southern Calif, Norris Comprehens Canc Ctr & Hosp, Los Angeles, CA USA; [Culine, S.] Hop St Louis, Paris, France; [Sternberg, C. N.] San Camillo Hosp, Rome, Italy; [Sternberg, C. N.] Forlanini Hosp, Rome, Italy; [Mai, Y.; Poehlein, C. H.; Perini, R. F.] Merck, Kenilworth, NJ USA; [Bajorin, D. F.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA	Harvard University; Dana-Farber Cancer Institute; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Instituto Valenciano De Oncologia; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Radboud University Nijmegen; University of Pennsylvania; Pennsylvania Medicine; Laval University; University of Ulsan; University of California System; University of California San Francisco; Comprehensive Cancer Centers of Nevada; Yale University; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Sydney; Macquarie University; University of Southern California; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Azienda Ospedaliera San Camillo-Forlanini; Merck & Company; Memorial Sloan Kettering Cancer Center	Bellmunt, J (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA.	joaquim_bellmunt@dfci.harvard.edu	Re, Giovanni Lo/ABE-1780-2020; Hendriks, Mathijs P./AGR-5663-2022; Gurney, Howard/ABF-6924-2020; Necchi, Andrea/L-6021-2017; Choueiri, Toni/K-5238-2019; gerritsen, Winald/H-8031-2014; Stanculeanu, Dana Lucia/AAB-7964-2019; Quinn, David/N-3730-2019	Re, Giovanni Lo/0000-0003-1169-2359; Hendriks, Mathijs P./0000-0001-6687-5393; Gurney, Howard/0000-0003-0217-5261; Necchi, Andrea/0000-0002-3007-2756; Choueiri, Toni/0000-0002-9201-3217; Stanculeanu, Dana Lucia/0000-0003-3930-2543; Quinn, David/0000-0002-1411-0417; Espinosa Arranz, Enrique/0000-0001-6562-7902; Fradet, Yves/0000-0002-7581-2500; Kanesvaran, Ravindran/0000-0002-2351-881X; Agerbaek, Mads/0000-0003-3923-6136; OUDARD, Stephane/0000-0003-0893-285X	Merck; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Merck(Merck & Company); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Merck; KEYNOTE-045 ClinicalTrials.gov number, NCT02256436.	Apolo AB, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.e15501; Balar A, 2016, ANN ONCOL S6, V27; Barlesi F, 2016, ANN ONCOL S6, V27; Bellmunt J, 2013, ANN ONCOL, V24, P1466, DOI 10.1093/annonc/mdt007; Bellmunt J, 2010, J CLIN ONCOL, V28, P1850, DOI 10.1200/JCO.2009.25.4599; Bellmunt J, 2009, J CLIN ONCOL, V27, P4454, DOI 10.1200/JCO.2008.20.5534; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; De Santis M, 2012, J CLIN ONCOL, V30, P191, DOI 10.1200/JCO.2011.37.3571; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Jamieson NB, 2016, CANC GENE THER; Massard C, 2016, J CLIN ONCOL, V34, P3119, DOI 10.1200/JCO.2016.67.9761; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Oing C, 2016, J UROLOGY, V195, P254, DOI 10.1016/j.juro.2015.06.115; Plimack ER, 2017, LANCET ONCOL; Raggi D, 2016, ANN ONCOL, V27, P49, DOI 10.1093/annonc/mdv509; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Seront E, 2015, CANCER TREAT REV, V41, P341, DOI 10.1016/j.ctrv.2015.03.004; Sharma P, 2016, LANCET ONCOL, V17, P1590, DOI 10.1016/S1470-2045(16)30496-X; Sonpavde G, 2013, EUR UROL, V63, P717, DOI 10.1016/j.eururo.2012.11.042; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Yang YF, 2016, ONCOTARGET, V7, P74350, DOI 10.18632/oncotarget.11291; Zhang TF, 2016, ONCOTARGET, V7, P73068, DOI 10.18632/oncotarget.12230	24	1936	1982	2	127	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2017	376	11					1015	1026		10.1056/NEJMoa1613683	http://dx.doi.org/10.1056/NEJMoa1613683			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO0QT	28212060	Green Published, Green Accepted			2022-12-28	WOS:000396403700006
J	Richner, JM; Himansu, S; Dowd, KA; Butler, SL; Salazar, V; Fox, JM; Julander, JG; Tang, WW; Shresta, S; Pierson, TC; Ciaramella, G; Diamond, MS				Richner, Justin M.; Himansu, Sunny; Dowd, Kimberly A.; Butler, Scott L.; Salazar, Vanessa; Fox, Julie M.; Julander, Justin G.; Tang, William W.; Shresta, Sujan; Pierson, Theodore C.; Ciaramella, Giuseppe; Diamond, Michael S.			Modified mRNA Vaccines Protect against Zika Virus Infection	CELL			English	Article							ANTIBODY-DEPENDENT ENHANCEMENT; CROSS-REACTIVE ANTIBODIES; MALE SEXUAL TRANSMISSION; DENGUE VIRUS; DNA VACCINE; IN-VIVO; IMMUNE-RESPONSES; ENVELOPE PROTEIN; STRUCTURAL BASIS; MOUSE MODEL	The emergence of ZIKV infection has prompted a global effort to develop safe and effective vaccines. We engineered a lipid nanoparticle (LNP) encapsulated modified mRNA vaccine encoding wild-type or variant ZIKV structural genes and tested immunogenicity and protection in mice. Two doses of modified mRNA LNPs encoding prM-E genes that produced virus-like particles resulted in high neutralizing antibody titers (similar to 1/100,000) that protected against ZIKV infection and conferred sterilizing immunity. To offset a theoretical concern of ZIKV vaccines inducing antibodies that cross-react with the related dengue virus (DENV), we designed modified prM-E RNA encoding mutations destroying the conserved fusion-loop epitope in the E protein. This variant protected against ZIKV and diminished production of antibodies enhancing DENV infection in cells or mice. A modified mRNA vaccine can prevent ZIKV disease and be adapted to reduce the risk of sensitizing individuals to subsequent exposure to DENV, should this become a clinically relevant concern.	[Richner, Justin M.; Salazar, Vanessa; Fox, Julie M.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Himansu, Sunny; Butler, Scott L.; Ciaramella, Giuseppe] Valera LLC, 500 Technol Sq, Cambridge, MA 02139 USA; [Dowd, Kimberly A.; Pierson, Theodore C.] NIH, Viral Pathogenesis Sect, Bldg 10, Bethesda, MD 20892 USA; [Julander, Justin G.] Utah State Univ, Inst Antiviral Res, Logan, UT 84335 USA; [Tang, William W.; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA	Washington University (WUSTL); National Institutes of Health (NIH) - USA; Utah System of Higher Education; Utah State University; La Jolla Institute for Immunology; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Ciaramella, G (corresponding author), Valera LLC, 500 Technol Sq, Cambridge, MA 02139 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.	Giuseppe.Ciaramella@Valeratx.com; diamond@wusm.wustl.edu	Diamond, Michael/AAH-1733-2019; Fox, Julie/GLQ-8895-2022	Diamond, Michael/0000-0002-8791-3165; Fox, Julie/0000-0003-0567-738X; Salazar, Vanessa/0000-0002-1947-6039; Dowd, Kimberly/0000-0003-3641-6852; Richner, Justin/0000-0002-5344-118X; Tang, William/0000-0001-7036-6460	NIH-NIAID [R01 AI073755, R01 AI104972, P01 AI106695, R01 AI116813]; DARPA [W911NF-13-1-0417]; Moderna; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116813, ZIAAI001209, P01AI106695, R01AI073755, R01AI104972] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Moderna; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the NIH-NIAID (R01 AI073755, R01 AI104972, and P01 AI106695 to M.S.D; R01 AI116813 to S.S), the intramural program of NIH-NIAID (T.C.P), a research grant from DARPA (agreement #W911NF-13-1-0417), and by a research grant from Moderna. We thank W. H. Hui (University of California, Los Angeles) for performing the negative stain imaging of the SVPs. M.S.D. is a consultant for Inbios, Visterra, and Takeda Pharmaceuticals and on the Scientific Advisory Boards of Moderna and OvaGene. S.H., S.L.B., and G.C. are employees of Valera LLC, a Moderna Venture focusing on the development of therapeutic approaches for infectious diseases, including ZIKV mRNA vaccines.	Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0004682, 10.1371/journal.pntd.0004750]; Anderson BR, 2011, NUCLEIC ACIDS RES, V39, P9329, DOI 10.1093/nar/gkr586; Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bogers WM, 2015, J INFECT DIS, V211, P947, DOI 10.1093/infdis/jiu522; Boonnak K, 2008, J VIROL, V82, P3939, DOI 10.1128/JVI.02484-07; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brien James D, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15d03s31; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Chabierski S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-246; Chen S, 2016, J CONTROL RELEASE, V235, P236, DOI 10.1016/j.jconrel.2016.05.059; Claudio N, 2013, EMBO J, V32, P1214, DOI 10.1038/emboj.2013.80; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Costa SM, 2007, VIROLOGY, V358, P413, DOI 10.1016/j.virol.2006.08.052; Costa SM, 2006, VACCINE, V24, P4562, DOI 10.1016/j.vaccine.2005.08.022; Crill WD, 2007, J GEN VIROL, V88, P1169, DOI 10.1099/vir.0.82640-0; Crill WD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00334; Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049; Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009; Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477; Hekele A, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.54; Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793; Hughes HR, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-115; Hung CF, 2007, MOL THER, V15, P1211, DOI 10.1038/sj.mt.6300121; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377; Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028; Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X; Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762; MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500; Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394; Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21; Oehler E, 2013, EUROSURVEILLANCE, V19, P20720, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720; Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Pardi N, 2017, METHODS MOL BIOL, V1499, P109, DOI 10.1007/978-1-4939-6481-9_6; Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436; Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16; Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070; Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16; van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898; Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11; Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336; Williams KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003157; Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974; Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020	72	461	493	27	259	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2017	168	6					1114	+		10.1016/j.cell.2017.02.017	http://dx.doi.org/10.1016/j.cell.2017.02.017			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8ZF	28222903	Green Accepted, Bronze			2022-12-28	WOS:000396287900018
J	Hammersley, B				Hammersley, Brian			John David Thornhill OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		THORNHILL JD, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2017	356								j865	10.1136/bmj.j865	http://dx.doi.org/10.1136/bmj.j865			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KQ	28219906				2022-12-28	WOS:000395630800003
J	Sancar, A				Sancar, Aziz			Oliver Smithies (1925-2017)	SCIENCE			English	Biographical-Item									[Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys Genet Med, Chapel Hill, NC 27516 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys Genet Med, Chapel Hill, NC 27516 USA.	aziz_sancar@med.unc.edu			NIGMS NIH HHS [R35 GM118102] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118102] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		SMITHIES O, PUBLICATION LIST	1	1	1	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					695	695		10.1126/science.aam8635	http://dx.doi.org/10.1126/science.aam8635			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2AC	28209861				2022-12-28	WOS:000395117700023
J	Algernon, SR				Algernon, S. R.			IN CYGNUS AND IN HELL A ticket to ride	NATURE			English	Editorial Material									[Algernon, S. R.] Univ N Carolina, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill	Algernon, SR (corresponding author), Univ N Carolina, Chapel Hill, NC 27514 USA.								0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					386	386		10.1038/542386a	http://dx.doi.org/10.1038/542386a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2LQ	28202959	Bronze			2022-12-28	WOS:000394451600046
J	Lyon, J				Lyon, Jeff			Cassidy Rolls Up His Sleeves	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2017	317	6					576	576		10.1001/jama.2017.0508	http://dx.doi.org/10.1001/jama.2017.0508			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4NG	28196235				2022-12-28	WOS:000426800900002
J	Parekh, A; Hoagland, GW				Parekh, Anand; Hoagland, G. William			Medical Liability Reform in a New Political Environment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Parekh, Anand; Hoagland, G. William] Bipartisan Policy Ctr, 1225 Eye St,Ste 1000, Washington, DC 20005 USA		Parekh, A (corresponding author), Bipartisan Policy Ctr, 1225 Eye St,Ste 1000, Washington, DC 20005 USA.	aparekh@bipartisanpolicy.org						Congressional Budget Office, LIM MED MALPR CLAIMS; Emanuel Z, REDUCING COST DEFENS; Kachalia A, 2014, HEALTH AFFAIR, V33, P59, DOI 10.1377/hlthaff.2013.0834; Mello MM, 2014, JAMA-J AM MED ASSOC, V312, P2146, DOI 10.1001/jama.2014.10705; Mello MM, 2010, HEALTH AFFAIR, V29, P1569, DOI 10.1377/hlthaff.2009.0807; Sage WM, 2014, HEALTH AFFAIR, V33, P11, DOI 10.1377/hlthaff.2013.0930; Stamm JA, 2016, AM J MED, V129, P20, DOI 10.1016/j.amjmed.2015.08.026; US Department of Health and Human Services, APPR MED MALPR PAYM	8	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2017	317	13					1311	1312		10.1001/jama.2017.1405	http://dx.doi.org/10.1001/jama.2017.1405			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ9VR	28199458				2022-12-28	WOS:000398434200011
J	Nemeth, G; Laszlovszky, I; Czobor, P; Szalai, E; Szatmari, B; Harsanyi, J; Barabssy, A; Debelle, M; Durgam, S; Bitter, I; Marder, S; Fleischhacker, WW				Nemeth, Gyorgy; Laszlovszky, Istvan; Czobor, Pal; Szalai, Erzsebet; Szatmari, Balazs; Harsanyi, Judit; Barabssy, Agota; Debelle, Marc; Durgam, Suresh; Bitter, Istvan; Marder, Stephen; Fleischhacker, W. Wolfgang			Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial	LANCET			English	Article							RECEPTOR PARTIAL AGONIST; ACTIVE-CONTROLLED TRIAL; POST-HOC ANALYSES; DOPAMINE D-3; ANTIPSYCHOTIC-LIKE; CLINICAL-TRIALS; IN-VIVO; AMISULPRIDE; PLACEBO; OLANZAPINE	Background Although predominant negative symptoms of schizophrenia can be severe enough to cause persistent impairment, effective treatment options are lacking. We aimed to assess the new generation antipsychotic cariprazine in adult patients with predominant negative symptoms. Methods In this randomised, double-blind, phase 3b trial, we enrolled adults aged 18-65 years with long-term (> 2 year), stable schizophrenia and predominant negative symptoms (> 6 months) at 66 study centres (mainly hospitals and university clinics, with a small number of private practices) in 11 European countries. Patients were randomly assigned (1: 1) by an interactive web response system to 26 weeks of monotherapy with fixed-dose oral cariprazine (3 mg, 4.5 mg [target dose], or 6 mg per day) or risperidone (3 mg, 4 mg [target dose], or 6 mg per day); previous medication was discontinued over 2 weeks. The primary outcome was change from baseline to week 26 or end of treatment on the Positive and Negative Syndrome Scale factor score for negative symptoms (PANSS-FSNS) analysed in a modified intention-to-treat population of patients who had follow-up assessments within 5 days after last receipt of study drugs with a mixed-effects model for repeated measures. Safety was assessed in all patients who received at least one dose of study drug. This study is registered with EudraCT, number 2012-005485-36. Findings Between May 27, 2013, and Nov 17, 2014, 533 patients were screened and 461 (86%) patients were randomised to treatment (230 for cariprazine and 231 for risperidone); 460 were included in the safety population (one patient discontinued before study drug intake). 227 (99%) of 230 patients in the cariprazine group and 229 (99%) of 230 patients in the risperidone group were included in the modified intention-to-treat population (178 [77%] in each group completed 26 weeks of treatment). Mean daily doses were 4.2 mg (SD 0.6) for cariprazine and 3.8 mg (0.4) for risperidone. Treatment-emergent adverse events (eg, insomnia, akathisia, worsening of schizophrenia, headache, anxiety) were reported in 123 (54%) patients treated with cariprazine and 131 (57%) patients treated with risperidone. Use of cariprazine led to a greater least squares mean change in PANSS-FSNS from baseline to week 26 than did risperidone (-8 .90 points for cariprazine vs -7.44 points for risperidone; least squares mean difference -1.46, 95% CI-2.39 to -0.53; p= 0.0022; effect size 0.31). One patient in the risperidone group died of a cause regarded as unrelated to treatment. Interpretation Our results support the efficacy of cariprazine in the treatment of predominant negative symptoms of schizophrenia. Funding Gedeon Richter Plc.	[Nemeth, Gyorgy; Laszlovszky, Istvan; Szalai, Erzsebet; Szatmari, Balazs; Harsanyi, Judit; Barabssy, Agota; Debelle, Marc] Gedeon Richter Plc, Div Med, H-1103 Budapest, Hungary; [Czobor, Pal; Bitter, Istvan] Semmelweis Univ, Dept Psychiat & Psychotherapy, Budapest, Hungary; [Durgam, Suresh] Forest Res Inst, Clin Dev, Jersey City, NJ USA; [Marder, Stephen] Univ Calif Los Angeles, Sect Psychosis, Semel Inst Neurosci, Los Angeles, CA USA; [Fleischhacker, W. Wolfgang] Med Univ Innsbruck, Dept Psychiat Psychotherapy & Psychosomat, Innsbruck, Austria	Gedeon Richter Chemistry Works; Semmelweis University; University of California System; University of California Los Angeles; Medical University of Innsbruck	Nemeth, G (corresponding author), Gedeon Richter Plc, Div Med, H-1103 Budapest, Hungary.	gy.nemeth@richter.hu	Németh, György/AAU-4876-2020; Group, Prescott Medical Communications/AAE-7494-2019; Bitter, Istvan/J-8196-2017	Bitter, Istvan/0000-0002-9464-4709	Gedeon Richter Plc.	Gedeon Richter Plc.	Gedeon Richter Plc.	Arango C, 2013, SCHIZOPHR RES, V150, P346, DOI 10.1016/j.schres.2013.07.026; BOYER P, 1995, BRIT J PSYCHIAT, V166, P68, DOI 10.1192/bjp.166.1.68; Brain C, 2013, EUR NEUROPSYCHOPHARM, V23, P1754, DOI 10.1016/j.euroneuro.2013.09.001; Buchanan RW, 2007, SCHIZOPHRENIA BULL, V33, P1013, DOI 10.1093/schbul/sbl057; Buchanan RW, 2012, J CLIN PSYCHOPHARM, V32, P36, DOI 10.1097/JCP.0b013e31823f880a; Cho DI, 2010, ARCH PHARM RES, V33, P1521, DOI 10.1007/s12272-010-1005-8; Danion JM, 1999, AM J PSYCHIAT, V156, P610; Debelle M, 2014, EUR NEUROPSYCHOPHARM, V24, pS534, DOI 10.1016/S0924-977X(14)70855-7; Debelle M, 2015, EUR PSYCHIAT, V30, DOI 10.1016/S0924-9338(15)30197-8; European Medicines Agency, 2012, EMACHMP400722010; Girgis RR, 2016, PSYCHOPHARMACOLOGY, V233, P3503, DOI 10.1007/s00213-016-4382-y; Gyertyan I, 2008, N-S ARCH PHARMACOL, V378, P529, DOI 10.1007/s00210-008-0311-x; Gyertyan I, 2011, NEUROCHEM INT, V59, P925, DOI 10.1016/j.neuint.2011.07.002; Joyce JN, 2005, DRUG DISCOV TODAY, V10, P917, DOI 10.1016/S1359-6446(05)03491-4; Kiss B, 2012, SCHIZOPHR RES, V136, pS190, DOI 10.1016/S0920-9964(12)70588-1; Kiss B, 2010, J PHARMACOL EXP THER, V333, P328, DOI 10.1124/jpet.109.160432; Laughren T, 2011, SCHIZOPHRENIA BULL, V37, P255, DOI 10.1093/schbul/sbq162; Lecrubier Y, 2006, ACTA PSYCHIAT SCAND, V114, P319, DOI 10.1111/j.1600-0447.2006.00887.x; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lindenmayer JP, 2007, J CLIN PSYCHIAT, V68, P368, DOI 10.4088/JCP.v68n0303; Loo H, 1997, BRIT J PSYCHIAT, V170, P18, DOI 10.1192/bjp.170.1.18; Marder SR, 2013, SCHIZOPHR RES, V150, P328, DOI 10.1016/j.schres.2013.07.058; Marder SR, 2011, SCHIZOPHRENIA BULL, V37, P250, DOI 10.1093/schbul/sbq161; Milev P, 2005, AM J PSYCHIAT, V162, P495, DOI 10.1176/appi.ajp.162.3.495; Moller HJ, 2015, EUR ARCH PSY CLIN N, V265, P567, DOI 10.1007/s00406-015-0596-y; Mohr PE, 2004, SCHIZOPHR RES, V71, P83, DOI 10.1016/j.schres.2003.11.008; Neill JC, 2016, EUR NEUROPSYCHOPHARM, V26, P3, DOI 10.1016/j.euroneuro.2015.11.016; Olie JP, 2006, INT CLIN PSYCHOPHARM, V21, P143; PAILLEREMARTINOT ML, 1995, AM J PSYCHIAT, V152, P130; Papp M, 2014, BEHAV PHARMACOL, V25, P567, DOI 10.1097/FBP.0000000000000070; Zimnisky R, 2013, PSYCHOPHARMACOLOGY, V226, P91, DOI 10.1007/s00213-012-2896-5	31	163	177	2	30	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2017	389	10074					1103	1113		10.1016/s0140-6736(17)30060-0	http://dx.doi.org/10.1016/s0140-6736(17)30060-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0SR	28185672				2022-12-28	WOS:000396408700026
J	Cheng, SJ				Cheng, Susan J.			How I'm standing up for science	SCIENCE			English	Editorial Material									[Cheng, Susan J.] Cornell Univ, Ecol, Ithaca, NY 14850 USA	Cornell University	Cheng, SJ (corresponding author), Cornell Univ, Ecol, Ithaca, NY 14850 USA.								0	1	1	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					878	878		10.1126/science.355.6327.878	http://dx.doi.org/10.1126/science.355.6327.878			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28232580				2022-12-28	WOS:000395127600043
J	Zhu, YFPP; Hedrick, CC; Gaddis, DE				Zhu, Yanfang Peipei; Hedrick, Catherine C.; Gaddis, Dalia E.			CARDIOVASCULAR DISEASE Hematopoietic stem cells gone rogue Somatic mutations in hematopoietic stem cells aggravate cardiovascular disease	SCIENCE			English	Editorial Material							DNA METHYLATION; TET2; 5-CARBOXYLCYTOSINE; ATHEROSCLEROSIS		[Zhu, Yanfang Peipei; Hedrick, Catherine C.; Gaddis, Dalia E.] La Jolla Inst Allergy & Immunol, 9420 Athena Circle, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Hedrick, CC (corresponding author), La Jolla Inst Allergy & Immunol, 9420 Athena Circle, La Jolla, CA 92037 USA.	hedrick@lji.org		Zhu, Yanfang Peipei/0000-0001-6908-0860				Abbate A, 2013, AM J CARDIOL, V111, P1394, DOI 10.1016/j.amjcard.2013.01.287; [Anonymous], 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00364; Cao Q, 2014, ENDOCRINOLOGY, V155, P4925, DOI 10.1210/en.2014-1595; Dunn J, 2014, J CLIN INVEST, V124, P3187, DOI 10.1172/JCI74792; Fuster JJ, 2017, SCIENCE, V355, P842, DOI 10.1126/science.aag1381; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Liu RJ, 2013, CIRCULATION, V128, P2047, DOI 10.1161/CIRCULATIONAHA.113.002887; Montagner S, 2016, CELL REP, V15, P1566, DOI 10.1016/j.celrep.2016.04.044; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Mozaffarian D, 2016, CIRCULATION, V133, P447, DOI 10.1161/CIR.0000000000000366; Ridker PM, 2016, CIRC RES, V118, P145, DOI 10.1161/CIRCRESAHA.115.306656; Ridker PM, 2014, EUR HEART J, V35, P1782, DOI 10.1093/eurheartj/ehu203	14	1	1	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					798	799		10.1126/science.aam7939	http://dx.doi.org/10.1126/science.aam7939			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28232539				2022-12-28	WOS:000395127600021
J	Cheng, CW; Villani, V; Buono, R; Wei, M; Kumar, S; Yilmaz, OH; Cohen, P; Sneddon, JB; Perin, L; Longo, VD				Cheng, Chia-Wei; Villani, Valentina; Buono, Roberta; Wei, Min; Kumar, Sanjeev; Yilmaz, Omer H.; Cohen, Pinchas; Sneddon, Julie B.; Perin, Laura; Longo, Valter D.			Fasting-Mimicking Diet Promotes Ngn3-Driven beta-Cell Regeneration to Reverse Diabetes	CELL			English	Article							STEM-CELLS; INSULIN-RESISTANCE; GLUCOSE; DEDIFFERENTIATION; PROGENITORS; TYPE-1; MICE; MASS; PROLIFERATION; MECHANISMS	Stem-cell-based therapies can potentially reverse organ dysfunction and diseases, but the removal of impaired tissue and activation of a program leading to organ regeneration pose major challenges. In mice, a 4-day fasting mimicking diet (FMD) induces a stepwise expression of Sox17 and Pdx-1, followed by Ngn3-driven generation of insulin-producing b cells, resembling that observed during pancreatic development. FMD cycles restore insulin secretion and glucose homeostasis in both type 2 and type 1 diabetes mouse models. In human type 1 diabetes pancreatic islets, fasting conditions reduce PKA and mTOR activity and induce Sox2 and Ngn3 expression and insulin production. The effects of the FMD are reversed by IGF-1 treatment and recapitulated by PKA and mTOR inhibition. These results indicate that a FMD promotes the reprogramming of pancreatic cells to restore insulin generation in islets from T1D patients and reverse both T1D and T2D phenotypes in mouse models.	[Cheng, Chia-Wei; Buono, Roberta; Wei, Min; Cohen, Pinchas; Longo, Valter D.] Univ Southern Calif, Dept Biol Sci, Sch Gerontol, Longev Inst, 3715 McClintock Ave, Los Angeles, CA 90089 USA; [Villani, Valentina; Perin, Laura] Univ Southern Calif, GOFARR Lab Organ Regenerat Res & Cell Therapeut, Childrens Hosp Los Angeles, Div Urol,Saban Res Inst, Los Angeles, CA 90027 USA; [Sneddon, Julie B.] Univ Calif San Francisco, Ctr Diabet, 513 Parnassus Ave, San Francisco, CA 94143 USA; [Kumar, Sanjeev; Longo, Valter D.] Univ Southern Calif, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Keck Sch Med, Los Angeles, CA 90027 USA; [Buono, Roberta; Longo, Valter D.] IFOM FIRC Inst Mol Oncol, Via Adamello 16, I-20139 Milan, Italy; [Cheng, Chia-Wei; Yilmaz, Omer H.] MIT, Koch Inst, 500 Main St, Cambridge, MA 02139 USA	University of Southern California; Children's Hospital Los Angeles; University of Southern California; University of California System; University of California San Francisco; University of Southern California; IFOM - FIRC Institute of Molecular Oncology; Massachusetts Institute of Technology (MIT)	Longo, VD (corresponding author), Univ Southern Calif, Dept Biol Sci, Sch Gerontol, Longev Inst, 3715 McClintock Ave, Los Angeles, CA 90089 USA.; Longo, VD (corresponding author), Univ Southern Calif, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Keck Sch Med, Los Angeles, CA 90027 USA.; Longo, VD (corresponding author), IFOM FIRC Inst Mol Oncol, Via Adamello 16, I-20139 Milan, Italy.	vlongo@usc.edu	Villani, Valentina/ABB-8016-2020	/0000-0003-1088-923X	NIH/NIA [AG20642, AG025135, P01 AG034906]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020642, R01AG025135, P01AG034906] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Lora Barsky (USC Flow Cytometry Core Facility) for assistance in the FACS analysis, Michael Sheard (CHLA Flourescence Activated Cell Sorting Core) for assistance in the cytokines profiling, and Gerrardo Navarrete for preparing the diet. This study was funded in part by NIH/NIA grants AG20642, AG025135, and P01 AG034906 to V.D.L. V.D.L. has equity interest in L-Nutra, a company that develops medical food. All shares will be donated to charitable organizations.	Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586; Arakawa K, 2001, BRIT J PHARMACOL, V132, P578, DOI 10.1038/sj.bjp.0703829; Arnes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052026; Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; Barnosky AR, 2014, TRANSL RES, V164, P302, DOI 10.1016/j.trsl.2014.05.013; Ben-Othman N, 2017, CELL, V168, P73, DOI 10.1016/j.cell.2016.11.002; Blum B, 2014, ELIFE, V3, DOI 10.7554/eLife.02809; Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012; Brereton MF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5639; Cheng CW, 2014, CELL STEM CELL, V14, P810, DOI 10.1016/j.stem.2014.04.014; Chera S, 2014, NATURE, V514, P503, DOI 10.1038/nature13633; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Cook JR, 2015, DIABETES, V64, P1951, DOI 10.2337/db14-1506; Dirice E, 2014, DIABETES, V63, P188, DOI 10.2337/db13-0204; Dor Y, 2013, NEW ENGL J MED, V368, P572, DOI 10.1056/NEJMcibr1214034; Fiorina P, 2008, AM J TRANSPLANT, V8, P1990, DOI 10.1111/j.1600-6143.2008.02353.x; Gomez DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133862; Grunnet LG, 2009, DIABETES, V58, P1807, DOI 10.2337/db08-0178; Haeusler RA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6190; Heinrich C, 2015, NAT CELL BIOL, V17, P204, DOI 10.1038/ncb3108; Hsu FL, 2013, DIABETES, V62, P628, DOI 10.2337/db12-0585; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Kim-Muller JY, 2014, CELL METAB, V20, P593, DOI 10.1016/j.cmet.2014.08.012; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Laviano A, 2012, NEW ENGL J MED, V366, P2319, DOI 10.1056/NEJMcibr1202395; Lebastchi J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007708; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Li J, 2017, CELL, V168, P86, DOI 10.1016/j.cell.2016.11.010; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Matthews DR, 2001, DIABETES OBES METAB, V3, pS28; McKnight KD, 2010, CELL STEM CELL, V6, P300, DOI 10.1016/j.stem.2010.03.003; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Milanesi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042177; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Pipeleers D, 2002, ANN NY ACAD SCI, V958, P69; Rabinovitch A, 1998, DIABETES METAB REV, V14, P129, DOI 10.1002/(SICI)1099-0895(199806)14:2<129::AID-DMR208>3.3.CO;2-M; Raffaghello L, 2008, P NATL ACAD SCI USA, V105, P8215, DOI 10.1073/pnas.0708100105; Sneddon JB, 2012, NATURE, V491, P765, DOI 10.1038/nature11463; Stanger BZ, 2008, DIABETES, V57, P1461, DOI 10.2337/db08-0454; Talchai SC, 2015, DIABETES, V64, P2868, DOI 10.2337/db14-1696; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Tonne JM, 2013, DIS MODEL MECH, V6, P1236, DOI 10.1242/dmm.012591; Van de Casteele M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.52; Villani V, 2014, CYTOTHERAPY, V16, P41, DOI 10.1016/j.jcyt.2013.08.010; Wang S, 2009, P NATL ACAD SCI USA, V106, P9715, DOI 10.1073/pnas.0904247106; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; Weinberg N, 2007, DIABETES, V56, P1299, DOI 10.2337/db06-1654; Weir GC, 2013, ISLETS, V5, P233, DOI 10.4161/isl.27494; Wu KK, 2008, CURR PROTOC PHARM UN, DOI DOI 10.1002/0471141755.PH0547S40.HTTP://; Xiao XW, 2013, J CLIN INVEST, V123, P2207, DOI 10.1172/JCI66323; Xu J, 2015, CELL STEM CELL, V16, P119, DOI 10.1016/j.stem.2015.01.013; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Yin DP, 2006, DIABETES, V55, P3256, DOI 10.2337/db05-1275; Zhernakova A, 2006, GENES IMMUN, V7, P544, DOI 10.1038/sj.gene.6364326; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	60	181	195	1	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					775	+		10.1016/j.cell.2017.01.040	http://dx.doi.org/10.1016/j.cell.2017.01.040			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28235195	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000396284800008
J	Coulais, C; Sounas, D; Alu, A				Coulais, Corentin; Sounas, Dimitrios; Alu, Andrea			Static non-reciprocity in mechanical metamaterials	NATURE			English	Article							MICROLATTICES; INSULATOR; DESIGN	Reciprocity is a general, fundamental principle governing various physical systems, which ensures that the transfer function-the transmission of a physical quantity, say light intensity-between any two points in space is identical, regardless of geometrical or material asymmetries. Breaking this transmission symmetry offers enhanced control over signal transport, isolation and source protection(1-6). So far, devices that break reciprocity (and therefore show non-reciprocity) have been mostly considered in dynamic systems involving electromagnetic, acoustic and mechanical wave propagation associated with fields varying in space and time. Here we show that it is possible to break reciprocity in static systems, realizing mechanical metamaterials(7-16) that exhibit vastly different output displacements under excitation from different sides, as well as one-way displacement amplification. This is achieved by combining large nonlinearities with suitable geometrical asymmetries and/or topological features. In addition to extending non-reciprocity and isolation to statics, our work sheds light on energy propagation in nonlinear materials with asymmetric crystalline structures and topological properties. We anticipate that breaking reciprocity will open avenues for energy absorption, conversion and harvesting, soft robotics, prosthetics and optomechanics.	[Coulais, Corentin] AMOLF, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands; [Coulais, Corentin] Leiden Univ, Huygens Kamerlingh Onnes Lab, POB 9504, NL-2300 RA Leiden, Netherlands; [Sounas, Dimitrios; Alu, Andrea] Univ Texas Austin, Dept Elect & Comp Engn, Austin, TX 78701 USA; [Coulais, Corentin] Univ Amsterdam, Van Der Waals Zeeman Inst, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands	AMOLF; Leiden University; Leiden University - Excl LUMC; University of Texas System; University of Texas Austin; University of Amsterdam	Coulais, C (corresponding author), AMOLF, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands.	coulais@amolf.nl	Coulais, Corentin/P-3920-2015; Alu, Andrea/A-1328-2007	Coulais, Corentin/0000-0002-3174-5836; Alu, Andrea/0000-0002-4297-5274	Netherlands Organization for Scientific Research (NWO), VENI [NWO-680-47-445]; Air Force Office of Scientific Research [FA9550-13-1-0204]; Office of Naval Research [N00014-15-1-2685]; National Science Foundation; Simons Foundation	Netherlands Organization for Scientific Research (NWO), VENI(Netherlands Organization for Scientific Research (NWO)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Office of Naval Research(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); Simons Foundation	We thank D. Ursem for technical assistance. We are grateful to M. van Hecke, V. Vitelli, A. Souslov, Y. Hadad, A. Meeussen and S. Waitukaitis for discussions. C.C. acknowledges funding from the Netherlands Organization for Scientific Research (NWO), VENI grant no. NWO-680-47-445. D.S. and A.A. were supported by the Air Force Office of Scientific Research with grant no. FA9550-13-1-0204, the Office of Naval Research with grant no. N00014-15-1-2685, the National Science Foundation and the Simons Foundation.	Aspelmeyer M, 2014, REV MOD PHYS, V86, P1391, DOI 10.1103/RevModPhys.86.1391; Betti E., 1872, NUOVO CIMENTO, V7-8, P69, DOI [10.1007/BF02824597, DOI 10.1007/BF02824597]; Brule S, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.133901; CASIMIR HBG, 1945, REV MOD PHYS, V17, P343, DOI 10.1103/RevModPhys.17.343; CHARLTON TM, 1960, NATURE, V187, P231, DOI 10.1038/187231a0; Chen BGG, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.135501; Chen BGG, 2014, P NATL ACAD SCI USA, V111, P13004, DOI 10.1073/pnas.1405969111; Coulais C, 2016, NATURE, V535, P529, DOI 10.1038/nature18960; Estep NA, 2014, NAT PHYS, V10, P923, DOI [10.1038/NPHYS3134, 10.1038/nphys3134]; Fan L, 2012, SCIENCE, V335, P447, DOI 10.1126/science.1214383; Fleury R, 2014, SCIENCE, V343, P516, DOI 10.1126/science.1246957; Florijn B, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.175503; Frenzel T, 2016, ADV MATER, V28, P5865, DOI 10.1002/adma.201600610; Huber SD, 2016, NAT PHYS, V12, P621, DOI 10.1038/nphys3801; Hussein MI, 2014, APPL MECH REV, V66, DOI 10.1115/1.4026911; Kadic M, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/12/126501; Kane CL, 2014, NAT PHYS, V10, P39, DOI [10.1038/nphys2835, 10.1038/NPHYS2835]; LAKES R, 1987, SCIENCE, V235, P1038, DOI 10.1126/science.235.4792.1038; Lira H, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.033901; Love AEH, 2013, TREATISE MATH THEORY; Lubensky TC, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/7/073901; Maxwell J.C., 1864, PHILOS MAG, V27, P294, DOI [10.1080/14786446408643668, DOI 10.1080/14786446408643668]; Meeussen AS, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.041029; Mullin T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.084301; Nash LM, 2015, P NATL ACAD SCI USA, V112, P14495, DOI 10.1073/pnas.1507413112; Paulose J, 2015, P NATL ACAD SCI USA, V112, P7639, DOI 10.1073/pnas.1502939112; Paulose J, 2015, NAT PHYS, V11, P153, DOI 10.1038/NPHYS3185; Peng B, 2014, NAT PHYS, V10, P394, DOI [10.1038/nphys2927, 10.1038/NPHYS2927]; Potton RJ, 2004, REP PROG PHYS, V67, P717, DOI 10.1088/0034-4885/67/5/R03; Schaedler TA, 2011, SCIENCE, V334, P962, DOI 10.1126/science.1211649; Shan SC, 2015, ADV MATER, V27, P4296, DOI 10.1002/adma.201501708; Silverberg JL, 2014, SCIENCE, V345, P647, DOI 10.1126/science.1252876; Susstrunk R, 2015, SCIENCE, V349, P47, DOI 10.1126/science.aab0239; Timoshenko S.P, 1965, THEORY OF STRUCTURES	34	161	161	21	304	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2017	542	7642					461	+		10.1038/nature21044	http://dx.doi.org/10.1038/nature21044			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM1RG	28192786	Green Submitted			2022-12-28	WOS:000395094100032
J	Chen, LX; Liu, PF; Evans, TC; Ettwiller, LM				Chen, Lixin; Liu, Pingfang; Evans, Thomas C; Ettwiller, Laurence M.			DNA damage is a pervasive cause of sequencing errors, directly confounding variant identification	SCIENCE			English	Article							SOMATIC MUTATION; CANCER; CELLS; DISCOVERY; BASE	Mutations in somatic cells generate a heterogeneous genomic population and may result in serious medical conditions. Although cancer is typically associated with somatic variations, advances in DNA sequencing indicate that cell-specific variants affect a number of phenotypes and pathologies. Here, we show that mutagenic damage accounts for the majority of the erroneous identification of variants with low to moderate (1 to 5%) frequency. More important, we found signatures of damage in most sequencing data sets in widely used resources, including the 1000 Genomes Project and The Cancer Genome Atlas, establishing damage as a pervasive cause of sequencing errors. The extent of this damage directly confounds the determination of somatic variants in these data sets.	[Chen, Lixin; Liu, Pingfang; Evans, Thomas C; Ettwiller, Laurence M.] New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA	New England Biolabs	Evans, TC; Ettwiller, LM (corresponding author), New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA.	evanst@neb.com; ettwiller@neb.com		Ettwiller, Laurence/0000-0002-3957-6539	New England Biolabs Inc.	New England Biolabs Inc.	We would like to thank S. Kaiser, A. Messelaar, T. Vincze, and C. Lin for information technology and compliance with the TCGA hosting guidelines; L. Mazzola, J. Bybee, and D. Rivizzigno for sequencing; and R. Roberts, W. Jack, T. Carlow, A. Gardner, H. Runz, E. Dimalanta, and S. Russello for critical comments. The results shown here are in part based on data generated by the 1000 Genomes Projects and the TCGA Research Network: https://cancergenome.nih.gov. This research was supported by New England Biolabs Inc. L.E., T.C.E., L.C., and P.L. are inventors on U.S. provisional serial number 62/376,165, submitted by New England Biolabs Inc., which covers improved sequence accuracy determination of a nucleic acid sample. Sequencing data have been deposited at the European Nucleotide Archive under accession number PRJEB16681. The algorithm for the GIV score is available at https://github.com/Ettwiller/Damage-estimator. Disclosure declaration: All authors are employees of New England Biolabs Inc. Ethics statement: DNA samples in this study were collected under the BioChain Institute Inc. Institutional Review Board (IRB). This IRB is registered with the Office for Human Research Protections (OHRP), registration number IRB00008283, and has been issued with Federal Wide Assurance (FWA), FWA00017355, for the Protection of Human Subjects for Institutions within the United States by OHRP of the U.S. Department of Health and Human Services. The DNA was collected using an informed consent form approved by Biochain's IRB. The nature and possible consequences of the studies were explained in the informed consent form.	Alexandrov LB, 2015, NAT GENET, V47, P1402, DOI 10.1038/ng.3441; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Bendl J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004962; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; CHENG KC, 1992, J BIOL CHEM, V267, P166; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Do HD, 2015, CLIN CHEM, V61, P64, DOI 10.1373/clinchem.2014.223040; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082; Newman AM, 2016, NAT BIOTECHNOL, V34, P547, DOI 10.1038/nbt.3520; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; TCHOU J, 1993, MUTAT RES, V299, P277, DOI 10.1016/0165-1218(93)90104-L	16	130	132	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					752	+		10.1126/science.aai8690	http://dx.doi.org/10.1126/science.aai8690			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2AC	28209900	Green Submitted			2022-12-28	WOS:000395117700044
J	Rucklidge, M				Rucklidge, Miles			Frederic Salkeld Plumpton OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2017	356								j812	10.1136/bmj.j812	http://dx.doi.org/10.1136/bmj.j812			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GP	28213586				2022-12-28	WOS:000394580000008
J	Lara-Sanchez, H; Vallejo, LA				Lara-Sanchez, Hugo; Vallejo, Luis A.			Eosinophilic Otitis Media	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lara-Sanchez, Hugo; Vallejo, Luis A.] Rio Hortega Univ Hosp, Valladolid, Spain	Hospital del Rio Hortega	Lara-Sanchez, H (corresponding author), Rio Hortega Univ Hosp, Valladolid, Spain.	hugo_lara_s@hotmail.com	valdezate, Luis Angel vallejo/AAG-4022-2019	valdezate, Luis Angel vallejo/0000-0002-7365-9231					0	10	11	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2017	376	7					E10	E10		10.1056/NEJMicm1510852	http://dx.doi.org/10.1056/NEJMicm1510852			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0QJ	28199806				2022-12-28	WOS:000396402700001
J	[Anonymous]				[Anonymous]			CHEMISTRY Helium succumbs to pressure	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					274	274		10.1038/542274b	http://dx.doi.org/10.1038/542274b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7YF	28202960	Bronze			2022-12-28	WOS:000454457400001
J	[Anonymous]				[Anonymous]			PHYSIOLOGY Cells remember high altitude	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					275	275		10.1038/542275e	http://dx.doi.org/10.1038/542275e			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7YF	28202965	Bronze			2022-12-28	WOS:000454457400009
J	Scadding, GW; Calderon, MA; Shamji, MH; Eifan, AO; Penagos, M; Dumitru, F; Sever, ML; Bahnson, HT; Lawson, K; Harris, KM; Plough, AG; Panza, JL; Qin, TL; Lim, N; Tchao, NK; Togias, A; Durham, SR				Scadding, Guy W.; Calderon, Moises A.; Shamji, Mohamed H.; Eifan, Aarif O.; Penagos, Martin; Dumitru, Florentina; Sever, Michelle L.; Bahnson, Henry T.; Lawson, Kaitie; Harris, Kristina M.; Plough, Audrey G.; Panza, Joy Laurienzo; Qin, Tielin; Lim, Noha; Tchao, Nadia K.; Togias, Alkis; Durham, Stephen R.		Immune Tolerance Network GRASS Stu	Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis The GRASS Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY ALLERGY; EFFICACY; RHINOCONJUNCTIVITIS; CESSATION; ASTHMA; SAFETY; TABLET	Importance Sublingual immunotherapy and subcutaneous immunotherapy are effective in seasonal allergic rhinitis. Three years of continuous treatment with subcutaneous immunotherapy and sublingual immunotherapy has been shown to improve symptoms for at least 2 years following discontinuation of treatment. Objective To assess whether 2 years of treatment with grass pollen sublingual immunotherapy, compared with placebo, provides improved nasal response to allergen challenge at 3-year follow-up. Design, Setting, and Participants A randomized double-blind, placebo-controlled, 3-parallel-group study performed in a single academic center, Imperial College London, of adult patients with moderate to severe seasonal allergic rhinitis (interfering with usual daily activities or sleep). First enrollment was March 2011, last follow-up was February 2015. Interventions Thirty-six participants received 2 years of sublingual immunotherapy (daily tablets containing 15 mu g of major allergen Phleum p 5 and monthly placebo injections), 36 received subcutaneous immunotherapy (monthly injections containing 20 mu g of Phleum p 5 and daily placebo tablets) and 34 received matched double-placebo. Nasal allergen challenge was performed before treatment, at 1 and 2 years of treatment, and at 3 years (1 year after treatment discontinuation). Main Outcomes and Measures Total nasal symptom scores (TNSS; range; 0 [best] to 12 [worst]) were recorded between 0 and 10 hours after challenge. The minimum clinically important difference for change in TNSS within an individual is 1.08. The primary outcome was TNSS comparing sublingual immunotherapy vs placebo at year 3. Subcutaneous immunotherapy was included as a positive control. The study was not powered to compare sublingual immunotherapy with subcutaneous immunotherapy. Results Among 106 randomized participants (mean age, 33.5 years; 34 women [32.1%]), 92 completed the study at 3 years. In the intent-to-treat population, mean TNSS score for the sublingual immunotherapy group was 6.36 (95% CI, 5.76 to 6.96) at pretreatment and 4.73 (95% CI, 3.97 to 5.48) at 3 years, and for the placebo group, the score was 6.06 (95% CI, 5.23 to 6.88) at pretreatment and 4.81 (95% CI, 3.97 to 5.65) at 3 years. The between-group difference (adjusted for baseline) was -0.18 (95% CI, -1.25 to 0.90; [P = .75]). Conclusions and Relevance Among patients with moderate to severe seasonal allergic rhinitis, 2 years of sublingual grass pollen immunotherapy was not significantly different from placebo in improving the nasal response to allergen challenge at 3-year follow-up.	[Scadding, Guy W.; Calderon, Moises A.; Shamji, Mohamed H.; Eifan, Aarif O.; Penagos, Martin; Dumitru, Florentina; Durham, Stephen R.] Imperial Coll, London, England; [Scadding, Guy W.; Calderon, Moises A.; Shamji, Mohamed H.; Eifan, Aarif O.; Penagos, Martin; Dumitru, Florentina; Durham, Stephen R.] Royal Brompton & Harefield Hosp NHS Fdn Trust, London, England; [Sever, Michelle L.; Bahnson, Henry T.; Lawson, Kaitie] Rho Fed Syst Div, Chapel Hill, NC USA; [Bahnson, Henry T.] Benaroya Res Inst, Immune Tolerance Network, Seattle, WA USA; [Harris, Kristina M.; Qin, Tielin; Lim, Noha] Immune Tolerance Network, Bethesda, MD USA; [Plough, Audrey G.; Tchao, Nadia K.] Immune Tolerance Network, San Francisco, CA USA; [Panza, Joy Laurienzo; Togias, Alkis] NIAID, Rockville, MD USA; [Tchao, Nadia K.] Amgen Inc, Dept Early Dev Hematol Oncol, San Francisco, CA USA	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Benaroya Research Institute; Immune Tolerance Network; Immune Tolerance Network; Immune Tolerance Network; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Amgen	Durham, SR (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Allergy & Clin Immunol, Sect Inflammat Repair & Dev, Dovehouse St, London SW3 6LY, England.	s.durham@imperial.ac.uk	Shamji, Mohamed/AAU-8811-2020; Qin, Tielin/H-4564-2019; Lim, Noha/ABA-2509-2020; Shamji, Mohamed/AAD-1788-2019	Shamji, Mohamed/0000-0003-3425-3463; Penagos, Martin/0000-0002-9488-194X; Eifan, Aarif/0000-0003-4098-4211	DAIT-NIAID, National Institutes of Health (NIH) [NO1-AI-15416, UM1AI109565, UM2AI117870]; DAIT-NIAID [UM2AI117870, HHSN272200800029C, HHSN272201200004C, HHSN272201200002C]; MRC [G0601303] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI015416, UM2AI117870, UM1AI109565] Funding Source: NIH RePORTER	DAIT-NIAID, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DAIT-NIAID; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The trial was conducted by the ITN with financial support from the DAIT-NIAID, National Institutes of Health (NIH) under award numbers NO1-AI-15416, UM1AI109565, and UM2AI117870; the following DAIT-NIAID-funded groups: Statistical and Clinical Coordinating Centers (contract HHSN272200800029C and grant UM2AI117870), Clinical Site Monitoring Center (contract HHSN272201200004C), and Regulatory Management Center (contract HHSN272201200002C); ALK-Abello A/S Horsholm, Denmark supplied Alutard SQ Grass Pollen, and Grazax, and matching placebos used for the GRASS clinical trial to DAIT-NIAID without charge. Dr Durham served as the sponsor of the Medicines and Healthcare Products Regulatory Agency Clinical Trial Application.	Bousquet J, 2012, J ALLERGY CLIN IMMUN, V130, P1049, DOI 10.1016/j.jaci.2012.07.053; Bousquet J, 1998, J ALLERGY CLIN IMMUN, V102, P558, DOI 10.1016/S0091-6749(98)70271-4; Bousquet PJ, 2009, J ALLERGY CLIN IMMUN, V123, P1349, DOI 10.1016/j.jaci.2009.02.033; Canonica GW, 2007, ALLERGY, V62, P317, DOI 10.1111/j.1398-9995.2006.01312.x; Canonica GW, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-6; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; Cox L, 2010, J ALLERGY CLIN IMMUN, V125, P569, DOI 10.1016/j.jaci.2009.10.060; Di Bona D, 2015, JAMA INTERN MED, V175, P1301, DOI 10.1001/jamainternmed.2015.2840; Didier A, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0057-8; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Durham SR, 2016, J ALLERGY CLIN IMMUN, V137, P339, DOI 10.1016/j.jaci.2015.12.1298; Durham SR, 2012, J ALLERGY CLIN IMMUN, V129, P717, DOI 10.1016/j.jaci.2011.12.973; Francis JN, 2008, J ALLERGY CLIN IMMUN, V121, P1120, DOI 10.1016/j.jaci.2008.01.072; Frew AJ, 2006, J ALLERGY CLIN IMMUN, V117, P319, DOI 10.1016/j.jaci.2005.11.014; GLEICH GJ, 1982, J ALLERGY CLIN IMMUN, V70, P261, DOI 10.1016/0091-6749(82)90062-8; Juniper EF, 2000, CLIN EXP ALLERGY, V30, P132; Jutel M, 2015, J ALLERGY CLIN IMMUN, V136, P556, DOI 10.1016/j.jaci.2015.04.047; Khinchi MS, 2004, ALLERGY, V59, P45, DOI 10.1046/j.1398-9995.2003.00387.x; Lima MT, 2002, CLIN EXP ALLERGY, V32, P507, DOI 10.1046/j.0954-7894.2002.01327.x; Lin SY, 2013, JAMA-J AM MED ASSOC, V309, P1278, DOI 10.1001/jama.2013.2049; Lin SY, 2013, COMP EFFECTIVENESS R; Maloney J, 2016, ANN ALLERG ASTHMA IM, V116, P59, DOI 10.1016/j.anai.2015.10.024; Maloney J, 2014, ANN ALLERG ASTHMA IM, V112, P146, DOI 10.1016/j.anai.2013.11.018; Meltzer EO, 2009, J ALLERGY CLIN IMMUN, V124, pS43, DOI 10.1016/j.jaci.2009.05.013; Ott H, 2009, ALLERGY, V64, P1394, DOI [10.1111/j.1398-9995.2008.01875.x, 10.1111/j.1398-9995.2009.02194.x]; Passalacqua G, 2013, J ALLERGY CLIN IMMUN, V132, P93, DOI 10.1016/j.jaci.2013.03.039; REINSCH CH, 1967, NUMER MATH, V10, P177, DOI 10.1007/BF02162161; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Salo PM, 2011, J ALLERGY CLIN IMMUN, V127, P1226, DOI 10.1016/j.jaci.2010.12.1106; Scadding GW, 2015, ALLERGY, V70, P689, DOI 10.1111/all.12608; Scadding GW, 2012, J IMMUNOL METHODS, V384, P25, DOI 10.1016/j.jim.2012.06.013; Shamji MH, 2012, ALLERGY, V67, P217, DOI 10.1111/j.1398-9995.2011.02745.x; Walker SM, 2011, CLIN EXP ALLERGY, V41, P1177, DOI 10.1111/j.1365-2222.2011.03794.x; Wheatley LM, 2015, NEW ENGL J MED, V372, P456, DOI 10.1056/NEJMcp1412282	34	116	119	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2017	317	6					615	625		10.1001/jama.2016.21040	http://dx.doi.org/10.1001/jama.2016.21040			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8LI	28196255	Green Accepted, Green Published			2022-12-28	WOS:000394870900016
J	Eurich, DT; Marrie, TJ; Minhas-Sandhu, JK; Majumdar, SR				Eurich, Dean T.; Marrie, Thomas J.; Minhas-Sandhu, Jasjeet K.; Majumdar, Sumit R.			Risk of heart failure after community acquired pneumonia: prospective controlled study with 10 years of follow-up	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR EVENTS; PNEUMOCOCCAL PNEUMONIA; CARDIAC COMPLICATIONS; MORTALITY; HOSPITALIZATION; ASSOCIATION; OUTCOMES; ADULTS; CARE; STRATIFICATION	OBJECTIVE To determine the attributable risk of community acquired pneumonia on incidence of heart failure throughout the age range of affected patients and severity of the infection. DESIGN Cohort study. SETTING Six hospitals and seven emergency departments in Edmonton, Alberta, Canada, 2000-02. PARTICIPANTS 4988 adults with community acquired pneumonia and no history of heart failure were prospectively recruited and matched on age, sex, and setting of treatment (inpatient or outpatient) with up to five adults without pneumonia (controls) or prevalent heart failure (n=23 060). MAIN OUTCOME MEASURES Risk of hospital admission for incident heart failure or a combined endpoint of heart failure or death up to 2012, evaluated using multivariable Cox proportional hazards analyses. RESULTS The average age of participants was 55 years, 2649 (53.1%) were men, and 63.4% were managed as outpatients. Over a median of 9.9 years (interquartile range 5.9-10.6), 11.9% (n=592) of patients with pneumonia had incident heart failure compared with 7.4% (n=1712) of controls (adjusted hazard ratio 1.61, 95% confidence interval 1.44 to 1.81). Patients with pneumonia aged 65 or less had the lowest absolute increase (but greatest relative risk) of heart failure compared with controls (4.8% v 2.2%; adjusted hazard ratio 1.98, 95% confidence interval 1.5 to 2.53), whereas patients with pneumonia aged more than 65 years had the highest absolute increase (but lowest relative risk) of heart failure (24.8% v 18.9%; adjusted hazard ratio 1.55, 1.36 to 1.77). Results were consistent in the short term (90 days) and intermediate term (one year) and whether patients were treated in hospital or as outpatients. CONCLUSION Our results show that community acquired pneumonia substantially increases the risk of heart failure across the age and severity range of cases. This should be considered when formulating post-discharge care plans and preventive strategies, and assessing downstream episodes of dyspnoea.	[Eurich, Dean T.; Majumdar, Sumit R.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Eurich, Dean T.; Minhas-Sandhu, Jasjeet K.; Majumdar, Sumit R.] Univ Alberta, ACHORD, Li Ka Shing Ctr 2 040, Edmonton, AB T6G 2E1, Canada; [Marrie, Thomas J.] Dalhousie Univ, Fac Med, Dept Med, Halifax, NS, Canada; [Majumdar, Sumit R.] Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB, Canada	University of Alberta; University of Alberta; Dalhousie University; University of Alberta	Eurich, DT (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.; Eurich, DT (corresponding author), Univ Alberta, ACHORD, Li Ka Shing Ctr 2 040, Edmonton, AB T6G 2E1, Canada.	deurich@ualberta.ca			Canada Research Chair Award from the Government of Canada; Capital Health; Abbott Canada; Pfizer Canada; Janssen-Ortho Canada	Canada Research Chair Award from the Government of Canada; Capital Health; Abbott Canada(Abbott Laboratories); Pfizer Canada(Pfizer); Janssen-Ortho Canada	DTE receives salary support through a Canada Research Chair Award from the Government of Canada. SRM holds the Endowed Chair in Patient Health Management from the Faculties of Medicine and Dentistry and Pharmacy and Pharmaceutical Sciences, University of Alberta. TJM has received grants-in-aid from Capital Health, and unrestricted grants from Abbott Canada, Pfizer Canada, and Janssen-Ortho Canada.	Adamuz J, 2014, J INFECTION, V68, P534, DOI 10.1016/j.jinf.2014.02.006; Aliberti S, 2014, CURR OPIN INFECT DIS, V27, P295, DOI [10.1097/QCO.0000000000000060, 10.1097/QCO.0000000000000055]; Bazaz R, 2013, J INFECTION, V66, P1, DOI 10.1016/j.jinf.2012.09.009; Becker T, 2007, DIABETES RES CLIN PR, V78, P392, DOI 10.1016/j.diabres.2007.05.003; Cabre M, 2008, MED CLIN-BARCELONA, V131, P167, DOI 10.1157/13124262; Corrales-Medina VF, 2015, JAMA-J AM MED ASSOC, V313, P264, DOI 10.1001/jama.2014.18229; Corrales-Medina VF, 2015, AM HEART J, V170, P306, DOI 10.1016/j.ahj.2015.04.028; Corrales-Medina VF, 2014, MAYO CLIN PROC, V89, P60, DOI 10.1016/j.mayocp.2013.09.015; Corrales-Medina VF, 2012, CIRCULATION, V125, P773, DOI 10.1161/CIRCULATIONAHA.111.040766; Corrales-Medina VF, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001048; Corrales-Medina VF, 2010, LANCET INFECT DIS, V10, P83, DOI 10.1016/S1473-3099(09)70331-7; Diaz A, 2005, ARCH BRONCONEUMOL, V41, P20; ESPOSITO AL, 1984, ARCH INTERN MED, V144, P945, DOI 10.1001/archinte.144.5.945; Eurich DT, 2015, AM J RESP CRIT CARE, V192, P597, DOI 10.1164/rccm.201501-0140OC; Fernandez-Sabe N, 2003, MEDICINE, V82, P159, DOI 10.1097/00005792-200305000-00002; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fine MJ, 1999, ARCH INTERN MED, V159, P970, DOI 10.1001/archinte.159.9.970; Huang SS, 2011, VACCINE, V29, P3398, DOI 10.1016/j.vaccine.2011.02.088; Janssens JP, 1996, J AM GERIATR SOC, V44, P539, DOI 10.1111/j.1532-5415.1996.tb01439.x; Marrie TJ, 2005, CHEST, V127, P1260, DOI 10.1378/chest.127.4.1260; MARRIE TJ, 1989, REV INFECT DIS, V11, P586; Marrie TJ, 2000, JAMA-J AM MED ASSOC, V283, P749, DOI 10.1001/jama.283.6.749; McAlister FA, 2005, DIABETES CARE, V28, P810, DOI 10.2337/diacare.28.4.810; Menendez R, 2004, THORAX, V59, P960, DOI 10.1136/thx.2003.017756; Mortensen EM, 2014, JAMA-J AM MED ASSOC, V311, P2199, DOI 10.1001/jama.2014.4304; Musher DM, 2007, CLIN INFECT DIS, V45, P158, DOI 10.1086/518849; Perry TW, 2011, AM J MED, V124, P244, DOI 10.1016/j.amjmed.2010.11.014; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Querol-Ribelles JM, 2005, INT J ANTIMICROB AG, V25, P75, DOI 10.1016/j.ijantimicag.2004.07.013; Schembri S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1235; So L, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-161; Udris EM, 2001, AM HEART J, V142, P1003, DOI 10.1067/mhj.2001.119130; Van Eeden S, 2012, AM J RESP CRIT CARE, V186, P11, DOI 10.1164/rccm.201203-0455PP; Viasus D, 2013, J INFECTION, V66, P27, DOI 10.1016/j.jinf.2012.09.003; Wang Y, 2014, NEW ENGL J MED, V370, P341, DOI 10.1056/NEJMsa1300991; Yende S, 2007, J AM GERIATR SOC, V55, P518, DOI 10.1111/j.1532-5415.2007.01100.x; Yende S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022847	37	45	46	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2017	356								j413	10.1136/bmj.j413	http://dx.doi.org/10.1136/bmj.j413			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GI	28193610	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000394579300002
J	Carleo, G; Troyer, M				Carleo, Giuseppe; Troyer, Matthias			Solving the quantum many-body problem with artificial neural networks	SCIENCE			English	Article							MATRIX RENORMALIZATION-GROUP; PRODUCT STATES; GROUND-STATE; DYNAMICS; SYSTEMS	The challenge posed by the many-body problem in quantum physics originates from the difficulty of describing the nontrivial correlations encoded in the exponential complexity of the many-body wave function. Here we demonstrate that systematic machine learning of the wave function can reduce this complexity to a tractable computational form for some notable cases of physical interest. We introduce a variational representation of quantum states based on artificial neural networks with a variable number of hidden neurons. A reinforcement-learning scheme we demonstrate is capable of both finding the ground state and describing the unitary time evolution of complex interacting quantum systems. Our approach achieves high accuracy in describing prototypical interacting spins models in one and two dimensions.	[Carleo, Giuseppe; Troyer, Matthias] ETH, Theoret Phys, CH-8093 Zurich, Switzerland; [Troyer, Matthias] Microsoft Res, Quantum Architectures & Computat Grp, Redmond, WA 98052 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Microsoft	Carleo, G (corresponding author), ETH, Theoret Phys, CH-8093 Zurich, Switzerland.	gcarleo@ethz.ch	Troyer, Matthias/B-7826-2008; Carleo, Giuseppe/M-6198-2013	Troyer, Matthias/0000-0002-1469-9444; Carleo, Giuseppe/0000-0002-8887-4356	European Research Council (ERC) through ERC Advanced Grant SIMCOFE; Swiss National Science Foundation through National Center of Competence in Research Quantum Science and Technology (QSIT); Microsoft Research; Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA) via Massachusetts Institute of Technology Lincoln Laboratory Air Force [FA8721-05-C-0002]	European Research Council (ERC) through ERC Advanced Grant SIMCOFE(European Research Council (ERC)); Swiss National Science Foundation through National Center of Competence in Research Quantum Science and Technology (QSIT); Microsoft Research(Microsoft); Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA) via Massachusetts Institute of Technology Lincoln Laboratory Air Force	We acknowledge discussions with F. Becca, J. F. Carrasquilla, M. Dolfi, J. Osorio, D. Patane, and S. Sorella. The time-dependent MPS results have been obtained with the open-source implementation available as a part of the Algorithms and Libraries for Physics Simulations (ALPS) project (33, 42). This work was supported by the European Research Council (ERC) through ERC Advanced Grant SIMCOFE, by the Swiss National Science Foundation through National Center of Competence in Research Quantum Science and Technology (QSIT), and by Microsoft Research. This paper is based on work supported in part by the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA) via Massachusetts Institute of Technology Lincoln Laboratory Air Force contract no. FA8721-05-C-0002. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of ODNI, IARPA, or the U.S. government. The U.S. government is authorized to reproduce and distribute reprints for governmental purposes, notwithstanding any copyright annotation thereon. The authors agree to making the code used in this paper available upon reasonable request.	Bauer B, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/05/P05001; Carlson J, 2015, REV MOD PHYS, V87, P1067, DOI 10.1103/RevModPhys.87.1067; CEPERLEY D, 1986, SCIENCE, V231, P555, DOI 10.1126/science.231.4738.555; Daley AJ, 2004, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2004/04/P04005; Dirac PAM, 1930, P CAMB PHILOS SOC, V26, P376; Dolfi M, 2014, COMPUT PHYS COMMUN, V185, P3430, DOI 10.1016/j.cpc.2014.08.019; Eisert J, 2015, NAT PHYS, V11, P124, DOI [10.1038/nphys3215, 10.1038/NPHYS3215]; Foulkes WMC, 2001, REV MOD PHYS, V73, P33, DOI 10.1103/RevModPhys.73.33; Freericks JK, 2014, INT J MOD PHYS B, V28, DOI 10.1142/S0217979214300217; Frenkel Y. I., 1934, INT SERIES MONOGRAPH; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; HORNIK K, 1991, NEURAL NETWORKS, V4, P251, DOI 10.1016/0893-6080(91)90009-T; KOLMOGOROV AN, 1956, DOKL AKAD NAUK SSSR+, V108, P179; Le Roux N, 2008, NEURAL COMPUT, V20, P1631, DOI 10.1162/neco.2008.04-07-510; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lubasch M, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.064425; Marti KH, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/103008; MCMILLAN WL, 1965, PHYS REV, V138, pA442, DOI 10.1103/PhysRev.138.A442; Mezzacapo F, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083026; Montorsi A., 1992, HUBBARD MODEL COLLEC, DOI [10.1142/1346, DOI 10.1142/1346]; Norouzi Mohammad, 2009, 2009 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2735, DOI 10.1109/CVPRW.2009.5206577; Orus R, 2014, ANN PHYS-NEW YORK, V349, P117, DOI 10.1016/j.aop.2014.06.013; Polkovnikov A, 2011, REV MOD PHYS, V83, P863, DOI 10.1103/RevModPhys.83.863; Rommer S, 1997, PHYS REV B, V55, P2164, DOI 10.1103/PhysRevB.55.2164; Sandvik AW, 1997, PHYS REV B, V56, P11678, DOI 10.1103/PhysRevB.56.11678; Schoenholz SS, 2016, NAT PHYS, V12, P469, DOI [10.1038/nphys3644, 10.1038/NPHYS3644]; Schollwock U, 2011, ANN PHYS-NEW YORK, V326, P96, DOI 10.1016/j.aop.2010.09.012; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Sohn Kihyuk, 2012, ICML; Sorella S, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2746035; Thouless D. J., 1972, QUANTUM MECH MANY BO; Torlai G, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.165134; Troyer M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.170201; Verstraete F, 2008, ADV PHYS, V57, P143, DOI 10.1080/14789940801912366; Vidal G, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.040502; Wang L, 2016, PHYS REV B, V94, DOI [10.1103/PhysRevB.94.195105, DOI 10.1103/PHYSREVB.94.195105]; WHITE SR, 1992, PHYS REV LETT, V69, P2863, DOI 10.1103/PhysRevLett.69.2863; White SR, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.076401	40	953	965	24	466	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					602	605		10.1126/science.aag2302	http://dx.doi.org/10.1126/science.aag2302			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK0SF	28183973	Green Submitted			2022-12-28	WOS:000393636700042
J	Hush, MR				Hush, Michael R.			Machine learning for quantum physics	SCIENCE			English	Editorial Material									[Hush, Michael R.] Univ New South Wales, Sch Engn & Informat Technol, Canberra, ACT 2600, Australia	University of New South Wales Sydney	Hush, MR (corresponding author), Univ New South Wales, Sch Engn & Informat Technol, Canberra, ACT 2600, Australia.	m.hush@unsw.edu.au						Aaronson S., 2013, QUANTUM COMPUTING DE; Carleo G, 2017, SCIENCE, V355, P602, DOI 10.1126/science.aag2302; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Krenn M, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.090405; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Schollwock U, 2011, ANN PHYS-NEW YORK, V326, P96, DOI 10.1016/j.aop.2010.09.012; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961	9	21	21	5	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					580	580		10.1126/science.aam6564	http://dx.doi.org/10.1126/science.aam6564			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK0SF	28183936				2022-12-28	WOS:000393636700027
J	Luo, XY; Zou, YQ; Wu, LN; Liu, Q; Han, MF; Tey, MK; You, L				Luo, Xin-Yu; Zou, Yi-Quan; Wu, Ling-Na; Liu, Qi; Han, Ming-Fei; Tey, Meng Khoon; You, Li			Deterministic entanglement generation from driving through quantum phase transitions	SCIENCE			English	Article							SPIN STATES; LIMIT; ATOMS	Many-body entanglement is often created through the system evolution, aided by nonlinear interactions between the constituting particles. These very dynamics, however, can also lead to fluctuations and degradation of the entanglement if the interactions cannot be controlled. Here, we demonstrate near-deterministic generation of an entangled twin-Fock condensate of similar to 11,000 atoms by driving a rubidium-87 Bose-Einstein condensate undergoing spin mixing through two consecutive quantum phase transitions (QPTs). We directly observe number squeezing of 10.7 +/- 0.6 decibels and normalized collective spin length of 0.99 +/- 0.01. Together, these observations allow us to infer an entanglement-enhanced phase sensitivity of similar to 6 decibels beyond the standard quantum limit and an entanglement breadth of similar to 910 atoms. Our work highlights the power of generating large-scale useful entanglement by taking advantage of the different entanglement landscapes separated by QPTs.	[Luo, Xin-Yu; Zou, Yi-Quan; Wu, Ling-Na; Liu, Qi; Han, Ming-Fei; Tey, Meng Khoon; You, Li] Tsinghua Univ, Dept Phys, State Key Lab Low Dimens Quantum Phys, Beijing 100084, Peoples R China; [Tey, Meng Khoon; You, Li] Collaborat Innovat Ctr Quantum Matter, Beijing, Peoples R China	Tsinghua University	Tey, MK; You, L (corresponding author), Tsinghua Univ, Dept Phys, State Key Lab Low Dimens Quantum Phys, Beijing 100084, Peoples R China.; Tey, MK; You, L (corresponding author), Collaborat Innovat Ctr Quantum Matter, Beijing, Peoples R China.	mengkhoon_tey@mail.tsinghua.edu.cn; lyou@mail.tsinghua.edu.cn	Luo, Xin-Yu/Y-4776-2018	Luo, Xin-Yu/0000-0001-5104-3797; You, Li/0000-0002-3919-4768; Tey, Meng Khoon/0000-0002-4861-527X; Zou, Yi-Quan/0000-0002-5868-1844; Wu, Ling-Na/0000-0003-4722-5883; Liu, Qi/0000-0002-7379-9090	National Basic Research Program of China (973 program) [2013CB922004, 2014CB921403]; Natural Science Foundation of China [91121005, 91421305, 11574177, 11374176, 11404184, 11654001, 91636213]; Tsinghua University Initiative Scientific Research Program [20111081008]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University Initiative Scientific Research Program	We acknowledge helpful discussions with R. Wang and B. Gao. This work is supported by the National Basic Research Program of China (973 program) (grants 2013CB922004 and 2014CB921403), the Natural Science Foundation of China (grants 91121005, 91421305, 11574177, 11374176, 11404184, 11654001, and 91636213), and by the Tsinghua University Initiative Scientific Research Program (grant 20111081008).	Anquez M, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.155301; Appel J, 2009, P NATL ACAD SCI USA, V106, P10960, DOI 10.1073/pnas.0901550106; Bookjans EM, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.210406; Cox KC, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.093602; Cramer M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3161; Duan LM, 2000, PHYS REV LETT, V85, P3991, DOI 10.1103/PhysRevLett.85.3991; Gross C, 2011, NATURE, V480, P219, DOI 10.1038/nature10654; Gross C, 2010, NATURE, V464, P1165, DOI 10.1038/nature08919; Hoang TM, 2016, P NATL ACAD SCI USA, V113, P9475, DOI 10.1073/pnas.1600267113; HOLLAND MJ, 1993, PHYS REV LETT, V71, P1355, DOI 10.1103/PhysRevLett.71.1355; Hosten O, 2016, NATURE, V529, P505, DOI 10.1038/nature16176; Killoran N, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.150501; KITAGAWA M, 1993, PHYS REV A, V47, P5138, DOI 10.1103/PhysRevA.47.5138; Kuzmich A, 2000, PHYS REV LETT, V85, P1594, DOI 10.1103/PhysRevLett.85.1594; Law CK, 1998, PHYS REV LETT, V81, P5257, DOI 10.1103/PhysRevLett.81.5257; Linnemann D, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.013001; Lucke B, 2011, SCIENCE, V334, P773, DOI 10.1126/science.1208798; Lucke B, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.155304; McConnell R, 2015, NATURE, V519, P439, DOI 10.1038/nature14293; Osterloh A, 2002, NATURE, V416, P608, DOI 10.1038/416608a; Oszmaniec M, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.041044; Pezze L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.100401; Pu H, 2000, PHYS REV LETT, V85, P3987, DOI 10.1103/PhysRevLett.85.3987; Riedel MF, 2010, NATURE, V464, P1170, DOI 10.1038/nature08988; Schleier-Smith MH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.073604; Sorensen AS, 2001, PHYS REV LETT, V86, P4431, DOI 10.1103/PhysRevLett.86.4431; Stamper-Kurn DM, 2013, REV MOD PHYS, V85, P1191, DOI 10.1103/RevModPhys.85.1191; Strobel H, 2014, SCIENCE, V345, P424, DOI 10.1126/science.1250147; Zhang Z, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.180401	30	140	141	7	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					620	+		10.1126/science.aag1106	http://dx.doi.org/10.1126/science.aag1106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK0SF	28183976	Green Submitted			2022-12-28	WOS:000393636700046
J	Lambert, AW; Pattabiraman, DR; Weinberg, RA				Lambert, Arthur W.; Pattabiraman, Diwakar R.; Weinberg, Robert A.			Emerging Biological Principles of Metastasis	CELL			English	Review							EPITHELIAL-MESENCHYMAL TRANSITION; CIRCULATING TUMOR-CELLS; BREAST-CANCER CELLS; STEM-LIKE CELLS; BONE-MARROW; LUNG ADENOCARCINOMA; T-CELLS; COLLECTIVE INVASION; DISTANT METASTASIS; BRAIN METASTASIS	Metastases account for the great majority of cancer-associated deaths, yet this complex process remains the least understood aspect of cancer biology. As the body of research concerning metastasis continues to grow at a rapid rate, the biological programs that underlie the dissemination and metastatic outgrowth of cancer cells are beginning to come into view. In this review we summarize the cellular and molecular mechanisms involved in metastasis, with a focus on carcinomas where the most is known, and we highlight the general principles of metastasis that have begun to emerge.	[Lambert, Arthur W.; Pattabiraman, Diwakar R.; Weinberg, Robert A.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Weinberg, Robert A.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA; [Weinberg, Robert A.] MIT, Ludwig Ctr Mol Oncol, 77 Massachusetts Ave, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Weinberg, RA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA.; Weinberg, RA (corresponding author), MIT, Ludwig Ctr Mol Oncol, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu		Pattabiraman, Diwakar/0000-0002-2418-6458	American Cancer Society - New England Division - Ellison Foundation Postdoctoral Fellowship [PF-15-131-01-CSM]; National Health and Medical Research Council of Australia [NHMRC APP1071853]; K99/R00 Pathway to Independence Award [NIH/NCI 1K99CA201574-01A1]; NIH [R01-CA078461]; Breast Cancer Research Foundation; Advanced Medical Research Foundation; Ludwig Center for Molecular Oncology; NATIONAL CANCER INSTITUTE [K99CA201574, R01CA078461] Funding Source: NIH RePORTER	American Cancer Society - New England Division - Ellison Foundation Postdoctoral Fellowship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); K99/R00 Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Advanced Medical Research Foundation; Ludwig Center for Molecular Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank all members of the R.A.W. laboratory for fruitful discussions and especially Tsukasa Shibue for critical review of the manuscript. We would also like to thank Meredith Leffler for preparation of the figures. A.W.L. is supported by an American Cancer Society - New England Division - Ellison Foundation Postdoctoral Fellowship (PF-15-131-01-CSM). D.R.P. was supported by a C.J. Martin Overseas Biomedical Fellowship from the National Health and Medical Research Council of Australia (NHMRC APP1071853) and is currently supported by a K99/R00 Pathway to Independence Award (NIH/NCI 1K99CA201574-01A1). Work in the R.A.W. laboratory is supported by grants from the NIH (R01-CA078461), the Breast Cancer Research Foundation, the Advanced Medical Research Foundation, and the Ludwig Center for Molecular Oncology. R.A.W. is an American Cancer Society Research Professor and a Daniel K. Ludwig Cancer Research Professor.	Aceto N, 2015, TRENDS CANCER, V1, P44, DOI 10.1016/j.trecan.2015.07.006; Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Balic M, 2006, CLIN CANCER RES, V12, P5615, DOI 10.1158/1078-0432.CCR-06-0169; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Bednarz-Knoll N, 2012, CANCER METAST REV, V31, P673, DOI 10.1007/s10555-012-9370-z; Bidwell BN, 2012, NAT MED, V18, P1224, DOI 10.1038/nm.2830; Bonapace L, 2014, NATURE, V515, DOI 10.1038/nature13862; Bonnomet A, 2012, ONCOGENE, V31, P3741, DOI 10.1038/onc.2011.540; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Bragado P, 2013, NAT CELL BIOL, V15, P1351, DOI 10.1038/ncb2861; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Cheung KJ, 2016, P NATL ACAD SCI USA, V113, pE854, DOI 10.1073/pnas.1508541113; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Chung YC, 2016, EUR J CLIN INVEST, V46, P1002, DOI 10.1111/eci.12683; Clever D, 2016, CELL, V166, P1117, DOI 10.1016/j.cell.2016.07.032; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Cox TR, 2014, CLIN CANCER RES, V20, P3637, DOI 10.1158/1078-0432.CCR-13-1059; de Boer M, 2010, J NATL CANCER I, V102, P410, DOI 10.1093/jnci/djq008; De Cock JM, 2016, CANCER RES, V76, P6778, DOI 10.1158/0008-5472.CAN-16-0608; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Denny SK, 2016, CELL, V166, P328, DOI 10.1016/j.cell.2016.05.052; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; El Touny LH, 2014, J CLIN INVEST, V124, P156, DOI 10.1172/JCI70259; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Fan F, 2012, CANCER MED-US, V1, P5, DOI 10.1002/cam4.4; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Franco AT, 2015, BLOOD, V126, P582, DOI 10.1182/blood-2014-08-531582; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gao H, 2016, CELL, V166, P47, DOI 10.1016/j.cell.2016.06.009; Gao H, 2012, CELL, V150, P764, DOI 10.1016/j.cell.2012.06.035; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; GASIC GJ, 1968, P NATL ACAD SCI USA, V61, P46, DOI 10.1073/pnas.61.1.46; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ghajar CM, 2015, NAT REV CANCER, V15, P238, DOI 10.1038/nrc3910; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Goss PE, 2010, NAT REV CANCER, V10, P871, DOI 10.1038/nrc2933; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; Grosse-Wilde A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126522; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Haffner MC, 2013, J CLIN INVEST, V123, P4918, DOI 10.1172/JCI70354; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harper KL, 2016, NATURE; Headley MB, 2016, NATURE, V531, P513, DOI 10.1038/nature16985; Hong T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004569; Hosseini H., 2016, NATURE; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Huh SJ, 2010, CANCER RES, V70, P6071, DOI 10.1158/0008-5472.CAN-09-4442; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Jacob LS, 2015, CANCER RES, V75, P3713, DOI 10.1158/0008-5472.CAN-15-0562; Jordan NV, 2011, CELL CYCLE, V10, P2865, DOI 10.4161/cc.10.17.17188; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/j.ccr.2013.04.017; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karaman S, 2014, J CLIN INVEST, V124, P922, DOI 10.1172/JCI71606; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Kobayashi A, 2011, J EXP MED, V208, P2641, DOI 10.1084/jem.20110840; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kohler S, 2010, BRIT J CANCER, V102, P602, DOI 10.1038/sj.bjc.6605492; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Kopp HG, 2009, CANCER RES, V69, P7775, DOI 10.1158/0008-5472.CAN-09-2123; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Labelle M, 2014, P NATL ACAD SCI USA, V111, pE3053, DOI 10.1073/pnas.1411082111; Labelle M, 2012, CANCER DISCOV, V2, P1091, DOI 10.1158/2159-8290.CD-12-0329; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Latil M., 2016, CELL STEM CELL; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; Lee HJ, 2014, CANCER CELL, V26, P207, DOI 10.1016/j.ccr.2014.05.019; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li CMC, 2015, GENE DEV, V29, P1850, DOI 10.1101/gad.267393.115; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Long HX, 2015, ONCOTARGET, V6, P5846, DOI 10.18632/oncotarget.3462; Loo JM, 2015, CELL, V160, P393, DOI 10.1016/j.cell.2014.12.018; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Lundgren K, 2009, BRIT J CANCER, V101, P1769, DOI 10.1038/sj.bjc.6605369; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Malladi S, 2016, CELL, V165, P45, DOI 10.1016/j.cell.2016.02.025; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin YD, 2015, CELL REP, V13, P2456, DOI 10.1016/j.celrep.2015.11.025; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; Miyamoto DT, 2015, SCIENCE, V349, P1351, DOI 10.1126/science.aab0917; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Mouw JK, 2014, NAT MED, V20, P360, DOI 10.1038/nm.3497; Muller-Hermelink N, 2008, CANCER CELL, V13, P507, DOI 10.1016/j.ccr.2008.04.001; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Naxerova K, 2015, NAT REV CLIN ONCOL, V12, P258, DOI 10.1038/nrclinonc.2014.238; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nieswandt B, 1999, CANCER RES, V59, P1295; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Obenauf AC, 2015, TRENDS CANCER, V1, P76, DOI 10.1016/j.trecan.2015.07.009; Obenauf AC, 2015, NATURE, V520, P368, DOI 10.1038/nature14336; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Ozturk S, 2016, P NATL ACAD SCI USA, V113, P638, DOI 10.1073/pnas.1514663113; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Palumbo JS, 2007, BLOOD, V110, P133, DOI 10.1182/blood-2007-01-065995; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rankin EB, 2016, SCIENCE, V352, P175, DOI 10.1126/science.aaf4405; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Revenu C, 2009, CURR OPIN GENET DEV, V19, P338, DOI 10.1016/j.gde.2009.04.007; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Ross JB, 2015, NAT CELL BIOL, V17, P651, DOI 10.1038/ncb3148; Sagiv JY, 2015, CELL REP, V10, P562, DOI 10.1016/j.celrep.2014.12.039; Sampson VB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102041; Schliekelman MJ, 2015, CANCER RES, V75, P1789, DOI 10.1158/0008-5472.CAN-14-2535; Schumacher D, 2013, CANCER CELL, V24, P130, DOI 10.1016/j.ccr.2013.05.008; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Shibue T, 2013, CANCER CELL, V24, P481, DOI 10.1016/j.ccr.2013.08.012; Shibue T, 2012, CANCER DISCOV, V2, P706, DOI 10.1158/2159-8290.CD-11-0239; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Sosa MS, 2011, CLIN CANCER RES, V17, P5850, DOI 10.1158/1078-0432.CCR-10-2574; Spicer JD, 2012, CANCER RES, V72, P3919, DOI 10.1158/0008-5472.CAN-11-2393; Spiegel A, 2016, CANCER DISCOV, V6, P630, DOI 10.1158/2159-8290.CD-15-1157; Steeg PS, 2016, NAT REV CANCER, V16, P201, DOI 10.1038/nrc.2016.25; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Strilic B, 2016, NATURE, V536, P215, DOI 10.1038/nature19076; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Turajlic S, 2016, SCIENCE, V352, P169, DOI 10.1126/science.aaf2784; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Veracini L, 2015, ONCOTARGET, V6, P7570, DOI 10.18632/oncotarget.3071; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Weng DS, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3102; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Wolf MJ, 2012, CANCER CELL, V22, P91, DOI 10.1016/j.ccr.2012.05.023; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Yu M, 2014, SCIENCE, V345, P216, DOI 10.1126/science.1253533; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; Zhou DH, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.37	197	1485	1521	34	556	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2017	168	4					670	691		10.1016/j.cell.2016.11.037	http://dx.doi.org/10.1016/j.cell.2016.11.037			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8VJ	28187288	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000396277600017
J	Chavan, D				Chavan, Deepti			WHAT YOUR PATIENT IS THINKING Fighting TB requires empowered patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2017	356								i6344	10.1136/bmj.i6344	http://dx.doi.org/10.1136/bmj.i6344			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4FX	28179263	Bronze			2022-12-28	WOS:000394578200001
J	Siegmund, B				Siegmund, Britta			Is intensity the solution for FMT in ulcerative colitis?	LANCET			English	Editorial Material							TRANSPLANTATION		[Siegmund, Britta] Charite, Med Klin Gastroenterol Infektiol Rheumatol, D-12200 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Siegmund, B (corresponding author), Charite, Med Klin Gastroenterol Infektiol Rheumatol, D-12200 Berlin, Germany.	britta.siegmund@charite.de	Siegmund, Britta/E-6929-2018	Siegmund, Britta/0000-0002-0055-958X	Abbvie; Falk; Ferring; Hospira; MSD; Mundipharma; Takeda; Pfizer	Abbvie(AbbVie); Falk; Ferring(Ferring Pharmaceuticals); Hospira; MSD; Mundipharma; Takeda(Takeda Pharmaceutical Company Ltd); Pfizer(Pfizer)	I declare personal fees from Abbvie, Falk, Ferring, Hospira, MSD, Mundipharma, and Takeda and grants from Hospira and Pfizer, all outside the therapeutic area discussed here.	Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; Paramsothy S, 2017, LANCET; Rehman A, 2016, GUT, V65, P238, DOI 10.1136/gutjnl-2014-308341; Rossen NG, 2015, GASTROENTEROLOGY, V149, P110, DOI 10.1053/j.gastro.2015.03.045; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vermeire S, 2016, J CROHNS COLITIS, V10, P387, DOI 10.1093/ecco-jcc/jjv203	7	11	11	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2017	389	10075					1170	1172		10.1016/S0140-6736(17)30313-6	http://dx.doi.org/10.1016/S0140-6736(17)30313-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EP1KL	28214090				2022-12-28	WOS:000397143700009
J	Sewankambo, NK; Mafigiri, DK				Sewankambo, Nelson K.; Mafigiri, David K.			Educating religious leaders to create demand for medical male circumcision	LANCET			English	Editorial Material							HIV PREVENTION; MEN; UGANDA		[Sewankambo, Nelson K.] Makerere Univ, Sch Med, Coll Hlth Sci, POB 7072, Kampala, Uganda; [Mafigiri, David K.] Makerere Univ, Sch Social Sci, Coll Humanities & Social Sci, Kampala, Uganda	Makerere University; Makerere University	Sewankambo, NK (corresponding author), Makerere Univ, Sch Med, Coll Hlth Sci, POB 7072, Kampala, Uganda.	sewankam@infocom.co.ug		Mafigiri, David/0000-0002-2699-4248	Wellcome Trust; UK Government [107742/Z/15/Z]	Wellcome Trust(Wellcome TrustEuropean Commission); UK Government	NKS is an investigator with Rakai Health Sciences Program, Uganda, and Director of THRiVE, a DELTAS Africa programme, supported by Wellcome Trust and the UK Government with grant 107742/Z/15/Z. We declare no further competing interests.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Downs JA, 2017, LANCET; Downs JA, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002802; Gasasira RA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-134; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Parkhurst JO, 2015, SOC SCI MED, V135, P15, DOI 10.1016/j.socscimed.2015.04.020; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Turinawe EB, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0147-7; Turinawe EB, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0074-7; Warraich HJ, 2009, EMERG INFECT DIS, V15, P978, DOI 10.3201/eid1506.090087	11	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2017	389	10074					1080	1082		10.1016/S0140-6736(17)30318-5	http://dx.doi.org/10.1016/S0140-6736(17)30318-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0SR	28214094	hybrid, Green Accepted			2022-12-28	WOS:000396408700006
J	Powers, RE; Wang, SY; Liu, TY; Rapoport, TA				Powers, Robert E.; Wang, Songyu; Liu, Tina Y.; Rapoport, Tom A.			Reconstitution of the tubular endoplasmic reticulum network with purified components	NATURE			English	Article							HOMOTYPIC ER FUSION; MEMBRANE-PROTEINS; AMPHIPATHIC HELIX; PROVIDE INSIGHT; ATLASTIN; GENERATION; CELLS	Organelles display characteristic morphologies that are intimately tied to their cellular function, but how organelles are shaped is poorly understood. The endoplasmic reticulum is particularly intriguing, as it comprises morphologically distinct domains, including a dynamic network of interconnected membrane tubules. Several membrane proteins have been implicated in network formation(1-5), but how exactly they mediate network formation and whether they are all required are unclear. Here we reconstitute a dynamic tubular membrane network with purified endoplasmic reticulum proteins. Proteoliposomes containing the membrane-fusing GTPase Sey1p (refs 6, 7) and the curvature-stabilizing protein Yop1p (refs 8, 9) from Saccharomyces cerevisiae form a tubular network upon addition of GTP. The tubules rapidly fragment when GTP hydrolysis of Sey1p is inhibited, indicating that network maintenance requires continuous membrane fusion and that Yop1p favours the generation of highly curved membrane structures. Sey1p also forms networks with other curvature-stabilizing proteins, including reticulon(8) and receptor expression-enhancing proteins (REEPs)(10) from different species. Atlastin, the vertebrate orthologue of Sey1p(6,11), forms a GTP-hydrolysis-dependent network on its own, serving as both a fusion and curvature-stabilizing protein. Our results show that organelle shape can be generated by a surprisingly small set of proteins and represents an energy-dependent steady state between formation and disassembly.	[Powers, Robert E.; Wang, Songyu; Liu, Tina Y.; Rapoport, Tom A.] Harvard Med Sch, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA; [Powers, Robert E.; Wang, Songyu; Liu, Tina Y.; Rapoport, Tom A.] Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA; [Liu, Tina Y.] Univ Calif Berkeley, 731 Stanley Hall,MS 3220, Berkeley, CA 94720 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of California System; University of California Berkeley	Rapoport, TA (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.; Rapoport, TA (corresponding author), Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu		Liu, Tina/0000-0003-1297-7102	National Institutes of Health/National Institute of General Medical Sciences [T32 GM008313]; Charles King Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Charles King Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Tukachinsky for help with protein purifications, M. Kozlov for discussions, A. Daga for material, the Nikon Imaging Center at Harvard Medical School, the Harvard Medical School electron microscopy facility, and the ICCB-Longwood Screening Facility for help. We thank M. Kozlov, J. Hu, and H. Tukachinsky for reading the manuscript. R.E.P. is supported by National Institutes of Health/National Institute of General Medical Sciences T32 GM008313 training grant. S.W. is supported by a fellowship from the Charles King Trust. T.A.R. is a Howard Hughes Medical Institute Investigator.	Anwar K, 2012, J CELL BIOL, V197, P209, DOI 10.1083/jcb.201111115; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Brady JP, 2015, P NATL ACAD SCI USA, V112, pE639, DOI 10.1073/pnas.1415882112; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Chen S, 2015, P NATL ACAD SCI USA, V112, P418, DOI 10.1073/pnas.1423026112; Chen SL, 2013, CURR OPIN CELL BIOL, V25, P428, DOI 10.1016/j.ceb.2013.02.006; English AR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013227; Faust JE, 2015, J BIOL CHEM, V290, P4772, DOI 10.1074/jbc.M114.601823; Goyal U, 2013, BBA-MOL CELL RES, V1833, P2492, DOI 10.1016/j.bbamcr.2013.04.009; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; LEE C, 1988, CELL, V54, P37, DOI 10.1016/0092-8674(88)90177-8; Liu TY, 2015, P NATL ACAD SCI USA, V112, pE1851, DOI 10.1073/pnas.1504368112; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; Shemesh T, 2014, P NATL ACAD SCI USA, V111, pE5243, DOI 10.1073/pnas.1419997111; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wang S, 2016, ELIFE, V5, DOI 10.7554/eLife.14211; Wang SY, 2013, J CELL BIOL, V203, P801, DOI 10.1083/jcb.201308001; Yan LM, 2015, J CELL BIOL, V210, P961, DOI 10.1083/jcb.201502078; Zhang D, 2010, CURR BIOL, V20, P1029, DOI 10.1016/j.cub.2010.04.017; Zhang H, 2016, TRENDS CELL BIOL, V26, P934, DOI 10.1016/j.tcb.2016.06.002	25	65	67	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					257	+		10.1038/nature21387	http://dx.doi.org/10.1038/nature21387			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0GQ	28225760	Green Submitted, Green Accepted			2022-12-28	WOS:000395688700042
J	Suga, M; Akita, F; Sugahara, M; Kubo, M; Nakajima, Y; Nakane, T; Yamashita, K; Umena, Y; Nakabayashi, M; Yamane, T; Nakano, T; Suzuki, M; Masuda, T; Inoue, S; Kimura, T; Nomura, T; Yonekura, S; Yu, LJ; Sakamoto, T; Motomura, T; Chen, JH; Kato, Y; Noguchi, T; Tono, K; Joti, Y; Kameshima, T; Hatsui, T; Nango, E; Tanaka, R; Naitow, H; Matsuura, Y; Yamashita, A; Yamamoto, M; Nureki, O; Yabashi, M; Ishikawa, T; Iwata, S; Shen, JR				Suga, Michihiro; Akita, Fusamichi; Sugahara, Michihiro; Kubo, Minoru; Nakajima, Yoshiki; Nakane, Takanori; Yamashita, Keitaro; Umena, Yasufumi; Nakabayashi, Makoto; Yamane, Takahiro; Nakano, Takamitsu; Suzuki, Mamoru; Masuda, Tetsuya; Inoue, Shigeyuki; Kimura, Tetsunari; Nomura, Takashi; Yonekura, Shinichiro; Yu, Long-Jiang; Sakamoto, Tomohiro; Motomura, Taiki; Chen, Jing-Hua; Kato, Yuki; Noguchi, Takumi; Tono, Kensuke; Joti, Yasumasa; Kameshima, Takashi; Hatsui, Takaki; Nango, Eriko; Tanaka, Rie; Naitow, Hisashi; Matsuura, Yoshinori; Yamashita, Ayumi; Yamamoto, Masaki; Nureki, Osamu; Yabashi, Makina; Ishikawa, Tetsuya; Iwata, So; Shen, Jian-Ren			Light-induced structural changes and the site of O=O bond formation in PSII caught by XFEL	NATURE			English	Article							OXYGEN-EVOLVING COMPLEX; X-RAY-DIFFRACTION; PHOTOSYNTHETIC WATER OXIDATION; PHOTOSYSTEM-II; INFRARED DETECTION; OXIDIZING COMPLEX; PROTON RELEASE; MECHANISM; STATE; BINDING	Photosystem II (PSII) is a huge membrane-protein complex consisting of 20 different subunits with a total molecular mass of 350 kDa for a monomer. It catalyses light-driven water oxidation at its catalytic centre, the oxygen-evolving complex (OEC)(1-3). The structure of PSII has been analysed at 1.9 angstrom resolution by synchrotron radiation X-rays, which revealed that the OEC is a Mn4CaO5 cluster organized in an asymmetric, `distorted-chair' form(4). This structure was further analysed with femtosecond X-ray free electron lasers (XFEL), providing the `radiation damage-free'(5) structure. The mechanism of O=O bond formation, however, remains obscure owing to the lack of intermediate-state structures. Here we describe the structural changes in PSII induced by two-flash illumination at room temperature at a resolution of 2.35 angstrom using time-resolved serial femtosecond crystallography with an XFEL provided by the SPring-8 angstrom compact free-electron laser. An isomorphous difference Fourier map between the two-flash and dark-adapted states revealed two areas of apparent changes: around the QB/non-haem iron and the Mn4CaO5 cluster. The changes around the QB/non-haem iron region reflected the electron and proton transfers induced by the two-flash illumination. In the region around the OEC, a water molecule located 3.5 angstrom from the Mn4CaO5 cluster disappeared from the map upon two-flash illumination. This reduced the distance between another water molecule and the oxygen atom O4, suggesting that proton transfer also occurred. Importantly, the two-flash-minus-dark isomorphous difference Fourier map showed an apparent positive peak around O5, a unique mu 4-oxo-bridge located in the quasi-centre of Mn1 and Mn4 (refs 4,5). This suggests the insertion of a new oxygen atom (O6) close to O5, providing an O=O distance of 1.5 angstrom between these two oxygen atoms. This provides a mechanism for the O=O bond formation consistent with that proposed previously(6,7.)	[Suga, Michihiro; Akita, Fusamichi; Nakajima, Yoshiki; Umena, Yasufumi; Nakabayashi, Makoto; Yamane, Takahiro; Nakano, Takamitsu; Yonekura, Shinichiro; Yu, Long-Jiang; Sakamoto, Tomohiro; Motomura, Taiki; Chen, Jing-Hua; Shen, Jian-Ren] Okayama Univ, Res Inst Interdisciplinary Sci, 3-1-1 Tsushima Naka, Okayama 7008530, Japan; [Suga, Michihiro; Akita, Fusamichi; Nakajima, Yoshiki; Umena, Yasufumi; Nakabayashi, Makoto; Yamane, Takahiro; Nakano, Takamitsu; Yonekura, Shinichiro; Yu, Long-Jiang; Sakamoto, Tomohiro; Motomura, Taiki; Chen, Jing-Hua; Iwata, So; Shen, Jian-Ren] Okayama Univ, Grad Sch Nat Sci & Technol, 3-1-1 Tsushima Naka, Okayama 7008530, Japan; [Akita, Fusamichi; Kubo, Minoru] Japan Sci & Technol Agcy, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan; [Sugahara, Michihiro; Kubo, Minoru; Yamashita, Keitaro; Suzuki, Mamoru; Masuda, Tetsuya; Inoue, Shigeyuki; Kimura, Tetsunari; Nomura, Takashi; Hatsui, Takaki; Nango, Eriko; Tanaka, Rie; Naitow, Hisashi; Matsuura, Yoshinori; Yamashita, Ayumi; Yamamoto, Masaki; Yabashi, Makina; Ishikawa, Tetsuya; Iwata, So] RIKEN, SPring Ctr 8, 1-1-1 Kouto,Sayo Cho, Mikazuki, Hyogo 6795148, Japan; [Nakane, Takanori; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan; [Suzuki, Mamoru] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Masuda, Tetsuya] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Uji, Kyoto 6110011, Japan; [Inoue, Shigeyuki] Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Hongo, Tokyo 1130033, Japan; [Kimura, Tetsunari] Kobe Univ, Grad Sch Sci, Dept Chem, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan; [Motomura, Taiki; Shen, Jian-Ren] Univ Hyogo, Grad Sch Life Sci, Dept Picobiol, 3-2-1 Kouto,Kamigori Cho, Kobe, Hyogo 6781297, Japan; [Chen, Jing-Hua; Shen, Jian-Ren] Chinese Acad Sci, Inst Bot, Key Lab Photobiol, 20 Nanxincun, Beijing 100093, Peoples R China; [Kato, Yuki; Noguchi, Takumi] Nagoya Univ, Grad Sch Sci, Div Mat Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan; [Tono, Kensuke; Joti, Yasumasa] Japan Synchrotron Radiat Res Inst, 1-1-1 Kouto, Sayo, Hyogo 6795198, Japan; [Nango, Eriko] Kyoto Univ, Grad Sch Med, Dept Cell Biol, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan	Okayama University; Okayama University; Japan Science & Technology Agency (JST); RIKEN; University of Tokyo; Osaka University; Kyoto University; University of Tokyo; Kobe University; University of Hyogo; Chinese Academy of Sciences; Institute of Botany, CAS; Nagoya University; Japan Synchrotron Radiation Research Institute; Kyoto University	Suga, M (corresponding author), Okayama Univ, Res Inst Interdisciplinary Sci, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	s.iwata@mfour.med.kyoto-u.ac.jp; shen@cc.okayama-u.ac.jp	Ishikawa, Tetsuya/I-4775-2012; Yabashi, Makina/A-2832-2015; Akita, Fusamichi/C-2034-2015; Suzuki, Mamoru/G-6576-2016; NUREKI, OSAMU/G-4960-2014; Kimura, Tetsunari/AAN-9156-2021; Noguchi, Takumi/I-7105-2014; Umena, Yasufumi/AAD-5472-2019; Shen, Jian-Ren/B-2558-2011; Yamamoto, Masaki/B-7844-2015	Ishikawa, Tetsuya/0000-0002-6906-9909; Yabashi, Makina/0000-0002-2472-1684; Akita, Fusamichi/0000-0003-0537-6157; Suzuki, Mamoru/0000-0001-7071-5093; Kimura, Tetsunari/0000-0003-1650-7298; Nakane, Takanori/0000-0003-2697-2767; Yamamoto, Masaki/0000-0002-1311-1768; Yamane, Takahiro/0000-0003-3251-384X; Masuda, Tetsuya/0000-0001-5857-5753; Motomura, Taiki/0000-0002-9646-7347; Nango, Eriko/0000-0001-9851-7355; Yonekura, Shinichiro/0000-0001-5376-9081; Nakabayashi, Makoto/0000-0002-4751-6667; Yamashita, Keitaro/0000-0002-5442-7582; Nakajima, Yoshiki/0000-0002-0529-8075	Okayama University; JSPS KAKENHI [JP15H01642, JP16H06162, JP16H06296, JP16K21181, JP15H05588, JP15H03841, JP15H01055, JP24000018]; MEXT, Japan; Asahi Glass Foundation; Kato Memorial Bioscience Foundation; Inamori Foundation; Japan Science and Technology agency (JST); PRESTO from JST; Pioneering Project 'Dynamic Structural Biology' of RIKEN; CAS [XDB17030100]; Grants-in-Aid for Scientific Research [16H06162, 26440028] Funding Source: KAKEN	Okayama University; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Asahi Glass Foundation; Kato Memorial Bioscience Foundation; Inamori Foundation; Japan Science and Technology agency (JST)(Japan Science & Technology Agency (JST)); PRESTO from JST(Japan Science & Technology Agency (JST)); Pioneering Project 'Dynamic Structural Biology' of RIKEN; CAS(Chinese Academy of Sciences); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Kawakami and N. Kamiya for sharing unpublished information, H. Mino for information on the flash illumination conditions and H. Ago and K. Yamaguchi for discussions. This work was supported by a program for promoting the enhancement of research universities at Okayama University, JSPS KAKENHI Grant Nos JP15H01642, JP16H06162, JP16H06296 (M. Suga), JP16K21181 (F.A.), JP15H05588 (Y.U.), JP15H03841, JP15H01055 (M.K.) and JP24000018 (J.-R.S.), an X-ray Free Electron Laser Priority Strategy Program (J.-R.S., S.Iw.) from MEXT, Japan, an Asahi Glass Foundation (F.A.), a Kato Memorial Bioscience Foundation (F.A.), an Inamori Foundation (M. Suga), the Research Acceleration Program from Japan Science and Technology agency (JST) (S.Iw.), PRESTO from JST (M.K. and F.A.), a grant from Pioneering Project 'Dynamic Structural Biology' of RIKEN (M.K.), and the Strategic Priority Research Program of CAS (XDB17030100) (J.-R. S.). The XFEL experiments were performed at beamline 3 of SACLA with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (proposal nos 2013B1259, 2014A1243, 2014A6927, 2014B1281, 2014B6927, 2014B8048, 2015A1108, 2015A6522, 2015B2108, 2015B6522, 2015B8044, 2016A2542, 2016A6621 and 2016A8033), and we thank the staff at SACLA for their help. We also acknowledge computational support from the SACLA HPC system and the Mini-K supercomputer system.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barty A, 2014, J APPL CRYSTALLOGR, V47, P1118, DOI 10.1107/S1600576714007626; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Collaborative Computational Project, ACTA CRYSTALLOGR D, V50, P760; Cox N, 2014, SCIENCE, V345, P804, DOI 10.1126/science.1254910; DUISENBERG AJM, 1992, J APPL CRYSTALLOGR, V25, P92, DOI 10.1107/S0021889891010634; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Isobe H, 2012, DALTON T, V41, P13727, DOI 10.1039/c2dt31420g; Isobe H, 2016, INORG CHEM, V55, P502, DOI 10.1021/acs.inorgchem.5b02471; Kabsch W, 2014, ACTA CRYSTALLOGR D, V70, P2204, DOI 10.1107/S1399004714013534; Kameshima T, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4867668; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Kern J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5371; Kern J, 2013, SCIENCE, V340, P491, DOI 10.1126/science.1234273; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Kupitz C, 2014, NATURE, V513, P261, DOI 10.1038/nature13453; Najafpour MM, 2016, CHEM REV, V116, P2886, DOI 10.1021/acs.chemrev.5b00340; Nakamura S, 2015, BIOCHEMISTRY-US, V54, P5045, DOI 10.1021/acs.biochem.5b00568; Nakane T, 2016, J APPL CRYSTALLOGR, V49, P1035, DOI 10.1107/S1600576716005720; Nango E, 2016, SCIENCE, V354, P1552, DOI 10.1126/science.aah3497; Noguchi T, 2002, BIOCHEMISTRY-US, V41, P2322, DOI 10.1021/bi011954k; Noguchi T, 2001, BIOCHEMISTRY-US, V40, P1497, DOI 10.1021/bi0023807; Perez-Navarro M, 2016, CURR OPIN CHEM BIOL, V31, P113, DOI 10.1016/j.cbpa.2016.02.007; Rapatskiy L, 2012, J AM CHEM SOC, V134, P16619, DOI 10.1021/ja3053267; Saito K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9488; Saito K, 2013, P NATL ACAD SCI USA, V110, P7690, DOI 10.1073/pnas.1300817110; Shen JR, 2015, ANNU REV PLANT BIOL, V66, P23, DOI 10.1146/annurev-arplant-050312-120129; SHEN JR, 1993, BIOCHEMISTRY-US, V32, P1825, DOI 10.1021/bi00058a017; Shen JR, 2000, BIOCHEMISTRY-US, V39, P14739, DOI 10.1021/bi001402m; Shevela D, 2012, BBA-BIOENERGETICS, V1817, P1134, DOI 10.1016/j.bbabio.2012.04.003; Shoji M, 2015, CHEM PHYS LETT, V636, P172, DOI 10.1016/j.cplett.2015.07.039; Siegbahn PEM, 2013, BBA-BIOENERGETICS, V1827, P1003, DOI 10.1016/j.bbabio.2012.10.006; Siegbahn PEM, 2009, ACCOUNTS CHEM RES, V42, P1871, DOI 10.1021/ar900117k; Siegbahn PEM, 2008, CHEM-EUR J, V14, P8290, DOI 10.1002/chem.200800445; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Sugahara M, 2015, NAT METHODS, V12, P61, DOI [10.1038/nmeth.3172, 10.1038/NMETH.3172]; Suzuki H, 2005, BIOCHEMISTRY-US, V44, P1708, DOI 10.1021/bi0483312; Suzuki H, 2009, J AM CHEM SOC, V131, P7849, DOI 10.1021/ja901696m; Takaoka T, 2016, J PHYS CHEM LETT, V7, P1925, DOI 10.1021/acs.jpclett.6b00656; Tono K, 2015, J SYNCHROTRON RADIAT, V22, P532, DOI 10.1107/S1600577515004464; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; White TA, 2012, J APPL CRYSTALLOGR, V45, P335, DOI 10.1107/S0021889812002312; Yamanaka S, 2011, CHEM PHYS LETT, V511, P138, DOI 10.1016/j.cplett.2011.06.021; Yano J, 2014, CHEM REV, V114, P4175, DOI 10.1021/cr4004874; Young ID, 2016, NATURE, V540, P453, DOI 10.1038/nature20161	45	392	397	16	450	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					131	+		10.1038/nature21400	http://dx.doi.org/10.1038/nature21400			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0AA	28219079	Green Submitted			2022-12-28	WOS:000395671500047
J	Strauss, M				Strauss, Mark			Planet Earth to get a daily selfie	SCIENCE			English	News Item																			0	13	13	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					782	783		10.1126/science.355.6327.782	http://dx.doi.org/10.1126/science.355.6327.782			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28232529				2022-12-28	WOS:000395127600011
J	Rubio, MAT; Gaston, KW; McKenney, KM; Fleming, IMC; Paris, Z; Limbach, PA; Alfonzo, JD				Rubio, Mary Anne T.; Gaston, Kirk W.; McKenney, Katherine M.; Fleming, Ian M. C.; Paris, Zdenek; Limbach, Patrick A.; Alfonzo, Juan D.			Editing and methylation at a single site by functionally interdependent activities	NATURE			English	Article							ENCODED TRANSFER-RNAS; LEISHMANIA-TARENTOLAE; TRYPANOSOMA-BRUCEI; DNA DEAMINATION; ANTICODON LOOP; MITOCHONDRIA; MARSUPIALS; DISCOVERY	Nucleic acids undergo naturally occurring chemical modifications. Over 100 different modifications have been described and every position in the purine and pyrimidine bases can be modified; often the sugar is also modified(1). Despite recent progress, the mechanism for the biosynthesis of most modifications is not fully understood, owing, in part, to the difficulty associated with reconstituting enzyme activity in vitro. Whereas some modifications can be efficiently formed with purified components, others may require more intricate pathways(2). A model for modification interdependence, in which one modification is a prerequisite for another, potentially explains a major hindrance in reconstituting enzymatic activity in vitro(3). This model was prompted by the earlier discovery of tRNA cytosine-to-uridine editing in eukaryotes, a reaction that has not been recapitulated in vitro and the mechanism of which remains unknown. Here we show that cytosine 32 in the anticodon loop of Trypanosoma brucei tRNA(Thr) is methylated to 3-methylcytosine (m(3)C) as a pre-requisite for C-to-U deamination. Formation of m(3)C in vitro requires the presence of both the T. brucei m(3)C methyltransferase TRM140 and the deaminase ADAT2/3. Once formed, m(3)C is deaminated to 3-methyluridine (m3U) by the same set of enzymes. ADAT2/3 is a highly mutagenic enzyme(4), but we also show that when co-expressed with the methyltransferase its mutagenicity is kept in check. This helps to explain how T. brucei escapes 'wholesale deamination'(5) of its genome while harbouring both enzymes in the nucleus. This observation has implications for the control of another mutagenic deaminase, human AID, and provides a rationale for its regulation.	[Rubio, Mary Anne T.; Gaston, Kirk W.; McKenney, Katherine M.; Fleming, Ian M. C.; Paris, Zdenek; Alfonzo, Juan D.] Ohio State Univ, Dept Microbiol, Ohio State Biochem Program, Columbus, OH 43210 USA; [Rubio, Mary Anne T.; Gaston, Kirk W.; McKenney, Katherine M.; Fleming, Ian M. C.; Paris, Zdenek; Alfonzo, Juan D.] Ohio State Univ, Dept Microbiol, Ctr RNA Biol, Columbus, OH 43210 USA; [Gaston, Kirk W.; Limbach, Patrick A.] Univ Cincinnati, Dept Chem, Rieveschl Labs Mass Spectrometry, Cincinnati, OH 45221 USA; [Paris, Zdenek] Univ South Bohemia, Inst Parasitol, Ctr Biol, Ceske Budejovice 37005, Czech Republic; [Paris, Zdenek] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; University of Cincinnati; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice	Alfonzo, JD (corresponding author), Ohio State Univ, Dept Microbiol, Ohio State Biochem Program, Columbus, OH 43210 USA.; Alfonzo, JD (corresponding author), Ohio State Univ, Dept Microbiol, Ctr RNA Biol, Columbus, OH 43210 USA.	Alfonzo.1@osu.edu	Paris, Zdenek/G-7349-2014	Paris, Zdenek/0000-0003-1019-7719	NIH [GM084065, GM058843]; Czech Science Foundation [15-21450Y]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084065, R01GM058843, R56GM058843] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Czech Science Foundation(Grant Agency of the Czech Republic); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was funded by NIH grants GM084065 to J.D.A. and GM058843 to P.A.L. and a Czech Science Foundation (15-21450Y) grant to Z.P. We thank V. Gopalan, J. Rinehart and D. Schoenberg for comments and suggestions on the manuscript.	Alfonzo JD, 1999, EMBO J, V18, P7056, DOI 10.1093/emboj/18.24.7056; Borner GV, 1996, EMBO J, V15, P5949, DOI 10.1002/j.1460-2075.1996.tb00981.x; Carter Jr C. W., 1998, MODIFICATION EDITING, P363; Crain PF, 2002, RNA, V8, P752, DOI 10.1017/S1355838202022045; Fleming IMC, 2016, SCI REP-UK, V6, DOI 10.1038/srep21438; Gaston KW, 2007, NUCLEIC ACIDS RES, V35, P6740, DOI 10.1093/nar/gkm745; Helm M, 2014, CHEM BIOL, V21, P174, DOI 10.1016/j.chembiol.2013.10.015; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kapushoc ST, 2000, J BIOL CHEM, V275, P37907, DOI 10.1074/jbc.M007838200; Kapushoc ST, 2002, RNA, V8, P57, DOI 10.1017/S1355838202012281; LONERGAN KM, 1993, SCIENCE, V259, P812, DOI 10.1126/science.8430334; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; MORL M, 1995, NUCLEIC ACIDS RES, V23, P3380, DOI 10.1093/nar/23.17.3380; Petersen-Mahrt S, 2005, IMMUNOL REV, V203, P80, DOI 10.1111/j.0105-2896.2005.00232.x; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Randau L, 2009, SCIENCE, V324, P657, DOI 10.1126/science.1170123; RANDERATH K, 1975, BIOCHEM BIOPH RES CO, V63, P157, DOI 10.1016/S0006-291X(75)80024-6; Ross R, 2016, METHODS, V107, P73, DOI 10.1016/j.ymeth.2016.03.016; Rubio MAT, 2007, P NATL ACAD SCI USA, V104, P7821, DOI 10.1073/pnas.0702394104; Rubio MAT, 2006, J BIOL CHEM, V281, P115, DOI 10.1074/jbc.M510136200; Sample PJ, 2015, NUCLEIC ACIDS RES, V43, P4262, DOI 10.1093/nar/gkv286; Spears JL, 2011, METHODS MOL BIOL, V718, P209, DOI 10.1007/978-1-61779-018-8_13; Teng G, 2007, ANNU REV GENET, V41, P107, DOI 10.1146/annurev.genet.41.110306.130340; Zhou WB, 2014, PLANT PHYSIOL, V166, P1985, DOI 10.1104/pp.114.250498	24	44	44	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2017	542	7642					494	+		10.1038/nature21396	http://dx.doi.org/10.1038/nature21396			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM1RG	28230119	Green Accepted			2022-12-28	WOS:000395094100040
J	Zhou, YH; Zheng, MH				Zhou, Yong-Hai; Zheng, Ming-Hua			SPOT DIAGNOSIS Abnormality in a fetus on ultrasound	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Zhou, Yong-Hai] Wenzhou Med Univ, Affiliated Hosp 2, Dept Pediat, Wenzhou, Zhejiang, Peoples R China; [Zhou, Yong-Hai] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China; [Zheng, Ming-Hua] Wenzhou Med Univ, Affiliated Hosp 1, Liver Res Ctr, Dept Hepatol, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Zheng, MH (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Liver Res Ctr, Dept Hepatol, Wenzhou, Zhejiang, Peoples R China.	zhengmh@wmu.edu.cn	Zheng, Ming-Hua/H-5584-2019	Zheng, Ming-Hua/0000-0003-4984-2631				Persson EK, 2007, CHILD NERV SYST, V23, P1111, DOI 10.1007/s00381-007-0324-7; Wyldes M, 2004, ARCH DIS CHILD-FETAL, V89, pF9, DOI 10.1136/fn.89.1.F9	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2017	356								j688	10.1136/bmj.j688	http://dx.doi.org/10.1136/bmj.j688			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KY	28232322				2022-12-28	WOS:000395631700002
J	Fouin, P; Williams, M				Fouin, Pierre; Williams, Michael			Gavin Beddie Taylor OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2017	356								j873	10.1136/bmj.j873	http://dx.doi.org/10.1136/bmj.j873			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KQ	28223267				2022-12-28	WOS:000395630800009
J	Kuppers, M				Kueppers, Michael			Dwarf planet Ceres and the ingredients of life	SCIENCE			English	Editorial Material							WATER-ICE; SOURCE REGIONS; ORGANICS; SURFACE; EARTH		[Kueppers, Michael] European Space Agcy, European Space Astron Ctr, Camino Bajo Castillo S-N, Madrid, Spain	European Space Agency	Kuppers, M (corresponding author), European Space Agcy, European Space Astron Ctr, Camino Bajo Castillo S-N, Madrid, Spain.	michael.kueppers@sciops.esa.int						Altwegg K, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600285; Campins H, 2010, NATURE, V464, P1320, DOI 10.1038/nature09029; Capaccioni F, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0628; Combes J.-P., 2016, SCIENCE, V353; De Sanctis MC, 2017, SCIENCE, V355, P719, DOI 10.1126/science.aaj2305; Drake MJ, 2002, NATURE, V416, P39, DOI 10.1038/416039a; Jewitt D, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/3/66; Kuppers M, 2014, NATURE, V505, P525, DOI 10.1038/nature12918; Licandro J, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201015339; McCord TB, 2011, SPACE SCI REV, V163, P63, DOI 10.1007/s11214-010-9729-9; Platz T., 2016, NATURE, V1; Prettyman TH, 2017, SCIENCE, V355, P55, DOI 10.1126/science.aah6765; Rivkin AS, 2010, NATURE, V464, P1322, DOI 10.1038/nature09028; Walsh KJ, 2012, METEORIT PLANET SCI, V47, P1941, DOI 10.1111/j.1945-5100.2012.01418.x	16	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					692	693		10.1126/science.aal4765	http://dx.doi.org/10.1126/science.aal4765			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2AC	28209859				2022-12-28	WOS:000395117700021
J	Schauer, PR; Bhatt, DL; Kirwan, JP; Wolski, K; Aminian, A; Brethauer, SA; Navaneethan, SD; Singh, RP; Pothier, CE; Nissen, SE; Kashyap, SR				Schauer, Philip R.; Bhatt, Deepak L.; Kirwan, John P.; Wolski, Kathy; Aminian, Ali; Brethauer, Stacy A.; Navaneethan, Sankar D.; Singh, Rishi P.; Pothier, Claire E.; Nissen, Steven E.; Kashyap, Sangeeta R.		STAMPEDE Investigators	Bariatric Surgery versus Intensive Medical Therapy for Diabetes-5-Year Outcomes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							Y GASTRIC BYPASS; LIFE-STYLE; OBESE-PATIENTS; TYPE-2; MANAGEMENT; MELLITUS; TRIAL; INTERVENTION; ASSOCIATION; REMISSION	BACKGROUND Long-term results from randomized, controlled trials that compare medical therapy with surgical therapy in patients with type 2 diabetes are limited. METHODS We assessed outcomes 5 years after 150 patients who had type 2 diabetes and a bodymass index (BMI; the weight in kilograms divided by the square of the height in meters) of 27 to 43 were randomly assigned to receive intensive medical therapy alone or intensive medical therapy plus Roux-en-Y gastric bypass or sleeve gastrectomy. The primary outcome was a glycated hemoglobin level of 6.0% or less with or without the use of diabetes medications. RESULTS Of the 150 patients who underwent randomization, 1 patient died during the 5-year follow-up period; 134 of the remaining 149 patients (90%) completed 5 years of followup. At baseline, the mean (+/- SD) age of the 134 patients was 49 +/- 8 years, 66% were women, the mean glycated hemoglobin level was 9.2 +/- 1.5%, and the mean BMI was 37 +/- 3.5. At 5 years, the criterion for the primary end point was met by 2 of 38 patients (5%) who received medical therapy alone, as compared with 14 of 49 patients (29%) who underwent gastric bypass (unadjusted P =0.01, adjusted P =0.03, P =0.08 in the intentionto-treat analysis) and 11 of 47 patients (23%) who underwent sleeve gastrectomy (unadjusted P =0.03, adjusted P =0.07, P =0.17 in the intention-to-treat analysis). Patients who underwent surgical procedures had a greater mean percentage reduction from baseline in glycated hemoglobin level than did patients who received medical therapy alone (2.1% vs. 0.3%, P =0.003). At 5 years, changes from baseline observed in the gastric-bypass and sleeve-gastrectomy groups were superior to the changes seen in the medical-therapy group with respect to body weight (-23%, -19%, and -5% in the gastric-bypass, sleevegastrectomy, and medical-therapy groups, respectively), triglyceride level (-40%, -29%, and -8%), high-density lipoprotein cholesterol level (32%, 30%, and 7%), use of insulin (-35%, -34%, and -13%), and quality-of-life measures (general health score increases of 17, 16, and 0.3; scores on the RAND 36-Item Health Survey ranged from 0 to 100, with higher scores indicating better health) (P< 0.05 for all comparisons). No major late surgical complications were reported except for one reoperation. CONCLUSIONS Five-year outcome data showed that, among patients with type 2 diabetes and a BMI of 27 to 43, bariatric surgery plus intensive medical therapy was more effective than intensive medical therapy alone in decreasing, or in some cases resolving, hyperglycemia.	[Schauer, Philip R.; Aminian, Ali; Brethauer, Stacy A.] Cleveland Clin, Bariatr & Metab Inst, M61,9500 Euclid Ave, Cleveland, OH 44195 USA; [Kirwan, John P.] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA; [Wolski, Kathy; Pothier, Claire E.; Nissen, Steven E.] Cleveland Clin, Cleveland Clin Coordinating Ctr Clin Res, Cleveland, OH 44106 USA; [Singh, Rishi P.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA; [Kashyap, Sangeeta R.] Cleveland Clin, Inst Endocrinol, Cleveland, OH 44106 USA; [Bhatt, Deepak L.] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Med Sch, Boston, MA USA; [Navaneethan, Sankar D.] Baylor Coll Med, Nephrol Sect, Houston, TX 77030 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Baylor College of Medicine	Schauer, PR (corresponding author), Cleveland Clin, Bariatr & Metab Inst, M61,9500 Euclid Ave, Cleveland, OH 44195 USA.	schauep@ccf.org	Kirwan, John P/G-6942-2012	Kashyap, Sangeeta/0000-0002-7489-6650; Schauer, Philip/0000-0002-4029-7537	Ethicon Endo-Surgery [NCT00432809]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089547] Funding Source: NIH RePORTER	Ethicon Endo-Surgery; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by Ethicon Endo-Surgery and others; STAMPEDE ClinicalTrials. gov number, NCT00432809.	Arterburn DE, 2015, JAMA-J AM MED ASSOC, V313, P62, DOI 10.1001/jama.2014.16968; Brethauer SA, 2013, ANN SURG, V258, P628, DOI 10.1097/SLA.0b013e3182a5034b; Courcoulas AP, 2015, JAMA SURG, V150, P931, DOI 10.1001/jamasurg.2015.1534; Cummings DE, 2016, DIABETOLOGIA, V59, P945, DOI 10.1007/s00125-016-3903-x; Diabet Contr Complicat Trial Res Grp, 1998, ARCH OPHTHALMOL-CHIC, V116, P874; Ding SA, 2015, J CLIN ENDOCR METAB, V100, P2546, DOI 10.1210/jc.2015-1443; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Halperin F, 2014, JAMA SURG, V149, P716, DOI 10.1001/jamasurg.2014.514; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Ikramuddin S, 2015, LANCET DIABETES ENDO, V3, P413, DOI 10.1016/S2213-8587(15)00089-3; Kashyap SR, 2013, DIABETES CARE, V36, P2175, DOI 10.2337/dc12-1596; Kashyap SR, 2010, DIABETES OBES METAB, V12, P452, DOI 10.1111/j.1463-1326.2009.01172.x; Kolandaivelu K, 2014, EUR HEART J, V35, P3267, DOI 10.1093/eurheartj/ehu364; Liang ZW, 2013, DIABETES RES CLIN PR, V101, P50, DOI 10.1016/j.diabres.2013.04.005; Mingrone G, 2015, LANCET, V386, P964, DOI 10.1016/S0140-6736(15)00075-6; Parikh M, 2014, ANN SURG, V260, P617, DOI 10.1097/SLA.0000000000000919; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Schauer PR, 2014, NEW ENGL J MED, V370, P2002, DOI [10.1056/NEJMoa1401329, 10.1056/NEJMc1407393]; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Singh RP, 2015, DIABETES CARE, V38, pE32, DOI 10.2337/dc14-2035; Sjostrom L, 2014, JAMA-J AM MED ASSOC, V311, P2297, DOI 10.1001/jama.2014.5988; Vest AR, 2012, HEART, V98, P1763, DOI 10.1136/heartjnl-2012-301778; Wentworth JM, 2014, LANCET DIABETES ENDO, V2, P545, DOI 10.1016/S2213-8587(14)70066-X	24	1346	1387	7	157	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2017	376	7					641	651		10.1056/NEJMoa1600869	http://dx.doi.org/10.1056/NEJMoa1600869			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO0QJ	28199805	Green Accepted			2022-12-28	WOS:000396402700015
J	[Anonymous]				[Anonymous]			Seven days in medicine: 8-14 February 2017	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2017	356								j802	10.1136/bmj.j802	http://dx.doi.org/10.1136/bmj.j802			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GN	28209573				2022-12-28	WOS:000394579800005
J	Crum, AJ; Leibowitz, KA; Verghese, A				Crum, Alia J.; Leibowitz, Kari A.; Verghese, Abraham			Making mindset matter	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							STRESS		[Crum, Alia J.] Stanford Univ, Psychol, Stanford, CA 94305 USA; [Leibowitz, Kari A.] Stanford Univ, Stanford, CA 94305 USA; [Verghese, Abraham] Stanford Univ, Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Crum, AJ (corresponding author), Stanford Univ, Psychol, Stanford, CA 94305 USA.	crum@stanford.edu						Amanzio M, 2009, PAIN, V146, P261, DOI 10.1016/j.pain.2009.07.010; Benedetti F, 2003, PREV TREAT, P356, DOI [10.1037/1522-3736.6.1.61a, DOI 10.1037/1522-3736.6.1.61A.]; Colloca L, 2012, JAMA-J AM MED ASSOC, V307, P567, DOI 10.1001/jama.2012.115; Crum AJ, 2007, PSYCHOL SCI, V18, P165, DOI 10.1111/j.1467-9280.2007.01867.x; Crum AJ, 2013, J PERS SOC PSYCHOL, V104, P716, DOI 10.1037/a0031201; Crum AJ, 2011, HEALTH PSYCHOL, V30, P424, DOI 10.1037/a0023467; Del Canale S, 2012, ACAD MED, V87, P1243, DOI 10.1097/ACM.0b013e3182628fbf; Elder A, 2013, JAMA-J AM MED ASSOC, V310, P799, DOI 10.1001/jama.2013.227195; Espay AJ, 2015, NEUROLOGY, V84, P794, DOI 10.1212/WNL.0000000000001282; Finkelstein SR, 2010, J CONSUM RES, V37, P357, DOI 10.1086/652248; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Hojat M, 2011, ACAD MED, V86, P359, DOI 10.1097/ACM.0b013e3182086fe1; Kam-Hansen S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006175; Keller A, 2012, HEALTH PSYCHOL, V31, P677, DOI 10.1037/a0026743; Manios ED, 2008, AM J HYPERTENS, V21, P153, DOI 10.1038/ajh.2007.43; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Rakel DP, 2009, FAM MED, V41, P494; Verghese A, 2015, AM J MED, V128, P1322, DOI 10.1016/j.amjmed.2015.06.004; Verghese A, 2011, ANN INTERN MED, V155, P550, DOI 10.7326/0003-4819-155-8-201110180-00013	19	33	33	3	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	2017	356								j674	10.1136/bmj.j674	http://dx.doi.org/10.1136/bmj.j674			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL4GM	28202443				2022-12-28	WOS:000394579700004
J	Young, K				Young, Kelly			PATIENT COMMENTARY US opioid epidemic: it's harder to get the painkillers I legitimately need	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Young, Kelly] Rheumatoid Patient Fdn, Cocoa, FL 32923 USA		Young, K (corresponding author), Rheumatoid Patient Fdn, Cocoa, FL 32923 USA.	kelly@rawarrior.com						Johnson H, 2014, MMWR-MORBID MORTAL W, V356, P569	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	2017	356								j784	10.1136/bmj.j784	http://dx.doi.org/10.1136/bmj.j784			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GM	28202464				2022-12-28	WOS:000394579700009
J	Torjesen, I				Torjesen, Ingrid			Participants in women's health intervention trials show improved health outcomes	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Nijjar SK, 2017, BJOG-INT J OBSTET GY, V124, P863, DOI 10.1111/1471-0528.14528	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2017	356								j778	10.1136/bmj.j778	http://dx.doi.org/10.1136/bmj.j778			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GL	28196795				2022-12-28	WOS:000394579600008
J	Cantalapiedra, JL; Prado, JL; Fernandez, MH; Alberdi, MT				Cantalapiedra, J. L.; Prado, J. L.; Hernandez Fernandez, M.; Alberdi, M. T.			Decoupled ecomorphological evolution and diversification in Neogene-Quaternary horses	SCIENCE			English	Article							ADAPTIVE RADIATION; BODY-SIZE; DIVERSITY; EXTINCTION; DISPARITY; EQUINAE; RATES	Evolutionary theory has long proposed a connection between trait evolution and diversification rates. In this work, we used phylogenetic methods to evaluate the relationship of lineage-specific speciation rates and the mode of evolution of body size and tooth morphology in the Neogene and Quaternary radiation of horses (7 living and 131 extinct species). We show that diversification pulses are a recurrent feature of equid evolution but that these pulses are not correlated with rapid bursts in phenotypic evolution. Instead, rapid cladogenesis seems repeatedly associated with extrinsic factors that relaxed diversity bounds, such as increasing productivity and geographic dispersals into the Old World. This evidence suggests that diversity dynamics in Equinae were controlled mainly by ecological limits under diversity dependence rather than rapid ecomorphological differentiation.	[Cantalapiedra, J. L.] Leibniz Inst Evolut & Biodiversitatsforsch, Museum Naturkunde, Invalidenstr 43, D-10115 Berlin, Germany; [Cantalapiedra, J. L.; Alberdi, M. T.] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, Jose Gutierrez Abascal 2, E-28006 Madrid, Spain; [Prado, J. L.] Univ Nacl Ctr Prov Buenos Aires UNICEN, Inst Invest Arqueol & Paleontol Cuaternario Pampe, CONICET, Del Valle 5737,B7400JWI, Buenos Aires, DF, Argentina; [Hernandez Fernandez, M.] Univ Complutense Madrid, Dept Palaeontol, Fac Ciencias Geol, Jose Antonio Novais 2, E-28040 Madrid, Spain; [Hernandez Fernandez, M.] UCM, Dept Cambio Medioambiental, Inst Geociencias, CSIC, Jose Antonio Novais 2, Madrid 28040, Spain	Leibniz Institut fur Evolutions und Biodiversitatsforschung; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Complutense University of Madrid; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UCM - Instituto de Geociencias (IGEO)	Cantalapiedra, JL (corresponding author), Leibniz Inst Evolut & Biodiversitatsforsch, Museum Naturkunde, Invalidenstr 43, D-10115 Berlin, Germany.; Cantalapiedra, JL (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, Jose Gutierrez Abascal 2, E-28006 Madrid, Spain.	jlopezcant@gmail.com	Prado, Jose Luis/N-2001-2019; Alberdi, Maria Teresa/ABG-8623-2020; Cantalapiedra, Juan L/L-2135-2014; Fernández, Manuel Hernández/I-5012-2013	Prado, Jose Luis/0000-0003-0579-8747; Alberdi, Maria Teresa/0000-0002-7071-360X; Cantalapiedra, Juan L/0000-0003-0913-7735; Fernández, Manuel Hernández/0000-0001-5640-9647	Humboldt Foundation (Germany); Spanish government [CGL2010-19116/BOS, CGL 2015-68333P, AECID A/030111/10, ANPCYT-PICT-11-0561, FONCYT PICT 2015-1512]; Argentinian government [CGL2010-19116/BOS, CGL 2015-68333P, AECID A/030111/10, ANPCYT-PICT-11-0561, FONCYT PICT 2015-1512]	Humboldt Foundation (Germany)(Alexander von Humboldt Foundation); Spanish government(Spanish GovernmentEuropean Commission); Argentinian government	Data are available in the supplementary materials. This work was supported by the Humboldt Foundation (Germany) and the Spanish and Argentinian governments (projects CGL2010-19116/BOS, CGL2015-68333P, AECID A/030111/10, ANPCYT-PICT-11-0561, and FONCYT PICT 2015-1512). We thank F. Bibi, J. Muller, M. Fortelius, J. Saarinen, and three anonymous reviewers for comments. We acknowledge technical assistance from J. M. Beaulieu, G. Slater, D. W. Bapst, N. J. Matzke, J. Uyeda, L. Harmon, and W. Gearty.	Badgley C, 2016, CR PALEVOL, V15, P763, DOI 10.1016/j.crpv.2015.09.004; Bapst DW, 2012, P NATL ACAD SCI USA, V109, P3428, DOI 10.1073/pnas.1113870109; Damuth J, 2011, BIOL REV, V86, P733, DOI 10.1111/j.1469-185X.2011.00176.x; Eronen JT, 2012, GEOLOGY, V40, P823, DOI 10.1130/G33147.1; FOOTE M, 1991, PALAEONTOLOGY, V34, P461; Forsten A., 1991, QUATERN INT, V19, P71; Fritz SA, 2016, P NATL ACAD SCI USA, V113, P10908, DOI 10.1073/pnas.1602145113; Guthrie RD, 2003, NATURE, V426, P169, DOI 10.1038/nature02098; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; Harmon LJ, 2010, EVOLUTION, V64, P2385, DOI 10.1111/j.1558-5646.2010.01025.x; Hopkins MJ, 2015, P NATL ACAD SCI USA, V112, P3758, DOI 10.1073/pnas.1418153112; HULBERT RC, 1993, PALEOBIOLOGY, V19, P216, DOI 10.1017/S0094837300015888; Lister AM, 2013, NATURE, V500, P331, DOI 10.1038/nature12275; MacFadden B.J., 1992, FOSSIL HORSES SYSTEM; MACFADDEN BJ, 1988, BIOL J LINN SOC, V35, P37, DOI 10.1111/j.1095-8312.1988.tb00457.x; MACFADDEN BJ, 1988, NATURE, V336, P466, DOI 10.1038/336466a0; Maguire KC, 2008, PALAEOGEOGR PALAEOCL, V267, P175, DOI 10.1016/j.palaeo.2008.06.014; Marsh C.O., 1879, AM J SCI, V17, P499, DOI [10.2475/ajs.s3-17.102.499, DOI 10.2475/AJS.S3-17.102.499]; Marshall CR, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0217; Moen D, 2014, TRENDS ECOL EVOL, V29, P190, DOI 10.1016/j.tree.2014.01.010; Pires MM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1952; Semprebon GM, 2016, PALAEOGEOGR PALAEOCL, V442, P110, DOI 10.1016/j.palaeo.2015.11.004; Shoemaker L, 2014, ECOL LETT, V17, P211, DOI 10.1111/ele.12221; Simoes M, 2016, TRENDS ECOL EVOL, V31, P27, DOI 10.1016/j.tree.2015.10.007; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Slater GJ, 2012, EVOLUTION, V66, P3931, DOI 10.1111/j.1558-5646.2012.01723.x; Slater GJ, 2010, P ROY SOC B-BIOL SCI, V277, P3097, DOI 10.1098/rspb.2010.0408; Stromberg CAE, 2011, ANNU REV EARTH PL SC, V39, P517, DOI 10.1146/annurev-earth-040809-152402; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P24	29	56	56	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					627	629		10.1126/science.aag1772	http://dx.doi.org/10.1126/science.aag1772			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK0SF	28183978	Green Submitted			2022-12-28	WOS:000393636700048
J	Derworiz, C				Derworiz, Colette			Why are grizzlies dying on Canada's railway tracks?	SCIENCE			English	News Item									[Derworiz, Colette] Banff Natl Pk, Calgary, AB, Canada		Derworiz, C (corresponding author), Banff Natl Pk, Calgary, AB, Canada.								0	0	0	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					561	561		10.1126/science.355.6325.561	http://dx.doi.org/10.1126/science.355.6325.561			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK0SF	28183922				2022-12-28	WOS:000393636700013
J	Glisovic, P; Forte, AM				Glisovic, Petar; Forte, Alessandro M.			On the deep-mantle origin of the Deccan Traps	SCIENCE			English	Article							PLUME DYNAMICS; FLOOD BASALTS; VOLCANISM; BOUNDARY; DRIVEN; CONVECTION; GENERATION; BENEATH; OCEAN; AGES	The Deccan Traps in west-central India constitute one of Earth's largest continental flood basalt provinces, whose eruption played a role in the Cretaceous-Paleogene extinction event. The unknown mantle structure under the Indian Ocean at the start of the Cenozoic presents a challenge for connecting the event to a deep mantle origin. We used a back-and-forth iterative method for time-reversed convection modeling, which incorporates tomography-based, present-day mantle heterogeneity to reconstruct mantle structure at the start of the Cenozoic. We show a very low-density, deep-seated upwelling that ascends beneath the Reunion hot spot at the time of the Deccan eruptions. We found a second active upwelling below the Comores hot spot that likely contributed to the region of partial melt feeding the massive eruption.	[Glisovic, Petar; Forte, Alessandro M.] Univ Quebec, Geotop, Montreal, PQ H3C 3P8, Canada; [Forte, Alessandro M.] Univ Florida, Dept Geol Sci, Gainesville, FL 32603 USA	University of Quebec; University of Quebec Montreal; State University System of Florida; University of Florida	Glisovic, P (corresponding author), Univ Quebec, Geotop, Montreal, PQ H3C 3P8, Canada.	glisovic.petar@uqam.ca	; Glisovic, Petar/D-5971-2014	Forte, Alessandro/0000-0002-3530-0455; Glisovic, Petar/0000-0001-5636-7731	Natural Sciences and Engineering Research Council of Canada; University of Florida	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Florida(University of Florida)	The authors acknowledge the support of this work provided by the Natural Sciences and Engineering Research Council of Canada. A.M.F. acknowledges the additional support provided by the University of Florida. We thank D. Rowley for his reconstructions of the Cenozoic plate boundaries and for the discussions regarding the plate kinematic constraints over this time period. We also thank S. Zahirovic for providing us with plate configuration files generated with Gplates software. The authors are grateful to N. Simmons and S. Grand for the collaboration that resulted in the global tomography model used in this study. Additional thanks to N. Simmons for the schematic in fig. S3. The convection simulations in this study were carried out thanks to supercomputing facilities of Calcul Quebec consortia at Universite de Montreal. P.G. and A.M.F. both developed the scientific concepts and modeling techniques presented here and jointly wrote the paper. P.G. created the figures. All data needed to evaluate the conclusions are presented in the paper and supplementary materials. Additional data related to this paper may be requested from the authors.	Bardintzeff JM, 2010, GONDWANA RES, V18, P295, DOI 10.1016/j.gr.2009.11.010; Becker TW, 2011, EARTH PLANET SC LETT, V310, P453, DOI 10.1016/j.epsl.2011.08.021; Cande SC, 2011, NATURE, V475, P47, DOI 10.1038/nature10174; Chenet AL, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005644; Class C, 1998, J PETROL, V39, P881, DOI 10.1093/petrology/39.5.881; COURTILLOT V, 1986, EARTH PLANET SC LETT, V80, P361, DOI 10.1016/0012-821X(86)90118-4; EMERICK CM, 1982, EARTH PLANET SC LETT, V60, P415, DOI 10.1016/0012-821X(82)90077-2; Fontaine FR, 2015, GEOPHYS J INT, V203, P107, DOI 10.1093/gji/ggv279; Forte A.M., 2015, TREATISE GEOPHYS, V1, P853, DOI [10.1016/B978-0-444-53802-4.00028-2, DOI 10.1016/B978-0-444-53802-4.00028-2]; Ganerod M, 2011, GEOL SOC SPEC PUBL, V357, P229, DOI 10.1144/SP357.12; Glisovic P, 2012, GEOPHYS J INT, V190, P785, DOI 10.1111/j.1365-246X.2012.05549.x; Glisovic P, 2016, J GEOPHYS RES-SOL EA, V121, P4067, DOI 10.1002/2016JB012841; Glisovic P, 2014, EARTH PLANET SC LETT, V390, P146, DOI 10.1016/j.epsl.2014.01.010; Hirschmann MM, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000070; Keller G, 2012, EARTH LIFE, P759, DOI [10.1007/978-90-481-3428-1_25, DOI 10.1007/978-90-481-3428-1_25]; Malfait WJ, 2014, NAT GEOSCI, V7, P122, DOI [10.1038/ngeo2042, 10.1038/NGEO2042]; Moucha R, 2011, NAT GEOSCI, V4, P707, DOI [10.1038/ngeo1235, 10.1038/NGEO1235]; Parisio L, 2016, J GEOL SOC LONDON, V173, P679, DOI 10.1144/jgs2015-133; Renne PR, 2015, SCIENCE, V350, P76, DOI 10.1126/science.aac7549; Rowley DB, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601107; Schoene B, 2015, SCIENCE, V347, P182, DOI 10.1126/science.aaa0118; Sen G, 2011, TOPICS IN IGNEOUS PETROLOGY: A TRIBUTE TO PROFESSOR MIHIR K. BOSE, P29, DOI 10.1007/978-90-481-9600-5_2; Sheth HC, 2001, GEOPHYS RES LETT, V28, P3513, DOI 10.1029/2001GL012921; Sheth HC, 2005, GEOL SOC AM SPEC PAP, V388, DOI 10.1130/2005.2388(29); Simmons NA, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007631; Torsvik TH, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000227; van Hinsbergen DJJ, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008051; WHITE R, 1989, J GEOPHYS RES-SOLID, V94, P7685, DOI 10.1029/JB094iB06p07685; Zhao DP, 2007, GONDWANA RES, V12, P335, DOI 10.1016/j.gr.2007.03.001	29	31	33	3	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					613	+		10.1126/science.aah4390	http://dx.doi.org/10.1126/science.aah4390			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK0SF	28183974				2022-12-28	WOS:000393636700044
J	Malakoff, D				Malakoff, David			Putting the brakes on highway deaths	SCIENCE			English	Editorial Material																			0	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					569	569		10.1126/science.355.6325.569	http://dx.doi.org/10.1126/science.355.6325.569			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK0SF	28183928				2022-12-28	WOS:000393636700019
J	Malakoff, D				Malakoff, David			A simple recipe for saving lives	SCIENCE			English	Editorial Material																			0	2	2	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					571	571		10.1126/science.355.6325.571	http://dx.doi.org/10.1126/science.355.6325.571			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK0SF	28183929				2022-12-28	WOS:000393636700020
J	Buntin, MB; Ayanian, JZ				Buntin, Melinda B.; Ayanian, John Z.			Social Risk Factors and Equity in Medicare Payment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Buntin, Melinda B.] Vanderbilt Univ, Sch Med, Dept Hlth Policy, 221 Kirkland Hall, Nashville, TN 37235 USA; [Ayanian, John Z.] Univ Michigan, Inst Healthcare Policy & Innovat, Div Gen Med, Sch Med,Dept Hlth Management & Policy,Sch Publ H, Ann Arbor, MI 48109 USA; [Ayanian, John Z.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA	Vanderbilt University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Buntin, MB (corresponding author), Vanderbilt Univ, Sch Med, Dept Hlth Policy, 221 Kirkland Hall, Nashville, TN 37235 USA.							Burwell SM, 2015, NEW ENGL J MED, V372, P897, DOI 10.1056/NEJMp1500445; Department of IIealth and IIuman Services Office of the Assistant Secretary for Planning and Evaluation, 2016, REP C SOC RISK FACT; *NAT AC SCI ENG ME, 2017, ACC SOC RISK FACT ME; National Quality Forum, 2014, RISK ADJ SOC STAT OT; Taylor EF, 2009, AHRQ PUBLICATION	5	51	51	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2017	376	6					507	510		10.1056/NEJMp1700081	http://dx.doi.org/10.1056/NEJMp1700081			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ8XL	28177864				2022-12-28	WOS:000393510500002
J	Dive, C; Brady, G				Dive, Caroline; Brady, Ged			SnapShot: Circulating Tumor Cells	CELL			English	Editorial Material							LUNG-CANCER; CTCS		[Dive, Caroline; Brady, Ged] Univ Manchester, Canc Res UK Manchester Inst, Manchester M20 4BX, Lancs, England	Cancer Research UK; University of Manchester	Dive, C (corresponding author), Univ Manchester, Canc Res UK Manchester Inst, Manchester M20 4BX, Lancs, England.			Dive, Caroline/0000-0002-1726-8850	Cancer Research UK [19278, 20465] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Alberter B, 2016, EXPERT REV MOL DIAGN, V16, P25, DOI 10.1586/14737159.2016.1121099; Alix-Panabieres C, 2016, CANCER DISCOV, V6, P479, DOI 10.1158/2159-8290.CD-15-1483; Au SH, 2016, P NATL ACAD SCI USA, V113, P4947, DOI 10.1073/pnas.1524448113; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Hodgkinson CL, 2014, NAT MED, V20, P897, DOI 10.1038/nm.3600; Krebs MG, 2014, NAT REV CLIN ONCOL, V11, P129, DOI 10.1038/nrclinonc.2013.253; Maheswaran S, 2015, CANCER RES, V75, P2411, DOI 10.1158/0008-5472.CAN-15-0145; Marrinucci D, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016003; Miyamoto DT, 2015, SCIENCE, V349, P1351, DOI 10.1126/science.aab0917; Williamson SC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13322	10	47	48	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2017	168	4							742.e1	10.1016/j.cell.2017.01.026	http://dx.doi.org/10.1016/j.cell.2017.01.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8VJ	28187292	Bronze			2022-12-28	WOS:000396277600021
J	Vig, S				Vig, Stella			Stella Vig: The bare necessities-and chocolate	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2017	356								j587	10.1136/bmj.j587	http://dx.doi.org/10.1136/bmj.j587			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4FX	28179235				2022-12-28	WOS:000394578200008
J	Djulbegovic, B; Guyatt, GH				Djulbegovic, Benjamin; Guyatt, Gordon H.			Progress in evidence-based medicine: a quarter century on	LANCET			English	Review							RANDOMIZED CONTROLLED-TRIALS; CLINICAL-PRACTICE GUIDELINES; SHARED DECISION-MAKING; USERS GUIDES; QUALITY; CARE; GRADE; BIAS; RECOMMENDATIONS; STRENGTH	In response to limitations in the understanding and use of published evidence, evidence-based medicine (EBM) began as a movement in the early 1990s. EBM's initial focus was on educating clinicians in the understanding and use of published literature to optimise clinical care, including the science of systematic reviews. EBM progressed to recognise limitations of evidence alone, and has increasingly stressed the need to combine critical appraisal of the evidence with patient's values and preferences through shared decision making. In another progress, EBM incorporated and further developed the science of producing trustworthy clinical practice guidelines pioneered by investigators in the 1980s. EBM's enduring contributions to clinical medicine include placing the practice of medicine on a solid scientific basis, the development of more sophisticated hierarchies of evidence, the recognition of the crucial role of patient values and preferences in clinical decision making, and the development of the methodology for generating trustworthy recommendations.	[Djulbegovic, Benjamin] Univ S Florida, Morsani Coll Med, Program Comparat Effectiveness Res, Dept Internal Med, Tampa, FL 33612 USA; [Djulbegovic, Benjamin] Univ S Florida, Morsani Coll Med, Div Evidence Based Med, Dept Internal Med, Tampa, FL 33612 USA; [Djulbegovic, Benjamin] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Djulbegovic, Benjamin] Tampa Gen Hosp, Tampa, FL 33606 USA; [Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON, Canada	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; Tampa General Hospital; McMaster University; McMaster University	Djulbegovic, B (corresponding author), Univ S Florida, USF Hlth, Program Comparat Effectiveness Res, Tampa, FL 33612 USA.	bdjulbeg@health.usf.edu						Agoritsas T, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7624; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; ALTMAN DG, 1994, BRIT MED J, V308, P283, DOI 10.1136/bmj.308.6924.283; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; [Anonymous], 2016, MEDLINE FACT SHEET; [Anonymous], 2011, FIND WHAT WORKS HLTH; Antes G, 2003, LANCET, V361, P978, DOI 10.1016/S0140-6736(03)12838-3; Appelt KC, 2011, JUDGM DECIS MAK, V6, P252; Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Berenson RA, 2013, NEW ENGL J MED, V369, P2079, DOI 10.1056/NEJMp1312287; Carrasco-Labra A, 2014, USERS GUIDES MED LIT; Chalmers I, 2005, CLIN TRIALS, V2, P229; CHALMERS I, 1993, ANN NY ACAD SCI, V703, P156, DOI 10.1111/j.1749-6632.1993.tb26345.x; Chalmers I., 2007, TREATING INDIVIDUALS, P37; Chalmers I, 2007, J ROY SOC MED, V100, P440, DOI 10.1258/jrsm.100.10.440; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chalmers I, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f105; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Cochrane A. L, 1972, PUBLIC HEALTH, DOI DOI 10.1016/S0033-3506(73)80082-4; Dickersin Kay, 2007, BMJ, V334 Suppl 1, ps10, DOI 10.1136/bmj.39062.639444.94; Djulbegovic B, 2014, USERS GUIDES MED LIT; Djulbegovic B., 2000, EVISENCE BASES ONCOL, V1, P2; Djulbegovic B, 2014, JAMA-J AM MED ASSOC, V312, P1293, DOI 10.1001/jama.2014.10713; Djulbegovic B, 2014, J ONCOL PRACT, V10, P200, DOI 10.1200/JOP.2013.001364; Djulbegovic B, 2011, JAMA-J AM MED ASSOC, V305, P2005, DOI 10.1001/jama.2011.650; Djulbegovic B, 2009, CANCER CONTROL, V16, P158, DOI 10.1177/107327480901600208; Dowsett M, 2015, LANCET, V386, P1341, DOI 10.1016/S0140-6736(15)61074-1; Eddy D, 1980, CA Cancer J Clin, V30, P193; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P3077, DOI 10.1001/jama.263.22.3077; Eddy DM, 2005, HEALTH AFFAIR, V24, P9, DOI 10.1377/hlthaff.24.1.9; EDDY DM, 1988, HEALTH AFFAIR, V7, P19, DOI 10.1377/hlthaff.7.1.19; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P1839, DOI 10.1001/jama.263.13.1839; Elshaug AG, 2012, MED J AUSTRALIA, V197, P556, DOI 10.5694/mja12.11083; Field MJ, 1990, CLIN PRACTICE GUIDEL; Gilbert R, 2005, INT J EPIDEMIOL, V34, P874, DOI 10.1093/ije/dyi088; Goldacre B, 2016, NATURE, V530, P7, DOI 10.1038/530007a; GRADE Working Group, 2016, LIST GRADE WORK GROU; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Greenhalgh T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3725; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; Guyatt G, 2014, USERS GUIDES MED LIT; Guyatt G., 1991, ACP J CLUB A, VA-16, P114; Guyatt GH, 2000, BRIT MED J, V320, P954, DOI 10.1136/bmj.320.7240.954; GUYATT GH, 1990, ANN INTERN MED, V112, P293, DOI 10.7326/0003-4819-112-4-293; GUYATT GH, 1995, JAMA-J AM MED ASSOC, V274, P1800, DOI 10.1001/jama.274.22.1800; Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290; Guyatt G, 2013, CHEST, V144, P365, DOI 10.1378/chest.13-0463; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2013, J CLIN EPIDEMIOL, V66, P158, DOI 10.1016/j.jclinepi.2012.01.012; Hargraves I, 2016, HEALTH AFFAIR, V35, P627, DOI 10.1377/hlthaff.2015.1354; Hastie R., 2010, RATIONAL CHOICE UNCE; Haynes RB, 2006, JAMA-J AM MED ASSOC, V295, P1801, DOI 10.1001/jama.295.15.1801; Hozo I, 2017, J EVAL CLIN PRACT, V23, P49, DOI 10.1111/jep.12490; Institute of Medicine (IOM), 2015, VIT SIGNS COR METR H; Ioannidis JPA, 2016, J CLIN EPIDEMIOL, V73, P82, DOI 10.1016/j.jclinepi.2016.02.012; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Smith M, 2013, BEST CARE LOWER COST; Jackson Rod, 2006, Evid Based Med, V11, P35, DOI 10.1136/ebm.11.2.35; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Karanicolas PJ, 2008, CHEST, V133, P1067, DOI 10.1378/chest.08-0068; Kristiansen A, 2014, CHEST, V146, P735, DOI 10.1378/chest.13-2993; Kwag KH, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5234; Lau J, N ENGL J MED, V327, P248; Lind J, 1753, TREATISE SCURVY 3 PA; Lipkus IM, 2007, MED DECIS MAKING, V27, P696, DOI 10.1177/0272989x07307271; Lohr KN, 2010, MED CARE, V48, pS3, DOI 10.1097/MLR.0b013e3181e10434; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Maggio LA, 2013, ACAD MED, V88, P1022, DOI 10.1097/ACM.0b013e3182951959; Makary MA, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2139; Mann H, 2013, J ROY SOC MED, V106, P30, DOI 10.1177/0141076812474779; Matthews JR., 1995, QUANTIFICATION QUEST, DOI 10.1515/9781400821808; McCartney M, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2452; McGauran N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-37; Michaels D, 2005, SCI AM, V292, P96, DOI 10.1038/scientificamerican0605-96; Miles A, 1999, J EVAL CLIN PRACT, V5, P97, DOI 10.1046/j.1365-2753.1999.00205.x; Miles A, 1997, J Eval Clin Pract, V3, P83, DOI 10.1046/j.1365-2753.1997.00103.x; Miles A, 2000, J EVAL CLIN PRACT, V6, P77, DOI 10.1046/j.1365-2753.2000.00255.x; Miles A., 2015, EDUCACI N M DICA, V16, P25, DOI [10.1016/j.edumed.2015.05.001, DOI 10.1016/J.EDUMED.2015.05.001]; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Montori VM, 2008, JAMA-J AM MED ASSOC, V300, P1814, DOI 10.1001/jama.300.15.1814; Moore TJ, 1995, DEADLY MED; Moynihan R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001655; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; Paynter R., 2016, EPC METHODS EXPLORAT; Pirolli P, 1999, PSYCHOL REV, V106, P643, DOI 10.1037/0033-295X.106.4.643; Porzsolt F, 2015, PRAGMAT OBS RES, V6, P47, DOI 10.2147/POR.S89946; Pronovost PJ, 2013, JAMA-J AM MED ASSOC, V310, P2501, DOI 10.1001/jama.2013.281334; Rettig R. A., 2007, FALSE HOPE BONE MARR; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sackett DL, 2000, CAN MED ASSOC J, V162, P1311; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; SACKETT DL, 1986, CHEST, V89, pS2, DOI 10.1378/chest.89.2_Supplement.2S; Schunemann HJ, 2015, SYST REV-LONDON, V4, DOI 10.1186/2046-4053-4-4; Schwartz LM, 2009, ANN INTERN MED, V150, P516, DOI 10.7326/0003-4819-150-8-200904210-00106; Siemieniuk RAC, 2015, ANN INTERN MED, V163, P519, DOI 10.7326/M15-0715; Sim I, 2016, ANN INTERN MED, V164, P562, DOI 10.7326/M15-2970; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Straus SE, 2005, EVIDENCE BASED MED P; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Timmermans S, 2005, HEALTH AFFAIR, V24, P18, DOI 10.1377/hlthaff.24.1.18; Vandvik PO, 2013, CHEST, V144, P381, DOI 10.1378/chest.13-0746; Vincent S, 2005, CANCER TREAT REV, V31, P319, DOI 10.1016/j.ctrv.2005.04.001; WENNBERG J, 1986, NEW ENGL J MED, V314, P310, DOI 10.1056/NEJM198601303140509; West S, 2002, 47 AG HLTH CAR RES Q; Worrall J, 2002, PHILOS SCI, V69, pS316, DOI 10.1086/341855; Young C, 2005, LANCET, V366, P107, DOI 10.1016/S0140-6736(05)66846-8; 1979, CAN MED ASS J, V121, P1193	111	358	387	13	113	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 22	2017	390	10092					415	423		10.1016/S0140-6736(16)31592-6	http://dx.doi.org/10.1016/S0140-6736(16)31592-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FB1NU	28215660				2022-12-28	WOS:000405911300030
J	Nijssen, EC; Rennenberg, RJ; Nelemans, PJ; Essers, BA; Janssen, MM; Vermeeren, MA; van Ommen, V; Wildberger, JE				Nijssen, Estelle C.; Rennenberg, Roger J.; Nelemans, Patty J.; Essers, Brigitte A.; Janssen, Marga M.; Vermeeren, Marja A.; van Ommen, Vincent; Wildberger, Joachim E.			Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial	LANCET			English	Article							ACUTE KIDNEY INJURY; INDUCED NEPHROTOXICITY; CORONARY-ANGIOGRAPHY; MEDIA; OUTCOMES; DISEASE	Background Intravenous saline is recommended in clinical practice guidelines as the cornerstone for preventing contrast-induced nephropathy in patients with compromised renal function. However, clinical-effectiveness and cost-effectiveness of this prophylactic hydration treatment in protecting renal function has not been adequately studied in the population targeted by the guidelines, against a group receiving no prophylaxis. This was the aim of the AMACING trial. Methods AMACING is a prospective, randomised, phase 3, parallel-group, open-label, non-inferiority trial of patients at risk of contrast-induced nephropathy according to current guidelines. High-risk patients (with an estimated glomerular filtration rate [eGFR] of 30-59 mL per min/1.73 m(2)) aged 18 years and older, undergoing an elective procedure requiring iodinated contrast material administration at Maastricht University Medical Centre, the Netherlands, were randomly assigned (1:1) to receive intravenous 0.9% NaCl or no prophylaxis. We excluded patients with eGFR lower than 30 mL per min/1.73 m(2), previous dialysis, or no referral for intravenous hydration. Randomisation was stratified by predefined risk factors. The primary outcome was incidence of contrast-induced nephropathy, defined as an increase in serum creatinine from baseline of more than 25% or 44 mu mol/L within 2-6 days of contrast exposure, and cost-effectiveness of no prophylaxis compared with intravenous hydration in the prevention of contrast-induced nephropathy. We measured serum creatinine immediately before, 2-6 days, and 26-35 days after contrast-material exposure. Laboratory personnel were masked to treatment allocation. Adverse events and use of resources were systematically recorded. The non-inferiority margin was set at 2.1%. Both intention-to-treat and per-protocol analyses were done. This trial is registered with ClinicalTrials.gov, number NCT02106234. Findings Between June 17, 2014, and July 17, 2016, 660 consecutive patients were randomly assigned to receive no prophylaxis (n = 332) or intravenous hydration (n = 328). 2-6 day serum creatinine was available for 307 (92%) of 332 patients in the no prophylaxis group and 296 (90%) of 328 patients in the intravenous hydration group. Contrast-induced nephropathy was recorded in eight (2.6%) of 307 non-hydrated patients and in eight (2.7%) of 296 hydrated patients. The absolute difference (no hydration vs hydration) was -0.10% (one-sided 95% CI -2.25 to 2.06; one-tailed p = 0.4710). No hydration was cost-saving relative to hydration. No haemodialysis or related deaths occurred within 35 days. 18 (5.5%) of 328 patients had complications associated with intravenous hydration. Interpretation We found no prophylaxis to be non-inferior and cost-saving in preventing contrast-induced nephropathy compared with intravenous hydration according to current clinical practice guidelines.	[Nijssen, Estelle C.; Janssen, Marga M.; Wildberger, Joachim E.] Maastricht Univ, Med Ctr, Dept Radiol & Nucl Med, NL-6202 AZ Maastricht, Netherlands; [Rennenberg, Roger J.] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [Nelemans, Patty J.] Maastricht Univ, Med Ctr, Dept Epidemiol, Maastricht, Netherlands; [Essers, Brigitte A.] Maastricht Univ, Med Ctr, Dept Clin Epidemiol & Med Technol Assessment, Maastricht, Netherlands; [Vermeeren, Marja A.; van Ommen, Vincent] Maastricht Univ, Med Ctr, Dept Cardiol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University	Nijssen, EC (corresponding author), Maastricht Univ, Med Ctr, Dept Radiol & Nucl Med, NL-6202 AZ Maastricht, Netherlands.	estelle.nijssen@mumc.nl	Rennenberg, Roger/L-6552-2019	Wildberger, Joachim/0000-0002-4810-6854	Stichting de Weijerhorst	Stichting de Weijerhorst	Stichting de Weijerhorst.	Balemans CEA, 2012, RADIOLOGY, V263, P706, DOI 10.1148/radiol.12111667; BARTELS ED, 1954, ACTA MED SCAND, V150, P297; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Bruck K, 2016, J AM SOC NEPHROL, V27, P2135, DOI 10.1681/ASN.2015050542; Christiansen C, 2005, TOXICOLOGY, V209, P185, DOI 10.1016/j.tox.2004.12.020; European Society of Urogenital Radiology, 2014, ESUR GUID CONTR MED; Hakkaart-van Roijen L, 2015, OPDRACHT ZORGINSTITU, P12; Hilton AK, 2008, MED J AUSTRALIA, V189, P509, DOI 10.5694/j.1326-5377.2008.tb02147.x; HOU SH, 1983, AM J MED, V74, P243, DOI 10.1016/0002-9343(83)90618-6; James MT, 2013, CIRC-CARDIOVASC INTE, V6, P37, DOI 10.1161/CIRCINTERVENTIONS.112.974493; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Jurado-Roman A, 2015, AM J CARDIOL, V115, P1174, DOI 10.1016/j.amjcard.2015.02.004; Katzberg RW, 2010, RADIOLOGY, V256, P21, DOI 10.1148/radiol.10092000; Kooiman J, 2014, J THROMB HAEMOST, V12, P1658, DOI 10.1111/jth.12701; LaBounty TM, 2012, AM J CARDIOL, V109, P1594, DOI 10.1016/j.amjcard.2012.01.380; Luo Y, 2014, INTERNAL MED, V53, P2265, DOI 10.2169/internalmedicine.53.1853; McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; Morcos SK, 1999, EUR RADIOL, V9, P1602, DOI 10.1007/s003300050894; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; NICE, 2013, GUID 2 AC KIDN INJ P; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; PORTER GA, 1990, AM J CARDIOL, V66, pF18, DOI 10.1016/0002-9149(90)90636-F; Prowle JR, 2010, NAT REV NEPHROL, V6, P107, DOI 10.1038/nrneph.2009.213; Rudnick MR, 2008, CLIN J AM SOC NEPHRO, V3, P261, DOI 10.2215/CJN.04951107; Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0; Thomsen HS, 2008, ACTA RADIOL, V49, P646, DOI 10.1080/02841850801995413; Veligheids Management Systeem, 2009, VMS VEIL VOORK NIER	27	257	268	4	39	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2017	389	10076					1312	1322		10.1016/S0140-6736(17)30057-0	http://dx.doi.org/10.1016/S0140-6736(17)30057-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ2OF	28233565				2022-12-28	WOS:000397908700024
J	Aletaha, D; Bingham, CO; Tanaka, Y; Agarwal, P; Kurrasch, R; Tak, PP; Popik, S				Aletaha, Daniel; Bingham, Clifton O., III; Tanaka, Yoshiya; Agarwal, Prasheen; Kurrasch, Regina; Tak, Paul P.; Popik, Sharon			Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study	LANCET			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; ANTITUMOR NECROSIS FACTOR; INADEQUATE RESPONSE; MONOCLONAL-ANTIBODY; RECEPTOR INHIBITION; CONTROLLED-TRIAL; METHOTREXATE; TOCILIZUMAB; DISEASE; INTERLEUKIN-6	Background Sirukumab, a human monoclonal antibody that selectively binds to the interleukin-6 cytokine with high affinity, is under development for the treatment of rheumatoid arthritis and other diseases. We aimed to assess the efficacy and safety of sirukumab for rheumatoid arthritis in a phase 3 study (SIRROUND-T). Methods We did a randomised, double-blind, placebo-controlled, parallel-group, multicentre study at 183 hospitals and private rheumatology clinics in 20 countries (Argentina, Australia, Austria, Belgium, Canada, France, Germany, Italy, Japan, Lithuania, Mexico, Netherlands, Poland, Portugal, Russia, South Korea, Spain, Taiwan, UK, and USA). Eligible participants were patients with active rheumatoid arthritis aged at least 18 years, with four or more of 68 tender joints and four or more of 66 swollen joints, who were refractory or intolerant to previous treatment with at least one anti-TNF drug. We randomly assigned patients (1: 1: 1) via a central interactive voice or web response system to either placebo every 2 weeks, 50 mg sirukumab every 4 weeks, or 100 mg sirukumab every 2 weeks, all given for 52 weeks or less. We allowed participants to continue using any concomitant disease-modifying antirheumatic drugs (DMARDs). We based the randomisation on a computer-generated, permuted-block schedule stratified by use of methotrexate at baseline (0, >0 to < 12.5 mg/week, or >= 12.5 mg/week). Masking was achieved with the use of multipart labels on the study drug containers which contained directions for use and other information, but not the drug's identity. Treatments were administered by subcutaneous injection; patients assigned to 50 mg sirukumab given every 4 weeks also received a placebo injection every 2 weeks to maintain masking. At week 18, placebo-treated patients meeting early escape criteria (< 20% improvement in swollen and tender joint counts) were randomly reassigned to either 50 mg or 100 mg of sirukumab. All remaining placebo-treated patients were subsequently randomly reassigned at week 24 to either sirukumab dose (crossover). The primary outcome was the proportion of patients who achieved a response of at least 20% improvement at week 16 according to American College of Rheumatology criteria (ACR20) in the intention-to-treat population (all randomly assigned participants). Safety analyses included all participants who received at least one dose (partial or complete) of study drug. This study is registered at EudraCT (number: 2010-022243-38) and ClinicalTrials. gov (number: NCT01606761). Findings Between July 25, 2012, and Jan 12, 2016, we randomly assigned 878 patients to treatment: 294 to placebo, 292 to 50 mg sirukumab every 4 weeks, and 292 to 100 mg sirukumab every 2 weeks. 523 (60%) of 878 patients had previously received two or more biological treatments including non-TNF drugs, and 166 (19%) of 878 were not taking a DMARD at baseline. The proportions of patients who achieved an ACR20 response at week 16 were 117 (40%) of 292 with 50 mg sirukumab every 4 weeks, and 132 (45%) of 292 with 100 mg sirukumab every 2 weeks versus 71 (24%) of 294 with placebo; differences compared with placebo were 0.16 (95% CI 0.09-0.23) for 50 mg sirukumab every 4 weeks and 0.21 (0.14-0.29) for 100 mg sirukumab every 2 weeks (both p< 0.0001). Adverse event incidences in the 24-week placebo-controlled period were similar across groups (at least one event occurred for 182 patients assigned to placebo [62%, including early escape patients switched to sirukumab at week 18] of 294; 194 [66%] of 292 with 50 mg sirukumab every 4 weeks; and 207 [71%] of 292 with 100 mg sirukumab every 2 weeks). The most common adverse events in this period were injection-site erythema (four [1%] with placebo, 22 [8%] with 50 mg sirukumab every 4 weeks, and 41 [14%] with 100 mg sirukumab every 2 weeks). At week 52, of all patients receiving sirukumab including those reassigned from placebo, the most common adverse events were again injection-site erythema (33 [8%] of 416 with 50 mg sirukumab every 4 weeks and 66 [16%] of 418 with 100 mg sirukumab every 2 weeks). Interpretation In patients with active rheumatoid arthritis who were refractory or intolerant to anti-TNF drugs and other biological treatments, both dosing regimens of sirukumab were well tolerated and significantly improved signs and symptoms of the disease, compared with placebo, in this difficult-to-treat population.	[Aletaha, Daniel] Med Univ Vienna, Div Rheumatol, Dept Internal Med 3, Vienna, Austria; [Bingham, Clifton O., III] Johns Hopkins Univ, Div Rheumatol, Baltimore, MD USA; [Tanaka, Yoshiya] Univ Occupat & Environm Hlth, Dept Internal Med, Kitakyushu, Fukuoka, Japan; [Agarwal, Prasheen; Popik, Sharon] Janssen Res & Dev LLC, Spring House, PA USA; [Kurrasch, Regina] GlaxoSmithKline, Collegeville, PA USA; [Tak, Paul P.] GlaxoSmithKline, Stevenage, Herts, England	Medical University of Vienna; Johns Hopkins University; University of Occupational & Environmental Health - Japan; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; GlaxoSmithKline; GlaxoSmithKline	Tak, PP (corresponding author), GlaxoSmithKline, Res & Dev, Stevenage SG1 2NY, Herts, England.	paul-peter.x.tak@gsk.com		Gomez-Reino, Juan/0000-0001-5229-6294	Janssen Research & Development, LLC; GlaxoSmithKline	Janssen Research & Development, LLC; GlaxoSmithKline(GlaxoSmithKline)	Janssen Research & Development, LLC, and GlaxoSmithKline.	AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; Chen YF, 2006, HEALTH TECHNOL ASSES, V10, P1, DOI 10.3310/hta10420; Du Pan SM, 2012, ANN RHEUM DIS, V71, P997, DOI 10.1136/annrheumdis-2011-200882; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Emery P, 2012, RHEUMATOLOGY, V51, pV22, DOI 10.1093/rheumatology/kes115; Fleischmann R, 2017, ARTHRITIS RHEUMATOL, V69, P277, DOI 10.1002/art.39944; Genovese MC, 2008, ARTHRITIS RHEUM-US, V58, P2968, DOI 10.1002/art.23940; Genovese MC, 2015, ARTHRITIS RHEUMATOL, V67, P1424, DOI 10.1002/art.39093; Haapakoski R, 2015, BRAIN BEHAV IMMUN, V49, P206, DOI 10.1016/j.bbi.2015.06.001; Hsu B, 2015, ANN RHEUM DIS, V74, P720, DOI 10.1136/annrheumdis-2015-eular.4081; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Kekow J, 2012, BIOL-TARGETS THER, V6, P191, DOI 10.2147/BTT.S32244; Kivitz A, 2014, ARTHRIT CARE RES, V66, P1653, DOI 10.1002/acr.22384; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Kosinski M, 2000, ARTHRITIS RHEUM-US, V43, P1478, DOI 10.1002/1529-0131(200007)43:7<1478::AID-ANR10>3.0.CO;2-M; Lindqvist D, 2009, BIOL PSYCHIAT, V66, P287, DOI 10.1016/j.biopsych.2009.01.030; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Matcham F, 2013, RHEUMATOLOGY, V52, P2136, DOI 10.1093/rheumatology/ket169; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Shetty A, 2014, DRUG DES DEV THER, V8, P349, DOI 10.2147/DDDT.S41437; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Smolen JS, 2014, ANN RHEUM DIS, V73, P1616, DOI 10.1136/annrheumdis-2013-205137; Tak PP, 2012, RHEUMATOLOGY, V51, P600, DOI 10.1093/rheumatology/ker300; Tanaka Y, 2014, ANN RHEUM DIS, V73, P1595, DOI 10.1136/annrheumdis-2013-205002; Tanaka Y, 2014, MOD RHEUMATOL, V24, P399, DOI 10.3109/14397595.2013.843757; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Xu ZH, 2011, BRIT J CLIN PHARMACO, V72, P270, DOI 10.1111/j.1365-2125.2011.03964.x	27	75	82	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2017	389	10075					1206	1217		10.1016/S0140-6736(17)30401-4	http://dx.doi.org/10.1016/S0140-6736(17)30401-4			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP1KL	28215362				2022-12-28	WOS:000397143700033
J	Pfenninger, S				Pfenninger, Stefan			Energy scientists must show their workings	NATURE			English	Editorial Material									[Pfenninger, Stefan] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Pfenninger, S (corresponding author), Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland.	stefan.pfenninger@usys.ethz.ch		Pfenninger, Stefan/0000-0002-8420-9498					0	70	70	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2017	542	7642					393	393		10.1038/542393a	http://dx.doi.org/10.1038/542393a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM1RG	28230147	Bronze			2022-12-28	WOS:000395094100004
J	Hirst, R; Newcombe, J				Hirst, Rosalind; Newcombe, Joyce			Vera Alma Sullivan OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		SULLIVAN VA, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2017	356								j872	10.1136/bmj.j872	http://dx.doi.org/10.1136/bmj.j872			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KQ	28219897				2022-12-28	WOS:000395630800008
J	Howie, AJ				Howie, Alexander J.			Douglas B Brewer OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		BREWER DB, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2017	356								j867	10.1136/bmj.j867	http://dx.doi.org/10.1136/bmj.j867			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KQ	28223281				2022-12-28	WOS:000395630800004
J	[Anonymous]				[Anonymous]			BMJ CONFIDENTIAL Peter Aitken: Psychiatrist of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	2017	356								j612	10.1136/bmj.j612	http://dx.doi.org/10.1136/bmj.j612			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL4GM	28202498				2022-12-28	WOS:000394579700003
J	McCall, C				McCall, Chris			Australia's new coal mine plan: a "public health disaster"	LANCET			English	Editorial Material																			0	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2017	389	10069					588	588		10.1016/S0140-6736(17)30329-X	http://dx.doi.org/10.1016/S0140-6736(17)30329-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9AF	28195047				2022-12-28	WOS:000394910800012
J	Kiziltan, B; Baumgardt, H; Loeb, A				Kiziltan, Bulent; Baumgardt, Holger; Loeb, Abraham			An intermediate-mass black hole in the centre of the globular cluster 47 Tucanae	NATURE			English	Article							MILLISECOND PULSARS; COMPACT BINARIES; WINDS DRIVEN; EVOLUTION; SYSTEMS; STARS; CORE; GAS	Intermediate-mass black holes should help us to understand the evolutionary connection between stellar-mass and super-massive black holes(1). However, the existence of intermediate-mass black holes is still uncertain, and their formation process is therefore unknown(2). It has long been suspected that black holes with masses 100 to 10,000 times that of the Sun should form and reside in dense stellar systems(3-6). Therefore, dedicated observational campaigns have targeted globular clusters for many decades, searching for signatures of these elusive objects. All candidate signatures appear radio-dim and do not have the X-ray to radio flux ratios required for accreting black holes(7). Based on the lack of an electromagnetic counterpart, upper limits of 2,060 and 470 solar masses have been placed on the mass of a putative black hole in 47 Tucanae (NGC 104) from radio and X-ray observations, respectively(8,9). Here we show there is evidence for a central black hole in 47 Tucanae with a mass of 2, 200(-800)(+1,500) solar masses when the dynamical state of the globular cluster is probed with pulsars. The existence of an intermediate-mass black hole in the centre of one of the densest clusters with no detectable electromagnetic counterpart suggests that the black hole is not accreting at a sufficient rate to make it electromagnetically bright and therefore, contrary to expectations, is gas-starved. This intermediate-mass black hole might be a member of an electromagnetically invisible population of black holes that grow into supermassive black holes in galaxies.	[Kiziltan, Bulent; Loeb, Abraham] Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA; [Baumgardt, Holger] Univ Queensland, Sch Math & Phys, St Lucia, Qld 4068, Australia	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Queensland	Kiziltan, B (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	bkiziltan@cfa.harvard.edu		Kiziltan, Bulent/0000-0002-7109-6391	Black Hole Initiative at Harvard University through John Templeton Foundation	Black Hole Initiative at Harvard University through John Templeton Foundation	This work was supported in part by the Black Hole Initiative at Harvard University, through the grant from the John Templeton Foundation.	Alexander T, 2014, SCIENCE, V345, P1330, DOI 10.1126/science.1251053; BAHCALL JN, 1976, ASTROPHYS J, V209, P214, DOI 10.1086/154711; Baumgardt H, 2005, ASTROPHYS J, V620, P238, DOI 10.1086/426893; Baumgardt H, 2017, MON NOT R ASTRON SOC, V464, P2174, DOI 10.1093/mnras/stw2488; COLEMAN GD, 1977, ASTROPHYS J, V218, P792, DOI 10.1086/155736; De Rijcke S, 2006, MON NOT R ASTRON SOC, V368, pL43, DOI 10.1111/j.1745-3933.2006.00153.x; Ebisuzaki T, 2001, ASTROPHYS J, V562, pL19, DOI 10.1086/338118; Freire PC, 2001, MON NOT R ASTRON SOC, V326, P901, DOI 10.1046/j.1365-8711.2001.04493.x; Freire PC, 2001, ASTROPHYS J, V557, pL105, DOI 10.1086/323248; Giersz M, 2015, MON NOT R ASTRON SOC, V454, P3150, DOI 10.1093/mnras/stv2162; Grindlay JE, 2001, SCIENCE, V292, P2290, DOI 10.1126/science.1061135; Maccarone TJ, 2007, NATURE, V445, P183, DOI 10.1038/nature05434; McLaughlin DE, 2006, ASTROPHYS J SUPPL S, V166, P249, DOI 10.1086/505692; Miller MC, 2002, MON NOT R ASTRON SOC, V330, P232, DOI 10.1046/j.1365-8711.2002.05112.x; Morscher M, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/1/9; Pan Z, 2016, MON NOT R ASTRON SOC, V459, pL26, DOI 10.1093/mnrasl/slw037; PHINNEY ES, 1992, PHILOS T ROY SOC A, V341, P39, DOI 10.1098/rsta.1992.0084; Richstone D, 1998, NATURE, V395, pA14; Ridolfi A, 2016, MON NOT R ASTRON SOC, V462, P2918, DOI 10.1093/mnras/stw1850; SCOTT EH, 1978, ASTROPHYS J, V222, P612, DOI 10.1086/156177; SIGURDSSON S, 1993, NATURE, V364, P423, DOI 10.1038/364423a0; Smith GH, 1999, PUBL ASTRON SOC PAC, V111, P980, DOI 10.1086/316410; Soria R, 2014, SCIENCE, V343, P1330, DOI 10.1126/science.1248759; SPERGEL DN, 1991, NATURE, V352, P221, DOI 10.1038/352221a0; Strader J, 2012, ASTROPHYS J LETT, V750, DOI 10.1088/2041-8205/750/2/L27; Volonteri M, 2012, SCIENCE, V337, P544, DOI 10.1126/science.1220843; Watkins LL, 2015, ASTROPHYS J, V803, DOI 10.1088/0004-637X/803/1/29; Zwart SFP, 2004, NATURE, V428, P724, DOI 10.1038/nature02448	30	103	104	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					203	205		10.1038/nature21361	http://dx.doi.org/10.1038/nature21361			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK2DJ	28179649	Green Submitted			2022-12-28	WOS:000393737500034
J	Schreurs, BW; Hannink, G				Schreurs, B. Willem; Hannink, Gerjon			Total joint arthroplasty in younger patients: heading for trouble?	LANCET			English	Editorial Material							TOTAL HIP-REPLACEMENT; OUTCOMES		[Schreurs, B. Willem; Hannink, Gerjon] Radboud Univ Nijmegen Med Ctr, Dept Orthopaed, Nijmegen, Netherlands	Radboud University Nijmegen	Schreurs, BW (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Orthopaed, Nijmegen, Netherlands.	wim.schreurs@radboudumc.nl	Schreurs, B.W./L-4639-2015; Hannink, Gerjon/A-2597-2015	Hannink, Gerjon/0000-0001-9526-3775	Stryker	Stryker	BWS is President of the European Hip Society, and reports educational grants from Stryker. GH declares no competing interests.	Bayliss LE, 2016, LANCET; Bozic KJ, 2012, J AM ACAD ORTHOP SUR, V20, P402, DOI 10.5435/JAAOS-20-06-402; Carr AJ, 2012, LANCET, V379, P1331, DOI 10.1016/S0140-6736(11)60752-6; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Kurtz SM, 2009, CLIN ORTHOP RELAT R, V467, P2606, DOI 10.1007/s11999-009-0834-6; Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7; Lee PTH, 2014, BONE JOINT J, V96B, P1047, DOI 10.1302/0301-620X.96B8.31587; Makela KT, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7592; National Joint Registry for England Wales and Northern Ireland, 12 ANN REP; te Stroet MAJ, 2015, CLIN ORTHOP RELAT R, V473, P3867, DOI 10.1007/s11999-015-4293-y; Troelsen A, 2013, CLIN ORTHOP RELAT R, V471, P2052, DOI [10.1007/s11999-013-2941-7, 10.1007/s11999-013-3017-4]; Zipkin DA, 2014, ANN INTERN MED, V161, P270, DOI 10.7326/M14-0295	12	34	37	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2017	389	10077					1374	1375		10.1016/S0140-6736(17)30190-3	http://dx.doi.org/10.1016/S0140-6736(17)30190-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EQ8OJ	28209372	hybrid, Green Submitted			2022-12-28	WOS:000398345100008
J	Qaseem, A; Wilt, TJ; McLean, RM; Forciea, MA				Qaseem, A.; Wilt, T. J.; McLean, R. M.; Forciea, M. A.			Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain	ANNALS OF INTERNAL MEDICINE			English	Editorial Material													McLean, Rachael/AAF-7596-2019	McLean, Rachael/0000-0002-0005-328X					0	1	1	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2017	166	7					I20	I21		10.7326/P17-9032	http://dx.doi.org/10.7326/P17-9032			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ4PT	28192791				2022-12-28	WOS:000398061100004
J	Szempruch, A; Guttman, M				Szempruch, Anthony; Guttman, Mitchell			Linking Protein and RNA Function within the Same Gene	CELL			English	Editorial Material									[Szempruch, Anthony; Guttman, Mitchell] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology	Guttman, M (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	mguttman@caltech.edu						Boeing S, 2016, CELL REP, V15, P1597, DOI 10.1016/j.celrep.2016.04.047; Engreitz JM, 2016, NAT REV MOL CELL BIO, V17, P756, DOI 10.1038/nrm.2016.126; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Williamson L, 2017, CELL, V168, P843, DOI 10.1016/j.cell.2017.01.019	10	1	1	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2017	168	5					753	755		10.1016/j.cell.2017.02.014	http://dx.doi.org/10.1016/j.cell.2017.02.014			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8YB	28235192	Bronze			2022-12-28	WOS:000396284800004
J	Cohen, J				Cohen, Jon			THE BIRTH OF CRISPR INC.	SCIENCE			English	Editorial Material																			0	7	8	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					680	684		10.1126/science.355.6326.680	http://dx.doi.org/10.1126/science.355.6326.680			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2AC	28209854				2022-12-28	WOS:000395117700016
J	Katsowich, N; Elbaz, N; Pal, RR; Mills, E; Kobi, S; Kahan, T; Rosenshine, I				Katsowich, Naama; Elbaz, Netanel; Pal, Ritesh Ranjan; Mills, Erez; Kobi, Simi; Kahan, Tamar; Rosenshine, Ilan			Host cell attachment elicits posttranscriptional regulation in infecting enteropathogenic bacteria	SCIENCE			English	Article							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; III SECRETION; ENTEROCYTE EFFACEMENT; PROTEIN TRANSLOCATION; EPITHELIAL-CELLS; VIRULENCE FACTOR; CHAPERONE; IDENTIFICATION; SYSTEMS; GENE	The mechanisms by which pathogens sense the host and respond by remodeling gene expression are poorly understood. Enteropathogenic Escherichia coli (EPEC), the cause of severe intestinal infection, employs a type III secretion system (T3SS) to inject effector proteins into intestinal epithelial cells. These effectors subvert host cell processes to promote bacterial colonization. We show that the T3SS also functions to sense the host cell and to trigger in response posttranscriptional remodeling of gene expression in the bacteria. We further show that upon effector injection, the effector-bound chaperone (CesT), which remains in the EPEC cytoplasm, antagonizes the posttranscriptional regulator CsrA. The CesT-CsrA interaction provokes reprogramming of expression of virulence and metabolic genes. This regulation is likely required for the pathogen's adaptation to life on the epithelium surface.	[Katsowich, Naama; Elbaz, Netanel; Pal, Ritesh Ranjan; Mills, Erez; Kobi, Simi; Rosenshine, Ilan] Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Microbiol & Mol Genet, Fac Med, IL-9112102 Jerusalem, Israel; [Kahan, Tamar] Hebrew Univ Jerusalem, Bioinformat Unit, Fac Med, IL-9112102 Jerusalem, Israel; [Mills, Erez] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Mills, Erez] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Mills, Erez] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Mills, Erez] Univ Washington, Dept Immunol & Med, Seattle, WA 98195 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rosenshine, I (corresponding author), Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Microbiol & Mol Genet, Fac Med, IL-9112102 Jerusalem, Israel.	ilanr@ekmd.huji.ac.il		Pal, Ritesh/0000-0002-7513-6792; mills, erez/0000-0003-2070-4008	Israel Academy of Sciences and Humanities; Carol and Leonard Berall Endowment	Israel Academy of Sciences and Humanities; Carol and Leonard Berall Endowment	We. tank J. Kapei S. Gruenheid. M. Donnenberg. and G. Frankel for providing antibodies and strains; R. Kulkarni for providing and running the CsrA predicting script: A. Winer. M. Elgradly-Weiss. I. Hershko-Shaley and L. Argaman to technical help: and S. Ben Yehuda.: G. Segal: and J. Sivaraman for reacting the manuscript. The work was funded by a grant from the Israel Academy of Sciences and Humanities. N.K. is a recipient of a fellowship from the Carol and Leonard Berall Endowment. I.R. is an Etta Rosensohn Professor of Bacteriology. Plasmids and bacterial stains described in this paper are available from I.R. under a material transfer agreement wit the Hebrew University of Jerusalem.	Abe A, 1999, MOL MICROBIOL, V33, P1162, DOI 10.1046/j.1365-2958.1999.01558.x; Aroeti B, 2012, GUT MICROBES, V3, P267, DOI 10.4161/gmic.19814; Bhatt S, 2009, INFECT IMMUN, V77, P3552, DOI 10.1128/IAI.00418-09; Dubey AK, 2003, J BACTERIOL, V185, P4450, DOI 10.1128/JB.185.15.4450-4460.2003; Edwards AN, 2011, MOL MICROBIOL, V80, P1561, DOI 10.1111/j.1365-2958.2011.07663.x; Elliott SJ, 2002, INFECT IMMUN, V70, P2271, DOI 10.1128/IAI.70.5.2271-2277.2002; Elliott SJ, 1999, MOL MICROBIOL, V33, P1176, DOI 10.1046/j.1365-2958.1999.01559.x; Esquerre T, 2016, SCI REP-UK, V6, DOI 10.1038/srep25057; Gruenheid S, 2004, MOL MICROBIOL, V51, P1233, DOI 10.1046/j.1365-2958.2003.03911.x; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kim J, 2007, CELL HOST MICROBE, V2, P160, DOI 10.1016/j.chom.2007.07.010; Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166; Kulkarni PR, 2014, NUCLEIC ACIDS RES, V42, P6811, DOI 10.1093/nar/gku309; Lai YS, 2013, CELL MICROBIOL, V15, P1796, DOI 10.1111/cmi.12179; Mills E, 2008, CELL HOST MICROBE, V3, P104, DOI 10.1016/j.chom.2007.11.007; Mills E, 2013, MBIO, V4, DOI 10.1128/mBio.00303-13; Mundy R, 2004, INFECT IMMUN, V72, P2288, DOI 10.1128/IAI.72.4.2288-2302.2004; O'Connell CB, 2004, MOL MICROBIOL, V52, P1613, DOI 10.1111/j.1365-2958.2004.04101.x; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Schubert M, 2007, NAT STRUCT MOL BIOL, V14, P807, DOI 10.1038/nsmb1285; Thomas NA, 2005, MOL MICROBIOL, V57, P1762, DOI 10.1111/j.1365-2958.2005.04802.x; Thomas NA, 2007, J BIOL CHEM, V282, P29634, DOI 10.1074/jbc.M706019200; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vakulskas CA, 2015, MICROBIOL MOL BIOL R, V79, P193, DOI 10.1128/MMBR.00052-14; Wolff C, 1998, MOL MICROBIOL, V28, P143, DOI 10.1046/j.1365-2958.1998.00782.x; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Yen H, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005121	28	50	53	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					735	738		10.1126/science.aah4886	http://dx.doi.org/10.1126/science.aah4886			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2AC	28209897				2022-12-28	WOS:000395117700040
J	Reddy, MA				Reddy, M. Ashwin			Judith Eve Kingston OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2017	356								j809	10.1136/bmj.j809	http://dx.doi.org/10.1136/bmj.j809			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GP	28213458				2022-12-28	WOS:000394580000006
J	Cherkin, DC; Anderson, ML; Sherman, KJ; Balderson, BH; Cook, AJ; Hansen, KE; Turner, JA				Cherkin, Daniel C.; Anderson, Melissa L.; Sherman, Karen J.; Balderson, Benjamin H.; Cook, Andrea J.; Hansen, Kelly E.; Turner, Judith A.			Two-Year Follow-up of a Randomized Clinical Trial of Mindfulness-Based Stress Reduction vs Cognitive Behavioral Therapy or Usual Care for Chronic Low Back Pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Cherkin, Daniel C.; Anderson, Melissa L.; Sherman, Karen J.; Balderson, Benjamin H.; Cook, Andrea J.; Hansen, Kelly E.] Grp Hlth Res Inst, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA; [Turner, Judith A.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Cherkin, DC (corresponding author), Grp Hlth Res Inst, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.	cherkin.d@ghc.org			National Center for Complementary and Integrative Health (NCCIH) of the National Institutes of Health [R01AT006226]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT006226] Funding Source: NIH RePORTER	National Center for Complementary and Integrative Health (NCCIH) of the National Institutes of Health; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	Research reported in this publication was supported by grant R01AT006226 from the National Center for Complementary and Integrative Health (NCCIH) of the National Institutes of Health.	Cherkin DC, 2016, JAMA-J AM MED ASSOC, V315, P1240, DOI 10.1001/jama.2016.2323; Cherkin DC, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-211; Lamb SE, 2012, PAIN, V153, P494, DOI 10.1016/j.pain.2011.11.016; Von Korff M, 2005, PAIN, V113, P323, DOI 10.1016/j.pain.2004.11.007; Wang ML, 2006, BIOMETRICAL J, V48, P302, DOI 10.1002/bimj.200510188	5	45	49	6	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2017	317	6					642	644		10.1001/jama.2016.17814	http://dx.doi.org/10.1001/jama.2016.17814			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8LI	28196244				2022-12-28	WOS:000394870900021
J	Klasco, RS; Glinert, LH				Klasco, Richard S.; Glinert, Lewis H.			Language for Actionable Recommendations in Clinical Guidelines Avoiding Hedging and Equivocation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UPDATE		[Klasco, Richard S.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Glinert, Lewis H.] Dartmouth Coll, Linguist Program, Hanover, NH 03755 USA	Harvard University; Beth Israel Deaconess Medical Center; Dartmouth College	Klasco, RS (corresponding author), Beth Israel Deaconess Med Ctr, Dept Emergency Med, Clin Ctr 2, One Deaconess Rd, Boston, MA 02215 USA.	rklasco@bidmc.harvard.edu		Glinert, Lewis/0000-0001-9421-6723				American Psychiatric Association, 2016, AM PSYCH ASS PRACT G, V3; [Anonymous], 2011, CLIN PRACTICE GUIDEL, DOI 10.1542/peds.2010-3318; CRICHTON M, 1975, NEW ENGL J MED, V293, P1257, DOI 10.1056/NEJM197512112932413; Izquierdo Rolando, 2011, J Bone Joint Surg Am, V93, P203; Levine GN, 2016, CIRCULATION, V134, pE123, DOI 10.1161/CIR.0000000000000404; Nast A, 2013, DTSCH ARZTEBL INT, V110, P663, DOI 10.3238/arztebl.2013.0663; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Rosenfeld RM, 2015, OTOLARYNG HEAD NECK, V152, P598, DOI 10.1177/0194599815574247	8	11	11	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2017	317	6					583	584		10.1001/jama.2016.20670	http://dx.doi.org/10.1001/jama.2016.20670			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8LI	28196262				2022-12-28	WOS:000394870900008
J	Levin, BJ; Huang, YY; Peck, SC; Wei, Y; Campo, AMD; Marks, JA; Franzosa, EA; Huttenhower, C; Balskus, EP				Levin, B. J.; Huang, Y. Y.; Peck, S. C.; Wei, Y.; Campo, A. Martinez-del; Marks, J. A.; Franzosa, E. A.; Huttenhower, C.; Balskus, E. P.			A prominent glycyl radical enzyme in human gut microbiomes metabolizes trans-4-hydroxy-L-proline	SCIENCE			English	Article							PYRUVATE FORMATE-LYASE; SEQUENCE SIMILARITY NETWORKS; COMPARATIVE METAGENOMICS; ROSEBURIA INULINIVORANS; CLOSTRIDIUM-BUTYRICUM; PROFILING REVEALS; ESCHERICHIA-COLI; P-CRESOL; GLYCEROL; PROLINE	The human microbiome encodes vast numbers of uncharacterized enzymes, limiting our functional understanding of this community and its effects on host health and disease. By incorporating information about enzymatic chemistry into quantitative metagenomics, we determined the abundance and distribution of individual members of the glycyl radical enzyme superfamily among the microbiomes of healthy humans. We identified many uncharacterized family members, including a universally distributed enzyme that enables commensal gut microbes and human pathogens to dehydrate trans-4-hydroxy-L-proline, the product of the most abundant human posttranslational modification. This "chemically guided functional profiling" workflow can therefore use ecological context to facilitate the discovery of enzymes in microbial communities.	[Levin, B. J.; Huang, Y. Y.; Peck, S. C.; Campo, A. Martinez-del; Marks, J. A.; Balskus, E. P.] Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA; [Wei, Y.] MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Franzosa, E. A.; Huttenhower, C.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Franzosa, E. A.; Huttenhower, C.; Balskus, E. P.] Broad Inst, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Balskus, EP (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	balskus@chemistry.harvard.edu		Peck, Spencer/0000-0002-1599-6635; Huang, Yolanda (Yue)/0000-0003-1263-1515; Huttenhower, Curtis/0000-0002-1110-0096	Harvard University; Packard Fellowship for Science and Engineering; George W. Merck Fund; National Institutes of Health [U54DE023798]; National Science Foundation [DBI-1053486, EAGER 1453942]; NSF Graduate Research Fellowship Program [DGE1144152]; Agency for Science, Technology and Research (A*STAR) Singapore; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U54DE023798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Harvard University; Packard Fellowship for Science and Engineering; George W. Merck Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); Agency for Science, Technology and Research (A*STAR) Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Financial support was provided by Harvard University, the Packard Fellowship for Science and Engineering (E.P.B.), the George W. Merck Fund (E.P.B.), the National Institutes of Health (U54DE023798) (C.H.), and the National Science Foundation (DBI-1053486 and EAGER 1453942) (C.H.). B.J.L. acknowledges support from the NSF Graduate Research Fellowship Program (DGE1144152), and Y.W. acknowledges support from the Agency for Science, Technology and Research (A*STAR) Singapore. The computations in this paper were run on the Odyssey cluster supported by the FAS Division of Science, Research Computing Group at Harvard University. We thank J. Stubbe for helpful advice and feedback on this manuscript. We also thank the Klinman lab (Univ. of California Berkeley) for providing the plasmid pPH149, J. Nicoludis (Gaudet lab, Harvard University) for providing P1 phage lysate, J. Wang for assistance with GC-MS experiments, K. Chatman for assistance with LC-MS/MS experiments, and H. Nakamura for help with the synthesis of 5-deazariboflavin. A protocol that allows users to perform chemically guided functional profiling with their own data sets is available at http://scholar.harvard.edu/balskus/metagenomic-profiling.	ADAMS E, 1980, ANNU REV BIOCHEM, V49, P1005, DOI 10.1146/annurev.bi.49.070180.005041; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Becker A, 1999, NAT STRUCT BIOL, V6, P969; Blaser MJ, 2016, MBIO, V7, DOI 10.1128/mBio.00714-16; Brown SD, 2012, J BIOL CHEM, V287, P35, DOI 10.1074/jbc.R111.283408; Campbell EL, 2014, IMMUNITY, V40, P66, DOI 10.1016/j.immuni.2013.11.020; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109; Daniel R, 1998, FEMS MICROBIOL REV, V22, P553, DOI 10.1111/j.1574-6976.1998.tb00387.x; DEUTCH AH, 1982, NUCLEIC ACIDS RES, V10, P7701, DOI 10.1093/nar/10.23.7701; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Ellrott K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000798; Feliks M, 2012, J PHYS CHEM B, V116, P7076, DOI 10.1021/jp301165b; Franzosa EA, 2015, NAT REV MICROBIOL, V13, P360, DOI 10.1038/nrmicro3451; Franzosa EA, 2014, P NATL ACAD SCI USA, V111, pE2329, DOI 10.1073/pnas.1319284111; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Huang H, 2015, J AM CHEM SOC, V137, P14570, DOI 10.1021/jacs.5b08968; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jackson S, 2006, J BACTERIOL, V188, P8487, DOI 10.1128/JB.01370-06; Joice R, 2014, CELL METAB, V20, P731, DOI 10.1016/j.cmet.2014.10.003; Kaminski J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004557; KNAPPE J, 1990, FEMS MICROBIOL LETT, V75, P383, DOI 10.1111/j.1574-6968.1990.tb04108.x; Kolmeder CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029913; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; LaMattina JW, 2016, J BIOL CHEM, V291, P15515, DOI 10.1074/jbc.M116.721142; Lohman JR, 2015, P NATL ACAD SCI USA, V112, P12693, DOI 10.1073/pnas.1515460112; LOVITT RW, 1987, J APPL BACTERIOL, V62, P71, DOI 10.1111/j.1365-2672.1987.tb02382.x; Martinez-del Campo A, 2015, MBIO, V6, DOI 10.1128/mBio.00042-15; MATTILA KJ, 1989, BRIT MED J, V298, P779, DOI 10.1136/bmj.298.6676.779; MEAD GC, 1971, J GEN MICROBIOL, V67, P47, DOI 10.1099/00221287-67-1-47; Nayfach S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0611-7; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; O'Brien JR, 2004, BIOCHEMISTRY-US, V43, P4635, DOI 10.1021/bi035930k; Persico AM, 2013, NEUROTOXICOL TERATOL, V36, P82, DOI 10.1016/j.ntt.2012.09.002; Phang JM, 2010, ANNU REV NUTR, V30, P441, DOI 10.1146/annurev.nutr.012809.104638; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Raynaud C, 2003, P NATL ACAD SCI USA, V100, P5010, DOI 10.1073/pnas.0734105100; Reichard P, 1997, TRENDS BIOCHEM SCI, V22, P81, DOI 10.1016/S0968-0004(97)01003-7; Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Scott KP, 2006, J BACTERIOL, V188, P4340, DOI 10.1128/JB.00137-06; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Selmer T, 2005, BIOL CHEM, V386, P981, DOI 10.1515/BC.2005.114; Selmer T, 2001, EUR J BIOCHEM, V268, P1363, DOI 10.1046/j.1432-1327.2001.02001.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; Wagner AFV, 2001, BIOCHEM BIOPH RES CO, V285, P456, DOI 10.1006/bbrc.2001.5186; WAGNER AFV, 1992, P NATL ACAD SCI USA, V89, P996, DOI 10.1073/pnas.89.3.996; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wecksler SR, 2009, BIOCHEMISTRY-US, V48, P10151, DOI 10.1021/bi900918b	54	95	99	4	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325							eaai8386	10.1126/science.aai8386	http://dx.doi.org/10.1126/science.aai8386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK0SF	28183913	Green Accepted			2022-12-28	WOS:000393636700039
J	Malakoff, D				Malakoff, David			Clear findings, smoggy debate	SCIENCE			English	Editorial Material																			0	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					567	567		10.1126/science.355.6325.567	http://dx.doi.org/10.1126/science.355.6325.567			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK0SF	28183926				2022-12-28	WOS:000393636700017
J	Matthews, KRW; Evans, KM; Lane, NF				Matthews, Kirstin R. W.; Evans, Kenneth M.; Lane, Neal F.			Science advice in the Trump White House	SCIENCE			English	Editorial Material									[Matthews, Kirstin R. W.; Evans, Kenneth M.; Lane, Neal F.] Rice Univ, Baker Inst Publ Policy, Sci & Technol Policy Program, Houston, TX 77005 USA	Rice University	Matthews, KRW (corresponding author), Rice Univ, Baker Inst Publ Policy, Sci & Technol Policy Program, Houston, TX 77005 USA.	krwm@rice.edu	Matthews, Kirstin RW/D-2496-2017	Matthews, Kirstin RW/0000-0002-3702-0414	Richard Lounsbery Foundation	Richard Lounsbery Foundation	This paper is based on (1), which was funded by a grant from the Richard Lounsbery Foundation. The authors thank the Baker Institute staff and interns, especially research assistants S. Tsao and C. Shields.	Bush G. H. W., 1990, 12700 EOP PRES COUNC; Center for the Study of the Presidency and Congress, 2000, ADV INN IMPR S T ADV; Clinton W. J., 1993, 1288 EOP NAT SCI TEC; Dull M, 2009, PRES STUD Q, V39, P432, DOI 10.1111/j.1741-5705.2009.03699.x; Lane N. F., 2016, VITAL ROLE WHITE HOU; Lane NF, 2009, CELL, V139, P847, DOI 10.1016/j.cell.2009.11.024; Marburger III J. H., 2008, COMMUNICATION; Mervis J., 2016, SCI INSIDER     0612; National Academies of Sciences Engineering and Medicine, 2008, SCI TECHN AM PROGR E; Sargent J. F., 2016, OFFICE SCI TECHNOLOG; Sargent J. F., 2010, FEDERAL CHIEF TECHNO	11	1	2	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					574	576		10.1126/science.aal4340	http://dx.doi.org/10.1126/science.aal4340			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK0SF	28183933				2022-12-28	WOS:000393636700024
J	Arabi, YM; Balkhy, HH; Hayden, FG; Bouchama, A; Luke, T; Baillie, JK; Al-Omari, A; Hajeer, AH; Senga, M; Denison, MR; Nguyen-Van-Tam, JS; Shindo, N; Bermingham, A; Chappell, JD; Van Kerkhove, MD; Fowler, RA				Arabi, Yaseen M.; Balkhy, Hanan H.; Hayden, Frederick G.; Bouchama, Abderrezak; Luke, Thomas; Baillie, J. Kenneth; Al-Omari, Awad; Hajeer, Ali H.; Senga, Mikiko; Denison, Mark R.; Nguyen-Van-Tam, Jonathan S.; Shindo, Nahoko; Bermingham, Alison; Chappell, James D.; Van Kerkhove, Maria D.; Fowler, Robert A.			Middle East Respiratory Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONAVIRUS MERS-COV; SAUDI-ARABIA; ACCESSORY PROTEINS; BROAD-SPECTRUM; MOUSE MODEL; INFECTION; OUTBREAK; TRANSMISSION; RIBAVIRIN; PNEUMONIA	Between September 2012 and January 20, 2017, the World Health Organization (WHO) received reports from 27 countries of 1879 laboratory-confirmed cases in humans of the Middle East respiratory syndrome (MERS) caused by infection with the MERS coronavirus (MERS-CoV) and at least 659 related deaths. Cases of MERS-CoV infection continue to occur, including sporadic zoonotic infections in humans across the Arabian Peninsula, occasional importations and associated clusters in other regions, and outbreaks of nonsustained human-to-human transmission in health care settings. Dromedary camels are considered to be the most likely source of animal-to-human transmission. MERS-CoV enters host cells after binding the dipeptidyl peptidase 4 (DPP-4) receptor and the carcinoembryonic antigen-related cell-adhesion molecule 5 (CEACAM5) cofactor ligand, and it replicates efficiently in the human respiratory epithelium. Illness begins after an incubation period of 2 to 14 days and frequently results in hypoxemic respiratory failure and the need for multiorgan support. However, asymptomatic and mild cases also occur. Real-time reverse-transcription-polymerase-chain-reaction (RT-PCR) testing of respiratory secretions is the mainstay for diagnosis, and samples from the lower respiratory tract have the greatest yield among seriously ill patients. There is no antiviral therapy of proven efficacy, and thus treatment remains largely supportive; potential vaccines are at an early developmental stage. There are multiple gaps in knowledge regarding the evolution and transmission of the virus, disease pathogenesis, treatment, and prospects for a vaccine. The ongoing occurrence of MERS in humans and the associated high mortality call for a continued collaborative approach toward gaining a better understanding of the infection both in humans and in animals. MERS-CoV was first identified in September 20121 in a patient from Saudi Arabia who had hypoxemic respiratory failure and multiorgan illness. Subsequent cases have included infections in humans across the Arabian Peninsula, occasional importations and associated clusters in other regions, and outbreaks of nonsustained human-tohuman transmission in health care settings (Fig. 1).	[Arabi, Yaseen M.; Bouchama, Abderrezak] King Saud bin Abdulaziz Univ Hlth Sci, King Abdulaziz Med City, Dept Intens Care, Riyadh, Saudi Arabia; [Balkhy, Hanan H.] King Saud bin Abdulaziz Univ Hlth Sci, King Abdulaziz Med City, Dept Infect Prevent & Control, Riyadh, Saudi Arabia; [Hajeer, Ali H.] King Saud bin Abdulaziz Univ Hlth Sci, King Abdulaziz Med City, Dept Pathol & Lab, Riyadh, Saudi Arabia; [Arabi, Yaseen M.; Balkhy, Hanan H.; Bouchama, Abderrezak; Hajeer, Ali H.] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Al-Omari, Awad] Dr Sulaiman Al Habib Grp Hosp, Dept Intens Care, Riyadh, Saudi Arabia; [Al-Omari, Awad] Alfaisal Univ, Riyadh, Saudi Arabia; [Hayden, Frederick G.] Univ Virginia, Sch Med, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA; [Luke, Thomas] Naval Med Res Ctr, Dept Viral & Rickettsial Dis, Silver Spring, MD USA; [Baillie, J. Kenneth] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Baillie, J. Kenneth] Royal Infirm Edinburgh NHS Trust, Intens Care Unit, Edinburgh, Midlothian, Scotland; [Nguyen-Van-Tam, Jonathan S.] Univ Nottingham, Div Epidemiol & Publ Hlth, Hlth Protect & Influenza Res Grp, Nottingham, England; [Bermingham, Alison] Publ Hlth England, Virus Reference Lab, London, England; [Senga, Mikiko; Shindo, Nahoko; Fowler, Robert A.] WHO, Dept Pandem & Epidem Dis, Geneva, Switzerland; [Denison, Mark R.; Chappell, James D.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Van Kerkhove, Maria D.] Inst Pasteur, Ctr Global Hlth, Paris, France; [Fowler, Robert A.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Fowler, Robert A.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON, Canada; [Fowler, Robert A.] Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON, Canada	King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Alfaisal University; University of Virginia; Naval Medical Research Center (NMRC); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; University of Nottingham; Public Health England; World Health Organization; Vanderbilt University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Arabi, YM (corresponding author), King Saud bin Abdulaziz Univ Hlth Sci, King Abdulaziz Med City, POB 22490, Riyadh 11426, Saudi Arabia.	arabi@ngha.med.sa	Leung, Czarina C. H./B-2816-2015; Gomersall, Charles D/J-1540-2012; Denison, Mark/O-7258-2018	Leung, Czarina C. H./0000-0002-3291-8663; Gomersall, Charles D/0000-0002-8494-8063; Hajeer, Ali H./0000-0003-2727-9964; Arabi, Yaseen/0000-0001-5735-6241; Al-Omari, Awad/0000-0002-4866-5330; Van Kerkhove, Maria/0000-0002-6135-0018; Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655; BOUCHAMA, abderrezak/0000-0003-3089-5936; Baillie, John Kenneth/0000-0001-5258-793X; Denison, Mark/0000-0003-2655-0900	Wellcome Trust Intermediate Clinical Fellowship; Wellcome-Beit Prize [103258/Z/13/Z, 103258/Z/13/A]; Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant; Intensive Care Foundation; Heart and Stroke Foundation, Ontario Provincial Office; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241863, BBS/E/D/20241866, BBS/E/D/20241864] Funding Source: researchfish; Wellcome Trust [103258/Z/13/Z] Funding Source: researchfish; BBSRC [BBS/E/D/20241864, BBS/E/D/20241863, BBS/E/D/20241866] Funding Source: UKRI	Wellcome Trust Intermediate Clinical Fellowship(Wellcome Trust); Wellcome-Beit Prize; Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Intensive Care Foundation; Heart and Stroke Foundation, Ontario Provincial Office(Heart & Stroke Foundation of Ontario); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by a Wellcome Trust Intermediate Clinical Fellowship and a Wellcome-Beit Prize (103258/Z/13/Z and 103258/Z/13/A, both to Dr. Baillie), a Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant (to the Roslin Institute), the Intensive Care Foundation, and an award from the Heart and Stroke Foundation, Ontario Provincial Office (to Dr. Fowler).	Agrawal AS, 2016, HUM VACC IMMUNOTHER, V12, P2351, DOI 10.1080/21645515.2016.1177688; Agrawal AS, 2015, J VIROL, V89, P3659, DOI 10.1128/JVI.03427-14; Al-Abdallat MM, 2014, CLIN INFECT DIS, V59, P1225, DOI 10.1093/cid/ciu359; Al-Gethamy M, 2015, CLIN INFECT DIS, V60, P973, DOI 10.1093/cid/ciu1135; Al-Tawfiq JA, 2016, FRONT MED-PRC, V10, P111, DOI 10.1007/s11684-016-0446-y; Alraddadi BM, 2016, EMERG INFECT DIS, V22, P49, DOI 10.3201/eid2201.151340; [Anonymous], 2016, CAM IS ABS 2 YEAR HA; Arabi YM, 2015, INFECTION, V43, P495, DOI 10.1007/s15010-015-0720-y; Arabi YM, 2016, EMERG INFECT DIS, V22, P1554, DOI 10.3201/eid2209.151164; Arabi YM, 2014, ANN INTERN MED, V160, P389, DOI 10.7326/M13-2486; Arwady MA, 2016, EMERG INFECT DIS, V22, P1395, DOI 10.3201/eid2208.152015; Auyeung TW, 2005, J INFECTION, V51, P98, DOI 10.1016/j.jinf.2004.09.008; Balkhy HH, 2016, INFECT CONT HOSP EP, V37, P1147, DOI 10.1017/ice.2016.132; Bin SY, 2016, CLIN INFECT DIS, V62, P755, DOI 10.1093/cid/civ1020; Chan CM, 2016, J VIROL, V90, P9114, DOI 10.1128/JVI.01133-16; Chan JFW, 2013, J INFECTION, V67, P606, DOI 10.1016/j.jinf.2013.09.029; Chan JFW, 2015, J INFECT DIS, V212, P1904, DOI 10.1093/infdis/jiv392; Chan JFW, 2013, J INFECT DIS, V207, P1743, DOI 10.1093/infdis/jit123; Corman VM, 2012, EUROSURVEILLANCE, V17, P2; Corman VM, 2012, EUROSURVEILLANCE, V17, P3; Corman VM, 2016, CLIN INFECT DIS, V62, P477, DOI 10.1093/cid/civ951; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; de Wit E, 2013, P NATL ACAD SCI USA, V110, P16598, DOI 10.1073/pnas.1310744110; Drosten C, 2015, CLIN INFECT DIS, V60, P369, DOI 10.1093/cid/ciu812; Drosten C, 2014, NEW ENGL J MED, V371, P828, DOI 10.1056/NEJMoa1405858; Dunning JW, 2014, LANCET INFECT DIS, V14, P8, DOI 10.1016/S1473-3099(13)70327-X; Falzarano D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004250; Falzarano D, 2013, NAT MED, V19, P1313, DOI 10.1038/nm.3362; Faure E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088716; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gierer S, 2013, J VIROL, V87, P5502, DOI 10.1128/JVI.00128-13; Hocke AC, 2013, AM J RESP CRIT CARE, V188, P882, DOI 10.1164/rccm.201305-0954LE; Jiang LW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008140; Johnson RF, 2015, VIROLOGY, V485, P422, DOI 10.1016/j.virol.2015.07.013; Josset L, 2013, MBIO, V4, DOI 10.1128/mBio.00165-13; Ki M, 2015, EPIDEMIOL HLTH, V2015, P37, DOI DOI 10.4178/EPIH/E2015033; Kim SY, 2016, EMERG INFECT DIS, V22, P1813, DOI 10.3201/eid2210.160218; Kim SH, 2016, CLIN INFECT DIS, V63, P363, DOI 10.1093/cid/ciw239; Korea Centers for Disease Control and Prevention, 2015, Osong Public Health Res Perspect, V6, P269, DOI 10.1016/j.phrp.2015.08.006; Kraaij-Dirkzwager M, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.21.20817; Liu DX, 2014, ANTIVIR RES, V109, P97, DOI 10.1016/j.antiviral.2014.06.013; Lokugamage KG, 2015, J VIROL, V89, P10970, DOI 10.1128/JVI.01352-15; Mair-Jenkins J, 2015, J INFECT DIS, V211, P80, DOI 10.1093/infdis/jiu396; Memish ZA, 2014, INT J INFECT DIS, V29, P307, DOI 10.1016/j.ijid.2014.10.002; Memish ZA, 2014, J INFECT DIS, V210, P1590, DOI 10.1093/infdis/jiu292; Memish ZA, 2014, PEDIATR INFECT DIS J, V33, P904, DOI 10.1097/INF.0000000000000325; Memish ZA, 2013, NEW ENGL J MED, V368, P2487, DOI 10.1056/NEJMoa1303729; Mielech AM, 2014, VIROLOGY, V450, P64, DOI 10.1016/j.virol.2013.11.040; Millet JK, 2014, P NATL ACAD SCI USA, V111, P15214, DOI 10.1073/pnas.1407087111; Min CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep25359; Muller MA, 2015, LANCET INFECT DIS, V15, P559, DOI 10.1016/S1473-3099(15)70090-3; Munster VJ, 2013, NEW ENGL J MED, V368, P1560, DOI 10.1056/NEJMc1215691; Muth D, 2015, J CLIN MICROBIOL, V53, P2951, DOI 10.1128/JCM.01368-15; Ng DL, 2016, AM J PATHOL, V186, P652, DOI 10.1016/j.ajpath.2015.10.024; Oboho IK, 2015, NEW ENGL J MED, V372, P846, DOI 10.1056/NEJMoa1408636; Omrani AS, 2014, LANCET INFECT DIS, V14, P1090, DOI 10.1016/S1473-3099(14)70920-X; Park WB, 2015, EMERG INFECT DIS, V21, P2186, DOI 10.3201/eid2112.151421; Payne DC, 2014, J INFECT DIS, V209, P1870, DOI 10.1093/infdis/jiu068; Schneider E, 2015, EMERG INFECT DIS, V21, P1220, DOI 10.3201/eid2107.141888; Shalhoub S, 2015, J ANTIMICROB CHEMOTH, V70, P2129, DOI 10.1093/jac/dkv085; Smith EC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003565; Tang XC, 2014, P NATL ACAD SCI USA, V111, pE2018, DOI 10.1073/pnas.1402074111; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; van Doremalen N, 2014, J VIROL, V88, P9220, DOI 10.1128/JVI.00676-14; Van Kerkhove MD, 2013, INFLUENZA OTHER RESP, V7, P231, DOI 10.1111/irv.12068; Who Mers-Cov Research Group, 2013, PLoS Curr, V5, DOI 10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8; World Health Organization, 2015, INF PREV CONTR HLTH; World Health Organization, 2015, SURV HUM INF MIDDL E; Yang YA, 2013, PROTEIN CELL, V4, P331, DOI 10.1007/s13238-013-2093-2; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhao JC, 2014, P NATL ACAD SCI USA, V111, P4970, DOI 10.1073/pnas.1323279111; Zumla A, 2015, INT J INFECT DIS, V40, P71, DOI 10.1016/j.ijid.2015.09.005	73	274	293	1	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2017	376	6					584	594		10.1056/NEJMsr1408795	http://dx.doi.org/10.1056/NEJMsr1408795			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8XL	28177862	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000393510500018
J	Maus, MV				Maus, Marcela V.			IMMUNOLOGY T-cell tweaks to target tumours	NATURE			English	Editorial Material								Immune cells known as T cells can destroy tumour cells, but their clinical use requires complex preparation and the cells can lose effectiveness over time. A new approach might improve the efficiency of T-cell therapy. See Letter p. 113	[Maus, Marcela V.] Harvard Med Sch, Dept Med, Boston, MA 02114 USA; [Maus, Marcela V.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Maus, MV (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02114 USA.; Maus, MV (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.	mvmaus@mgh.harvard.edu						Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Frigault MJ, 2015, CANCER IMMUNOL RES, V3, P356, DOI 10.1158/2326-6066.CIR-14-0186; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Long A. H., 2015, NAT MED, V6, P581; Maus MV, 2016, CLIN CANCER RES, V22, P1875, DOI 10.1158/1078-0432.CCR-15-1433; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Ren J., 2017, CLIN CANC RES; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Scholler J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003761; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Wang JB, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1121; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862	12	2	2	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					48	49		10.1038/nature21506	http://dx.doi.org/10.1038/nature21506			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN0AA	28225762				2022-12-28	WOS:000395671500029
J	Hawkes, N				Hawkes, Nigel			Screening does not reduce mental disorders in returning soldiers, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item															US Congressionally Directed Medical Research Programs	US Congressionally Directed Medical Research Programs	The study was supported by the US Congressionally Directed Medical Research Programs, which funds research aimed at improving the health of US service personnel.	Rona RJ, 2017, LANCET, V389, P1410, DOI 10.1016/S0140-6736(16)32398-4	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2017	356								j861	10.1136/bmj.j861	http://dx.doi.org/10.1136/bmj.j861			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL4GP	28213549				2022-12-28	WOS:000394580000012
J	Servick, K				Servick, Kelly			CLINICAL TRIALS Failed spinal cord trial offers cautionary tale	SCIENCE			English	News Item																			0	7	8	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					679	679		10.1126/science.355.6326.679	http://dx.doi.org/10.1126/science.355.6326.679			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2AC	28209853				2022-12-28	WOS:000395117700015
J	Arif, A; Terenzi, F; Potdar, AA; Jia, J; Sacks, J; China, A; Halawani, D; Vasu, K; Li, XX; Brown, JM; Chen, J; Kozma, SC; Thomas, G; Fox, PL				Arif, Abul; Terenzi, Fulvia; Potdar, Alka A.; Jia, Jie; Sacks, Jessica; China, Arnab; Halawani, Dalia; Vasu, Kommireddy; Li, Xiaoxia; Brown, J. Mark; Chen, Jie; Kozma, Sara C.; Thomas, George; Fox, Paul L.			EPRS is a critical mTORC1-S6K1 effector that influences adiposity in mice	NATURE			English	Article							ACID TRANSPORT PROTEIN-1; TRANSFER-RNA SYNTHETASE; DIET-INDUCED OBESITY; TRANSLATIONAL CONTROL; SKELETAL-MUSCLE; PPAR-GAMMA; NONCANONICAL FUNCTION; S6 PHOSPHORYLATION; CHOLESTERYL ESTERS; INSULIN-RESISTANCE	Metabolic pathways that contribute to adiposity and ageing are activated by the mammalian target of rapamycin complex 1 (mTORC1) and p70 ribosomal protein S6 kinase 1 (S6K1) axis(1-3). However, known mTORC1-S6K1 targets do not account for observed loss-of-function phenotypes, suggesting that there are additional downstream effectors of this pathway(4-6). Here we identify glutamylprolyl-tRNA synthetase (EPRS) as an mTORC1-S6K1 target that contributes to adiposity and ageing. Phosphorylation of EPRS at Ser999 by mTORC1-S6K1 induces its release from the aminoacyl tRNA multisynthetase complex, which is required for execution of noncanonical functions of EPRS beyond protein synthesis(7,8). To investigate the physiological function of EPRS phosphorylation, we generated Eprs knock-in mice bearing phospho-deficient Ser999-to-Ala (S999A) and phospho-mimetic (S999D) mutations. Homozygous S999A mice exhibited low body weight, reduced adipose tissue mass, and increased lifespan, similar to S6K1-deficient mice(9-11) and mice with adipocyte-specific deficiency of raptor, an mTORC1 constituent(12). Substitution of the Eprs(S999D) allele in S6K1-deficient mice normalized body mass and adiposity, indicating that EPRS phosphorylation mediates S6K1-dependent metabolic responses. In adipocytes, insulin stimulated S6K1-dependent EPRS phosphorylation and release from the multisynthetase complex. Interaction screening revealed that phospho-EPRS binds SLC27A1 (that is, fatty acid transport protein 1, FATP1)(13-15), inducing its translocation to the plasma membrane and long-chain fatty acid uptake. Thus, EPRS and FATP1 are terminal mTORC1-S6K1 axis effectors that are critical for metabolic phenotypes.	[Arif, Abul; Terenzi, Fulvia; Jia, Jie; Sacks, Jessica; China, Arnab; Halawani, Dalia; Vasu, Kommireddy; Brown, J. Mark; Fox, Paul L.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Potdar, Alka A.] Cedars Sinai Med Ctr, F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Los Angeles, CA 90048 USA; [Li, Xiaoxia] Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA; [Chen, Jie] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Kozma, Sara C.; Thomas, George] IDIBELL, Bellvitge Biomed Res Inst, ICO, Catalan Inst Oncol, Barcelona, Spain; [Kozma, Sara C.; Thomas, George] Univ Barcelona, Fac Med, Dept Physiol Sci 2, Barcelona 08908, Spain; [Thomas, George] Univ Cincinnati, Coll Med, Dept Internal Med, Div Hematol & Oncol, Cincinnati, OH USA	Cleveland Clinic Foundation; Cedars Sinai Medical Center; Cleveland Clinic Foundation; University of Illinois System; University of Illinois Urbana-Champaign; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Barcelona; University System of Ohio; University of Cincinnati	Fox, PL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA.	foxp@ccf.org	Halawani, Dalia/AAN-3261-2021; Kommireddy, Vasu/C-3928-2018	Kommireddy, Vasu/0000-0002-7608-7566; Jia, Jie/0000-0002-9583-1055; Halawani, Dalia/0000-0003-4738-0656; Chen, Jie/0000-0002-7887-3747	NIH [P01HL029582, P01HL076491, R01GM086430, R01GM115476, P50CA150964, R01AR048914, R01GM089771, R01CA158768]; AHA SDG [10SDG3930003]; CIHR fellowship; AHA fellowship; Spanish Ministry [BFU2012-38867, SAF2011-24967]; Fundacio La Marato de TV3 [174/U/2016]; CIG European Commission [PCIG10-GA-2011-304160]; NATIONAL CANCER INSTITUTE [P50CA150964, R01CA158768] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582, P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086430, R01GM089771, R01GM115476] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA SDG(American Heart Association); CIHR fellowship(Canadian Institutes of Health Research (CIHR)); AHA fellowship(American Heart Association); Spanish Ministry(Spanish Government); Fundacio La Marato de TV3; CIG European Commission; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants P01HL029582, P01HL076491, R01GM086430, R01GM115476, and P50CA150964 (to P.L.F.), by AHA SDG 10SDG3930003 (to A.A), by CIHR fellowship (to D.H), by AHA fellowship (to K.V.), by NIH R01AR048914 and R01GM089771 (to J.C.), by Spanish Ministry BFU2012-38867 and Fundacio La Marato de TV3 #174/U/2016 grants (to S.C.K.), and by NIH R01CA158768, Spanish Ministry SAF2011-24967, and CIG European Commission PCIG10-GA-2011-304160 grants (to G.T.). We thank P Bhattaram for helpful discussion.	Arif A, 2012, MOL CELL BIOL, V32, P5046, DOI 10.1128/MCB.01168-12; Arif A, 2011, P NATL ACAD SCI USA, V108, P1415, DOI 10.1073/pnas.1011275108; Arif A, 2009, MOL CELL, V35, P164, DOI 10.1016/j.molcel.2009.05.028; Burkholder Tanya, 2012, Curr Protoc Mouse Biol, V2, P145; Carnevalli LS, 2010, DEV CELL, V18, P763, DOI 10.1016/j.devcel.2010.02.018; CARSON SD, 1983, BIOCHIM BIOPHYS ACTA, V750, P317, DOI 10.1016/0005-2760(83)90034-6; CASNELLIE JE, 1991, METHOD ENZYMOL, V200, P115; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Ge YJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1434, DOI 10.1152/ajpcell.00248.2009; GOLDSTEIN JL, 1981, ARTERIOSCLEROSIS, V1, P210, DOI 10.1161/01.ATV.1.3.210; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kawasome H, 1998, P NATL ACAD SCI USA, V95, P5033, DOI 10.1073/pnas.95.9.5033; Kim JK, 2004, J CLIN INVEST, V113, P756, DOI 10.1172/JCI200418917; KOZMA SC, 1993, J BIOL CHEM, V268, P7134; Kraus D, 2014, NATURE, V508, P258, DOI 10.1038/nature13198; Lamming DW, 2013, CELL METAB, V18, P465, DOI 10.1016/j.cmet.2013.08.002; Lee J, 2015, CELL REP, V10, P266, DOI 10.1016/j.celrep.2014.12.023; Lee RG, 2005, J LIPID RES, V46, P1205, DOI 10.1194/jlr.M500018-JLR200; Liao JF, 2005, J LIPID RES, V46, P597, DOI 10.1194/jlr.D400023-JLR200; Lin MH, 2015, J INVEST DERMATOL, V135, P462, DOI 10.1038/jid.2014.378; Lobo S, 2007, J LIPID RES, V48, P609, DOI 10.1194/jlr.M600441-JLR200; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Miao J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7498; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Ray PS, 2007, EMBO J, V26, P3360, DOI 10.1038/sj.emboj.7601774; Ray PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098493; Richards MR, 2006, J LIPID RES, V47, P665, DOI 10.1194/jlr.M500514-JLR200; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Ruvinsky I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005618; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Song EK, 2012, CELL REP, V2, P1607, DOI 10.1016/j.celrep.2012.10.018; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Thomas G, 2013, CELL REP, V5, P508, DOI 10.1016/j.celrep.2013.08.047; Tumaneng K, 2012, CURR BIOL, V22, pR368, DOI 10.1016/j.cub.2012.03.003; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wiczer BM, 2009, J LIPID RES, V50, P2502, DOI 10.1194/jlr.M900218-JLR200; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011; Yi SA, 2016, MOL CELL, V62, P443, DOI 10.1016/j.molcel.2016.03.011	54	73	80	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					357	+		10.1038/nature21380	http://dx.doi.org/10.1038/nature21380			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2LQ	28178239	Green Accepted			2022-12-28	WOS:000394451600039
J	[Anonymous]				[Anonymous]			CONSERVATION Penguins caught in ecological trap	NATURE			English	Editorial Material																			0	0	0	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					275	275		10.1038/542275a	http://dx.doi.org/10.1038/542275a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7YF	28202976	Bronze			2022-12-28	WOS:000454457400005
J	[Anonymous]				[Anonymous]			INFECTION How malaria boosts its spread	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2017	542	7641					275	275		10.1038/542275c	http://dx.doi.org/10.1038/542275c			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7YF	28202964	Bronze			2022-12-28	WOS:000454457400007
J	Horton, R				Horton, Richard			Offline: Revolution-a prescription for health?	LANCET			English	Editorial Material												richard.horton@lancet.com							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2017	389	10069					586	586		10.1016/S0140-6736(17)30316-1	http://dx.doi.org/10.1016/S0140-6736(17)30316-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9AF	28195045	Bronze			2022-12-28	WOS:000394910800010
J	[Anonymous]				[Anonymous]			CLARIFICATION	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					1	1		10.1038/542176a	http://dx.doi.org/10.1038/542176a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VI4ZT	28179670	Bronze			2022-12-28	WOS:000491118900001
J	Fleischmann, R				Fleischmann, Roy			Interleukin-6 inhibition for rheumatoid arthritis	LANCET			English	Editorial Material									[Fleischmann, Roy] Univ Texas Southwestern Med Ctr Dallas, Metroplex Clin Res Ctr, Dallas, TX 75231 USA	Metroplex Clinical Research Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Fleischmann, R (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Metroplex Clin Res Ctr, Dallas, TX 75231 USA.	rfleischmann@arthdocs.com			Genentech-Roche; Sanofi-Aventis; GlaxoSmithKline	Genentech-Roche(Roche HoldingGenentech); Sanofi-Aventis(Sanofi-Aventis); GlaxoSmithKline(GlaxoSmithKline)	I have received clinical study grants and consulting fees from Genentech-Roche and Sanofi-Aventis, and consulting fees from GlaxoSmithKline, but not for the clinical development of sirukumab.	Aletaha D, 2017, LANCET; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Fleischmann R, 2016, SEMIN ARTHRITIS RHEU, V46, P279, DOI 10.1016/j.semarthrit.2016.07.006; Fleischmann R, 2017, ARTHRITIS RHEUMATOL, V69, P277, DOI 10.1002/art.39944; STRAND V, 2015, ARTHRITIS RHEUMA S10, V67; TAYLOR PC, 2016, ARTHRITIS RHEUMA S10, V68	6	6	8	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2017	389	10075					1168	1170		10.1016/S0140-6736(17)30405-1	http://dx.doi.org/10.1016/S0140-6736(17)30405-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EP1KL	28215663				2022-12-28	WOS:000397143700008
J	Emami, SN; Lindberg, BG; Hua, S; Hill, SR; Mozuraitis, R; Lehmann, P; Birgersson, G; Borg-Karlson, AK; Ignell, R; Faye, I				Emami, S. Noushin; Lindberg, Bo G.; Hua, Susanna; Hill, Sharon R.; Mozuraitis, Raimondas; Lehmann, Philipp; Birgersson, Goran; Borg-Karlson, Anna-Karin; Ignell, Rickard; Faye, Ingrid			A key malaria metabolite modulates vector blood seeking, feeding, and susceptibility to infection	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; ATTRACTIVENESS; INCREASES; MANIPULATION; MEMORY	Malaria infection renders humans more attractive to Anopheles gambiae sensu lato mosquitoes than uninfected people. The mechanisms remain unknown. We found that an isoprenoid precursor produced by Plasmodium falciparum, (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP), affects A. gambiae s. l. blood meal seeking and feeding behaviors as well as susceptibility to infection. HMBPP acts indirectly by triggering human red blood cells to increase the release of CO2, aldehydes, and monoterpenes, which together enhance vector attraction and stimulate vector feeding. When offered in a blood meal, HMBPP modulates neural, antimalarial, and oogenic gene transcription without affecting mosquito survival or fecundity; in a P. falciparum-infected blood meal, sporogony is increased.	[Emami, S. Noushin; Lindberg, Bo G.; Hua, Susanna; Faye, Ingrid] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, SE-10691 Stockholm, Sweden; [Emami, S. Noushin; Hill, Sharon R.; Birgersson, Goran; Ignell, Rickard] SLU, Dept Plant Protect Biol, Unit Chem Ecol, SE-23053 Alnarp, Sweden; [Mozuraitis, Raimondas; Borg-Karlson, Anna-Karin] Royal Inst Technol, Dept Chem, Organ Chem, SE-10044 Stockholm, Sweden; [Mozuraitis, Raimondas] Nat Res Ctr, Inst Ecol, Lab Chem & Behav Ecol, LT-08412 Vilnius, Lithuania; [Lehmann, Philipp] Stockholm Univ, Dept Zool, SE-10691 Stockholm, Sweden	Stockholm University; Swedish University of Agricultural Sciences; Royal Institute of Technology; Nature Research Center - Lithuania; Stockholm University	Faye, I (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, SE-10691 Stockholm, Sweden.	ingrid.faye@su.se	Lehmann, Philipp/AEO-0158-2022; Hill, Sharon R/A-5121-2008	Hill, Sharon R/0000-0002-6474-0214; Emami, S. Noushin/0000-0001-7239-4457; /0000-0002-1719-2294; Lehmann, Philipp/0000-0001-8344-6830; Faye, Ingrid/0000-0003-4382-7238	INFRAVEC, its Bioinformatics Access Facility and Illumina sequencing; Sven and Lilly Lawski Foundation; Linnaeus Initiative "Insect chemical ecology, ethology and evolution, IC-E3 Formas, SLU"; Knut and Alice Wallenberg Foundation [KAW 2012.0058]	INFRAVEC, its Bioinformatics Access Facility and Illumina sequencing; Sven and Lilly Lawski Foundation; Linnaeus Initiative "Insect chemical ecology, ethology and evolution, IC-E3 Formas, SLU"; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	Supported by INFRAVEC (I.F.), its Bioinformatics Access Facility and Illumina sequencing (B.G.L. and S.N.E.), a postdoctoral scholarship from the Sven and Lilly Lawski Foundation (S.N.E.), the Linnaeus Initiative "Insect chemical ecology, ethology and evolution, IC-E3 Formas, SLU," and Knut and Alice Wallenberg Foundation grant KAW 2012.0058. We thank INFRAVEC for Illumina sequencing; T. Svensson for valuable assistance and knowledge transfer in the two-choice olfactometer technique; A. Cravcenco for synthesizing (2E)-2-methylbut-2-ene-1,4-diol; M. Troye-Blomberg for financial support to S.N.E.; and L. Ranford-Cartwright for comments and proofreading of the manuscript. Materials are made available by a materials transfer agreement from Stockholm University. All data required to understand and assess the conclusions of this research are available in the main text, supplementary materials, and via the following repositories: The data presented in this publication have been deposited in National Centre for Biotechnology's Gene Expression Omnibus and are accessible through GEO Series accession number GSE94316. S.N.E., I.F., R.I., S.H., and G.B. are inventors on a patent application (Great Britain patent application no. 1701743.5) submitted by the main applicant, S.N.E. (Potter Clarkson LLP-Stockholm University), that covers the phagostimulatory effects of HMBPP and the synthetic attractant odor blend. Author contributions: I.F. and S.N.E. conceived the study; the initial dual-choice assay was designed by S.N.E., I. F., and R.M.; and performed by S.N.E. and R.M.; R.I. and S.R.H. designed and S.N.E. performed the two-choice olfactometer assay; R.M., A.-K.B.-K., and G.B. designed and performed the GC-MS and analyzed the results; G.B. designed the SPME collection of volatiles and designed the release of volatiles for bioassay; R.M., P.L., and S.N.E. designed and performed the respirometry experiments; S.N.E. designed and S.N.E. and S.H. performed the mosquito fitness study; S.N.E. performed parasite culturing, mosquito infections, the feeding proportion study, and the statistical analyses; B.G.L. designed the temporal transcriptome study and prepared RNA for Illumina sequencing; S.N.E., B.G.L., and S.R.H. performed bioinformatics analyses of the sequencing data; B.G.L. performed the mosquito total protein assay; B.G.L. and S.N.E. constructed figures and tables; I. F., S.N.E., and S.H. designed and S.H. created the artwork; and I. F., B.G.L., R.I., S.R.H., and S.N.E. wrote the manuscript. All authors proofread and commented on the final draft of the manuscript. The authors declare no competing financial interests.	Batista EPA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-251; Berna AZ, 2015, J INFECT DIS, V212, P1120, DOI 10.1093/infdis/jiv176; Branicky R, 2009, NEURON, V62, P458, DOI 10.1016/j.neuron.2009.05.005; Cornet S, 2013, ECOL LETT, V16, P323, DOI 10.1111/ele.12041; De Moraes CM, 2014, P NATL ACAD SCI USA, V111, P11079, DOI 10.1073/pnas.1405617111; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; FRAME GW, 1972, J INVEST DERMATOL, V59, P155, DOI 10.1111/1523-1747.ep12625939; Hakimi MA, 2015, CURR OPIN MICROBIOL, V26, P24, DOI 10.1016/j.mib.2015.04.003; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Kelly M, 2015, MBIO, V6, DOI 10.1128/mBio.00235-15; Kidokoro Y, 2003, NEUROSIGNALS, V12, P13, DOI 10.1159/000068912; Koella JC, 1998, P ROY SOC B-BIOL SCI, V265, P763, DOI 10.1098/rspb.1998.0358; Lacroix R, 2005, PLOS BIOL, V3, P1590, DOI 10.1371/journal.pbio.0030298; Lee RTH, 2016, DEVELOPMENT, V143, P367, DOI 10.1242/dev.120154; Li F, 2009, NEW ENGL J MED, V361, P302, DOI 10.1056/NEJMcibr0902052; Lindberg BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073868; Mohr I, 2012, CELL HOST MICROBE, V12, P470, DOI 10.1016/j.chom.2012.09.006; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; Muller HM, 1995, EXP PARASITOL, V81, P371, DOI 10.1006/expr.1995.1128; Narbonne-Reveau K, 2006, MECH DEVELOP, V123, P197, DOI 10.1016/j.mod.2006.01.001; Newquist G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072524; Obbard DJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-274; Omondi BA, 2015, J EXP BIOL, V218, P2482, DOI 10.1242/jeb.116798; Ouedraogo AL, 2008, ACTA TROP, V105, P28, DOI 10.1016/j.actatropica.2007.09.003; Park D, 2014, J NEUROSCI, V34, P13195, DOI 10.1523/JNEUROSCI.2075-14.2014; Raikhel A. S., 2016, ADV INSECT PHYSL, V51; SMALLEY ME, 1981, T ROY SOC TROP MED H, V75, P318, DOI 10.1016/0035-9203(81)90349-7; Vasudevan A, 2015, ISME J, V9, P2112, DOI 10.1038/ismej.2015.33; Williams M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118911; Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138	30	59	61	3	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI		1076	1080		10.1126/science.aah4563	http://dx.doi.org/10.1126/science.aah4563			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VY	28183997				2022-12-28	WOS:000396348900045
J	Liu, YJ; Lu, YQ; Yang, XS; Zheng, XL; Wen, SH; Wang, F; Vidal, X; Zhao, JB; Liu, DM; Zhou, ZG; Ma, CS; Zhou, JJ; Piper, JA; Xi, P; Jin, DY				Liu, Yujia; Lu, Yiqing; Yang, Xusan; Zheng, Xianlin; Wen, Shihui; Wang, Fan; Vidal, Xavier; Zhao, Jiangbo; Liu, Deming; Zhou, Zhiguang; Ma, Chenshuo; Zhou, Jiajia; Piper, James A.; Xi, Peng; Jin, Dayong			Amplified stimulated emission in upconversion nanoparticles for super-resolution nanoscopy	NATURE			English	Article							RESONANCE ENERGY-TRANSFER; PHOTON-AVALANCHE; STED MICROSCOPY; UPCONVERTING NANOPARTICLES; NANOCRYSTALS; LUMINESCENCE; LASER; FLUORESCENCE; RESOLUTION; EFFICIENT	Lanthanide-doped glasses and crystals are attractive for laser applications because the metastable energy levels of the trivalent lanthanide ions facilitate the establishment of population inversion and amplified stimulated emission at relatively low pump power(1-3). At the nanometre scale, lanthanide-doped upconversion nanoparticles (UCNPs) can now be made with precisely controlled phase, dimension and doping level(4,5). When excited in the near-infrared, these UCNPs emit stable, bright visible luminescence at a variety of selectable wavelengths(6-9), with single-nanoparticle sensitivity(10-13), which makes them suitable for advanced luminescence microscopy applications. Here we show that UCNPs doped with high concentrations of thulium ions (Tm3+), excited at a wavelength of 980 nanometres, can readily establish a population inversion on their intermediate metastable H-3(4) level: the reduced inter-emitter distance at high Tm3+ doping concentration leads to intense cross-relaxation, inducing a photon-avalanche-like effect that rapidly populates the metastable H-3(4) level, resulting in population inversion relative to the H-3(6) ground level within a single nanoparticle. As a result, illumination by a laser at 808 nanometres, matching the upconversion band of the H-3(4)-> H-3(6) transition, can trigger amplified stimulated emission to discharge the H-3(4) intermediate level, so that the upconversion pathway to generate blue luminescence can be optically inhibited. We harness these properties to realize low-power super-resolution stimulated emission depletion (STED) microscopy and achieve nanometre-scale optical resolution (nanoscopy), imaging single UCNPs; the resolution is 28 nanometres, that is, 1/36th of the wavelength. These engineered nanocrystals offer saturation intensity two orders of magnitude lower than those of fluorescent probes currently employed in stimulated emission depletion microscopy, suggesting a new way of alleviating the square-root law that typically limits the resolution that can be practically achieved by such techniques.	[Liu, Yujia; Lu, Yiqing; Zheng, Xianlin; Wen, Shihui; Wang, Fan; Vidal, Xavier; Zhao, Jiangbo; Liu, Deming; Zhou, Zhiguang; Ma, Chenshuo; Piper, James A.; Xi, Peng; Jin, Dayong] Macquarie Univ, ARC Ctr Excellence Nanoscale BioPhoton CNBP, Adv Cytometry Labs, Sydney, NSW 2109, Australia; [Liu, Yujia; Lu, Yiqing; Zheng, Xianlin; Wang, Fan; Vidal, Xavier; Zhao, Jiangbo; Liu, Deming; Piper, James A.; Jin, Dayong] Macquarie Univ, Dept Phys & Astron, Sydney, NSW 2109, Australia; [Liu, Yujia; Yang, Xusan; Xi, Peng] Peking Univ, Dept Biomed Engn, Coll Engn, Beijing 100871, Peoples R China; [Liu, Yujia] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200241, Peoples R China; [Wen, Shihui; Wang, Fan; Zhou, Zhiguang; Zhou, Jiajia; Jin, Dayong] Univ Technol Sydney, Fac Sci, IBMD, Sydney, NSW 2007, Australia	Macquarie University; Macquarie University; Peking University; Shanghai Jiao Tong University; University of Technology Sydney	Lu, YQ; Xi, P; Jin, DY (corresponding author), Macquarie Univ, ARC Ctr Excellence Nanoscale BioPhoton CNBP, Adv Cytometry Labs, Sydney, NSW 2109, Australia.; Lu, YQ; Jin, DY (corresponding author), Macquarie Univ, Dept Phys & Astron, Sydney, NSW 2109, Australia.; Xi, P (corresponding author), Peking Univ, Dept Biomed Engn, Coll Engn, Beijing 100871, Peoples R China.; Jin, DY (corresponding author), Univ Technol Sydney, Fac Sci, IBMD, Sydney, NSW 2007, Australia.	yiqing.lu@mq.edu.au; xipeng@pku.edu.cn; dayong.jin@uts.edu.au	wen, shihui/H-4299-2014; Jin, Dayong/D-9652-2011; Zhao, Jiangbo/A-7886-2015; jin, dayong/U-6740-2018; Vidal, Xavier/K-6775-2012; Xi, Peng/A-9768-2012; Lu, Yiqing/D-2298-2013; Jin, Dayong/AAY-2402-2021; zhou, jiajia/ABA-7671-2021; wang, fan/U-8375-2017	wen, shihui/0000-0002-4670-4658; Jin, Dayong/0000-0003-1046-2666; Zhao, Jiangbo/0000-0002-5883-6017; Vidal, Xavier/0000-0001-8026-2016; Xi, Peng/0000-0001-6626-4840; Lu, Yiqing/0000-0001-6584-1853; Jin, Dayong/0000-0003-1046-2666; , chenshuo/0000-0001-9701-2566; Zheng, Xianlin/0000-0002-6462-9129; Piper, James/0000-0001-9503-6855; Yang, Xusan/0000-0001-8429-6299; Zhou, Jiajia/0000-0002-0605-5745; wang, fan/0000-0001-7403-3305	Australian Research Council (ARC) [FT 130100517]; ARC Centre of Excellence for Nanoscale BioPhotonics [CE140100003]; Natural Science Foundation of China [61428501, 31327901, 61475010]; National Instrumentation Project of China [2013YQ03065102]; Macquarie University Research Fellowship	Australian Research Council (ARC)(Australian Research Council); ARC Centre of Excellence for Nanoscale BioPhotonics(Australian Research Council); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Instrumentation Project of China; Macquarie University Research Fellowship	This project was primarily supported by the Australian Research Council (ARC) Future Fellowship Scheme (D.J., FT 130100517), the ARC Centre of Excellence for Nanoscale BioPhotonics (CE140100003), the Natural Science Foundation of China (61428501, 31327901, 61475010), and the National Instrumentation Project of China (2013YQ03065102). Y. Lu acknowledges support from a Macquarie University Research Fellowship.	Auzel F, 2004, CHEM REV, V104, P139, DOI 10.1021/cr020357g; AUZEL F, 1995, J LUMIN, V65, P45, DOI 10.1016/0022-2313(94)00071-J; Buchegger B, 2016, ACS NANO, V10, P1954, DOI 10.1021/acsnano.5b05863; Chen GY, 2010, ACS NANO, V4, P3163, DOI 10.1021/nn100457j; CHIVIAN JS, 1979, APPL PHYS LETT, V35, P124, DOI 10.1063/1.91044; Chmyrov A, 2013, NAT METHODS, V10, P737, DOI 10.1038/nmeth.2556; COLLINGS BC, 1994, J LUMIN, V62, P271, DOI 10.1016/0022-2313(94)90047-7; Donnert G, 2006, P NATL ACAD SCI USA, V103, P11440, DOI 10.1073/pnas.0604965103; Gargas DJ, 2014, NAT NANOTECHNOL, V9, P300, DOI [10.1038/NNANO.2014.29, 10.1038/nnano.2014.29]; Goldner P, 1996, OPT MATER, V5, P239, DOI 10.1016/0925-3467(96)00003-1; Han KY, 2009, NANO LETT, V9, P3323, DOI 10.1021/nl901597v; Hanne J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8127; Harke B, 2008, OPT EXPRESS, V16, P4154, DOI 10.1364/OE.16.004154; He LN, 2011, NAT NANOTECHNOL, V6, P428, DOI [10.1038/nnano.2011.99, 10.1038/NNANO.2011.99]; Jackson SD, 2012, NAT PHOTONICS, V6, P423, DOI [10.1038/NPHOTON.2012.149, 10.1038/nphoton.2012.149]; Joubert MF, 1999, OPT MATER, V11, P181, DOI 10.1016/S0925-3467(98)00043-3; JOUBERT MF, 1993, PHYS REV B, V48, P10031, DOI 10.1103/PhysRevB.48.10031; Koenderink AF, 2015, SCIENCE, V348, P516, DOI 10.1126/science.1261243; Kolesov R, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.153413; Leutenegger M, 2010, OPT EXPRESS, V18, P26417, DOI 10.1364/OE.18.026417; Liu DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10254; Lu YQ, 2014, NAT PHOTONICS, V8, P33, DOI [10.1038/NPHOTON.2013.322, 10.1038/nphoton.2013.322]; Mai HX, 2007, J PHYS CHEM C, V111, P13721, DOI 10.1021/jp073920d; Park YI, 2009, ADV MATER, V21, P4467, DOI 10.1002/adma.200901356; Rabouw FT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4610; Scheps R, 1996, PROG QUANT ELECTRON, V20, P271, DOI 10.1016/0079-6727(95)00007-0; Sedlmeier A, 2015, CHEM SOC REV, V44, P1526, DOI 10.1039/c4cs00186a; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; STONEMAN RC, 1990, OPT LETT, V15, P486, DOI 10.1364/OL.15.000486; URQUHART P, 1988, IEE PROC-J, V135, P385, DOI 10.1049/ip-j.1988.0071; Wang F, 2011, NAT MATER, V10, P968, DOI [10.1038/nmat3149, 10.1038/NMAT3149]; Wang F, 2010, NATURE, V463, P1061, DOI 10.1038/nature08777; Willig KI, 2007, NAT METHODS, V4, P915, DOI 10.1038/NMETH1108; Wu RT, 2015, OPT EXPRESS, V23, P32401, DOI 10.1364/OE.23.032401; Wu SW, 2009, P NATL ACAD SCI USA, V106, P10917, DOI 10.1073/pnas.0904792106; Zhao JB, 2013, NAT NANOTECHNOL, V8, P729, DOI 10.1038/nnano.2013.171	36	510	520	94	1328	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					229	+		10.1038/nature21366	http://dx.doi.org/10.1038/nature21366			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0GQ	28225761				2022-12-28	WOS:000395688700036
J	Abbasi, J				Abbasi, Jennifer			Amid Reports of Infant Deaths, FTC Cracks Down on Homeopathy While FDA Investigates	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	8	8	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2017	317	8					793	795		10.1001/jama.2016.19090	http://dx.doi.org/10.1001/jama.2016.19090			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM7PW	28196192				2022-12-28	WOS:000395505600002
J	Bleichert, F; Botchan, MR; Berger, JM				Bleichert, Franziska; Botchan, Michael R.; Berger, James M.			Mechanisms for initiating cellular DNA replication	SCIENCE			English	Review							ORIGIN RECOGNITION COMPLEX; MINICHROMOSOME MAINTENANCE PROTEIN; ESCHERICHIA-COLI; STRUCTURAL BASIS; FUNCTIONAL-ANALYSIS; ATP-HYDROLYSIS; IN-VITRO; CHROMOSOME-REPLICATION; CRYSTAL-STRUCTURE; MCM2-7 HELICASE	Cellular DNA replication factories depend on ring-shaped hexameric helicases to aid DNA synthesis by processively unzipping the parental DNA helix. Replicative helicases are loaded onto DNA by dedicated initiator, loader, and accessory proteins during the initiation of DNA replication in a tightly regulated, multistep process. We discuss here themolecular choreography of DNA replication initiation across the three domains of life, highlighting similarities and differences in the strategies used to deposit replicative helicases onto DNA and to melt the DNA helix in preparation for replisome assembly. Although initiators and loaders are phylogenetically related, the mechanisms they use for accomplishing similar tasks have diverged considerably and in an unpredictable manner.	[Bleichert, Franziska; Berger, James M.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Botchan, Michael R.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Bleichert, Franziska] Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Johns Hopkins University; University of California System; University of California Berkeley; Friedrich Miescher Institute for Biomedical Research	Bleichert, F; Berger, JM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.; Botchan, MR (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Bleichert, F (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	franziska.bleichert@fmi.ch; mbotchan@berkeley.edu; jmberger@jhmi.edu			NIH [GM071747, CA030490]; NATIONAL CANCER INSTITUTE [R01CA030490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071747] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	All authors contributed to the writing and editing of the manuscript. This work was supported by NIH grants GM071747 to J.M.B. and CA030490 to M.R.B. and J.M.B.	Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Alberts B., 2008, MOL BIOL CEL, V5th ed.; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P4658, DOI 10.1093/nar/27.23.4658; Arias-Palomo E, 2013, CELL, V153, P438, DOI 10.1016/j.cell.2013.03.006; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Balasov M, 2007, MOL CELL BIOL, V27, P3143, DOI 10.1128/MCB.02382-06; Barlow JH, 2014, CELL MOL LIFE SCI, V71, P4545, DOI 10.1007/s00018-014-1721-1; Bazin A, 2015, NUCLEIC ACIDS RES, V43, P8564, DOI 10.1093/nar/gkv792; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bell SP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010124; Bicknell LS, 2011, NAT GENET, V43, P356, DOI 10.1038/ng.775; Bicknell LS, 2011, NAT GENET, V43, P350, DOI 10.1038/ng.776; Bleichert F, 2015, NATURE, V519, P321, DOI 10.1038/nature14239; Bleichert F, 2013, ELIFE, V2, DOI 10.7554/eLife.00882; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Boos D, 2012, CURR OPIN CELL BIOL, V24, P423, DOI 10.1016/j.ceb.2012.01.011; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Brezellec P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13271; BROACH JR, 1982, COLD SPRING HARB SYM, V47, P1165, DOI 10.1101/SQB.1983.047.01.132; Bruck I, 2015, NUCLEUS-PHILA, V6, P449, DOI 10.1080/19491034.2015.1115938; Capaldi SA, 2004, NUCLEIC ACIDS RES, V32, P4821, DOI 10.1093/nar/gkh819; Caspi R, 2001, EMBO J, V20, P3262, DOI 10.1093/emboj/20.12.3262; CASSLER MR, 1995, EMBO J, V14, P5833, DOI 10.1002/j.1460-2075.1995.tb00271.x; Chesnokov I, 2001, P NATL ACAD SCI USA, V98, P11997, DOI 10.1073/pnas.211342798; Cho WH, 2006, P NATL ACAD SCI USA, V103, P11521, DOI 10.1073/pnas.0604990103; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Chuang RY, 1999, P NATL ACAD SCI USA, V96, P2656, DOI 10.1073/pnas.96.6.2656; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Coster G, 2014, MOL CELL, V55, P666, DOI 10.1016/j.molcel.2014.06.034; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; Das Mitali, 2014, Mol Biol Int, V2014, P574850, DOI 10.1155/2014/574850; Davey MJ, 2002, EMBO J, V21, P3148, DOI 10.1093/emboj/cdf308; Deegan TD, 2016, CURR OPIN STRUC BIOL, V37, P145, DOI 10.1016/j.sbi.2016.01.014; DIFFLEY JFX, 1992, NATURE, V357, P169, DOI 10.1038/357169a0; Donczew R, 2012, NUCLEIC ACIDS RES, V40, P9647, DOI 10.1093/nar/gks742; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Dueber EC, 2011, NUCLEIC ACIDS RES, V39, P3621, DOI 10.1093/nar/gkq1308; Dueber ELC, 2007, SCIENCE, V317, P1210, DOI 10.1126/science.1143690; Eaton ML, 2011, GENOME RES, V21, P164, DOI 10.1101/gr.116038.110; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Evrin C, 2014, NUCLEIC ACIDS RES, V42, P2257, DOI 10.1093/nar/gkt1148; Evrin C, 2013, NUCLEIC ACIDS RES, V41, P3162, DOI 10.1093/nar/gkt043; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Fragkos M, 2015, NAT REV MOL CELL BIO, V16, P360, DOI 10.1038/nrm4002; Frigola J, 2013, NATURE, V495, P339, DOI 10.1038/nature11920; Froelich CA, 2014, ELIFE, V3, DOI 10.7554/eLife.01993; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; Gambus A, 2011, J BIOL CHEM, V286, P11855, DOI 10.1074/jbc.M110.199521; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Gaudier M, 2007, SCIENCE, V317, P1213, DOI 10.1126/science.1143664; GILLE H, 1991, EMBO J, V10, P1579, DOI 10.1002/j.1460-2075.1991.tb07678.x; Giordano-Coltart J, 2005, P NATL ACAD SCI USA, V102, P69, DOI 10.1073/pnas.0408690102; Gomez-Llorente Y, 2005, J BIOL CHEM, V280, P40909, DOI 10.1074/jbc.M509760200; Grainge I, 2006, J MOL BIOL, V363, P355, DOI 10.1016/j.jmb.2006.07.076; Guernsey DL, 2011, NAT GENET, V43, P360, DOI 10.1038/ng.777; Hills SA, 2014, CURR BIOL, V24, pR435, DOI 10.1016/j.cub.2014.04.012; Ioannou C, 2006, NUCLEIC ACIDS RES, V34, P5247, DOI 10.1093/nar/gkl690; Itsathitphaisarn O, 2012, CELL, V151, P267, DOI 10.1016/j.cell.2012.09.014; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jiang Y, 2006, PLASMID, V55, P194, DOI 10.1016/j.plasmid.2005.11.001; Kang S, 2014, MOL CELL, V55, P655, DOI 10.1016/j.molcel.2014.06.033; Kawakami H, 2005, J BIOL CHEM, V280, P27420, DOI 10.1074/jbc.M502764200; Kawasaki Y, 2006, GENES CELLS, V11, P745, DOI 10.1111/j.1365-2443.2006.00975.x; KEARSEY S, 1984, CELL, V37, P299, DOI 10.1016/0092-8674(84)90326-X; Kelch BA, 2016, BIOPOLYMERS, V105, P532, DOI 10.1002/bip.22827; Kelch BA, 2011, SCIENCE, V334, P1675, DOI 10.1126/science.1211884; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; Klemm RD, 1997, CELL, V88, P493, DOI 10.1016/S0092-8674(00)81889-9; Klotz-Noack K, 2011, MOL CELL, V41, P495, DOI 10.1016/j.molcel.2011.02.014; Kong DC, 2003, EMBO J, V22, P3441, DOI 10.1093/emboj/cdg319; KOONIN EV, 1992, NUCLEIC ACIDS RES, V20, P1997, DOI 10.1093/nar/20.8.1997; Krause M, 1997, J MOL BIOL, V274, P365, DOI 10.1006/jmbi.1997.1404; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Leipe DD, 2000, GENOME RES, V10, P5; Leipe DD, 1999, NUCLEIC ACIDS RES, V27, P3389, DOI 10.1093/nar/27.17.3389; Li NN, 2015, NATURE, V524, P186, DOI 10.1038/nature14685; Liu JY, 2000, MOL CELL, V6, P637, DOI 10.1016/S1097-2765(00)00062-9; Lo YH, 2009, NUCLEIC ACIDS RES, V37, P804, DOI 10.1093/nar/gkn999; Lyubimov AY, 2012, P NATL ACAD SCI USA, V109, P11999, DOI 10.1073/pnas.1209406109; Lyubimov AY, 2011, CURR OPIN STRUC BIOL, V21, P240, DOI 10.1016/j.sbi.2011.01.002; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Majernik AI, 2008, BIOCHEM J, V409, P511, DOI 10.1042/BJ20070213; Makarova KS, 2005, NUCLEIC ACIDS RES, V33, P4626, DOI 10.1093/nar/gki775; Makowska-Grzyska M, 2010, MOL CELL, V37, P90, DOI 10.1016/j.molcel.2009.12.031; Marinsek N, 2006, EMBO REP, V7, P539, DOI 10.1038/sj.embor.7400649; Marques CA, 2016, NUCLEIC ACIDS RES, V44, P4763, DOI 10.1093/nar/gkw147; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; MATSUI M, 1985, J MOL BIOL, V184, P529, DOI 10.1016/0022-2836(85)90299-2; Matsunaga F, 2010, EXTREMOPHILES, V14, P21, DOI 10.1007/s00792-009-0284-9; McGarry KC, 2004, P NATL ACAD SCI USA, V101, P2811, DOI 10.1073/pnas.0400340101; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Noguchi K, 2006, EMBO J, V25, P5372, DOI 10.1038/sj.emboj.7601396; O'Shea VL, 2014, CURR OPIN STRUC BIOL, V25, P16, DOI 10.1016/j.sbi.2013.11.006; On KF, 2014, EMBO J, V33, P605, DOI 10.1002/embj.201387369; Pasero P, 1997, GENE DEV, V11, P1504, DOI 10.1101/gad.11.12.1504; Pietroni P, 2008, J BIOL CHEM, V283, P28338, DOI 10.1074/jbc.M804371200; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2005, J BIOL CHEM, V280, P39740, DOI 10.1074/jbc.M508515200; Remus D, 2004, EMBO J, V23, P897, DOI 10.1038/sj.emboj.7600077; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Richardson TT, 2016, NATURE, V534, P412, DOI 10.1038/nature17962; Rivera-Mulia JC, 2016, CURR OPIN CELL BIOL, V40, P168, DOI 10.1016/j.ceb.2016.03.022; Robinson A, 2012, CURR DRUG TARGETS, V13, P352, DOI 10.2174/138945012799424598; Robinson NP, 2004, CELL, V116, P25, DOI 10.1016/S0092-8674(03)01034-1; Rozgaja TA, 2011, MOL MICROBIOL, V82, P475, DOI 10.1111/j.1365-2958.2011.07827.x; Samson RY, 2016, MOL CELL, V61, P287, DOI 10.1016/j.molcel.2015.12.005; Samson RY, 2013, CELL REP, V3, P485, DOI 10.1016/j.celrep.2013.01.002; Sanchez-Pulido L, 2011, BIOINFORMATICS, V27, P1885, DOI 10.1093/bioinformatics/btr332; Sanchez-Pulido L, 2010, CURR BIOL, V20, pR509, DOI 10.1016/j.cub.2010.05.021; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Seitz H, 2000, MOL MICROBIOL, V37, P1270, DOI 10.1046/j.1365-2958.2000.02096.x; Shechter DF, 2000, J BIOL CHEM, V275, P15049, DOI 10.1074/jbc.M000398200; Shen Z, 2010, MOL CELL, V40, P99, DOI 10.1016/j.molcel.2010.09.021; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Siddiqui K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012930; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Soni RK, 2005, BIOCHEM J, V389, P541, DOI 10.1042/BJ20050062; Speck C, 1999, EMBO J, V18, P6169, DOI 10.1093/emboj/18.21.6169; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; Stelter M, 2012, STRUCTURE, V20, P554, DOI 10.1016/j.str.2012.01.020; Strycharska MS, 2013, MOL CELL, V52, P844, DOI 10.1016/j.molcel.2013.11.016; Sun JC, 2014, GENE DEV, V28, P2291, DOI 10.1101/gad.242313.114; Sun JC, 2013, NAT STRUCT MOL BIOL, V20, P944, DOI 10.1038/nsmb.2629; Sun JC, 2012, STRUCTURE, V20, P534, DOI 10.1016/j.str.2012.01.011; Sutton MD, 1997, J BIOL CHEM, V272, P23017, DOI 10.1074/jbc.272.37.23017; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Tanaka S, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010371; Thomae AW, 2008, P NATL ACAD SCI USA, V105, P1692, DOI 10.1073/pnas.0707260105; Ticau S, 2015, CELL, V161, P513, DOI 10.1016/j.cell.2015.03.012; Tiengwe C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032674; Trakselis MA, 2003, J MOL BIOL, V326, P435, DOI 10.1016/S0022-2836(02)01330-X; Tsai KL, 2009, J MOL BIOL, V393, P1056, DOI 10.1016/j.jmb.2009.09.002; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Velten M, 2003, MOL CELL, V11, P1009, DOI 10.1016/S1097-2765(03)00130-8; Wang JM, 2004, J STRUCT BIOL, V148, P259, DOI 10.1016/j.jsb.2004.07.003; Wei Z, 2010, J BIOL CHEM, V285, P12469, DOI 10.1074/jbc.C109.094599; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yao Nina Y, 2012, Subcell Biochem, V62, P259, DOI 10.1007/978-94-007-4572-8_14; Yardimci H, 2014, NAT STRUCT MOL BIOL, V21, P20, DOI 10.1038/nsmb.2738; Yeeles JTP, 2015, NATURE, V519, P431, DOI 10.1038/nature14285; Yuan ZN, 2016, NAT STRUCT MOL BIOL, V23, P217, DOI 10.1038/nsmb.3170	158	111	115	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327							eaah6317	10.1126/science.aah6317	http://dx.doi.org/10.1126/science.aah6317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28209641				2022-12-28	WOS:000395127600032
J	Gismondi, RA; de Souza, LFF				Gismondi, Ronaldo A.; de Souza, Luiz F. F.			Empyema Necessitatis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gismondi, Ronaldo A.; de Souza, Luiz F. F.] Univ Fed Fluminense, Rio De Janeiro, Brazil	Universidade Federal Fluminense	Gismondi, RA (corresponding author), Univ Fed Fluminense, Rio De Janeiro, Brazil.	ronaldogismondi@gmail.com	Gismondi, Ronaldo Altenburg/ABB-5885-2021	Gismondi, Ronaldo Altenburg/0000-0002-0884-4190					0	6	6	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2017	376	8					E13	E13		10.1056/NEJMicm1608914	http://dx.doi.org/10.1056/NEJMicm1608914			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JO	28225672				2022-12-28	WOS:000395627900011
J	Cohen, J				Cohen, Jon			INFECTIOUS DISEASE Easier cure for resistant TB	SCIENCE			English	News Item																			0	4	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					677	677		10.1126/science.355.6326.677	http://dx.doi.org/10.1126/science.355.6326.677			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2AC	28209851				2022-12-28	WOS:000395117700013
J	Cornwall, W				Cornwall, Warren			ENVIRONMENTAL POLICY Demise of stream rule won't revitalize coal industry	SCIENCE			English	News Item																			0	1	1	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					674	675		10.1126/science.355.6326.674	http://dx.doi.org/10.1126/science.355.6326.674			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2AC	28209847				2022-12-28	WOS:000395117700010
J	Swift, J				Swift, Joseph			Convergence The Idea at the Heart of Science	SCIENCE			English	Book Review									[Swift, Joseph] NYU, Ctr Genom & Syst Biol, New York, NY 10003 USA	New York University	Swift, J (corresponding author), NYU, Ctr Genom & Syst Biol, New York, NY 10003 USA.	jas1310@nyu.edu						Laughlin R.B., 2006, DIFFERENT UNIVERSE R; Watson Peter., 2017, CONVERGENCE IDEA HEA	2	0	0	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					701	701		10.1126/science.aal4353	http://dx.doi.org/10.1126/science.aal4353			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2AC	28209864				2022-12-28	WOS:000395117700027
J	Wise, J				Wise, Jacqui			GPs are unsure about prescribing tamoxifen to prevent breast cancer	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Independent Cancer Taskforce, 2015, ACH WORLD CLASS CANC; National Institute for Health and Care Excellence, 2013, FAM BREAST CANC CLAS; Smith SG, 2017, BRIT J GEN PRACT, V67, pE414, DOI 10.3399/bjgp17X689377	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2017	356								j772	10.1136/bmj.j772	http://dx.doi.org/10.1136/bmj.j772			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GL	28196826				2022-12-28	WOS:000394579600006
J	Diss, G; Gagnon-Arsenault, I; Dion-Cote, AM; Vignaud, H; Ascencio, DI; Berger, CM; Landry, CR				Diss, Guillaume; Gagnon-Arsenault, Isabelle; Dion-Cote, Anne-Marie; Vignaud, Helene; Ascencio, Diana I.; Berger, Caroline M.; Landry, Christian R.			Gene duplication can impart fragility, not robustness, in the yeast protein interaction network	SCIENCE			English	Article							LIVING CELLS; EVOLUTION; COMPENSATION; REDUNDANCY	The maintenance of duplicated genes is thought to protect cells from genetic perturbations, but the molecular basis of this robustness is largely unknown. By measuring the interaction of yeast proteins with their partners in wild-type cells and in cells lacking a paralog, we found that 22 out of 56 paralog pairs compensate for the lost interactions. An equivalent number of pairs exhibit the opposite behavior and require each other's presence for maintaining their interactions. These dependent paralogs generally interact physically, regulate each other's abundance, and derive from ancestral self-interacting proteins. This reveals that gene duplication may actually increase mutational fragility instead of robustness in a large number of cases.	[Diss, Guillaume; Gagnon-Arsenault, Isabelle; Dion-Cote, Anne-Marie; Vignaud, Helene; Ascencio, Diana I.; Berger, Caroline M.; Landry, Christian R.] Univ Laval, Dept Biol, Quebec City, PQ, Canada; [Diss, Guillaume; Gagnon-Arsenault, Isabelle; Dion-Cote, Anne-Marie; Vignaud, Helene; Ascencio, Diana I.; Berger, Caroline M.; Landry, Christian R.] Univ Laval, Quebec Network Res Prot Funct Engn & Applicat, Quebec City, PQ, Canada; [Diss, Guillaume; Gagnon-Arsenault, Isabelle; Dion-Cote, Anne-Marie; Vignaud, Helene; Ascencio, Diana I.; Berger, Caroline M.; Landry, Christian R.] Univ Laval, Inst Biol Integrat & Syst, Quebec City, PQ, Canada; [Diss, Guillaume] Barcelona Inst Sci & Technol, EMBL CRG Syst Biol Res Unit, Ctr Genom Regulat, Doctor Aiguader 88, Barcelona 08003, Spain; [Diss, Guillaume] Univ Pompeu Fabra, Barcelona 08003, Spain; [Ascencio, Diana I.] Inst Politecn Nacl, Lab Nacl Genom Biodiversidad LANGEBIO, Ctr Invest & Estudios Avanzados, Guanajuato, Mexico; [Dion-Cote, Anne-Marie] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Laval University; Laval University; Laval University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Cornell University	Landry, CR (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ, Canada.; Landry, CR (corresponding author), Univ Laval, Quebec Network Res Prot Funct Engn & Applicat, Quebec City, PQ, Canada.; Landry, CR (corresponding author), Univ Laval, Inst Biol Integrat & Syst, Quebec City, PQ, Canada.	christian.landry@bio.ulaval.ca	Diss, Guillaume/K-8390-2017; Diss, Guillaume/O-3859-2019	Diss, Guillaume/0000-0001-9153-4523; Diss, Guillaume/0000-0001-9153-4523; Landry, Christian/0000-0003-3028-6866; ASCENCIO, DIANA/0000-0003-4808-1244	Canadian Institutes of Health Research [299432, 324265]; European Union [608959]; Spanish Ministry of Economy and Competitiveness, "Centro de Excelencia Severo Ochoa"; Centres de Recerca de Catalunya Programme/Generalitat de Catalunya	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); European Union(European Commission); Spanish Ministry of Economy and Competitiveness, "Centro de Excelencia Severo Ochoa"; Centres de Recerca de Catalunya Programme/Generalitat de Catalunya	The data reported in this article is available in the supplementary materials. Funding for this project comes from Canadian Institutes of Health Research grants 299432 and 324265 to C.R.L. C.R.L. holds the Canada Research Chair in Evolutionary Cell and Systems Biology. G.D. is a Marie-Curie Fellow and received funding from the European Union's Seventh Framework Programme for research, technological development, and demonstration under grant agreement 608959. We acknowledge support of the Spanish Ministry of Economy and Competitiveness, "Centro de Excelencia Severo Ochoa 2013-2017" and of the Centres de Recerca de Catalunya Programme/Generalitat de Catalunya. The authors thank E. D. Levy, S. Peisajovich, B. Lehner, A. Deluna, A. M. New, and N. Aubin-Horth for comments and K. Adams for sharing data files. G.D. and C.R.L. designed the research, analyzed the results, and wrote the manuscript, with help from I.G.-A. G.D., I.G.-A., A.-M.D.-C., H.V., D.I.A., and C.M.B. performed experiments. A.-M.D.-C., H.V., D.I.A., and C.M.B. provided comments on the manuscript.	Baker CR, 2013, SCIENCE, V342, P104, DOI 10.1126/science.1240810; Bridgham JT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000191; DeLuna A, 2008, NAT GENET, V40, P676, DOI 10.1038/ng.123; DeLuna A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000347; Diss G, 2014, J EXP ZOOL PART B, V322, P488, DOI 10.1002/jez.b.22555; Diss G, 2013, CELL REP, V3, P2155, DOI 10.1016/j.celrep.2013.05.004; Dixit PD, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003023; Fares MA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003176; Force A, 1999, GENETICS, V151, P1531; Freschi L, 2013, MOL BIOSYST, V9, P36, DOI 10.1039/c2mb25265a; Gray MW, 2010, SCIENCE, V330, P920, DOI 10.1126/science.1198594; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hsiao TL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000014; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; Kemmeren P, 2014, CELL, V157, P740, DOI 10.1016/j.cell.2014.02.054; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Vavouri T, 2008, TRENDS GENET, V24, P485, DOI 10.1016/j.tig.2008.08.005; Veitia RA, 2013, TRENDS GENET, V29, P385, DOI 10.1016/j.tig.2013.04.004; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269	20	62	62	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					630	633		10.1126/science.aai7685	http://dx.doi.org/10.1126/science.aai7685			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK0SF	28183979				2022-12-28	WOS:000393636700049
J	Wang, HP; Weiss, BP; Bai, XN; Downey, BG; Wang, J; Wang, JJ; Suavet, C; Fu, RR; Zucolotto, ME				Wang, Huapei; Weiss, Benjamin P.; Bai, Xue-Ning; Downey, Brynna G.; Wang, Jun; Wang, Jiajun; Suavet, Clement; Fu, Roger R.; Zucolotto, Maria E.			Lifetime of the solar nebula constrained by meteorite paleomagnetism	SCIENCE			English	Article							ANGRITE PARENT BODY; PROTOPLANETARY DISK; CHONDRITES; DIFFERENTIATION; PLANETESIMALS; EVOLUTION; SYSTEM; INSTABILITY; CHONDRULES; ACCRETION	A key stage in planet formation is the evolution of a gaseous and magnetized solar nebula. However, the lifetime of the nebular magnetic field and nebula are poorly constrained. We present paleomagnetic analyses of volcanic angrites demonstrating that they formed in a near-zero magnetic field (<0.6 microtesla) at 4563.5 +/- 0.1 million years ago, similar to 3.8 million years after solar system formation. This indicates that the solar nebula field, and likely the nebular gas, had dispersed by this time. This sets the time scale for formation of the gas giants and planet migration. Furthermore, it supports formation of chondrules after 4563.5 million years ago by non-nebular processes like planetesimal collisions. The core dynamo on the angrite parent body did not initiate until about 4 to 11 million years after solar system formation.	[Wang, Huapei; Weiss, Benjamin P.; Downey, Brynna G.; Suavet, Clement; Fu, Roger R.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA USA; [Bai, Xue-Ning] Harvard Smithsonian Ctr Astrophys, Inst Theory & Computat, 60 Garden St, Cambridge, MA 02138 USA; [Wang, Jun; Wang, Jiajun] Brookhaven Natl Lab, Natl Synchrotron Light Source 2, Upton, NY 11973 USA; [Zucolotto, Maria E.] Museu Nacl, Rio De Janeiro, Brazil; [Wang, Huapei] China Univ Geosci, 388 Lumo Rd, Wuhan 430074, Hubei, Peoples R China	Massachusetts Institute of Technology (MIT); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; United States Department of Energy (DOE); Brookhaven National Laboratory; China University of Geosciences	Wang, HP (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA USA.	huapei@mit.edu	Bai, Xue-Ning/AAK-7772-2021; Bai, Xuening/H-7346-2017; 王, 家钧/AAH-4288-2021; Bai, Xue-Ning/AGO-2685-2022	Bai, Xue-Ning/0000-0001-6906-9549; Bai, Xuening/0000-0001-6906-9549; /0000-0003-1676-3494; Bai, Xuening/0000-0003-1172-3039; Zucolotto, Maria/0000-0003-2896-1105; /0000-0003-3635-2676	NASA [NNX15AH72G]; NASA Solar System Exploration and Research Virtual Institute [NNA14AB01A]; U.S. Rosetta program; U.S. Department of Energy, Office of Basic Energy Science [DE-AC02-98CH10886]; DOE Office of Science [DE-AC02-06CH11357]; DOE [DE-SC0012704]	NASA(National Aeronautics & Space Administration (NASA)); NASA Solar System Exploration and Research Virtual Institute; U.S. Rosetta program; U.S. Department of Energy, Office of Basic Energy Science(United States Department of Energy (DOE)); DOE Office of Science(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE))	We thank D. Kent for assistance with hysteresis and thermomagnetic measurements in the Rutgers Paleomagnetism Laboratory; E. Martin and C. Ross for assistance with hysteresis measurements at MIT; P. Rochette for providing the Galapagos lava samples; J. Crowley, F. Nimmo, E. Lima, and S. Balbus for useful discussions; C. Jones for use of the PaleoMag 3.1 software; and B. Carbone for administrative assistance. We also thank the American Natural History Museum for providing Angra dos Reis and Sahara 99555; the Museu Nacional, Brazil, for providing Angra dos Reis; and the National Institute for Polar Research, Japan, for providing Asuka 881371. The D'Orbigny samples were privately acquired and are curated at MIT. Paleomagnetic analysis data are provided in the supplementary materials. This research was funded by the NASA Emerging Worlds program grant NNX15AH72G, the NASA Solar System Exploration and Research Virtual Institute grant NNA14AB01A, the U.S. Rosetta program, and a generous gift from Thomas F. Peterson Jr. The use of the National Synchrotron Light Source (NSLS) was supported by the U.S. Department of Energy, Office of Basic Energy Science under contract DE-AC02-98CH10886. This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract DE-AC02-06CH11357. Use of APS beamline 8BM is partially supported by the National Synchrotron Light Source II, Brookhaven National Laboratory, under DOE contract DE-SC0012704. We also thank five anonymous reviewers for their helpful reviews.	Alexander R., 2014, PROTOSTARS PLANETS, P475, DOI DOI 10.2458/AZU_UAPRESS_9780816531240-CH021; Amelin Y., 2012, METEORIT PLANET SC S, V75, P5199; Bai XN, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/2/137; Bell CPM, 2013, MON NOT R ASTRON SOC, V434, P806, DOI 10.1093/mnras/stt1075; Busemann H, 2006, GEOCHIM COSMOCHIM AC, V70, P5403, DOI 10.1016/j.gca.2006.08.015; Chaussidon M, 2015, GEOPHYS MONOGR SER, V212, P1; Desch SJ, 2002, METEORIT PLANET SCI, V37, P183, DOI 10.1111/j.1945-5100.2002.tb01104.x; Elkins-Tanton LT, 2011, EARTH PLANET SC LETT, V305, P1, DOI 10.1016/j.epsl.2011.03.010; Fu RR, 2014, SCIENCE, V346, P1089, DOI 10.1126/science.1258022; Helled R., 2014, PROTOSTARS PLANETS, P643; Johansen A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500109; Keil K, 2012, CHEM ERDE-GEOCHEM, V72, P191, DOI 10.1016/j.chemer.2012.06.002; Kominami J, 2004, ICARUS, V167, P231, DOI 10.1016/j.icarus.2003.10.005; Krot AN, 2005, NATURE, V436, P989, DOI 10.1038/nature03830; Mamajek EE, 2009, AIP CONF PROC, V1158, P3, DOI 10.1063/1.3215910; McKibbin SJ, 2015, GEOCHIM COSMOCHIM AC, V157, P13, DOI 10.1016/j.gca.2015.02.019; McNally CP, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/1/62; Mikouchi T., 2001, METEORIT PLANET SCI, V36, pA134; Nelson RP, 2013, MON NOT R ASTRON SOC, V435, P2610, DOI 10.1093/mnras/stt1475; Neumann W, 2014, EARTH PLANET SC LETT, V395, P267, DOI 10.1016/j.epsl.2014.03.033; PODOSEK FA, 1994, METEORITICS, V29, P6, DOI 10.1111/j.1945-5100.1994.tb00649.x; Roberts J. H., 2013, WORKSH PLAN FORM DIF, V1768; Sarafian A. R., 2015, LUN PLAN SCI C 46; Schiller M, 2015, EARTH PLANET SC LETT, V420, P45, DOI 10.1016/j.epsl.2015.03.028; Scott ERD, 2007, ANNU REV EARTH PL SC, V35, P577, DOI 10.1146/annurev.earth.35.031306.140100; SHAW J, 1974, GEOPHYS J ROY ASTR S, V39, P133, DOI 10.1111/j.1365-246X.1974.tb05443.x; Stephens IW, 2014, NATURE, V514, P597, DOI 10.1038/nature13850; Sterenborg MG, 2013, PHYS EARTH PLANET IN, V214, P53, DOI 10.1016/j.pepi.2012.10.006; Suavet C, 2014, GEOCHEM GEOPHY GEOSY, V15, P2733, DOI 10.1002/2013GC005215; Takeuchi T, 2001, ASTROPHYS J, V557, P990, DOI 10.1086/322252; Tauxe L, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000635; Turner N. J., 2014, PROTOSTARS PLANETS, P411, DOI DOI 10.2458/AZU_UAPRESS_9780816531240-CH018; Warren PH, 2011, EARTH PLANET SC LETT, V311, P93, DOI 10.1016/j.epsl.2011.08.047; Weiss BP, 2008, SCIENCE, V322, P713, DOI 10.1126/science.1162459; Weiss BP, 2010, SPACE SCI REV, V152, P341, DOI 10.1007/s11214-009-9580-z	40	98	99	4	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					623	+		10.1126/science.aaf5043	http://dx.doi.org/10.1126/science.aaf5043			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK0SF	28183977				2022-12-28	WOS:000393636700047
J	Harrison, LB; Nash, MJ; Fitzmaurice, D; Thachil, J				Harrison, Laura B.; Nash, Michael J.; Fitzmaurice, David; Thachil, Jecko			RATIONAL TESTING Investigating easy bruising in an adult	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Harrison, Laura B.] Univ Manchester, Manchester, Lancs, England; [Nash, Michael J.; Thachil, Jecko] Cent Manchester Univ Hosp NHS Fdn Trust, Dept Haematol, Manchester, Lancs, England; [Fitzmaurice, David] Univ Birmingham, Coll Med & Dent Sci, Inst Appl Hlth Res, Primary Care Clin Sci,Primary Care, Birmingham, W Midlands, England	University of Manchester; University of Manchester; University of Birmingham	Thachil, J (corresponding author), Cent Manchester Univ Hosp NHS Fdn Trust, Dept Haematol, Manchester, Lancs, England.	jecko.thachil@cmft.nhs.uk						Ballas M, 2008, AM FAM PHYSICIAN, V77, P1117; Karnath B, 2005, HOSP PHYS, V41, P35; Laffan M, BMJ BEST PRACTICE; National Institute for Health and Care Excellence (NICE), CLIN KNOWL SUMM CKS; Rodeghiero F, 2010, J THROMB HAEMOST, V8, P2063, DOI 10.1111/j.1538-7836.2010.03975.x; Thomas AE, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1285; Wang TF, BMJ BEST PRACTICE	7	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2017	356								j251	10.1136/bmj.j251	http://dx.doi.org/10.1136/bmj.j251			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4GB	28183694				2022-12-28	WOS:000394578600001
J	Hotamisligil, GS				Hotamisligil, Gokhan S.			Inflammation, metaflammation and immunometabolic disorders	NATURE			English	Review							INDUCED INSULIN-RESISTANCE; ENDOPLASMIC-RETICULUM STRESS; ADIPOSE-TISSUE INFLAMMATION; NECROSIS-FACTOR-ALPHA; DIET-INDUCED OBESITY; REGULATORY T-CELLS; SKELETAL-MUSCLE; METABOLIC DYSFUNCTION; FATTY-ACIDS; ER STRESS	Proper regulation and management of energy, substrate diversity and quantity, as well as macromolecular synthesis and breakdown processes, are fundamental to cellular and organismal survival and are paramount to health. Cellular and multicellular organization are defended by the immune response, a robust and critical system through which self is distinguished from non-self, pathogenic signals are recognized and eliminated, and tissue homeostasis is safeguarded. Many layers of evolutionarily conserved interactions occur between immune response and metabolism. Proper maintenance of this delicate balance is crucial for health and has important implications for many pathological states such as obesity, diabetes, and other chronic non-communicable diseases.	[Hotamisligil, Gokhan S.] Broad Inst Harvard & MIT, Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Hotamisligil, Gokhan S.] Broad Inst Harvard & MIT, Harvard TH Chan Sch Publ Hlth, Sabri Ulker Ctr, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Broad Institute	Hotamisligil, GS (corresponding author), Broad Inst Harvard & MIT, Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.; Hotamisligil, GS (corresponding author), Broad Inst Harvard & MIT, Harvard TH Chan Sch Publ Hlth, Sabri Ulker Ctr, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Duarte, Graziela Biude Silva/Q-7728-2016; Braga, Tarcio T/E-4827-2014	Braga, Tarcio T/0000-0002-2989-1076	National Institutes of Health [DK052539, HL125753, Al116901]; JDRF [2SRA-2016-147-Q-R]; Union Chemique Belge; Servier; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); Union Chemique Belge; Servier(Servier); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	I am grateful to all members of the Hotamisligil laboratory for helpful discussions, and especially G. Parlakgul for the initial preparation of figures, and K. Claiborn for discussions and invaluable editorial assistance. Work in the Hotamisligil laboratory is supported by grants from the National Institutes of Health (DK052539, HL125753, Al116901), the JDRF (2SRA-2016-147-Q-R), and sponsored research agreements from Union Chemique Belge and Servier.	Agrawal N, 2016, CELL METAB, V23, P675, DOI 10.1016/j.cmet.2016.03.003; Arruda AP, 2015, CELL METAB, V22, P381, DOI 10.1016/j.cmet.2015.06.010; Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; Bettigole SE, 2015, ANNU REV IMMUNOL, V33, P107, DOI 10.1146/annurev-immunol-032414-112116; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Bogue MA, 2015, MAMM GENOME, V26, P511, DOI 10.1007/s00335-015-9595-6; Boriushkin E, 2016, SCI REP-UK, V6, DOI 10.1038/srep25013; Brines M, 2014, MOL MED, V20, P658, DOI 10.2119/molmed.2014.00215; Brown AE, 2015, AM J PHYSIOL-ENDOC M, V308, pE63, DOI 10.1152/ajpendo.00115.2014; Burska AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128889; Cerami A, 2012, ANN RHEUM DIS, V71, P55, DOI 10.1136/annrheumdis-2011-200800; Chen SS, 2014, BIOCHEM BIOPH RES CO, V443, P814, DOI 10.1016/j.bbrc.2013.12.051; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Collino M, 2014, BRIT J PHARMACOL, V171, P5802, DOI 10.1111/bph.12888; Coward WR, 2006, J IMMUNOL, V176, P5284, DOI 10.4049/jimmunol.176.9.5284; Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; DiAngelo JR, 2009, P NATL ACAD SCI USA, V106, P20853, DOI 10.1073/pnas.0906749106; Dimas AS, 2014, DIABETES, V63, P2158, DOI 10.2337/db13-0949; Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275; Fan RR, 2016, NAT MED, V22, P780, DOI 10.1038/nm.4114; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; FOX MJ, 1947, ARCH INTERN MED, V79, P614, DOI 10.1001/archinte.1947.00220120044003; Freemerman AJ, 2014, J BIOL CHEM, V289, P7884, DOI 10.1074/jbc.M113.522037; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Fujita H, 2015, EMBO J, V34, P1042, DOI 10.15252/embj.201489897; Fuster JJ, 2015, DIABETES, V64, P1235, DOI 10.2337/db14-1164; Gehart H, 2010, EMBO REP, V11, P834, DOI 10.1038/embor.2010.160; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Goldfine AB, 2013, ANN INTERN MED, V159, P1, DOI 10.7326/0003-4819-159-1-201307020-00003; Gonzalez-Teran B, 2016, EMBO J, V35, P536, DOI 10.15252/embj.201591857; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Hassan RH, 2016, J BIOL CHEM, V291, P3019, DOI 10.1074/jbc.M115.686949; HAUSBERGER FX, 1966, ANAT RECORD, V154, P651, DOI 10.1002/ar.1091540311; He Y, 2013, EUR J IMMUNOL, V43, P1147, DOI 10.1002/eji.201243187; HELLMAN B, 1965, ANN NY ACAD SCI, V131, P541, DOI 10.1111/j.1749-6632.1965.tb34819.x; Henriksbo BD, 2014, DIABETES, V63, P3742, DOI 10.2337/db13-1398; Herder C, 2015, TRENDS ENDOCRIN MET, V26, P551, DOI 10.1016/j.tem.2015.08.001; Hett EC, 2013, NAT CHEM BIOL, V9, P398, DOI [10.1038/nchembio.1236, 10.1038/NCHEMBIO.1236]; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Hull-Thompson J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000460; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107; Jain P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053522; Ji YW, 2012, J BIOL CHEM, V287, P13561, DOI 10.1074/jbc.M112.350066; Jin CC, 2013, CELL METAB, V17, P873, DOI 10.1016/j.cmet.2013.05.011; Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760; Kebede MA, 2014, TRENDS ENDOCRIN MET, V25, P493, DOI 10.1016/j.tem.2014.06.006; Keestra-Gounder AM, 2016, NATURE, V532, P394, DOI 10.1038/nature17631; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kewalramani G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026947; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Kothari V, 2016, J INFLAMM RES, V9, P27, DOI 10.2147/JIR.S86917; Kwon H, 2014, CELL REP, V9, P1574, DOI 10.1016/j.celrep.2014.10.068; Lancaster GI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10626; Lancaster GI, 2014, TRENDS IMMUNOL, V35, P262, DOI 10.1016/j.it.2014.02.008; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lee JY, 2003, J BIOL CHEM, V278, P37041, DOI 10.1074/jbc.M305213200; Lefere S, 2016, CELL MOL LIFE SCI, V73, P3419, DOI 10.1007/s00018-016-2222-1; Li PP, 2016, CELL, V167, P973, DOI 10.1016/j.cell.2016.10.025; Li W, 2013, J NAVIGATION, V1, P1, DOI DOI 10.2119/M0LMED.2013.00064; Li Y, 2016, CELL, V167, P1099, DOI 10.1016/j.cell.2016.10.017; Lim JX, 2013, FASEB J, V27, P4757, DOI 10.1096/fj.13-232702; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lynch L, 2014, IMMUNOLOGY, V142, P337, DOI 10.1111/imm.12269; Mabery EM, 2010, J INNATE IMMUN, V2, P371, DOI 10.1159/000315050; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; McGarry JD, 1998, AM J CLIN NUTR, V67, p500S, DOI 10.1093/ajcn/67.3.500S; Miao HM, 2014, CELL REP, V7, P223, DOI 10.1016/j.celrep.2014.02.047; Michel CI, 2011, CELL METAB, V14, P33, DOI 10.1016/j.cmet.2011.04.009; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Montes VN, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.11; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Morris SNS, 2012, BBA-MOL BASIS DIS, V1822, P1230, DOI 10.1016/j.bbadis.2012.04.012; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Nishimoto S, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501332; Nishimura S, 2013, CELL METAB, V18, P759, DOI 10.1016/j.cmet.2013.09.017; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Pasco MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036583; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; PEKALA P, 1983, J EXP MED, V157, P1360, DOI 10.1084/jem.157.4.1360; RANDLE PJ, 1963, LANCET, V1, P785; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sampey BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038812; Scheen AJ, 2015, DIABETES METAB, V41, P183, DOI 10.1016/j.diabet.2015.02.003; Schirmer M, 2016, CELL, V167, P1125, DOI 10.1016/j.cell.2016.10.020; Schork NJ, 2015, NATURE, V520, P609, DOI 10.1038/520609a; Serra C, 2003, J CELL PHYSIOL, V196, P89, DOI 10.1002/jcp.10278; Shimizu I, 2013, CELL METAB, V18, P491, DOI 10.1016/j.cmet.2013.09.001; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; Song F, 2014, DIABETES, V63, P1948, DOI 10.2337/db13-1636; Song Y, 2015, MOL IMMUNOL, V68, P341, DOI 10.1016/j.molimm.2015.09.007; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Szendroedi J, 2014, P NATL ACAD SCI USA, V111, P9597, DOI 10.1073/pnas.1409229111; ter Horst R, 2016, CELL, V167, P1111, DOI 10.1016/j.cell.2016.10.018; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Toubal A, 2013, TRENDS ENDOCRIN MET, V24, P625, DOI 10.1016/j.tem.2013.09.006; Tsaousidou E, 2014, CELL REP, V9, P1495, DOI 10.1016/j.celrep.2014.10.045; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Turner N, 2008, TRENDS ENDOCRIN MET, V19, P324, DOI 10.1016/j.tem.2008.08.001; Tynan GA, 2014, DIABETES, V63, P2037, DOI 10.2337/db13-1476; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vereecke L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6103; Waeber G, 2000, NAT GENET, V24, P291, DOI 10.1038/73523; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Xie M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13280; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Yang L, 2015, SCIENCE, V349, P500, DOI 10.1126/science.aaa0079; Yi ZA, 2014, DIABETES, V63, P2751, DOI 10.2337/db13-1657; Yilmaz M, 2016, DIABETES, V65, P1800, DOI 10.2337/db16-0251; Youssef OA, 2015, P NATL ACAD SCI USA, V112, P5023, DOI 10.1073/pnas.1424044112; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	140	1009	1052	20	322	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					177	185		10.1038/nature21363	http://dx.doi.org/10.1038/nature21363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK2DJ	28179656				2022-12-28	WOS:000393737500030
J	Savage, N				Savage, Neil			Getting Data Sharing Right to Help Fulfill the Promise of Cancer Genomics	CELL			English	Editorial Material								Limited access to the profusion of sequence information derived from cancer patients worldwide stymies basic research and clinical decisions. Efforts are underway to streamline and safeguard data use.											0	5	5	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2017	168	4					551	554		10.1016/j.cell.2017.01.003	http://dx.doi.org/10.1016/j.cell.2017.01.003			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8VJ	28187273	Bronze			2022-12-28	WOS:000396277600003
J	Vander Heiden, MG; DeBerardinis, RJ				Vander Heiden, Matthew G.; DeBerardinis, Ralph J.			Understanding the Intersections between Metabolism and Cancer Biology	CELL			English	Review							CELL LUNG-CANCER; ELECTRON-TRANSPORT CHAIN; OXIDATIVE STRESS; TUMOR METABOLISM; PYRUVATE-KINASE; MITOCHONDRIAL METABOLISM; THERAPEUTIC RESPONSE; GLUTAMINE-METABOLISM; MUTANT IDH; NAD PLUS	Transformed cells adapt metabolism to support tumor initiation and progression. Specific metabolic activities can participate directly in the process of transformation or support the biological processes that enable tumor growth. Exploiting cancer metabolism for clinical benefit requires defining the pathways that are limiting for cancer progression and understanding the context specificity of metabolic preferences and liabilities in malignant cells. Progress toward answering these questions is providing new insight into cancer biology and can guide the more effective targeting of metabolism to help patients.	[Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Vander Heiden, Matthew G.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Vander Heiden, Matthew G.] Dana Farber Canc Inst, Boston, MA 02115 USA; [DeBerardinis, Ralph J.] Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr, Res Inst, Dept Pediat, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.] Univ Texas Southwestern Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Vander Heiden, MG (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Vander Heiden, MG (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Vander Heiden, MG (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.; DeBerardinis, RJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr, Res Inst, Dept Pediat, Dallas, TX 75390 USA.; DeBerardinis, RJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.	mvh@mit.edu; ralph.deberardinis@utsouthwestern.edu			NCI [CA168653, CA201276, CA157996]; Ludwig Center at MIT, SU2C; Lustgarten Foundation; Howard Hughes Medical Institute; Cancer Prevention and Research Institute of Texas [RP160089]; V Foundation; Robert A. Welch Foundation [I-1733]; NATIONAL CANCER INSTITUTE [R21CA198028, R01CA201276, R01CA157996, R01CA168653] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ludwig Center at MIT, SU2C; Lustgarten Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cancer Prevention and Research Institute of Texas; V Foundation; Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We regret that due to space limitations we were unable to cite many excellent studies that shaped our modern understanding of cancer metabolism. We thank members of the R.J.D. and M.G.V.H. laboratories for insight and extensive critique of the manuscript and Brooke Bevis for help with figures. M.G.V.H. is supported by the NCI (CA168653, CA201276), the Ludwig Center at MIT, SU2C, the Lustgarten Foundation, and the Howard Hughes Medical Institute (Faculty Scholars Award). R.J.D. is supported by grants from the NCI (CA157996), Cancer Prevention and Research Institute of Texas (RP160089), V Foundation (Translational Research Award), Robert A. Welch Foundation (I-1733), and the Howard Hughes Medical Institute (Faculty Scholars Award). M.G.V.H. is on the scientific advisory board of Agios Pharmaceuticals and Aeglea Biotherapeutics, and R.J.D. is on the scientific advisory board of Agios Pharmaceuticals.	Aird KM, 2013, CELL REP, V3, P1252, DOI 10.1016/j.celrep.2013.03.004; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Andronesi OC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002693; Andrzejewski S, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-12; Bao XR, 2016, ELIFE, V5, DOI 10.7554/eLife.10575; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Boros LG, 2000, CANCER RES, V60, P1183; Boudreau A, 2016, NAT CHEM BIOL, V12, P779, DOI 10.1038/nchembio.2143; Brand A, 2016, CELL METAB, V24, P657, DOI 10.1016/j.cmet.2016.08.011; Burtscher M, 2014, AGING DIS, V5, P274, DOI 10.14336/AD.2014.0500274; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Cairns RA, 2016, NAT REV CANCER, V16, P613, DOI 10.1038/nrc.2016.100; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chen C, 2013, GENE DEV, V27, P1974, DOI 10.1101/gad.226613.113; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; COCCO P, 1987, J EPIDEMIOL COMMUN H, V41, P89, DOI 10.1136/jech.41.2.89; Coloff JL, 2016, CELL METAB, V23, P867, DOI 10.1016/j.cmet.2016.03.016; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; CURI R, 1988, BIOCHEM J, V250, P383, DOI 10.1042/bj2500383; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Davidson SM, 2017, NAT MED, V23, P235, DOI 10.1038/nm.4256; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; Dayton TL, 2016, GENE DEV, V30, P1020, DOI 10.1101/gad.278549.116; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Dietrich LEP, 2013, J BACTERIOL, V195, P1371, DOI 10.1128/JB.02273-12; Erez A, 2015, NAT REV CANCER, V15, P440, DOI 10.1038/nrc3949; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Fang M, 2010, CELL, V143, P711, DOI 10.1016/j.cell.2010.10.010; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fletcher M, 2015, CANCER RES, V75, P275, DOI 10.1158/0008-5472.CAN-14-1491; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; Gaglio D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004715; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gaude E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13041; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Gui DY, 2016, CELL METAB, V24, P716, DOI 10.1016/j.cmet.2016.09.006; Guo JY, 2016, GENE DEV, V30, P1704, DOI 10.1101/gad.283416.116; Hakimi AA, 2016, CANCER CELL, V29, P104, DOI 10.1016/j.ccell.2015.12.004; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Henrich FC, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1184802; Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Hosios AM, 2016, DEV CELL, V36, P540, DOI 10.1016/j.devcel.2016.02.012; Howell JJ, 2013, BIOCHEM SOC T, V41, P906, DOI 10.1042/BST20130041; Hu J, 2013, NAT BIOTECHNOL, V31, P522, DOI 10.1038/nbt.2530; Israelsen WJ, 2015, SEMIN CELL DEV BIOL, V43, P43, DOI 10.1016/j.semcdb.2015.08.004; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Janzer A, 2014, P NATL ACAD SCI USA, V111, P10574, DOI 10.1073/pnas.1409844111; Jiang L, 2015, ONCOGENE, V34, P3908, DOI 10.1038/onc.2014.321; Jiang L, 2016, NATURE, V532, P255, DOI 10.1038/nature17393; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kamphorst JJ, 2015, CANCER RES, V75, P544, DOI 10.1158/0008-5472.CAN-14-2211; Kats LM, 2014, CELL STEM CELL, V14, P329, DOI 10.1016/j.stem.2013.12.016; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Krall AS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11457; Kryukov GV, 2016, SCIENCE, V351, P1214, DOI 10.1126/science.aad5214; Kuehne A, 2015, MOL CELL, V59, P359, DOI 10.1016/j.molcel.2015.06.017; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Lunt SY, 2015, MOL CELL, V57, P95, DOI 10.1016/j.molcel.2014.10.027; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Maher EA, 2012, NMR BIOMED, V25, P1234, DOI 10.1002/nbm.2794; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Marjon K, 2016, CELL REP, V15, P574, DOI 10.1016/j.celrep.2016.03.043; Mavrakis KJ, 2016, SCIENCE, V351, P1208, DOI 10.1126/science.aad5944; Mayers JR, 2016, SCIENCE, V353, P1161, DOI 10.1126/science.aaf5171; Meiser J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601273; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Navarro P, 2016, CELL REP, V15, P2705, DOI 10.1016/j.celrep.2016.05.052; Nelson SJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006070; Palm W, 2015, CELL, V162, P259, DOI 10.1016/j.cell.2015.06.017; Phillips MM, 2013, CANCER RES TREAT, V45, P251, DOI 10.4143/crt.2013.45.4.251; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Platten M, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00673; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Qiu B, 2015, CANCER DISCOV, V5, P652, DOI 10.1158/2159-8290.CD-14-1507; Rabinovich S, 2015, NATURE, V527, P379, DOI 10.1038/nature15529; Robbins MEC, 2004, INT J RADIAT BIOL, V80, P251, DOI 10.1080/09553000410001692726; Saha SK, 2014, NATURE, V513, P110, DOI 10.1038/nature13441; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Sciacovelli M, 2016, NATURE, V537, P544, DOI 10.1038/nature19353; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Sellers K, 2015, J CLIN INVEST, V125, P687, DOI 10.1172/JCI72873; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Sousa CM, 2016, NATURE, V536, P479, DOI 10.1038/nature19084; Stams WAG, 2003, BLOOD, V101, P2743, DOI 10.1182/blood-2002-08-2446; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Svensson RU, 2016, NAT MED, V22, P1108, DOI 10.1038/nm.4181; Sykes DB, 2016, CELL, V167, P171, DOI 10.1016/j.cell.2016.08.057; Szenajch J, 2010, BBA-REV CANCER, V1806, P82, DOI 10.1016/j.bbcan.2010.04.002; Tateishi K, 2015, CANCER CELL, V28, P773, DOI 10.1016/j.ccell.2015.11.006; Titov DV, 2016, SCIENCE, V352, P231, DOI 10.1126/science.aad4017; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Venneti S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1009; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wenzel C, 2014, EXP CELL RES, V323, P131, DOI 10.1016/j.yexcr.2014.01.017; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; White E, 2013, GENE DEV, V27, P2065, DOI 10.1101/gad.228122.113; White RM, 2011, NATURE, V471, P518, DOI 10.1038/nature09882; Witney TH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac6117; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Yuneva MO, 2012, CELL METAB, V15, P157, DOI 10.1016/j.cmet.2011.12.015; Zhang G, 2016, J CLIN INVEST, V126, P1834, DOI 10.1172/JCI82661; Zhang W, 2012, NAT CELL BIOL, V14, P276, DOI 10.1038/ncb2432; Zheng L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7001	126	1082	1087	29	338	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2017	168	4								10.1016/j.cell.2016.12.039	http://dx.doi.org/10.1016/j.cell.2016.12.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8VJ	28187287	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000396277600016
J	Specht, JM; Davidson, NE				Specht, Jennifer M.; Davidson, Nancy E.			Optimal duration of trastuzumab for early HER2-positive breast cancer	LANCET			English	Editorial Material							ADJUVANT TRASTUZUMAB; PHASE-3 TRIAL; OPEN-LABEL; CHEMOTHERAPY; MULTICENTER; PERTUZUMAB; WOMEN		[Specht, Jennifer M.; Davidson, Nancy E.] Univ Washington, Sch Med, Dept Med, Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Davidson, NE (corresponding author), Univ Washington, Sch Med, Dept Med, Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA.	ndavidson@fredhutch.org	Specht, Jennifer/N-7174-2019		Genentech	Genentech(Roche HoldingGenentech)	JMS has received research support to her institution for clinical trials from Genentech (owned by Roche, the company that sponsored the HERA trial); none of these trials are relevant or represent any conflict to this Comment. NED declares no competing interests.	Cameron D, 2017, LANCET; Chan A, 2016, LANCET ONCOL, V17, P367, DOI 10.1016/S1470-2045(15)00551-3; Gianni L, 2012, LANCET ONCOL, V13, P25, DOI 10.1016/S1470-2045(11)70336-9; Goldhirsch A, 2013, LANCET, V382, P1021, DOI 10.1016/S0140-6736(13)61094-6; Mavroudis D, 2015, ANN ONCOL, V26, P1333, DOI 10.1093/annonc/mdv213; Perez EA, 2014, J CLIN ONCOL, V32, P3744, DOI 10.1200/JCO.2014.55.5730; Perez EA, 2011, J CLIN ONCOL, V29, P4491, DOI 10.1200/JCO.2011.36.7045; Piccart-Gebhart M, 2016, J CLIN ONCOL, V34, P1034, DOI 10.1200/JCO.2015.62.1797; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Pivot X, 2013, LANCET ONCOL, V14, P741, DOI 10.1016/S1470-2045(13)70225-0; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Swain SM, 2015, NEW ENGL J MED, V372, P724, DOI 10.1056/NEJMoa1413513	12	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2017	389	10075					1167	1168		10.1016/S0140-6736(17)30322-7	http://dx.doi.org/10.1016/S0140-6736(17)30322-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EP1KL	28215659				2022-12-28	WOS:000397143700007
J	Wu, M; Pastor-Pareja, JC; Xu, T				Wu, Ming; Pastor-Pareja, Jose Carlos; Xu, Tian			Interaction between Ras(V12) and scribbled clones induces tumour growth and invasion (vol 463, pg 545, 2010)	NATURE			English	Correction													Pastor-Pareja, Jose Carlos/ABE-6917-2021	Pastor-Pareja, Jose Carlos/0000-0002-3823-4473				Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702	1	1	1	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645								10.1038/nature21397	http://dx.doi.org/10.1038/nature21397			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28199313	Bronze			2022-12-28	WOS:000396337400058
J	Otis, JM; Namboodiri, VMK; Matan, AM; Voets, ES; Mohorn, EP; Kosyk, O; McHenry, JA; Robinson, JE; Resendez, SL; Rossi, MA; Stuber, GD				Otis, James M.; Namboodiri, Vijay M. K.; Matan, Ana M.; Voets, Elisa S.; Mohorn, Emily P.; Kosyk, Oksana; McHenry, Jenna A.; Robinson, J. Elliott; Resendez, Shanna L.; Rossi, Mark A.; Stuber, Garret D.			Prefrontal cortex output circuits guide reward seeking through divergent cue encoding	NATURE			English	Article							COCAINE-INDUCED REINSTATEMENT; NUCLEUS-ACCUMBENS; IN-VIVO; PROJECTIONS; NEURONS; RAT; BEHAVIOR; INHIBITION; ATTENTION; DOPAMINE	The prefrontal cortex is a critical neuroanatomical hub for controlling motivated behaviours across mammalian species(1-3). In addition to intra-cortical connectivity, prefrontal projection neurons innervate subcortical structures that contribute to reward-seeking behaviours, such as the ventral striatum and midline thalamus(4). While connectivity among these structures contributes to appetitive behaviours(5-13), how projection-specific prefrontal neurons encode reward-relevant information to guide reward seeking is unknown. Here we use in vivo two-photon calcium imaging to monitor the activity of dorsomedial prefrontal neurons in mice during an appetitive Pavlovian conditioning task. At the population level, these neurons display diverse activity patterns during the presentation of reward-predictive cues. However, recordings from prefrontal neurons with resolved projection targets reveal that individual corticostriatal neurons show response tuning to reward-predictive cues, such that excitatory cue responses are amplified across learning. By contrast, corticothalamic neurons gradually develop new, primarily inhibitory responses to reward-predictive cues across learning. Furthermore, bidirectional optogenetic manipulation of these neurons reveals that stimulation of corticostriatal neurons promotes conditioned reward-seeking behaviour after learning, while activity in corticothalamic neurons suppresses both the acquisition and expression of conditioned reward seeking. These data show how prefrontal circuitry can dynamically control rewardseeking behaviour through the opposing activities of projection-specific cell populations.	[Otis, James M.; Namboodiri, Vijay M. K.; Matan, Ana M.; Voets, Elisa S.; Mohorn, Emily P.; Kosyk, Oksana; McHenry, Jenna A.; Robinson, J. Elliott; Resendez, Shanna L.; Rossi, Mark A.; Stuber, Garret D.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [Namboodiri, Vijay M. K.; Stuber, Garret D.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Robinson, J. Elliott; Stuber, Garret D.] Univ N Carolina, Neurosci Curriculum, Chapel Hill, NC 27599 USA; [Stuber, Garret D.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Stuber, GD (corresponding author), Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA.; Stuber, GD (corresponding author), Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA.; Stuber, GD (corresponding author), Univ N Carolina, Neurosci Curriculum, Chapel Hill, NC 27599 USA.; Stuber, GD (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.	gstuber@med.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022; Otis, James/AFD-4354-2022; Core, Vector/CAF-4832-2022	Robinson, J. Elliott/0000-0001-9417-3938; Stuber, Garret/0000-0003-1730-4855	National Institutes of Health [NIDA: F32-DA041184, R01-DA032750, R01-DA038168, NICHD: T32-HD079124, NIMH: T32-MH093315]; Brain and Behavior Research Foundation; Children's Tumor Foundation [016-01-006]; Foundation of Hope; UNC Neuroscience Center (Helen Lyng White Fellowship); UNC Neuroscience Center Microscopy Core [P30 NS045892]; UNC Department of Psychiatry; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH093315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007431, P30NS045892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F30AA021312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA032750, F32DA041184, R01DA038168, R01DA032750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain and Behavior Research Foundation; Children's Tumor Foundation; Foundation of Hope; UNC Neuroscience Center (Helen Lyng White Fellowship); UNC Neuroscience Center Microscopy Core; UNC Department of Psychiatry; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Smith and J. Stirman for helpful discussions. This study was funded by grants from the National Institutes of Health (NIDA: F32-DA041184, J.M.O.; R01-DA032750, G.D.S.; R01-DA038168, G.D.S.; NICHD: T32-HD079124, S.L.R.; NIMH: T32-MH093315, J.A.M.), the Brain and Behavior Research Foundation (G.D.S.), the Children's Tumor Foundation (016-01-006, J.E.R.), the Foundation of Hope (G.D.S.), the UNC Neuroscience Center (Helen Lyng White Fellowship, V.M.K.N.), the UNC Neuroscience Center Microscopy Core (P30 NS045892), and the UNC Department of Psychiatry (G.D.S.).	Bossert JM, 2012, J NEUROSCI, V32, P4982, DOI 10.1523/JNEUROSCI.0005-12.2012; Bouret S, 2004, EUR J NEUROSCI, V20, P791, DOI 10.1111/j.1460-9568.2004.03526.x; Britt JP, 2012, NEURON, V76, P790, DOI 10.1016/j.neuron.2012.09.040; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Conte WL, 2009, NAT PROTOC, V4, P1157, DOI 10.1038/nprot.2009.93; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Do-Monte FH, 2015, NATURE, V519, P460, DOI 10.1038/nature14030; Haight JL, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00079; Harris KD, 2013, NATURE, V503, P51, DOI 10.1038/nature12654; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Igelstrom KM, 2010, NEUROSCIENCE, V168, P706, DOI 10.1016/j.neuroscience.2010.04.018; Kaifosh P, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00080; Kim H, 2016, CELL, V164, P208, DOI 10.1016/j.cell.2015.11.038; Kobayashi S, 2006, NEURON, V51, P861, DOI 10.1016/j.neuron.2006.08.031; Kohavi R., 1995, IJCAI, V95, P1137; Langworthy OR, 1939, AM J PHYSIOL, V126, P158, DOI 10.1152/ajplegacy.1939.126.1.158; Ma YY, 2014, NEURON, V83, P1453, DOI 10.1016/j.neuron.2014.08.023; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; McFarland K, 2003, J NEUROSCI, V23, P3531; McFarland K, 2001, J NEUROSCI, V21, P8655; McGlinchey EM, 2016, J NEUROSCI, V36, P8700, DOI 10.1523/JNEUROSCI.1291-15.2016; Moorman DE, 2015, P NATL ACAD SCI USA, V112, P9472, DOI 10.1073/pnas.1507611112; Neumann PA, 2016, NEUROPSYCHOPHARMACOL, V41, P2399, DOI 10.1038/npp.2016.52; Otis JM, 2013, J NEUROSCI, V33, P1271, DOI 10.1523/JNEUROSCI.3463-12.2013; Pascoli V, 2014, NATURE, V509, P459, DOI 10.1038/nature13257; Paxinos G, 2007, MOUSE BRAIN STEREOTA; Penzo MA, 2015, NATURE, V519, P455, DOI 10.1038/nature13978; Peters J, 2008, J NEUROSCI, V28, P6046, DOI 10.1523/JNEUROSCI.1045-08.2008; Pinto A, 2000, NEUROSCIENCE, V97, P635, DOI 10.1016/S0306-4522(00)00042-7; Resendez SL, 2016, NAT PROTOC, V11, P566, DOI 10.1038/nprot.2016.021; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Soudais C, 2001, FASEB J, V15, P2283, DOI 10.1096/fj.01-0321fje; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Stefanik MT, 2013, ADDICT BIOL, V18, P50, DOI 10.1111/j.1369-1600.2012.00479.x; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Ye L, 2016, CELL, V165, P1776, DOI 10.1016/j.cell.2016.05.010	40	199	202	3	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					103	+		10.1038/nature21376	http://dx.doi.org/10.1038/nature21376			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0AA	28225752	Green Submitted, Green Accepted			2022-12-28	WOS:000395671500041
J	Chan, LN; Chen, ZS; Braas, D; Lee, JW; Xiao, G; Geng, HM; Cosgun, KN; Hurtz, C; Shojaee, S; Cazzaniga, V; Schjerven, H; Ernst, T; Hochhaus, A; Kornblau, SM; Konopleva, M; Pufall, MA; Cazzaniga, G; Liu, GJ; Milne, TA; Koeffler, HP; Ross, TS; Sanchez-Garcia, I; Borkhardt, A; Yamamoto, KR; Dickins, RA; Graeber, TG; Muschen, M				Chan, Lai N.; Chen, Zhengshan; Braas, Daniel; Lee, Jae-Woong; Xiao, Gang; Geng, Huimin; Cosgun, Kadriye Nehir; Hurtz, Christian; Shojaee, Seyedmehdi; Cazzaniga, Valeria; Schjerven, Hilde; Ernst, Thomas; Hochhaus, Andreas; Kornblau, Steven M.; Konopleva, Marina; Pufall, Miles A. .; Cazzaniga, Giovanni; Liu, Grace J.; Milne, Thomas A.; Koeffler, H. Phillip; Ross, Theodora S.; Sanchez-Garcia, Isidro; Borkhardt, Arndt; Yamamoto, Keith R.; Dickins, Ross A.; Graeber, Thomas G.; Mueschen, Markus			Metabolic gatekeeper function of B-lymphoid transcription factors	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MINIMAL RESIDUAL DISEASE; HEMATOPOIETIC STEM-CELLS; REGULATORY NETWORK; ENERGY STRESS; GENE; ACTIVATION; EXPRESSION; DIFFERENTIATION; MACROPHAGES	B-lymphoid transcription factors, such as PAX5 and IKZF1, are critical for early B-cell development(1,2), yet lesions of the genes encoding these transcription factors occur in over 80% of cases of pre-B-cell acute lymphoblastic leukaemia (ALL)(3,4). The importance of these lesions in ALL has, until now, remained unclear. Here, by combining studies using chromatin immunoprecipitation with sequencing and RNA sequencing, we identify a novel B-lymphoid program for transcriptional repression of glucose and energy supply. Our metabolic analyses revealed that PAX5 and IKZF1 enforce a state of chronic energy deprivation, resulting in constitutive activation of the energy-stress sensor AMPK(5-7). Dominant-negative mutants of PAX5 and IKZF1, however, relieved this glucose and energy restriction. In a transgenic pre-B ALL mouse model, the heterozygous deletion of Pax5 increased glucose uptake and ATP levels by more than 25-fold. Reconstitution of PAX5 and IKZF1 in samples from patients with pre-B ALL restored a non-permissive state and induced energy crisis and cell death. A CRISPR/Cas9-based screen of PAX5 and IKZF1 transcriptional targets identified the products of NR3C1 (encoding the glucocorticoid receptor)(8), TXNIP (encoding a glucose-feedback sensor)(9) and CNR2 (encoding a cannabinoid receptor)(10) as central effectors of B-lymphoid restriction of glucose and energy supply. Notably, transport-independent lipophilic methyl-conjugates of pyruvate and tricarboxylic acid cycle metabolites bypassed the gatekeeper function of PAX5 and IKZF1 and readily enabled leukaemic transformation. Conversely, pharmacological TXNIP and CNR2 agonists and a small-molecule AMPK inhibitor strongly synergized with glucocorticoids, identifying TXNIP, CNR2 and AMPK as potential therapeutic targets. Furthermore, our results provide a mechanistic explanation for the empirical finding that glucocorticoids are effective in the treatment of B-lymphoid but not myeloid malignancies. Thus, B-lymphoid transcription factors function as metabolic gatekeepers by limiting the amount of cellular ATP to levels that are insufficient for malignant transformation.	[Chan, Lai N.; Chen, Zhengshan; Lee, Jae-Woong; Xiao, Gang; Cosgun, Kadriye Nehir; Mueschen, Markus] Beckman Res Inst, Dept Syst Biol, Pasadena, CA 91016 USA; [Chan, Lai N.; Chen, Zhengshan; Lee, Jae-Woong; Xiao, Gang; Cosgun, Kadriye Nehir; Mueschen, Markus] City Hope Natl Med Ctr, Pasadena, CA 91016 USA; [Chan, Lai N.; Chen, Zhengshan; Lee, Jae-Woong; Xiao, Gang; Cosgun, Kadriye Nehir; Mueschen, Markus] City Hope Comprehens Canc Ctr, Duarte, CA 91010 USA; [Braas, Daniel; Graeber, Thomas G.] Univ Calif Los Angeles, Metabol Ctr, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Braas, Daniel; Graeber, Thomas G.] Univ Calif Los Angeles, Crump Inst Mol Imaging, Los Angeles, CA 90095 USA; [Geng, Huimin; Hurtz, Christian; Shojaee, Seyedmehdi; Cazzaniga, Valeria; Schjerven, Hilde; Yamamoto, Keith R.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Geng, Huimin; Hurtz, Christian; Shojaee, Seyedmehdi; Cazzaniga, Valeria; Schjerven, Hilde; Yamamoto, Keith R.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Ernst, Thomas; Hochhaus, Andreas] Univ Klinikum Jena, Klin Innere Med 2, Hamatol Onkol, D-07743 Jena, Germany; [Kornblau, Steven M.; Konopleva, Marina] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Pufall, Miles A. .] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Cazzaniga, Giovanni] Univ Milano Bicocca, Ctr Ric Tettamanti Clin Pediat, Osped S Gerardo, I-20052 Monza, MB, Italy; [Liu, Grace J.; Dickins, Ross A.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Milne, Thomas A.] Univ Oxford, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England; [Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Koeffler, H. Phillip] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Ross, Theodora S.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med & Canc Genet, Dallas, TX 75390 USA; [Sanchez-Garcia, Isidro] Univ Salamanca, CSIC, Inst Biol Mol Celular & Cancer, Expt Therapeut & Translat Oncol Program, Salamanca 37007, Spain; [Sanchez-Garcia, Isidro] Inst Biomed Res Salamanca IBSAL, Salamanca 37007, Spain; [Borkhardt, Arndt] Heinrich Heine Univ, Fac Med, Pediat Oncol Hematol & Clin Immunol, D-40225 Dusseldorf, Germany	City of Hope; City of Hope; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Friedrich Schiller University of Jena; University of Texas System; UTMD Anderson Cancer Center; University of Iowa; San Gerardo Hospital; University of Milano-Bicocca; Monash University; University of Oxford; National University of Singapore; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Texas System; University of Texas Southwestern Medical Center Dallas; Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; University of Salamanca; Heinrich Heine University Dusseldorf	Muschen, M (corresponding author), Beckman Res Inst, Dept Syst Biol, Pasadena, CA 91016 USA.; Muschen, M (corresponding author), City Hope Natl Med Ctr, Pasadena, CA 91016 USA.; Muschen, M (corresponding author), City Hope Comprehens Canc Ctr, Duarte, CA 91010 USA.	mmuschen@coh.org	SANCHEZ-GARCIA, ISIDRO/A-5631-2019; Dickins, Ross A/K-2852-2012; Schjerven, Hilde/I-1437-2013; Milne, Thomas/E-1872-2016; Cazzaniga, Giovanni/K-6338-2016	Dickins, Ross A/0000-0003-4112-5304; SANCHEZ-GARCIA, ISIDRO/0000-0001-6989-9905; Xiao, Gang/0000-0002-9476-3847; Ross, Theodora/0000-0002-9166-1802; Schjerven, Hilde/0000-0001-9287-3375; Pufall, Miles/0000-0002-7022-6916; Milne, Thomas/0000-0002-0413-4271; Cosgun, Kadriye/0000-0003-4181-744X; Lee, Jaewoong/0000-0001-7952-5544; Cazzaniga, Giovanni/0000-0003-2955-4528	NIH/NCI [R35CA197628, R01CA137060, R01CA157644, R01CA172558]; Wellcome Trust; Leukemia and Lymphoma Scholar award; Howard Hughes Medical Institute [HHMI-55108547]; Alex's Lemonade Stand Foundation for Childhood Cancer; William Lawrence & Blanche Hughes Foundation for childhood cancer; Norman and Sadie Lee Foundation; Falk Trust through a Falk Medical Research Trust; Cancer Research Institute (CRI) through a Clinic and Laboratory Integration Program (CLIP) grant; Melanoma Research Alliance; German Bundesministerium fur Bildung und Forschung, BMBF; German Carreras Foundation [DJCLS R13/26]; NATIONAL CANCER INSTITUTE [R01CA137060, R01CA157644, R35CA197628, R01CA172558, R01CA169458, R01CA213138, R01CA139032, R00CA149088, P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_00016/6, MC_UU_12009/6] Funding Source: researchfish; MRC [MC_UU_00016/6, MC_UU_12009/6] Funding Source: UKRI	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission); Leukemia and Lymphoma Scholar award(Leukemia and Lymphoma Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Alex's Lemonade Stand Foundation for Childhood Cancer; William Lawrence & Blanche Hughes Foundation for childhood cancer; Norman and Sadie Lee Foundation; Falk Trust through a Falk Medical Research Trust; Cancer Research Institute (CRI) through a Clinic and Laboratory Integration Program (CLIP) grant; Melanoma Research Alliance; German Bundesministerium fur Bildung und Forschung, BMBF(Federal Ministry of Education & Research (BMBF)); German Carreras Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the NIH/NCI through Outstanding Investigator Award R35CA197628 (to M.M.), R01CA137060, R01CA157644 and R01CA172558 (to M.M.), a Wellcome Trust Senior Investigator Award and a Leukemia and Lymphoma Scholar award (to M.M.), the Howard Hughes Medical Institute HHMI-55108547 (to M.M.), the Alex's Lemonade Stand Foundation for Childhood Cancer (to M.M.), the William Lawrence & Blanche Hughes Foundation for childhood cancer (to M.M.), the Norman and Sadie Lee Foundation (for Pediatric Cancer, to M.M.), the Falk Trust through a Falk Medical Research Trust Catalyst Award (to M.M.), Cancer Research Institute (CRI) through a Clinic and Laboratory Integration Program (CLIP) grant (to M.M.), the Melanoma Research Alliance Established Investigator Award (to T.G.G.), the German Bundesministerium fur Bildung und Forschung, BMBF (to A.H.) and the German Carreras Foundation (DJCLS R13/26) (to A.B. and I.S.-G.). T.G.G. is an American Cancer Society Research Scholar. M.M. is a Howard Hughes Medical Institute (HHMI) Faculty Scholar.	Bose S, 1998, BLOOD, V92, P3362, DOI 10.1182/blood.V92.9.3362; Brennan-Speranza TC, 2012, J CLIN INVEST, V122, P4172, DOI 10.1172/JCI63377; Cazzaniga G, 2011, BLOOD, V118, P5559, DOI 10.1182/blood-2011-07-366542; Damm F, 2014, CANCER DISCOV, V4, P1088, DOI 10.1158/2159-8290.CD-14-0104; Di Tullio A, 2011, P NATL ACAD SCI USA, V108, P17016, DOI 10.1073/pnas.1112169108; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Foley SB, 2013, CELL REP, V5, P51, DOI 10.1016/j.celrep.2013.08.037; Fretz JA, 2010, ENDOCRINOLOGY, V151, P1611, DOI 10.1210/en.2009-0987; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Hanus L, 1999, P NATL ACAD SCI USA, V96, P14228, DOI 10.1073/pnas.96.25.14228; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Kang HN, 2010, BLOOD, V115, P1394, DOI 10.1182/blood-2009-05-218560; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; Liu GJ, 2014, GENE DEV, V28, P1337, DOI 10.1101/gad.240416.114; Martin-Lorenzo A, 2015, CANCER DISCOV, V5, P1328, DOI 10.1158/2159-8290.CD-15-0892; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Nogueiras R, 2009, PHARMACOL RES, V60, P93, DOI 10.1016/j.phrs.2009.04.004; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Ochiai K, 2012, NAT IMMUNOL, V13, P300, DOI 10.1038/ni.2210; Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Stoltzman CA, 2011, J BIOL CHEM, V286, P38027, DOI 10.1074/jbc.M111.275503; Swaminathan S, 2015, NAT IMMUNOL, V16, P766, DOI 10.1038/ni.3160; Thai M, 2014, CELL METAB, V19, P694, DOI 10.1016/j.cmet.2014.03.009; Wiemels JL, 1999, LANCET, V354, P1499, DOI 10.1016/S0140-6736(99)09403-9; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	38	134	135	4	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2017	542	7642					479	+		10.1038/nature21076	http://dx.doi.org/10.1038/nature21076			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM1RG	28192788	Green Accepted, Green Submitted			2022-12-28	WOS:000395094100037
J	Raymond, EG; Blanchard, K; Blumenthal, PD; Cleland, K; Foster, AM; Gold, M; Gross-Man, D; Pendergast, MK; Westhoff, CL; Winikoff, B				Raymond, Elizabeth G.; Blanchard, Kelly; Blumenthal, Paul D.; Cleland, Kelly; Foster, Angel M.; Gold, Marji; Gross-Man, Daniel; Pendergast, Mary K.; Westhoff, Carolyn L.; Winikoff, Beverly		Mifeprex Rems Study Grp	Sixteen Years of Overregulation: Time to Unburden Mifeprex	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEDICAL ABORTION; HOME-USE; MIFEPRISTONE; MISOPROSTOL; SAFETY; ACCEPTABILITY; PHYSICIAN; SERVICES; ACCESS		[Raymond, Elizabeth G.; Winikoff, Beverly] Gynu Hlth Projects, New York, NY 10010 USA; [Westhoff, Carolyn L.] Columbia Univ, New York, NY USA; [Gold, Marji] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Blanchard, Kelly] Ibis Reprod Hlth, Cambridge, MA USA; [Blumenthal, Paul D.] Stanford Univ, Dept Obstet & Gynecol, Sch Med, Div Family Planning Serv & Res, Stanford, CA 94305 USA; [Gross-Man, Daniel] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Adv New Stand Reprod Hlth, San Francisco, CA USA; [Cleland, Kelly] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; [Foster, Angel M.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada; [Pendergast, Mary K.] Pendergast Consulting, Washington, DC USA	Columbia University; Yeshiva University; Albert Einstein College of Medicine; Stanford University; University of California System; University of California San Francisco; Princeton University; University of Ottawa	Raymond, EG (corresponding author), Gynu Hlth Projects, New York, NY 10010 USA.							Abbas D, 2015, CONTRACEPTION, V92, P197, DOI 10.1016/j.contraception.2015.06.018; [Anonymous], 2014, Obstet Gynecol, V123, P676, DOI 10.1097/01.AOG.0000444454.67279.7d; [Anonymous], 2015, APPR RISK EV MIT STR; Berger R, 2013, ANN EMERG MED, V61, P475, DOI 10.1016/j.annemergmed.2013.02.008; Chen MJ, 2015, OBSTET GYNECOL, V126, P12, DOI 10.1097/AOG.0000000000000897; Chong E, 2015, CONTRACEPTION, V92, P215, DOI 10.1016/j.contraception.2015.06.026; Cleland K, 2015, CONTRACEPTION, V92, P179, DOI 10.1016/j.contraception.2015.06.016; Creinin MD, 2014, CONTRACEPTION, V89, P148, DOI 10.1016/j.contraception.2014.01.016; FDA, APPR DRUG PROD THER, V42nd; FDA, 2016, APPR RISK EV MIT STR; FDA, APPR RISK EV MIT STR APPR RISK EV MIT STR; Food and Drug Administration, 2016, FED REG; Foster AM, 2015, CONTRACEPTION, V92, P200, DOI 10.1016/j.contraception.2015.06.022; Fuentes Pradera M A, 2006, Rev Esp Anestesiol Reanim, V53, P669; Gold M, 2015, CONTRACEPTION, V92, P194, DOI 10.1016/j.contraception.2015.06.011; Grossman D, 2011, OBSTET GYNECOL, V118, P296, DOI 10.1097/AOG.0b013e318224d110; Grossman D, 2011, CONTRACEPTION, V83, P504, DOI 10.1016/j.contraception.2010.08.023; Grossman DA, 2013, AM J PUBLIC HEALTH, V103, P73, DOI 10.2105/AJPH.2012.301097; Jerman J, 2014, WOMEN HEALTH ISS, V24, pE419, DOI 10.1016/j.whi.2014.05.002; Jones RK, 2013, J WOMENS HEALTH, V22, P706, DOI 10.1089/jwh.2013.4283; Lowe G, 2012, J SEX MED, V9, P265, DOI 10.1111/j.1743-6109.2011.02537.x; National Abortion Federation, 2014, 2014 CLIN POL GUID; Raymond EG, 2016, JAMA INTERN MED, V176, P585, DOI 10.1001/jamainternmed.2016.0573; Raymond EG, 2013, CONTRACEPTION, V87, P26, DOI 10.1016/j.contraception.2012.06.011; Raymond EG, 2012, OBSTET GYNECOL, V119, P215, DOI 10.1097/AOG.0b013e31823fe923; Sheldon WR, 2015, CONTRACEPTION, V92, P182, DOI 10.1016/j.contraception.2015.06.017; Stafford RS, 2012, CLIN PHARMACOL THER, V91, P920, DOI 10.1038/clpt.2012.22; Swica Y, 2013, CONTRACEPTION, V88, P122, DOI 10.1016/j.contraception.2012.10.021; Weitz TA, 2013, AM J PUBLIC HEALTH, V103, P454, DOI 10.2105/AJPH.2012.301159; Winans S Alexander, 2013, Hosp Pharm, V48, P227, DOI 10.1310/hpj4803-227; Wing DA, 2010, OBSTET GYNECOL, V115, P825, DOI 10.1097/AOG.0b013e3181d53843	31	64	65	2	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2017	376	8					790	794		10.1056/NEJMsb1612526	http://dx.doi.org/10.1056/NEJMsb1612526			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JO	28225670				2022-12-28	WOS:000395627900014
J	Zhao, BXS; Wang, X; Beadell, AV; Lu, ZK; Shi, HL; Kuuspalu, A; Ho, RK; He, C				Zhao, Boxuan Simen; Wang, Xiao; Beadell, Alana V.; Lu, Zhike; Shi, Hailing; Kuuspalu, Adam; Ho, Robert K.; He, Chuan			m(6)A-dependent maternal mRNA clearance facilitates zebrafish maternal-to-zygotic transition	NATURE			English	Article							EMBRYONIC STEM-CELLS; NUCLEAR-RNA; METHYLATION; TRANSCRIPTOME; REVEALS	The maternal-to-zygotic transition (MZT) is one of the most profound and tightly orchestrated processes during the early life of embryos, yet factors that shape the temporal pattern of vertebrate MZT are largely unknown. Here we show that over one-third of zebrafish maternal messenger RNAs (mRNAs) can be N-6-methyladenosine (m(6)A) modified, and the clearance of these maternal mRNAs is facilitated by an m(6)A-binding protein, Ythdf2. Removal of Ythdf2 in zebrafish embryos decelerates the decay of m(6)A-modified maternal mRNAs and impedes zygotic genome activation. These embryos fail to initiate timely MZT, undergo cell-cycle pause, and remain developmentally delayed throughout larval life. Our study reveals m(6)A-dependent RNA decay as a previously unidentified maternally driven mechanism that regulates maternal mRNA clearance during zebrafish MZT, highlighting the critical role of m(6)A mRNA methylation in transcriptome switching and animal development.	[Zhao, Boxuan Simen; Wang, Xiao; Lu, Zhike; Shi, Hailing; He, Chuan] Univ Chicago, Dept Chem & Inst Biophys Dynam, 929 East 57th St, Chicago, IL 60637 USA; [Zhao, Boxuan Simen; Wang, Xiao; Lu, Zhike; Shi, Hailing; He, Chuan] Univ Chicago, Howard Hughes Med Inst, 929 East 57th St, Chicago, IL 60637 USA; [Beadell, Alana V.; Kuuspalu, Adam; Ho, Robert K.] Univ Chicago, Dept Organismal Biol & Anat, 1027 East 57th St, Chicago, IL 60637 USA; [He, Chuan] Univ Chicago, Dept Biochem & Mol Biol, 929 East 57th St, Chicago, IL 60637 USA	University of Chicago; Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago	He, C (corresponding author), Univ Chicago, Dept Chem & Inst Biophys Dynam, 929 East 57th St, Chicago, IL 60637 USA.; He, C (corresponding author), Univ Chicago, Howard Hughes Med Inst, 929 East 57th St, Chicago, IL 60637 USA.; He, C (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 East 57th St, Chicago, IL 60637 USA.	chuanhe@uchicago.edu	Shi, Hailing/AAW-5351-2021; Zhao, Boxuan/Q-2159-2019	Shi, Hailing/0000-0001-7355-378X; Zhao, Boxuan/0000-0002-3729-4511; Wang, Xiao/0000-0002-3090-9894; Beadell, Alana/0000-0001-6245-1649	National Institutes of Health [HG008688, GM113194, HD072598]; National Science Foundation [CHE-1048528]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072598] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health HG008688, GM113194 (both to C.H.), and HD072598 (to R.K.H.). C.H. is an investigator of the Howard Hughes Medical Institute (HHMI). B.S.Z. is an HHMI International Student Research fellow. The Mass Spectrometry Facility of the University of Chicago is funded by National Science Foundation (CHE-1048528). We thank H. Pickersgill for editing help.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Chen K, 2015, ANGEW CHEM INT EDIT, V54, P1587, DOI 10.1002/anie.201410647; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DESROSIERS R, 1975, FED PROC, V34, P628; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; KANE DA, 1993, DEVELOPMENT, V119, P447; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Laver JD, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0659-4; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Lee MT, 2013, NATURE, V503, P360, DOI 10.1038/nature12632; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/nmeth.3453, 10.1038/NMETH.3453]; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Mishima Y, 2016, MOL CELL, V61, P874, DOI 10.1016/j.molcel.2016.02.027; Rabani M, 2014, CELL, V159, P1698, DOI 10.1016/j.cell.2014.11.015; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Stoeckius M, 2014, EMBO J, V33, P1751, DOI 10.15252/embj.201488769; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Thisse B, 2014, METHODS MOL BIOL, V1211, P53, DOI 10.1007/978-1-4939-1459-3_5; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Walser CB, 2011, CURR OPIN GENET DEV, V21, P431, DOI 10.1016/j.gde.2011.03.003; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	36	310	336	12	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2017	542	7642					475	+		10.1038/nature21355	http://dx.doi.org/10.1038/nature21355			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM1RG	28192787	Green Accepted			2022-12-28	WOS:000395094100036
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: We can save billions without cutting care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Appleby J, 2015, EU IMM NHS STAFF; Fullfact, 2016, EU IMM NHS STAFF; Hwang MJ, 2014, ANN ROY COLL SURG, V96, P343, DOI 10.1308/003588414X13946184902000; King's Fund, 2016, NHS BUDG IT HAS CHAN; Meacock R, 2015, HEALTH ECON, V24, P907, DOI 10.1002/hec.3207; Oliver D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7243; Public Accounts Committee, 2017, NHS TREATM OV PAT; Thomas JM. Meirion, 2017, DAILY MAIL	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2017	356								j890	10.1136/bmj.j890	http://dx.doi.org/10.1136/bmj.j890			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KS	28223266	Bronze, Green Published			2022-12-28	WOS:000395631000010
J	Goldman, GT; Berman, E; Halpern, M; Johnson, C; Kothari, Y; Reed, G; Rosenberg, AA				Goldman, Gretchen T.; Berman, Emily; Halpern, Michael; Johnson, Charise; Kothari, Yogin; Reed, Genna; Rosenberg, Andrew A.			Ensuring scientific integrity in the Age of Trump	SCIENCE			English	Editorial Material									[Goldman, Gretchen T.; Berman, Emily; Halpern, Michael; Johnson, Charise; Kothari, Yogin; Reed, Genna; Rosenberg, Andrew A.] Union Concerned Scientists, Cambridge, MA 02138 USA		Goldman, GT (corresponding author), Union Concerned Scientists, Cambridge, MA 02138 USA.	ggoldman@ucsusa.org		Reed, Genna/0000-0002-9602-1193				Goldman G., 2015, PROGR PROBLEMS GOVT; GRIFO F, 2008, FEDERAL SCI PUBLIC G; Halpern M, 2015, SCIENCE, V348, P479, DOI 10.1126/science.aac4245; Mooney Chris, 2005, REPUBLICAN WAR SCI; Negar Azimi, 2016, NEW YORKER; Office of Inspector General Department of the Interior, 2006, INV REP ALL JUL MACD; Otto SL, 2016, WAR SCI WHOS WAGING; REVKIN AC, 2004, NY TIMES        1019, pF1; Rosenberg AA, 2015, SCIENCE, V348, P964, DOI 10.1126/science.aab2939; Ryan P., 2016, A BETTER WAY; U. S. Environmental Protection Agency, 2015, FY 2015 ALL; UCS, 2004, SCI STAT REST SCI IN; UCS, 2007, VOIC FED SCI; UCS, 2017, PRES SCI INT FED POL; Wagner W., 2012, BENDING SCI SPECIAL; Williamson E., 2007, WASHINGTON POST	16	16	16	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					696	698		10.1126/science.aam5733	http://dx.doi.org/10.1126/science.aam5733			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EM2AC	28209862				2022-12-28	WOS:000395117700024
J	Levin, E; Lopez-Martinez, G; Fane, B; Davidowitz, G				Levin, E.; Lopez-Martinez, G.; Fane, B.; Davidowitz, G.			Hawkmoths use nectar sugar to reduce oxidative damage from flight	SCIENCE			English	Article							MANDUCA-SEXTA; HOVERING FLIGHT; FEEDING BATS; METABOLISM; FUEL; CARBOHYDRATE; HUMMINGBIRDS; CONSUMPTION; STRESS; MOTHS	Nectar-feeding animals have among the highest recorded metabolic rates. High aerobic performance is linked to oxidative damage in muscles. Antioxidants in nectar are scarce to nonexistent. We propose that nectarivores use nectar sugar to mitigate the oxidative damage caused by the muscular demands of flight. We found that sugar-fed moths had lower oxidative damage to their flight muscle membranes than unfed moths. Using respirometry coupled with delta C-13 analyses, we showed that moths generate antioxidant potential by shunting nectar glucose to the pentose phosphate pathway (PPP), resulting in a reduction in oxidative damage to the flight muscles. We suggest that nectar feeding, the use of PPP, and intense exercise are causally linked and have allowed the evolution of powerful fliers that feed on nectar.	[Levin, E.; Davidowitz, G.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Lopez-Martinez, G.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Fane, B.] Univ Arizona, Sch Plant Sci, Tucson, AZ USA; [Fane, B.] Univ Arizona, Inst BIO5, Tucson, AZ USA	University of Arizona; New Mexico State University; University of Arizona; University of Arizona	Levin, E (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	levineran1@gmail.com	Lopez-Martinez, Giancarlo/AAE-8134-2020; Levin, Eran/GPF-5345-2022	Lopez-Martinez, Giancarlo/0000-0002-7937-5002; Levin, Eran/0000-0002-9972-7028	NSF [IOS-1053318]	NSF(National Science Foundation (NSF))	This study was supported by NSF grant IOS-1053318 to G.D. We thank H. Costa for maintaining the moth colony and R. Tzach and L. Braulke for fruitful discussion. The authors declare no conflicts of interest.	BARTHOLOMEW GA, 1978, J EXP BIOL, V76, P11; Beaulieu M, 2013, ANIM BEHAV, V86, P17, DOI 10.1016/j.anbehav.2013.05.022; Benedict F. G., 1937, CARNEGIE I WASH PUBL, V489; Benito A, 2015, TUMOR CELL METABOLIS, P143; Costantini D., 2014, OXIDATIVE STRESS HO; CURELLO S, 1985, EXPERIENTIA, V41, P42, DOI 10.1007/BF02005863; Dudley R., 2000, BIOMECHANICS INSECT; ELIA M, 1988, AM J CLIN NUTR, V47, P591, DOI 10.1093/ajcn/47.4.591; Fisher-Wellman Kelsey, 2009, Dyn Med, V8, P1, DOI 10.1186/1476-5918-8-1; Halliwell B., 2015, FREE RADICALS BIOL M; Holland RA, 2006, SCIENCE, V313, P794, DOI 10.1126/science.1127272; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Kleiber M., 1961, FIRE LIFE INTRO ANIM; Lushchak Volodymyr I, 2012, J Amino Acids, V2012, P736837, DOI 10.1155/2012/736837; Nicolson S.W., 2007, NECTARIES NECTAR; O'Brien DM, 1999, J EXP BIOL, V202, P441; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; PRINZINGER R, 1992, J THERM BIOL, V17, P71, DOI 10.1016/0306-4565(92)90001-V; Reyes-DelaTorre A., 2012, CARBOHYDRATE METABOL; Schaefer HM, 2008, FUNCT ECOL, V22, P303, DOI 10.1111/j.1365-2435.2007.01363.x; Schwilch R, 2001, IBIS, V143, P24, DOI 10.1111/j.1474-919X.2001.tb04166.x; SUAREZ RK, 1990, P NATL ACAD SCI USA, V87, P9207, DOI 10.1073/pnas.87.23.9207; Thompson SN, 1999, BBA-GEN SUBJECTS, V1472, P565, DOI 10.1016/S0304-4165(99)00163-4; Voigt CC, 2007, FUNCT ECOL, V21, P913, DOI 10.1111/j.1365-2435.2007.01321.x; Voigt CC, 1999, J COMP PHYSIOL B, V169, P38, DOI 10.1007/s003600050191; Welch KC, 2006, PHYSIOL BIOCHEM ZOOL, V79, P1082, DOI 10.1086/507665; Welch KC, 2016, ANN NY ACAD SCI, V1365, P15, DOI 10.1111/nyas.12737; ZIEGLER R, 1991, J COMP PHYSIOL B, V161, P125, DOI 10.1007/BF00262874; ZIEGLER R, 1986, J INSECT PHYSIOL, V32, P903, DOI 10.1016/0022-1910(86)90106-X	29	50	50	6	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2017	355	6326					733	734		10.1126/science.aah4634	http://dx.doi.org/10.1126/science.aah4634			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2AC	28209896				2022-12-28	WOS:000395117700039
J	Horton, R; Kleinert, S; Linklater, S; Mullan, Z				Horton, Richard; Kleinert, Sabine; Linklater, Sarah; Mullan, Zoe			Research misconduct and the INTERGROWTH-21st study	LANCET			English	Editorial Material							INTERNATIONAL STANDARDS; PROJECT		[Horton, Richard; Kleinert, Sabine] The Lancet, London EC2Y 5AS, England; [Linklater, Sarah] Lancet Diabet & Endocrinol, London EC2Y 5AS, England; [Mullan, Zoe] Lancet Global Hlth, London EC2Y 5AS, England		Horton, R (corresponding author), The Lancet, London EC2Y 5AS, England.	editorial@lancet.com						[Anonymous], 1995, PHYS STAT UINT ANT; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15; Kiserud T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002220; Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2; Villar J, 2015, LANCET GLOB HEALTH, V3, pE681, DOI 10.1016/S2214-109X(15)00163-1; Villar J, 2014, LANCET DIABETES ENDO, V2, P781, DOI 10.1016/S2213-8587(14)70121-4; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; WHO, 2016, RES DISP FET GROWTH	8	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2017	389	10069					584	585		10.1016/S0140-6736(17)30321-5	http://dx.doi.org/10.1016/S0140-6736(17)30321-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9AF	28195044	hybrid			2022-12-28	WOS:000394910800009
J	Malakoff, D				Malakoff, David			Genetic divide	SCIENCE			English	Editorial Material																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					572	572		10.1126/science.355.6325.572-a	http://dx.doi.org/10.1126/science.355.6325.572-a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK0SF	28183930				2022-12-28	WOS:000393636700021
J	Oh, NR; Kim, BH; Cho, SY; Nam, S; Rogers, SP; Jiang, YR; Flanagan, JC; Zhai, Y; Kim, JH; Lee, JY; Yu, YJ; Cho, YK; Hur, G; Zhang, JQ; Trefonas, P; Rogers, JA; Shim, M				Oh, Nuri; Kim, Bong Hoon; Cho, Seong-Yong; Nam, Sooji; Rogers, Steven P.; Jiang, Yiran; Flanagan, Joseph C.; Zhai, You; Kim, Jae-Hwan; Lee, Jungyup; Yu, Yongjoon; Cho, Youn Kyoung; Hur, Gyum; Zhang, Jieqian; Trefonas, Peter; Rogers, John A.; Shim, Moonsub			Double-heterojunction nanorod light-responsive LEDs for display applications	SCIENCE			English	Article							EMITTING-DIODES; QUANTUM DOTS; AUGER RECOMBINATION; PERFORMANCE; NANOCRYSTALS; ELECTRONICS	Dual-functioning displays, which can simultaneously transmit and receive information and energy through visible light, would enable enhanced user interfaces and device-to-device interactivity. We demonstrate that double heterojunctions designed into colloidal semiconductor nanorods allow both efficient photocurrent generation through a photovoltaic response and electroluminescence within a single device. These dual-functioning, all-solution-processed double-heterojunction nanorod light-responsive light-emitting diodes open feasible routes to a variety of advanced applications, fromtouchless interactive screens to energy harvesting and scavenging displays and massively parallel display-to-display data communication.	[Oh, Nuri; Kim, Bong Hoon; Cho, Seong-Yong; Rogers, Steven P.; Jiang, Yiran; Flanagan, Joseph C.; Zhai, You; Kim, Jae-Hwan; Rogers, John A.; Shim, Moonsub] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Mat Sci & Engn, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Nam, Sooji] Elect & Telecommun Res Inst, Informat Control Device Res Sect, Daejeon 305700, South Korea; [Lee, Jungyup; Yu, Yongjoon; Cho, Youn Kyoung; Hur, Gyum] Univ Illinois, Dept Biomol & Chem Engn, Urbana, IL 61801 USA; [Zhang, Jieqian; Trefonas, Peter] Dow Elect Mat, 455 Forest St, Marlborough, MA 01752 USA	University of Illinois System; University of Illinois Urbana-Champaign; Electronics & Telecommunications Research Institute - Korea (ETRI); University of Illinois System; University of Illinois Urbana-Champaign	Oh, NR; Shim, M (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Mat Sci & Engn, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA.	5nuri.oh@gmail.com; mshim@illinois.edu	Cho, Youn Kyoung/HGD-2624-2022; Zhai, You/J-5697-2019; Kim, Bong Hoon/AAS-9495-2021; Shim, Moonsub/A-7875-2009; Cho, Seong-Yong/AAB-3355-2020; huang, yonggang/O-6236-2019; Rogers, John/L-2798-2016; Oh, Nuri/D-3547-2017	Zhai, You/0000-0001-5421-9372; Kim, Bong Hoon/0000-0002-4610-0176; Shim, Moonsub/0000-0001-7781-1029; Cho, Seong-Yong/0000-0001-6948-171X; WANG, KE/0000-0003-2004-2745; Yu, Yongjoon/0000-0003-0142-1600; Oh, Nuri/0000-0001-9145-8911; Flanagan, Joseph/0000-0002-4090-4149	Dow Chemical Company; NSF [DMR-1507170]	Dow Chemical Company; NSF(National Science Foundation (NSF))	We thank H. Oh for helpful discussions on programming software for the control circuitry. This material is based on work supported by the Dow Chemical Company and the NSF (grant no. DMR-1507170). Experiments were carried out, in part, in the Frederick Seitz Materials Research Laboratory Central Facilities, University of Illinois. N.O., S.N., Y.Z., P.T., and M.S. are inventors on patents US 20150243837 A1, US 8937294 B2, and US 9123638 B2, which are held by the University of Illinois and Dow Chemical and cover the synthesis of double-heterojunction nanorods. N.O., B.H.K., S.-Y.C., P.T., J.Z., J.A.R., and M.S. are inventors on patent applications 62/312629, 62/312633, and 62/312641, which were submitted by the University of Illinois and Dow Chemical and cover the dual light-emitting and light-detecting operation of LEDs and their uses.	Bae WK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3661; Carey GH, 2015, CHEM REV, V115, P12732, DOI 10.1021/acs.chemrev.5b00063; Choi MK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8149; Chuang CHM, 2014, NAT MATER, V13, P796, DOI [10.1038/nmat3984, 10.1038/NMAT3984]; Dai XL, 2014, NATURE, V515, P96, DOI 10.1038/nature13829; Dietz P, 2003, LECT NOTES COMPUT SC, V2864, P175; DiSalvo FJ, 1999, SCIENCE, V285, P703, DOI 10.1126/science.285.5428.703; Gomez DE, 2009, ACS NANO, V3, P2281, DOI 10.1021/nn900296q; He J, 2015, P IEEE, V103, P619, DOI 10.1109/JPROC.2015.2396991; Kaltenbrunner M, 2013, NATURE, V499, P458, DOI 10.1038/nature12314; Kamat PV, 2013, J PHYS CHEM LETT, V4, P908, DOI 10.1021/jz400052e; Kim BH, 2016, ACS NANO, V10, P4920, DOI 10.1021/acsnano.5b06387; Lim J, 2014, ADV MATER, V26, P8034, DOI 10.1002/adma.201403620; Nam S, 2015, ACS NANO, V9, P878, DOI 10.1021/nn506577p; Oertel DC, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2136227; Oh N, 2016, J AM CHEM SOC, V138, P10444, DOI 10.1021/jacs.6b03834; Oh N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4642; Park YS, 2014, ACS NANO, V8, P7288, DOI 10.1021/nn5023473; Shirasaki Y, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.217403; Shirasaki Y, 2013, NAT PHOTONICS, V7, P13, DOI 10.1038/nphoton.2012.328; Tsonev D, 2014, IEEE PHOTONIC TECH L, V26, P637, DOI 10.1109/LPT.2013.2297621; Vogel U., 2015, SOC INF DISP INT S, V46, P66	22	159	161	16	240	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					616	619		10.1126/science.aal2038	http://dx.doi.org/10.1126/science.aal2038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK0SF	28183975				2022-12-28	WOS:000393636700045
J	Lim, WA; June, CH				Lim, Wendell A.; June, Carl H.			The Principles of Engineering Immune Cells to Treat Cancer	CELL			English	Review							CHIMERIC ANTIGEN RECEPTOR; CD8(+) T-CELLS; SERIOUS ADVERSE EVENT; ANTITUMOR-ACTIVITY; B-CELL; ADOPTIVE TRANSFER; CARDIOVASCULAR TOXICITY; METASTATIC MELANOMA; TUMOR-ANTIGENS; HOST-DISEASE	Chimeric antigen receptor (CAR) T cells have proven that engineered immune cells can serve as a powerful new class of cancer therapeutics. Clinical experience has helped to define the major challenges that must be met to make engineered T cells a reliable, safe, and effective platform that can be deployed against a broad range of tumors. The emergence of synthetic biology approaches for cellular engineering is providing us with a broadly expanded set of tools for programming immune cells. We discuss how these tools could be used to design the next generation of smart T cell precision therapeutics.	[Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, UCSF Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA; [June, Carl H.] Univ Penn, Dept Pathol & Lab Med, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USA; [June, Carl H.] Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Lim, WA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, UCSF Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA.; June, CH (corresponding author), Univ Penn, Dept Pathol & Lab Med, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USA.; June, CH (corresponding author), Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA.	wendell.lim@ucsf.edu; cjune@exchange.upenn.edu			NIH [P50GM081879, R01 CA196277, 5R01CA120409]; Parker Institute for Cancer Immunotherapy; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA120409, R01CA196277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Institute for Cancer Immunotherapy; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors apologize to colleagues for work that we are unable to cite due to space constraints. We thank members of the Lim and June labs for comments. W.A.L. is supported by grants from the NIH (P50GM081879, R01 CA196277), the Parker Institute for Cancer Immunotherapy, and the Howard Hughes Medical Institute. C.H.J. is supported by grants from the NIH (5R01CA120409) and is a member of the Parker Institute for Cancer Immunotherapy, which supports the University of Pennsylvania Cancer Immunotherapy Program. W.A.L. is a founder of Cell Design Labs and a member of its scientific advisory board. C.H.J. is a founder of Tmunity Therapeutics and a member of its scientific advisory board.	Ahmed N, 2015, J CLIN ONCOL, V33, P1688, DOI 10.1200/JCO.2014.58.0225; Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; Aleksic M, 2012, EUR J IMMUNOL, V42, P3174, DOI 10.1002/eji.201242606; Ali SA, 2016, BLOOD, V128, P1688, DOI 10.1182/blood-2016-04-711903; Barrett DM, 2014, CYTOTHERAPY, V16, P619, DOI 10.1016/j.jcyt.2013.10.013; Bendle GM, 2010, NAT MED, V16, P565, DOI 10.1038/nm.2128; Boice M, 2016, CELL, V167, P405, DOI 10.1016/j.cell.2016.08.032; Bregni M, 2006, Bone Marrow Transplant, V38, P527, DOI 10.1038/sj.bmt.1705479; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brudno JN, 2016, J CLIN ONCOL, V34, P1112, DOI 10.1200/JCO.2015.64.5929; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Cameron BJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006034; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Caruso HG, 2015, CANCER RES, V75, P3505, DOI 10.1158/0008-5472.CAN-15-0139; Cekic C, 2013, J EXP MED, V210, P2693, DOI 10.1084/jem.20130249; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chinnasamy N, 2011, J IMMUNOL, V186, P685, DOI 10.4049/jimmunol.1001775; Chong E.A., 2016, BLOOD; Collins RH, 1997, J CLIN ONCOL, V15, P433, DOI 10.1200/JCO.1997.15.2.433; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; Crespo J, 2013, CURR OPIN IMMUNOL, V25, P214, DOI 10.1016/j.coi.2012.12.003; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Di Stasi A, 2009, BLOOD, V113, P6392, DOI 10.1182/blood-2009-03-209650; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Fedorov VD, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006597; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Fischbach MA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005568; Fitzgerald J.C., 2016, CRIT CARE MED, V45, pe124; Foster AE, 2008, J IMMUNOTHER, V31, P500, DOI 10.1097/CJI.0b013e318177092b; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Fritsch RD, 2005, J IMMUNOL, V175, P6489, DOI 10.4049/jimmunol.175.10.6489; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Gianni L, 2008, J CLIN ONCOL, V26, P3777, DOI 10.1200/JCO.2007.14.9401; Grada Z, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.32; GROSS G, 1989, P NATL ACAD SCI USA, V86, P10024, DOI 10.1073/pnas.86.24.10024; Guedan S, 2014, BLOOD, V124, P1070, DOI 10.1182/blood-2013-10-535245; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hickman ES, 2016, J BIOMOL SCREEN, V21, P769, DOI 10.1177/1087057116637837; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Hombach AA, 2013, MOL THER, V21, P2268, DOI 10.1038/mt.2013.192; Hurton LV, 2016, P NATL ACAD SCI USA, V113, pE7788, DOI 10.1073/pnas.1610544113; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; John LB, 2013, CLIN CANCER RES, V19, P5636, DOI 10.1158/1078-0432.CCR-13-0458; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; June CH, 2007, J CLIN INVEST, V117, P1204, DOI 10.1172/JCI31446; Kageyama S, 2015, CLIN CANCER RES, V21, P2268, DOI 10.1158/1078-0432.CCR-14-1559; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kawalekar OU, 2016, IMMUNITY, V44, P380, DOI 10.1016/j.immuni.2016.01.021; Kerkar SP, 2010, CANCER RES, V70, P6725, DOI 10.1158/0008-5472.CAN-10-0735; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Klebanoff CA, 2016, NAT MED, V22, P26, DOI 10.1038/nm.4015; Kudo K, 2014, CANCER RES, V74, P93, DOI 10.1158/0008-5472.CAN-13-1365; Lamers C. H. J., 2006, J CLIN ONCOL, V24, pE20, DOI [10.1200/JCO.2006.05.9964, DOI 10.1200/JCO.2006.05.9964]; Lamers CHJ, 2013, MOL THER, V21, P904, DOI 10.1038/mt.2013.17; Lamers CHJ, 2011, BLOOD, V117, P72, DOI 10.1182/blood-2010-07-294520; Lanitis E, 2013, CANCER IMMUNOL RES, V1, P43, DOI 10.1158/2326-6066.CIR-13-0008; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Levine BL, 2002, NAT MED, V8, P47, DOI 10.1038/nm0102-47; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Liu XJ, 2015, CANCER RES, V75, P3596, DOI 10.1158/0008-5472.CAN-15-0159; Ma JSY, 2016, P NATL ACAD SCI USA, V113, pE450, DOI 10.1073/pnas.1524193113; Mahoney KM, 2015, NAT REV DRUG DISCOV, V14, P561, DOI 10.1038/nrd4591; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Mitsuyasu RT, 2000, BLOOD, V96, P785, DOI 10.1182/blood.V96.3.785.015k10_785_793; Mondal AM, 2013, J CLIN INVEST, V123, P5247, DOI 10.1172/JCI70355; Moon EK, 2011, CLIN CANCER RES, V17, P4719, DOI 10.1158/1078-0432.CCR-11-0351; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Morsut L, 2016, CELL, V164, P780, DOI 10.1016/j.cell.2016.01.012; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Narayanan P, 2011, J CLIN INVEST, V121, P1524, DOI 10.1172/JCI44327; Odorizzi PM, 2015, J EXP MED, V212, P1125, DOI 10.1084/jem.20142237; Omazic B, 2016, BIOL BLOOD MARROW TR, V22, P676, DOI 10.1016/j.bbmt.2015.12.017; Pardoll DM, 1999, P NATL ACAD SCI USA, V96, P5340, DOI 10.1073/pnas.96.10.5340; Parkhurst MR, 2011, MOL THER, V19, P620, DOI 10.1038/mt.2010.272; Parkhurst MR, 2009, CLIN CANCER RES, V15, P169, DOI 10.1158/1078-0432.CCR-08-1638; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Paulos CM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000448; Pegram HJ, 2012, BLOOD, V119, P4133, DOI 10.1182/blood-2011-12-400044; Peng DJ, 2015, NATURE, V527, P249, DOI 10.1038/nature15520; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Prosser ME, 2012, MOL IMMUNOL, V51, P263, DOI 10.1016/j.molimm.2012.03.023; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Pulko V, 2016, NAT IMMUNOL, V17, P966, DOI 10.1038/ni.3483; Raman MCC, 2016, SCI REP-UK, V6, DOI 10.1038/srep18851; Rapoport AP, 2015, NAT MED, V21, P914, DOI 10.1038/nm.3910; Ren J., 2016, CLIN CANC RES; Ribas A, 2013, NEW ENGL J MED, V368, P1365, DOI 10.1056/NEJMc1302338; Richer MJ, 2016, J IMMUNOL, V197, P1009, DOI 10.4049/jimmunol.1600847; Riches JC, 2013, BLOOD, V121, P1612, DOI 10.1182/blood-2012-09-457531; RIDDELL SR, 1992, SCIENCE, V257, P238; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rodgers DT, 2016, P NATL ACAD SCI USA, V113, pE459, DOI 10.1073/pnas.1524155113; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; ROSENBERG SA, 1988, NEW ENGL J MED, V319, P1676, DOI 10.1056/NEJM198812223192527; Roybal KT, 2016, CELL, V167, P419, DOI 10.1016/j.cell.2016.09.011; Roybal KT, 2016, CELL, V164, P770, DOI 10.1016/j.cell.2016.01.011; Roychoudhuri R, 2016, NAT IMMUNOL, V17, P851, DOI 10.1038/ni.3441; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Rufer N, 2001, BLOOD, V98, P597, DOI 10.1182/blood.V98.3.597; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Schietinger A, 2012, SCIENCE, V335, P723, DOI 10.1126/science.1214277; Scholler J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003761; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Song DG, 2012, BLOOD, V119, P696, DOI 10.1182/blood-2011-03-344275; Spencer D., 2016, US Patent, Patent No. [20,160,058,857, 20160058857]; Stone JD, 2015, CURR OPIN IMMUNOL, V33, P16, DOI 10.1016/j.coi.2015.01.003; Sukumar M, 2016, CELL METAB, V23, P63, DOI 10.1016/j.cmet.2015.11.002; Symons HJ, 2008, BIOL BLOOD MARROW TR, V14, P499, DOI 10.1016/j.bbmt.2008.02.013; Teachey DT, 2016, CANCER DISCOV, V6, P664, DOI 10.1158/2159-8290.CD-16-0040; Teng MWL, 2015, CANCER RES, V75, P2139, DOI 10.1158/0008-5472.CAN-15-0255; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Topp MS, 2003, J EXP MED, V198, P947, DOI 10.1084/jem.20021288; Turtle CJ, 2016, J CLIN INVEST, V126, P2123, DOI 10.1172/JCI85309; Tyrakis PA, 2016, NATURE, V540, P236, DOI 10.1038/nature20165; van den Berg JH, 2015, MOL THER, V23, P1541, DOI 10.1038/mt.2015.60; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wang XL, 2011, BLOOD, V118, P1255, DOI 10.1182/blood-2011-02-337360; WEIDEN PL, 1979, NEW ENGL J MED, V300, P1068, DOI 10.1056/NEJM197905103001902; WENG NP, 1995, P NATL ACAD SCI USA, V92, P11091, DOI 10.1073/pnas.92.24.11091; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wilkie S, 2012, J CLIN IMMUNOL, V32, P1059, DOI 10.1007/s10875-012-9689-9; Winkelstein JA, 2006, MEDICINE, V85, P193, DOI 10.1097/01.md.0000229482.27398.ad; Wu CY, 2015, SCIENCE, V350, DOI 10.1126/science.aab4077; Yu H, 2017, AM J HEMATOL, V92, pE11, DOI 10.1002/ajh.24594; Zah E, 2016, CANCER IMMUNOL RES, V4, P498, DOI 10.1158/2326-6066.CIR-15-0231; Zhang SQ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1278; Zhao Y, 2007, J IMMUNOL, V179, P5845, DOI 10.4049/jimmunol.179.9.5845; Zhong S, 2013, P NATL ACAD SCI USA, V110, P6973, DOI 10.1073/pnas.1221609110; Zhou JH, 2005, J IMMUNOL, V175, P7046, DOI 10.4049/jimmunol.175.10.7046	139	586	624	31	414	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2017	168	4					724	740		10.1016/j.cell.2017.01.016	http://dx.doi.org/10.1016/j.cell.2017.01.016			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8VJ	28187291	Bronze, Green Accepted			2022-12-28	WOS:000396277600020
J	Yurgelun, MB; Chenevix-Trench, G; Lippman, SM				Yurgelun, Matthew B.; Chenevix-Trench, Georgia; Lippman, Scott M.			Translating Germline Cancer Risk into Precision Prevention	CELL			English	Editorial Material							PANCREATIC-CANCER; BREAST; CARRIERS	Study of the biology of tumors caused by germline mutations has led to recent paradigm-changing therapy and is driving precision prevention efforts, including immune oncology and early detection research. Here, we explore recent biologic advances that are redefining the spectrum of cancers linked to various hereditary predisposition syndromes and can be leveraged to improve personalized risk assessment and develop novel interventions to prevent or intercept cancer.	[Yurgelun, Matthew B.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Yurgelun, Matthew B.] Harvard Med Sch, Boston, MA 02215 USA; [Chenevix-Trench, Georgia] QIMR Berghofer Med Res Inst, Brisbane, Qld 4029, Australia; [Lippman, Scott M.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; QIMR Berghofer Medical Research Institute; University of California System; University of California San Diego	Lippman, SM (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	slippman@ucsd.edu	Chenevix-Trench, Georgia/AAV-2014-2020	Chenevix-Trench, Georgia/0000-0002-1878-2587				Belcheva A, 2014, CELL, V158, P288, DOI 10.1016/j.cell.2014.04.051; Communal L, 2016, ONCOTARGET, V7, P45317, DOI 10.18632/oncotarget.9638; Connor AA, 2016, JAMA ONCOL; Dunning AM, 2016, NAT GENET, V48, P374, DOI 10.1038/ng.3521; Kotsopoulos J, 2016, J NATL CANC I; Kuchenbaecker K.B., J NATL CANC I; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Milne RL, 2016, ENDOCR-RELAT CANCER, V23, pT69, DOI 10.1530/ERC-16-0277; Montrose DC, 2016, CANCER PREV RES, V9, P721, DOI 10.1158/1940-6207.CAPR-16-0095; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Nolan E, 2016, NAT MED, V22, P933, DOI 10.1038/nm.4118; Salo-Mullen EE, 2015, CANCER-AM CANCER SOC, V121, P4382, DOI 10.1002/cncr.29664; Spira A, 2016, P NATL ACAD SCI USA, V113, P10750, DOI 10.1073/pnas.1608077113; Vasen H, 2016, J CLIN ONCOL, V34, P2010, DOI 10.1200/JCO.2015.64.0730; Yurgelun M.B., 2017, J CLIN ONCOL	15	15	15	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2017	168	4					566	570		10.1016/j.cell.2017.01.031	http://dx.doi.org/10.1016/j.cell.2017.01.031			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8VJ	28187278	Bronze			2022-12-28	WOS:000396277600007
J	Iacobucci, G				Iacobucci, Gareth			GP contract deal removes "bureaucratic workload" and brings 1% pay rise	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2017	356								j687	10.1136/bmj.j687	http://dx.doi.org/10.1136/bmj.j687			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4FV	28174183				2022-12-28	WOS:000394578000014
J	Downs, JA; Mwakisole, AH; Chandika, AB; Lugoba, S; Kassim, R; Laizer, E; Magambo, KA; Lee, MH; Kalluvya, SE; Downs, DJ; Fitzgerald, DW				Downs, Jennifer A.; Mwakisole, Agrey H.; Chandika, Alphonce B.; Lugoba, Shibide; Kassim, Rehema; Laizer, Evarist; Magambo, Kinanga A.; Lee, Myung Hee; Kalluvya, Samuel E.; Downs, David J.; Fitzgerald, Daniel W.			Educating religious leaders to promote uptake of male circumcision in Tanzania: a cluster randomised trial	LANCET			English	Article							HIV PREVENTION; MEN; INTERVENTIONS	Background Male circumcision is being widely deployed as an HIV prevention strategy in countries with high HIV incidence, but its uptake in sub-Saharan Africa has been below targets. We did a study to establish whether educating religious leaders about male circumcision would increase uptake in their village. Methods In this cluster randomised trial in northwest Tanzania, eligible villages were paired by proximity (< 60 km) and the time that a free male circumcision outreach campaign from the Tanzanian Ministry of Health became available in their village. All villages received the standard male circumcision outreach activities provided by the Ministry of Health. Within the village pairs, villages were randomly assigned by coin toss to receive either additional education for Christian church leaders on scientific, religious, and cultural aspects of male circumcision (intervention group), or standard outreach only (control group). Church leaders or their congregations were not masked to random assignment. The educational intervention consisted of a 1-day seminar co-taught by a Tanzanian pastor and a Tanzanian clinician who worked with the Ministry of Health, and meetings with the study team every 2 weeks thereafter, for the duration of the circumcision campaign. The primary outcome was the proportion of male individuals in a village who were circumcised during the campaign, using an intention-to-treat analysis that included all men in the village. This trial is registered with ClinicalTrials. gov, number NCT 02167776. Findings Between June 15, 2014, and Dec 10, 2015, we provided education for church leaders in eight intervention villages and compared the outcomes with those in eight control villages. In the intervention villages, 52.8% (30 889 of 58 536) of men were circumcised compared with 29.5% (25 484 of 86 492) of men in the eight control villages (odds ratio 3.2 [95% CI, 1.4-7.3]; p= 0.006). Interpretation Education of religious leaders had a substantial effect on uptake of male circumcision, and should be considered as part of male circumcision programmes in other sub-Saharan African countries. This study was conducted in one region in Tanzania; however, we believe that our intervention is generalisable. We equipped church leaders with knowledge and tools, and ultimately each leader established the most culturally-appropriate way to promote male circumcision. Therefore, we think that the process of working through religious leaders can serve as an innovative model to promote healthy behaviour, leading to HIV prevention and other clinically relevant outcomes, in a variety of settings. Funding Bill & Melinda Gates Foundation, National Institutes of Health, and the Mulago Foundation. Copyright c The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.	[Downs, Jennifer A.; Lee, Myung Hee; Fitzgerald, Daniel W.] Weill Cornell Med Coll, Dept Med, Ctr Global Hlth, New York, NY 10065 USA; [Mwakisole, Agrey H.; Laizer, Evarist; Downs, David J.] St Paul Coll, Mwanza, Tanzania; [Chandika, Alphonce B.] Bugando Med Ctr, Dept Surg, Mwanza, Tanzania; [Lugoba, Shibide; Kassim, Rehema; Kalluvya, Samuel E.] Bugando Med Ctr, Care & Treatment Ctr, Mwanza, Tanzania; [Downs, Jennifer A.; Magambo, Kinanga A.; Kalluvya, Samuel E.] Bugando Med Ctr, Dept Med, Mwanza, Tanzania; [Mwakisole, Agrey H.; Downs, David J.] Fuller Theol Seminary, Pasadena, CA 91101 USA	Cornell University	Downs, JA (corresponding author), Weill Cornell Med Coll, Dept Med, Ctr Global Hlth, New York, NY 10065 USA.	jna2002@med.cornell.edu		Downs, Jennifer/0000-0001-9537-204X	Bill & Melinda Gates Foundation; National Institutes of Health; Mulago Foundation; Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative [OPP1107849] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI110238, K24AI098627] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mulago Foundation; Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Bill & Melinda Gates Foundation, National Institutes of Health, and the Mulago Foundation.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Campbell MK, 2007, ANNU REV PUBL HEALTH, V28, P213, DOI 10.1146/annurev.publhealth.28.021406.144016; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Colvin C, 2014, GLOB HEALTH-SCI PRAC, V2, P219, DOI 10.9745/GHSP-D-14-00026; Creswell J.W., 2015, RES DESIGN QUANTITAT; Downs JA, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002802; Doyle AM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000287; Ezeanolue EE, 2015, LANCET GLOB HEALTH, V3, pE692, DOI 10.1016/S2214-109X(15)00195-3; Francis SA, 2009, J RELIG HEALTH, V48, P6, DOI 10.1007/s10943-008-9171-4; Gasasira RA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-134; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Lugo L, 2010, TOLERANCE TENSION IS; National Bureau of Statistics and Office of Chief Government Statistician, 2013, UN REP TANZ 2012 POP; National Bureau of Statistics (Tanzania) & ICF Macro, 2011, TANZ DEM HLTH SURV 2; Nnko S, 2001, SEX TRANSM DIS, V28, P214, DOI 10.1097/00007435-200104000-00005; Parkhurst JO, 2015, SOC SCI MED, V135, P15, DOI 10.1016/j.socscimed.2015.04.020; Sandelowski M, 2003, QUAL HEALTH RES, V13, P905, DOI 10.1177/1049732303253488; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Smith J., 1999, QUALITATIVE HLTH PSY; Watson-Jones D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123701; Weijer C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001346; Weiss HA, 2008, TROP MED INT HEALTH, V13, P1054, DOI 10.1111/j.1365-3156.2008.02107.x; Wight D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-788; Williams MV, 2011, J URBAN HEALTH, V88, P517, DOI 10.1007/s11524-010-9526-5; Willms Dennis G, 2004, Afr J AIDS Res, V3, P23, DOI 10.2989/16085900409490315; Willms DG, 2011, SEX TRANSM INFECT, V87, P611, DOI 10.1136/sextrans-2011-050045	29	17	18	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2017	389	10074					1124	1132		10.1016/s0140-6736(16)32055-4	http://dx.doi.org/10.1016/s0140-6736(16)32055-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0SR	28214093	Green Published, hybrid			2022-12-28	WOS:000396408700028
J	Peng, M; Yin, N; Li, MO				Peng, Min; Yin, Na; Li, Ming O.			SZT2 dictates GATOR control of mTORC1 signalling	NATURE			English	Article							RAG GTPASES; NUTRIENT REGULATION; COMPLEX; PATHWAY; TORC1; ACTIVATION; ENCEPHALOPATHY; METABOLISM; INHIBITORS; INTERACT	Mechanistic target of rapamycin complex 1 (TORC1) integrates nutrient signals to control cell growth and organismal homeostasis across eukaryotes(1-4). The evolutionarily conserved GATOR complex regulates mTORC1 signalling through Rag GTPases, and GATOR1 displays GTPase activating protein (GAP) activity for RAGA and RAGB (RAGA/B) and GATOR2 has been proposed to be an inhibitor of GATOR1(5,6). Furthermore, the metazoan-specific SESN proteins function as guanine nucleotide dissociation inhibitors (GDIs) for RAGA/B, and interact with GATOR2 with unknown effects(7-9). Here we show that SZT2 (seizure threshold 2), a metazoan-specific protein mutated in epilepsy(10-13), recruits a fraction of mammalian GATOR1 and GATOR2 to form a SZT2-orchestrated GATOR (SOG) complex with an essential role in GATOR-and SESN-dependent nutrient sensing and mTORC1 regulation. The interaction of SZT2 with GATOR1 and GATOR2 was synergistic, and an intact SOG complex was required for its localization at the lysosome. SZT2 deficiency resulted in constitutive mTORC1 signalling in cells under nutrient-deprived conditions and neonatal lethality in mice, which was associated with failure to inactivate mTORC1 during fasting. Hyperactivation of mTORC1 in SZT2-deficient cells could be partially corrected by overexpression of the GATOR1 component DEPDC5, and by the lysosome-targeted GATOR2 component WDR59 or lysosome-targeted SESN2. These findings demonstrate that SZT2 has a central role in dictating GATOR-dependent nutrient sensing by promoting lysosomal localization of SOG, and reveal an unexpected function of lysosome-located GATOR2 in suppressing mTORC1 signalling through SESN recruitment.	[Peng, Min; Yin, Na; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA.	lim@mskcc.org	Peng, Min/O-3770-2017	Peng, Min/0000-0002-5885-0660; li, ming/0000-0002-1383-0535	Leukemia & Lymphoma Society Scholar Award; Functional Genomics Initiative Grant from Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center Support Grant/Core Grant [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); Functional Genomics Initiative Grant from Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Memorial Sloan Kettering Cancer Center Support Grant/Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank H. Erdjument-Bromage at the Microchemistry and Proteomics Core for help with the mass spectrometry experiments, and J. Xie for the WDR59 antibody. This work was supported by a Leukemia & Lymphoma Society Scholar Award (M.O.L.), a Functional Genomics Initiative Grant from Memorial Sloan Kettering Cancer Center (M.O.L.), a Faculty Scholar grant from the Howard Hughes Medical Institute (M.O.L.), and the Memorial Sloan Kettering Cancer Center Support Grant/Core Grant (P30 CA008748).	Algret R, 2014, MOL CELL PROTEOMICS, V13, P2855, DOI 10.1074/mcp.M114.039388; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Basel-Vanagaite L, 2013, AM J HUM GENET, V93, P524, DOI 10.1016/j.ajhg.2013.07.005; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; Dokudovskaya S, 2015, J CELL SCI, V128, P2219, DOI 10.1242/jcs.168922; Dokudovskaya S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006478; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Falcone M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082810; Frankel WN, 2009, GENES BRAIN BEHAV, V8, P568, DOI 10.1111/j.1601-183X.2009.00509.x; Jewell JL, 2013, TRENDS BIOCHEM SCI, V38, P233, DOI 10.1016/j.tibs.2013.01.004; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim SG, 2013, MOL CELLS, V35, P463, DOI 10.1007/s10059-013-0138-2; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Panchaud N, 2013, CELL CYCLE, V12, P2948, DOI 10.4161/cc.26000; Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112; Parmigiani A, 2014, CELL REP, V9, P1281, DOI 10.1016/j.celrep.2014.10.019; Peng M, 2014, CELL, V159, P122, DOI 10.1016/j.cell.2014.08.038; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Toutzaris D, 2010, FREE RADICAL BIO MED, V48, P811, DOI 10.1016/j.freeradbiomed.2009.12.023; Venkatesan C, 2016, EPILEPTIC DISORD, V18, P195, DOI 10.1684/epd.2016.0828; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Wong M, 2013, EXPERT REV NEUROTHER, V13, P657, DOI [10.1586/ern.13.48, 10.1586/ERN.13.48]	28	101	106	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					433	+		10.1038/nature21378	http://dx.doi.org/10.1038/nature21378			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28199315	Green Accepted			2022-12-28	WOS:000396337400053
J	Zhang, SC; Kang, LX; Wang, X; Tong, LM; Yang, LW; Wang, ZQ; Qi, K; Deng, SB; Li, QW; Bai, XD; Ding, F; Zhang, J				Zhang, Shuchen; Kang, Lixing; Wang, Xiao; Tong, Lianming; Yang, Liangwei; Wang, Zequn; Qi, Kuo; Deng, Shibin; Li, Qingwen; Bai, Xuedong; Ding, Feng; Zhang, Jin			Arrays of horizontal carbon nanotubes of controlled chirality grown using designed catalysts	NATURE			English	Article							SELECTIVE GROWTH; OXIDE CATALYSTS; DIAMETER; RAMAN	The semiconductor industry is increasingly of the view that Moore's law-which predicts the biennial doubling of the number of transistors per microprocessor chip-is nearing its end(1). Consequently, the pursuit of alternative semiconducting materials for nanoelectronic devices, including single-walled carbon nanotubes (SWNTs), continues(2-4). Arrays of horizontal nanotubes are particularly appealing for technological applications because they optimize current output. However, the direct growth of horizontal SWNT arrays with controlled chirality, that would enable the arrays to be adapted for a wider range of applications and ensure the uniformity of the fabricated devices, has not yet been achieved. Here we show that horizontal SWNT arrays with predicted chirality can be grown from the surfaces of solid carbide catalysts by controlling the symmetries of the active catalyst surface. We obtained horizontally aligned metallic SWNT arrays with an average density of more than 20 tubes per micrometre in which 90 per cent of the tubes had chiral indices of (12, 6), and semiconducting SWNT arrays with an average density of more than 10 tubes per micrometre in which 80 per cent of the nanotubes had chiral indices of (8, 4). The nanotubes were grown using uniform size Mo2C and WC solid catalysts. Thermodynamically, the SWNT was selectively nucleated by matching its structural symmetry and diameter with those of the catalyst. We grew nanotubes with chiral indices of (2m, m) (where m is a positive integer), the yield of which could be increased by raising the concentration of carbon to maximize the kinetic growth rate in the chemical vapour deposition process. Compared to previously reported methods, such as cloning(5,6), seeding(7,8) and specific-structure-matching growth(9-11), our strategy of controlling the thermodynamics and kinetics offers more degrees of freedom, enabling the chirality of as-grown SWNTs in an array to be tuned, and can also be used to predict the growth conditions required to achieve the desired chiralities.	[Zhang, Shuchen; Kang, Lixing; Tong, Lianming; Yang, Liangwei; Wang, Zequn; Deng, Shibin; Zhang, Jin] Peking Univ, Beijing Sci & Engn Ctr Nanocarbons, Coll Chem & Mol Engn, Ctr Nanochem,Beijing Natl Lab Mol Sci,Key Lab Phy, Beijing 100871, Peoples R China; [Kang, Lixing; Li, Qingwen] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Suzhou 215123, Peoples R China; [Wang, Xiao; Ding, Feng] Inst Basic Sci, Ctr Multidimens Carbon Mat, Ulsan 689798, South Korea; [Wang, Xiao; Ding, Feng] Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China; [Qi, Kuo; Bai, Xuedong] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China; [Ding, Feng] Ulsan Natl Inst Sci & Technol, Sch Mat Sci & Engn, Ulsan 689798, South Korea	Chinese Academy of Sciences; Peking University; Chinese Academy of Sciences; Suzhou Institute of Nano-Tech & Nano-Bionics, CAS; Institute for Basic Science - Korea (IBS); Hong Kong Polytechnic University; Chinese Academy of Sciences; Institute of Physics, CAS; Ulsan National Institute of Science & Technology (UNIST)	Zhang, J (corresponding author), Peking Univ, Beijing Sci & Engn Ctr Nanocarbons, Coll Chem & Mol Engn, Ctr Nanochem,Beijing Natl Lab Mol Sci,Key Lab Phy, Beijing 100871, Peoples R China.	jinzhang@pku.edu.cn	Tong, Lianming/B-6000-2012; Li, Q/AAA-6688-2020; Tong, Lianming/ABA-8370-2021; DING, FENG/D-5938-2011; Wang, Xiao/AAL-8698-2020	Tong, Lianming/0000-0001-7771-4077; DING, FENG/0000-0001-9153-9279; Wang, Xiao/0000-0002-4251-9412; Li, Qingwen/0000-0001-8081-786X	Ministry of Science and Technology of China [2016YFA0200101, 2016YFA0200104]; National Natural Science Foundation of China [51432002, 21129001, 21233001]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We are grateful to K. Jiang (Tsinghua University, China), K. Liu (Peking University, China) and R. Horn (Deakin University, Australia) for discussions. This work was supported by the Ministry of Science and Technology of China (2016YFA0200101 and 2016YFA0200104) and the National Natural Science Foundation of China (grant 51432002, 21129001 and 21233001).	Artyukhov VI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5892; Bachilo SM, 2003, J AM CHEM SOC, V125, P11186, DOI 10.1021/ja036622c; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Cao Q, 2015, SCIENCE, V350, P68, DOI 10.1126/science.aac8006; CHEN Y, 1992, CATAL LETT, V12, P51, DOI 10.1007/BF00767188; Ding F, 2009, P NATL ACAD SCI USA, V106, P2506, DOI 10.1073/pnas.0811946106; Dresselhaus MS, 2005, PHYS REP, V409, P47, DOI 10.1016/j.physrep.2004.10.006; Fenglan Z., 2003, J MATER CHEM, V13, P1206; Franklin AD, 2013, NATURE, V498, P443, DOI 10.1038/498443a; Gao J, 2015, SCIENCE, V348, P686, DOI 10.1126/science.aaa7048; Gutierrez-Alejandre A, 1998, CATAL LETT, V56, P29, DOI 10.1023/A:1019076121915; He MS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01460; He MS, 2012, NANOSCALE, V4, P7394, DOI 10.1039/c2nr32276e; HU HC, 1995, J PHYS CHEM-US, V99, P10897, DOI 10.1021/j100027a034; Hu Y, 2013, SMALL, V9, P1306, DOI 10.1002/smll.201202940; Huang SM, 2009, J AM CHEM SOC, V131, P2094, DOI 10.1021/ja809635s; Liu BL, 2012, CHEM COMMUN, V48, P2409, DOI 10.1039/c2cc16491d; Liu J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2205; Sanchez-Valencia JR, 2014, NATURE, V512, P61, DOI 10.1038/nature13607; Shulaker MM, 2013, NATURE, V501, P526, DOI 10.1038/nature12502; Tanaka T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.114001; Waldrop MM, 2016, NATURE, V530, P144, DOI 10.1038/530144a; Wang H, 2015, CARBON, V81, P1, DOI 10.1016/j.carbon.2014.09.063; Xie Y-C., 1990, ADV CATAL, P1, DOI DOI 10.1016/S0360-0564(08)60362-4; Yang F, 2014, NATURE, V510, P522, DOI 10.1038/nature13434; Yao YG, 2007, NAT MATER, V6, P283, DOI 10.1038/nmat1865; Yao YG, 2009, NANO LETT, V9, P1673, DOI 10.1021/nl900207v; Yu XC, 2010, NANO LETT, V10, P3343, DOI 10.1021/nl1010178; Zhang SC, 2015, J AM CHEM SOC, V137, P8904, DOI 10.1021/jacs.5b05384; Zhu HW, 2008, J CRYST GROWTH, V310, P5473, DOI 10.1016/j.jcrysgro.2008.09.174	30	265	274	63	978	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					234	+		10.1038/nature21051	http://dx.doi.org/10.1038/nature21051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN0GQ	28199307				2022-12-28	WOS:000395688700037
J	Couzin-Frankel, J				Couzin-Frankel, Jennifer			Publication ban upends NIH lab, collaborators Citing protocol violations, institute won't allow use of 25 years of data	SCIENCE			English	News Item																			0	0	0	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					783	784		10.1126/science.355.6327.783	http://dx.doi.org/10.1126/science.355.6327.783			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28232530				2022-12-28	WOS:000395127600012
J	Lewis, K; Shan, Y				Lewis, Kim; Shan, Yue			INFECTIOUS DISEASE Why tolerance invites resistance Bacteria that encounter antibiotics first become tolerant and then resistant to them	SCIENCE			English	Editorial Material							PSEUDOMONAS-AERUGINOSA		[Lewis, Kim; Shan, Yue] Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA	Northeastern University	Lewis, K (corresponding author), Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA.	k.lewis@neu.edu	Ren, Guogang/P-4540-2017; Shan, Yue/R-2196-2018	Ren, Guogang/0000-0001-8865-1526; 				Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Fridman O, 2014, NATURE, V513, P418, DOI 10.1038/nature13469; Levin-Reisman I, 2017, SCIENCE, V355, P826, DOI 10.1126/science.aaj2191; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Schumacher MA, 2015, NATURE, V524, P59, DOI 10.1038/nature14662; Shan Y, 2017, MBIO, V8, DOI 10.1128/mBio.02267-16	10	23	26	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2017	355	6327					796	796		10.1126/science.aam7926	http://dx.doi.org/10.1126/science.aam7926			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM2DW	28232537				2022-12-28	WOS:000395127600019
J	Franke, K; Berens, P; Schubert, T; Bethge, M; Euler, T; Baden, T				Franke, Katrin; Berens, Philipp; Schubert, Timm; Bethge, Matthias; Euler, Thomas; Baden, Tom			Inhibition decorrelates visual feature representations in the inner retina	NATURE			English	Article							CELL AXON TERMINALS; BIPOLAR CELLS; GANGLION-CELLS; MOUSE RETINA; MAMMALIAN RETINA; LATERAL INHIBITION; SLICE PREPARATION; TIGER SALAMANDER; AMACRINE CELLS; SPACE-TIME	The retina extracts visual features for transmission to the brain. Different types of bipolar cell split the photoreceptor input into parallel channels and provide the excitatory drive for downstream visual circuits. Mouse bipolar cell types have been described at great anatomical and genetic detail, but a similarly deep understanding of their functional diversity is lacking. Here, by imaging light-driven glutamate release from more than 13,000 bipolar cell axon terminals in the intact retina, we show that bipolar cell functional diversity is generated by the interplay of dendritic excitatory inputs and axonal inhibitory inputs. The resulting centre and surround components of bipolar cell receptive fields interact to decorrelate bipolar cell output in the spatial and temporal domains. Our findings highlight the importance of inhibitory circuits in generating functionally diverse excitatory pathways and suggest that decorrelation of parallel visual pathways begins as early as the second synapse of the mouse visual system.	[Franke, Katrin; Berens, Philipp; Schubert, Timm; Bethge, Matthias; Euler, Thomas; Baden, Tom] Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany; [Franke, Katrin; Berens, Philipp; Bethge, Matthias; Euler, Thomas; Baden, Tom] Univ Tubingen, Bernstein Ctr Computat Neurosci, Tubingen, Germany; [Franke, Katrin; Berens, Philipp; Schubert, Timm; Euler, Thomas; Baden, Tom] Univ Tubingen, Inst Ophthalm Res, Tubingen, Germany; [Franke, Katrin] Univ Tubingen, Int Max Planck Res Sch, Grad Sch Neural & Behav Sci, Tubingen, Germany; [Bethge, Matthias] Univ Tubingen, Inst Theoret Phys, Tubingen, Germany; [Bethge, Matthias] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Baden, Tom] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Max Planck Society; Eberhard Karls University of Tubingen; Max Planck Society; University of Sussex	Euler, T; Baden, T (corresponding author), Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany.; Euler, T; Baden, T (corresponding author), Univ Tubingen, Bernstein Ctr Computat Neurosci, Tubingen, Germany.; Euler, T; Baden, T (corresponding author), Univ Tubingen, Inst Ophthalm Res, Tubingen, Germany.; Baden, T (corresponding author), Univ Sussex, Sch Life Sci, Brighton, E Sussex, England.	thomas.euler@cin.uni-tuebingen.de; tom@badenlab.org	Berens, Philipp/A-5653-2009	Berens, Philipp/0000-0002-0199-4727; Euler, Thomas/0000-0002-4567-6966; Franke, Katrin/0000-0002-8649-4835	Deutsche Forschungsgemeinschaft (DFG) [EXC307, BA 5283/1-1, BE 5601/1-1]; German Federal Ministry of Education and Research (BMBF) [FKZ 01GQ1002, FKZ 01GQ1601]; BW-Stiftung [AZ1.16101.09]; University of Tubingen [2125-0-0]; European Commission [H2020 ERC-StG 677687 'NeuroVisEco']; National Institute of Neurological Disorders and Stroke [U01NS090562]; National Eye Institute of the National Institutes of Health [1R01EY023766]; NATIONAL EYE INSTITUTE [R01EY023766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090562] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BW-Stiftung; University of Tubingen; European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Eske for technical support, C. Behrens for help with EM data, J. Juttner for help with virus injection; X. Pitkow and R. Taylor for discussions; and L. L. Looger, the Janelia Research Campus of the Howard Hughes Medical Institute and the Genetically-Encoded Neuronal Indicator and Effector (GENIE) Project for making the viral constructs (AAV9.hSyn.iGluSnFR.WPRE.SV40, AAV9.CAG.Flex.iGluSnFR.WPRE.SV40 and AAV9.Syn.Flex.GCaMP6f.WPRE.SV40) publically available. This work was supported by the Deutsche Forschungsgemeinschaft (DFG; EXC307 to T.E.; BA 5283/1-1 to T.B.; BE 5601/1-1 to P.B.), the German Federal Ministry of Education and Research (BMBF; FKZ 01GQ1002 to M.B. and T.E.; FKZ 01GQ1601 to P.B.), the BW-Stiftung (AZ1.16101.09 to T.B.), the intramural fortune program of the University of Tubingen (2125-0-0 to T.B.), the European Commission (H2020 ERC-StG 677687 'NeuroVisEco' to T.B.), the National Institute of Neurological Disorders and Stroke (U01NS090562 to T.E.) and the National Eye Institute (1R01EY023766 to T.E.) of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders.	Atick J. J., 1990, NEURAL COMPUT, V320, P1; Baden T, 2016, NATURE, V529, P345, DOI 10.1038/nature16468; Baden T, 2013, NEURON, V80, P1206, DOI 10.1016/j.neuron.2013.09.030; Baden T, 2013, CURR BIOL, V23, P48, DOI 10.1016/j.cub.2012.11.006; Barlow HB, 1961, SENS COMMUN, V6, P57; Behrens C, 2016, ELIFE, V5, DOI 10.7554/eLife.20041; Bishop C.M., 2006, PATTERN RECOGN; Borghuis BG, 2013, J NEUROSCI, V33, P10972, DOI 10.1523/JNEUROSCI.1241-13.2013; Breuninger T, 2011, J NEUROSCI, V31, P6504, DOI 10.1523/JNEUROSCI.0616-11.2011; Buldyrev I, 2013, J PHYSIOL-LONDON, V591, P303, DOI 10.1113/jphysiol.2012.243113; Burrone J, 2000, J NEUROSCI, V20, P568, DOI 10.1523/JNEUROSCI.20-02-00568.2000; Chen MG, 2014, J NEUROPHYSIOL, V112, P1950, DOI 10.1152/jn.00283.2014; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Demb JB, 2012, VISUAL NEUROSCI, V29, P51, DOI 10.1017/S0952523811000368; Deneve S, 2016, NAT NEUROSCI, V19, P375, DOI 10.1038/nn.4243; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; DeVries SH, 2006, NEURON, V50, P735, DOI 10.1016/j.neuron.2006.04.034; Dreosti E, 2011, NAT NEUROSCI, V14, P951, DOI 10.1038/nn.2841; Eggers ED, 2011, VISUAL NEUROSCI, V28, P95, DOI 10.1017/S0952523810000209; Eggers ED, 2010, J NEUROPHYSIOL, V103, P25, DOI 10.1152/jn.00458.2009; Euler T, 1996, J NEUROSCI, V16, P2934; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Euler T, 1998, J NEUROPHYSIOL, V79, P1384, DOI 10.1152/jn.1998.79.3.1384; Euler T, 2014, NAT REV NEUROSCI, V15, P507, DOI 10.1038/nrn3783; Euler T, 2009, PFLUG ARCH EUR J PHY, V457, P1393, DOI 10.1007/s00424-008-0603-5; Giridhar S, 2011, P NATL ACAD SCI USA, V108, P5843, DOI 10.1073/pnas.1015165108; Greene MJ, 2016, CELL REP, V14, P1892, DOI 10.1016/j.celrep.2016.02.001; Grimes WN, 2009, NAT NEUROSCI, V12, P585, DOI 10.1038/nn.2302; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Ichinose T, 2005, J PHYSIOL-LONDON, V565, P517, DOI 10.1113/jphysiol.2005.083436; Kemmler R, 2014, J NEUROSCI, V34, P11826, DOI 10.1523/JNEUROSCI.0272-14.2014; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Liang ZY, 2010, J NEUROSCI, V30, P5533, DOI 10.1523/JNEUROSCI.4733-09.2010; Lindstrom SH, 2014, J PHYSIOL-LONDON, V592, P1457, DOI 10.1113/jphysiol.2013.265033; LUKASIEWICZ PD, 1994, J NEUROSCI, V14, P1213, DOI 10.1523/JNEUROSCI.14-03-01213.1994; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; Masland RH, 2012, VISUAL NEUROSCI, V29, P3, DOI 10.1017/S0952523811000344; Nikolaev A, 2013, NAT NEUROSCI, V16, P934, DOI 10.1038/nn.3408; Pitkow X, 2012, NAT NEUROSCI, V15, P628, DOI 10.1038/nn.3064; Puller C, 2013, NEUROSCIENCE, V243, P136, DOI 10.1016/j.neuroscience.2013.03.054; Puthussery T, 2014, J NEUROSCI, V34, P7611, DOI 10.1523/JNEUROSCI.4855-13.2014; Rosa JM, 2016, NEURON, V90, P308, DOI 10.1016/j.neuron.2016.03.015; Roska B, 2000, J NEUROSCI, V20, P1941; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120; Schubert T, 2008, J NEUROPHYSIOL, V100, P304, DOI 10.1152/jn.90202.2008; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Szczurek E, 2010, J COMPUT BIOL, V17, P953, DOI 10.1089/cmb.2010.0034; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; Vinje W. E., 2007, SCIENCE, V1273, P1273; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Yatsenko D., 2015, PREPRINT; Zaghloul KA, 2003, J NEUROSCI, V23, P2645	57	109	109	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2017	542	7642					439	+		10.1038/nature21394	http://dx.doi.org/10.1038/nature21394			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM1RG	28178238	Green Accepted, Green Submitted			2022-12-28	WOS:000395094100028
J	Kilmer, B				Kilmer, Beau			Recreational Cannabis - Minimizing the Health Risks from Legalization	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kilmer, Beau] RAND Drug Policy Res Ctr, Santa Monica, CA 90401 USA		Kilmer, B (corresponding author), RAND Drug Policy Res Ctr, Santa Monica, CA 90401 USA.							Caulkins J., 2016, MARIJUANA LEGALIZATI, DOI DOI 10.7249/CB525-1; Caulkins J.P., 2015, CONSIDERING MARIJUAN; Silins E, 2014, LANCET PSYCHIAT, V1, P286, DOI 10.1016/S2215-0366(14)70307-4; van der Pol P, 2014, ADDICTION, V109, P1101, DOI 10.1111/add.12508; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309	5	43	45	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2017	376	8					705	707		10.1056/NEJMp1614783	http://dx.doi.org/10.1056/NEJMp1614783			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EM9JO	28225673				2022-12-28	WOS:000395627900001
J	Poolman, RW; Agoritsas, T; Siemieniuk, RAC; Harris, IA; Schipper, IB; Mollon, B; Smith, M; Albin, A; Nador, S; Sasges, W; Schandelmaier, S; Lytvyn, L; Kuijpers, T; van Beers, LWAH; Verhofstad, MHJ; Vandvik, PO				Poolman, Rudolf W.; Agoritsas, Thomas; Siemieniuk, Reed A. C.; Harris, Ian A.; Schipper, Inger B.; Mollon, Brent; Smith, Maureen; Albin, Alexandra; Nador, Sally; Sasges, Will; Schandelmaier, Stefan; Lytvyn, Lyubov; Kuijpers, Ton; van Beers, Loes W. A. H.; Verhofstad, Michael H. J.; Vandvik, Per Olav			RAPID RECOMMENDATIONS Low intensity pulsed ultrasound (LIPUS) for bone healing: a clinical practice guideline	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GRADE; MATURATION; FRACTURES; QUALITY; CALLUS		[Poolman, Rudolf W.; van Beers, Loes W. A. H.] Joint Res, OLVG, Dept Orthopaed Surg, NL-1090 HM Amsterdam, Netherlands; [Agoritsas, Thomas; Siemieniuk, Reed A. C.; Schandelmaier, Stefan] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4L8, Canada; [Agoritsas, Thomas] Univ Hosp Geneva, Div Gen Internal Med, CH-1211 Geneva, Switzerland; [Agoritsas, Thomas] Univ Hosp Geneva, Div Clin Epidemiol, CH-1211 Geneva, Switzerland; [Siemieniuk, Reed A. C.] Univ Toronto, Dept Med, Toronto, ON M5G 2C4, Canada; [Harris, Ian A.] UNSW Australia, South Western Sydney Clin Sch, Sydney, NSW 2052, Australia; [Harris, Ian A.] Ingham Inst Appl Med Res, Whitlam Orthopaed Res Ctr, Liverpool, NSW 2170, Australia; [Schipper, Inger B.] Leiden Univ, Med Ctr, Dept Surg, NL-2333 Leiden, Netherlands; [Mollon, Brent] Orillia Soldiers Mem Hosp, Orillia, ON L3V 5W6, Canada; [Nador, Sally] Kindred Northlake Hosp, Northlake, TX USA; [Schandelmaier, Stefan] Univ Basel Hosp, Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Lytvyn, Lyubov] Oslo Univ Hosp, Forskningsveien 2b, N-0317 Oslo, Norway; [Kuijpers, Ton] Dutch Coll Gen Practitioners, NL-3502 GE Utrecht, Netherlands; [van Beers, Loes W. A. H.] OLVG, Dept Physiotherapy, NL-1090 HM Amsterdam, Netherlands; [Verhofstad, Michael H. J.] Erasmus MC Univ Rotterdam, Dept Surg, Trauma Res Unit Erasmus, NL-3000 CA Rotterdam, Netherlands; [Vandvik, Per Olav] Univ Oslo, Inst Hlth & Soc, Fac Med, N-0318 Oslo, Norway; [Vandvik, Per Olav] Innlandet Hosp Trust Div, Dept Med, Gjovik, Norway	McMaster University; University of Geneva; University of Geneva; University of Toronto; University of New South Wales Sydney; Ingham Institute for Applied Medical Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Basel; University of Oslo; Erasmus University Rotterdam; Erasmus MC; University of Oslo; Innlandet Hospital Trust	Poolman, RW (corresponding author), Joint Res, OLVG, Dept Orthopaed Surg, NL-1090 HM Amsterdam, Netherlands.	rwp@jointresearch.org	Schipper, Inger/ABE-7796-2021; Poolman, Rudolf/AAM-7815-2020; Schandelmaier, Stefan/GLV-3722-2022; Agoritsas, Thomas/F-4321-2014	Schipper, Inger/0000-0001-9952-3079; Poolman, Rudolf/0000-0003-3178-2247; Schandelmaier, Stefan/0000-0002-8429-0337; Agoritsas, Thomas/0000-0002-6182-9969; Verhofstad, Michael/0000-0001-8448-5903				ALONSOCOELLO P, 2016, BMJ-BRIT MED J, V353, P2089, DOI [DOI 10.1136/BMJ.I2089, 10.1136/bmj.i2089]; [Anonymous], 2005, KNOWLEDGE ENTERPRISE; Barrena E, 2016, EVALUATION OF EFFICA; Busse JW, 2008, ACTA ORTHOP, V79, P689, DOI 10.1080/17453670810016722; Busse JW, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5351; Donaldson LJ, 2008, J EPIDEMIOL COMMUN H, V62, P174, DOI 10.1136/jech.2006.056622; Ebrahim S, 2014, CAN J SURG, V57, pE105, DOI 10.1503/cjs.010113; El-Mowafi H, 2005, INT ORTHOP, V29, P121, DOI 10.1007/s00264-004-0625-3; Food and Drug Administration, 2000, APPR ORD; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Kisch T, 2015, BONE MICROCIRCULATIO; Mills LA, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002276; National Institute for Health and Clinical Excellence, 2010, LOW INT PULS ULTR PR; OrthoInfo, 2011, OST KNEE; Poolman RW, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b11; Prasad V, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-1; Rue JPH, 2004, ORTHOPEDICS, V27, P1192, DOI 10.3928/0147-7447-20041101-18; Schandelmaier S, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j656; Scolaro JA, 2014, J BONE JOINT SURG AM, V96A, P674, DOI 10.2106/JBJS.M.00081; Siemieniuk RA, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5191; Tsumaki N, 2004, J BONE JOINT SURG AM, V86A, P2399, DOI 10.2106/00004623-200411000-00006; Vandvik PO, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5085; Wachovia Capital Markets, 2007, EQ RES BON GROWTH ST	24	44	46	3	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2017	356								j576	10.1136/bmj.j576	http://dx.doi.org/10.1136/bmj.j576			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KS	28228381	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000395631000002
J	Blute, ML; Abramson, JS; Cronin, KC; Nardi, V				Blute, Michael L.; Abramson, Jeremy S.; Cronin, Kevin C.; Nardi, Valentina			Case 5-2017: A 19-Year-Old Man with Hematuria and a Retroperitoneal Mass	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VASCULAR CASTLEMANS-DISEASE; LYMPH-NODE HYPERPLASIA; DENDRITIC CELL-SARCOMA; INTERLEUKIN-6; SILTUXIMAB; RITUXIMAB; SURGERY; TRIAL		[Blute, Michael L.] Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA; [Abramson, Jeremy S.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Cronin, Kevin C.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Nardi, Valentina] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Blute, Michael L.] Harvard Med Sch, Dept Urol, Boston, MA 02115 USA; [Abramson, Jeremy S.] Harvard Med Sch, Dept Med, Boston, MA USA; [Cronin, Kevin C.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Nardi, Valentina] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Blute, ML (corresponding author), Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA.; Blute, ML (corresponding author), Harvard Med Sch, Dept Urol, Boston, MA 02115 USA.		Abramson, Jeremy/N-5178-2019					[Anonymous], 1954, N Engl J Med, V250, P26; Bower M, 2007, ANN INTERN MED, V147, P836, DOI 10.7326/0003-4819-147-12-200712180-00003; CASTLEMAN B, 1956, CANCER, V9, P822, DOI 10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4; Chan ACL, 2001, HISTOPATHOLOGY, V38, P510, DOI 10.1046/j.1365-2559.2001.01134.x; CHAN JKC, 1994, AM J SURG PATHOL, V18, P517, DOI 10.1097/00000478-199405000-00013; Chan JKC, 1997, CANCER, V79, P294; Chang KC, 2014, MODERN PATHOL, V27, P823, DOI 10.1038/modpathol.2013.202; Chen WC, 2006, CANCER GENET CYTOGEN, V164, P110, DOI 10.1016/j.cancergencyto.2005.06.009; Cokelaere K, 2002, AM J SURG PATHOL, V26, P662, DOI 10.1097/00000478-200205000-00013; Gerard L, 2007, J CLIN ONCOL, V25, P3350, DOI 10.1200/JCO.2007.10.6732; KELLER AR, 1972, CANCER-AM CANCER SOC, V29, P670, DOI 10.1002/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#; Lewis JJ, 1998, ANN SURG, V228, P355, DOI 10.1097/00000658-199809000-00008; Milose Jaclyn C, 2011, Open Access J Urol, V4, P1, DOI 10.2147/OAJU.S15063; Noh OK, 2013, RADIAT ONCOL J, V31, P48, DOI 10.3857/roj.2013.31.1.48; Pauwels P, 2000, AM J SURG PATHOL, V24, P882, DOI 10.1097/00000478-200006000-00016; Polizzotto MN, 2013, BLOOD, V122, P4189, DOI 10.1182/blood-2013-08-519959; Porter GA, 2006, CANCER-AM CANCER SOC, V106, P1610, DOI 10.1002/cncr.21761; Soumerai JD, 2014, CANCER CONTROL, V21, P266, DOI 10.1177/107327481402100403; Talat N, 2012, ANN SURG, V255, P677, DOI 10.1097/SLA.0b013e318249dcdc; van Rhee F, 2014, LANCET ONCOL, V15, P966, DOI 10.1016/S1470-2045(14)70319-5; van Rhee F, 2010, J CLIN ONCOL, V28, P3701, DOI 10.1200/JCO.2009.27.2377; Van Roggen J F, 2000, Sarcoma, V4, P17, DOI 10.1155/S1357714X00000049; Wang HW, 2016, SEMIN DIAGN PATHOL, V33, P294, DOI 10.1053/j.semdp.2016.05.006; YOSHIZAKI K, 1989, BLOOD, V74, P1360	24	9	9	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2017	376	7					684	692		10.1056/NEJMcpc1610100	http://dx.doi.org/10.1056/NEJMcpc1610100			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO0QJ	28199810				2022-12-28	WOS:000396402700020
J	Brook, RH				Brook, Robert H.			Should the Definition of Health Include a Measure of Tolerance?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brook, Robert H.] RAND Hlth, Santa Monica, CA 90401 USA	RAND Corporation	Brook, RH (corresponding author), RAND Hlth, Santa Monica, CA 90401 USA.	robert_brook@rand.org						Aosved AC, 2009, J APPL SOC PSYCHOL, V39, P2321, DOI 10.1111/j.1559-1816.2009.00528.x; Brook RH, 1979, MED CARE S, V17, pi; Chandra A., 2016, BUILDING NATL CULTUR, DOI 10.7249/RR1199; Mathers C. D., 2000, GLOBAL PROGRAMME EVI; Sacks Jonathan, 2015, NOT GODS NAME CONFRO	5	3	3	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2017	317	6					585	586		10.1001/jama.2016.14372	http://dx.doi.org/10.1001/jama.2016.14372			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL8LI	28196260				2022-12-28	WOS:000394870900009
J	Gokhale, V; Agarkar, S				Gokhale, Varada; Agarkar, Sumita			Persistent Pupillary Membrane	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gokhale, Varada; Agarkar, Sumita] Sankara Nethralaya, Madras, Tamil Nadu, India		Gokhale, V (corresponding author), Sankara Nethralaya, Madras, Tamil Nadu, India.	drsar@snmail.org							0	3	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2017	376	6					561	561		10.1056/NEJMicm1507964	http://dx.doi.org/10.1056/NEJMicm1507964			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ8XL	28177872				2022-12-28	WOS:000393510500010
J	Catalano, PM				Catalano, Patrick M.			Clarification of RCOG advice on obese women in pregnancy Reply	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									[Catalano, Patrick M.] Case Western Reserve Univ, Metrohlth Med Ctr, Cleveland, OH 44109 USA	Case Western Reserve University; MetroHealth System	Catalano, PM (corresponding author), Case Western Reserve Univ, Metrohlth Med Ctr, Cleveland, OH 44109 USA.	pcatalano@metrohealth.org	Catalano, Patrick/GVR-9069-2022	Shankar, Kartik/0000-0002-7964-9026	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD022965] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000080] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))			0	387	403	12	130	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2017	356								j1631	10.1136/bmj.j1631	http://dx.doi.org/10.1136/bmj.j1631			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ4EN	28179267				2022-12-28	WOS:000398027200004
J	Catalano, PM; Shankar, K				Catalano, Patrick M.; Shankar, Kartik			Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BODY-MASS INDEX; GESTATIONAL WEIGHT-GAIN; OF-MEDICINE RECOMMENDATIONS; LIFE-STYLE INTERVENTION; MATERNAL OBESITY; DENSITY-LIPOPROTEIN; METABOLIC SYNDROME; CESAREAN DELIVERY; FOLLICULAR-FLUID; AMINO-ACID	Obesity is the most common medical condition in women of reproductive age. Obesity during pregnancy has short term and long term adverse consequences for both mother and child. Obesity causes problems with infertility, and in early gestation it causes spontaneous pregnancy loss and congenital anomalies. Metabolically, obese women have increased insulin resistance in early pregnancy, which becomes manifest clinically in late gestation as glucose intolerance and fetal overgrowth. At term, the risk of cesarean delivery and wound complications is increased. Postpartum, obese women have an increased risk of venous thromboembolism, depression, and difficulty with breast feeding. Because 50-60% of overweight or obese women gain more than recommended by Institute of Medicine gestational weight guidelines, postpartum weight retention increases future cardiometabolic risks and prepregnancy obesity in subsequent pregnancies. Neonates of obese women have increased body fat at birth, which increases the risk of childhood obesity. Although there is no unifying mechanism responsible for the adverse perinatal outcomes associated with maternal obesity, on the basis of the available data, increased prepregnancy maternal insulin resistance and accompanying hyperinsulinemia, inflammation, and oxidative stress seem to contribute to early placental and fetal dysfunction. We will review the pathophysiology underlying these data and try to shed light on the specific underlying mechanisms	[Catalano, Patrick M.] MetroHlth Med Ctr, Ctr Reprod Hlth, Dept Obstet & Gynecol, Cleveland, OH USA; [Catalano, Patrick M.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Shankar, Kartik] Univ Arkansas Med Sci, Arkansas Childrens Nutr Ctr, Little Rock, AR 72205 USA; [Shankar, Kartik] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA	MetroHealth System; Case Western Reserve University; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Catalano, PM (corresponding author), MetroHlth Med Ctr, Ctr Reprod Hlth, Dept Obstet & Gynecol, Cleveland, OH USA.; Catalano, PM (corresponding author), Case Western Reserve Univ, Cleveland, OH 44106 USA.	pcatalano@metrohealth.org	Catalano, Patrick/GVR-9069-2022	Shankar, Kartik/0000-0002-7964-9026	Eunice Kennedy Shriver National Institute of Child Health and development [HD-11089-19]; USDA Agricultural Research Service CRIS [625151000-010-05S]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD022965] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000080] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); USDA Agricultural Research Service CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors are supported in part by the following grants: Eunice Kennedy Shriver National Institute of Child Health and development HD-11089-19 (PMC) and USDA Agricultural Research Service CRIS 625151000-010-05S (KS).	Alderete TL, 2015, AM J CLIN NUTR, V102, P1381, DOI 10.3945/ajcn.115.115451; Alvarez JJ, 1996, J LIPID RES, V37, P299; [Anonymous], 2015, Obstet Gynecol, V126, pe112, DOI 10.1097/AOG.0000000000001211; [Anonymous], 2015, Obstet Gynecol, V125, P1268, DOI 10.1097/01.AOG.0000465192.34779.dc; [Anonymous], 2011, Obstet Gynecol, V117, P1472, DOI 10.1097/AOG.0b013e3182238c31; [Anonymous], 2015, GLOB HLTH OBS IND ES; Aris IM, 2015, AM J CLIN NUTR, V102, P1104, DOI 10.3945/ajcn.115.117614; Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Basu S, 2011, OBESITY, V19, P476, DOI 10.1038/oby.2010.215; Bausenwein J, 2010, MOL HUM REPROD, V16, P117, DOI 10.1093/molehr/gap078; Bellver J, 2013, FERTIL STERIL, V100, P1050, DOI 10.1016/j.fertnstert.2013.06.001; Bellver J, 2011, FERTIL STERIL, V95, P2335, DOI 10.1016/j.fertnstert.2011.03.021; Blumfield M, 2012, NUTRIENTS, V4, P1958, DOI 10.3390/nu4121958; Bodnar LM, 2010, AM J CLIN NUTR, V91, P1642, DOI 10.3945/ajcn.2009.29008; Bogaerts A, 2013, OBSTET GYNECOL, V122, P999, DOI 10.1097/AOG.0b013e3182a7f63e; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Boots CE, 2014, FERTIL STERIL, V102, P455, DOI 10.1016/j.fertnstert.2014.05.005; Brass E, 2013, PLACENTA, V34, P503, DOI 10.1016/j.placenta.2013.03.009; Brite J, 2014, INT J OBESITY, V38, P878, DOI 10.1038/ijo.2013.244; Calabuig-Navarro V, 2016, AM J CLIN NUTR, V103, P1064, DOI 10.3945/ajcn.115.124651; Collado MC, 2012, PEDIATR RES, V72, P77, DOI 10.1038/pr.2012.42; Catalano P, 2015, SOC REPR INV 62 ANN; Catalano PM, 2007, OBSTET GYNECOL, V109, P419, DOI 10.1097/01.AOG.0000253311.44696.85; Catalano PM, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.02.004; Catalano PM, 2012, DIABETES CARE, V35, P780, DOI 10.2337/dc11-1790; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; Catalano PM, 1999, AM J OBSTET GYNECOL, V180, P903, DOI 10.1016/S0002-9378(99)70662-9; CATALANO PM, 1993, AM J PHYSIOL, V264, pE60, DOI 10.1152/ajpendo.1993.264.1.E60; CATALANO PM, 1992, OBSTET GYNECOL, V79, P46; Catalano PM, 2016, OBSTET NORM IN PRESS, P900; Centre for Maternal and Child Enquiries; Royal College of Obstetricians and Gynaecologists, 2010, MAN WOM OB PREGN CMA; Challier JC, 2008, PLACENTA, V29, P274, DOI 10.1016/j.placenta.2007.12.010; Chandler-Laney PC, 2011, DIABETES CARE, V34, P741, DOI 10.2337/dc10-1503; Chen YH, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.09.006; Chu SY, 2007, OBES REV, V8, P385, DOI 10.1111/j.1467-789X.2007.00397.x; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Colleran HL, 2012, J ACAD NUTR DIET, V112, P553, DOI 10.1016/j.jand.2011.12.004; Correa A, 2013, NUTR REV, V71, pS68, DOI 10.1111/nure.12058; Coyne K, 2016, INT J OBESITY, V40, P171, DOI 10.1038/ijo.2015.159; Crume TL, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.06.035; Crume TL, 2015, J CLIN ENDOCR METAB, V100, P1672, DOI 10.1210/jc.2014-2949; Danielsen I, 2014, OBESITY, V22, P1351, DOI 10.1002/oby.20650; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Diaz P, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121798; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; Ditchfield AM, 2015, INT J OBESITY, V39, P557, DOI 10.1038/ijo.2014.212; Dodd JM, 2010, BJOG-INT J OBSTET GY, V117, P1316, DOI 10.1111/j.1471-0528.2010.02540.x; Dodd JM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1285; Dolinoy DC, 2007, PEDIATR RES, V61, p30R, DOI 10.1203/pdr.0b013e31804575f7; Donahue SMA, 2011, AM J CLIN NUTR, V93, P780, DOI 10.3945/ajcn.110.005801; Dresner M, 2006, BJOG-INT J OBSTET GY, V113, P1178, DOI 10.1111/j.1471-0528.2006.01048.x; Dube E, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.098095; Duhl AJ, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.022; Ehrlich SF, 2011, OBSTET GYNECOL, V117, P1323, DOI 10.1097/AOG.0b013e31821aa358; El Hajj N, 2013, DIABETES, V62, P1320, DOI 10.2337/db12-0289; FAHRAEUS L, 1985, OBSTET GYNECOL, V66, P468; Farah N, 2012, CYTOKINE, V60, P96, DOI 10.1016/j.cyto.2012.05.024; Farley DM, 2010, PLACENTA, V31, P718, DOI 10.1016/j.placenta.2010.06.006; Faucett AM, 2016, AM J PERINAT, V33, P991, DOI 10.1055/s-0036-1580609; Fernandez-Barres S, 2016, PEDIATR OBES, V11, P491, DOI 10.1111/ijpo.12092; Fields DA, 2012, PEDIATR OBES, V7, P304, DOI 10.1111/j.2047-6310.2012.00059.x; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fraser A, 2011, AM J CLIN NUTR, V93, P1285, DOI 10.3945/ajcn.110.008326; Friis CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057467; Friis CM, 2013, OBESITY, V21, pE124, DOI 10.1002/oby.20120; Gaillard R, 2016, OBESITY, V24, P1320, DOI 10.1002/oby.21484; Gauster M, 2011, DIABETES, V60, P2457, DOI 10.2337/db10-1434; Gemma C, 2009, OBESITY, V17, P1032, DOI 10.1038/oby.2008.605; Getahun D, 2007, AM J OBSTET GYNECOL, V196, P530, DOI 10.1016/j.ajog.2006.12.036; Glazer NL, 2004, EPIDEMIOLOGY, V15, P733, DOI 10.1097/01.ede.0000142151.16880.03; Godfrey KM, 2017, LANCET DIABETES ENDO, V5, P53, DOI 10.1016/S2213-8587(16)30107-3; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Guenard F, 2013, P NATL ACAD SCI USA, V110, P11439, DOI 10.1073/pnas.1216959110; Gunderson Erica P, 2009, Obstet Gynecol Clin North Am, V36, P317, DOI 10.1016/j.ogc.2009.04.001; Gunderson EP, 2015, ANN INTERN MED, V163, P889, DOI 10.7326/M15-0807; Hadiati DR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007462.pub3; Han SS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009021.pub2; Harmon KA, 2011, DIABETES CARE, V34, P2198, DOI 10.2337/dc11-0723; Hibbard JU, 2006, OBSTET GYNECOL, V108, P125, DOI 10.1097/01.AOG.0000223871.69852.31; Hull HR, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.796; Huypens P, 2016, NAT GENET, V48, P497, DOI 10.1038/ng.3527; Jain AP, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.018; Jansson N, 2013, J CLIN ENDOCR METAB, V98, P105, DOI 10.1210/jc.2012-2667; JONES CJP, 1993, AM J REPROD IMMUNOL, V30, P136, DOI 10.1111/j.1600-0897.1993.tb00614.x; Juhasz G, 2005, OBSTET GYNECOL, V106, P741, DOI 10.1097/01.AOG.0000177972.32941.65; Jungheim ES, 2011, FERTIL STERIL, V95, P1970, DOI 10.1016/j.fertnstert.2011.01.154; Kanungo J, 2011, OBSTET GYNECOL, V118, P872, DOI [10.1097/AOG.0b013e31822add60, 10.1097/AOG.0b013e3182310c4c]; Kapadia MZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132650; Kiel DW, 2007, OBSTET GYNECOL, V110, P752, DOI 10.1097/01.AOG.0000278819.17190.87; Kirkegaard H, 2014, AM J CLIN NUTR, V99, P312, DOI 10.3945/ajcn.113.067405; Kirwan JP, 2002, DIABETES, V51, P2207, DOI 10.2337/diabetes.51.7.2207; Knudsen VK, 2008, EUR J CLIN NUTR, V62, P463, DOI 10.1038/sj.ejcn.1602745; Knudsen VK, 2013, BRIT J NUTR, V109, P1471, DOI 10.1017/S0007114512003443; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; La Vignera S, 2011, EUR REV MED PHARMACO, V15, P267; Larsen TB, 2007, THROMB RES, V120, P505, DOI 10.1016/j.thromres.2006.12.003; Lassance L, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.02.026; Lassance L, 2015, J CLIN ENDOCR METAB, V100, pE11, DOI 10.1210/jc.2014-2792; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; Leermakers ETM, 2017, CLIN NUTR, V36, P477, DOI 10.1016/j.clnu.2015.12.017; Lemas DJ, 2015, INT J OBESITY, V39, P1437, DOI 10.1038/ijo.2015.109; Lemas DJ, 2016, AM J CLIN NUTR, V103, P1291, DOI 10.3945/ajcn.115.126375; Lindholm ES, 2013, PROSTAG LEUKOTR ESS, V88, P211, DOI 10.1016/j.plefa.2012.11.007; Lindsay CA, 1997, OBSTET GYNECOL, V89, P377, DOI 10.1016/S0029-7844(96)00517-0; Lipsky LM, 2016, MATERN CHILD NUTR, V12, P569, DOI 10.1111/mcn.12149; Lovelady CA, 2000, NEW ENGL J MED, V342, P449, DOI 10.1056/NEJM200002173420701; Ludwig DS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001521; Luke B, 2011, HUM REPROD, V26, P245, DOI 10.1093/humrep/deq306; Mackeen AD, 2012, COCHRANE DB SYST REV, V11, DOI [10.1002/14651858.CD0033577, DOI 10.1002/14651858.CD0033577]; Magkos F, 2016, CELL METAB, V23, P591, DOI 10.1016/j.cmet.2016.02.005; Makgoba M, 2012, BJOG-INT J OBSTET GY, V119, P276, DOI 10.1111/j.1471-0528.2011.03156.x; Mamun AA, 2009, CIRCULATION, V119, P1720, DOI 10.1161/CIRCULATIONAHA.108.813436; Maslova E, 2016, CLIN NUTR, V35, P475, DOI 10.1016/j.clnu.2015.03.018; Metwally M, 2008, FERTIL STERIL, V90, P714, DOI 10.1016/j.fertnstert.2007.07.1290; Mhyre JM, 2007, INT ANESTHESIOL CLIN, V45, P51, DOI 10.1097/AIA.0b013e31802b8a90; Michels KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025254; Moon RJ, 2013, J CLIN ENDOCR METAB, V98, P299, DOI 10.1210/jc.2012-2482; Mostello D, 2010, OBSTET GYNECOL, V116, P667, DOI 10.1097/AOG.0b013e3181ed74ea; Muktabhant B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007145.pub3; Nascimento SL, 2014, INT J OBESITY, V38, P626, DOI 10.1038/ijo.2013.183; NAUMANN RW, 1995, OBSTET GYNECOL, V85, P412, DOI 10.1016/0029-7844(94)00427-F; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; Nuthalapaty FS, 2004, OBSTET GYNECOL, V103, P452; O'Tierney-Ginn P, 2015, J CLIN ENDOCR METAB, V100, P159, DOI 10.1210/jc.2014-3281; O'Tierney-Ginn P, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.031; O'Toole ML, 2003, J WOMENS HEALTH, V12, P991, DOI 10.1089/154099903322643910; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Oken E, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.027; Oken E, 2009, AM J EPIDEMIOL, V170, P173, DOI 10.1093/aje/kwp101; Phelan S, 2014, AM J CLIN NUTR, V99, P302, DOI 10.3945/ajcn.113.070151; Poston L, 2015, LANCET DIABETES ENDO, V3, P767, DOI 10.1016/S2213-8587(15)00227-2; Quinlivan JA, 2011, OBSTET GYNECOL, V118, P1395, DOI 10.1097/AOG.0b013e3182396bc6; Radaelli T, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.019; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Renault KM, 2015, AM J CLIN NUTR, V102, P1475, DOI 10.3945/ajcn.115.110551; Renault KM, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.029; Reynolds RM, 2010, J CLIN ENDOCR METAB, V95, P5365, DOI 10.1210/jc.2010-0697; Roberts VHJ, 2009, PLACENTA, V30, P169, DOI 10.1016/j.placenta.2008.11.019; Rodriguez-Bernal CL, 2010, AM J CLIN NUTR, V91, P1659, DOI 10.3945/ajcn.2009.28866; Rohrer F, 1921, MUNCHEN MED WOCHEN, V68, P580; Rono K, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-70; Rudolph MC, 2017, INT J OBESITY, V41, P510, DOI 10.1038/ijo.2016.211; RYAN EA, 1985, DIABETES, V34, P380, DOI 10.2337/diabetes.34.4.380; Ryckman KK, 2016, AJP REP, V6, pE329, DOI 10.1055/s-0036-1592414; Saben J, 2014, PLACENTA, V35, P171, DOI 10.1016/j.placenta.2014.01.003; Saben JL, 2016, CELL REP, V16, P1, DOI 10.1016/j.celrep.2016.05.065; Sagedal LR, 2017, BJOG-INT J OBSTET GY, V124, P97, DOI 10.1111/1471-0528.13862; Santoro N, 2004, J CLIN ENDOCR METAB, V89, P2622, DOI 10.1210/jc.2003-031578; Sattar N, 1998, INT J OBESITY, V22, P432, DOI 10.1038/sj.ijo.0800604; Scifres CM, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.038; Scifres CM, 2011, J CLIN ENDOCR METAB, V96, pE1083, DOI 10.1210/jc.2010-2084; Sewell MF, 2006, AM J OBSTET GYNECOL, V195, P1100, DOI 10.1016/j.ajog.2006.06.014; Shankar K, 2011, ENDOCRINOLOGY, V152, P4158, DOI 10.1210/en.2010-1078; Shapiro ALB, 2016, INT J OBESITY, V40, P1056, DOI 10.1038/ijo.2016.79; Sohlberg S, 2012, AM J HYPERTENS, V25, P120, DOI 10.1038/ajh.2011.175; Soubry A, 2015, INT J OBESITY, V39, P650, DOI 10.1038/ijo.2013.193; Starling AP, 2015, AM J CLIN NUTR, V101, P302, DOI 10.3945/ajcn.114.094946; Stendell-Hollis NR, 2013, J WOMENS HEALTH, V22, P48, DOI 10.1089/jwh.2012.3707; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Streuling I, 2011, BJOG-INT J OBSTET GY, V118, P278, DOI 10.1111/j.1471-0528.2010.02801.x; Tanentsapf Ida, 2011, BMC Pregnancy Childbirth, V11, P81, DOI 10.1186/1471-2393-11-81; Thakali KM, 2014, PEDIATR RES, V76, P202, DOI 10.1038/pr.2014.72; Thangaratinam S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2088; Thangaratinam S, 2010, BJOG-INT J OBSTET GY, V117, P1309, DOI 10.1111/j.1471-0528.2010.02670.x; Thomas DM, 2012, AM J CLIN NUTR, V95, P115, DOI 10.3945/ajcn.111.024307; Tielemans MJ, 2016, AM J CLIN NUTR, V103, P83, DOI 10.3945/ajcn.115.110742; Tsyvian PB, 2015, J DEV ORIG HLTH DIS, V6, P278, DOI 10.1017/S2040174415001117; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Valckx SDM, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-13; van den Broek M, 2015, AM J CLIN NUTR, V102, P873, DOI 10.3945/ajcn.114.102905; Verdam FJ, 2013, OBESITY, V21, pE607, DOI 10.1002/oby.20466; Vinter CA, 2011, DIABETES CARE, V34, P2502, DOI 10.2337/dc11-1150; von Ungern-Sternberg BS, 2004, ANAESTHESIA, V59, P743, DOI 10.1111/j.1365-2044.2004.03832.x; Vricella LK, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.085; Wallace JM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-40; Walsh Jennifer M, 2012, BMJ, V345, pe5605, DOI 10.1136/bmj.e5605; Walter JR, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.012; Waterland RA, 2014, ANNU REV NUTR, V34, P337, DOI 10.1146/annurev-nutr-071813-105315; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Waters TP, 2012, J CLIN ENDOCR METAB, V97, P3648, DOI 10.1210/jc.2012-1781; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Whitaker RC, 2004, PEDIATRICS, V114, pE29, DOI 10.1542/peds.114.1.e29; WHO, 2013, DAT STAT CHALL OB QU; Wloch C, 2012, BJOG-INT J OBSTET GY, V119, P1324, DOI 10.1111/j.1471-0528.2012.03452.x; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; Yin J, 2012, EUR J CLIN NUTR, V66, P1329, DOI 10.1038/ejcn.2012.122; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627	193	387	403	12	130	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2017	356								j1	10.1136/bmj.j1	http://dx.doi.org/10.1136/bmj.j1			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL4FX	28179267	Green Published			2022-12-28	WOS:000394578200002
